Skyward/2024/FY/Annual report: Difference between revisions
Index sections (topic tags) |
doc_archive: publish vycbjm4dw4 |
||
| Line 9: | Line 9: | ||
| publication_date = 2025-03-03 |
| publication_date = 2025-03-03 |
||
| language = English |
| language = English |
||
| pages = 24 |
|||
| source_url = https://www.sec.gov/Archives/edgar/data/1519449/000151944925000011/0001519449-25-000011-index.htm |
| source_url = https://www.sec.gov/Archives/edgar/data/1519449/000151944925000011/0001519449-25-000011-index.htm |
||
| |
| summary_md = <!-- ARCHIVE_MD_LINK_HERE --> |
||
| intro_sentence = This article |
| intro_sentence = This article summarizes Skyward's Annual report published on 2025-03-03 (24 pages). |
||
| wide = yes |
|||
| document = Document:Skyward/2024/FY/Annual report |
|||
| doc_id = vycbjm4dw4 |
|||
}} |
}} |
||
''This article |
''This article summarizes Skyward's Annual report published on 2025-03-03 (24 pages).'' |
||
== Cover == |
|||
{{Indexing|Cover||kind=table|order=1}} |
|||
{{chunk|doc=vycbjm4dw4|c=1|p=1}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable" |
{| id="t1" class="wikitable" |
||
|+ Cover |
|||
|- |
|||
! style="text-align:left" | USD ($) |
! style="text-align:left" | USD ($) |
||
! style="text-align: |
! style="text-align:left" | 12 Months Ended |
||
! style="text-align: |
! style="text-align:right" | |
||
! style="text-align: |
! style="text-align:right" | |
||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
! style="text-align:left" | Dec. 31, 2024 |
! style="text-align:left" | Dec. 31, 2024 |
||
! |
! style="text-align:right" | Feb. 26, 2025 |
||
! |
! style="text-align:right" | Jun. 30, 2024 |
||
|- |
|- |
||
| style="text-align:left" | Cover [Abstract] |
| style="text-align:left" | Cover [Abstract] |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Document Type |
| style="text-align:left" | Document Type |
||
| style="text-align:left" | 10-K |
| style="text-align:left" | 10-K |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Document Annual Report |
| style="text-align:left" | Document Annual Report |
||
| style="text-align:left" | true |
| style="text-align:left" | true |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Document Period End Date |
| style="text-align:left" | Document Period End Date |
||
| style="text-align:left" | Dec. 31, 2024 |
| style="text-align:left" | Dec. 31, 2024 |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Current Fiscal Year End Date |
| style="text-align:left" | Current Fiscal Year End Date |
||
| style="text-align:left" | --12-31 |
| style="text-align:left" | --12-31 |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Document Transition Report |
| style="text-align:left" | Document Transition Report |
||
| style="text-align:left" | false |
| style="text-align:left" | false |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Entity File Number |
| style="text-align:left" | Entity File Number |
||
| style="text-align:left" | 001-41591 |
| style="text-align:left" | 001-41591 |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Entity Registrant Name |
| style="text-align:left" | Entity Registrant Name |
||
| style="text-align:left" | SKYWARD SPECIALTY INSURANCE GROUP, INC. |
| style="text-align:left" | SKYWARD SPECIALTY INSURANCE GROUP, INC. |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Entity Incorporation, State or Country Code |
| style="text-align:left" | Entity Incorporation, State or Country Code |
||
| style="text-align:left" | DE |
| style="text-align:left" | DE |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Entity Tax Identification Number |
| style="text-align:left" | Entity Tax Identification Number |
||
| style="text-align:left" | 14-1957288 |
| style="text-align:left" | 14-1957288 |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Entity Address, Address Line One |
| style="text-align:left" | Entity Address, Address Line One |
||
| style="text-align:left" | 800 Gessner Road |
| style="text-align:left" | 800 Gessner Road |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Entity Address, Address Line Two |
| style="text-align:left" | Entity Address, Address Line Two |
||
| style="text-align:left" | Suite 600 |
| style="text-align:left" | Suite 600 |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Entity Address, City or Town |
| style="text-align:left" | Entity Address, City or Town |
||
| style="text-align:left" | Houston |
| style="text-align:left" | Houston |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Entity Address, State or Province |
| style="text-align:left" | Entity Address, State or Province |
||
| style="text-align:left" | TX |
| style="text-align:left" | TX |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Entity Address, Postal Zip Code |
| style="text-align:left" | Entity Address, Postal Zip Code |
||
| style="text-align:left" | 77024-4284 |
| style="text-align:left" | 77024-4284 |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | City Area Code |
| style="text-align:left" | City Area Code |
||
| style="text-align:left" | 713 |
| style="text-align:left" | 713 |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Local Phone Number |
| style="text-align:left" | Local Phone Number |
||
| style="text-align:left" | 935-4800 |
| style="text-align:left" | 935-4800 |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Title of 12(b) Security |
| style="text-align:left" | Title of 12(b) Security |
||
| style="text-align:left" | Common stock, par value $0.01 |
| style="text-align:left" | Common stock, par value $0.01 |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Trading Symbol |
| style="text-align:left" | Trading Symbol |
||
| style="text-align:left" | SKWD |
| style="text-align:left" | SKWD |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Security Exchange Name |
| style="text-align:left" | Security Exchange Name |
||
| style="text-align:left" | NASDAQ |
| style="text-align:left" | NASDAQ |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Entity Well-known Seasoned Issuer |
| style="text-align:left" | Entity Well-known Seasoned Issuer |
||
| style="text-align:left" | No |
| style="text-align:left" | No |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Entity Voluntary Filers |
| style="text-align:left" | Entity Voluntary Filers |
||
| style="text-align:left" | No |
| style="text-align:left" | No |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Entity Current Reporting Status |
| style="text-align:left" | Entity Current Reporting Status |
||
| style="text-align:left" | No |
| style="text-align:left" | No |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Entity Interactive Data Current |
| style="text-align:left" | Entity Interactive Data Current |
||
| style="text-align:left" | Yes |
| style="text-align:left" | Yes |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Entity Filer Category |
| style="text-align:left" | Entity Filer Category |
||
| style="text-align:left" | Large Accelerated Filer |
| style="text-align:left" | Large Accelerated Filer |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Entity Small Business |
| style="text-align:left" | Entity Small Business |
||
| style="text-align:left" | false |
| style="text-align:left" | false |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Entity Emerging Growth Company |
| style="text-align:left" | Entity Emerging Growth Company |
||
| style="text-align:left" | false |
| style="text-align:left" | false |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | ICFR Auditor Attestation Flag |
| style="text-align:left" | ICFR Auditor Attestation Flag |
||
| style="text-align:left" | true |
| style="text-align:left" | true |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Document Financial Statement Error Correction [Flag] |
| style="text-align:left" | Document Financial Statement Error Correction [Flag] |
||
| style="text-align:left" | false |
| style="text-align:left" | false |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Entity Shell Company |
| style="text-align:left" | Entity Shell Company |
||
| style="text-align:left" | false |
| style="text-align:left" | false |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Entity Public Float |
| style="text-align:left" | Entity Public Float |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | 1,333,367,336 |
||
|- |
|- |
||
| style="text-align:left" | Entity Common Stock, Shares Outstanding |
| style="text-align:left" | Entity Common Stock, Shares Outstanding |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| |
| style="text-align:right" | 40,127,908 |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Documents Incorporated by Reference |
| style="text-align:left" | Documents Incorporated by Reference |
||
| style="text-align:left" | Portions of the Registrant’s Proxy Statement relating to the 2025 annual meeting of stockholders (the “2025 Proxy Statement”), which will be filed within 120 days of December 31, 2024, are incorporated by reference into Part III of this Form 10-K. |
| style="text-align:left" | Portions of the Registrant’s Proxy Statement relating to the 2025 annual meeting of stockholders (the “2025 Proxy Statement”), which will be filed within 120 days of December 31, 2024, are incorporated by reference into Part III of this Form 10-K. |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Entity Central Index Key |
| style="text-align:left" | Entity Central Index Key |
||
| style="text-align:left" | 0001519449 |
| style="text-align:left" | 0001519449 |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Amendment Flag |
| style="text-align:left" | Amendment Flag |
||
| style="text-align:left" | false |
| style="text-align:left" | false |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Document Fiscal Year Focus |
| style="text-align:left" | Document Fiscal Year Focus |
||
| style="text-align:left" | 2024 |
| style="text-align:left" | 2024 |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Document Fiscal Period Focus |
| style="text-align:left" | Document Fiscal Period Focus |
||
| style="text-align:left" | FY |
| style="text-align:left" | FY |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|} |
|} |
||
</div> |
</div> |
||
== Audit Information == |
|||
{{Indexing|Audit Information|Auditor name, auditor location, auditor firm ID|x856lnzuq2|kind=table|order=2}} |
|||
{{chunk|doc=vycbjm4dw4|c=2|p=2}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable" |
{| id="t2" class="wikitable" |
||
|+ Auditor name, location, and firm ID by 12 months ended |
|||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! style="text-align: |
! style="text-align:right" | 12 Months Ended |
||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
! |
! style="text-align:right" | Dec. 31, 2024 |
||
|- |
|- |
||
| style="text-align:left" | Audit Information [Abstract] |
| style="text-align:left" | Audit Information [Abstract] |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Auditor Name |
| style="text-align:left" | Auditor Name |
||
| |
| style="text-align:right" | Ernst & Young LLP |
||
|- |
|- |
||
| style="text-align:left" | Auditor Location |
| style="text-align:left" | Auditor Location |
||
| |
| style="text-align:right" | Houston, Texas |
||
|- |
|- |
||
| style="text-align:left" | Auditor Firm ID |
| style="text-align:left" | Auditor Firm ID |
||
| |
| style="text-align:right" | 42 |
||
|} |
|} |
||
</div> |
</div> |
||
| Line 243: | Line 255: | ||
== Business == |
== Business == |
||
=== Who We Are === |
|||
{{Indexing|Who We Are|Skyward Specialty, commercial P&C products, non-admitted (E&S) and admitted basis, general liability, excess liability, professional liability, cyber, media liability, commercial auto, group accident and health, property, agriculture, credit, surety, workers’ compensation, specialty reinsurance|4cr8sbi842|2ku0sqq9xf|lht8rybaqk|kind=prose|order=3|f1=Year founded|v1=2006|f2=Former name(s)|v2=Houston International Insurance Group, Ltd.|f3=Primary segments|v3=commercial property and casualty (P&C)|f4=Principal lines|v4=general liability, excess liability, professional liability, commercial auto, group accident and health, property, agriculture, credit, surety, and workers’ compensation}} |
|||
{{chunk|doc=vycbjm4dw4|c=3|p=8}} |
|||
'''Company formation and business overview''' |
|||
* Skyward Specialty was formed as a Delaware corporation on January 3, 2006, as an insurance holding company. |
|||
* The company operated under the name Houston International Insurance Group, Ltd. until rebranding as Skyward Specialty in November 2020. |
|||
* Skyward Specialty is a growing specialty insurance company delivering commercial [[Definition:Property & casualty|property and casualty]] ([[Definition:Property & casualty|P&C]]) products and solutions on a non-admitted (E&S) and admitted basis, predominantly in the United States. |
|||
* The business focuses on underserved, dislocated, and/or markets where standard insurance coverages are insufficient. |
|||
* Customers typically require highly specialized, customized underwriting solutions and claims capabilities. |
|||
* The company develops and delivers tailored insurance products and services for niche markets. |
|||
{{chunk|doc=vycbjm4dw4|c=4|p=8}} |
|||
'''Diversified portfolio and strategy''' |
|||
* The portfolio of insured risks is highly diversified across industries, distribution channels, and [[Definition:Business mix|lines of business]]. |
|||
* [[Definition:Business mix|Lines of business]] include general liability, excess liability, professional liability (including cyber and media liability insurance), commercial auto, group accident and health, property, agriculture, credit, surety, and workers’ compensation. |
|||
* The company insures both short and medium duration liabilities. |
|||
* The [[Definition:Business mix|business mix]] is principally primary insurance and balanced between E&S and admitted markets. |
|||
* A small portion of the business is specialty reinsurance (principally agriculture and credit), focused on attractive specialty classes where approaching through reinsurance is more efficient due to factors like cost of entry and geographic expansion costs. |
|||
* This diversification, including businesses not typically aligned with traditional [[Definition:Property & casualty|P&C]] pricing cycles, combined with underwriting and claims expertise, is expected to consistently produce strong growth and profitability across all insurance pricing cycles. |
|||
{{chunk|doc=vycbjm4dw4|c=5|p=8}} |
|||
'''Leadership and competitive advantages''' |
|||
* The company is led by an entrepreneurial executive management team with decades of insurance leadership experience in the global [[Definition:Property & casualty|P&C]] industry. |
|||
* Leadership is supported by an experienced team with a broad skill set aligned with the company's strategy. |
|||
* High-quality leadership, underwriting and claims teams, technology DNA, advanced analytics capabilities, diversified book of business, and strong competitive position in chosen market niches are expected to enable continued profitable business growth. |
|||
* The aim is to deliver long-term value for shareholders by generating best-in-class underwriting profitability and book value per share growth across [[Definition:Property & casualty|P&C]] market cycles. |
|||
{{chunk|doc=vycbjm4dw4|c=6|p=8}} |
|||
'''Financial strength ratings''' |
|||
* All insurance company subsidiaries are group rated. |
|||
* Subsidiaries have financial strength ratings of "A" (Excellent) from A.M. Best Company ("A.M. Best") with a stable outlook. |
|||
=== Our Business and Our Strategy === |
|||
{{chunk|doc=vycbjm4dw4|c=7|p=8}} |
|||
'''Reportable segment and underwriting divisions overview''' |
|||
* One reportable segment offers a broad array of insurance coverages to various market niches. |
|||
* Eight distinct underwriting divisions exist, each with dedicated underwriting leadership and technical staff. |
|||
* This structure and expertise aim to serve customer needs, be a value-add partner to distributors, and earn attractive risk-adjusted returns. |
|||
* For the year ended December 31, 2024, 44% of [[Definition:Gross written premiums|gross written premiums]] were on an admitted basis and 56% were non-admitted. |
|||
{{chunk|doc=vycbjm4dw4|c=8|p=8}} |
|||
'''Accident & Health underwriting division''' |
|||
* The Accident & Health (A&H) underwriting division provides medical stop loss to employers who self-insure employee benefits, and covers group and single-employer captives. |
|||
* The approach for managing medical costs and claims oversight enables partnerships with select distribution partners. |
|||
* It targets small and medium-sized enterprise market segments seeking to control healthcare costs by self-insuring a portion of their healthcare insurance. |
|||
* Products are written on an admitted basis and distributed primarily through retail and wholesale broker partners. |
|||
{{chunk|doc=vycbjm4dw4|c=9|p=8}} |
|||
'''Captives underwriting division''' |
|||
* The Captives underwriting division provides group captive solutions by leveraging underwriting and claims expertise from other divisions. |
|||
* This allows for broadening market reach and writing profitable business with limited additional expense. |
|||
* The division writes property, general liability, commercial auto, excess liability, and workers’ compensation [[Definition:Business mix|lines of business]] on an E&S and admitted basis. |
|||
* Business is often administered through partnerships with third-party captive managers. |
|||
{{chunk|doc=vycbjm4dw4|c=10|p=8}} |
|||
'''Global Property and Agriculture underwriting division''' |
|||
* The Global Property underwriting unit provides property-only solutions to large multi-jurisdictional entities with complex property exposures. |
|||
* This business is written entirely on an E&S basis and distributed through retail and select wholesale brokers. |
|||
* The Global Agriculture underwriting unit provides secondary and reinsurance solutions for crop, livestock, and other renewable resources. |
|||
{{chunk|doc=vycbjm4dw4|c=11|p=8}} |
|||
'''Industry Solutions underwriting division''' |
|||
* The Industry Solutions underwriting division includes three units: construction, energy, and inland marine. |
|||
* Construction and energy units provide general liability, excess liability, commercial auto, workers’ compensation, and adjacent inland marine solutions. |
|||
* These are written principally on an admitted basis for middle market construction and energy production/servicing customers, including alternative/renewable energy. |
|||
* The inland marine unit focuses on logistics and other specialty property risk for assets in transit. |
|||
* Industry segments often have high severity exposures, addressed with multi-line solutions by skilled underwriters and claims professionals. |
|||
* Products are distributed through retail agents and brokers and a select network of wholesalers. |
|||
{{chunk|doc=vycbjm4dw4|c=12|p=8}} |
|||
'''Professional Lines underwriting division''' |
|||
* The Professional Lines underwriting division includes three units: management liability, professional liability (including cyber and media liability), and allied health (including life sciences). |
|||
* Professional liability and allied health provide primary and excess claims-made liability products. |
|||
* These are offered on an E&S and admitted basis, distributed through wholesale and retail brokers depending on the product. |
|||
{{chunk|doc=vycbjm4dw4|c=13|p=8}} |
|||
'''Programs underwriting division''' |
|||
* The Programs underwriting division partners with program administrators focused on specific markets aligned with the company's expertise and strategy. |
|||
* Partnering with program administrators is considered optimal for profitable participation or market reach, especially when administrators have competitive advantages like scale or proprietary technology. |
|||
* The division writes property, general liability, commercial auto liability, excess liability, and workers’ compensation [[Definition:Business mix|lines of business]] on an E&S and admitted basis. |
|||
{{chunk|doc=vycbjm4dw4|c=14|p=8}} |
|||
'''Surety underwriting division''' |
|||
* The Surety underwriting division provides contract, commercial, and transactional surety solutions for trade and services organizations requiring bonding. |
|||
* It primarily focuses on small to medium-sized enterprises with aggregate bond programs up to approximately USD 75.0m for contract and USD 100.0m for commercial and transactional. |
|||
* This business is written on an admitted basis and distributed through retail agents and brokers. |
|||
{{chunk|doc=vycbjm4dw4|c=15|p=8}} |
|||
'''Transactional E&S underwriting division''' |
|||
* The Transactional E&S underwriting division provides primary and excess non-catastrophe prone property and general liability solutions. |
|||
* It emphasizes risks considered hard to place due to complexity, loss history, or limited operating history (e.g., start-ups). |
|||
* Success in this market is determined by technical underwriting, thoughtful coverage provisions, pricing, and high-quality broker service. |
|||
* The market is accessed exclusively through wholesale brokers. |
|||
{{chunk|doc=vycbjm4dw4|c=16|p=8}} |
|||
'''Exited business''' |
|||
* [[Definition:Business mix|Business units]] and [[Definition:Business mix|lines of business]] previously exited and placed into run-off are referred to as "exited business". |
|||
{{chunk|doc=vycbjm4dw4|c=17|p=8}} |
|||
'''Strategy and "Rule Our Niche"''' |
|||
* The company seeks to lead in chosen market niches and establish sustainable competitive positions. |
|||
* The strategy, referred to as "Rule Our Niche," is underpinned by five key elements. |
|||
* The first element is providing differentiated products, services, and solutions that meet the unique needs of target markets. |
|||
* The second element is attracting and retaining exceptional underwriting and claims talent and incentivizing professionals aligned with organizational and corporate goals. |
|||
* The third element is amplifying expertise with advanced technology and analytics for superior risk selection, pricing, and claims management. |
|||
* The fourth element is empowering underwriting and claims teams with considerable authority for decision-making and expertise application. |
|||
* The fifth element is fostering a culture that promotes nimbleness and responsiveness to market opportunities and dislocation. |
|||
* This strategy forms the basis for building a strong defensible market position, creating a competitive moat, and winning in chosen markets. |
|||
* The principles of this strategy are believed to be key to achieving and sustaining best-in-class underwriting results through [[Definition:Property & casualty|P&C]] insurance pricing cycles. |
|||
* The company consistently strives for excellence in risk selection, pricing, and claims outcomes, amplified by advanced technology and analytics. |
|||
=== Our Competitive Strengths === |
|||
{{chunk|doc=vycbjm4dw4|c=18|p=8}} |
|||
'''Competitive strengths overview''' |
|||
* Competitive strengths include focus on profitable niches, highly skilled underwriters, superior claims staff, superior business intelligence platform, advanced technology, diversified business, attractive culture, and experienced leadership. |
|||
{{chunk|doc=vycbjm4dw4|c=19|p=8}} |
|||
'''Profitable niches and underwriting''' |
|||
* Focus on profitable niches of the market that require technical underwriting and claims management as barriers to entry. |
|||
* Niche areas of commercial lines [[Definition:Property & casualty|P&C]] markets are an attractive subset of the [[Definition:Property & casualty|P&C]] insurance market, offering opportunities for attractive risk-adjusted returns. |
|||
* Actively targets underserved, dislocated, or markets where standard products are insufficient. |
|||
* Risks within core markets require efficient, individual underwriting to generate acceptable, sustainable underwriting profit. |
|||
* Underwriting divisions are built around deeply experienced underwriters empowered with appropriate authority to make decisions. |
|||
* This structure enables offering innovative and unique products and solutions to distribution partners and customers, regardless of risk complexity. |
|||
* Underwriters' experience is augmented with data and predictive analytics to differentiate risk selection and pricing decisions while enhancing efficiency. |
|||
* Focus on hiring underwriting and technical staff whose expertise and experience differentiate the company. |
|||
* Underwriting teams are knowledgeable, experienced, and empowered, which is critical for success in markets with risks difficult to automate. |
|||
* Professionals are given freedom to use expertise and judgment in evaluating and pricing risks, rather than strict underwriting rules. |
|||
{{chunk|doc=vycbjm4dw4|c=20|p=8}} |
|||
'''Claims staff and operations''' |
|||
* Cultivated a best-in-class and highly specialized team of claims professionals knowledgeable about the niches and [[Definition:Business mix|lines of business]] served. |
|||
* Claims professionals systematically address first-party claims with fair and equitable solutions and third-party claims with holistic and comprehensive responses. |
|||
* Aims to ensure consistent and early loss recognition of indemnity and loss adjustment expenses (LAE). |
|||
* Responds quickly to claims with specialized adjusters equipped with expertise, advanced technology, and analytics. |
|||
* Technology is deeply embedded in the claims process, leveraging a technology-enabled platform and tools from first notice of loss to investigation to settlement. |
|||
* Analytics capabilities provide senior leadership and claims teams with real-time, detailed information on open claims and benchmarks against closed claims. |
|||
* Industry expertise, nimble culture, and technology-embedded claims processes enable fair and appropriate claims outcomes for customers. |
|||
{{chunk|doc=vycbjm4dw4|c=21|p=8}} |
|||
'''Business intelligence and technology''' |
|||
* SkyBI, the business intelligence platform, provides senior leadership and technical teams with real-time intelligence for superior decision-making. |
|||
* SkyBI reflects best practices learned from the management team's experience in [[Definition:Property & casualty|P&C]] insurance and technology sectors. |
|||
* SkyBI is a single, comprehensive enterprise-wide data repository for reporting, business intelligence, analytics, and advanced data capabilities. |
|||
* Provides information and performance metrics across the company in an easy-to-consume visualized format. |
|||
* Data can be filtered by categories including distributor, customer segment, [[Definition:Business mix|line of business]], specific industry, individual underwriter, and specific risk feature. |
|||
* SkyBI aids in establishing clear line of sight to objectives and facilitating decision-making processes. |
|||
* Every underwriting and claims decision can be augmented with new types of risk data and advanced technology. |
|||
* Underwriting decisions are backed by reliable historical data and in-depth risk evaluation from intentional investment in data collection and processing. |
|||
* Underwriting and claims prowess is amplified by combining historical data with new forms of risk data and predictive analytics. |
|||
* Generative artificial intelligence is utilized in underwriting and claims handling where it enhances effectiveness and efficiency without sacrificing employee expertise. |
|||
{{chunk|doc=vycbjm4dw4|c=22|p=8}} |
|||
'''Diversified business''' |
|||
* Built a diversified group of underwriting divisions spanning multiple [[Definition:Business mix|product lines]], industries, geographies, and distribution channels. |
|||
* Includes business not typically aligned with traditional [[Definition:Property & casualty|P&C]] cycles. |
|||
* Aims to evolve with and adapt to the market by growing certain lines when conditions are favorable and limiting exposure when conditions are less favorable. |
|||
* Diversity of the book allows response to and capitalization on market opportunities and dislocations across insurance market and pricing cycles, resulting in a durable insurance franchise. |
|||
{{chunk|doc=vycbjm4dw4|c=23|p=8}} |
|||
'''Culture and leadership''' |
|||
* Built a distinctive winning culture, evidenced by internal surveys, public information (Glassdoor, LinkedIn), and selection as a "Best Places to Work in Insurance". |
|||
* Key to culture and operating approach is a flat structure of communication and decision-making. |
|||
* Staff are trusted to make decisions that produce or exceed desired financial results and are supported by a clear system of performance measurement. |
|||
* Adopted a hybrid work schedule providing employees with remote working flexibility. |
|||
* Maintains an entrepreneurial environment that encourages and rewards a proactive approach to capitalize on market disruption. |
|||
* This environment is consistent with identity as a specialty insurer and a foundation for attracting talent and delivering best-in-class results. |
|||
* Led by CEO Andrew Robinson, the executive leadership team is experienced, innovative, and entrepreneurial. |
|||
* Leadership team has a track record of success in senior management roles at industry-leading [[Definition:Property & casualty|P&C]] companies and in starting new businesses. |
|||
* Entire senior leadership's compensation is directly aligned with shareholders. |
|||
* A material portion of each leader's compensation is in long-term and short-term incentives tied to delivering sustainable, best-in-class underwriting returns. |
|||
* Executive leadership team has additional long-term incentive targets tied directly to growth in book value per share. |
|||
=== Our Strategy in Action === |
|||
{{chunk|doc=vycbjm4dw4|c=24|p=8}} |
|||
'''Rule Our Niche strategy tenets''' |
|||
* The "Rule Our Niche" strategy aims to generate best-in-class underwriting profitability for niches and create superior long-term shareholder value through growth in book value per share. |
|||
* Core tenets include attracting and retaining blue-chip underwriting and claims talent to expand and enhance market position. |
|||
* The company seeks to hire talented technical underwriting professionals with long-standing industry relationships and claims professionals with niche expertise. |
|||
* These relationships are crucial for steady access to preferred business. |
|||
* The company believes it is a company of choice for top industry talent and will continue to grow its market position by recruiting world-class talent in chosen markets. |
|||
{{chunk|doc=vycbjm4dw4|c=25|p=8}} |
|||
'''Technology leverage''' |
|||
* The company leverages its technology DNA to differentiate itself from competitors. |
|||
* It has demonstrated a differentiated ability to use new forms of risk data and advanced technology in complex, higher severity risk categories within the specialty [[Definition:Property & casualty|P&C]] insurance market. |
|||
* SkyBI enables prompt sensing and quick response to market changes. |
|||
* Core operating platforms allow efficient entry into new markets without complex systems. |
|||
* This technological advantage positions the company for profitable growth and expansion into additional specialty market niches where it can establish a strong and defensible market position. |
|||
{{chunk|doc=vycbjm4dw4|c=26|p=8}} |
|||
'''Business growth and market trends''' |
|||
* The company aims to profitably grow existing [[Definition:Business mix|lines of business]] and expand with new underwriting divisions. |
|||
* It is positioned to capitalize on trends impacting customers in the United States and globally. |
|||
* Trends include increased demand for specialized insurance due to rising and complex risks from climate change/severe weather, supply chain uncertainty, financial inflation, cyber risk, novel health risks, increased litigation, attorney involvement, jury awards, and healthcare delivery/cost. |
|||
* Another market trend is the emergence of "micro cycles and micro dislocations" where [[Definition:Property & casualty|P&C]] market segments experience hardening and softening at different times. |
|||
* The company has reacted quickly to these trends by launching new underwriting units (many not aligned with [[Definition:Property & casualty|P&C]] cycles), entering underserved markets, partnering with advanced technology providers, and launching new captive solutions. |
|||
* [[Definition:Gross written premiums|Gross written premium]] growth and profitability indicate momentum and position the company for continued expansion and growth in target markets. |
|||
{{chunk|doc=vycbjm4dw4|c=27|p=8}} |
|||
'''Underwriting performance and operational excellence''' |
|||
* The company differentiates on daily excellence to drive best-in-class underwriting performance. |
|||
* Achieving long-term goals, including best-in-class underwriting returns and growth in book value per share, depends on day-to-day operational execution across all functional departments (underwriting, product management, claims management). |
|||
* SkyBI provides a foundation for senior management to monitor performance, including renewal rates, new business pricing, portfolio performance for individual underwriters, and claims aging/reserving practices/outcomes by claims adjusters. |
|||
* Focus on fundamentals driving underwriting excellence is central to the strategy. |
|||
* Cross-functional collaboration ensures underwriting, claims, actuarial, and product management teams regularly review performance and trends to implement portfolio, pricing, and coverage changes quickly. |
|||
{{chunk|doc=vycbjm4dw4|c=28|p=8}} |
|||
'''Balance sheet strength and reserving practices''' |
|||
* The company uses its balance sheet to capture a larger market share. |
|||
* It is committed to establishing and maintaining a strong balance sheet, starting with conservative loss reserves and strong capitalization ratios. |
|||
* This is imperative for maintaining confidence of customers, distribution partners, reinsurers, regulators, rating agencies, and shareholders. |
|||
* Claims case reserve practices aim to reserve to the expected ultimate loss within 90 days of the first notice of loss. |
|||
* The company maintains incurred but not reported reserves ("IBNR") that, combined with case reserves, are above the actuarial central estimate. |
|||
* Loss reserves represent the best estimate of ultimate losses. |
|||
=== Marketing and Distribution === |
|||
{{chunk|doc=vycbjm4dw4|c=29|p=8}} |
|||
'''Marketing and distribution strategy''' |
|||
* The company's marketing and distribution approach mirrors its underwriting strategy and is a key facet of its "Rule Our Niche" strategy. |
|||
* Underwriting teams and the company maintain strong relationships and reputations with distribution partners, facilitating new affiliations. |
|||
* The company wins with distribution partners due to deep expertise in niche markets, high-caliber underwriters, a culture of innovation, thoughtful product lineup and design, and speed/quality of responsiveness. |
|||
* All underwriting divisions invest significant time and effort in sustaining and expanding distribution partner loyalty and long-term relationships. |
|||
* The choice of distribution partners is tailored to access specific business, mirroring the tailored underwriting approach for insureds. |
|||
* Products are distributed through retail agents, wholesale brokers, select program administrators, and captive managers. |
|||
* This distribution approach allows effective and efficient access to targeted business based on market niche needs and dynamics. |
|||
=== Underwriting === |
|||
{{chunk|doc=vycbjm4dw4|c=30|p=8}} |
|||
'''Underwriting strategy and approach''' |
|||
* Underwriting approach is embedded in the "Rule Our Niche" strategy and is core to market success. |
|||
* Underwriting teams are specialized within eight divisions, focusing on specific niches. |
|||
* Underwriting approach is underpinned by hiring experienced, best-in-class, and diverse technical underwriters with established track records in specific specialty niche markets. |
|||
* Underwriters' skill sets are amplified with advanced technology and data analytics, and they are empowered with appropriate decision-making authority. |
|||
* This approach is considered key to superior risk selection and pricing, and producing sustainable best-in-class underwriting results across market cycles. |
|||
* Capabilities and experience of underwriting professionals are augmented using new forms of data and analytics for risk selection and pricing. |
|||
* Underwriting data is captured in the SkyBI business intelligence platform. |
|||
* SkyBI is a comprehensive data repository forming the foundation of reporting, analytics, and other data capabilities, and is a key tool for senior management and business leaders. |
|||
* The company is highly selective in policies chosen to bind. |
|||
* Underwriters are encouraged to move on quickly if they cannot reasonably expect to bind coverage at a premium and coverage terms that meet company standards. |
|||
* When accepting risks, terms and price are established to suit the underlying exposure. |
|||
* In the admitted market, the company ensures approved forms and filed rates are appropriate and adequate for accepted risks, while allowing flexibility for specific/unique exposures. |
|||
* In the E&S market, freedom of rate and form is used to ensure risk and coverage are appropriate for unique needs and exposures. |
|||
* Policies are crafted to offer affordable and appropriate protection for insureds' exposures, while constructing coverage for predictable potential losses and managed claims costs. |
|||
* Underwriting teams are supported by active engagement and collaboration with Claims, Actuarial, Product Management, Legal and Compliance, and Finance departments. |
|||
* This collaboration ensures trends in business, legal and tort developments, and competitor and regulatory actions are analyzed, shared, and acted upon timely. |
|||
* Underwriters are viewed as the center of the company, with all support functions incentivized and measured to support underwriting profitability targets. |
|||
* This structure helps surface opportunities and issues early, contributing to nimbleness and ability to leverage market disruptions. |
|||
* Underwriting controls and procedures are regularly reviewed to ensure underwriters profitably underwrite each market served. |
|||
=== Claims Management === |
|||
{{chunk|doc=vycbjm4dw4|c=31|p=8}} |
|||
'''Claims management principles and operations''' |
|||
* Skyward's claims department is guided by six principles: prompt and comprehensive claim investigations using advanced analytics and technology; quality claims handling service with customer engagement; prompt establishment of reserves reflecting ultimate loss estimates; effective pursuit of contribution and subrogation; detection and prevention of fraud; and disciplined litigation management. |
|||
* Skyward Specialty was formed as a Delaware corporation on January 3, 2006, as an insurance holding company <sup>p. 1</sup>. |
|||
* Continuous training is provided to claim staff on claim evaluation, strategy, litigation management, good-faith claims handling, and best practices to achieve timely and optimal claim outcomes. |
|||
* The company operated under the name Houston International Insurance Group, Ltd. until rebranding as Skyward Specialty in November 2020 <sup>p. 1</sup>. |
|||
* The majority of claims are handled in-house. |
|||
* Skyward Specialty is a growing specialty insurance company providing commercial property and casualty (P&C) products and solutions <sup>p. 1</sup>. |
|||
* Third Party Administrators (TPAs) are utilized for certain claims, including programs, captives, occupational accident, workers compensation, and runoff claims. |
|||
* Products are delivered on both a non-admitted (E&S) and admitted basis, primarily in the United States <sup>p. 1</sup>. |
|||
* TPAs are actively managed, overseen, and regularly audited to ensure compliance with Skyward's claims handling and reserving guidelines and general best practices. |
|||
* The company focuses on underserved, dislocated, and markets where standard insurance coverages are insufficient <sup>p. 1</sup>. |
|||
* Independent legal counsel is retained for liability claims against an insured, selected based on geographical location and expertise. |
|||
* Customers typically require highly specialized, customized underwriting solutions and claims capabilities <sup>p. 1</sup>. |
|||
* Litigation guidelines have been developed for claims professionals and outside counsel to ensure appropriate defense for insureds. |
|||
* The portfolio of insured risks is highly diversified, covering customers in various industries and distributed through multiple channels <sup>p. 1</sup>. |
|||
* A legal spend management solution is employed to analyze legal invoices for adherence to case handling and billing practice standards, ensuring reasonable and customary legal costs. |
|||
* Lines of business include general liability, excess liability, professional liability (including cyber and media liability insurance), commercial auto, group accident and health, property, agriculture, credit, surety, and workers’ compensation <sup>p. 1</sup>. |
|||
* The company insures both short and medium duration liabilities <sup>p. 1</sup>. |
|||
* The business mix is principally primary insurance and balanced between E&S and admitted markets <sup>p. 1</sup>. |
|||
* A small portion of the business is specialty reinsurance, primarily in agriculture and credit, focused on attractive specialty classes <sup>p. 1</sup>. |
|||
* This diversification, including businesses not typically aligned with traditional P&C pricing cycles, combined with underwriting and claims expertise, aims to produce consistent growth and profitability across all insurance pricing cycles <sup>p. 1</sup>. |
|||
* The company is led by an entrepreneurial executive management team with decades of insurance leadership experience in the global P&C industry <sup>p. 1</sup>. |
|||
* The leadership is supported by an experienced team aligned with the company's strategy <sup>p. 1</sup>. |
|||
* The company believes its leadership, underwriting and claims teams, technology DNA, advanced analytics capabilities, diversified book of business, and strong competitive position enable continued profitable growth <sup>p. 1</sup>. |
|||
* The aim is to deliver long-term shareholder value by generating best-in-class underwriting profitability and book value per share growth across P&C market cycles <sup>p. 1</sup>. |
|||
* All insurance company subsidiaries are group rated and hold financial strength ratings of "A" (Excellent) from A.M. Best Company, with a stable outlook <sup>p. 1</sup>. |
|||
{{chunk|doc=vycbjm4dw4|c=32|p=8}} |
|||
{{Indexing|Our Business and Our Strategy|Reportable segment, underwriting divisions, Accident & Health (A&H), Captives, Global Property, Global Agriculture, medical stop loss, group captive solutions, property-only solutions, secondary and reinsurance solutions|1ut79wn2dy|8c6rwjjmzf|lht8rybaqk|kind=prose|order=4|f1=Number of segments|v1=one|f2=Reportable segments|v2=one|f3=Gross written premiums|v3=44% admitted and 56% non-admitted}} |
|||
'''Claims technology and efficiency initiatives''' |
|||
* Technology is leveraged to gain efficiencies in the claims-handling process. |
|||
* The company operates with one reportable segment offering a broad array of insurance coverages across various market niches <sup>p. 2</sup>. |
|||
* A Claims Development Severity Predictor, a predictive model, has been created and implemented to identify claims likely to lead to large loss development. |
|||
* Each of the eight distinct underwriting divisions has dedicated underwriting leadership and technical staff with deep experience <sup>p. 2</sup>. |
|||
* This model allows for early identification, proactive claims management, and summarization of development reasons, and has been integrated into the claims review and management workflow. |
|||
* This structure and expertise aim to serve customer needs effectively, be a value-add partner to distributors, and earn attractive risk-adjusted returns <sup>p. 2</sup>. |
|||
* A "quick strike" program has been implemented for commercial auto claims to respond efficiently to claim reports. |
|||
* For the year ended December 31, 2024, ''gross written premiums'' were 44% admitted and 56% non-admitted <sup>p. 2</sup>. |
|||
* The "quick strike" program involves deploying experienced investigators and vendors to the scene of a reported auto accident, ideally within two hours, regardless of location. |
|||
* ''Accident & Health (A&H)'' underwriting division provides medical stop loss to self-insured employers and covers group and single-employer captives <sup>p. 2</sup>. |
|||
* This quick response aids in evaluating accident facts and circumstances for rapid investigation and, if appropriate, resolving third-party claims quickly. |
|||
* The A&H division targets small and medium-sized enterprise market segments seeking to control healthcare costs by self-insuring a portion of their healthcare insurance <sup>p. 2</sup>. |
|||
* A&H products are written on an admitted basis and distributed primarily through retail and wholesale brokers <sup>p. 2</sup>. |
|||
* ''Captives'' underwriting division provides group captive solutions by leveraging underwriting and claims expertise from other divisions <sup>p. 2</sup>. |
|||
* The Captives division writes property, general liability, commercial auto, excess liability, and workers’ compensation lines on both E&S and admitted bases <sup>p. 2</sup>. |
|||
* This business is often administered through partnerships with third-party captive managers <sup>p. 2</sup>. |
|||
* ''Global Property'' underwriting unit provides property-only solutions to large multi-jurisdictional entities with complex property exposures <sup>p. 2</sup>. |
|||
* Global Property business is written entirely on an E&S basis and distributed through retail and select wholesale brokers <sup>p. 2</sup>. |
|||
* The company's position in Global Property has been curated over more than ten years <sup>p. 2</sup>. |
|||
* ''Global Agriculture'' underwriting unit provides secondary and reinsurance solutions for crop, livestock, and other renewable resources <sup>p. 2</sup>. |
|||
* ''Industry Solutions'' underwriting division includes three units: construction, energy, and inland marine <sup>p. 2</sup>. |
|||
* Construction and energy underwriting units provide general liability, excess liability, commercial auto, workers’ compensation, and adjacent inland marine solutions <sup>p. 2</sup>. |
|||
* These solutions are written principally on an admitted basis for middle market construction and energy production/servicing customers, including alternative/renewable energy fields <sup>p. 2</sup>. |
|||
* The inland marine underwriting unit focuses on logistics and other specialty property risk for assets constantly in motion <sup>p. 2</sup>. |
|||
* Industry Solutions products are distributed through retail agents and brokers and a select network of wholesalers <sup>p. 2</sup>. |
|||
* ''Professional Lines'' underwriting division includes three units: management liability, professional liability (including cyber and media liability), and allied health (including life sciences) <sup>p. 2</sup>. |
|||
* Professional liability and allied health provide primary and excess claims-made liability products on E&S and admitted bases <sup>p. 2</sup>. |
|||
* These products are distributed through both wholesale and retail brokers, depending on the product <sup>p. 2</sup>. |
|||
* ''Programs'' underwriting division partners with program administrators focused on specific markets aligned with the company's expertise and strategy <sup>p. 2</sup>. |
|||
* Programs division writes property, general liability, commercial auto liability, excess liability, and workers’ compensation lines on E&S and admitted bases <sup>p. 2</sup>. |
|||
* ''Surety'' underwriting division provides contract, commercial, and transactional surety solutions for trade and services organizations <sup>p. 2</sup>. |
|||
* The Surety division focuses on small to medium-sized enterprises with aggregate bond programs up to approximately $75.0 million for contract and $100.0 million for commercial and transactional <sup>p. 2</sup>. |
|||
* Surety business is written on an admitted basis and distributed through retail agents and brokers <sup>p. 2</sup>. |
|||
* ''Transactional E&S'' underwriting division provides primary and excess non-catastrophe prone property and general liability solutions <sup>p. 2</sup>. |
|||
* This division emphasizes risks considered hard to place due to complexity, loss history, or limited operating history (e.g., startups) <sup>p. 2</sup>. |
|||
* The Transactional E&S division accesses the market exclusively through wholesale brokers <sup>p. 2</sup>. |
|||
* The company has business units and lines of business previously exited and placed into run-off, referred to as "exited business" <sup>p. 2</sup>. |
|||
* The company's strategy, referred to as "Rule Our Niche," aims to lead in chosen market niches and establish sustainable competitive positions <sup>p. 2</sup>. |
|||
* Key elements of the strategy include: providing differentiated products, attracting and retaining talent, amplifying expertise with technology and analytics, empowering underwriting and claims teams, and fostering a nimble culture <sup>p. 2</sup>. |
|||
* The strategy forms the basis for building a strong defensible market position, creating a competitive moat, and winning in chosen markets <sup>p. 2</sup>. |
|||
* The principles of the strategy are considered key to achieving and sustaining best-in-class underwriting results through P&C insurance pricing cycles <sup>p. 2</sup>. |
|||
* The company strives for excellence in risk selection, pricing, and claims outcomes, amplified by advanced technology and analytics <sup>p. 2</sup>. |
|||
{{chunk|doc=vycbjm4dw4|c=33|p=8}} |
|||
{{Indexing|Our Competitive Strengths|Niche market focus, underwriting approach, underwriting staff, claims team, claims process, SkyBI platform, data repository, business intelligence platform, advanced technology, new risk data|c6zoq3weio|8c6rwjjmzf|2264mja9fc|kind=prose|order=5|f1=Competitive advantages|v1=focus on profitable niches, highly skilled underwriters, superior claims staff and operations, superior business intelligence platform, advanced technology and new risk data, diversified business, attractive and winning culture, high-quality, experienced leadership team}} |
|||
'''Claims team structure and collaboration''' |
|||
* Claims handlers and managers are organized by [[Definition:Business mix|line of business]] to ensure specialized expertise in handling claims. |
|||
* ''Competitive strengths'' include a focus on profitable niches, highly skilled underwriters, superior claims staff and operations, a superior business intelligence platform, advanced technology and new risk data for underwriting and claims, a diversified business, an attractive and winning culture, and a high-quality, experienced leadership team <sup>p. 3</sup>. |
|||
* Managers and adjusters collaborate closely with underwriting partners to inform them of legal trends and emerging claims issues. |
|||
* ''Niche market focus'': The company targets underserved, dislocated, or complex commercial lines P&C markets that require technical underwriting and claims management, aiming for attractive risk-adjusted returns <sup>p. 3</sup>. |
|||
* The goal of this collaboration is to educate underwriters on emerging areas of loss experience to assist in their risk selection processes. |
|||
* ''Underwriting approach'': The company empowers deeply experienced underwriters with authority to make decisions, enabling innovative products and solutions for challenging risks, augmented by data and predictive analytics for risk selection and pricing <sup>p. 3</sup>. |
|||
* ''Underwriting staff'': The company hires underwriting and technical staff with expertise and experience, allowing them freedom to use judgment in evaluating and pricing complex risks rather than adhering to strict underwriting rules <sup>p. 3</sup>. |
|||
* ''Claims team'': The company has a specialized team of claims professionals knowledgeable in their niches, addressing first-party claims with fair solutions and third-party claims with comprehensive responses, focusing on early loss recognition of indemnity and loss adjustment expenses (LAE) <sup>p. 3</sup>. |
|||
* ''Claims process'': The company uses specialized adjusters, advanced technology, and analytics for quick claim resolution, embedding technology from first notice of loss to settlement, and providing real-time detailed information on open and closed claims <sup>p. 3</sup>. |
|||
* ''SkyBI platform'': SkyBI is the company's business intelligence platform, providing real-time intelligence to senior leadership and technical teams for decision-making, built on best practices from P&C insurance and technology sectors <sup>p. 3</sup>. |
|||
* ''Data repository'': SkyBI serves as a single, comprehensive enterprise-wide data repository for reporting, business intelligence, analytics, and advanced data capabilities, offering visualized information and performance metrics filterable by categories like distributor, customer segment, line of business, industry, underwriter, and risk feature <sup>p. 3</sup>. |
|||
* ''Technology and data in decisions'': The company believes in augmenting underwriting and claims decisions with new risk data and advanced technology, combining historical data with new forms of risk data and predictive analytics <sup>p. 3</sup>. |
|||
* ''Generative AI'': Generative artificial intelligence is utilized in underwriting and claims handling to enhance effectiveness and efficiency without sacrificing employee expertise <sup>p. 3</sup>. |
|||
* ''Diversified business'': The company has built diversified underwriting divisions across product lines, industries, geographies, and distribution channels, including business not typically aligned with traditional P&C cycles <sup>p. 3</sup>. |
|||
* ''Market adaptability'': The company aims to adapt to market conditions by growing certain lines when favorable and limiting exposure when less favorable, believing this diversity allows it to capitalize on market opportunities and dislocations <sup>p. 3</sup>. |
|||
* ''Company culture'': The company has a distinctive culture, evidenced by internal surveys, public information (Glassdoor, LinkedIn), and recognition as a "Best Places to Work in Insurance" <sup>p. 3</sup>. |
|||
* ''Culture characteristics'': Key aspects include a flat communication and decision-making structure, trust in staff decisions, a clear performance measurement system, and a hybrid work schedule <sup>p. 3</sup>. |
|||
* ''Entrepreneurial environment'': The company maintains an entrepreneurial environment that encourages and rewards proactive approaches to market disruption, consistent with its identity as a specialty insurer and foundational for attracting talent and delivering results <sup>p. 3</sup>. |
|||
* ''Leadership team'': The executive leadership team, led by CEO Andrew Robinson, is experienced, innovative, and entrepreneurial, with a track record in senior management roles at industry-leading P&C companies and in building new businesses <sup>p. 3</sup>. |
|||
* ''Leadership compensation'': Senior leadership compensation is aligned with shareholders, with a material portion in long-term and short-term incentives tied to delivering sustainable underwriting returns <sup>p. 3</sup>. |
|||
* ''Executive incentives'': Executive leadership has additional long-term incentive targets directly tied to growth in book value per share <sup>p. 3</sup>. |
|||
=== Technology === |
|||
{{Indexing|Our Strategy in Action|'Rule Our Niche' strategy, underwriting profitability, shareholder value, book value per share, underwriting and claims talent, technology DNA, SkyBI, core operating platforms, existing lines of business, new underwriting divisions, climate change, severe weather events, supply chain uncertainty, financial inflation|8c6rwjjmzf|2264mja9fc|kind=prose|order=6|f1=Strategic priorities|v1='Rule Our Niche' strategy}} |
|||
{{chunk|doc=vycbjm4dw4|c=34|p=8}} |
|||
* The "Rule Our Niche" strategy guides all activities from recruiting to claims resolution <sup>p. 4</sup>. |
|||
'''Technology strategy and platforms''' |
|||
* The goal of the "Rule Our Niche" strategy is to generate best-in-class underwriting profitability for niches and create superior long-term shareholder value through growth in book value per share <sup>p. 4</sup>. |
|||
* Core tenets of the "Rule Our Niche" strategy include attracting and retaining blue-chip underwriting and claims talent to expand and enhance market position <sup>p. 4</sup>. |
|||
* The company seeks to hire talented technical underwriting professionals with long-standing industry relationships with distribution partners and claims professionals with expertise in specific niches <sup>p. 4</sup>. |
|||
* These relationships are crucial for consistent access to preferred business <sup>p. 4</sup>. |
|||
* The company aims to grow its market position by recruiting world-class talent in chosen markets <sup>p. 4</sup>. |
|||
* Another core tenet is leveraging technology DNA to differentiate from competitors <sup>p. 4</sup>. |
|||
* The company has demonstrated an ability to use new forms of risk data and advanced technology in complex, higher severity risk categories within the specialty P&C insurance market <sup>p. 4</sup>. |
|||
* SkyBI enables prompt sensing and quick response to market changes <sup>p. 4</sup>. |
|||
* Core operating platforms allow efficient entry into new markets without complex systems <sup>p. 4</sup>. |
|||
* The technological advantage positions the company for profitable growth and expansion into additional specialty market niches <sup>p. 4</sup>. |
|||
* The strategy also includes profitably growing existing lines of business and expanding with new underwriting divisions <sup>p. 4</sup>. |
|||
* The company is positioned to capitalize on trends impacting customers in the United States and globally <sup>p. 4</sup>. |
|||
* One trend is the rising demand for specialized insurance due to increasing risk complexity from climate change, severe weather events, supply chain uncertainty, financial inflation, cyber risk, novel health risks, increased litigation, attorney involvement, jury awards, and healthcare delivery/cost <sup>p. 4</sup>. |
|||
* Another market trend is the emergence of "micro cycles and micro dislocations" where different P&C market segments experience hardening and softening at varying times <sup>p. 4</sup>. |
|||
* The company has reacted quickly to these trends by launching new underwriting units (some not aligned with P&C cycles), entering underserved markets, partnering on advanced technology, and launching new captive solutions <sup>p. 4</sup>. |
|||
* Gross written premium growth and profitability indicate momentum and position the company for continued expansion and growth <sup>p. 4</sup>. |
|||
* Differentiating on daily excellence to drive best-in-class underwriting performance is also a core tenet <sup>p. 4</sup>. |
|||
* Achieving long-term goals, including best-in-class underwriting returns and growth in book value per share, depends on execution across all functional departments, including underwriting, product management, and claims management <sup>p. 4</sup>. |
|||
* SkyBI provides a foundation for senior management to monitor performance, including renewal rates, new business pricing, portfolio performance for individual underwriters, and claims aging, reserving practices, and outcomes by claims adjusters <sup>p. 4</sup>. |
|||
* The strategy centers on fundamentals that drive underwriting excellence <sup>p. 4</sup>. |
|||
* Cross-functional collaboration ensures underwriting, claims, actuarial, and product management teams regularly review performance and trends to implement portfolio, pricing, and coverage changes quickly <sup>p. 4</sup>. |
|||
* The company uses its balance sheet to capture a larger market share <sup>p. 4</sup>. |
|||
* The company is committed to maintaining a strong balance sheet, starting with conservative loss reserves and strong capitalization ratios <sup>p. 4</sup>. |
|||
* This commitment is considered imperative to maintain confidence from customers, distribution partners, reinsurers, regulators, rating agencies, and shareholders <sup>p. 4</sup>. |
|||
* Claims case reserve practices aim to reserve to the expected ultimate loss within 90 days of the first notice of loss <sup>p. 4</sup>. |
|||
* The company's practice is to maintain incurred but not reported reserves ("IBNR") that, combined with case reserves, exceed the actuarial central estimate <sup>p. 4</sup>. |
|||
* Loss reserves represent the company's best estimate of ultimate losses <sup>p. 4</sup>. |
|||
* Technology is central to Skyward's operations and decision-making, driving competitive advantages. |
|||
{{Indexing|Marketing and Distribution|Marketing and distribution approach, 'Rule Our Niche' strategy, underwriting teams, distribution partners, retail agents, wholesale brokers, program administrators, captive managers|la5wuhtx31|kind=prose|order=7|f1=Distribution channels|v1=retail agents, wholesale brokers, select program administrators, and captive managers}} |
|||
* Skyward deploys technology in three primary functional ways: Superior Business Intelligence Platform, Predictive Analytics Technology, and Core Transactional Platforms. |
|||
* Superior Business Intelligence Platform: |
|||
** SkyBI provides senior leadership and technical teams with real-time intelligence for decision-making. |
|||
** SkyBI incorporates best practices from management's experience in [[Definition:Property & casualty|P&C]] insurance and technology sectors. |
|||
** SkyBI is a single, comprehensive enterprise-wide data repository for reporting, business intelligence, analytics, and advanced data capabilities. |
|||
** It provides information and performance metrics across the Company in a visualized format. |
|||
** Data can be filtered by categories including distributor, customer segment, [[Definition:Business mix|line of business]], specific industry, individual underwriter, and specific risk feature. |
|||
** SkyBI helps establish clear line of sight to objectives and facilitates decision-making. |
|||
* Predictive Analytics Technology: |
|||
** Skyward augments employee capabilities using new risk data and predictive analytics, including AI, for risk selection, pricing, and claims handling. |
|||
** Actions within each underwriting division are intentional to "Rule Our Niche". |
|||
** Skyward aims for constant innovation, with actions specific to each division/market served. |
|||
* Core Transactional Platforms: |
|||
** Core operating platforms (policy administration, underwriting workbench, billing, claims systems) are designed for nimble scaling and business expansion. |
|||
** Skyward generally uses customized third-party vendor applications for core operating platforms. |
|||
** The core platform organization is used for all business except accident & health, global property, agriculture, and surety, which require dedicated core processing components due to unique features. |
|||
** Data from all divisions' core operating platforms flows to SkyBI with comparable data quality and granularity. |
|||
* The use of advanced technology for underwriting and claims, SkyBI, and core operating platforms creates a flywheel effect. |
|||
* This effect allows underwriters to better select risk, claims professionals to better adjudicate claims, unit leaders to better communicate with reinsurance and third-party partners, and senior leadership to better evaluate business trends. |
|||
* These tools also improve communication accuracy, effectiveness, and efficiency with distribution partners, reinsurers, and other third-party partners. |
|||
{{chunk|doc=vycbjm4dw4|c=35|p=8}} |
|||
* ''Marketing and distribution'' approach mirrors underwriting and is a key facet of the "Rule Our Niche" strategy <sup>p. 5</sup>. |
|||
'''Cybersecurity and data protection''' |
|||
* ''Underwriting teams'' and the Company have strong relationships with distribution partners and reputations that help establish new affiliations <sup>p. 5</sup>. |
|||
* ''Distribution partners'' are won over by deep expertise in niche markets, high-caliber underwriters, culture of innovation, thoughtful product line-up and design, and speed and quality of responsiveness <sup>p. 5</sup>. |
|||
* ''Underwriting divisions'' invest time and effort in sustaining and expanding distribution partner loyalty and long-term relationships <sup>p. 5</sup>. |
|||
* ''Distribution partners'' are chosen to access specific business, similar to how underwriting is tailored to insureds' needs <sup>p. 5</sup>. |
|||
* ''Products are distributed'' through retail agents, wholesale brokers, select program administrators, and captive managers <sup>p. 5</sup>. |
|||
* ''Distribution approach'' allows effective and efficient access to targeted business based on market niche needs and dynamics <sup>p. 5</sup>. |
|||
* Skyward faces external threats to its IT systems, including system failure, customer data theft attempts, and ransomware attacks. |
|||
{{Indexing|Underwriting|Underwriting approach, 'Rule Our Niche' strategy, underwriting teams, data analytics, SkyBI, risk selection, pricing, policy binding, admitted market, E&S market|cos78e4bvi|llbwb4tj3c|2264mja9fc|kind=prose|order=8}} |
|||
* The technology infrastructure is designed to function through major disruptions. |
|||
* Data is replicated in real-time to a third-party cloud disaster recovery site for use during major system failures. |
|||
* Data is backed up daily for system restoration. |
|||
* Actions to prevent system and data disruptions include: |
|||
** Actively monitoring Cybersecurity and Infrastructure Security Agency’s (“CISA”) cybersecurity directives. |
|||
** Taking immediate action on identified vulnerabilities in directives. |
|||
** Conducting monthly vulnerability scans on all network-attached devices at all locations, with patching applied as needed. |
|||
** Requiring two-factor authentication for system access. |
|||
** Conducting monthly security training for all employees. |
|||
** Implementing endpoint detection agents for threat detection and response. |
|||
** Performing desktop scenarios to practice responses to breaches with cybersecurity insurance partners and retained security consultants. |
|||
** Performing annual penetration testing. |
|||
* Skyward constantly reviews its security breach posture and regularly implements updated processes, best practices, and tools. |
|||
=== Reinsurance === |
|||
* The underwriting approach is central to the "Rule Our Niche" strategy and market success <sup>p. 6</sup>. |
|||
* Underwriting teams are specialized within eight divisions, focusing on specific niches <sup>p. 6</sup>. |
|||
* The underwriting approach is built on hiring experienced, best-in-class, and diverse technical underwriters with proven track records in specialty niche markets <sup>p. 6</sup>. |
|||
* Underwriters' skills are enhanced with advanced technology and data analytics, and they are given authority to make decisions <sup>p. 6</sup>. |
|||
* This approach aims for superior risk selection and pricing, leading to sustainable best-in-class underwriting results across market cycles <sup>p. 6</sup>. |
|||
* The company augments underwriting professionals' capabilities and experience using new forms of data and analytics for risk selection and pricing <sup>p. 6</sup>. |
|||
* Underwriting data is captured in the business intelligence platform, SkyBI <sup>p. 6</sup>. |
|||
* SkyBI is a comprehensive data repository that forms the foundation for reporting, analytics, and other data capabilities, serving as a key tool for senior management and business leaders <sup>p. 6</sup>. |
|||
* The company is highly selective in binding policies <sup>p. 6</sup>. |
|||
* Underwriters are encouraged to move on from prospective opportunities if they cannot bind coverage at a premium and terms meeting company standards <sup>p. 6</sup>. |
|||
* When accepting risks, terms and prices are carefully established to suit the underlying exposure <sup>p. 6</sup>. |
|||
* In the admitted market, the company ensures approved forms and filed rates are appropriate and adequate for accepted risks, while allowing flexibility for specific/unique exposures <sup>p. 6</sup>. |
|||
* In the E&S market, freedom of rate and form is used to match risk and coverage to unique needs and exposures <sup>p. 6</sup>. |
|||
* Policies are crafted to offer affordable and appropriate protection for insureds' exposures, and to construct coverage for predictable losses and managed claims costs <sup>p. 6</sup>. |
|||
* Underwriting teams receive support and collaboration from Claims, Actuarial, Product Management, Legal and Compliance, and Finance departments <sup>p. 6</sup>. |
|||
* This collaboration ensures timely analysis and action on business trends, legal and tort developments, and competitor and regulatory actions <sup>p. 6</sup>. |
|||
* Underwriters are considered central to the company, with all support functions incentivized and measured to help achieve underwriting profitability targets <sup>p. 6</sup>. |
|||
* This structure helps identify opportunities and issues early, contributing to nimbleness and the ability to leverage market disruptions <sup>p. 6</sup>. |
|||
* Underwriting controls and procedures are regularly reviewed to ensure profitable underwriting in each market served <sup>p. 6</sup>. |
|||
{{chunk|doc=vycbjm4dw4|c=36|p=8}} |
|||
{{Indexing|Claims Management|Claims department, advanced analytics, technology, customer service, reserve establishment, contribution, subrogation, fraud detection, litigation management, Third Party Administrators (TPAs), independent legal counsel, legal spend management solution, Claims Development Severity Predictor, 'quick strike' program, commercial auto claims|drz6uloidk|2264mja9fc|kind=prose|order=9}} |
|||
'''Reinsurance strategy and types''' |
|||
* Reinsurance is strategically purchased from third parties to protect capital from severity events (large single event losses or catastrophes) and reduce earnings volatility. |
|||
* Skyward's claims department operates on principles including prompt and comprehensive investigations using advanced analytics and technology, quality customer service, timely reserve establishment, effective pursuit of contribution and subrogation, fraud detection and prevention, and disciplined litigation management <sup>p. 7</sup>. |
|||
* Reinsurance contracts are predominantly one year in length and renew annually, primarily in January and June. |
|||
* Continuous training is provided to claims staff on claim evaluation, strategy, litigation management, good-faith claims handling, and best practices to achieve timely and optimal claim outcomes <sup>p. 7</sup>. |
|||
* Factors influencing changes to reinsurance purchases at annual renewal include plans to change underlying insurance coverage, updated loss activity, capital and surplus levels, changes in risk appetite, and the cost and availability of reinsurance treaties. |
|||
* The majority of claims are handled in-house, but Third Party Administrators (TPAs) are utilized for specific instances such as programs, captives, occupational accident, workers compensation, and runoff claims <sup>p. 7</sup>. |
|||
* Quota share, excess of loss, and facultative reinsurance coverage are purchased to limit exposure from losses on any one occurrence. |
|||
* TPAs are actively managed, overseen, and regularly audited to ensure compliance with Skyward's claims handling and reserving guidelines and general best practices <sup>p. 7</sup>. |
|||
* The mix of reinsurance purchased considers efficiency, cost, risk appetite, and specific factors of underlying risks. |
|||
* For liability claims against an insured, independent legal counsel is retained based on geographical location and expertise to ensure effective and efficient defense <sup>p. 7</sup>. |
|||
* Quota share reinsurance involves the reinsurer assuming a specified percentage of losses from a defined class of business in exchange for a corresponding percentage of premiums, net of a ceding commission. |
|||
* Litigation guidelines have been developed for claims professionals and outside counsel to ensure appropriate defense for insureds <sup>p. 7</sup>. |
|||
* Excess of loss reinsurance involves the reinsurer assuming all or a portion of losses for an individual claim or event above a specified amount, in exchange for a negotiated premium, and includes the catastrophe reinsurance program. |
|||
* A legal spend management solution is used to analyze legal invoices for adherence to case handling and billing practice standards, ensuring reasonable and customary legal costs <sup>p. 7</sup>. |
|||
* Facultative coverage is a reinsurance contract on individual risks, used to supplement treaty limits or cover risks/perils excluded from treaty reinsurance. |
|||
* Technology is leveraged to gain efficiencies in claims handling, including the development and implementation of a Claims Development Severity Predictor <sup>p. 7</sup>. |
|||
* The Claims Development Severity Predictor is a predictive model that identifies claims likely to lead to large loss development, enabling early identification, proactive management, and integration into the claims review and management workflow <sup>p. 7</sup>. |
|||
* A "quick strike" program has been implemented for commercial auto claims, deploying experienced investigators and vendors to accident scenes, ideally within two hours, to evaluate facts and circumstances and resolve third-party claims quickly <sup>p. 7</sup>. |
|||
* Claims handlers and managers are organized by line of business to ensure specialized expertise in claims handling <sup>p. 7</sup>. |
|||
* Claims managers and adjusters collaborate with underwriting partners to inform them of legal trends and emerging claims issues, educating underwriters on loss experience for risk selection <sup>p. 7</sup>. |
|||
{{chunk|doc=vycbjm4dw4|c=37|p=8}} |
|||
{{Indexing|Technology|SkyBI, business intelligence platform, predictive analytics technology, AI, risk selection, pricing, claims handling, core transactional platforms, policy administration, underwriting workbench, billing, claims systems, accident & health, global property, agriculture, surety|2264mja9fc|kind=prose|order=10}} |
|||
'''Property catastrophe reinsurance program''' |
|||
* As of December 31, 2024, property insurance represented 29% of [[Definition:Gross written premiums|gross written premiums]]. |
|||
* Technology is central to Skyward Specialty Insurance Group's operations and decision-making, aiming for long-term competitive advantage <sup>p. 8</sup>. |
|||
* Aggregation of property writings by geographic area is actively managed and continuously monitored to limit potential loss from severe events like hurricanes, convective storms, and earthquakes. |
|||
* ''SkyBI'' is a business intelligence platform providing real-time intelligence to senior leadership and technical teams for decision-making <sup>p. 8</sup>. |
|||
* Catastrophe reinsurance is purchased to further mitigate aggregation of property losses due to a single event or series of events. |
|||
* SkyBI incorporates best practices from management's experience in P&C insurance and technology sectors <sup>p. 8</sup>. |
|||
* Third-party stochastic and internal deterministic models are used to analyze the risk of loss aggregation from such events, providing a quantitative view of Probable Maximum Loss (PML) events. |
|||
* SkyBI is a single, comprehensive enterprise-wide data repository for reporting, business intelligence, analytics, and advanced data capabilities <sup>p. 8</sup>. |
|||
* Based on modeling, an event beyond a 1 in 250-year PML would be required to exhaust the USD 36.0m property catastrophe coverage. |
|||
* SkyBI provides information and performance metrics across the Company in a visualized format <sup>p. 8</sup>. |
|||
* The company aims to expose no more than 3.0% of stockholders’ equity to a catastrophic loss less than a 1 in 250-year event. |
|||
* Data in SkyBI can be filtered by categories such as distributor, customer segment, line of business, industry, underwriter, and risk feature <sup>p. 8</sup>. |
|||
* The current reinsurance program is believed to provide coverage well in excess of theoretical losses from any recorded historical event. |
|||
* ''Predictive analytics technology'' augments employee capabilities using new risk data and predictive analytics, including AI, for risk selection, pricing, and claims handling <sup>p. 8</sup>. |
|||
* Underwriting divisions intentionally "Rule Our Niche" by innovating specifically for each division/market served <sup>p. 8</sup>. |
|||
* ''Core transactional platforms'' include policy administration, underwriting workbench, billing, and claims systems, designed for nimble scaling and business expansion <sup>p. 8</sup>. |
|||
* The Company generally uses customized third-party vendor core operating applications <sup>p. 8</sup>. |
|||
* The core platform organization is used for all business except accident & health, global property, agriculture, and surety, which require dedicated core processing components due to unique features <sup>p. 8</sup>. |
|||
* Data from all divisions' core operating platforms flows to the SkyBI platform with comparable data quality and granularity <sup>p. 8</sup>. |
|||
* Advanced technology for underwriting and claims, SkyBI, and core operating platforms create a flywheel effect, improving risk selection, claims adjudication, communication with partners, and trend evaluation by senior leadership <sup>p. 8</sup>. |
|||
* These tools also enhance communication with distribution partners, reinsurers, and other third-party partners <sup>p. 8</sup>. |
|||
* The Company faces external threats to its information technology systems, including system failure, data theft attempts, and ransomware attacks <sup>p. 8</sup>. |
|||
* Technology infrastructure is designed to function through major disruptions <sup>p. 8</sup>. |
|||
* Data is replicated in real-time to a third-party cloud disaster recovery site for major system failures <sup>p. 8</sup>. |
|||
* Data is backed up daily for system restoration <sup>p. 8</sup>. |
|||
* Actions to prevent system disruptions and data breaches include: |
|||
** Actively monitoring Cybersecurity and Infrastructure Security Agency’s (“CISA”) cybersecurity directives and taking immediate action on identified vulnerabilities <sup>p. 8</sup>. |
|||
** Conducting monthly vulnerability scans on all network-attached devices at all locations, with patching as needed <sup>p. 8</sup>. |
|||
** Requiring two-factor authentication for system access <sup>p. 8</sup>. |
|||
** Conducting monthly security training for all employees <sup>p. 8</sup>. |
|||
** Implementing endpoint detection agents for threat detection and response <sup>p. 8</sup>. |
|||
** Performing desktop scenarios to practice responses to breaches with cybersecurity insurance partners and security consultants <sup>p. 8</sup>. |
|||
** Performing annual penetration testing <sup>p. 8</sup>. |
|||
* The Company continuously reviews its security breach posture and implements updated processes, best practices, and tools <sup>p. 8</sup>. |
|||
{{chunk|doc=vycbjm4dw4|c=38|p=8}} |
|||
{{Indexing|Reinsurance|Reinsurance, severity events, catastrophes, earnings volatility, quota share, excess of loss, facultative coverage, property insurance, geographic aggregation, hurricanes, convective storms, earthquakes, catastrophe reinsurance, stochastic models, deterministic models|20fueoa3q1|8ihdrbirer|caxaby4jlv|kind=prose|order=11|f1=Reinsurance types|v1=quota share, excess of loss, and facultative coverage|f2=Property insurance GWP|v2=29% of gross written premiums}} |
|||
'''Reinsurer credit quality and recoverables''' |
|||
* Reinsurance is sought from reinsurers rated at least "A-" ("Excellent") or better by A.M. Best. |
|||
* Reinsurance is strategically purchased from third parties to protect capital from severity events (large single event losses or catastrophes) and reduce earnings volatility <sup>p. 9</sup>. |
|||
* As of December 31, 2024, 99% of reinsurance recoverables were from reinsurers rated "A-" (Excellent) or better by A.M. Best, or were collateralized by the reinsurer. |
|||
* Reinsurance contracts are predominantly one year in length and renew annually, primarily in January and June <sup>p. 9</sup>. |
|||
* The company retains primary liability to policyholders if reinsurers are unable to pay claims, potentially resulting in losses. |
|||
* Factors influencing reinsurance purchases at renewal include changes to underlying insurance coverage, updated loss activity, capital and surplus levels, risk appetite changes, and the cost and availability of treaties <sup>p. 9</sup>. |
|||
* Allowances are established for uncollectible reinsurance amounts. |
|||
* ''Reinsurance types'' purchased include quota share, excess of loss, and facultative coverage to limit exposure from losses on any one occurrence <sup>p. 9</sup>. |
|||
* The |
* The allowance for uncollectible reinsurance was USD 2.3m at December 31, 2024 and 2023. |
||
* ''Quota share reinsurance'' involves a reinsurer assuming a specified percentage of losses from a defined business class in exchange for a corresponding percentage of premiums, net of a ceding commission <sup>p. 9</sup>. |
|||
* ''Excess of loss reinsurance'' involves a reinsurer assuming all or a portion of losses for an individual claim or event above a specified amount, in exchange for a negotiated premium, including catastrophe reinsurance <sup>p. 9</sup>. |
|||
* ''Facultative coverage'' is for individual risks, used to supplement treaty limits or cover risks/perils excluded from treaty reinsurance <sup>p. 9</sup>. |
|||
* As of December 31, 2024, property insurance represented ''29% of gross written premiums'' <sup>p. 9</sup>. |
|||
* Aggregation of property writings by geographic area is actively managed and monitored to limit potential loss from severe events like hurricanes, convective storms, and earthquakes <sup>p. 9</sup>. |
|||
* Catastrophe reinsurance is purchased to further mitigate aggregated property losses from single or series of events <sup>p. 9</sup>. |
|||
* Third-party stochastic and internal deterministic models are used to analyze aggregation risk and inform catastrophe reinsurance purchases <sup>p. 9</sup>. |
|||
* These models provide a quantitative view of Probable Maximum Loss (PML) events, which estimate expected loss levels for a given return period <sup>p. 9</sup>. |
|||
* Based on modeling, an event beyond a ''1 in 250-year PML'' would be required to exhaust the ''$36.0 million property catastrophe coverage'' <sup>p. 9</sup>. |
|||
* The company aims to expose no more than ''3.0% of stockholders’ equity'' to a catastrophic loss less than a 1 in 250-year event <sup>p. 9</sup>. |
|||
* The current reinsurance program is believed to provide coverage well in excess of theoretical losses from any recorded historical event <sup>p. 9</sup>. |
|||
* Reinsurance is sought from reinsurers rated at least ''"A-" ("Excellent") or better by A.M. Best'' <sup>p. 9</sup>. |
|||
* As of December 31, 2024, ''99% of reinsurance recoverables'' were from reinsurers rated "A-" (Excellent) or better by A.M. Best, or were collateralized <sup>p. 9</sup>. |
|||
* Primary liability to policyholders is retained if reinsurers fail to pay claims, potentially resulting in losses <sup>p. 9</sup>. |
|||
* An allowance for uncollectible reinsurance is established for reinsurers unable to honor obligations <sup>p. 9</sup>. |
|||
* The ''allowance for uncollectible reinsurance'' was ''$2.3 million'' at December 31, 2024, and December 31, 2023 <sup>p. 9</sup>. |
|||
{{chunk|doc=vycbjm4dw4|c=39|p=8}} |
|||
{{Indexing|Maximum company retention by line of business||kind=table|order=12}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable" |
{| id="t1001" class="wikitable" |
||
|+ Maximum Company Retention by [[Definition:Business mix|Line of Business]] |
|||
|- |
|||
! style="text-align:left" | [[Definition:Business mix|Line of Business]] |
|||
! style="text-align:left" | Maximum Company Retention |
! style="text-align:left" | Maximum Company Retention |
||
|- |
|- |
||
| style="text-align:left" | Accident & Health |
| style="text-align:left" | Accident & Health |
||
| style="text-align:left" | $0.90 million per occurrence |
| style="text-align:left" | $0.90 million per occurrence |
||
|- |
|- |
||
| Line 491: | Line 686: | ||
</div> |
</div> |
||
{{fn note|1=1|2=Legal defense expenses can force exposure above the maximum company retention for Excess Casualty, Commercial Auto and General Liability.}} |
|||
{{fn note|1=2|2=Reinsurance is subject to a loss ratio cap or aggregate level of loss cover that exceeds a modeled 1:250-year PML event.}} |
|||
{{fn note|1=3|2=Catastrophe loss protection is purchased up to $36.0 million in excess of $12.0 million retention, which provides cover for a 1:250-year PML event.}} |
|||
{{Indexing|Reinsurance by company||kind=table|order=13}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable" |
{| id="t1002" class="wikitable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! style="text-align:right" | |
||
! style="text-align: |
! style="text-align:right" | |
||
|- |
|- |
||
! style="text-align:left" | Reinsurer |
! style="text-align:left" | Reinsurer |
||
! |
! style="text-align:right" | Reinsurance Recoverables |
||
! |
! style="text-align:right" | AM Best Rating |
||
|- |
|- |
||
| style="text-align:left" | Everest Reinsurance Co. |
| style="text-align:left" | Everest Reinsurance Co. |
||
| |
| style="text-align:right" | 154,181 |
||
| |
| style="text-align:right" | A+ |
||
|- |
|- |
||
| style="text-align:left" | eMaxx Captives (1) |
| style="text-align:left" | eMaxx Captives (1) |
||
| |
| style="text-align:right" | 144,196 |
||
| |
| style="text-align:right" | n/r |
||
|- |
|- |
||
| style="text-align:left" | Partner Reinsurance Co. of the US |
| style="text-align:left" | Partner Reinsurance Co. of the US |
||
| |
| style="text-align:right" | 52,442 |
||
| |
| style="text-align:right" | A+ |
||
|- |
|- |
||
| style="text-align:left" | General Reinsurance Corp |
| style="text-align:left" | General Reinsurance Corp |
||
| |
| style="text-align:right" | 48,234 |
||
| |
| style="text-align:right" | A++ |
||
|- |
|- |
||
| style="text-align:left" | Swiss Reinsurance America Corp |
| style="text-align:left" | Swiss Reinsurance America Corp |
||
| |
| style="text-align:right" | 37,789 |
||
| |
| style="text-align:right" | A+ |
||
|- |
|- |
||
| style="text-align:left" | ACE (Chubb Property & Casualty Ins Company) |
| style="text-align:left" | ACE (Chubb [[Definition:Property & casualty|Property & Casualty]] Ins Company) |
||
| |
| style="text-align:right" | 36,527 |
||
| |
| style="text-align:right" | A+ |
||
|- |
|- |
||
| style="text-align:left" | RGA Reinsurance Company |
| style="text-align:left" | RGA Reinsurance Company |
||
| |
| style="text-align:right" | 24,945 |
||
| |
| style="text-align:right" | A+ |
||
|- |
|- |
||
| style="text-align:left" | Randall & Quilter (R&Q Bermuda (SAC) Ltd) (2) |
| style="text-align:left" | Randall & Quilter (R&Q Bermuda (SAC) Ltd) (2) |
||
| |
| style="text-align:right" | 22,663 |
||
| |
| style="text-align:right" | n/r |
||
|- |
|- |
||
| style="text-align:left" | Aspen Insurance UK Limited |
| style="text-align:left" | Aspen Insurance UK Limited |
||
| |
| style="text-align:right" | 19,998 |
||
| |
| style="text-align:right" | A |
||
|- |
|- |
||
| style="text-align:left" | Insurance Company of the West |
| style="text-align:left" | Insurance Company of the West |
||
| |
| style="text-align:right" | 18,112 |
||
| |
| style="text-align:right" | A |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Top 10 Total</b> |
||
| |
| style="text-align:right" | <b>559,087</b> |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | All Others |
| style="text-align:left" | All Others |
||
| |
| style="text-align:right" | 298,789 |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total |
||
| |
| style="text-align:right" | 857,876 |
||
| |
| style="text-align:right" | — |
||
|} |
|} |
||
</div> |
</div> |
||
{{fn note|1=1|2=This reinsurer facilitates our eMaxx captive. At December 31, 2024, we held collateral in a statutory trust of $188.9 million on our net reinsurance recoverables.}} |
|||
{{fn note|1=2|2=This reinsurer facilitated our LPT reinsurance agreement which was commuted effective January 31, 2025. At December 31, 2024, we held collateral in a statutory trust of $22.7 million on our net reinsurance recoverables.}} |
|||
=== Enterprise Risk Management === |
|||
{{Indexing|Enterprise Risk Management|Enterprise risk management (ERM), risk-adjusted return, underwriting, asset portfolio construction, liability duration, market cyclicality, reinsurance, investment strategy, SVP of Finance & ERM, ERM Committee, Economic Capital Model (ECM), risk tolerances, Board's Risk Committee, risk register, operational processes|w8ma8usdpx|d00txlz1as|kind=prose|order=14}} |
|||
{{chunk|doc=vycbjm4dw4|c=40|p=8}} |
|||
* Our enterprise risk management (ERM) is integrated into nearly every aspect of the company and guides daily activities <sup>p. 10</sup>. |
|||
'''Enterprise Risk Management Framework''' |
|||
* The ERM approach aims to achieve an acceptable risk-adjusted return for shareholders while maintaining trust and reliability for those served <sup>p. 10</sup>. |
|||
* The company is intentional in its underwriting and asset portfolio construction <sup>p. 10</sup>. |
|||
* The company balances liability duration and market cyclicality of its underwriting portfolio <sup>p. 10</sup>. |
|||
* Reinsurance is used to manage volatility outside of risk tolerances <sup>p. 10</sup>. |
|||
* The investment strategy targets a diversified portfolio that balances yield, liquidity, volatility, and potential for principal loss <sup>p. 10</sup>. |
|||
* The Senior Vice President (SVP) of Finance & ERM oversees critical ERM processes and chairs the cross-functional corporate ERM Committee <sup>p. 10</sup>. |
|||
* The company formalizes its view of risk and solvency using an Economic Capital Model (ECM) to quantify potential economic loss <sup>p. 10</sup>. |
|||
* ECM output measures potential earnings and capital loss for various scenarios <sup>p. 10</sup>. |
|||
* These outputs are measured against risk tolerances set and updated annually by the ERM Committee and discussed with the Board's Risk Committee <sup>p. 10</sup>. |
|||
* The ECM provides a probabilistic modeled view of earnings and capital loss, incorporating potential losses from catastrophes, reserving, underwriting, market, credit risk, strategic, and operational risks <sup>p. 10</sup>. |
|||
* The SVP of Finance & ERM, with the ERM Committee, maintains a comprehensive risk register with accountabilities for mitigation and monitoring <sup>p. 10</sup>. |
|||
* The top 10 risks are identified, quantified by the SVP of Finance & ERM and the ERM Committee, and reviewed quarterly <sup>p. 10</sup>. |
|||
* Reports on these risks are submitted to the Risk Committee regularly by the SVP of Finance & ERM and the ERM Committee <sup>p. 10</sup>. |
|||
* Operational processes and controls are designed to identify, assess, and manage key risks continuously <sup>p. 10</sup>. |
|||
* The Underwriting Committee oversees changes in risk appetite, product line, and division expansion <sup>p. 10</sup>. |
|||
* Claims handling practices are monitored through regular internal audits, monthly large loss reviews, and a watchlist for potential high severity claims <sup>p. 10</sup>. |
|||
* Actuarial performs quarterly reserve studies, and the Reserve Committee meets quarterly to review and respond to loss emergence trends <sup>p. 10</sup>. |
|||
* Key observations from reserve studies are discussed with the CEO <sup>p. 10</sup>. |
|||
* Underwriting divisions assess rate change and retention on existing business, new business quality and pricing adequacy, and loss emergence versus expectations on a monthly and quarterly basis <sup>p. 10</sup>. |
|||
* The SkyBI platform provides real-time portfolio, underwriting, claims, and actuarial analytics to support these processes <sup>p. 10</sup>. |
|||
* ERM is central to decision-making and daily activities <sup>p. 10</sup>. |
|||
* ERM is a core component of the strategy to achieve market-leading risk-adjusted returns for shareholders <sup>p. 10</sup>. |
|||
* The company's Enterprise Risk Management (ERM) is embedded in its operations and guides daily activities. |
|||
{{Indexing|Reserves|Reserves, incurred and reported claims, IBNR reserves, uncollectible reinsurance, ultimate liability, case reserve, claims management, actuarial reserving techniques, loss reserves|rmmhubj8mh|e40m7ou132|rhstabgyn2|kind=prose|order=15}} |
|||
* The ERM approach aims to achieve an acceptable risk-adjusted return for shareholders while maintaining trust and reliability for those served. |
|||
* The company is intentional in its underwriting and asset portfolio construction, balancing liability duration and market cyclicality of the underwriting portfolio. |
|||
* Reinsurance is used to manage volatility outside of risk tolerances. |
|||
* The investment strategy targets a diversified portfolio that balances portfolio yield, liquidity, volatility, and potential for principal loss. |
|||
* The Senior Vice President (SVP) of Finance & ERM oversees critical ERM processes and chairs the cross-functional corporate ERM Committee. |
|||
* The company formalizes its view of risk and solvency as potential economic loss using its Economic Capital Model (ECM). |
|||
* The ECM output measures potential earnings and capital loss for various scenarios, which are then measured against risk tolerances. |
|||
* Risk tolerances are set and updated annually by the ERM Committee and discussed with the Board's Risk Committee. |
|||
* The ECM provides a probabilistic modeled view of earnings and capital loss, integrating potential losses from catastrophes, reserving, underwriting, market, credit risk, strategic, and operational risks. |
|||
* The SVP of Finance & ERM and the ERM Committee review and maintain a comprehensive risk register with accountabilities for mitigation. |
|||
* The top 10 risks are identified, quantified, and reviewed quarterly by the SVP of Finance & ERM and the ERM Committee. |
|||
* Reports on these risks are submitted regularly to the Risk Committee by the SVP of Finance & ERM and the ERM Committee. |
|||
{{chunk|doc=vycbjm4dw4|c=41|p=8}} |
|||
* The company maintains reserves for specific claims incurred and reported, IBNR reserves, and reserves for uncollectible reinsurance when appropriate <sup>p. 11</sup>. |
|||
'''Operational Risk Management Processes''' |
|||
* The ultimate liability may be greater or less than current reserves, and there is a risk of reserves proving inadequate in the insurance industry <sup>p. 11</sup>. |
|||
* Reserves are continually monitored using new information on reported claims and statistical analyses <sup>p. 11</sup>. |
|||
* Anticipated inflation is implicitly reflected in the reserving process through analysis of cost trends and review of historical development <sup>p. 11</sup>. |
|||
* The company does not discount its reserves for losses and LAE to reflect estimated present value <sup>p. 11</sup>. |
|||
* When a claim is reported, a ''case reserve'' is established for the estimated ultimate payment amount after assessing coverage, damages, and other investigations <sup>p. 11</sup>. |
|||
* Case reserve estimates are based on the company's reserving practices and the claims adjuster’s experience and knowledge of the claim type and value <sup>p. 11</sup>. |
|||
* Case reserves are revised periodically based on subsequent developments for each claim <sup>p. 11</sup>. |
|||
* For more information on claims management, refer to the section "Claims Management" in Item 1 <sup>p. 11</sup>. |
|||
* ''IBNR reserves'' are established in accordance with industry practice to cover estimated future loss payments on incurred claims not yet reported and potential development on reported claims <sup>p. 11</sup>. |
|||
* IBNR reserves are estimated using generally accepted actuarial reserving techniques that consider quantitative loss experience data and qualitative factors <sup>p. 11</sup>. |
|||
* Loss reserves are regularly reviewed using various actuarial techniques <sup>p. 11</sup>. |
|||
* Reserve estimates are updated as historical loss experience develops, additional claims are reported and/or settled, and new information becomes available <sup>p. 11</sup>. |
|||
* Reserves can be increased or decreased over time as claims move towards settlement, impacting earnings through adverse development or reserve releases <sup>p. 11</sup>. |
|||
* For additional information on loss reserves, refer to Item 7 of Form 10-K, "Management’s Discussion and Analysis of Financial Condition and Results of Operations - “Results of Operations - Losses and LAE” and “Critical Accounting Policies” <sup>p. 11</sup>. |
|||
* Operational processes and controls are designed to identify, assess, and manage key risks continuously. |
|||
{{Indexing|Investments|Investment portfolio, predictable and stable returns, strategic investments, Enterprise Based Asset Allocation model, Economic Capital Model, investment risk, cash and cash equivalents, investment-grade fixed-maturity securities, Investment Committee of the Board of Directors, third-party investment management firms|966xer0dpm|kind=prose|order=16}} |
|||
* The Underwriting Committee oversees changes in risk appetite, [[Definition:Business mix|product line]], and division expansion. |
|||
* Claims handling practices are monitored against guidelines through regular internal audits, monthly large loss reviews, and a watchlist of potential high-severity claims. |
|||
* Actuarial performs quarterly reserve studies, and the Reserve Committee meets quarterly to review and respond to loss emergence trends. |
|||
* Key observations from actuarial reviews are discussed with the CEO. |
|||
* Underwriting divisions assess rate change and retention on existing business, new business quality, pricing adequacy, and loss emergence compared to expected on a monthly and quarterly basis. |
|||
* The SkyBI platform provides real-time portfolio, underwriting, claims, and actuarial analytics to support these processes. |
|||
{{chunk|doc=vycbjm4dw4|c=42|p=8}} |
|||
* The company aims to maintain a balanced investment portfolio primarily consisting of investments that yield predictable and stable returns <sup>p. 12</sup>. |
|||
'''ERM Strategic Importance''' |
|||
* The portfolio is augmented by strategic investments designed for attractive risk-adjusted returns <sup>p. 12</sup>. |
|||
* An Enterprise Based Asset Allocation model is used for investment allocation strategy <sup>p. 12</sup>. |
|||
* This model is integrated into the Economic Capital Model, allowing for an understanding of investment allocation impact on capital, liquidity, and risk profile across various market scenarios <sup>p. 12</sup>. |
|||
* The company actively manages and monitors investment risk to balance stable growth and liquidity with compliance to insurance regulatory and rating agency frameworks <sup>p. 12</sup>. |
|||
* The investment portfolio mainly includes cash and cash equivalents and investment-grade fixed-maturity securities <sup>p. 12</sup>. |
|||
* Additional investments are included if they align with the company's risk appetite <sup>p. 12</sup>. |
|||
* The Investment Committee of the Board of Directors reviews and approves the investment policy and strategy <sup>p. 12</sup>. |
|||
* This committee meets quarterly to review investment activities, tactics, and new investment opportunities <sup>p. 12</sup>. |
|||
* The portfolio is directed internally and includes both self-managed investments and portfolios managed by select third-party investment management firms <sup>p. 12</sup>. |
|||
* For further discussion on investments and related market risks, refer to Item 7 of this Form 10-K, "Management’s Discussion and Analysis of Financial Condition and Results of Operations—Investments" <sup>p. 12</sup>. |
|||
* ERM is central to the company's decision-making and daily activities. |
|||
{{Indexing|Competition|Specialty lines property & casualty insurance market, specialty and standard insurers, program administrators, pricing, company reputation, financial strength, broker relationships, product terms and conditions, independent rating agency ratings, claims payment, underwriting and claims teams, Markel Corporation, W.R. Berkley Corporation, American Financial Group Inc., Tokio Marine Holdings, Inc., CNA Financial Corporation, Hiscox, Ltd., RLI Corp., Intact Finance Corporation, Kinsale Capital Group, Inc.|c6zoq3weio|kind=prose|order=17|f1=Key competitors|v1=Markel Corporation, W.R. Berkley Corporation, American Financial Group Inc., Tokio Marine Holdings, Inc., CNA Financial Corporation, Hiscox, Ltd., RLI Corp., Intact Finance Corporation, Kinsale Capital Group, Inc.}} |
|||
* ERM is a core component of the strategy to achieve market-leading risk-adjusted returns for shareholders. |
|||
=== Reserves === |
|||
* The specialty lines property & casualty insurance market includes many markets and sub-markets, each with distinct customer needs, products, services, and specific economic and structural features <sup>p. 13</sup>. |
|||
* Competition in underwriting divisions comes from other specialty and standard insurers and program administrators <sup>p. 13</sup>. |
|||
* Competition factors include pricing, company reputation and financial strength, broker relationships, product terms and conditions, independent rating agency ratings, speed and reputation of claims payment, and the experience and reputation of underwriting and claims teams <sup>p. 13</sup>. |
|||
* Due to the diversity of underwriting divisions, competition is broad, with some competitors specific to only a subset of divisions <sup>p. 13</sup>. |
|||
* Notable competitors include Markel Corporation, W.R. Berkley Corporation, American Financial Group Inc., Tokio Marine Holdings, Inc., CNA Financial Corporation, Hiscox, Ltd., RLI Corp., Intact Finance Corporation, and Kinsale Capital Group, Inc. <sup>p. 13</sup>. |
|||
{{chunk|doc=vycbjm4dw4|c=43|p=8}} |
|||
{{Indexing|Our Structure|Great Midwest Insurance Company (GMIC), Houston Specialty Company (HSIC), Imperium Insurance Company (IIC), Oklahoma Specialty Insurance Company (OSIC), Skyward Re, Skyward Underwriters Agency, Inc., Skyward Service Company, Skyward Specialty No. 1 Limited Company, surety T-listing market, captive reinsurance company, LPT, Lloyd’s corporate member|cmtswfs0go|kind=prose|order=18|f1=Legal name|v1=Skyward Specialty Insurance Group, Inc.|f2=Holding-company structure|v2=GMIC, HSIC, IIC, OSIC, Skyward Re, Skyward Underwriters Agency, Inc., Skyward Service Company, Skyward Specialty No. 1 Limited Company|f3=State of incorporation|v3=Delaware (for parent)}} |
|||
'''Reserve management and methodology''' |
|||
* Reserves are maintained for specific claims incurred and reported, IBNR reserves, and uncollectible reinsurance. |
|||
* Operations are conducted principally through four insurance companies: Great Midwest Insurance Company (GMIC), Houston Specialty Company (HSIC), Imperium Insurance Company (IIC), and Oklahoma Specialty Insurance Company (OSIC) <sup>p. 14</sup>. |
|||
* Ultimate liability may differ from current reserves. |
|||
* ''GMIC'' is the largest insurance subsidiary, underwriting multiple lines of insurance on an admitted basis in all 50 states and the District of Columbia, and is a certified surety bond company listed with the Department of the Treasury <sup>p. 14</sup>. |
|||
* The insurance industry carries the risk of inadequate reserves. |
|||
* ''HSIC'' is a subsidiary of GMIC, underwriting multiple lines of insurance on a surplus lines basis in 50 states, the District of Columbia, and select foreign countries <sup>p. 14</sup>. |
|||
* Reserves are continually monitored using new information on reported claims and statistical analyses. |
|||
* ''IIC'' is a subsidiary of HSIC, underwriting on an admitted basis in all 50 states and the District of Columbia <sup>p. 14</sup>. |
|||
* Anticipated inflation is implicitly reflected in the reserving process through cost trend analysis and historical development review. |
|||
* ''OSIC'' is a subsidiary of IIC, and is an approved surplus lines company in 49 states and the District of Columbia <sup>p. 14</sup>. |
|||
* Reserves for losses and LAE are not discounted to reflect estimated present value. |
|||
* The insurance company subsidiaries were restacked into the current organizational structure effective December 31, 2024, to provide the growing surety business with necessary capital for the surety T-listing market <sup>p. 14</sup>. |
|||
* Case reserves are established when a claim is reported for the estimated ultimate payment, following assessment of coverage, damages, and investigation. |
|||
* ''Skyward Re'' is a wholly-owned captive reinsurance company domiciled in the Cayman Islands, incorporated on January 7, 2020 <sup>p. 14</sup>. |
|||
* Estimates for case reserves are based on reserving practices and the claims adjuster's experience and knowledge of the claim type and value. |
|||
* Skyward Re was established to facilitate an LPT, which was commuted effective January 31, 2025 <sup>p. 14</sup>. |
|||
* Case reserves are periodically revised based on subsequent developments for each claim. |
|||
* Three non-insurance companies are also operated: Skyward Underwriters Agency, Inc., Skyward Service Company, and Skyward Specialty No. 1 Limited Company <sup>p. 14</sup>. |
|||
* IBNR reserves are established for estimated future loss payments on incurred but not yet reported claims and potential development on reported claims. |
|||
* ''Skyward Underwriters Agency, Inc.'' is a licensed agent, managing general agent, and reinsurance broker <sup>p. 14</sup>. |
|||
* IBNR reserves are estimated using generally accepted actuarial reserving techniques that consider quantitative loss experience data and qualitative factors. |
|||
* ''Skyward Service Company'' provides various administrative services to the subsidiaries <sup>p. 14</sup>. |
|||
* Loss reserves are regularly reviewed using various actuarial techniques. |
|||
* ''Skyward Specialty No. 1 Limited Company'' is a UK company and an authorized Lloyd’s corporate member <sup>p. 14</sup>. |
|||
* Reserve estimates are updated as historical loss experience develops, additional claims are reported/settled, and new information becomes available. |
|||
* ''Skyward Specialty Insurance Group, Inc.'' (Delaware corporation) is the parent company <sup>p. 14</sup>. |
|||
* Reserves can be increased or decreased over time as claims move towards settlement, impacting earnings through adverse development or reserve releases. |
|||
* Skyward Specialty Insurance Group, Inc. has direct relationships with Skyward Service Company (Delaware corporation), Great Midwest Insurance Company (Texas stock insurance company), Skyward Underwriters Agency, Inc. (Texas corporation), Skyward Specialty No. 1 Limited (United Kingdom company), and Skyward Re (Cayman Islands corporation) <sup>p. 14</sup>. |
|||
* Additional information on loss reserves is available in Item 7 of Form 10-K, "Management’s Discussion and Analysis of Financial Condition and Results of Operations - “Results of Operations - Losses and LAE” and “Critical Accounting Policies.”". |
|||
* Each entity in the organizational structure is wholly-owned by its immediate parent <sup>p. 14</sup>. |
|||
=== Investments === |
|||
{{Indexing|Geographic distribution of premiums||kind=table|order=19}} |
|||
{{chunk|doc=vycbjm4dw4|c=44|p=8}} |
|||
'''Investment strategy and management''' |
|||
* The company aims to maintain a balanced investment portfolio with predictable and stable returns, augmented by strategic investments for attractive risk-adjusted returns. |
|||
* An Enterprise Based Asset Allocation model is used for investment allocation, embedded in the Economic Capital Model, to assess the impact of decisions on capital, liquidity, and risk profile across market scenarios. |
|||
* Investment risk is actively managed to balance stable growth and liquidity with compliance to insurance regulatory and rating agency frameworks. |
|||
* The portfolio primarily consists of cash and cash equivalents and investment-grade fixed-maturity securities, with additional investments fitting the risk appetite. |
|||
* The Board of Directors' Investment Committee reviews and approves the investment policy and strategy. |
|||
* The Investment Committee meets quarterly to review investment activities, tactics, and new opportunities. |
|||
* The investment portfolio is directed internally and includes both self-managed investments and portfolios managed by select third-party investment management firms. |
|||
{{chunk|doc=vycbjm4dw4|c=45|p=8}} |
|||
'''Investment discussion reference''' |
|||
* Additional discussion on investments, including market risks, is available in Item 7 of Form 10-K, "Management’s Discussion and Analysis of Financial Condition and Results of Operations—Investments". |
|||
=== Competition === |
|||
{{chunk|doc=vycbjm4dw4|c=46|p=8}} |
|||
'''Competition in specialty [[Definition:Property & casualty|P&C]] insurance''' |
|||
* The specialty lines [[Definition:Property & casualty|property & casualty]] insurance market comprises many markets and sub-markets, each with distinct customer needs, products, services, and specific economic and structural features. |
|||
* Competition in underwriting divisions comes from other specialty and standard insurers, as well as program administrators. |
|||
* Competition factors include pricing, general reputation, perceived financial strength, broker relationships, product terms and conditions, independent rating agency ratings, speed and reputation of claims payment, and the experience and reputation of underwriting and claims teams. |
|||
* Due to the diversity of underwriting divisions, competition is broad, with some competitors specific to only a subset of divisions. |
|||
* Notable competitors include Markel Corporation, W.R. Berkley Corporation, American Financial Group Inc., Tokio Marine Holdings, Inc., CNA Financial Corporation, Hiscox, Ltd., RLI Corp., Intact Finance Corporation, and Kinsale Capital Group, Inc.. |
|||
=== Our Structure === |
|||
{{chunk|doc=vycbjm4dw4|c=47|p=8}} |
|||
'''Insurance company structure and operations''' |
|||
* Operations are conducted principally through four insurance companies: Great Midwest Insurance Company (GMIC), Houston Specialty Company (HSIC), Imperium Insurance Company (IIC), and Oklahoma Specialty Insurance Company (OSIC). |
|||
* GMIC, the largest insurance subsidiary, underwrites multiple lines of insurance on an admitted basis in all 50 states and the District of Columbia and is a certified surety bond company listed with the Department of the Treasury. |
|||
* HSIC, a subsidiary of GMIC, underwrites multiple lines of insurance on a surplus lines basis in 50 states, the District of Columbia, and select foreign countries. |
|||
* IIC, a subsidiary of HSIC, underwrites on an admitted basis in all 50 states and the District of Columbia. |
|||
* OSIC, a subsidiary of IIC, is an approved surplus lines company in 49 states and the District of Columbia. |
|||
* Effective December 31, 2024, the insurance company subsidiaries were restacked into the aforementioned organizational structure to provide the growing surety business with the capital needed to operate more effectively within the surety T-listing market. |
|||
{{chunk|doc=vycbjm4dw4|c=48|p=8}} |
|||
'''[[Definition:Gross written premiums|Gross written premiums]] geographic distribution''' |
|||
* The geographic distribution of [[Definition:Gross written premiums|gross written premiums]] for the year ended December 31, 2024, is presented in a table. |
|||
{{chunk|doc=vycbjm4dw4|c=49|p=8}} |
|||
'''Other subsidiaries and organizational structure''' |
|||
* Skyward Re, a wholly-owned captive reinsurance company domiciled in the Cayman Islands, was incorporated on January 7, 2020. |
|||
* Skyward Re was established to facilitate the LPT, which was commuted effective January 31, 2025. |
|||
* Three non-insurance companies are also operated: Skyward Underwriters Agency, Inc., Skyward Service Company, and Skyward Specialty No. 1 Limited Company. |
|||
* Skyward Underwriters Agency, Inc. is a licensed agent, managing general agent, and reinsurance broker. |
|||
* Skyward Service Company provides various administrative services to the subsidiaries. |
|||
* Skyward Specialty No. 1 Limited Company is a UK company and an authorized Lloyd’s corporate member. |
|||
* The organizational structure is detailed, with each entity wholly-owned by its immediate parent. |
|||
{{chunk|doc=vycbjm4dw4|c=50|p=8}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1003" class="wikitable fintable" |
||
|+ Our Structure |
|||
! style="text-align:left" | — |
|||
|- |
|||
! style="text-align:left" | |
|||
! class="col-s" style="text-align:right" | 2024 |
! class="col-s" style="text-align:right" | 2024 |
||
|- |
|- |
||
| Line 688: | Line 914: | ||
| style="text-align:right" | 41.5 |
| style="text-align:right" | 41.5 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total |
||
| style="text-align:right" | |
| style="text-align:right" | 100.0% |
||
|} |
|} |
||
</div> |
</div> |
||
{{chunk|doc=vycbjm4dw4|c=51|p=8}} |
|||
'''Our Structure''' |
|||
[[File:Skyward-2024-FY-Annual report-skwd-20241231_g1.jpg|thumb|Our Structure]] |
[[File:Skyward-2024-FY-Annual report-skwd-20241231_g1.jpg|thumb|Our Structure]] |
||
Chart / Image: |
|||
* SKYWARD SPECIALTY INSURANCE GROUP, INC. is a Delaware corporation. |
|||
* SKYWARD SPECIALTY INSURANCE GROUP, INC. has a subsidiary named SKYWARD SERVICE COMPANY. |
|||
* SKYWARD SERVICE COMPANY is a Delaware corporation. |
|||
* SKYWARD SPECIALTY INSURANCE GROUP, INC. has a subsidiary named GREAT MIDWEST INSURANCE COMPANY. |
|||
* GREAT MIDWEST INSURANCE COMPANY is a Texas stock insurance company. |
|||
* SKYWARD SPECIALTY INSURANCE GROUP, INC. has a subsidiary named SKYWARD UNDERWRITERS AGENCY, INC. |
|||
* SKYWARD UNDERWRITERS AGENCY, INC. is a Texas corporation. |
|||
* SKYWARD SPECIALTY INSURANCE GROUP, INC. has a subsidiary named SKYWARD SPECIALTY NO. 1 LIMITED. |
|||
* SKYWARD SPECIALTY NO. 1 LIMITED is a United Kingdom company. |
|||
* SKYWARD SPECIALTY INSURANCE GROUP, INC. has a subsidiary named SKYWARD RE. |
|||
* SKYWARD RE is a Cayman Islands corporation. |
|||
* GREAT MIDWEST INSURANCE COMPANY has a subsidiary named HOUSTON SPECIALTY INSURANCE COMPANY. |
|||
* HOUSTON SPECIALTY INSURANCE COMPANY is a Texas stock insurance company. |
|||
* HOUSTON SPECIALTY INSURANCE COMPANY has a subsidiary named IMPERIUM INSURANCE COMPANY. |
|||
* IMPERIUM INSURANCE COMPANY is a Texas stock insurance company. |
|||
* IMPERIUM INSURANCE COMPANY has a subsidiary named OKLAHOMA SPECIALTY INSURANCE COMPANY. |
|||
* OKLAHOMA SPECIALTY INSURANCE COMPANY is an Oklahoma insurance corporation. |
|||
=== Ratings === |
|||
{{Indexing|Ratings|Skyward Specialty Insurance Group, Inc., A.M. Best, financial strength rating, profitability, leverage, liquidity, book of business, reinsurance adequacy, quality and estimated market value of assets, adequacy of losses and loss expense reserves, surplus adequacy, capital structure, management experience and competence, market presence|u6q0bi3ei3|kind=prose|order=20|f1=Financial strength rating|v1=A (Excellent)|f2=Rating outlook|v2=stable|f3=Rating agencies|v3=A.M. Best}} |
|||
{{chunk|doc=vycbjm4dw4|c=52|p=8}} |
|||
* ''Skyward Specialty Insurance Group, Inc.'' has an "A" (Excellent) rating with a stable outlook from A.M. Best <sup>p. 15</sup>. |
|||
'''A.M. Best rating''' |
|||
* ''A.M. Best'' rates insurance companies based on factors relevant to policyholders <sup>p. 15</sup>. |
|||
* ''A.M. Best'' assigns 13 ratings to insurance companies, ranging from "A++" (Superior) to "D" (Poor) <sup>p. 15</sup>. |
|||
* The ''"A" (Excellent) rating'' is the third highest rating assigned by A.M. Best <sup>p. 15</sup>. |
|||
* ''A.M. Best'' evaluates a company's financial and operating performance by reviewing profitability, leverage, liquidity, book of business, reinsurance adequacy and soundness, quality and estimated market value of assets, adequacy of losses and loss expense reserves, surplus adequacy, capital structure, management experience and competence, and market presence <sup>p. 15</sup>. |
|||
* ''A.M. Best's ratings'' reflect its opinion on an insurance company's financial strength, operating performance, and ability to meet obligations to policyholders <sup>p. 15</sup>. |
|||
* ''A.M. Best ratings'' are based on factors relevant to policyholders, agents, insurance brokers, and intermediaries, and are not specifically related to securities issued by the company <sup>p. 15</sup>. |
|||
* Skyward Specialty Insurance Group, Inc. currently holds an "A" (Excellent) rating with a stable outlook from A.M. Best. |
|||
{{Indexing|Regulation|Insurance regulatory authorities, state insurance laws and regulations, capital and surplus requirements, licensing, product form and rate review, reserve adequacy standards, statutory accounting methods, financial report content, affiliate transactions, investment types and amounts, National Association of Insurance Commissioners (NAIC), federal government, insurance holding company system, Texas, Oklahoma|1nma8v7gjs|kind=prose|order=21}} |
|||
* The "A" (Excellent) rating is the third highest among the 13 ratings assigned by A.M. Best, which range from "A++" (Superior) to "D" (Poor). |
|||
* A.M. Best evaluates a company's financial and operating performance by reviewing profitability, leverage, liquidity, book of business, reinsurance adequacy, asset quality and market value, adequacy of losses and loss expense reserves, surplus adequacy, capital structure, management experience and competence, and market presence. |
|||
* A.M. Best's ratings reflect its opinion on an insurance company’s financial strength, operating performance, and ability to meet policyholder obligations. |
|||
* These ratings are based on factors relevant to policyholders, agents, insurance brokers, and intermediaries, and are not specifically related to securities issued by the company. |
|||
=== Regulation === |
|||
* We are regulated by insurance regulatory authorities in the states where we conduct business <sup>p. 16</sup>. |
|||
* State insurance laws and regulations are designed to protect policyholders, consumers, and claimants, not stockholders or other investors <sup>p. 16</sup>. |
|||
* The nature and extent of state regulation varies by jurisdiction <sup>p. 16</sup>. |
|||
* State insurance regulators have broad administrative power over matters such as capital and surplus requirements, licensing, product form and rate review, reserve adequacy standards, statutory accounting methods, financial report content, affiliate transactions, and investment types and amounts <sup>p. 16</sup>. |
|||
* Insurance company regulation is constantly changing due to governmental agencies and legislatures reacting to issues <sup>p. 16</sup>. |
|||
* Some state legislatures have considered or enacted laws that alter and increase state authority to regulate insurance companies and holding company systems as a protection against federal involvement <sup>p. 16</sup>. |
|||
* The National Association of Insurance Commissioners ("NAIC") and some state insurance regulators are re-examining existing laws and regulations, focusing on solvency issues, interpretations of existing laws, and the development of new laws <sup>p. 16</sup>. |
|||
* The federal government does not directly regulate the business of insurance, but federal initiatives often affect the industry through treatment of federal subsidiaries, regulation of quasi-governmental entities, and regulations from federal governmental departments <sup>p. 16</sup>. |
|||
* We operate as an insurance holding company system <sup>p. 16</sup>. |
|||
* We are subject to the insurance holding company laws of Texas, where our primary insurance companies are domiciled, and Oklahoma <sup>p. 16</sup>. |
|||
* These statutes require each insurance company in the system to register with the insurance department of its state of domicile <sup>p. 16</sup>. |
|||
* Registration involves furnishing information about operations within the holding company system that may materially affect the operations, management, or financial condition of domiciled insurers <sup>p. 16</sup>. |
|||
* All transactions among members of a holding company system must be fair and reasonable <sup>p. 16</sup>. |
|||
* Transactions between insurance subsidiaries and their parents and affiliates generally must be disclosed to state regulators <sup>p. 16</sup>. |
|||
* Notice to or prior approval from the applicable state insurance regulator is generally required for any material or extraordinary transaction <sup>p. 16</sup>. |
|||
{{chunk|doc=vycbjm4dw4|c=53|p=8}} |
|||
{{Indexing|Intellectual Property|Trademark registrations, intellectual property protection, trademarks, service marks|nd7yoiixiy|kind=prose|order=22}} |
|||
'''Regulation''' |
|||
* The company |
* The company is regulated by insurance regulatory authorities in the states where it conducts business. |
||
* State insurance laws and regulations primarily protect policyholders, consumers, and claimants, not stockholders or investors. |
|||
* The company will pursue additional ''trademark registrations'' and other intellectual property protection if deemed beneficial and cost-effective <sup>p. 17</sup>. |
|||
* State regulation varies by jurisdiction and generally grants broad administrative power to regulators. |
|||
* The company monitors its ''trademarks and service marks'' and protects them from unauthorized use as necessary <sup>p. 17</sup>. |
|||
* Regulatory powers include setting capital and surplus requirements, licensing insurers and producers, reviewing and approving product forms and rates, establishing reserve adequacy standards, prescribing statutory accounting methods and financial report formats, regulating affiliate transactions, and prescribing investment types and amounts. |
|||
* Insurance company regulation is constantly changing due to governmental agencies and legislatures reacting to issues. |
|||
* Some state legislatures have considered or enacted laws that alter and increase state authority to regulate insurance companies and holding company systems to prevent federal involvement. |
|||
* The National Association of Insurance Commissioners (NAIC) and some state insurance regulators are re-examining existing laws and regulations, focusing on insurer solvency, interpretations of existing laws, and development of new laws. |
|||
* Federal initiatives, such as treatment of federal subsidiaries, regulation of quasi-governmental entities, and regulations from federal departments, often affect the insurance industry despite the federal government not directly regulating insurance. |
|||
* The company operates as an insurance holding company system. |
|||
* The company is subject to insurance holding company laws in Texas, where its primary insurance companies are domiciled, and Oklahoma. |
|||
* These statutes require each insurance company in the system to register with its state of domicile's insurance department. |
|||
* Information concerning operations within the holding company system that may materially affect the operations, management, or financial condition of domiciled insurers must be furnished. |
|||
* All transactions among members of a holding company system must be fair and reasonable. |
|||
* Transactions between insurance subsidiaries and their parents and affiliates generally require disclosure to state regulators. |
|||
* Notice to or prior approval from the applicable state insurance regulator is generally required for any material or extraordinary transaction. |
|||
=== Intellectual Property === |
|||
{{Indexing|Employees and Human Capital|Employees, collective bargaining agreement, culture, diversity of thought, background, perspective, talent, competitive benefits package, medical, dental, vision insurance, 401(k) plan, paid time off, family leave, employee assistance programs, employee stock purchase plan, employee training and development, further education, professional development|v84q3tomll|kind=prose|order=23|f1=Employees|v1=approximately 580 as of December 31, 2024}} |
|||
{{chunk|doc=vycbjm4dw4|c=54|p=8}} |
|||
* ''Employees'': approximately 580 as of December 31, 2024 <sup>p. 18</sup>. |
|||
'''Trademark registrations and protection''' |
|||
* Employees are not subject to any collective bargaining agreement <sup>p. 18</sup>. |
|||
* The company is not aware of any current efforts to implement a collective bargaining agreement <sup>p. 18</sup>. |
|||
* The company has applied for various trademark registrations in the United States at both federal and state levels. |
|||
* The company believes it has good working relations with its employees <sup>p. 18</sup>. |
|||
* The company will pursue additional trademark registrations and other intellectual property protection if deemed beneficial and cost-effective. |
|||
* The company aims to be an employer of choice, including outside of the insurance sector <sup>p. 18</sup>. |
|||
* The company monitors its trademarks and service marks and protects them from unauthorized use as necessary. |
|||
* The company strives to create a culture fostering diversity of thought, background, and perspective <sup>p. 18</sup>. |
|||
* The company cultivates an exceptional workforce to perpetuate its ownership culture and achieve superior business results <sup>p. 18</sup>. |
|||
=== Employees and Human Capital === |
|||
* The company's goal is to attract, develop, and retain diverse talent, promoting a culture where different viewpoints are valued, and individuals feel respected, treated fairly, and have opportunities to excel <sup>p. 18</sup>. |
|||
* The company offers a competitive benefits package including medical, dental, and vision insurance, a 401(k) plan, paid time off, family leave, employee assistance programs, and an employee stock purchase plan available to all employees <sup>p. 18</sup>. |
|||
{{chunk|doc=vycbjm4dw4|c=55|p=8}} |
|||
* The company emphasizes employee training and development, providing opportunities for further education and professional development <sup>p. 18</sup>. |
|||
'''Employee overview and culture''' |
|||
* As of December 31, 2024, the company had approximately 580 employees. |
|||
* Employees are not subject to any collective bargaining agreement, and no current efforts to implement such an agreement are known. |
|||
* The company believes it has good working relations with its employees. |
|||
* The company aims to be an employer of choice, fostering a culture committed to diversity of thought, background, and perspective. |
|||
* The company strives to cultivate an exceptional workforce to perpetuate its ownership culture and achieve superior business results. |
|||
* The goal is to attract, develop, and retain diverse talent, promoting a culture where different viewpoints are valued, and individuals feel respected, treated fairly, and have opportunities to excel. |
|||
{{chunk|doc=vycbjm4dw4|c=56|p=8}} |
|||
'''Compensation and benefits''' |
|||
* The company offers a competitive benefits package to support employee well-being. |
|||
* Benefits include medical, dental, and vision insurance, a 401(k) plan, paid time off, family leave, and employee assistance programs. |
|||
* An employee stock purchase plan is available to all employees. |
|||
* The company emphasizes employee training and development, providing opportunities for further education and professional development. |
|||
== Risk Factors == |
== Risk Factors == |
||
{{chunk|doc=vycbjm4dw4|c=57|p=9}} |
|||
* Investing in the company's common stock involves a high degree of risk <sup>p. 19</sup>. |
|||
'''Investment risk disclosure''' |
|||
* Investors should carefully consider the risks and uncertainties described in the report, including consolidated financial statements and related notes, and other SEC filings, before investing <sup>p. 19</sup>. |
|||
* The listed risks and uncertainties are not exhaustive; additional unstated, unknown, or currently immaterial risks may also affect the company <sup>p. 19</sup>. |
|||
* If any of the described risks occur, the company's business, operating results, financial condition, and prospects could be materially harmed <sup>p. 19</sup>. |
|||
* Such events could lead to a decline in the price of the common stock, potentially resulting in a loss of part or all of an investment <sup>p. 19</sup>. |
|||
* Investing in the company's common stock involves a high degree of risk. |
|||
{{Indexing|Summary of Material Risk Factors|Underwriting risk, competition, distribution channels, reinsurance, loss reserves, financial strength rating, coverage interpretation, reinsurer reimbursement, claims payment, economic factors, recession, inflation, unemployment, economic activity, policy sales, claim frequency, premium defaults, falsified claims|w8ma8usdpx|gva2857foa|c6zoq3weio|la5wuhtx31|20fueoa3q1|rmmhubj8mh|kind=prose|order=24}} |
|||
* Investors should carefully consider the risks and uncertainties described in the report, including consolidated financial statements and SEC filings, before investing. |
|||
* The listed risks are not exhaustive; additional unstated, unknown, or currently immaterial risks may also affect the company. |
|||
* If any described risks occur, the company's business, operating results, financial condition, and prospects could be materially harmed. |
|||
* Such events could lead to a decline in the common stock price, resulting in a loss of part or all of an investment. |
|||
=== Summary of Material Risk Factors === |
|||
* ''Underwriting risk'': financial condition and results of operations could be materially adversely affected if underwriting risk is not accurately assessed <sup>p. 20</sup>. |
|||
* ''Competition'': intense competition for business in the industry <sup>p. 20</sup>. |
|||
* ''Distribution channels'': reliance on insurance retail agents and brokers, wholesalers, and program administrators exposes the business to risks that could adversely affect results <sup>p. 20</sup>. |
|||
* ''Reinsurance'': inability to purchase third-party reinsurance in desired amounts on commercially acceptable terms or terms that adequately protect the company may materially adversely affect business, financial condition, and results of operations <sup>p. 20</sup>. |
|||
* ''Loss reserves'': losses and loss expense reserves may be inadequate to cover actual losses, which could materially adversely affect financial condition, results of operations, and cash flows <sup>p. 20</sup>. |
|||
* ''Financial strength rating'': a decline in financial strength rating may adversely affect the amount of business written <sup>p. 20</sup>. |
|||
* ''Coverage interpretation'': unexpected changes in the interpretation of coverage or provisions, including loss limitations and exclusions, in policies could materially adversely affect financial condition and results of operations <sup>p. 20</sup>. |
|||
* ''Reinsurer reimbursement'': reinsurers may not reimburse for claims on a timely basis, or at all, which may materially adversely affect business, financial condition, and results of operations <sup>p. 20</sup>. |
|||
* ''Claims payment'': failure to accurately and timely pay claims could materially and adversely affect business, financial condition, results of operations, and prospects <sup>p. 20</sup>. |
|||
* ''Economic factors'': adverse economic factors, including recession, inflation, high unemployment, or lower economic activity, could lead to fewer policy sales, increased claim frequency, premium defaults, or falsified claims, affecting growth and profitability <sup>p. 20</sup>. |
|||
* ''Industry cyclicality'': the insurance business is historically cyclical, which may affect financial performance and cause operating results to vary quarter-to-quarter, and may not be indicative of future performance <sup>p. 20</sup>. |
|||
* ''Regulation'': extensive regulation may adversely affect the ability to achieve business objectives; non-compliance could result in penalties, including fines and suspensions, adversely affecting financial condition and results of operations <sup>p. 20</sup>. |
|||
* ''Key personnel'': adverse effects could result from the loss of one or more key personnel or an inability to attract and retain qualified personnel <sup>p. 20</sup>. |
|||
* ''Internal control'': ability to maintain effective internal control over financial and management systems and remediate material weaknesses <sup>p. 20</sup>. |
|||
* ''Public company costs'': costs will increase significantly as a public company, and management will need to devote substantial time to complying with public company regulations <sup>p. 20</sup>. |
|||
{{chunk|doc=vycbjm4dw4|c=58|p=9}} |
|||
{{Indexing|Risks Related to Our Business and Industry||kind=prose|order=25}} |
|||
'''business and operational risks''' |
|||
* Financial condition and results of operations could be materially adversely affected by inaccurate assessment of underwriting risk. |
|||
* ''Underwriting success'' depends on accurately assessing risks and establishing appropriate premium rates <sup>p. 21</sup>. |
|||
* Competition for business in the industry is intense. |
|||
* ''Competition'' in the insurance industry is intense, based on factors like price, reputation, financial strength, distribution relationships, product terms, ratings, claims payment speed, and underwriting team experience <sup>p. 21</sup>. |
|||
* Reliance on insurance retail agents and brokers, wholesalers, and program administrators exposes the business to certain risks that could adversely affect results. |
|||
* ''Increased competition'' could affect the ability to price products at risk-adequate rates, retain existing business, or underwrite new business on favorable terms <sup>p. 21</sup>. |
|||
* Inability to purchase third-party reinsurance in desired amounts on commercially acceptable terms or terms that adequately protect the company may materially adversely affect business, financial condition, and results of operations. |
|||
* ''Reliance on distribution channels'' (retail agents, brokers, wholesalers, program administrators) exposes the business to risks <sup>p. 21</sup>. |
|||
* Losses and loss expense reserves may be inadequate to cover actual losses, which could materially adversely affect financial condition, results of operations, and cash flows. |
|||
* ''Products'' are primarily distributed through independent retail agents and brokers who own "renewal rights" <sup>p. 21</sup>. |
|||
* A decline in financial strength rating may adversely affect the amount of business written. |
|||
* ''Relationships with distributors'' can be discontinued or become unprofitable <sup>p. 21</sup>. |
|||
* Unexpected changes in the interpretation of coverage or provisions, including loss limitations and exclusions, in policies could materially adversely affect financial condition and results of operations. |
|||
* ''Consolidation of insurance distribution firms'' may increase their influence on commission rates and concentrate business with particular brokers <sup>p. 21</sup>. |
|||
* Reinsurers may not reimburse claims on a timely basis, or at all, which may materially adversely affect business, financial condition, and results of operations. |
|||
* ''Credit risk'' is assumed when brokers collect premiums directly from policyholders, as the insured may not be liable if the broker fails to remit funds <sup>p. 21</sup>. |
|||
* Failure to accurately and timely pay claims could materially and adversely affect business, financial condition, results of operations, and prospects. |
|||
* ''Failure of brokers to remit premiums'' has not been material to date, but could require providing coverage without receiving payment <sup>p. 21</sup>. |
|||
* Adverse economic factors, including recession, inflation, high unemployment, or lower economic activity, could lead to fewer policy sales, increased claim frequency, premium defaults, or falsification of claims, affecting growth and profitability. |
|||
* ''Financial condition of new brokers'' is reviewed before transacting business <sup>p. 21</sup>. |
|||
* The insurance business is historically cyclical, which may affect financial performance and cause operating results to vary quarter-to-quarter, not indicative of future performance. |
|||
* ''Periodic reviews of distributors'' identify those not meeting profitability standards or business objectives, potentially leading to restricted access or termination <sup>p. 21</sup>. |
|||
* ''Deterioration in distributor relationships'' or uncompetitive compensation could lead distributors to place business with other carriers <sup>p. 21</sup>. |
|||
* ''Distributors exceeding authority'', failing to transfer premiums, or breaching obligations could expose the company to liability <sup>p. 21</sup>. |
|||
* ''Continued consolidation of insurance distribution firms'' could affect sales channels, leading to loss of market access or share, loss of talent, or increased commission costs <sup>p. 21</sup>. |
|||
* ''Digitization risks'' include distributors' ability to keep pace with technology, potentially losing customers to more technology-driven competitors <sup>p. 21</sup>. |
|||
* ''Inability to purchase third-party reinsurance'' on desired or adequate terms could materially adversely affect the business <sup>p. 21</sup>. |
|||
* ''Reinsurance'' is strategically purchased to protect capital from severity events and reduce earnings volatility <sup>p. 21</sup>. |
|||
* ''Failure to renew or expand reinsurance'' could increase loss exposure, potentially requiring a reduction in underwriting commitments <sup>p. 21</sup>. |
|||
* ''Reinsurers may exclude coverages'' or alter terms, leading to gaps in reinsurance protection and greater risk exposure <sup>p. 21</sup>. |
|||
* ''Losses and loss expense (LAE) reserves'' may be inadequate, impacting financial condition, results of operations, and cash flows <sup>p. 21</sup>. |
|||
* ''Reserves'' are estimates of ultimate claim settlement and administration costs, not exact calculations <sup>p. 21</sup>. |
|||
* ''Reserving process'' considers historical data and factors such as claims inflation, claims development patterns, pricing, legislative activity, social/economic patterns, and litigation/judicial/regulatory trends <sup>p. 21</sup>. |
|||
* ''Internal and external events'' can increase exposure to losses, and loss reserves are continually monitored <sup>p. 21</sup>. |
|||
* ''Uncertainties impacting reserve adequacy'' include the time to fully appreciate covered losses, new theories of liability enforced retroactively, volatility in financial markets, economic events, and increased costs due to "social inflation" <sup>p. 21</sup>. |
|||
* ''New theories of liability'' enforced retroactively or changes in claims/coverage issues could materially adversely affect financial condition or results <sup>p. 21</sup>. |
|||
* ''Volatility in financial markets'', economic events, and elevated inflationary conditions could increase claims frequency/severity and loss costs <sup>p. 21</sup>. |
|||
* ''Increased costs due to "social inflation"'' (medical/material costs, technology in vehicles, supply chain disruptions, attorney involvement, litigation financing, lawsuit abuse) could increase claims frequency/severity and affect reserve adequacy <sup>p. 21</sup>. |
|||
* ''Increased claims frequency'' could escalate evaluation and handling costs beyond established reserves <sup>p. 21</sup>. |
|||
* ''Inadequate reserves'' would require increases, reducing net income and stockholders' equity <sup>p. 21</sup>. |
|||
* ''Future loss experience'' substantially exceeding reserves could materially adversely affect future earnings, liquidity, and financial rating <sup>p. 21</sup>. |
|||
* ''A decline in financial strength rating'' may adversely affect the amount of business written <sup>p. 21</sup>. |
|||
* ''A.M. Best'' assigns financial strength ratings based on quantitative and qualitative analysis of balance sheet strength, operating performance, and business profile <sup>p. 21</sup>. |
|||
* ''A.M. Best rating'' as of the filing date is "A" (Excellent) with a stable outlook <sup>p. 21</sup>. |
|||
* ''Factors that could lead to a rating downgrade'' include changes in business practices, unfavorable financial/regulatory/market trends, losses exceeding reserves, unresolved issues with regulators, inability to retain key personnel, investment losses, limited liquidity, or changes in A.M. Best's capital adequacy methodology <sup>p. 21</sup>. |
|||
* ''A rating downgrade or withdrawal'' could cause distribution partners and insureds to choose competitors, increase reinsurance costs or reduce availability, or limit/prevent writing new and renewal insurance contracts <sup>p. 21</sup>. |
|||
* ''Increased scrutiny by rating organizations'' due to earnings and capital pressures in the financial industry could lead to adverse ratings consequences <sup>p. 21</sup>. |
|||
* ''Unexpected changes in interpretation of coverage'' or policy provisions (loss limitations, exclusions) could materially adversely affect financial condition and results <sup>p. 21</sup>. |
|||
* ''Loss limitations or exclusions'' in policies may not be enforceable as intended due to changing industry practices, legal, judicial, social, and other conditions <sup>p. 21</sup>. |
|||
* ''Court or regulatory actions'' could nullify limitations/exclusions or legislation could modify their use, leading to higher than anticipated losses and LAE <sup>p. 21</sup>. |
|||
* ''Court decisions'' may interpret policy exclusions narrowly, expanding coverage and requiring new exclusions <sup>p. 21</sup>. |
|||
* ''Changes in coverage interpretation'' may broaden coverage beyond underwriting intent or increase claims frequency/severity, with full liability potentially unknown for years <sup>p. 21</sup>. |
|||
* ''Reinsurers may not reimburse claims'' on a timely basis or at all, materially adversely affecting the business <sup>p. 21</sup>. |
|||
* ''Reinsurance contracts'' require premium payments to reinsurers who reimburse for covered policy claims, often many years later <sup>p. 21</sup>. |
|||
* ''Reinsurance'' does not relieve the ceding insurer of primary liability to policyholders <sup>p. 21</sup>. |
|||
* ''Reinsurers may default'' due to insolvency, lack of liquidity, operational failure, political/regulatory prohibitions, fraud, or disputes over agreement wordings <sup>p. 21</sup>. |
|||
* ''Disputes with reinsurers'' can be time-consuming, costly, and uncertain <sup>p. 21</sup>. |
|||
* ''Reinsurance recoverables'' totaled $857.9 million as of December 31, 2024 <sup>p. 21</sup>. |
|||
* ''Failure to accurately and timely pay claims'' could lead to regulatory/administrative actions, litigation, reputational damage, and adversely affect the business <sup>p. 21</sup>. |
|||
* ''Effective management of Third-Party Administrators (TPAs)'' and internal staff is crucial for handling claims volume <sup>p. 21</sup>. |
|||
* ''Ineffective TPA management'' or inability to handle claims volume could adversely affect growth and operating margins <sup>p. 21</sup>. |
|||
* ''Severe weather conditions'', earthquakes, man-made catastrophes, and the effects of climate change may adversely affect the business <sup>p. 21</sup>. |
|||
* ''Catastrophes'' include natural events (winter weather, storms, earthquakes, fires) and man-made events (explosions, war, terrorist attacks) <sup>p. 21</sup>. |
|||
* ''Changing weather patterns and climatic conditions'' increase unpredictability and frequency of natural disasters <sup>p. 21</sup>. |
|||
* ''Climate change'' may increase frequency and severity of extreme weather events, such as hurricane activity and wildfire risks <sup>p. 21</sup>. |
|||
* ''Catastrophe losses'' could materially adversely affect the business, even indirectly if insured businesses are impacted by events not directly covered <sup>p. 21</sup>. |
|||
* ''Inability to obtain reinsurance coverage'' at reasonable rates for severe weather and catastrophes could materially adversely affect the business <sup>p. 21</sup>. |
|||
* ''Pandemics, outbreaks, public health crises, and geopolitical/social events'' pose risks, with potential challenges to policy exclusions for virus-related claims <sup>p. 21</sup>. |
|||
* ''Changes to law and regulation related to climate change'' could directly affect the business <sup>p. 21</sup>. |
|||
* ''The current administration's stance'' on clean energy programs and withdrawal from the Paris Agreement could impact future legislative and regulatory actions <sup>p. 21</sup>. |
|||
* ''Unpredictable changes in federal, state, and local legislation'' based on climate change concerns could materially adversely affect business, operational, and financial results <sup>p. 21</sup>. |
|||
* ''Program administrators with quoting and binding authority'' could adversely affect results if they fail to comply with guidelines <sup>p. 21</sup>. |
|||
* ''Program administrators'' sell insurance products through retail agents and brokers and can bind certain risks without initial approval <sup>p. 21</sup>. |
|||
* ''Non-compliance by program administrators'' could lead to being bound on unanticipated risks, affecting estimated losses and LAE <sup>p. 21</sup>. |
|||
* ''Failure of renewals or new business from repeat insureds'' to meet expectations could materially adversely affect future written premium and results <sup>p. 21</sup>. |
|||
* ''Most contracts'' are one-year term and renewable, with some insureds being repeat customers for new contracts <sup>p. 21</sup>. |
|||
* ''Assumptions about renewal rates'' and repeat business are made in financial forecasting <sup>p. 21</sup>. |
|||
* ''Cyclical nature of insurance industry'' with intense price-based competition <sup>p. 21</sup>. |
|||
* ''Increased public attention to ESG matters'' may expose the company to negative public perception, reputational harm, additional costs, or stock price impact <sup>p. 21</sup>. |
|||
* ''Failure to respond to ESG expectations'' or backlash related to ESG topics could harm business and reputation <sup>p. 21</sup>. |
|||
* ''Damage to reputation'' from providing policies to certain insureds could decrease demand for products <sup>p. 21</sup>. |
|||
* ''Changes in accounting practices'' and future pronouncements may materially affect reported financial results and require additional expenses <sup>p. 21</sup>. |
|||
* ''Insurance subsidiaries'' must comply with Statutory Accounting Principles (SAP) <sup>p. 21</sup>. |
|||
* ''SAP and its components'' are subject to constant review by the NAIC and state insurance departments <sup>p. 21</sup>. |
|||
* ''Pending proposals'' before NAIC committees could negatively affect insurance industry participants if enacted <sup>p. 21</sup>. |
|||
{{chunk|doc=vycbjm4dw4|c=59|p=9}} |
|||
{{Indexing|Risks Related to the Market and Economic Conditions||kind=prose|order=26}} |
|||
'''regulatory and personnel risks''' |
|||
* Extensive regulation may adversely affect the ability to achieve business objectives; non-compliance could lead to penalties, including fines and suspensions, adversely affecting financial condition and results of operations. |
|||
* Adverse economic factors like recession, inflation, high unemployment, or lower economic activity can lead to fewer policy sales, increased claim frequency, premium defaults, or claim falsification, impacting growth and profitability <sup>p. 22</sup>. |
|||
* Adverse effects could result from the loss of key personnel or inability to attract and retain qualified personnel. |
|||
* ''Economic downturns'' characterized by higher unemployment, declining spending, and reduced corporate revenue generally affect demand for insurance products, impacting premium levels and profitability <sup>p. 22</sup>. |
|||
* Negative economic factors may hinder the ability to charge appropriate rates for risk, reduce the number of policies written, and limit opportunities for profitable underwriting <sup>p. 22</sup>. |
|||
* In an economic downturn, customers may reduce insurance needs, cancel policies, modify coverage, or not renew policies <sup>p. 22</sup>. |
|||
* Existing policyholders might exaggerate or falsify claims to obtain higher payments during an economic downturn <sup>p. 22</sup>. |
|||
* A significant collapse in economic segments such as construction, credit markets, or energy production and servicing could adversely affect results across multiple underwriting divisions <sup>p. 22</sup>. |
|||
* These outcomes would reduce underwriting profit if not reflected in charged rates <sup>p. 22</sup>. |
|||
* The insurance business is historically cyclical, which can cause operating results to vary quarterly and may not indicate future performance <sup>p. 22</sup>. |
|||
* ''Insurance carriers'' have experienced significant fluctuations in operating results due to competition, catastrophic events, capacity levels, litigation trends, regulatory constraints, and general economic conditions <sup>p. 22</sup>. |
|||
* The supply of insurance is linked to prevailing prices, insured losses, and industry capital levels, which fluctuate with investment rates of return <sup>p. 22</sup>. |
|||
* The insurance industry is cyclical, characterized by periods of intense price competition due to excessive underwriting capacity (soft market) and periods of increased premium levels due to capacity shortages (hard market) <sup>p. 22</sup>. |
|||
* Demand for insurance depends on factors like catastrophic event frequency and severity, capacity levels, new capital providers, and general economic conditions, all of which can contribute to price declines <sup>p. 22</sup>. |
|||
* The financial performance of most ''P&C insurance companies'' tends to follow cyclical market patterns, with higher gross written premium growth and improved profitability during hard market cycles <sup>p. 22</sup>. |
|||
* This cyclical market pattern can be more pronounced in the E&S market than in the standard insurance market <sup>p. 22</sup>. |
|||
* When the standard insurance market hardens, the E&S market typically hardens, and growth in the E&S market can be significantly more rapid <sup>p. 22</sup>. |
|||
* When conditions soften, customers previously in the E&S market may return to the admitted market, exacerbating rate decrease effects on financial results <sup>p. 22</sup>. |
|||
* The market may experience "micro cycles" where specific areas harden or soften independently and potentially more drastically than the overall market <sup>p. 22</sup>. |
|||
* Operating results are subject to fluctuation and have historically varied quarter-to-quarter <sup>p. 22</sup>. |
|||
* Quarterly results are expected to continue fluctuating due to general economic conditions, frequency/severity of catastrophe or insured events, fluctuating interest rates, claims exceeding loss reserves, competition, deviations from expected premium retention, adverse investment performance, and reinsurance coverage costs <sup>p. 22</sup>. |
|||
* ''Investment portfolio performance'' is subject to various investment risks that may adversely affect financial results <sup>p. 22</sup>. |
|||
* The company maintains a diversified investment portfolio managed by professional advisory firms and reviewed by its Investment Committee <sup>p. 22</sup>. |
|||
* Investments are subject to general economic conditions, market risks, and risks inherent to specific securities <sup>p. 22</sup>. |
|||
* Primary market risk exposures are to changes in interest rates and equity prices <sup>p. 22</sup>. |
|||
* A significant portion of the investment portfolio is in fixed maturity securities, or accounts/partnerships primarily invested in them <sup>p. 22</sup>. |
|||
* ''Interest rates'' rose materially during 2022 and 2023 <sup>p. 22</sup>. |
|||
* A low interest rate environment, potentially resulting from federal actions to slow inflation (e.g., recent rate cuts, Inflation Reduction Act of 2022), would pressure net investment income, especially for fixed maturity and short-term investments, adversely affecting operating results <sup>p. 22</sup>. |
|||
* Recent and future interest rate increases could cause values of fixed income securities portfolios to decline, with the magnitude depending on security duration and the extent of rate increases <sup>p. 22</sup>. |
|||
* Some fixed income securities with call or prepayment options create reinvestment risk in declining rate environments <sup>p. 22</sup>. |
|||
* Other fixed income securities, such as mortgage-backed and asset-backed securities, carry prepayment risk or may not prepay as quickly as expected in a rising interest rate environment <sup>p. 22</sup>. |
|||
* All fixed maturity securities, including those in separately managed accounts and limited partnerships, are subject to ''credit risk'' <sup>p. 22</sup>. |
|||
* Credit risk involves potential investment default or impairment due to deterioration in the financial condition of issuers or guarantors of securities held <sup>p. 22</sup>. |
|||
* Downgrades in credit ratings of fixed maturity securities could significantly negatively affect their market valuation <sup>p. 22</sup>. |
|||
* The company also invests in marketable preferred and common equity securities and exchange-traded funds, which are carried at fair market value and subject to potential losses and market value declines <sup>p. 22</sup>. |
|||
* Market and credit risks could reduce net investment income and result in realized investment losses <sup>p. 22</sup>. |
|||
* The investment portfolio faces increased valuation uncertainties when investment markets are illiquid, as with fixed maturity securities held to maturity, separately managed accounts, and limited partnership investments <sup>p. 22</sup>. |
|||
* Valuation of investments is more subjective in illiquid markets, increasing the risk that estimated fair value does not reflect actual transaction prices <sup>p. 22</sup>. |
|||
* Risks for all security types are managed through an investment policy that sets parameters including maximum investment percentages in certain securities and minimum credit quality levels <sup>p. 22</sup>. |
|||
* These investment parameters are believed to be within applicable guidelines established by the NAIC, the Texas Department of Insurance, and the Oklahoma Department of Insurance <sup>p. 22</sup>. |
|||
* The Investment Committee periodically reviews Enterprise Based Asset Allocation models for overall risk management <sup>p. 22</sup>. |
|||
* While seeking to preserve capital, the company cannot guarantee investment objectives will be achieved, and results may vary substantially <sup>p. 22</sup>. |
|||
* Investment strategies aim to not correlate with insurance and reinsurance exposures, but investment losses may occur concurrently with underwriting losses, exacerbating adverse effects <sup>p. 22</sup>. |
|||
* The company could be forced to sell investments to meet liquidity requirements <sup>p. 22</sup>. |
|||
* Premiums received are invested until needed for policyholder claims <sup>p. 22</sup>. |
|||
* The company manages the duration of its investment portfolio based on the duration of losses and LAE reserves to ensure sufficient liquidity and avoid liquidating investments to fund claims <sup>p. 22</sup>. |
|||
* Risks like inadequate losses and LAE reserves or unfavorable litigation trends could necessitate selling investments to fund liabilities <sup>p. 22</sup>. |
|||
* Investments may not be sold at favorable prices or at all, potentially resulting in significant realized losses depending on general market conditions, interest rates, and credit issues with individual securities <sup>p. 22</sup>. |
|||
{{chunk|doc=vycbjm4dw4|c=60|p=9}} |
|||
{{Indexing|Risks Related to the Regulatory Environment||kind=prose|order=27}} |
|||
'''internal control and public company costs''' |
|||
* Ability to maintain effective internal control over financial and management systems and remediate material weaknesses is a risk. |
|||
* Extensive regulation may adversely affect the company's ability to achieve business objectives <sup>p. 23</sup>. |
|||
* Costs will increase significantly as a public company, requiring substantial management time for compliance with public company regulations. |
|||
* Failure to comply with regulations may result in penalties, including fines and suspensions, adversely affecting financial condition and results of operations <sup>p. 23</sup>. |
|||
* Primary insurance subsidiaries (GMIC, HSIC, IIC) are extensively regulated in Texas and other operating states <sup>p. 23</sup>. |
|||
* Most insurance regulations protect policyholders' interests, not investors' or stockholders' <sup>p. 23</sup>. |
|||
* Regulations are administered by state departments of insurance and cover capital and surplus, investment and underwriting limitations, affiliate transactions, dividend limitations, changes in control, solvency, and other financial/non-financial aspects <sup>p. 23</sup>. |
|||
* Significant changes in laws and regulations could limit discretion or increase business costs <sup>p. 23</sup>. |
|||
* State insurance regulators conduct periodic examinations and require annual/other reports on financial condition and holding company issues <sup>p. 23</sup>. |
|||
* Regulatory requirements may impose timing and expense constraints, affecting business objectives <sup>p. 23</sup>. |
|||
* Insurance subsidiaries are part of an "insurance holding company system" under Texas statutes and regulations <sup>p. 23</sup>. |
|||
* Certain transactions between insurance subsidiaries and affiliates require prior notice to the Texas Department of Insurance, potentially causing business delays and additional expenses <sup>p. 23</sup>. |
|||
* Failure to file required notifications or comply with Texas insurance regulations could lead to significant fines, penalties, and impaired working relationships with the Texas Department of Insurance <sup>p. 23</sup>. |
|||
* State insurance regulators have broad discretion to deny or revoke licenses for regulation violations <sup>p. 23</sup>. |
|||
* The company's practices, based on interpretations of regulations or industry norms, may differ from regulatory authorities' interpretations <sup>p. 23</sup>. |
|||
* Lack of requisite licenses/approvals or non-compliance could lead to temporary suspension or preclusion from activities in a state, or other penalties <sup>p. 23</sup>. |
|||
* Changes in insurance industry regulation, laws, or interpretations could interfere with operations and increase compliance costs <sup>p. 23</sup>. |
|||
* Insurance subsidiaries are subject to risk-based capital requirements based on the NAIC model and Texas law <sup>p. 23</sup>. |
|||
* These requirements establish minimum risk-based capital for overall business operations and identify inadequately capitalized property and casualty insurers <sup>p. 23</sup>. |
|||
* Insurers below a calculated threshold may face regulatory action, including supervision, rehabilitation, or liquidation <sup>p. 23</sup>. |
|||
* Failure to maintain required risk-based capital levels could adversely affect regulatory authority to conduct business and the company's A.M. Best Rating <sup>p. 23</sup>. |
|||
* The company may become subject to additional government or market regulation, potentially having a material adverse impact on the business <sup>p. 23</sup>. |
|||
* Changes in laws related to asset/reserve valuation, surplus, investment/dividend limitations, enterprise risk, and risk-based capital could adversely affect the business <sup>p. 23</sup>. |
|||
* The U.S. federal government generally does not directly regulate the insurance industry, except for flood, nuclear, and terrorism risks <sup>p. 23</sup>. |
|||
* Potential federal legislation could affect the insurance industry in areas like privatization of Freddie Mac/Fannie Mae, reduction in federal subsidies for agriculture, tort reform, corporate governance, and taxation of reinsurance companies <sup>p. 23</sup>. |
|||
* Changes to U.S. tax laws and new tax policies could significantly negatively impact the overall economy and the company's business <sup>p. 23</sup>. |
|||
* Legislative or other actions related to taxes could negatively affect the company, its investments, or stockholders <sup>p. 23</sup>. |
|||
* Rules for U.S. federal income taxation are constantly under review by legislators, the IRS, and the U.S. Department of the Treasury <sup>p. 23</sup>. |
|||
* The company cannot predict the impact of tax law changes on itself, stockholders, or portfolio investments <sup>p. 23</sup>. |
|||
* New legislation, U.S. Treasury regulations, administrative interpretations, or court decisions could have adverse consequences <sup>p. 23</sup>. |
|||
* Stockholders are advised to consult tax advisors regarding tax legislative, regulatory, or administrative developments <sup>p. 23</sup>. |
|||
* The current administration's agenda includes potential U.S. tax law reform, with outlined intentions such as reducing the corporate tax rate, extending Tax Cuts and Jobs Act of 2017 (TCJA) provisions, and imposing new tariffs <sup>p. 23</sup>. |
|||
* The combined impact of extending TCJA tax benefits and new tariffs could lead to increases in the U.S. deficit, inflation, and interest rates <sup>p. 23</sup>. |
|||
* These factors could contribute to increased market interest rates and decreased U.S. economic growth, potentially leading to a recession, all of which could negatively impact the business <sup>p. 23</sup>. |
|||
* The company's ability to utilize net operating loss carryforwards (NOLs) and other tax attributes may be limited <sup>p. 23</sup>. |
|||
* As of December 31, 2024, the company had ''gross federal income tax NOLs'' of approximately $44.7 million <sup>p. 23</sup>. |
|||
* These NOLs are available to offset future taxable income, subject to annual limitations under Section 382 of the Internal Revenue Code of 1986 (the Code) <sup>p. 23</sup>. |
|||
* The NOLs are set to expire beginning in 2032 <sup>p. 23</sup>. |
|||
* Under Section 382 of the Code, an "ownership change" (greater than 50% change in equity ownership by certain stockholders over a rolling three-year period) can limit the use of pre-ownership change NOLs <sup>p. 23</sup>. |
|||
* Future ownership changes, some outside the company's control, may occur <sup>p. 23</sup>. |
|||
* Future regulatory changes could also limit the ability to utilize NOLs <sup>p. 23</sup>. |
|||
* Inability to offset future taxable income with NOLs could adversely affect net income and cash flows <sup>p. 23</sup>. |
|||
* As a holding company with operations primarily conducted by insurance subsidiaries, liquidity at the holding company level depends on cash dividends or permitted payments from insurance subsidiaries <sup>p. 23</sup>. |
|||
* Continued operation and growth require substantial capital <sup>p. 23</sup>. |
|||
* The company does not intend to declare and pay cash dividends on common stock in the foreseeable future <sup>p. 23</sup>. |
|||
* Ability to pay dividends to stockholders and meet debt obligations depends on dividends and distributions from primary insurance subsidiaries (GMIC, HSIC, IIC) <sup>p. 23</sup>. |
|||
* State insurance laws, including Texas laws, restrict the ability of GMIC, HSIC, and IIC to determine stockholder dividends <sup>p. 23</sup>. |
|||
* Insurance companies are required to maintain specified levels of statutory capital and surplus <sup>p. 23</sup>. |
|||
* Dividend payments are limited to the portion of available policyholder surplus derived from net profits <sup>p. 23</sup>. |
|||
* State insurance regulators have broad powers to prevent reduction of statutory surplus to inadequate levels <sup>p. 23</sup>. |
|||
* There is no assurance that dividends up to maximum calculated amounts would be permitted <sup>p. 23</sup>. |
|||
* State insurance regulators may adopt more restrictive statutory provisions regarding dividend payments in the future <sup>p. 23</sup>. |
|||
* Any future dividend determination will be at the discretion of the Board of Directors, based on results, financial condition, contractual restrictions, indebtedness, applicable law, and other relevant factors <sup>p. 23</sup>. |
|||
* Investors may need to sell common stock for gains, as immediate cash dividends are not expected <sup>p. 23</sup>. |
|||
* Applicable insurance laws may make a change of control difficult <sup>p. 23</sup>. |
|||
* Under Texas insurance laws, acquiring control of a domestic insurer requires written approval from the state insurance commissioner <sup>p. 23</sup>. |
|||
* Approval depends on factors including the acquirer's financial strength, plans for the insurer's future operations, and potential anti-competitive results <sup>p. 23</sup>. |
|||
* Texas insurance laws apply to direct and indirect acquisition of 10% or more of the voting stock of a Texas-domiciled insurer <sup>p. 23</sup>. |
|||
* Acquisition of 10% or more of the company's common stock would be considered an indirect change of control, triggering filing requirements under Texas insurance laws, unless a disclaimer of control is accepted <sup>p. 23</sup>. |
|||
* These requirements may discourage acquisition proposals and delay, deter, or prevent a change of control, even if stockholders consider it desirable <sup>p. 23</sup>. |
|||
=== Risks Related to Our Business and Industry === |
|||
{{chunk|doc=vycbjm4dw4|c=61|p=9}} |
|||
* Future capital requirements depend on factors such as the ability to write new business successfully and establish premium rates and reserves sufficient to cover losses <sup>p. 24</sup>. |
|||
'''Underwriting risk and competition''' |
|||
* If operational cash flows are insufficient to fund future operating requirements and cover claim losses, or if the capital position is adversely impacted by a decline in the fair value of the investment portfolio, catastrophe losses, or other events, additional funds may be needed through financings or growth may be curtailed <sup>p. 24</sup>. |
|||
* Factors affecting the amount and timing of capital needs include growth rate, profitability, claims experience, availability of reinsurance, market disruptions, and other unforeseeable developments <sup>p. 24</sup>. |
|||
* If additional capital is needed, equity or debt financing may not be available or may only be available on unfavorable terms <sup>p. 24</sup>. |
|||
* Equity financings could result in dilution to stockholders <sup>p. 24</sup>. |
|||
* Debt financings may impose covenants restricting business operations <sup>p. 24</sup>. |
|||
* Securities issued for capital raising may have rights, preferences, and privileges senior to common stock <sup>p. 24</sup>. |
|||
* Inability to obtain adequate capital on favorable terms could materially adversely affect operating plans, business, financial condition, or results of operations <sup>p. 24</sup>. |
|||
* Financial condition and results of operations could be materially adversely affected by inaccurate assessment of underwriting risk. |
|||
{{Indexing|Risks Related to Our Operations||kind=prose|order=29}} |
|||
* Underwriting success depends on accurately assessing risks and establishing appropriate premium rates. |
|||
* Employees, including management and underwriters, make decisions that expose the company to risk. |
|||
* Competition in the insurance industry is intense, coming from specialty insurance companies, standard insurance companies, and underwriting agencies. |
|||
* Competition factors include price, reputation, financial strength, distribution partner relationships, product terms, rating agency ratings, claims payment speed, and underwriting team experience. |
|||
* Increasing consolidation in the insurance industry may further increase competition. |
|||
* New industry or legislative developments could increase competition. |
|||
* Inability to compete successfully could change supply and demand for insurance, affect pricing ability, and impact retention of existing business or underwriting new business on favorable terms. |
|||
* Increased competition limiting business transactions could adversely affect operating results. |
|||
{{chunk|doc=vycbjm4dw4|c=62|p=9}} |
|||
* The company could be adversely affected by the loss of key personnel or an inability to attract and retain qualified personnel <sup>p. 25</sup>. |
|||
'''Distribution channel risks''' |
|||
* The company depends on attracting and retaining experienced personnel knowledgeable about its business <sup>p. 25</sup>. |
|||
* The talent pool for recruitment is limited and can fluctuate based on market dynamics specific to the industry <sup>p. 25</sup>. |
|||
* Higher demand for skilled employees could increase compensation expectations, making it difficult to retain and recruit key personnel and manage labor costs <sup>p. 25</sup>. |
|||
* Loss of key personnel or inability to attract talent could hinder the company's competitive position in specialized markets and adversely affect operations <sup>p. 25</sup>. |
|||
* Security breaches, data loss, cyberattacks, and IT failures could disrupt operations, damage reputation, and adversely affect business, operations, and financial results <sup>p. 25</sup>. |
|||
* The business relies heavily on information technology and telecommunications systems for underwriting, claims, policy processing, actuarial functions, payments, and financial reporting <sup>p. 25</sup>. |
|||
* Some systems may involve or rely on third-party systems not located on company premises or under its control <sup>p. 25</sup>. |
|||
* Events like natural catastrophes, terrorist attacks, industrial accidents, computer viruses, and cyber-attacks could cause system failures or inaccessibility for extended periods <sup>p. 25</sup>. |
|||
* Sustained or repeated system failures could limit the company's ability to process business, provide customer service, pay claims, or operate normally <sup>p. 25</sup>. |
|||
* Computer viruses, hackers, employee misconduct, and other external hazards could lead to security breaches or cyber-attacks <sup>p. 25</sup>. |
|||
* Despite security measures, systems and networks may experience breaches or interference, and third-party service providers will likely continue to face cybersecurity incidents <sup>p. 25</sup>. |
|||
* Such events could result in operational disruptions, unauthorized access, disclosure or loss of proprietary or customer data, leading to legal claims, regulatory scrutiny, reputational damage, costs, and loss of customers <sup>p. 25</sup>. |
|||
* SEC and state law requirements for public notification of incidents could exacerbate harm to the business <sup>p. 25</sup>. |
|||
* Advances in criminal capabilities, new vulnerabilities, exploitation attempts, data thefts, or physical break-ins could compromise security measures <sup>p. 25</sup>. |
|||
* Third parties to whom functions are outsourced are also subject to these risks <sup>p. 25</sup>. |
|||
* While the company reviews and assesses third-party cybersecurity controls, it cannot ensure complete success in preventing compromises or disclosures of confidential information <sup>p. 25</sup>. |
|||
* Increased use of third-party services (e.g., cloud technology, SaaS) can complicate identification and response to cyberattacks due to dynamic technologies <sup>p. 25</sup>. |
|||
* These risks could increase as vendors adopt more cloud-based software services <sup>p. 25</sup>. |
|||
* The company may not be able to manage its growth effectively <sup>p. 25</sup>. |
|||
* Future business growth may require additional capital, systems development, and skilled personnel <sup>p. 25</sup>. |
|||
* Failure to manage capital needs, expand systems and controls, allocate human resources, hire and train employees, and integrate acquired businesses could adversely affect the company <sup>p. 25</sup>. |
|||
* Inorganic growth through acquisition depends on identifying appropriate targets, negotiating favorable terms, completing transactions, and successfully integrating targets <sup>p. 25</sup>. |
|||
* The company may not realize anticipated benefits from acquisitions, such as revenue growth, operational efficiencies, or expected synergies <sup>p. 25</sup>. |
|||
* The company has experienced rapid growth in recent years, but these rates may not indicate future growth <sup>p. 25</sup>. |
|||
* Sustaining revenue growth consistent with recent history may not be possible in future periods <sup>p. 25</sup>. |
|||
* Revenue growth depends on factors including effective product pricing to attract and retain insureds without compromising profitability <sup>p. 25</sup>. |
|||
* Other factors include successful deployment and implementation of products, obtaining renewals, and providing excellent support to distribution partners <sup>p. 25</sup>. |
|||
* Attracting and retaining highly qualified underwriters and claims professionals is also a factor <sup>p. 25</sup>. |
|||
* Enhancing infrastructure and data reporting systems to efficiently deliver products is crucial <sup>p. 25</sup>. |
|||
* Successfully creating new distribution channels and introducing new/enhancing existing products are important for growth <sup>p. 25</sup>. |
|||
* The ability to successfully compete against larger companies and new market entrants, and increase brand awareness, also impacts revenue growth <sup>p. 25</sup>. |
|||
* Failure to accomplish these objectives makes forecasting future results difficult <sup>p. 25</sup>. |
|||
* Historical growth rates are not indicative of future performance and may decline <sup>p. 25</sup>. |
|||
* Revenue growth could slow or decline for various reasons, including those outlined <sup>p. 25</sup>. |
|||
* Operating expenses are expected to increase, and if revenue growth does not offset these increases, the business, financial position, and results of operations could be harmed, potentially impacting profitability <sup>p. 25</sup>. |
|||
* The effects of litigation are uncertain and could adversely affect the business <sup>p. 25</sup>. |
|||
* The company continually faces litigation risks, including disputes related to insurance claims and general commercial/corporate litigation <sup>p. 25</sup>. |
|||
* While not currently involved in unusual litigation, other industry members face class action lawsuits and other litigation with unpredictable outcomes and substantial amounts <sup>p. 25</sup>. |
|||
* Social inflation, particularly in third-party claims, can lead to oversized judgments <sup>p. 25</sup>. |
|||
* Litigation costs and settlement amounts can be inflated even when cases do not reach judgment <sup>p. 25</sup>. |
|||
* Litigation is based on various issues, including insurance and claim settlement practices <sup>p. 25</sup>. |
|||
* The company cannot predict future involvement in such litigation or its impact on the business <sup>p. 25</sup>. |
|||
* Loss of key vendor relationships or vendor failure to protect data could affect operations <sup>p. 25</sup>. |
|||
* The company relies on numerous vendors in the United States and abroad for computer hardware/software, claim adjustment, HR benefits management, and investment management services <sup>p. 25</sup>. |
|||
* Vendor bankruptcy, inability to provide services, system breaches, or failure to protect confidential information could lead to operational impairments and financial losses <sup>p. 25</sup>. |
|||
* Failure to properly assess and understand vendor risks, despite monitoring, could materially and adversely affect financial condition and results of operations <sup>p. 25</sup>. |
|||
* The company anticipates continued reliance on third-party software <sup>p. 25</sup>. |
|||
* While commercially reasonable alternatives to current licensed third-party software are believed to exist, this may not always be the case, or replacement could be difficult or costly <sup>p. 25</sup>. |
|||
* Integration of new third-party software may require significant work, time, and resources <sup>p. 25</sup>. |
|||
* Obtaining license agreements for additional or alternative third-party software may not be possible on commercially reasonable terms or at all <sup>p. 25</sup>. |
|||
* Many risks associated with third-party software use cannot be eliminated and could negatively affect the business <sup>p. 25</sup>. |
|||
* The company may fail to protect its intellectual property rights for its proprietary technology platform and brand, or may face infringement lawsuits <sup>p. 25</sup>. |
|||
* Success and competitive ability depend partly on intellectual property, including brand rights and proprietary technology in certain product lines <sup>p. 25</sup>. |
|||
* Protection primarily relies on copyright and trade secret laws, and confidentiality agreements with employees, customers, service providers, and partners <sup>p. 25</sup>. |
|||
* Steps taken to protect intellectual property may be inadequate <sup>p. 25</sup>. |
|||
* Efforts to enforce intellectual property rights may face defenses, counterclaims, and countersuits challenging validity, enforceability, and scope <sup>p. 25</sup>. |
|||
* Failure to secure, protect, and enforce intellectual property rights could adversely affect the brand and business <sup>p. 25</sup>. |
|||
* Success also depends on not infringing on others' intellectual property rights <sup>p. 25</sup>. |
|||
* Competitors and other entities may own or claim intellectual property related to the industry or the company <sup>p. 25</sup>. |
|||
* Future claims of infringement could lead to significant expenses, substantial damages, ongoing royalty payments, inability to offer services, or other unfavorable terms <sup>p. 25</sup>. |
|||
* Even if successful in a dispute, litigation could be costly, time-consuming, and divert management attention <sup>p. 25</sup>. |
|||
* Reliance on insurance retail agents, brokers, wholesalers, and program administrators exposes the company to certain risks. |
|||
{{Indexing|Risks Related to Ownership of Our Common Stock||kind=prose|order=30}} |
|||
* Most products are distributed through independent retail agents and brokers who own "renewal rights". |
|||
* Business model depends on relationships with and success of retail agents and brokers, wholesalers, and program administrators. |
|||
* Relationships with distributors can be discontinued or become unprofitable. |
|||
* Consolidation of insurance distribution firms may increase their influence on commission rates and concentration of business with particular brokers. |
|||
* Premiums collected by brokers and remitted to the company expose the company to credit risk, as payment to the broker may be considered payment to the company in certain jurisdictions. |
|||
* Failure of brokers to remit premiums could require the company to provide coverage despite non-payment, potentially declining underwriting profits and adversely affecting financial condition. |
|||
* The company reviews financial condition of new brokers and periodically reviews existing distributors for profitability and alignment with business objectives. |
|||
* Measures like restricting product access or terminating relationships with distributors may not achieve desired results due to contractual and regulatory requirements. |
|||
* Deterioration of distributor relationships or uncompetitive compensation could lead distributors to place more premium with other carriers. |
|||
* Distributors exceeding granted authority, failing to transfer collected premiums, or breaching obligations could expose the company to liability. |
|||
* Continued consolidation of insurance distribution firms could affect sales channels through loss of market access, market share, talent, or increased commission costs due to greater negotiating leverage. |
|||
* Disruption to sales channels could negatively impact results of operations and financial condition. |
|||
* Acceleration of digitization subjects the company to risks related to distributors' ability to keep pace, as customers may prefer technology-driven experiences. |
|||
{{chunk|doc=vycbjm4dw4|c=63|p=9}} |
|||
* Operating as a public company incurs increased costs and requires substantial management time for compliance initiatives <sup>p. 26</sup>. |
|||
'''Reinsurance availability and effectiveness''' |
|||
* Financial reporting and other requirements for public companies may exceed the current preparedness of accounting and management systems and resources <sup>p. 26</sup>. |
|||
* As a public company, and no longer an emerging growth company, significant legal, accounting, and other expenses are incurred that would not be present as a private company <sup>p. 26</sup>. |
|||
* Inability to purchase third-party reinsurance on desired or acceptable terms could materially adversely affect business, financial condition, and results of operations. |
|||
* Federal securities laws, including the Sarbanes-Oxley Act, the Dodd-Frank Act, and SEC/Nasdaq regulations, impose requirements on public companies for filing reports, establishing disclosure and financial controls, and corporate governance practices <sup>p. 26</sup>. |
|||
* Reinsurance is strategically purchased to protect capital from severity events and reduce earnings volatility. |
|||
* These regulations increase compliance costs, make activities more time-consuming, and require substantial management and personnel time for compliance <sup>p. 26</sup>. |
|||
* Failure to renew expiring contracts, enter new arrangements, or expand coverage could increase loss exposure. |
|||
* There is a risk of not being able to produce reliable financial statements, file them timely with the SEC, or comply with Nasdaq listing requirements <sup>p. 26</sup>. |
|||
* Increased loss exposure could necessitate reducing underwriting commitments, adversely affecting business, financial condition, and results of operations. |
|||
* Section 404 of the Sarbanes-Oxley Act mandates system and process evaluation and testing of internal control over financial reporting, requiring substantial accounting expense and management effort <sup>p. 26</sup>. |
|||
* Reinsurers may exclude certain coverages or alter terms in contracts, leading to gaps in reinsurance protection and greater risk/potential losses. |
|||
* Compliance with Section 404 necessitates maintaining accounting and finance staff and consultants with public company reporting, technical accounting, and internal control knowledge, and providing internal audit services <sup>p. 26</sup>. |
|||
* The process to document and evaluate internal control over financial reporting for Section 404 is costly and challenging, involving internal resources, outside consultants, a detailed work plan, control process improvements, testing, and continuous reporting <sup>p. 26</sup>. |
|||
{{chunk|doc=vycbjm4dw4|c=64|p=9}} |
|||
* There is a risk that neither the company nor its independent registered public accounting firm will conclude that internal control over financial reporting is effective within the prescribed timeframe, potentially leading to adverse financial market reactions or SEC investigations <sup>p. 26</sup>. |
|||
'''Loss and loss expense reserves adequacy''' |
|||
* As a public company, disclosure controls and procedures must be maintained to ensure timely and accurate reporting of information required by the Exchange Act <sup>p. 26</sup>. |
|||
* Disclosure controls and procedures or internal control over financial reporting may not prevent or detect all errors and fraud, as control systems provide only reasonable, not absolute, assurance <sup>p. 26</sup>. |
|||
* Inadequate losses and loss expense (LAE) reserves could materially adversely affect financial condition, results of operations, and cash flows. |
|||
* Inherent limitations in control systems mean that misstatements due to error or fraud may occur and go undetected <sup>p. 26</sup>. |
|||
* Success depends on accurately assessing risks of insured businesses and people. |
|||
* Failure to achieve and maintain effective internal controls, as required by Section 404 of the Sarbanes-Oxley Act, could harm operating results and financial condition, and negatively affect the common stock price <sup>p. 26</sup>. |
|||
* Reserves are established as the best estimate for ultimate payment of incurred claims and related adjustment costs. |
|||
* The company must document and test internal control procedures to satisfy Section 404(b) of the Sarbanes-Oxley Act, requiring annual management assessments of internal control over financial reporting effectiveness <sup>p. 26</sup>. |
|||
* Reserves are estimates, and ultimate liability may differ from the estimate. |
|||
* Deficiencies may be identified during assessments that cannot be remediated timely, and testing/maintaining internal controls may divert management attention <sup>p. 26</sup>. |
|||
* Reserving process considers historical data and factors such as claims inflation, claims development patterns, frequency and severity trends, product pricing, legislative activity, social and economic patterns, and litigation/judicial/regulatory trends. |
|||
* If internal control over financial reporting is concluded to be ineffective, remediation costs and scope could be significant, and material weaknesses may impede timely and accurate SEC filings <sup>p. 26</sup>. |
|||
* Variables are affected by internal and external events that could increase loss exposure. |
|||
* Such issues could cause investors to lose confidence, or lead to suspension/termination of Nasdaq listing, negatively affecting the common stock trading price <sup>p. 26</sup>. |
|||
* Loss reserves are continually monitored using new information, statistical techniques, and modeling simulations. |
|||
* A material weakness in internal control over information technology general controls (ITGCs) has been identified <sup>p. 26</sup>. |
|||
* The process assumes past experience, adjusted for current developments and trends, is appropriate for predicting future events. |
|||
* Failure to remediate the material weakness or maintain effective ITGCs could adversely affect the market price of common stock <sup>p. 26</sup>. |
|||
* No precise method exists for evaluating the impact of specific factors on reserve adequacy, and actual results may deviate substantially from estimates. |
|||
* The effectiveness of controls is subject to inherent limitations, meaning controls may not prevent or detect all misstatements, and even effective ITGCs provide only reasonable assurance <sup>p. 26</sup>. |
|||
* Uncertainties impacting reserve adequacy include: considerable time to fully appreciate covered loss extent, leading to increased loss estimates over time; new theories of liability enforced retroactively; failure of loss limitations or exclusions; changes in claims or coverage issues. |
|||
* Management, including the Chief Executive Officer, Chief Financial Officer, and Chief Information and Technology Officer, evaluated internal control over financial reporting as of December 31, 2024, using COSO's 2013 Integrated Framework <sup>p. 26</sup>. |
|||
* Volatility in financial markets, economic events, and other external factors may increase claim numbers and/or severity. |
|||
* Management concluded a material weakness existed as of December 31, 2024, related to ineffective implementation of ITGCs in user access for systems supporting financial reporting processes <sup>p. 26</sup>. |
|||
* Elevated inflationary conditions would increase loss costs. |
|||
* Related process-level IT dependent manual and automated controls relying on affected ITGCs or information from affected IT systems were also deemed ineffective <sup>p. 26</sup>. |
|||
* Adverse economic factors (recession, inflation, high unemployment, lower economic activity) could lead to fewer policy sales or increased claim frequency/severity and premium defaults, affecting growth and profitability. |
|||
* Additional information, including management's remediation plan, is available in "ITEM 9A. CONTROLS & PROCEDURES" in the Form 10-K <sup>p. 26</sup>. |
|||
* Increased costs due to "social inflation" (medical/material costs, technology in vehicles, supply chain disruptions, attorney involvement, litigation financing, lawsuit abuse) could increase claim frequency/severity and affect reserve adequacy. |
|||
* Failure to timely remediate the material weakness or maintain effective ITGCs and related controls could lead to significant resource expenditure, fines, penalties, investigations, or judgments, negatively impacting investor confidence and stock price <sup>p. 26</sup>. |
|||
* Increased claim frequency, even without liability, could escalate evaluation and handling costs beyond established reserves. |
|||
* The market price of common stock has been and is likely to remain highly volatile, fluctuating due to factors beyond the company's control <sup>p. 26</sup>. |
|||
* Entering new [[Definition:Business mix|lines of business]] or new theories of claims may increase claim frequency and handling costs. |
|||
* Securities markets worldwide experience significant price and volume fluctuations, which, along with general economic, market, or political conditions, could cause wide price fluctuations in the company's shares regardless of operating performance <sup>p. 26</sup>. |
|||
* Inadequate reserves would require increases, reducing net income and stockholders' equity in the period of identification. |
|||
* Investment in common stock is considered risky, requiring tolerance for significant loss and wide market value fluctuations <sup>p. 26</sup>. |
|||
* Future loss experience substantially exceeding established reserves could materially adversely affect future earnings, liquidity, and financial rating. |
|||
* Factors that could affect stock price include: market conditions, fluctuations in quarterly financial/operating results, new product/service introductions by the company or competitors, new/changed securities analysts' reports, operating results varying from expectations, short sales/hedging/derivative transactions, guidance provided (or changes/failure to meet it), strategic actions, announcements by the company/competitors/acquisition targets, sales of large blocks of stock, changes in Board/management/key personnel, regulatory/legal/political developments, public response to announcements, litigation/governmental investigations, changing economic conditions (including social inflation), changes in accounting principles, future indebtedness/securities issuance, default under debt agreements, exposure to capital/credit market risks, changes in credit ratings, and other events like natural disasters, war, or terrorism <sup>p. 26</sup>. |
|||
* Securities markets, including Nasdaq, have experienced extreme price and volume fluctuations unrelated to company operating performance <sup>p. 26</sup>. |
|||
{{chunk|doc=vycbjm4dw4|c=65|p=9}} |
|||
* Investors may not be able to resell shares at or above purchase price due to broad market fluctuations, general market, economic, and political conditions (e.g., recessions, loss of investor confidence, interest rate changes) <sup>p. 26</sup>. |
|||
'''Financial strength rating impact''' |
|||
* Such events could cause the stock price to fall and expose the company to securities class action litigation, which could be costly, divert management attention, or harm the business <sup>p. 26</sup>. |
|||
* Management has the authority to change underwriting guidelines or strategy without stockholder notice or approval <sup>p. 26</sup>. |
|||
* A decline in financial strength rating may adversely affect the amount of business written. |
|||
* This allows fundamental changes to operations without stockholder approval, potentially resulting in a strategy or underwriting guidelines materially different from those described in the "Business" section or elsewhere in the filing <sup>p. 26</sup>. |
|||
* Independent rating agencies like A.M. Best assess financial strength and quality of insurers. |
|||
* Anti-takeover provisions in organizational documents could delay a change in management and limit share price <sup>p. 26</sup>. |
|||
* A.M. Best ratings are based on quantitative and qualitative analysis of balance sheet strength, operating performance, and business profile. |
|||
* Provisions in the certificate of incorporation and bylaws could make it harder for a third party to acquire control, even if beneficial to common stock value, and prevent attempts to replace the Board or management, thus adversely affecting common stock price <sup>p. 26</sup>. |
|||
* A.M. Best financial strength ratings range from "A++" (Superior) to "F" (liquidation). |
|||
* Charter documents permit the Board to establish director numbers and fill vacancies, classify the Board into three classes with staggered three-year terms (directors removable only for cause), require super-majority voting for amendments, include blank-check preferred stock, eliminate stockholder ability to call special meetings, specify special meetings can only be called by the Board/Chairman/CEO, prohibit stockholder consent action by other than unanimous written consent, provide that Board vacancies are filled only by a majority of directors then in office, prohibit cumulative voting, and establish advance notice requirements for nominations or proposals at annual meetings <sup>p. 26</sup>. |
|||
* As of the filing date, A.M. Best assigned an "A" (Excellent) financial strength rating with a stable outlook to the company. |
|||
* As a Delaware corporation, the company is subject to Section 203 of the Delaware General Corporation Law, which may prohibit large stockholders (owning 15% or more of voting stock) from merging or combining with the company for a period <sup>p. 26</sup>. |
|||
* A.M. Best ratings provide an independent opinion of an insurer's ability to meet policyholder obligations and are not an evaluation for investors or a recommendation to buy/sell securities. |
|||
* The certificate of incorporation and bylaws designate the Court of Chancery of the State of Delaware as the exclusive forum for substantially all disputes between the company and its stockholders <sup>p. 26</sup>. |
|||
* A.M. Best's analysis includes peer comparisons, industry standards, operating plans, philosophy, and management assessments. |
|||
* This exclusive forum provision could limit stockholders' ability to obtain a favorable judicial forum for disputes with the company or its directors, officers, or employees <sup>p. 26</sup>. |
|||
* A.M. Best periodically reviews and may revise ratings downward based on analyses of balance sheet strength, operating performance, and business profile. |
|||
* The exclusive forum applies to derivative actions, claims of breach of fiduciary duty, claims arising under DGCL or charter/bylaws, actions to interpret/apply/enforce/determine validity of charter/bylaws, and claims governed by the internal affairs doctrine <sup>p. 26</sup>. |
|||
* Specific building blocks reviewed by A.M. Best include capital adequacy, operating performance, operating profile, and ERM. |
|||
* The certificate of incorporation and bylaws also state that federal district courts of the U.S. are the sole and exclusive forum for complaints asserting a cause of action under the Securities Act, unless the company consents otherwise <sup>p. 26</sup>. |
|||
* Other factors that could affect A.M. Best's analysis include: changes in business practices from the organizational plan; unfavorable financial, regulatory, or market trends (e.g., excess market capacity); losses exceeding loss reserves; unresolved issues with government regulators; inability to retain senior management or key personnel; significant investment portfolio losses or limited liquidity; or alterations to A.M. Best's capital adequacy assessment methodology. |
|||
* There is uncertainty whether a court would enforce this provision, and stockholders are not deemed to have waived compliance with federal securities laws <sup>p. 26</sup>. |
|||
* A downgrade or withdrawal of the rating could lead to: current and future distribution partners/insureds choosing higher-rated competitors; increased cost or reduced availability of reinsurance; or severe limitation/prevention of writing new and renewal insurance contracts. |
|||
* This exclusive forum provision would not apply to suits under the Exchange Act or other claims where federal courts have exclusive jurisdiction <sup>p. 26</sup>. |
|||
* Rating organizations may heighten scrutiny, increase review frequency/scope, request additional information, or increase capital/other requirements due to earnings and capital pressures on financial institutions. |
|||
* If enforced, this choice of forum provision may limit a stockholder's ability to bring a claim in a preferred judicial forum, potentially discouraging lawsuits <sup>p. 26</sup>. |
|||
* |
* There is no assurance the rating will remain at its current level, and adverse ratings consequences could materially affect financial condition and results of operations. |
||
{{chunk|doc=vycbjm4dw4|c=66|p=9}} |
|||
'''Policy interpretation changes''' |
|||
* Unexpected changes in interpretation of coverage or provisions, including loss limitations and exclusions, could materially adversely affect financial condition and results of operations. |
|||
* No assurance that loss limitations or exclusions will be enforceable as intended. |
|||
* Industry practices, legal, judicial, social, and other conditions can lead to unexpected claims and coverage issues. |
|||
* Policy limitations on claim periods may be shorter than statutory periods for policyholders. |
|||
* Courts or regulatory authorities could nullify/void limitations or exclusions, or legislation could modify/bar their use. |
|||
* Governmental actions could result in higher than anticipated losses and LAE. |
|||
* Court decisions, such as the 1995 Montrose decision in California, could narrowly read policy exclusions, expanding coverage and requiring new exclusions. |
|||
* These issues may adversely affect business by broadening coverage beyond underwriting intent or increasing claim frequency/severity. |
|||
* Changes may not become apparent until after affected insurance contracts are issued, meaning full liability may not be known for many years. |
|||
{{chunk|doc=vycbjm4dw4|c=67|p=9}} |
|||
'''Reinsurer non-payment risk''' |
|||
* Reinsurers may not reimburse claims timely or at all, materially adversely affecting business, financial condition, and results of operations. |
|||
* Reinsurance contracts require premium payments to reinsurers who reimburse for covered policy claims. |
|||
* Reinsurers may be called upon to reimburse claims many years after premiums were paid. |
|||
* Reinsurance makes the reinsurer liable but does not relieve the ceding insurer of primary liability to policyholders. |
|||
* The current reinsurance program aims to limit financial risk. |
|||
* Reinsurers may default due to insolvency, lack of liquidity, operational failure, political/regulatory prohibitions, fraud, asserted defenses, or documentation deficiencies. |
|||
* Disputes with reinsurers can be time-consuming, costly, and uncertain of success. |
|||
* These risks could lead to increased net losses and adversely affect financial condition. |
|||
* As of December 31, 2024, reinsurance recoverables totaled USD 857.9m. |
|||
{{chunk|doc=vycbjm4dw4|c=68|p=9}} |
|||
'''Claims payment accuracy and timeliness''' |
|||
* Failure to accurately and timely pay claims could materially and adversely affect business, financial condition, results of operations, and prospects. |
|||
* Factors affecting claims payment ability include training/experience of claims representatives (including TPAs), management effectiveness, and ability to develop/implement appropriate procedures and systems. |
|||
* Inaccurate or untimely claims payment could lead to regulatory/administrative actions, material litigation, reputational damage, and adverse effects on business, financial condition, results of operations, and prospects. |
|||
* Ineffective TPA management or inability of internal staff/TPAs to handle claim volume could adversely affect workload capacity. |
|||
* This could require slowing growth in affected markets and lead to decreased quality of claims work, adversely affecting operating margins. |
|||
{{chunk|doc=vycbjm4dw4|c=69|p=9}} |
|||
'''Catastrophic events and climate change''' |
|||
* Severe weather, climate change effects, catastrophes, pandemics, and man-made events may adversely affect business, results of operations, and financial condition. |
|||
* Business is exposed to severe weather, earthquakes, and man-made catastrophes (e.g., explosions, war, terrorist attacks, riots). |
|||
* Catastrophes include natural events like severe winter weather, convective storms/tornadoes, windstorms, hailstorms, thunderstorms, and fires. |
|||
* Changing weather patterns and climatic conditions (global warming) have increased unpredictability and frequency of natural disasters, including in historically unaffected areas. |
|||
* Climate change may increase frequency and severity of extreme weather events, leading to conditions that increase hurricane activity and wildfire risks. |
|||
* Catastrophe losses could materially adversely affect business, financial condition, and results of operations, even for events not directly insured (e.g., 2025 California wildfires leading to policy cancellations). |
|||
* Increased frequency and severity of weather events (e.g., hurricanes, convective storms) could materially increase losses and affect ability to predict, quantify, reinsure, and manage catastrophe risk. |
|||
* Extent of catastrophe losses depends on frequency/severity of insured events and total insured exposure in affected areas. |
|||
* Incidence and severity of catastrophes and severe weather are inherently unpredictable. |
|||
* Exposure to losses is managed by analyzing probability and severity of loss events and their impact on underwriting and investment portfolios. |
|||
* Indirect impact can occur if insured businesses are affected by catastrophes not directly covered, leading to non-payment of premiums on other products. |
|||
* Inability to obtain adequate reinsurance coverage at reasonable rates for severe weather and catastrophes could materially adversely affect business and results of operations. |
|||
* Business is exposed to risks from pandemics, outbreaks, public health crises, and geopolitical/social events. |
|||
* While policy terms are expected to preclude coverage for virus-related claims (e.g., COVID-19), court decisions and governmental actions may challenge exclusions or interpretations. |
|||
* Changes to law and regulation related to climate change could directly affect business. |
|||
* The current administration's comments and actions (e.g., President Trump signing an executive order to withdraw the U.S. from the Paris Agreement on January 20, 2025) suggest a shift in U.S. climate policy. |
|||
* Unclear future actions by the administration or support for legislative changes could have a material adverse effect on business, operational, and financial results. |
|||
{{chunk|doc=vycbjm4dw4|c=70|p=9}} |
|||
'''Program administrator compliance''' |
|||
* Failure of program administrators to comply with pre-established guidelines could adversely affect results of operations. |
|||
* Certain insurance products are marketed and distributed through program administrators with limited quoting and binding authority. |
|||
* Program administrators sell products to insureds via retail agents and brokers and can bind certain risks without initial approval. |
|||
* Non-compliance with underwriting guidelines or appointment terms could bind the company to unanticipated risks, adversely affecting results of operations. |
|||
{{chunk|doc=vycbjm4dw4|c=71|p=9}} |
|||
'''Renewal and new business expectations''' |
|||
* If actual renewals or new business from repeat insureds do not meet expectations, future written premium and operating results could be materially adversely affected. |
|||
* Most contracts are one-year term and renewable. |
|||
* Some insurance contracts do not renew, but insureds are repeat customers with regular new contracts. |
|||
* Financial forecasting includes assumptions about renewal rates and repeat business. |
|||
* Insurance and reinsurance industries are cyclical with intense, often price-based, competition. |
|||
* If renewals and repeat business fall short of expectations, or if the company chooses not to write them due to pricing, future written premium and operations would be materially adversely affected. |
|||
{{chunk|doc=vycbjm4dw4|c=72|p=9}} |
|||
'''ESG matters and accounting changes''' |
|||
* Increased public attention to environmental, social, and governance (ESG) matters may lead to negative public perception, reputational harm, additional costs, or impact stock price. |
|||
* Failure or perceived failure to meet investor/customer ESG expectations could harm business and reputation. |
|||
* Backlash from investors or customers regarding ESG topics could also harm business and reputation. |
|||
* Damage to reputation from providing policies to certain insureds could decrease demand, materially adversely affect business/operational/financial results, and require resources to rebuild reputation/competitive position/brand strength. |
|||
* Changes in accounting practices and future pronouncements may materially affect reported financial results. |
|||
* Developments in accounting practices may require considerable additional expenses for compliance, especially for prior period information or retroactive application. |
|||
* The impact of accounting changes and future pronouncements cannot be predicted but may affect net income, shareholder's equity, and other financial statement line items. |
|||
* Insurance subsidiaries must comply with statutory accounting principles (SAP). |
|||
* SAP and its components are subject to constant review by the NAIC, its task forces/committees, and state insurance departments. |
|||
* Pending proposals before NAIC committees/task forces, if enacted and adopted at state level, could negatively affect insurance industry participants. |
|||
* The NAIC continuously examines existing laws and regulations. |
|||
* It is unpredictable whether or in what form reforms will be enacted, or their positive/negative effect on the company. |
|||
=== Risks Related to the Market and Economic Conditions === |
|||
{{chunk|doc=vycbjm4dw4|c=73|p=9}} |
|||
'''Economic conditions and insurance demand''' |
|||
* Adverse economic factors like recession, inflation, high unemployment, or lower economic activity can reduce policy sales, increase claim frequency, lead to premium defaults, or cause claim falsification, impacting growth and profitability. |
|||
* Business revenue, economic conditions, capital market volatility and strength, and inflation affect the business and economic environment, influencing the ability to generate revenue and profits. |
|||
* Economic downturns with higher unemployment, declining spending, and reduced corporate revenue generally hurt demand for insurance products, affecting premium levels and profitability. |
|||
* Negative economic factors can hinder the ability to charge appropriate rates for risk, reduce the number of policies written, and limit opportunities for profitable underwriting. |
|||
* During economic downturns, customers may need less insurance, cancel policies, modify coverage, or not renew policies. |
|||
* Existing policyholders may exaggerate or falsify claims for higher payments. |
|||
* Significant collapse in economic segments like construction, credit markets, or energy production/servicing could adversely affect results across multiple underwriting divisions. |
|||
* These outcomes would reduce underwriting profit if not reflected in charged rates. |
|||
{{chunk|doc=vycbjm4dw4|c=74|p=9}} |
|||
'''Insurance market cyclicality''' |
|||
* The insurance business is historically cyclical, which can affect financial performance and cause operating results to vary quarter-to-quarter, not necessarily indicating future performance. |
|||
* Insurance carriers have historically experienced significant fluctuations in operating results due to competition, catastrophic events, capacity levels, litigation trends, regulatory constraints, and general economic conditions. |
|||
* The supply of insurance relates to prevailing prices, insured losses, and available industry capital, which can fluctuate with changes in investment returns. |
|||
* The insurance business is historically cyclical, characterized by periods of intense price competition due to excessive underwriting capacity (soft market) and periods of capacity shortages leading to increased premium levels (hard market). |
|||
* Demand for insurance depends on factors like frequency and severity of catastrophic events, capacity levels, new capital providers, and general economic conditions, all of which fluctuate and can contribute to price declines. |
|||
* [[Definition:Property & casualty|P&C]] insurance companies' profitability tends to follow this cyclical market pattern, with higher [[Definition:Gross written premiums|gross written premium]] growth and improved profitability during hard market cycles. |
|||
* This cyclical pattern is more pronounced in the E&S (Excess and Surplus) market than in the standard insurance market. |
|||
* When the standard insurance market hardens, the E&S market typically hardens, with significantly more rapid growth. |
|||
* When conditions soften, customers previously in the E&S market may return to the admitted market, exacerbating rate decrease effects on financial results. |
|||
* The market can experience "micro cycles" where specific areas harden or soften independently and more drastically than the overall market. |
|||
* Operating results are subject to fluctuation and have historically varied quarter-to-quarter. |
|||
* Quarterly results are expected to continue fluctuating due to general economic conditions, frequency/severity of catastrophes, fluctuating interest rates, claims exceeding loss reserves, competition, deviations from expected premium retention, adverse investment performance, and reinsurance costs. |
|||
{{chunk|doc=vycbjm4dw4|c=75|p=9}} |
|||
'''Investment portfolio performance and risks''' |
|||
* Performance of the investment portfolio is subject to various investment risks that may adversely affect financial results. |
|||
* Results of operations depend partly on investment portfolio performance. |
|||
* The company aims to hold a diversified investment portfolio managed by professional investment advisory firms according to its investment policy and reviewed by its Investment Committee. |
|||
* Investments are subject to general economic conditions, market risks, and risks inherent to specific securities. |
|||
* Primary market risk exposures are to changes in interest rates and equity prices. |
|||
* A significant portion of the investment portfolio is in fixed maturity securities, or separately managed accounts and limited partnerships primarily invested in fixed maturity securities. |
|||
* Interest rates rose materially in 2022 and 2023. |
|||
* A low interest rate environment, potentially from federal actions to slow inflation (e.g., recent rate cuts, Inflation Reduction Act of 2022), would pressure [[Definition:Net investment income|net investment income]], especially for fixed maturity and short-term investments, adversely affecting operating results. |
|||
* Recent and future interest rate increases could cause fixed income securities portfolios to decline in value, with magnitude depending on duration and rate increase. |
|||
* Some fixed income securities with call or prepayment options create reinvestment risk in declining rate environments. |
|||
* Other fixed income securities, like mortgage-backed and asset-backed securities, carry prepayment risk or may not prepay as quickly as expected in a rising interest rate environment. |
|||
* All fixed maturity securities, including those in separately managed accounts and limited partnerships, are subject to credit risk. |
|||
* Credit risk is the risk of investment default or impairment due to deterioration in the financial condition of issuers or guarantors. |
|||
* Downgrades in credit ratings of fixed maturity securities could significantly negatively affect their market valuation. |
|||
* The company also invests in marketable preferred and common equity securities and exchange-traded funds. |
|||
* These equity securities are carried at fair market value and are subject to potential losses and market value declines. |
|||
* Market and credit risks could reduce [[Definition:Net investment income|net investment income]] and result in realized investment losses. |
|||
* The investment portfolio faces increased valuation uncertainties when investment markets are illiquid, as with fixed maturity securities held to maturity, separately managed accounts, and limited partnership investments. |
|||
* Valuation of investments is more subjective in illiquid markets, increasing the risk that estimated fair value does not reflect actual transaction prices. |
|||
* Risks for all security types are managed through an investment policy that sets parameters including maximum investment percentages in certain securities and minimum credit quality levels, believed to be within NAIC, Texas Department of Insurance, and Oklahoma Department of Insurance guidelines. |
|||
* The Investment Committee periodically reviews Enterprise Based Asset Allocation models for overall risk management. |
|||
* While capital preservation is sought, investment objectives may not be achieved, and results can vary substantially over time. |
|||
* Investment strategies aim to be uncorrelated with insurance and reinsurance exposures, but investment losses may coincide with underwriting losses, exacerbating adverse effects. |
|||
{{chunk|doc=vycbjm4dw4|c=76|p=9}} |
|||
'''Investment liquidity and claims funding''' |
|||
* The company could be forced to sell investments to meet liquidity requirements. |
|||
* Premiums received are invested until needed for policyholder claims. |
|||
* The duration of the investment portfolio is managed based on the duration of losses and LAE (Loss Adjustment Expense) reserves to ensure sufficient liquidity and avoid liquidating investments to fund claims. |
|||
* Risks such as inadequate losses and LAE reserves or unfavorable litigation trends could necessitate selling investments to fund liabilities. |
|||
* Investments may not be sold at favorable prices or at all. |
|||
* Sales could result in significant realized losses depending on general market conditions, interest rates, and credit issues with individual securities. |
|||
=== Risks Related to the Regulatory Environment === |
|||
{{chunk|doc=vycbjm4dw4|c=77|p=9}} |
|||
'''Regulatory compliance and penalties''' |
|||
* Extensive regulation may adversely affect the ability to achieve business objectives. |
|||
* Failure to comply with regulations may result in penalties, including fines and suspensions, adversely affecting financial condition and results of operations. |
|||
* Primary insurance subsidiaries GMIC, HSIC, and IIC are subject to extensive regulation in Texas (state of domicile) and other operating states. |
|||
* Insurance regulations primarily protect policyholders, not investors or stockholders. |
|||
* Regulations are administered by state departments of insurance and cover capital and surplus, investment and underwriting limitations, affiliate transactions, [[Definition:Dividend|dividend]] limitations, changes in control, solvency, and other financial/non-financial aspects. |
|||
* Significant changes in laws and regulations could limit discretion or increase business costs. |
|||
* State insurance regulators conduct periodic examinations and require annual/other reports on financial condition and holding company issues. |
|||
* Regulatory requirements may impose timing and expense constraints, adversely affecting business objectives. |
|||
* Insurance subsidiaries are part of an "insurance holding company system" under Texas statutes and regulations. |
|||
* Certain transactions between insurance subsidiaries and affiliates require prior notice to the Texas Department of Insurance, potentially causing business delays and additional expenses. |
|||
* Failure to file required notifications or comply with other Texas insurance regulations may lead to significant fines and penalties and impair the working relationship with the Texas Department of Insurance. |
|||
* State insurance regulators have broad discretion to deny or revoke licenses for reasons including regulation violations. |
|||
* Practices based on interpretations of regulations or industry norms may differ from regulatory authorities' interpretations. |
|||
* Lack of requisite licenses/approvals or non-compliance could lead to regulators precluding, suspending, or penalizing activities in a state, adversely affecting business operations. |
|||
* Changes in insurance industry regulation, laws, or interpretations could interfere with operations and increase compliance costs. |
|||
{{chunk|doc=vycbjm4dw4|c=78|p=9}} |
|||
'''Capital requirements and financial stability''' |
|||
* Insurance subsidiaries are subject to risk-based capital requirements based on the NAIC's "risk based capital model" and Texas law's minimum capital and surplus restrictions. |
|||
* These requirements establish minimum risk-based capital for overall business operations and identify inadequately capitalized [[Definition:Property & casualty|property and casualty]] insurers by assessing asset/liability risks and [[Definition:Net written premiums|net written premium]] mix. |
|||
* Insurers below a calculated threshold may face regulatory actions like supervision, rehabilitation, or liquidation. |
|||
* Failure to maintain required risk-based capital levels could adversely affect the insurance subsidiary's ability to maintain regulatory authority and its A.M. Best Rating. |
|||
{{chunk|doc=vycbjm4dw4|c=79|p=9}} |
|||
'''Potential for new regulations and legislative changes''' |
|||
* The company may become subject to additional government or market regulation, which could materially adversely impact the business. |
|||
* Business could be adversely affected by changes in laws related to asset and reserve valuation, surplus requirements, investment and [[Definition:Dividend|dividend]] limitations, enterprise risk, and risk-based capital requirements. |
|||
* The U.S. federal government generally does not directly regulate the insurance industry, except for areas like flood, nuclear, and terrorism risks. |
|||
* Potential federal legislation could affect the insurance industry in areas such as privatization of government entities (e.g., Freddie Mac, Fannie Mae), reduction in federal subsidies for certain businesses (e.g., agriculture), tort reform, corporate governance, and taxation of reinsurance companies. |
|||
{{chunk|doc=vycbjm4dw4|c=80|p=9}} |
|||
'''Tax law changes and NOLs''' |
|||
* Changes to U.S. tax laws and new tax policies could significantly negatively impact the overall economy and the business. |
|||
* Legislative or other actions related to taxes could negatively affect the company, its investments, or stockholders. |
|||
* U.S. federal income tax rules are constantly under review by legislators, the IRS, and the U.S. Department of the Treasury. |
|||
* The company cannot predict the impact of tax law changes on itself, stockholders, or portfolio investments. |
|||
* New legislation, U.S. Treasury regulations, administrative interpretations, or court decisions could have adverse consequences. |
|||
* Stockholders are advised to consult tax advisors regarding tax legislative, regulatory, or administrative developments and their potential effect on investments. |
|||
* The current administration's agenda includes potential U.S. tax law reform, with outlined intentions such as reducing the corporate tax rate, extending certain provisions of the Tax Cuts and Jobs Act of 2017 (TCJA), and imposing new tariffs. |
|||
* The combined impact of extending TCJA tax benefits and new tariffs could increase the U.S. deficit, inflation, and interest rates, potentially leading to higher market interest rates, decreased U.S. economic growth, and a possible recession, all negatively impacting the business. |
|||
* The ability to utilize net operating loss carryforwards (NOLs) and other tax attributes may be limited. |
|||
* As of December 31, 2024, the company had gross federal income tax NOLs of approximately USD 44.7m available to offset future taxable income, prior to Section 382 limitations. |
|||
* These NOLs are set to expire beginning in 2032. |
|||
* Under Section 382 of the Internal Revenue Code, an "ownership change" (greater than 50% change in equity ownership by certain stockholders over a three-year period) can limit the use of pre-ownership change NOLs to offset post-ownership change income. |
|||
* Future ownership changes, some outside of control, may occur. |
|||
* Future regulatory changes could also limit the ability to utilize NOLs. |
|||
* Inability to offset future taxable income with NOLs could adversely affect net income and cash flows. |
|||
{{chunk|doc=vycbjm4dw4|c=81|p=9}} |
|||
'''Holding company liquidity and [[Definition:Dividend|dividend]] restrictions''' |
|||
* As a holding company, with operations primarily conducted by insurance subsidiaries, liquidity at the holding company level (including ability to pay [[Definition:Dividend|dividends]] and service debt) depends on cash [[Definition:Dividend|dividends]] or other permitted payments from insurance subsidiaries. |
|||
* Continued operation and growth require substantial capital, so cash [[Definition:Dividend|dividends]] on common stock are not intended in the foreseeable future. |
|||
* The ability to pay [[Definition:Dividend|dividends]] to stockholders and meet debt obligations largely depends on [[Definition:Dividend|dividends]] and distributions from primary insurance subsidiaries: GMIC, HSIC, and IIC. |
|||
* State insurance laws, including Texas laws, restrict the ability of GMIC, HSIC, and IIC to determine stockholder [[Definition:Dividend|dividends]]. |
|||
* State insurance regulators require insurance companies to maintain specified levels of statutory capital and surplus. |
|||
* [[Definition:Dividend|Dividend]] payments are limited to the portion of available policyholder surplus derived from net profits. |
|||
* State insurance regulators have broad powers to prevent reduction of statutory surplus to inadequate levels, and there is no assurance that maximum calculated [[Definition:Dividend|dividends]] would be permitted. |
|||
* State insurance regulators with jurisdiction over [[Definition:Dividend|dividend]] payments by insurance subsidiaries may adopt more restrictive statutory provisions in the future. |
|||
* Any future [[Definition:Dividend|dividend]] determination will be at the discretion of the Board of Directors, based on results of operations, financial condition, contractual debt restrictions, indebtedness, applicable law, and other relevant factors. |
|||
* Investors may need to sell common stock for gains, as immediate cash [[Definition:Dividend|dividends]] are not expected. |
|||
{{chunk|doc=vycbjm4dw4|c=82|p=9}} |
|||
'''Change of control regulations''' |
|||
* Applicable insurance laws may make it difficult to effect a change of control. |
|||
* Under Texas insurance laws, acquiring control of a domestic insurer requires written approval from the state insurance commissioner. |
|||
* Approval depends on factors including the acquirer's financial strength, plans for the insurer's future operations, and potential anti-competitive results. |
|||
* Texas insurance laws apply to direct and indirect acquisition of 10% or more of a Texas-domiciled insurer's voting stock. |
|||
* Acquisition of 10% or more of Skyward Specialty's common stock would be considered an indirect change of control, triggering applicable filing requirements under Texas insurance laws, unless a disclaimer of control filing is accepted by the Texas Insurance Department. |
|||
* These requirements may discourage acquisition proposals and delay, deter, or prevent a change of control, even if desirable to some stockholders. |
|||
=== Risks Related to Our Liquidity and Access to Capital === |
|||
{{chunk|doc=vycbjm4dw4|c=83|p=9}} |
|||
'''Future capital requirements and availability''' |
|||
* Additional capital may be required in the future, which may not be available or only available on unfavorable terms. |
|||
* Future capital requirements depend on factors including the ability to successfully write new business and establish premium rates and reserves sufficient to cover losses. |
|||
* If cash flows from operations are insufficient to fund future operating requirements and cover claim losses, or if the capital position is adversely impacted by a decline in the fair value of the investment portfolio, catastrophe losses, or other events, additional funds may be needed through financings or growth may be curtailed. |
|||
* Factors affecting the amount and timing of capital needs include growth rate, profitability, claims experience, reinsurance availability, market disruptions, and other unforeseeable developments. |
|||
* If additional capital is needed, equity or debt financing may not be available or may be available only on unfavorable terms. |
|||
* Equity financings could result in dilution to stockholders. |
|||
* Debt financings may involve covenants restricting business operations. |
|||
* Such securities may have rights, preferences, and privileges senior to common stock. |
|||
* Inability to obtain adequate capital on favorable terms could materially adversely affect operating plans, business, financial condition, or results of operations. |
|||
=== Risks Related to Our Operations === |
|||
{{chunk|doc=vycbjm4dw4|c=84|p=9}} |
|||
'''Personnel attraction and retention''' |
|||
* The company could be adversely affected by the loss of key personnel or inability to attract and retain qualified personnel. |
|||
* The company depends on attracting and retaining experienced personnel knowledgeable about its business. |
|||
* The talent pool for recruitment is limited and can fluctuate based on market dynamics specific to the industry. |
|||
* Higher demand for skilled employees could increase compensation expectations, making it difficult to retain and recruit key personnel and maintain desired labor costs. |
|||
* Inability to retain and attract talented personnel could prevent the company from maintaining its competitive position in specialized markets, adversely affecting results of operations. |
|||
{{chunk|doc=vycbjm4dw4|c=85|p=9}} |
|||
'''Information technology and cybersecurity risks''' |
|||
* Security breaches, data loss, cyberattacks, and IT failures could disrupt operations, damage reputation, and adversely affect business, operations, and financial results. |
|||
* The business is highly dependent on IT and telecommunications systems, including underwriting and claims systems. |
|||
* Systems are used for interacting with brokers and insureds, underwriting, policy preparation, premium processing, actuarial modeling, claims processing and payments, and financial statement preparation. |
|||
* Some systems may include or rely on third-party systems not on company premises or under its control. |
|||
* Events like natural catastrophes, terrorist attacks, industrial accidents, computer viruses, and cyber-attacks can cause systems to fail or be inaccessible for extended periods. |
|||
* Sustained or repeated system failures could severely limit the ability to write and process business, provide customer service, pay claims, or operate normally. |
|||
* Computer viruses, hackers, employee misconduct, and external hazards can expose systems to security breaches or disruptions. |
|||
* Security measures are in place, but systems and networks may still be subject to breaches or interference, and cybersecurity incidents are likely to continue. |
|||
* Such events can result in operational disruptions, unauthorized access, disclosure, or loss of proprietary or customer data. |
|||
* Consequences include legal claims, regulatory scrutiny and liability, reputational damage, costs for mitigation, and loss of customers or advisors. |
|||
* SEC and state law notification requirements for incidents could exacerbate harm to business, financial condition, and results of operations. |
|||
* Publicized attempted security breaches could harm business and reputation even if technology infrastructure and data confidentiality are protected. |
|||
* Advances in criminal capabilities, new vulnerabilities, exploitation attempts, data thefts, or physical system break-ins could compromise security measures. |
|||
* Third parties to whom functions are outsourced are also subject to these risks. |
|||
* While third-party providers' cybersecurity controls are reviewed, success in preventing compromises and disclosures cannot be ensured. |
|||
* Increased use of third-party services (e.g., cloud technology, SaaS) can make identifying and responding to cyberattacks more difficult due to dynamic technologies. |
|||
* These risks could increase as vendors adopt more cloud-based software services. |
|||
{{chunk|doc=vycbjm4dw4|c=86|p=9}} |
|||
'''Growth management and inorganic growth''' |
|||
* The company may not be able to manage its growth effectively. |
|||
* Future business growth may require additional capital, systems development, and skilled personnel. |
|||
* The company must meet capital needs, expand systems and internal controls, allocate human resources optimally, identify, hire, train, and develop qualified employees, and integrate acquired businesses. |
|||
* Failure to manage growth effectively could materially adversely affect business, financial condition, and results of operations. |
|||
* Success of inorganic growth through acquisitions depends on identifying appropriate targets, negotiating favorable terms, completing transactions, and successfully integrating targets. |
|||
* Anticipated benefits of acquisitions, such as revenue growth, operational efficiencies, or expected synergies, may not be realized. |
|||
{{chunk|doc=vycbjm4dw4|c=87|p=9}} |
|||
'''Future growth rates and profitability''' |
|||
* Recent rapid growth rates may not be indicative of future growth. |
|||
* Significant revenue growth has been experienced in recent years. |
|||
* Future periods may not sustain revenue growth consistent with recent history or at all. |
|||
* Revenue growth depends on factors including: |
|||
** Effective product pricing to attract and retain insureds without compromising profitability. |
|||
** Successful deployment and implementation of products, obtaining renewals, and providing excellent support to distribution partners. |
|||
** Attraction and retention of highly qualified underwriters and claims professionals. |
|||
** Enhancement of infrastructure and data reporting systems for effective and efficient product delivery. |
|||
** Successful creation of new distribution channels. |
|||
** Successful introduction of new products and enhancement of existing products. |
|||
** Successful competition against larger companies and new market entrants. |
|||
** Increased brand awareness. |
|||
* Failure to accomplish these objectives makes forecasting future results of operations difficult. |
|||
* Historical growth rate should not be considered indicative of future performance and may decline. |
|||
* Future revenue could grow more slowly or decline for various reasons, including those outlined. |
|||
* Operating expenses are expected to increase in future periods. |
|||
* If revenue growth does not offset possible expense increases, business, financial position, and results of operations could be harmed, and profitability may not be achieved or maintained. |
|||
{{chunk|doc=vycbjm4dw4|c=88|p=9}} |
|||
'''Litigation risks''' |
|||
* The effects of litigation on the business are uncertain and could have an adverse effect. |
|||
* The company continually faces risks associated with various types of litigation, including disputes related to insurance claims and general commercial/corporate litigation. |
|||
* The company is not currently involved in out-of-the-ordinary litigation with customers. |
|||
* Other insurance industry members are targets of class action lawsuits and other litigation, some involving substantial or indeterminate amounts with unpredictable outcomes. |
|||
* Social inflation, particularly in third-party claims, can lead to oversized judgments. |
|||
* Litigation costs and settlement amounts can be inflated beyond historical reasonable levels, even when cases do not reach judgment. |
|||
* Litigation is based on issues including insurance and claim settlement practices. |
|||
* The company cannot predict future involvement in such litigation or its impact on the business. |
|||
{{chunk|doc=vycbjm4dw4|c=89|p=9}} |
|||
'''Vendor relationships and third-party software''' |
|||
* Loss of key vendor relationships or vendor failure to protect data/information could affect operations. |
|||
* The company relies on services and products from many vendors in the U.S. and abroad. |
|||
* Vendors include those for computer hardware/software, claim adjustment services, human resource benefits management, and investment management. |
|||
* If a vendor experiences bankruptcy, becomes unable to provide services, has systems breached, or fails to protect confidential information, the company may suffer operational impairments and financial losses. |
|||
* While vendor risk is generally monitored, including security and stability of critical vendors, proper assessment of risks and costs in third-party relationships may fail, materially and adversely affecting financial condition and results of operations. |
|||
* The company anticipates continued reliance on third-party software. |
|||
* While commercially reasonable alternatives to current licensed third-party software are believed to exist, this may not always be the case, or replacement could be difficult or costly. |
|||
* Integration of new third-party software may require significant work and substantial investment of time and resources. |
|||
* Use of additional or alternative third-party software would require license agreements, which may not be available on commercially reasonable terms or at all. |
|||
* Many risks associated with third-party software use cannot be eliminated and could negatively affect the business. |
|||
{{chunk|doc=vycbjm4dw4|c=90|p=9}} |
|||
'''Intellectual property rights''' |
|||
* The company may fail or be unable to protect its intellectual property rights for its proprietary technology platform and brand. |
|||
* The company may be sued by third parties for alleged infringement of their proprietary rights. |
|||
* Success and ability to compete depend partly on intellectual property, including brand rights and proprietary technology in certain [[Definition:Business mix|product lines]]. |
|||
* Protection primarily relies on copyright and trade secret laws, and confidentiality agreements with employees, customers, service providers, and partners. |
|||
* Steps taken to protect intellectual property may be inadequate. |
|||
* Efforts to enforce intellectual property rights may face defenses, counterclaims, and countersuits challenging validity, enforceability, and scope. |
|||
* Failure to secure, protect, and enforce intellectual property rights could adversely affect the brand and business. |
|||
* Success also depends partly on not infringing on others' intellectual property rights. |
|||
* Competitors and other entities/individuals may own or claim intellectual property related to the industry or the company. |
|||
* Third parties may claim infringement of their intellectual property rights in the future, and the company may be found to be infringing. |
|||
* Claims or litigation could incur significant expenses. |
|||
* Successful assertion of claims could require substantial damages or ongoing royalty payments, prevent service offerings, or impose unfavorable terms. |
|||
* Even if the company prevails, litigation could be costly, time-consuming, and divert management and key personnel attention from business operations. |
|||
=== Risks Related to Ownership of Our Common Stock === |
|||
{{chunk|doc=vycbjm4dw4|c=91|p=9}} |
|||
'''Public company operating costs and compliance''' |
|||
* Operating as a public company incurs increased costs and requires substantial management time for compliance initiatives. |
|||
* Financial reporting and other requirements may exceed the adequacy of current accounting and management systems and resources. |
|||
* Significant legal, accounting, and other expenses are incurred as a public company, especially since no longer an emerging growth company. |
|||
* Federal securities laws (Sarbanes-Oxley Act, Dodd-Frank Act) and SEC/Nasdaq rules impose requirements for filing reports and maintaining effective disclosure, financial controls, and corporate governance. |
|||
* These regulations increase compliance costs, make activities more time-consuming, and demand significant management and personnel time. |
|||
* There is a risk of not producing reliable financial statements or filing them timely with the SEC, or complying with Nasdaq listing requirements. |
|||
* Section 404 of the Sarbanes-Oxley Act requires system and process evaluation and testing of internal control over financial reporting, leading to substantial accounting expense and management effort. |
|||
* Compliance with Section 404 necessitates maintaining accounting and finance staff/consultants with public company reporting, technical accounting, and internal control knowledge, and providing internal audit services. |
|||
* Achieving Section 404 compliance involves a costly and challenging process of documenting and evaluating internal control over financial reporting. |
|||
* This process requires dedicating internal resources, engaging outside consultants, adopting a detailed work plan, improving control processes, validating controls through testing, and implementing continuous reporting and improvement. |
|||
* There is a risk that neither the company nor its independent registered public accounting firm will conclude that internal control over financial reporting is effective within the prescribed timeframe, potentially leading to adverse financial market reactions and SEC investigations. |
|||
* Disclosure controls and procedures are required to ensure information for SEC reports is recorded, processed, summarized, and reported timely. |
|||
* Disclosure controls and internal control over financial reporting may not prevent or detect all errors and fraud due to inherent limitations of control systems. |
|||
* Control systems provide reasonable, not absolute, assurance, and their design is based on assumptions about future events, which may not hold true. |
|||
* Controls may become inadequate over time due to changing conditions or deterioration in compliance, leading to undetected misstatements. |
|||
* Failure to achieve and maintain effective internal controls, as required by Section 404 of the Sarbanes-Oxley Act, could harm operating results and financial condition, and negatively affect common stock market price. |
|||
* Section 404(b) of the Sarbanes-Oxley Act requires annual management assessments of the effectiveness of internal control over financial reporting. |
|||
* Implementing and maintaining substantial internal control systems and procedures is necessary to satisfy Exchange Act reporting requirements. |
|||
* Deficiencies identified during assessments may not be remediated timely, and testing/maintaining internal controls may divert management attention. |
|||
* Inability to conclude on an ongoing basis that internal control over financial reporting is effective under Section 404(b) could lead to significant remediation costs and scope. |
|||
* Material weaknesses or deficiencies in internal control could impede timely and accurate SEC report filings. |
|||
* Any of these issues could cause investors to lose confidence, or lead to suspension/termination of Nasdaq listing, negatively affecting stock price. |
|||
{{chunk|doc=vycbjm4dw4|c=92|p=9}} |
|||
'''Material weakness in ITGCs''' |
|||
* A material weakness in internal control over information technology general controls (ITGCs) has been identified. |
|||
* Failure to remediate this material weakness or maintain effective ITGCs could adversely affect the common stock market price. |
|||
* Controls and procedures have inherent limitations, meaning they may not prevent or detect all misstatements. |
|||
* Even an effective ITGC system provides only reasonable, not absolute, assurance. |
|||
* Management, including the CEO, CFO, and CIO/CTO, evaluated internal control over financial reporting as of December 31, 2024, using COSO criteria. |
|||
* A material weakness existed as of December 31, 2024, related to ineffective implementation of ITGCs in user access for systems supporting financial reporting. |
|||
* Related process-level IT dependent manual and automated controls relying on affected ITGCs or information from affected IT systems were also deemed ineffective. |
|||
* Additional information and management's remediation plan are in "ITEM 9A. CONTROLS & PROCEDURES" of Form 10-K. |
|||
* Failure to timely remediate the material weakness or maintain effective ITGCs could lead to significant resource expenditure, fines, penalties, investigations, or judgments, negatively affecting investor confidence and stock price. |
|||
{{chunk|doc=vycbjm4dw4|c=93|p=9}} |
|||
'''Stock price volatility and investment risk''' |
|||
* Operating results and stock price may be volatile or decline regardless of operating performance, risking loss of investment. |
|||
* The market price of common stock has been and is likely to remain highly volatile, influenced by many factors beyond control. |
|||
* Securities markets worldwide have experienced and will likely continue to experience significant price and volume fluctuations. |
|||
* Market volatility, general economic, market, or political conditions could cause wide price fluctuations regardless of operating performance. |
|||
* Investment in common stock is considered risky, suitable only for those who can withstand significant loss and wide market value fluctuations. |
|||
* Factors affecting stock price include: market conditions in the broader stock market; actual or anticipated fluctuations in quarterly financial and operating results; introduction of new products or services by the company or competitors; issuance of new or changed securities analysts’ reports or recommendations; results of operations varying from analyst and investor expectations; short sales, hedging, and other derivative transactions in common stock; company guidance, changes to it, or failure to meet it; strategic actions by the company or competitors; announcements by the company, competitors, or acquisition targets; sales or anticipated sales of large blocks of stock by directors, executive officers, and principal stockholders; additions or departures in the Board, senior management, or other key personnel; regulatory, legal, or political developments; public response to press releases or public announcements; litigation and governmental investigations; changing economic conditions, including social inflation; changes in accounting principles; future indebtedness or securities issuance; default under indebtedness agreements; exposure to capital and credit market risks affecting investment portfolio or capital resources; changes in credit ratings; and other events like natural disasters, war, or terrorism. |
|||
* Securities markets have experienced extreme price and volume fluctuations unrelated to company operating performance. |
|||
* Investors may not be able to resell shares at or above purchase price due to these factors. |
|||
* Broad market fluctuations, general market, economic, and political conditions (e.g., recessions, loss of investor confidence, interest rate changes) may negatively affect common stock market price. |
|||
* Stock markets, including Nasdaq, have experienced extreme price and volume fluctuations affecting equity securities. |
|||
* Such occurrences could cause stock price to fall and expose the company to costly securities class action litigation, diverting management attention and harming business. |
|||
{{chunk|doc=vycbjm4dw4|c=94|p=9}} |
|||
'''Underwriting guidelines and strategy changes''' |
|||
* Management can change underwriting guidelines or strategy without stockholder notice or approval. |
|||
* This allows fundamental changes to operations without stockholder approval, potentially resulting in a strategy or underwriting guidelines materially different from those described in the "Business" section or other filings. |
|||
{{chunk|doc=vycbjm4dw4|c=95|p=9}} |
|||
'''Anti-takeover provisions''' |
|||
* Anti-takeover provisions in organizational documents could delay management changes and limit share price. |
|||
* Provisions in the certificate of incorporation and bylaws could hinder third-party acquisition of control, even if beneficial to common stock value, and prevent stockholder attempts to replace the Board or management. |
|||
* These provisions could adversely affect common stock price. |
|||
* Charter documents permit the Board to establish director numbers and fill vacancies/new directorships. |
|||
* The Board of Directors is classified into three classes with staggered, three-year terms, and directors can only be removed for cause. |
|||
* Super-majority voting is required to amend provisions in the certificate of incorporation and bylaws. |
|||
* Blank-check preferred stock, with terms set by the Board, could delay or prevent transactions or control changes that might offer a premium price for common stock. |
|||
* Stockholders' ability to call special meetings is eliminated. |
|||
* Special meetings of stockholders can only be called by the Board, its chairman, or the CEO. |
|||
* Stockholder consent action is prohibited unless by unanimous written consent. |
|||
* Vacancies on the Board can only be filled by a majority of directors then in office, even if less than a quorum. |
|||
* Cumulative voting in director elections is prohibited. |
|||
* Advance notice requirements are established for director nominations or proposing matters at annual stockholder meetings. |
|||
* As a Delaware corporation, the company is subject to Section 203 of the Delaware General Corporation Law, which may prohibit large stockholders (15% or more of voting stock) from merging or combining for a period. |
|||
{{chunk|doc=vycbjm4dw4|c=96|p=9}} |
|||
'''Exclusive forum provisions''' |
|||
* The certificate of incorporation and bylaws designate the Court of Chancery of the State of Delaware as the exclusive forum for substantially all disputes between the company and its stockholders. |
|||
* This could limit stockholders' ability to obtain a favorable judicial forum for disputes with the company or its directors, officers, or employees. |
|||
* The Court of Chancery of the State of Delaware is the exclusive forum for: derivative actions on the company's behalf; actions asserting breach of fiduciary duty by directors, officers, employees, or stockholders; actions arising under DGCL or the certificate of incorporation/bylaws where DGCL confers jurisdiction; actions to interpret, apply, enforce, or determine validity of the certificate of incorporation or bylaws; and actions asserting a claim governed by the internal affairs doctrine. |
|||
* The certificate of incorporation and bylaws also state that federal district courts of the United States are the sole and exclusive forum for causes of action arising under the Securities Act, unless the company consents otherwise. |
|||
* Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over suits to enforce duties/liabilities created by the Securities Act. |
|||
* There is uncertainty whether a court would enforce the federal exclusive forum provision, and stockholders are not deemed to have waived compliance with federal securities laws. |
|||
* This exclusive forum provision would not apply to suits under the Exchange Act or other claims where federal courts have exclusive jurisdiction. |
|||
* If enforced, this choice of forum provision may limit a stockholder's ability to bring a claim in a preferred judicial forum, potentially discouraging lawsuits. |
|||
* If a court finds the choice of forum provision inapplicable or unenforceable, the company may incur additional costs resolving actions in other jurisdictions, which could materially adversely affect business, financial condition, or results of operations. |
|||
== Cybersecurity == |
== Cybersecurity == |
||
{{chunk|doc=vycbjm4dw4|c=97|p=10}} |
|||
* ''IT Systems'' are central to nearly all aspects of business operations, including internal/external communications, document/record management, and shared work environments <sup>p. 27</sup>. |
|||
'''Cybersecurity risk management and strategy''' |
|||
* ''Crisis Response Plan (CRP)'' is implemented to efficiently and effectively respond to cybersecurity incidents and threats, forming a component of the overall ERM strategy <sup>p. 27</sup>. |
|||
* ''Cybersecurity risk management'' processes are integrated into overall risk management, including annual evaluation by the enterprise risk management committee <sup>p. 27</sup>. |
|||
* IT Systems are central to nearly all business operations, including internal/external communications, document management, and shared work environments. |
|||
* ''Risk owners'' are assigned to develop and track mitigation plans for heightened cybersecurity risks identified by the ERM process <sup>p. 27</sup>. |
|||
* Responding to cybersecurity incidents and threats is a key component of the overall ERM strategy. |
|||
* ''Security events and data incidents'' are evaluated, ranked by severity, prioritized for response and remediation, and reviewed for materiality, operational/business impact, and privacy impact <sup>p. 27</sup>. |
|||
* A Crisis Response Plan (CRP) has been implemented to respond to cybersecurity incidents and threats. |
|||
* ''Cybersecurity risk management program'' leverages the National Institute of Standards and Technology framework, categorizing risks into identify, protect, detect, respond, recover, and govern <sup>p. 27</sup>. |
|||
* Management and IT personnel have implemented processes for assessing, identifying, managing, and escalating material cybersecurity risks, integrated into overall risk management. |
|||
* ''Company-wide policies and procedures'' address cybersecurity matters, including encryption standards, antivirus protection, remote access, multifactor authentication, confidential information, and internet/social media/email use <sup>p. 27</sup>. |
|||
* Cybersecurity risks are included in the annual risk universe evaluated by the enterprise risk management committee. |
|||
* ''Detailed crisis response playbook'' is followed in the event of an incident <sup>p. 27</sup>. |
|||
* Risk owners are assigned to develop and track mitigation plans for heightened cybersecurity risks identified by the ERM process. |
|||
* ''Investments in IT security'' have expanded to include additional end-user training, layered defenses, critical asset identification and protection, strengthened monitoring and alerting, and engagement of experts <sup>p. 27</sup>. |
|||
* Security events and data incidents are evaluated, ranked by severity, prioritized for response/remediation, and reviewed for materiality, operational/business impact, and privacy impact. |
|||
* ''Defenses are regularly tested'' through simulations and drills at a technical level (including penetration tests) and operational policy/procedure reviews with third-party experts <sup>p. 27</sup>. |
|||
* The cybersecurity risk management program uses the National Institute of Standards and Technology framework, categorizing risks into identify, protect, detect, respond, recover, and govern. |
|||
* ''IT security team'' monitors alerts, discusses threat levels/trends/remediation, prepares a quarterly cyber scorecard, collects data on cybersecurity threats/risk areas, and conducts an annual risk assessment <sup>p. 27</sup>. |
|||
* Company-wide policies and procedures cover cybersecurity matters, including encryption standards, antivirus protection, remote access, multifactor authentication, confidential information, and internet/social media/email use. |
|||
* ''Periodic external penetration tests, red team testing, and maturity testing'' are conducted to assess processes, procedures, and the threat landscape <sup>p. 27</sup>. |
|||
* A detailed crisis response playbook is followed in the event of an incident. |
|||
* ''Outside cybersecurity legal counsel'' would consult and coordinate with other third parties during an incident, including communication and notification, and cybersecurity vendors would perform investigation, recovery, and restoration services <sup>p. 27</sup>. |
|||
* Investments in IT security have expanded, including additional end-user training, layered defenses, critical asset identification/protection, strengthened monitoring/alerting, and expert engagement. |
|||
* ''Cybersecurity experts'' would assist with incident validation and ransomware demands, and cybersecurity insurance providers would be involved <sup>p. 27</sup>. |
|||
* Defenses are regularly tested through technical simulations and drills (including penetration tests) and operational policy/procedure reviews with third-party experts. |
|||
* ''Processes are implemented to oversee and identify risks'' from cybersecurity threats associated with key third-party service providers, requiring SOC-1 or SOC-2 reports and cybersecurity/disaster recovery plans <sup>p. 27</sup>. |
|||
* The IT security team monitors alerts, discusses threat levels/trends/remediation, prepares a quarterly cyber scorecard, collects cybersecurity data, and conducts an annual risk assessment. |
|||
* ''Cybersecurity risk management and strategy processes'' are overseen by leaders from the Information Security Team, with assistance from Compliance and Legal teams <sup>p. 27</sup>. |
|||
* Periodic external penetration tests, red team testing, and maturity testing are conducted to assess processes, procedures, and the threat landscape. |
|||
* ''Information Security Team leaders'' have decades of experience in IT roles, including security, auditing, compliance, systems, and programming <sup>p. 27</sup>. |
|||
* In an incident, outside cybersecurity legal counsel consults with other third parties, including communication/notification as required. |
|||
* ''These individuals'' monitor prevention, mitigation, detection, and remediation of cybersecurity incidents through their management and participation in risk management processes and report to the Risk Committee <sup>p. 27</sup>. |
|||
* Cybersecurity vendors perform investigation services and assist with recovery/restoration of impacted IT System services. |
|||
* ''Risk Committee of the Board of Directors'' oversees cybersecurity strategy, reviews cybersecurity and other IT risks, controls, and procedures, and receives periodic updates from management on cybersecurity measures <sup>p. 27</sup>. |
|||
* Cybersecurity experts assist with incident validation and ransomware demands. |
|||
* ''Review by the Risk Committee'' includes discussion of cybersecurity threat risks and their potential operational impact <sup>p. 27</sup>. |
|||
* Cybersecurity insurance providers are involved in incident response. |
|||
* ''Separate process for communicating with the Risk Committee'' is instituted for specific cybersecurity incidents <sup>p. 27</sup>. |
|||
* Processes are in place to oversee and identify cybersecurity risks from key third-party service providers. |
|||
* ''Crisis Management Team members'' would provide initial awareness communication of an incident to the CEO/Chair of the Board, who would inform the Chair of the Risk Committee <sup>p. 27</sup>. |
|||
* Third-party service providers are required to provide SOC-1 or SOC-2 reports and their cybersecurity/disaster recovery plans. |
|||
* ''Following initial assessment'', a follow-up communication would be provided to the CEO and Risk Committee Chair to determine if escalation to the full Board is warranted <sup>p. 27</sup>. |
|||
* ''Cybersecurity threats'' have not materially affected business strategy, results of operations, or financial condition <sup>p. 27</sup>. |
|||
{{chunk|doc=vycbjm4dw4|c=98|p=10}} |
|||
* ''A cybersecurity incident'' resulting in a serious compromise of IT Systems or a demand for payment to restore them could have a material adverse effect by negatively impacting business operations and diverting management/financial resources <sup>p. 27</sup>. |
|||
'''Cybersecurity governance and oversight''' |
|||
* Cybersecurity risk management and strategy processes are overseen by leaders from the Information Security Team, with assistance from Compliance and Legal teams. |
|||
* These individuals have decades of experience in IT roles, including security, auditing, compliance, systems, and programming. |
|||
* They monitor prevention, mitigation, detection, and remediation of cybersecurity incidents through their management and participation in risk management processes and the crisis response plan. |
|||
* They report appropriate items to the Risk Committee. |
|||
* The Risk Committee of the Board of Directors oversees cybersecurity strategy, reviews cybersecurity and other IT risks/controls/procedures, and receives periodic updates from management on cybersecurity measures. |
|||
* The review includes a thorough discussion of cybersecurity threat risks and their potential operational impact. |
|||
* A separate process exists for communicating with the Risk Committee during a specific cybersecurity incident. |
|||
* Members of the Crisis Management Team provide initial awareness communication to the CEO/Chair of the Board, who then informs the Chair of the Risk Committee. |
|||
* Following an initial assessment by senior management and IT Systems personnel, a follow-up communication is provided to the CEO and Risk Committee Chair to determine if escalation to the full Board is warranted. |
|||
{{chunk|doc=vycbjm4dw4|c=99|p=10}} |
|||
'''Cybersecurity risk impact''' |
|||
* Cybersecurity threats have not materially affected business strategy, results of operations, or financial condition. |
|||
* A cybersecurity incident resulting in a serious compromise of IT Systems or a demand for payment to restore IT Systems could have a material adverse effect. |
|||
* Such an incident could negatively impact the ability to operate the business effectively and divert management/financial resources. |
|||
== Properties == |
== Properties == |
||
{{chunk|doc=vycbjm4dw4|c=100|p=11}} |
|||
* ''Primary executive offices and insurance operations'' are leased in Houston, Texas <sup>p. 28</sup>. |
|||
'''Office facilities''' |
|||
* ''Office space'' in Houston is approximately 20,400 square feet <sup>p. 28</sup>. |
|||
* ''Lease for Houston office space'' expires in 2029 <sup>p. 28</sup>. |
|||
* The company leases its primary executive offices and insurance operations in Houston, Texas. |
|||
* ''Additional office space'' is leased as appropriate <sup>p. 28</sup>. |
|||
* These offices occupy approximately 20,400 square feet of space. |
|||
* ''Management considers office facilities'' suitable and adequate for current operations <sup>p. 28</sup>. |
|||
* The lease for the Houston office space expires in 2029. |
|||
* Additional office space is leased where appropriate. |
|||
* Management considers the office facilities suitable and adequate for current operations. |
|||
== Legal Proceedings == |
== Legal Proceedings == |
||
{{chunk|doc=vycbjm4dw4|c=101|p=12}} |
|||
* The company is involved in legal proceedings that occur in the ordinary course of business <sup>p. 29</sup>. |
|||
'''Legal proceedings''' |
|||
* The company believes that the outcome of these legal matters, individually and in aggregate, will not materially adversely affect its consolidated financial position <sup>p. 29</sup>. |
|||
* The company is party to legal proceedings arising in the ordinary course of business. |
|||
* The company believes the outcome of these matters, individually and in aggregate, will not have a material adverse effect on its consolidated financial position. |
|||
== Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities == |
== Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities == |
||
{{chunk|doc=vycbjm4dw4|c=102|p=13}} |
|||
* Our common shares started trading on the NASDAQ Global Select Market under the symbol "SKWD" on January 13, 2023 <sup>p. 30</sup>. |
|||
'''Common stock trading and holders''' |
|||
* Before January 13, 2023, there was no public market for our common shares <sup>p. 30</sup>. |
|||
* As of February 26, 2025, there were approximately 5 holders of record of our common stock <sup>p. 30</sup>. |
|||
* The number of record holders does not represent the total number of stockholders because many shares are held by brokers and other institutions on behalf of stockholders <sup>p. 30</sup>. |
|||
* Common shares began trading on the NASDAQ Global Select Market under the symbol "SKWD" on January 13, 2023. |
|||
{{Indexing|Securities Authorized for Issuance Under Equity Compensation Plans||kind=prose|order=31}} |
|||
* Prior to January 13, 2023, there was no public market for the company's common shares. |
|||
* As of February 26, 2025, there were approximately 5 holders of record of the common stock. |
|||
* The number of record holders does not represent the total number of stockholders due to shares being held by brokers and institutions on behalf of stockholders. |
|||
=== Securities Authorized for Issuance Under Equity Compensation Plans === |
|||
* Information regarding equity compensation plans will be included in the definitive proxy statement to be filed with the SEC for the 2025 Annual Meeting of Stockholders ("2025 Proxy Statement") and is incorporated by reference into this document <sup>p. 31</sup>. |
|||
{{chunk|doc=vycbjm4dw4|c=103|p=13}} |
|||
{{Indexing|Recent Sales of Unregistered Equity Securities||kind=prose|order=32}} |
|||
'''Equity compensation plan information''' |
|||
* Information regarding |
* Information regarding equity compensation plans will be included in the definitive proxy statement filed with the SEC for the 2025 Annual Meeting of Stockholders and is incorporated by reference. |
||
* The information presented in Item 5 reflects a 4-for-1 reverse stock split, effective January 3, 2023 <sup>p. 32</sup>. |
|||
* Immediately before the IPO, all preferred stock converted into 16,305,113 shares of common stock <sup>p. 32</sup>. |
|||
* The issuance of these common shares was exempt from Securities Act registration requirements under Section 3(a)(9) <sup>p. 32</sup>. |
|||
* This exemption applies to exchanges of securities by an issuer with existing security holders where no commission or remuneration was paid for soliciting the exchange <sup>p. 32</sup>. |
|||
* No underwriters were involved in this share issuance <sup>p. 32</sup>. |
|||
=== Recent Sales of Unregistered Equity Securities === |
|||
{{Indexing|Use of Proceeds from Initial Public Offering||kind=prose|order=33}} |
|||
{{chunk|doc=vycbjm4dw4|c=104|p=13}} |
|||
* ''IPO closing date'': January 18, 2023 <sup>p. 33</sup> |
|||
'''Securities issuance details''' |
|||
* ''Shares issued and sold by the company'': 4,750,000 shares of common stock <sup>p. 33</sup> |
|||
* ''Shares sold by selling stockholders'': 4,202,383 shares <sup>p. 33</sup> |
|||
* ''Underwriters' option exercise'': exercised in full to purchase 1,342,857 additional shares of common stock from selling stockholders <sup>p. 33</sup> |
|||
* ''Registration statement'': Form S-1 (File No. 333-265326) under the Securities Act <sup>p. 33</sup> |
|||
* ''SEC effective date'': January 12, 2023 <sup>p. 33</sup> |
|||
* ''Representatives of the underwriters'': Barclays Capital Inc. and Keefe, Bruyette & Woods, Inc. <sup>p. 33</sup> |
|||
* ''Public offering price'': $15.00 per share <sup>p. 33</sup> |
|||
* ''Net proceeds to the Company'': approximately $62.3 million, after deducting underwriting discounts and specific incremental expenses <sup>p. 33</sup> |
|||
* ''Proceeds distribution'': All proceeds from the IPO have been distributed to the Company’s insurance company subsidiaries <sup>p. 33</sup> |
|||
* Information regarding securities issued or granted during the period covered by this Annual Report on Form 10-K that were not registered under the Securities Act is set forth below. |
|||
{{Indexing|Issuer Purchases of Equity Securities||kind=prose|order=34}} |
|||
* The information in Item 5 reflects a 4-for-1 reverse stock split, effective January 3, 2023. |
|||
* Immediately before the IPO, all preferred stock converted into 16,305,113 shares of common stock. |
|||
* The issuance of these common shares was exempt from Securities Act registration requirements under Section 3(a)(9) of the Securities Act. |
|||
* This exemption applies to an exchange of securities by the issuer with existing security holders exclusively, where no commission or other remuneration was paid directly or indirectly for soliciting the exchange. |
|||
* No underwriters were involved in this share issuance. |
|||
=== Use of Proceeds from Initial Public Offering === |
|||
* The company did not purchase any of its equity securities during the period covered by this Annual Report on Form 10-K <sup>p. 34</sup>. |
|||
{{chunk|doc=vycbjm4dw4|c=105|p=13}} |
|||
{{Indexing|Dividends||kind=prose|order=35}} |
|||
'''IPO Details and Proceeds''' |
|||
* The IPO closed on January 18, 2023. |
|||
* The company does not currently intend to pay any ''cash dividends'' on its common stock in the foreseeable future <sup>p. 35</sup>. |
|||
* The company issued and sold 4,750,000 shares of common stock. |
|||
* Any future determination to pay ''dividends'' will be at the discretion of the Board of Directors <sup>p. 35</sup>. |
|||
* Selling stockholders sold 4,202,383 shares. |
|||
* ''Dividend payment'' will depend on results of operations, financial condition, restrictions by applicable law, and other factors deemed relevant by the Board of Directors <sup>p. 35</sup>. |
|||
* Underwriters fully exercised their option to purchase 1,342,857 additional shares of common stock from selling stockholders. |
|||
* Investors may need to sell all or part of their ''common stock holdings'' after price appreciation to realize future gains, as this may be the only way <sup>p. 35</sup>. |
|||
* The offer and sale of shares in the IPO were registered under the Securities Act via a Form S-1 registration statement (File No. 333-265326). |
|||
* Investors seeking ''immediate cash dividends'' should not purchase the company's common stock <sup>p. 35</sup>. |
|||
* The registration statement was declared effective by the SEC on January 12, 2023. |
|||
* Barclays Capital Inc. and Keefe, Bruyette & Woods, Inc. were representatives of the underwriters. |
|||
* The public offering price was USD 15.00 per share. |
|||
* Net proceeds to the Company were approximately USD 62.3m, after deducting underwriting discounts and specific incremental IPO expenses. |
|||
* All proceeds from the IPO were distributed to the Company’s insurance company subsidiaries. |
|||
=== Issuer Purchases of Equity Securities === |
|||
{{Indexing|Performance Graph||kind=prose|order=36}} |
|||
{{chunk|doc=vycbjm4dw4|c=106|p=13}} |
|||
* The performance graph compares the cumulative total shareholder return of an investment in ''Skyward Specialty Insurance Group's common stock'', the ''Nasdaq Composite Index'', and the ''Nasdaq Insurance Index'' <sup>p. 36</sup>. |
|||
'''Equity securities purchases''' |
|||
* The comparison period begins on ''January 13, 2023'', the date the common stock began trading on Nasdaq, and extends through ''December 31, 2024'' <sup>p. 36</sup>. |
|||
* The graph assumes an ''initial investment of $100'' <sup>p. 36</sup>. |
|||
* ''Historical returns'' are not indicative of future performance <sup>p. 36</sup>. |
|||
* The graph is not considered "soliciting material" or "filed" for purposes of ''Section 18 of the Exchange Act'', nor is it subject to liabilities under that Section <sup>p. 36</sup>. |
|||
* The graph is not deemed to be incorporated by reference into any filings under the ''Securities Act'' <sup>p. 36</sup>. |
|||
* ''Skyward Specialty Insurance Group, Inc. performance'': |
|||
** January 13, 2023: ''$100.00'' <sup>p. 36</sup> |
|||
** December 31, 2023: Approximately ''$175.00'' <sup>p. 36</sup> |
|||
** December 31, 2024: Approximately ''$265.00'' <sup>p. 36</sup> |
|||
* ''Nasdaq Composite Index performance'': |
|||
** January 13, 2023: ''$100.00'' <sup>p. 36</sup> |
|||
** December 31, 2023: Approximately ''$135.00'' <sup>p. 36</sup> |
|||
** December 31, 2024: Approximately ''$170.00'' <sup>p. 36</sup> |
|||
* ''Nasdaq Insurance Index performance'': |
|||
** January 13, 2023: ''$100.00'' <sup>p. 36</sup> |
|||
** December 31, 2023: Approximately ''$105.00'' <sup>p. 36</sup> |
|||
** December 31, 2024: Approximately ''$128.00'' <sup>p. 36</sup> |
|||
* The company did not purchase any of its equity securities during the period covered by this Annual Report on Form 10-K. |
|||
{{Indexing|Stock performance comparison||kind=table|order=37}} |
|||
=== Dividends === |
|||
{{chunk|doc=vycbjm4dw4|c=107|p=13}} |
|||
'''[[Definition:Dividend|Dividend]] policy''' |
|||
* The company does not currently intend to pay cash [[Definition:Dividend|dividends]] on its common stock in the foreseeable future. |
|||
* Any future [[Definition:Dividend|dividend]] payments will be at the discretion of the Board of Directors. |
|||
* Future [[Definition:Dividend|dividend]] determinations will depend on results of operations, financial condition, applicable legal restrictions, and other factors deemed relevant by the Board of Directors. |
|||
* Investors may need to sell common stock holdings to realize future gains, as price appreciation may not occur. |
|||
* Investors seeking immediate cash [[Definition:Dividend|dividends]] should not purchase the company's common stock. |
|||
=== Performance Graph === |
|||
{{chunk|doc=vycbjm4dw4|c=108|p=13}} |
|||
'''Shareholder return performance graph''' |
|||
* The performance graph compares the cumulative total shareholder return of an investment in the company's common stock, the Nasdaq Composite Index, and the Nasdaq Insurance Index. |
|||
* The comparison period is from January 13, 2023 (the date the common stock began trading on Nasdaq) through December 31, 2024. |
|||
* The graph assumes an initial investment of USD 100. |
|||
* Historical results are not indicative of future performance. |
|||
* The graph is not considered "soliciting material" or "filed" for purposes of Section 18 of the Exchange Act. |
|||
* The graph is not subject to liabilities under Section 18 of the Exchange Act. |
|||
* The graph is not incorporated by reference into any filings under the Securities Act. |
|||
{{chunk|doc=vycbjm4dw4|c=109|p=13}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1004" class="wikitable fintable" |
||
|+ Performance Graph |
|||
! style="text-align:left" | — |
|||
|- |
|||
! style="text-align:left" | |
|||
! class="col-s" style="text-align:right" | January 13, 2023 |
! class="col-s" style="text-align:right" | January 13, 2023 |
||
! class="col-s" style="text-align:right" | December 31, 2023 |
! class="col-s" style="text-align:right" | December 31, 2023 |
||
| Line 1,213: | Line 1,743: | ||
|} |
|} |
||
</div> |
</div> |
||
{{chunk|doc=vycbjm4dw4|c=110|p=13}} |
|||
'''Performance Graph''' |
|||
[[File:Skyward-2024-FY-Annual report-skwd-20241231_g2.jpg|thumb|Performance Graph]] |
[[File:Skyward-2024-FY-Annual report-skwd-20241231_g2.jpg|thumb|Performance Graph]] |
||
Chart / Image: |
|||
* Y-axis represents values from $100.00 to $300.00. |
|||
* X-axis represents dates: January 13, 2023, December 31, 2023, and December 31, 2024. |
|||
* The blue line with circular markers represents "Skyward Specialty Insurance Group, Inc.". |
|||
* The magenta line with circular markers represents "Nasdaq Composite Index". |
|||
* The cyan line with circular markers represents "Nasdaq Insurance Index". |
|||
* On January 13, 2023, Skyward Specialty Insurance Group, Inc. value is approximately $100.00. |
|||
* On January 13, 2023, Nasdaq Composite Index value is approximately $100.00. |
|||
* On January 13, 2023, Nasdaq Insurance Index value is approximately $100.00. |
|||
* On December 31, 2023, Skyward Specialty Insurance Group, Inc. value is approximately $175.00. |
|||
* On December 31, 2023, Nasdaq Composite Index value is approximately $135.00. |
|||
* On December 31, 2023, Nasdaq Insurance Index value is approximately $105.00. |
|||
* On December 31, 2024, Skyward Specialty Insurance Group, Inc. value is approximately $265.00. |
|||
* On December 31, 2024, Nasdaq Composite Index value is approximately $170.00. |
|||
* On December 31, 2024, Nasdaq Insurance Index value is approximately $128.00. |
|||
== Management’s Discussion and Analysis of Financial Condition and Results of Operations == |
== Management’s Discussion and Analysis of Financial Condition and Results of Operations == |
||
=== Overview === |
|||
{{chunk|doc=vycbjm4dw4|c=111|p=14}} |
|||
* The company is a growing specialty insurance company providing commercial P&C products and solutions on both non-admitted (E&S) and admitted bases, primarily in the United States <sup>p. 37</sup>. |
|||
'''Business overview and strategy''' |
|||
* The company focuses on underserved, dislocated, and/or markets where standard insurance coverages are insufficient for businesses <sup>p. 37</sup>. |
|||
* Customers typically require highly specialized, customized underwriting solutions and claims capabilities <sup>p. 37</sup>. |
|||
* The company develops and delivers tailored insurance products and services for each niche market it serves <sup>p. 37</sup>. |
|||
* The portfolio of insured risks is highly diversified, covering customers in various industries, distributed through multiple channels, and writing multiple lines of business <sup>p. 37</sup>. |
|||
* Lines of business include general liability, excess liability, professional liability (cyber and media liability insurance), commercial auto, group accident and health, property, agriculture, credit, surety, and workers’ compensation <sup>p. 37</sup>. |
|||
* The company insures both short and medium duration liabilities <sup>p. 37</sup>. |
|||
* The business mix is principally primary insurance, balanced between E&S and admitted markets <sup>p. 37</sup>. |
|||
* A small portion of the business is specialty reinsurance, primarily in agriculture and credit, focused on attractive specialty classes where reinsurance is more efficient due to factors like cost of entry and geographic expansion <sup>p. 37</sup>. |
|||
* This diversification allows the company to respond to market opportunities and dislocations by deploying capital with attractive risk-adjusted returns <sup>p. 37</sup>. |
|||
* The diversification, including businesses not typically aligned with traditional P&C pricing cycles, combined with underwriting and claims expertise, is expected to consistently produce strong growth and profitability across all insurance pricing cycles <sup>p. 37</sup>. |
|||
* The company aims to lead in chosen market niches and establish sustainable competitive positions, referring to this strategy as "Rule Our Niche" <sup>p. 37</sup>. |
|||
* This strategy forms the basis for building a strong defensible market position, creating a competitive moat, and winning chosen markets <sup>p. 37</sup>. |
|||
* The principles underlying this strategy are considered key to achieving and sustaining best-in-class underwriting results through P&C insurance pricing cycles <sup>p. 37</sup>. |
|||
* The company consistently strives for excellence in risk selection, pricing, and claims outcomes, amplified by advanced technology and analytics <sup>p. 37</sup>. |
|||
* The company is a specialty insurance provider of commercial [[Definition:Property & casualty|P&C]] products and solutions, primarily in the United States. |
|||
{{Indexing|Results of Operations||kind=prose|order=39}} |
|||
* Products are offered on both a non-admitted (E&S) and admitted basis. |
|||
* The company focuses on underserved, dislocated, or inadequately covered markets, requiring highly specialized and customized underwriting and claims solutions. |
|||
* The portfolio of insured risks is highly diversified across industries, distribution channels, and [[Definition:Business mix|lines of business]]. |
|||
* [[Definition:Business mix|Lines of business]] include general liability, excess liability, professional liability (cyber and media liability), commercial auto, group accident and health, property, agriculture, credit, surety, and workers’ compensation. |
|||
* The [[Definition:Business mix|business mix]] includes both short and medium duration liabilities, is principally primary insurance, and is balanced between E&S and admitted markets. |
|||
* A small portion of the business is specialty reinsurance, primarily in agriculture and credit, focused on attractive specialty classes where reinsurance is more efficient due to factors like cost of entry and geographic expansion. |
|||
* This diversification, including businesses not typically aligned with traditional [[Definition:Property & casualty|P&C]] pricing cycles, combined with underwriting and claims expertise, aims to produce consistent growth and profitability across all insurance pricing cycles. |
|||
* The company's strategy, "Rule Our Niche," focuses on leading in chosen market niches and establishing sustainable competitive positions. |
|||
* This strategy aims to build a strong defensible market position, create a competitive moat, and achieve best-in-class underwriting results through [[Definition:Property & casualty|P&C]] insurance pricing cycles. |
|||
* The company strives for excellence in risk selection, pricing, and claims outcomes, amplified by advanced technology and analytics. |
|||
=== Results of Operations === |
|||
* ''Net premiums earned'' were USD 1,004.0m in 2024, up from USD 800.0m in 2023 <sup>p. 38</sup>. |
|||
* ''Net investment income'' was USD 69.0m in 2024, up from USD 50.0m in 2023 <sup>p. 38</sup>. |
|||
* ''Net realized and unrealized gains on investments'' were USD 10.0m in 2024, down from USD 12.0m in 2023 <sup>p. 38</sup>. |
|||
* ''Other income'' was USD 1.0m in 2024, consistent with USD 1.0m in 2023 <sup>p. 38</sup>. |
|||
* ''Total revenues'' were USD 1,084.0m in 2024, up from USD 863.0m in 2023 <sup>p. 38</sup>. |
|||
* ''Losses and loss adjustment expenses'' were USD 600.0m in 2024, up from USD 470.0m in 2023 <sup>p. 38</sup>. |
|||
* ''Underwriting, acquisition and insurance expenses'' were USD 340.0m in 2024, up from USD 270.0m in 2023 <sup>p. 38</sup>. |
|||
* ''Interest expense'' was USD 10.0m in 2024, up from USD 8.0m in 2023 <sup>p. 38</sup>. |
|||
* ''Total expenses'' were USD 950.0m in 2024, up from USD 748.0m in 2023 <sup>p. 38</sup>. |
|||
* ''Income before income taxes'' was USD 134.0m in 2024, up from USD 115.0m in 2023 <sup>p. 38</sup>. |
|||
* ''Income tax expense'' was USD 28.0m in 2024, up from USD 24.0m in 2023 <sup>p. 38</sup>. |
|||
* ''Net income'' was USD 106.0m in 2024, up from USD 91.0m in 2023 <sup>p. 38</sup>. |
|||
* ''Net income attributable to common stockholders'' was USD 106.0m in 2024, up from USD 91.0m in 2023 <sup>p. 38</sup>. |
|||
* ''Earnings per share attributable to common stockholders—basic'' was USD 2.60 in 2024, up from USD 2.24 in 2023 <sup>p. 38</sup>. |
|||
* ''Earnings per share attributable to common stockholders—diluted'' was USD 2.59 in 2024, up from USD 2.23 in 2023 <sup>p. 38</sup>. |
|||
* ''Weighted-average common shares outstanding—basic'' were 40.7m in 2024, up from 40.6m in 2023 <sup>p. 38</sup>. |
|||
* ''Weighted-average common shares outstanding—diluted'' were 40.9m in 2024, up from 40.8m in 2023 <sup>p. 38</sup>. |
|||
{{chunk|doc=vycbjm4dw4|c=112|p=14}} |
|||
{{Indexing|Summary of financial performance||kind=table|order=40}} |
|||
'''Financial results summary''' |
|||
* The table summarizes results for the years ended December 31, 2024 and 2023. |
|||
{{chunk|doc=vycbjm4dw4|c=113|p=14}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1005" class="wikitable fintable" |
||
|+ [[Definition:Net written premiums|Net written premiums]], net earned premiums, & underwriting income by years ended December 31 |
|||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Years Ended December 31, |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col-m" style="text-align:right" | 2024 |
! class="col-m" style="text-align:right" | 2024 |
||
! class="col- |
! class="col-m" style="text-align:right" | 2023 |
||
|- |
|- |
||
| style="text-align:left" | Gross written premiums |
| style="text-align:left" | [[Definition:Gross written premiums|Gross written premiums]] |
||
| style="text-align:right" | 1,743,232 |
| style="text-align:right" | 1,743,232 |
||
| style="text-align:right" | 1,459,829 |
| style="text-align:right" | 1,459,829 |
||
|- |
|- |
||
| style="text-align:left" | Ceded written premiums |
| style="text-align:left" | Ceded written premiums |
||
| style="text-align:right" | |
| style="text-align:right" | (619,654) |
||
| style="text-align:right" | |
| style="text-align:right" | (549,138) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>[[Definition:Net written premiums|Net written premiums]]</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>1,123,578</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>910,691</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net earned premiums</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>1,056,722</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>829,143</b> |
||
|- |
|- |
||
| style="text-align:left" | Commission and fee income |
| style="text-align:left" | Commission and fee income |
||
| Line 1,296: | Line 1,832: | ||
| style="text-align:right" | 243,444 |
| style="text-align:right" | 243,444 |
||
|- |
|- |
||
| class="wt-indent-1" style="text-align:left" | |
| class="wt-indent-1" style="text-align:left" | <b>Underwriting income (1)</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>81,859</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>76,526</b> |
||
|- |
|- |
||
| style="text-align:left" | Net investment income |
| style="text-align:left" | [[Definition:Net investment income|Net investment income]] |
||
| style="text-align:right" | 80,686 |
| style="text-align:right" | 80,686 |
||
| style="text-align:right" | 40,322 |
| style="text-align:right" | 40,322 |
||
| Line 1,316: | Line 1,852: | ||
| style="text-align:right" | 85,984 |
| style="text-align:right" | 85,984 |
||
|- |
|- |
||
| style="text-align:left" | Adjusted operating income (1) |
| style="text-align:left" | Adjusted [[Definition:Underlying earnings|operating income]] (1) |
||
| style="text-align:right" | 126,650 |
| style="text-align:right" | 126,650 |
||
| style="text-align:right" | 80,847 |
| style="text-align:right" | 80,847 |
||
| Line 1,328: | Line 1,864: | ||
| style="text-align:right" | 28.6% |
| style="text-align:right" | 28.6% |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Combined ratio</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>92.3%</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>90.7%</b> |
||
|- |
|- |
||
| style="text-align:left" | Adjusted loss and LAE ratio (1) |
| style="text-align:left" | Adjusted loss and LAE ratio (1) |
||
| Line 1,340: | Line 1,876: | ||
| style="text-align:right" | 28.6% |
| style="text-align:right" | 28.6% |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Adjusted combined ratio (1)</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>91.2%</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>90.9%</b> |
||
|- |
|- |
||
| style="text-align:left" | Return on equity |
| style="text-align:left" | Return on equity |
||
| Line 1,362: | Line 1,898: | ||
</div> |
</div> |
||
{{fn note|1=1|2=See “Reconciliation of Non-GAAP Financial Measures” in this Item 2.}} |
|||
=== Reconciliation of Non-GAAP Financial Measures === |
|||
{{chunk|doc=vycbjm4dw4|c=114|p=14}} |
|||
* ''Adjusted Operating Income'' reconciliation to net income provided for years ended December 31, 2024 and 2023 <sup>p. 39</sup>. |
|||
'''Adjusted [[Definition:Underlying earnings|operating income]] reconciliation''' |
|||
* ''Underwriting Income'' reconciliation to income before federal income tax expense provided for years ended December 31, 2024 and 2023 <sup>p. 39</sup>. |
|||
* ''Adjusted Loss Ratio / Adjusted Combined Ratio'' reconciliation to loss and LAE ratio and combined ratio provided for years ended December 31, 2024 and 2023 <sup>p. 39</sup>. |
|||
* ''Tangible Stockholders’ Equity'' reconciliation to stockholders’ equity provided for years ended December 31, 2024 and 2023 <sup>p. 39</sup>. |
|||
* ''Adjusted Return on Equity'' reconciliation to return on equity provided for years ended December 31, 2024 and 2023 <sup>p. 39</sup>. |
|||
* ''Return on Tangible Equity'' reconciliation to return on equity provided for years ended December 31, 2024 and 2023 <sup>p. 39</sup>. |
|||
* ''Adjusted Return on Tangible Equity'' reconciliation to return on equity provided for years ended December 31, 2024 and 2023 <sup>p. 39</sup>. |
|||
* The table provides a reconciliation of adjusted [[Definition:Underlying earnings|operating income]] to net income for the years ended December 31, 2024 and 2023. |
|||
{{Indexing|Return on tangible equity reconciliation||kind=table|order=42}} |
|||
{{chunk|doc=vycbjm4dw4|c=115|p=14}} |
|||
'''Underwriting income reconciliation''' |
|||
* The table provides a reconciliation of underwriting income to income before federal income tax expense for the years ended December 31, 2024 and 2023. |
|||
{{chunk|doc=vycbjm4dw4|c=116|p=14}} |
|||
'''Adjusted loss ratio and adjusted combined ratio reconciliation''' |
|||
* The table provides a reconciliation of the adjusted loss and LAE ratio and adjusted combined ratio to the loss and LAE ratio and combined ratio for the years ended December 31, 2024 and 2023. |
|||
{{chunk|doc=vycbjm4dw4|c=117|p=14}} |
|||
'''Tangible stockholders’ equity reconciliation''' |
|||
* The table provides a reconciliation of tangible stockholders’ equity to stockholders’ equity for the years ended December 31, 2024 and 2023. |
|||
{{chunk|doc=vycbjm4dw4|c=118|p=14}} |
|||
'''Adjusted return on equity reconciliation''' |
|||
* The table provides a reconciliation of adjusted return on equity to return on equity for the years ended December 31, 2024 and 2023. |
|||
{{chunk|doc=vycbjm4dw4|c=119|p=14}} |
|||
'''Return on tangible equity reconciliation''' |
|||
* Return on tangible equity for the years ended December 31, 2024 and 2023 reconciles to return on equity. |
|||
{{chunk|doc=vycbjm4dw4|c=120|p=14}} |
|||
'''Adjusted return on tangible equity reconciliation''' |
|||
* Adjusted return on tangible equity for the years ended December 31, 2024 and 2023 reconciles to return on equity. |
|||
{{chunk|doc=vycbjm4dw4|c=121|p=14}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1006" class="wikitable fintable" |
||
|+ Adjusted [[Definition:Underlying earnings|operating income]] by pre-tax and after-tax |
|||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="2" style="text-align:center" | 2024 |
! colspan="2" style="text-align:center" | 2024 |
||
| Line 1,383: | Line 1,948: | ||
|- |
|- |
||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col- |
! class="col-m" style="text-align:right" | Pre-tax |
||
! class="col- |
! class="col-m" style="text-align:right" | After-tax |
||
! class="col- |
! class="col-m" style="text-align:right" | Pre-tax |
||
! class="col- |
! class="col-m" style="text-align:right" | After-tax |
||
|- |
|- |
||
| style="text-align:left" | Income as reported |
| style="text-align:left" | Income as reported |
||
| Line 1,407: | Line 1,972: | ||
|- |
|- |
||
| style="text-align:left" | Net impact of LPT |
| style="text-align:left" | Net impact of LPT |
||
| style="text-align:right" | |
| style="text-align:right" | (11,598) |
||
| style="text-align:right" | |
| style="text-align:right" | (9,162) |
||
| style="text-align:right" | 1,427 |
| style="text-align:right" | 1,427 |
||
| style="text-align:right" | 1,127 |
| style="text-align:right" | 1,127 |
||
|- |
|- |
||
| style="text-align:left" | Other (loss) income |
| style="text-align:left" | Other (loss) income |
||
| style="text-align:right" | |
| style="text-align:right" | (167) |
||
| style="text-align:right" | |
| style="text-align:right" | (132) |
||
| style="text-align:right" | |
| style="text-align:right" | (632) |
||
| style="text-align:right" | |
| style="text-align:right" | (499) |
||
|- |
|- |
||
| style="text-align:left" | Other expenses |
| style="text-align:left" | Other expenses |
||
| style="text-align:right" | |
| style="text-align:right" | (4,392) |
||
| style="text-align:right" | |
| style="text-align:right" | (3,470) |
||
| style="text-align:right" | |
| style="text-align:right" | (5,364) |
||
| style="text-align:right" | |
| style="text-align:right" | (4,238) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Adjusted [[Definition:Underlying earnings|operating income]]</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>162,640</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>126,650</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>103,599</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>80,847</b> |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Reconciliation of income before income taxes to underwriting income||kind=table|order=43}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1007" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col- |
! class="col-m" style="text-align:right" | 2024 |
||
! class="col- |
! class="col-m" style="text-align:right" | 2023 |
||
|- |
|- |
||
| style="text-align:left" | Income before income taxes |
| style="text-align:left" | Income before income taxes |
||
| Line 1,464: | Line 2,028: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Net investment income |
| style="text-align:left" | [[Definition:Net investment income|Net investment income]] |
||
| style="text-align:right" | 80,686 |
| style="text-align:right" | 80,686 |
||
| style="text-align:right" | 40,322 |
| style="text-align:right" | 40,322 |
||
| Line 1,473: | Line 2,037: | ||
|- |
|- |
||
| style="text-align:left" | Other loss |
| style="text-align:left" | Other loss |
||
| style="text-align:right" | |
| style="text-align:right" | (167) |
||
| style="text-align:right" | |
| style="text-align:right" | (632) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Underwriting income</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>81,859</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>76,526</b> |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Loss and combined ratios||kind=table|order=44}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1008" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col- |
! class="col-m" style="text-align:right" | 2024 |
||
! class="col- |
! class="col-m" style="text-align:right" | 2023 |
||
|- |
|- |
||
| style="text-align:left" | Net earned premiums |
| style="text-align:left" | Net earned premiums |
||
| Line 1,499: | Line 2,062: | ||
|- |
|- |
||
| style="text-align:left" | Pre-tax net impact of loss portfolio transfer |
| style="text-align:left" | Pre-tax net impact of loss portfolio transfer |
||
| style="text-align:right" | |
| style="text-align:right" | (11,598) |
||
| style="text-align:right" | 1,427 |
| style="text-align:right" | 1,427 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Adjusted losses and LAE</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>658,211</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>516,664</b> |
||
|- |
|- |
||
| style="text-align:left" | Loss ratio |
| style="text-align:left" | Loss ratio |
||
| Line 1,512: | Line 2,075: | ||
| style="text-align:left" | Less: Net impact of LPT |
| style="text-align:left" | Less: Net impact of LPT |
||
| style="text-align:right" | 1.1% |
| style="text-align:right" | 1.1% |
||
| style="text-align:right" | |
| style="text-align:right" | (0.2)% |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Adjusted loss ratio</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>62.3%</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>62.3%</b> |
||
|- |
|- |
||
| style="text-align:left" | Combined ratio |
| style="text-align:left" | Combined ratio |
||
| Line 1,524: | Line 2,087: | ||
| style="text-align:left" | Less: Net impact of LPT |
| style="text-align:left" | Less: Net impact of LPT |
||
| style="text-align:right" | 1.1% |
| style="text-align:right" | 1.1% |
||
| style="text-align:right" | |
| style="text-align:right" | (0.2)% |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Adjusted combined ratio</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>91.2%</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>90.9%</b> |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Stockholders’ equity and tangible stockholders’ equity||kind=table|order=45}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1009" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col- |
! class="col-m" style="text-align:right" | 2024 |
||
! class="col- |
! class="col-m" style="text-align:right" | 2023 |
||
|- |
|- |
||
| style="text-align:left" | Stockholders’ equity |
| style="text-align:left" | Stockholders’ equity |
||
| Line 1,548: | Line 2,110: | ||
| style="text-align:right" | 88,435 |
| style="text-align:right" | 88,435 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Tangible stockholders’ equity</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>706,651</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>572,596</b> |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Adjusted return on equity||kind=table|order=46}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1010" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col- |
! class="col-m" style="text-align:right" | 2024 |
||
! class="col- |
! class="col-m" style="text-align:right" | 2023 |
||
|- |
|- |
||
| style="text-align:left" | Numerator: adjusted operating income |
| style="text-align:left" | Numerator: adjusted [[Definition:Underlying earnings|operating income]] |
||
| style="text-align:right" | 126,650 |
| style="text-align:right" | 126,650 |
||
| style="text-align:right" | 80,847 |
| style="text-align:right" | 80,847 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Denominator: average stockholders’ equity</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>727,515</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>541,347</b> |
||
|- |
|- |
||
| style="text-align:left" | Adjusted return on equity |
| style="text-align:left" | Adjusted return on equity |
||
| Line 1,575: | Line 2,136: | ||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Return on tangible equity||kind=table|order=47}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1011" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col- |
! class="col-m" style="text-align:right" | 2024 |
||
! class="col- |
! class="col-m" style="text-align:right" | 2023 |
||
|- |
|- |
||
| style="text-align:left" | Numerator: net income |
| style="text-align:left" | Numerator: net income |
||
| Line 1,588: | Line 2,148: | ||
| style="text-align:right" | 85,984 |
| style="text-align:right" | 85,984 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Denominator: average tangible stockholders’ equity</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>639,624</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>452,194</b> |
||
|- |
|- |
||
| style="text-align:left" | Return on tangible equity |
| style="text-align:left" | Return on tangible equity |
||
| Line 1,597: | Line 2,157: | ||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Adjusted return on tangible equity||kind=table|order=48}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1012" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col- |
! class="col-m" style="text-align:right" | 2024 |
||
! class="col- |
! class="col-m" style="text-align:right" | 2023 |
||
|- |
|- |
||
| style="text-align:left" | Numerator: adjusted operating income |
| style="text-align:left" | Numerator: adjusted [[Definition:Underlying earnings|operating income]] |
||
| style="text-align:right" | 126,650 |
| style="text-align:right" | 126,650 |
||
| style="text-align:right" | 80,847 |
| style="text-align:right" | 80,847 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Denominator: average tangible stockholders’ equity</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>639,624</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>452,194</b> |
||
|- |
|- |
||
| style="text-align:left" | Adjusted return on tangible equity |
| style="text-align:left" | Adjusted return on tangible equity |
||
| Line 1,620: | Line 2,179: | ||
</div> |
</div> |
||
=== Underwriting Results === |
|||
{{Indexing|Underwriting Results|Net written premiums, net earned premiums, loss ratio, non-cat loss and LAE ratio, cat loss and LAE ratio, prior accident year development, IBNR, LPT|cos78e4bvi|rhstabgyn2|caxaby4jlv|kind=prose|order=49|f1=Net written premiums|v1=USD 1,123.6m|f2=Net earned premiums|v2=USD 1,056.7m|f3=Loss ratio increase|v3=1.3 points|f4=Catastrophe losses|v4=Hurricanes Helene, Beryl, Milton|f5=Adverse development 2024|v5=USD 25.7m|f6=Adverse development 2023|v6=USD 10.8m}} |
|||
{{chunk|doc=vycbjm4dw4|c=122|p=14}} |
|||
* ''Net written premiums'' were USD 1,123.6m compared to USD 910.7m in 2023, an increase of USD 212.9m or 23.4% <sup>p. 40</sup>. |
|||
'''Premiums''' |
|||
* ''Net earned premiums'' for 2024 were USD 1,056.7m compared to USD 829.1m for 2023, an increase of USD 227.6m, or 27.4% <sup>p. 40</sup>. |
|||
* The ''loss ratio'' increased 1.3 points in 2024 compared to 2023, primarily due to the net impact of prior accident year development related to the LPT, which added 1.1 points to the loss ratio <sup>p. 40</sup>. |
|||
* The ''non-cat loss and LAE ratio'' for 2024 improved 0.3 points compared to 2023, driven by a shift in the mix of business <sup>p. 40</sup>. |
|||
* The ''cat loss and LAE ratio'' for 2024 increased 0.3 points compared to 2023, primarily due to catastrophe losses from Hurricanes Helene and Beryl in Q3 2024 and Hurricane Milton in Q4 2024 <sup>p. 40</sup>. |
|||
* In 2024, the Company transitioned from evaluating reserves on a policy year basis to an accident year basis <sup>p. 40</sup>. |
|||
* This transition results in earlier recognition of underlying claim trends, better alignment of exposure to risks, and adherence to industry best practices <sup>p. 40</sup>. |
|||
* As a result of transitioning to an accident year basis, IBNR within short-tail/monoline specialty lines, multi-line solutions, and exited lines was reallocated for the years ended December 31, 2023, 2022, 2021, and 2020, with certain amounts conformed to the current year presentation <sup>p. 40</sup>. |
|||
* For the year ended December 31, 2024, the Company recognized ''adverse development'' related to prior years’ loss and loss expense reserves of USD 25.7m <sup>p. 40</sup>. |
|||
* Of this, USD 10.1m and USD 15.2m in multi-line solutions and exited lines, respectively, were related to losses previously subject to the LPT from accident years 2018 and prior <sup>p. 40</sup>. |
|||
* During the year ended December 31, 2023, the Company recognized ''adverse development'' related to prior years’ loss and loss expense reserves of USD 10.8m <sup>p. 40</sup>. |
|||
* Adverse development of USD 11.7m in multi-line solutions in 2023 was driven by greater than expected severity in auto, general, and excess liability lines of business, primarily from accident years 2020 to 2022 <sup>p. 40</sup>. |
|||
* This adverse development was partially offset by ''favorable development'' in short-tail/monoline specialty lines, specifically in the property line of business, primarily from accident years 2021 and 2022 <sup>p. 40</sup>. |
|||
* The ''expense ratio'' for 2024 increased 0.3 points compared to 2023, primarily driven by the business mix shift, partially offset by earnings leverage <sup>p. 40</sup>. |
|||
* The expense ratios presented exclude the impact of IPO related stock compensation and secondary offering expenses, which are reported in other expenses <sup>p. 40</sup>. |
|||
* Beginning January 1, 2024, we simplified the investment portfolio classifications to align with our strategy and the underlying risk characteristics of the portfolio." <sup>p. 40</sup> |
|||
* The prior period investment portfolio classifications have been reclassified to conform to the current period presentation <sup>p. 40</sup>. |
|||
* ''Net investment income'' for the year ended 2024 increased USD 40.4m compared to 2023 <sup>p. 40</sup>. |
|||
* The increase in income from our fixed income portfolio for 2024, when compared to 2023, was due to (i) a larger asset base as we continued to increase our allocation to this part of our investment portfolio and (ii) a higher book yield of 5.2% at December 31, 2024 compared to 4.5% at December 31, 2023." <sup>p. 40</sup> |
|||
* The increase in income from short-term investments & cash and cash equivalents for 2024 compared to 2023 was due to higher investment yields and a larger asset base <sup>p. 40</sup>. |
|||
* The fair value of the alternative and strategic investments portfolio for 2024 increased compared to 2023 due to an increase in the fair value of limited partnership investments <sup>p. 40</sup>. |
|||
* [[Definition:Net written premiums|Net written premiums]] were USD 1,123.6m compared to USD 910.7m in 2023, an increase of USD 212.9m or 23.4%. |
|||
{{Indexing|Gross written premiums by segment|Gross written premiums by segment, Industry Solutions, Global Property & Agriculture, Captives, Programs, Accident & Health, Transactional E&S, Professional Lines, Surety|wpkf9ycgxf|1ut79wn2dy|kind=table|order=50}} |
|||
* The increase in [[Definition:Net written premiums|net written premiums]] was primarily driven by the same reasons as [[Definition:Gross written premiums|gross written premiums]]. |
|||
* Net earned premiums for 2024 were USD 1,056.7m compared to USD 829.1m for 2023, an increase of USD 227.6m, or 27.4%. |
|||
* The increase in net earned premiums was primarily driven by the same reasons as [[Definition:Gross written premiums|gross written premiums]]. |
|||
* [[Definition:Gross written premiums|Gross written premiums]] increased YoY due to double-digit premium growth from captives, surety, transactional E&S, programs, and global property & agriculture underwriting divisions. |
|||
* The company broadened and diversified its product portfolio in 2024, growing in areas less exposed to [[Definition:Property & casualty|P&C]] cycles. |
|||
* [[Definition:Gross written premiums|Gross written premium]] increases were primarily driven by: new captive members and growth in existing captives; new product offerings, including participation in the Small Business Administration ("SBA") Bond Guarantee Program, and regional expansion in surety; new business and rate in transactional E&S; the addition of four new programs, including Aviation; and new business in global agriculture. |
|||
* [[Definition:Gross written premiums|Gross written premium]] increases were slightly offset by downward pricing pressure in the global property market and intentional actions to address profitability in commercial auto. |
|||
{{chunk|doc=vycbjm4dw4|c=123|p=14}} |
|||
'''Losses and LAE''' |
|||
* The 2024 loss ratio increased 1.3 points compared to 2023, primarily due to the net impact of prior accident year development related to the LPT, which added 1.1 points to the loss ratio. |
|||
* The non-cat loss and LAE ratio for 2024 improved 0.3 points compared to 2023, primarily driven by a shift in the mix of business. |
|||
* The 2024 cat loss and LAE ratio increased 0.3 points compared to 2023, primarily due to catastrophe losses from Hurricanes Helene and Beryl in Q3 2024 and Hurricane Milton in Q4 2024. |
|||
* In 2024, the Company transitioned from evaluating reserves on a policy year basis to an accident year basis, resulting in earlier recognition of underlying claim trends, better alignment of exposure to risks, and adherence to industry best practices. |
|||
* In prior years, the Company's methodology allocated IBNR from its policy year analysis to accident year. |
|||
* As a result of transitioning to accident year, IBNR within short-tail/monoline specialty lines, multi-line solutions, and exited lines was reallocated for the years ended December 31, 2023, 2022, 2021, and 2020, and certain amounts have been conformed to the current year presentation. |
|||
* For the year ended December 31, 2024, the Company recognized adverse development related to prior years’ loss and loss expense reserves of USD 25.7m. |
|||
* Of the USD 25.7m adverse development, USD 10.1m and USD 15.2m in multi-line solutions and exited lines, respectively, were related to losses previously subject to the LPT from accident years 2018 and prior. |
|||
* During the year ended December 31, 2023, the Company recognized adverse development related to prior years’ loss and loss expense reserves of USD 10.8m. |
|||
* Adverse development of USD 11.7m in multi-line solutions in 2023 was driven by greater than expected severity in auto, general, and excess liability [[Definition:Business mix|lines of business]] primarily from accident years 2020 to 2022. |
|||
* The 2023 adverse development was partially offset by favorable development in short-tail/monoline specialty lines, specifically in the property [[Definition:Business mix|line of business]] primarily from accident years 2021 and 2022. |
|||
{{chunk|doc=vycbjm4dw4|c=124|p=14}} |
|||
'''Expense Ratio''' |
|||
* The expense ratio for 2024 increased 0.3 points compared to 2023, primarily driven by [[Definition:Business mix|business mix]] shift partially offset by earnings leverage. |
|||
* The expense ratios presented exclude the impact of IPO related stock compensation and secondary offering expenses, which are reported in other expenses in the consolidated statements of operations and comprehensive income. |
|||
{{chunk|doc=vycbjm4dw4|c=125|p=14}} |
|||
'''Investment Results''' |
|||
* Beginning January 1, 2024, the company simplified investment portfolio classifications to align with strategy and underlying risk characteristics. |
|||
* The prior period has been reclassified to conform to the current period presentation. |
|||
* [[Definition:Net investment income|Net investment income]] for the year ended 2024 increased USD 40.4m compared to 2023. |
|||
* The increase in income from the fixed income portfolio for 2024 compared to 2023 was due to a larger asset base from increased allocation and a higher book yield of 5.2% at December 31, 2024 (prior: 4.5% at December 31, 2023). |
|||
* The increase in income from short-term investments & cash and cash equivalents for 2024 compared to 2023 was due to higher investment yields and a larger asset base. |
|||
* The fair value of the alternative and strategic investments portfolio for 2024 increased compared to 2023 due to an increase in the fair value of limited partnership investments. |
|||
{{chunk|doc=vycbjm4dw4|c=126|p=14}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1013" class="wikitable fintable" |
||
|+ Total [[Definition:Gross written premiums|gross written premiums]] by [[Definition:Business mix|line of business]] |
|||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="4" style="text-align:center" | Years Ended December 31, |
! colspan="4" style="text-align:center" | Years Ended December 31, |
||
| Line 1,663: | Line 2,245: | ||
| style="text-align:right" | 3.8% |
| style="text-align:right" | 3.8% |
||
|- |
|- |
||
| style="text-align:left" | Global Property & Agriculture |
| style="text-align:left" | Global Property & Agriculture |
||
| style="text-align:right" | 311,402 |
| style="text-align:right" | 311,402 |
||
| style="text-align:right" | 273,191 |
| style="text-align:right" | 273,191 |
||
| Line 1,681: | Line 2,263: | ||
| style="text-align:right" | 22.2% |
| style="text-align:right" | 22.2% |
||
|- |
|- |
||
| style="text-align:left" | Accident & Health |
| style="text-align:left" | Accident & Health |
||
| style="text-align:right" | 173,073 |
| style="text-align:right" | 173,073 |
||
| style="text-align:right" | 151,701 |
| style="text-align:right" | 151,701 |
||
| Line 1,687: | Line 2,269: | ||
| style="text-align:right" | 14.1% |
| style="text-align:right" | 14.1% |
||
|- |
|- |
||
| style="text-align:left" | Transactional E&S |
| style="text-align:left" | Transactional E&S |
||
| style="text-align:right" | 169,053 |
| style="text-align:right" | 169,053 |
||
| style="text-align:right" | 122,508 |
| style="text-align:right" | 122,508 |
||
| Line 1,705: | Line 2,287: | ||
| style="text-align:right" | 43.7% |
| style="text-align:right" | 43.7% |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total [[Definition:Gross written premiums|gross written premiums]] (1) |
||
| style="text-align:right" | |
| style="text-align:right" | 1,743,249 |
||
| style="text-align:right" | |
| style="text-align:right" | 1,459,847 |
||
| style="text-align:right" | |
| style="text-align:right" | 283,402 |
||
| style="text-align:right" | |
| style="text-align:right" | 19.4% |
||
|} |
|} |
||
</div> |
</div> |
||
{{fn note|1=1|2=Excludes exited business.}} |
|||
{{Indexing|Losses and LAE|Losses and LAE, Non-cat loss and LAE, Cat loss and LAE, Prior accident year development - LPT|cos78e4bvi|caxaby4jlv|kind=table|order=51}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1014" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="4" style="text-align:center" | Twelve months ended December 31, |
! colspan="4" style="text-align:center" | Twelve months ended December 31, |
||
| Line 1,727: | Line 2,308: | ||
|- |
|- |
||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Losses and LAE |
||
! style="text-align: |
! class="col-s" style="text-align:right" | % of Net Earned Premiums |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Losses and LAE |
||
! style="text-align: |
! class="col-s" style="text-align:right" | % of Net Earned Premiums |
||
|- |
|- |
||
! style="text-align:left" | Losses and LAE: |
! style="text-align:left" | Losses and LAE: |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
|- |
|- |
||
| class="wt-indent-1" style="text-align:left" | Non-cat loss and LAE |
| class="wt-indent-1" style="text-align:left" | Non-cat loss and LAE |
||
| Line 1,753: | Line 2,334: | ||
| style="text-align:right" | 11,598 |
| style="text-align:right" | 11,598 |
||
| style="text-align:right" | 1.1% |
| style="text-align:right" | 1.1% |
||
| style="text-align:right" | |
| style="text-align:right" | (1,427) |
||
| style="text-align:right" | |
| style="text-align:right" | (0.2)% |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total losses and LAE |
||
| style="text-align:right" | |
| style="text-align:right" | 669,809 |
||
| style="text-align:right" | |
| style="text-align:right" | 63.4% |
||
| style="text-align:right" | |
| style="text-align:right" | 515,237 |
||
| style="text-align:right" | |
| style="text-align:right" | 62.1% |
||
|- |
|||
| style="text-align:left" | <b>Adjusted losses and LAE (2) :</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| class="wt-indent-1" style="text-align:left" | Non-cat loss and LAE |
| class="wt-indent-1" style="text-align:left" | Non-cat loss and LAE |
||
| Line 1,774: | Line 2,361: | ||
| style="text-align:right" | 1.4% |
| style="text-align:right" | 1.4% |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total adjusted losses and LAE (2) |
||
| style="text-align:right" | |
| style="text-align:right" | 658,211 |
||
| style="text-align:right" | |
| style="text-align:right" | 62.3% |
||
| style="text-align:right" | |
| style="text-align:right" | 516,664 |
||
| style="text-align:right" | |
| style="text-align:right" | 62.3% |
||
|} |
|} |
||
</div> |
</div> |
||
{{fn note|1=1|2=Current accident year.}} |
|||
{{fn note|1=2|2=See "Reconciliation of Non-GAAP Financial Measures" included in this Item 2.}} |
|||
{{Indexing|Loss and LAE reserve development|Loss and LAE reserve development, Accident Year, Prior, LPT|rhstabgyn2|kind=table|order=52}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1015" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! colspan="2" style="text-align:center" | Development |
! colspan="2" style="text-align:center" | Development |
||
| Line 1,796: | Line 2,382: | ||
|- |
|- |
||
! style="text-align:left" | Accident Year |
! style="text-align:left" | Accident Year |
||
! class="col- |
! class="col-m" style="text-align:right" | 2024 |
||
! class="col- |
! class="col-m" style="text-align:right" | 2023 |
||
|- |
|- |
||
| style="text-align:left" | Prior |
| style="text-align:left" | Prior |
||
| Line 1,804: | Line 2,390: | ||
|- |
|- |
||
| style="text-align:left" | 2020 |
| style="text-align:left" | 2020 |
||
| style="text-align:right" | |
| style="text-align:right" | (606) |
||
| style="text-align:right" | 4,341 |
| style="text-align:right" | 4,341 |
||
|- |
|- |
||
| Line 1,812: | Line 2,398: | ||
|- |
|- |
||
| style="text-align:left" | 2022 |
| style="text-align:left" | 2022 |
||
| style="text-align:right" | |
| style="text-align:right" | (1,479) |
||
| style="text-align:right" | 1,807 |
| style="text-align:right" | 1,807 |
||
|- |
|- |
||
| Line 1,819: | Line 2,405: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total |
||
| style="text-align:right" | |
| style="text-align:right" | 25,728 |
||
| style="text-align:right" | |
| style="text-align:right" | 10,770 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Reserve development on losses subject to LPT</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>25,300</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>—</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Reserve development on losses excluding losses subject to LPT</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>428</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>10,770</b> |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Net expenses|Net expenses, Net policy acquisition expenses, Other operating and general expenses, Underwriting, acquisition and insurance expenses, commission and fee income|irxh3hcbqz|kind=table|order=53}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1016" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="4" style="text-align:center" | Twelve months ended December 31, |
! colspan="4" style="text-align:center" | Twelve months ended December 31, |
||
| Line 1,845: | Line 2,430: | ||
|- |
|- |
||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col- |
! class="col-m" style="text-align:right" | Expenses |
||
! class="col- |
! class="col-m" style="text-align:right" | % of Net Earned Premiums |
||
! class="col- |
! class="col-m" style="text-align:right" | Expenses |
||
! class="col- |
! class="col-m" style="text-align:right" | % of Net Earned Premiums |
||
|- |
|- |
||
| style="text-align:left" | Net policy acquisition expenses |
| style="text-align:left" | Net policy acquisition expenses |
||
| Line 1,862: | Line 2,447: | ||
| style="text-align:right" | 16.3% |
| style="text-align:right" | 16.3% |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Underwriting, acquisition and insurance expenses</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>311,757</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>29.5%</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>243,444</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>29.3%</b> |
||
|- |
|- |
||
| style="text-align:left" | Less: commission and fee income |
| style="text-align:left" | Less: commission and fee income |
||
| style="text-align:right" | |
| style="text-align:right" | (6,703) |
||
| style="text-align:right" | (0.6%) |
| style="text-align:right" | (0.6%) |
||
| style="text-align:right" | |
| style="text-align:right" | (6,064) |
||
| style="text-align:right" | (0.7%) |
| style="text-align:right" | (0.7%) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total net expenses |
||
| style="text-align:right" | |
| style="text-align:right" | 305,054 |
||
| style="text-align:right" | |
| style="text-align:right" | 28.9% |
||
| style="text-align:right" | |
| style="text-align:right" | 237,380 |
||
| style="text-align:right" | |
| style="text-align:right" | 28.6% |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Net investment income and gains|Net investment income and gains, Short-term investments & cash and cash equivalents, Fixed income, Equities, Alternative and strategic investments, Net unrealized gains on securities still held, Net realized losses|jpoeftv18u|j8uunnd14x|kind=table|order=54}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1017" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Twelve months ended December 31, |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
! style="text-align:left" | $ in thousands |
! style="text-align:left" | $ in thousands |
||
! class="col- |
! class="col-m" style="text-align:right" | 2024 |
||
! class="col- |
! class="col-m" style="text-align:right" | 2023 |
||
|- |
|- |
||
| style="text-align:left" | Short-term investments & cash and cash equivalents |
| style="text-align:left" | Short-term investments & cash and cash equivalents |
||
| style="text-align:right" | 17,643 |
| style="text-align:right" | 17,643 |
||
| style="text-align:right" | 11,677 |
| style="text-align:right" | 11,677 |
||
| Line 1,908: | Line 2,492: | ||
| style="text-align:left" | Alternative and strategic investments |
| style="text-align:left" | Alternative and strategic investments |
||
| style="text-align:right" | 2,667 |
| style="text-align:right" | 2,667 |
||
| style="text-align:right" | |
| style="text-align:right" | (10,114) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>[[Definition:Net investment income|Net investment income]]</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>80,686</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>40,322</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net unrealized gains on securities still held</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>7,921</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>11,130</b> |
||
|- |
|- |
||
| style="text-align:left" | Net realized losses |
| style="text-align:left" | Net realized losses |
||
| style="text-align:right" | |
| style="text-align:right" | (1,665) |
||
| style="text-align:right" | |
| style="text-align:right" | (58) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net investment gains</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>6,256</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>11,072</b> |
||
|} |
|} |
||
</div> |
</div> |
||
=== Investments === |
|||
{{Indexing|Investments|Fixed income portfolio, commercial mortgage loans, equities portfolio, alternative investments, strategic investments, market risk, credit risk, interest rate risk|966xer0dpm|utnmaoxh50|gp3o3dfk95|p7k94aok7u|m0cjxgvmvi|kind=prose|order=55|f1=Weighted average credit rating|v1=AA-|f2=Average duration fixed income portfolio 2024|v2=4.34 years|f3=Average duration fixed income portfolio 2023|v3=4.24 years|f4=Equities portfolio publicly traded|v4=100.0%}} |
|||
{{chunk|doc=vycbjm4dw4|c=127|p=14}} |
|||
* ''Fixed income portfolio'' primarily consists of investment grade fixed income securities, predominantly highly-rated and liquid bonds, and commercial mortgage loans <sup>p. 41</sup>. |
|||
'''Investment portfolio composition''' |
|||
* ''Weighted average credit rating'' of the available-for-sale fixed income portfolio was "AA-" by Standard & Poor’s Financial Services, LLC at December 31, 2024 and 2023 <sup>p. 41</sup>. |
|||
* ''Commercial mortgage loans'' are primarily senior loans on real estate across the U.S. <sup>p. 41</sup>. |
|||
* ''Average duration'' of the fixed income portfolio was approximately 4.34 years as of December 31, 2024, and 4.24 years as of December 31, 2023 <sup>p. 41</sup>. |
|||
* ''Equities portfolio'' primarily consists of domestic preferred stocks, common equities, exchange traded funds, limited partnerships, limited liability corporations, and other equity interests <sup>p. 41</sup>. |
|||
* ''100.0%'' of the equities portfolio is publicly traded <sup>p. 41</sup>. |
|||
* ''Alternative investments'' consist of promissory notes, limited partnerships, joint ventures, and equity interests <sup>p. 41</sup>. |
|||
* ''Underlying alternative investments'' are primarily floating rate senior secured loans, comprising short duration, collateralized, asset-oriented credit investments <sup>p. 41</sup>. |
|||
* ''Limited partnerships and joint ventures'' are subject to future increases or decreases in asset value as assets are monetized and income distributed <sup>p. 41</sup>. |
|||
* ''Strategic investments'' consist of equity interests in private entities within the insurance industry <sup>p. 41</sup>. |
|||
* ''Market risk'' is the risk of economic losses due to adverse changes in the estimated fair value of a financial instrument from changes in interest rates, equity prices, foreign currency exchange rates, and commodity prices <sup>p. 41</sup>. |
|||
* ''Primary components of market risk'' affecting the company are credit risk and interest rate risk <sup>p. 41</sup>. |
|||
* The company does not have significant exposure to foreign currency exchange rate risk or commodity risk <sup>p. 41</sup>. |
|||
* ''Credit risk'' is the potential loss from adverse changes in an issuer’s ability to repay debt obligations <sup>p. 41</sup>. |
|||
* The company has exposure to credit risk as a holder of debt instruments in its core fixed income and opportunistic fixed income portfolios <sup>p. 41</sup>. |
|||
* ''Investment policy'' is to invest primarily in debt instruments of high credit quality issuers and limit credit exposure to particular ratings categories and individual issuers <sup>p. 41</sup>. |
|||
* As of December 31, 2024, the ''core fixed income portfolio'' had an average rating of "AA-" <sup>p. 41</sup>. |
|||
* ''Approximately 81.5%'' of securities in the core fixed income portfolio were rated "A" or better by at least one nationally recognized rating organization at December 31, 2024 <sup>p. 41</sup>. |
|||
* The policy is to invest in investment grade fixed income securities for stability, supplemented by opportunistic fixed income and equity securities for diversification and risk-adjusted returns <sup>p. 41</sup>. |
|||
* As of December 31, 2024, ''approximately 1.7%'' of the core fixed income portfolio was unrated or rated below investment-grade <sup>p. 41</sup>. |
|||
* The company monitors the financial condition of all issuers in its portfolio through investment managers <sup>p. 41</sup>. |
|||
* The company is subject to ''credit risk'' with respect to third-party reinsurers <sup>p. 41</sup>. |
|||
* Reinsurance contracts do not limit ultimate obligations to pay claims, and amounts recoverable from reinsurers might not be collected <sup>p. 41</sup>. |
|||
* To address reinsurance credit risk, the company seeks to purchase reinsurance from reinsurers rated at least "A-" (Excellent) or better by A.M. Best <sup>p. 41</sup>. |
|||
* The company, along with its reinsurance broker, performs periodic credit reviews of reinsurers <sup>p. 41</sup>. |
|||
* As of December 31, 2024, ''99% of reinsurance recoverables'' were from reinsurers rated "A-" (Excellent) by A.M. Best or better, or were collateralized <sup>p. 41</sup>. |
|||
* If a reinsurer suffers a credit downgrade, options like commutation, novation, and letters of credit may be considered to lessen asset impairment risk <sup>p. 41</sup>. |
|||
* ''Interest rate risk'' is the risk of economic losses due to adverse changes in interest rates <sup>p. 41</sup>. |
|||
* The primary market risk to the investment portfolio is interest rate risk associated with fixed income securities <sup>p. 41</sup>. |
|||
* Fluctuations in interest rates directly affect the market valuation of fixed income securities <sup>p. 41</sup>. |
|||
* The company manages interest rate risk by investing in securities with varied maturity dates and managing the duration of the investment portfolio in relation to the duration of reserves <sup>p. 41</sup>. |
|||
* ''Duration'' is the weighted average payment period of cash flows, weighted by the present value of cash flows <sup>p. 41</sup>. |
|||
* Duration targets for the core fixed income investment portfolio are set after considering the estimated duration of liabilities and other factors <sup>p. 41</sup>. |
|||
* ''Weighted average effective duration'' of fixed maturity securities was 4.34 years as of December 31, 2024 <sup>p. 41</sup>. |
|||
* ''Fixed income securities'' subject to interest rate risk had a fair value of $1,292.2 million at December 31, 2024 <sup>p. 41</sup>. |
|||
* ''Opportunistic fixed income securities'' are excluded from interest rate sensitivity analysis as they are primarily floating rate and treated as held-to-maturity <sup>p. 41</sup>. |
|||
* Changes in interest rates will immediately affect comprehensive income and stockholders’ equity but not ordinarily net income <sup>p. 41</sup>. |
|||
* Actual results may differ from hypothetical changes in market rates assumed in sensitivity analysis <sup>p. 41</sup>. |
|||
* Sensitivity analysis does not reflect actions taken to mitigate hypothetical losses in fair value <sup>p. 41</sup>. |
|||
* ''Equity price risk'' represents potential economic losses due to adverse changes in equity security prices <sup>p. 41</sup>. |
|||
* As of December 31, 2024, ''approximately 6.7%'' of the fair value of the investment portfolio (excluding cash, cash equivalents, and short-term investments) was invested in equity securities <sup>p. 41</sup>. |
|||
* Equity price risk is managed through portfolio diversification and a tail-risk management strategy <sup>p. 41</sup>. |
|||
* The ''tail-risk management strategy'' is designed to provide protection for the equity portfolio if there is a significant decline in the S&P 500 within a 30-day period <sup>p. 41</sup>. |
|||
* The investment portfolio primarily consists of investment grade fixed income securities, which are predominantly highly-rated and liquid bonds, and commercial mortgage loans. |
|||
{{Indexing|Investment portfolio by asset class|Investment portfolio by asset class, Cash and cash equivalents, Short-term investments, Fixed income, Equities, Alternative and strategic investments|966xer0dpm|kind=table|order=56}} |
|||
{{chunk|doc=vycbjm4dw4|c=128|p=14}} |
|||
'''Fixed income portfolio credit quality and duration''' |
|||
* The weighted average credit rating of the available-for-sale fixed income portfolio was "AA-" by Standard & Poor’s Financial Services, LLC ("Standard & Poor’s") at December 31, 2024 and 2023. |
|||
* Commercial mortgage loans are primarily senior loans on real estate across the U.S.. |
|||
* The average duration of the fixed income portfolio was approximately 4.34 years at December 31, 2024, and 4.24 years at December 31, 2023. |
|||
{{chunk|doc=vycbjm4dw4|c=129|p=14}} |
|||
'''Equities portfolio composition''' |
|||
* The equities portfolio primarily consists of domestic preferred stocks, common equities, exchange traded funds, limited partnerships, limited liability corporations, and other types of equity interests. |
|||
* 100.0% of the equities portfolio is publicly traded. |
|||
{{chunk|doc=vycbjm4dw4|c=130|p=14}} |
|||
'''Alternative and strategic investments''' |
|||
* Alternative investments consist of promissory notes, limited partnerships, joint ventures, and equity interests. |
|||
* Underlying alternative investments are primarily floating rate senior secured loans, comprised of short duration, collateralized, asset-oriented credit investments. |
|||
* Limited partnerships and joint ventures are subject to future increases or decreases in asset value as assets are monetized and income is distributed. |
|||
* Strategic investments consist of equity interests in private entities within the insurance industry. |
|||
{{chunk|doc=vycbjm4dw4|c=131|p=14}} |
|||
'''Market risk overview''' |
|||
* Market risk is the risk of economic losses due to adverse changes in the estimated fair value of a financial instrument resulting from changes in interest rates, equity prices, foreign currency exchange rates, and commodity prices. |
|||
* The primary components of market risk affecting the company are credit risk and interest rate risk. |
|||
* The company does not have significant exposure to foreign currency exchange rate risk or commodity risk. |
|||
{{chunk|doc=vycbjm4dw4|c=132|p=14}} |
|||
'''Credit risk management''' |
|||
* Credit risk is the potential loss from adverse changes in an issuer’s ability to repay debt obligations. |
|||
* Exposure to credit risk exists as a holder of debt instruments in core fixed income and opportunistic fixed income portfolios. |
|||
* The risk management strategy and investment policy is to invest primarily in debt instruments of high credit quality issuers and to limit credit exposure by ratings categories and per issuer. |
|||
* At December 31, 2024, the core fixed income portfolio had an average rating of "AA-". |
|||
* Approximately 81.5% of securities in the core fixed income portfolio were rated "A" or better by at least one nationally recognized rating organization at December 31, 2024. |
|||
* The policy is to invest in investment grade fixed income securities for stable income, supplemented by opportunistic fixed income and equity securities for diversification and risk-adjusted returns. |
|||
* Approximately 1.7% of the core fixed income portfolio was unrated or rated below investment-grade at December 31, 2024. |
|||
* The company monitors the financial condition of all issuers in its portfolio through investment managers. |
|||
* Credit risk also exists with third-party reinsurers; the company is ultimately liable to policyholders for ceded risks. |
|||
* Reinsurance contracts do not limit ultimate obligations to pay claims, and amounts recoverable from reinsurers might not be collected. |
|||
* To address this, reinsurance is purchased from reinsurers rated at least "A-" (Excellent) or better by A.M. Best. |
|||
* Periodic credit reviews of reinsurers are performed with the reinsurance broker. |
|||
* At December 31, 2024, 99% of reinsurance recoverables were from reinsurers rated "A-" (Excellent) or better by A.M. Best, or were collateralized through funds held, trusts, and letters of credit by the reinsurer. |
|||
* If a reinsurer suffers a credit downgrade, options like commutation, novation, and letters of credit may be considered to lessen asset impairment risk. |
|||
{{chunk|doc=vycbjm4dw4|c=133|p=14}} |
|||
'''Interest rate risk management''' |
|||
* Interest rate risk is the risk of economic losses due to adverse changes in interest rates. |
|||
* The primary market risk to the investment portfolio is interest rate risk associated with fixed income securities. |
|||
* Fluctuations in interest rates directly affect the market valuation of these securities; rising rates decrease fair value, falling rates increase fair value. |
|||
* Interest rate risk is managed by investing in securities with varied maturity dates and by managing the duration of the investment portfolio in relation to the duration of reserves. |
|||
* Duration is the weighted average payment period of cash flows, weighted by the present value of cash flows. |
|||
* Duration targets for the core fixed income investment portfolio are set after considering the estimated duration of liabilities and other factors. |
|||
* Fixed maturity securities had a weighted average effective duration of 4.34 years as of December 31, 2024. |
|||
* Fixed income securities subject to interest rate risk had a fair value of USD 1,292.2m at December 31, 2024. |
|||
* Opportunistic fixed income securities are excluded from interest rate sensitivity analysis as they are primarily floating rate and treated as held-to-maturity. |
|||
* Changes in interest rates immediately affect comprehensive income and stockholders’ equity but not ordinarily net income. |
|||
* Actual results may differ from hypothetical changes in market rates assumed in sensitivity analysis. |
|||
* Sensitivity analysis does not reflect actions taken to mitigate hypothetical fair value losses. |
|||
{{chunk|doc=vycbjm4dw4|c=134|p=14}} |
|||
'''Equity price risk management''' |
|||
* Equity price risk represents potential economic losses due to adverse changes in equity security prices. |
|||
* At December 31, 2024, approximately 6.7% of the fair value of the investment portfolio (excluding cash and cash equivalents and short-term investments) was invested in equity securities. |
|||
* Equity price risk is managed through portfolio diversification. |
|||
* A tail-risk management strategy is maintained to provide protection for the equity portfolio if there is a significant decline in the S&P 500 within a 30-day period. |
|||
{{chunk|doc=vycbjm4dw4|c=135|p=14}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1018" class="wikitable fintable" |
||
|+ Investments |
|||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="2" style="text-align:center" | 2024 |
! colspan="2" style="text-align:center" | 2024 |
||
| Line 2,018: | Line 2,635: | ||
| style="text-align:right" | 9.4% |
| style="text-align:right" | 9.4% |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total portfolio |
||
| style="text-align:right" | |
| style="text-align:right" | 1,992,423 |
||
| style="text-align:right" | |
| style="text-align:right" | 100.0% |
||
| style="text-align:right" | |
| style="text-align:right" | 1,679,578 |
||
| style="text-align:right" | |
| style="text-align:right" | 100.0% |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Fixed income portfolio by security type|Fixed income portfolio by security type, U.S. government securities, Corporate securities and miscellaneous, Municipal securities, Residential mortgage-backed securities, Commercial mortgage-backed securities, Other asset-backed securities, Commercial mortgage loans|utnmaoxh50|kind=table|order=57}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1019" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="2" style="text-align:center" | 2024 |
! colspan="2" style="text-align:center" | 2024 |
||
| Line 2,035: | Line 2,651: | ||
|- |
|- |
||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col- |
! class="col-m" style="text-align:right" | Carrying Value |
||
! class="col-s" style="text-align:right" | % of Total |
! class="col-s" style="text-align:right" | % of Total |
||
! class="col- |
! class="col-m" style="text-align:right" | Carrying Value |
||
! class="col-s" style="text-align:right" | % of Total |
! class="col-s" style="text-align:right" | % of Total |
||
|- |
|- |
||
| Line 2,076: | Line 2,692: | ||
| style="text-align:right" | 17.4% |
| style="text-align:right" | 17.4% |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total fixed income portfolio, available-for-sale |
||
| style="text-align:right" | |
| style="text-align:right" | 1,292,218 |
||
| style="text-align:right" | |
| style="text-align:right" | 98.0% |
||
| style="text-align:right" | |
| style="text-align:right" | 1,017,651 |
||
| style="text-align:right" | |
| style="text-align:right" | 95.3% |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Commercial mortgage loans</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>26,490</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>2.0%</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>50,070</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>4.7%</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total fixed income portfolio |
||
| style="text-align:right" | |
| style="text-align:right" | 1,318,708 |
||
| style="text-align:right" | |
| style="text-align:right" | 100.0% |
||
| style="text-align:right" | |
| style="text-align:right" | 1,067,721 |
||
| style="text-align:right" | |
| style="text-align:right" | 100.0% |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Fixed income portfolio by credit rating|Fixed income portfolio by credit rating, AAA, AA, A, BBB, BB and Lower|ooly7l7133|kind=table|order=58}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1020" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="2" style="text-align:center" | 2024 |
! colspan="2" style="text-align:center" | 2024 |
||
| Line 2,140: | Line 2,755: | ||
| style="text-align:right" | 3.0% |
| style="text-align:right" | 3.0% |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total fixed income portfolio, available-for-sale |
||
| style="text-align:right" | |
| style="text-align:right" | 1,292,218 |
||
| style="text-align:right" | |
| style="text-align:right" | 100.0% |
||
| style="text-align:right" | |
| style="text-align:right" | 1,017,651 |
||
| style="text-align:right" | |
| style="text-align:right" | 100.0% |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Equity portfolio by type|Equity portfolio by type, Domestic common equities, International common equities, Preferred stock|966xer0dpm|kind=table|order=59}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1021" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="2" style="text-align:center" | 2024 |
! colspan="2" style="text-align:center" | 2024 |
||
| Line 2,157: | Line 2,771: | ||
|- |
|- |
||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col- |
! class="col-m" style="text-align:right" | Fair Value |
||
! class="col- |
! class="col-m" style="text-align:right" | % of Total Fair Value |
||
! class="col- |
! class="col-m" style="text-align:right" | Fair Value |
||
! class="col- |
! class="col-m" style="text-align:right" | % of Total Fair Value |
||
|- |
|- |
||
| style="text-align:left" | Domestic common equities |
| style="text-align:left" | Domestic common equities |
||
| Line 2,180: | Line 2,794: | ||
| style="text-align:right" | 6.2% |
| style="text-align:right" | 6.2% |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Equities</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>106,254</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>100.0%</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>118,249</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>100.0%</b> |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Interest rate sensitivity analysis|Interest rate sensitivity analysis, Estimated Fair Value, Estimated Change in Fair Value, Estimated % Increase (Decrease) in Fair Value|p7k94aok7u|kind=table|order=60}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1022" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col-s" style="text-align:right" | Estimated Fair Value |
! class="col-s" style="text-align:right" | Estimated Fair Value |
||
| Line 2,199: | Line 2,812: | ||
| style="text-align:left" | 300 basis point increase |
| style="text-align:left" | 300 basis point increase |
||
| style="text-align:right" | 1,118,982 |
| style="text-align:right" | 1,118,982 |
||
| style="text-align:right" | |
| style="text-align:right" | (173,236) |
||
| style="text-align:right" | |
| style="text-align:right" | (13.4)% |
||
|- |
|- |
||
| style="text-align:left" | 200 basis point increase |
| style="text-align:left" | 200 basis point increase |
||
| style="text-align:right" | 1,177,074 |
| style="text-align:right" | 1,177,074 |
||
| style="text-align:right" | |
| style="text-align:right" | (115,144) |
||
| style="text-align:right" | |
| style="text-align:right" | (8.9)% |
||
|- |
|- |
||
| style="text-align:left" | 100 basis point increase |
| style="text-align:left" | 100 basis point increase |
||
| style="text-align:right" | 1,234,820 |
| style="text-align:right" | 1,234,820 |
||
| style="text-align:right" | |
| style="text-align:right" | (57,398) |
||
| style="text-align:right" | |
| style="text-align:right" | (4.4)% |
||
|- |
|- |
||
| style="text-align:left" | No change |
| style="text-align:left" | No change |
||
| Line 2,234: | Line 2,847: | ||
</div> |
</div> |
||
=== Other Items === |
|||
{{Indexing|Other Items|Income tax expense, effective tax rate, federal income tax expense, Note 13, Income Taxes|kmocop7wiu|kind=prose|order=61|f1=Income tax expense 2024|v1=USD 33.9m|f2=Income tax expense 2023|v2=USD 24.1m|f3=Effective tax rate 2024|v3=22.2%|f4=Effective tax rate 2023|v4=21.9%}} |
|||
{{chunk|doc=vycbjm4dw4|c=136|p=14}} |
|||
* ''Income tax expense'' for the year ended December 31, 2024, was USD 33.9m <sup>p. 42</sup>. |
|||
'''Income taxes''' |
|||
* ''Income tax expense'' for the year ended December 31, 2023, was USD 24.1m <sup>p. 42</sup>. |
|||
* ''Effective tax rate'' for the year ended December 31, 2024, was 22.2% <sup>p. 42</sup>. |
|||
* ''Effective tax rate'' for the year ended December 31, 2023, was 21.9% <sup>p. 42</sup>. |
|||
* For a reconciliation between actual federal income tax expense and the amount computed at the indicated statutory rate for the years ended December 31, 2024 and 2023, refer to Note 13, “Income Taxes,” in the consolidated financial statements included in Item 8 of this Form 10-K <sup>p. 42</sup>. |
|||
* Income tax expense for the year ended December 31, 2024 was USD 33.9m, compared to USD 24.1m for the year ended December 31, 2023. |
|||
{{Indexing|Liquidity and Capital Resources|Holding company, insurance subsidiaries, GMIC, HSIC, IIC, OSIC, corporate service fees, consolidated U.S. federal income tax return, corporate tax allocation agreement, state insurance laws, insurance regulators, dividend payments|trbk6wt4s9|75shp9ailk|1nma8v7gjs|kind=prose|order=62|f1=Insurance subsidiaries|v1=GMIC, HSIC, IIC, OSIC}} |
|||
* The effective tax rate for the year ended December 31, 2024 was 22.2%, compared to 21.9% for the year ended December 31, 2023. |
|||
* For a reconciliation between actual federal income tax expense and the amount computed at the indicated statutory rate for the years ended December 31, 2024 and 2023, refer to Note 13, "Income Taxes" in the consolidated financial statements included in Item 8 of this Form 10-K. |
|||
=== Liquidity and Capital Resources === |
|||
* The company is organized as a holding company, with operations primarily conducted by wholly-owned insurance subsidiaries: GMIC, HSIC, and IIC (domiciled in Texas), and OSIC (domiciled in Oklahoma) <sup>p. 43</sup>. |
|||
* The holding company may receive cash from: corporate service fees from operating subsidiaries, payments from the consolidated tax allocation agreement, dividends from subsidiaries (subject to limitations), loans from banks, draws on a revolving loan agreement, and issuance of equity and debt securities <sup>p. 43</sup>. |
|||
* Proceeds from these sources may be used to contribute funds to insurance subsidiaries to support premium growth, pay dividends and taxes, and for other business purposes <sup>p. 43</sup>. |
|||
* Skyward Service Company receives ''corporate service fees'' from operating subsidiaries to reimburse it for most operating expenses, based on actual costs with no mark-up <sup>p. 43</sup>. |
|||
* The company files a ''consolidated U.S. federal income tax return'' with its subsidiaries <sup>p. 43</sup>. |
|||
* Under the ''corporate tax allocation agreement'', each participant is charged or refunded taxes based on what they would have paid or received if they filed on a separate return basis with the IRS <sup>p. 43</sup>. |
|||
* ''State insurance laws'' restrict the ability of insurance subsidiaries to declare stockholder dividends without prior regulatory approval <sup>p. 43</sup>. |
|||
* ''Insurance regulators'' require insurance companies to maintain specified levels of statutory capital and surplus <sup>p. 43</sup>. |
|||
* ''Dividend payments'' are limited to the portion of available policyholder surplus derived from net profits on an insurer’s business <sup>p. 43</sup>. |
|||
* Insurance regulators have broad powers to prevent the reduction of statutory surplus to inadequate levels, and there is no assurance that maximum calculated dividends would be permitted <sup>p. 43</sup>. |
|||
* State insurance regulatory authorities may adopt more restrictive statutory provisions regarding dividend payments by insurance subsidiaries in the future <sup>p. 43</sup>. |
|||
* The company's insurance subsidiaries did not pay dividends to the holding company for the years ended December 31, 2024, and 2023 <sup>p. 43</sup>. |
|||
* Additional information regarding insurance companies is available in Note 23, “Statutory Accounting Principles and Regulatory Matters,” to the consolidated financial statements in Item 8 of this Form 10-K <sup>p. 43</sup>. |
|||
* As of December 31, 2024, the ''holding company cash and investments'' were USD 2.9m, compared to USD 3.0m at December 31, 2023 <sup>p. 43</sup>. |
|||
* Management believes there is ''sufficient liquidity'' to meet operating cash needs, obligations, and committed capital expenditures for the next 12 months <sup>p. 43</sup>. |
|||
{{chunk|doc=vycbjm4dw4|c=137|p=14}} |
|||
{{Indexing|Cash Flows|Premiums received, claims, cash investment, operating expenses, capital expenditures, reinsurance, timing of cash flows, loss settlements, reinsurance receipts, net reinsurance recoverables, net premiums receivables, investing activities, financing activities|cs6p6hop55|kind=prose|order=63}} |
|||
'''Holding Company Structure and Funding''' |
|||
* The company is organized as a holding company, with operations primarily conducted by wholly-owned insurance subsidiaries: GMIC, HSIC (Texas-domiciled), and IIC (Texas-domiciled), and OSIC (Oklahoma-domiciled). |
|||
* ''Premiums received'' from insureds are the most significant source of cash, typically received at the beginning of the coverage period, net of commissions <sup>p. 44</sup>. |
|||
* The holding company receives cash through corporate service fees from operating subsidiaries, payments from consolidated tax allocation agreements, [[Definition:Dividend|dividends]] from subsidiaries (subject to limitations), bank loans, draws on revolving loan agreements, and issuance of equity and debt securities. |
|||
* ''Claims'' are the most significant cash outflow, occurring after premium receipt, often years later <sup>p. 44</sup>. |
|||
* Proceeds from these sources are used to contribute funds to insurance subsidiaries for premium growth, pay [[Definition:Dividend|dividends]] and taxes, and for other business purposes. |
|||
* ''Cash'' is invested in various investment securities to earn interest and dividends <sup>p. 44</sup>. |
|||
* ''Cash'' is also used for operating expenses (salaries, rent, taxes) and capital expenditures (technology systems) <sup>p. 44</sup>. |
|||
* ''Reinsurance'' is used to manage risk, involving ceding part of premiums to reinsurers and collecting cash back for covered losses <sup>p. 44</sup>. |
|||
* ''Timing of cash flows'' from operating activities can vary due to payment and receipt schedules <sup>p. 44</sup>. |
|||
* ''Significant payments and receipts'', such as loss settlements and reinsurance receipts, can influence operating cash flows <sup>p. 44</sup>. |
|||
* ''Management believes'' cash receipts from premiums and investment income are sufficient to cover cash outflows in the foreseeable future <sup>p. 44</sup>. |
|||
* ''Decrease in cash'' provided by operating activities in 2024 compared to 2023 was primarily due to increased cash outflows from net reinsurance recoverables and net premiums receivables <sup>p. 44</sup>. |
|||
* ''Cash from operations'' can vary period-to-period due to timing of premium receipts, claim payments, and reinsurance activity <sup>p. 44</sup>. |
|||
* ''Cash flows from operations'' in the past two years were primarily used to fund investing activities <sup>p. 44</sup>. |
|||
* ''Net cash used in investing activities'' in 2024 was primarily driven by purchases of fixed maturity securities, partially offset by sales and maturities of investment securities and sales of short-term investments <sup>p. 44</sup>. |
|||
* ''Net cash used in investing activities'' in 2023 was primarily driven by purchases of fixed maturity securities <sup>p. 44</sup>. |
|||
* ''Net cash used in financing activities'' in 2024 was driven by net payments on debt <sup>p. 44</sup>. |
|||
{{chunk|doc=vycbjm4dw4|c=138|p=14}} |
|||
{{Indexing|Cash flows|Cash flows, Operating activities, Investing activities, Financing activities, Change in cash and cash equivalents and restricted cash|cs6p6hop55|kind=table|order=64}} |
|||
'''Intercompany Reimbursements and Tax Allocation''' |
|||
* Skyward Service Company receives corporate service fees from operating subsidiaries to reimburse most incurred operating expenses. |
|||
* Expense reimbursement via corporate service fees is based on actual expected costs with no mark-up. |
|||
* The company files a consolidated U.S. federal income tax return with its subsidiaries. |
|||
* Under the corporate tax allocation agreement, each participant is charged or refunded taxes based on what they would have paid or received if filing on a separate return basis with the IRS. |
|||
{{chunk|doc=vycbjm4dw4|c=139|p=14}} |
|||
'''Insurance Subsidiary [[Definition:Dividend|Dividend]] Restrictions''' |
|||
* Applicable state insurance laws restrict insurance subsidiaries from declaring stockholder [[Definition:Dividend|dividends]] without prior regulatory approval. |
|||
* State insurance regulators require insurance companies to maintain specified levels of statutory capital and surplus. |
|||
* [[Definition:Dividend|Dividend]] payments are limited to the portion of available policyholder surplus derived from net profits on an insurer’s business. |
|||
* Insurance regulators have broad powers to prevent reduction of statutory surplus to inadequate levels, and there is no assurance that maximum calculated [[Definition:Dividend|dividends]] would be permitted. |
|||
* State insurance regulatory authorities may adopt more restrictive statutory provisions regarding [[Definition:Dividend|dividend]] payments in the future. |
|||
* Insurance subsidiaries did not pay [[Definition:Dividend|dividends]] to the holding company for the years ended December 31, 2024, and 2023. |
|||
* Additional information regarding insurance companies is available in Note 23, “Statutory Accounting Principles and Regulatory Matters” to the consolidated financial statements in Item 8 of Form 10-K. |
|||
{{chunk|doc=vycbjm4dw4|c=140|p=14}} |
|||
'''Holding Company Liquidity and Outlook''' |
|||
* The holding company had USD 2.9m in cash and investments at December 31, 2024, compared to USD 3.0m at December 31, 2023. |
|||
* The company believes it has sufficient liquidity to meet operating cash needs, obligations, and committed capital expenditures for the next 12 months. |
|||
=== Cash Flows === |
|||
{{chunk|doc=vycbjm4dw4|c=141|p=14}} |
|||
'''Cash flow sources and uses''' |
|||
* The most significant source of cash is premiums received from insureds, typically at the beginning of the coverage period, net of related commission. |
|||
* The most significant cash outflow is for claims incurred by policyholders, which occur after premium receipt, often years later. |
|||
* Cash is invested in various investment securities to earn interest and [[Definition:Dividend|dividends]]. |
|||
* Cash is also used for operating expenses (salaries, rent, taxes) and capital expenditures (technology systems). |
|||
* Reinsurance is used to manage policy risk, involving ceding part of premiums to reinsurers and collecting cash back when covered losses are paid. |
|||
* The timing of cash flows from operating activities can vary due to the timing of payments and receipts. |
|||
* Significant payments and receipts, including loss settlements and subsequent reinsurance receipts, can influence operating cash flows in a given period. |
|||
* Management believes cash receipts from premiums and investment income proceeds are sufficient to cover cash outflows in the foreseeable future. |
|||
{{chunk|doc=vycbjm4dw4|c=142|p=14}} |
|||
'''Cash flow summary''' |
|||
* The document provides a table detailing cash flows for the years ended December 31, 2024 and 2023. |
|||
{{chunk|doc=vycbjm4dw4|c=143|p=14}} |
|||
'''Operating cash flow drivers''' |
|||
* The decrease in cash provided by operating activities in 2024 compared to 2023 was primarily due to an increase in cash outflows from net reinsurance recoverables and net premiums receivables. |
|||
* Cash from operations can vary period-to-period due to the timing of premium receipts, claim payments, and reinsurance activity. |
|||
* Cash flows from operations in both 2023 and 2024 were primarily used to fund investing activities. |
|||
{{chunk|doc=vycbjm4dw4|c=144|p=14}} |
|||
'''Investing cash flow drivers''' |
|||
* Net cash used in investing activities in 2024 was primarily driven by purchases of fixed maturity securities, partially offset by sales and maturities of investment securities and sales of short-term investments. |
|||
* Net cash used in investing activities in 2023 was primarily driven by purchases of fixed maturity securities. |
|||
{{chunk|doc=vycbjm4dw4|c=145|p=14}} |
|||
'''Financing cash flow drivers''' |
|||
* Net cash used in financing activities in 2024 was driven by net payments on debt. |
|||
{{chunk|doc=vycbjm4dw4|c=146|p=14}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1023" class="wikitable fintable" |
||
|+ Change in cash and cash equivalents and restricted cash by activities |
|||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2024 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2023 |
||
|- |
|- |
||
! style="text-align:left" | Cash and cash equivalents provided by (used in): |
! style="text-align:left" | Cash and cash equivalents provided by (used in): |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | Operating activities |
| style="text-align:left" | Operating activities |
||
| Line 2,294: | Line 2,946: | ||
|- |
|- |
||
| style="text-align:left" | Investing activities |
| style="text-align:left" | Investing activities |
||
| style="text-align:right" | |
| style="text-align:right" | (243,694) |
||
| style="text-align:right" | |
| style="text-align:right" | (493,809) |
||
|- |
|- |
||
| style="text-align:left" | Financing activities |
| style="text-align:left" | Financing activities |
||
| style="text-align:right" | |
| style="text-align:right" | (4,232) |
||
| style="text-align:right" | 130,947 |
| style="text-align:right" | 130,947 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Change in cash and cash equivalents and restricted cash</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>57,189</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>(24,675)</b> |
||
|} |
|} |
||
</div> |
</div> |
||
=== Credit Agreements === |
|||
{{Indexing|Credit Agreements|FHLB Loan, Federal Home Loan Bank of Dallas, Revolving Credit Facility, Debentures, HSIC, SOFR|bhnpa5y4f0|b3bc9gy5x7|kind=prose|order=65|f1=FHLB Loan amount|v1=USD 57.0m|f2=FHLB Loan interest rate|v2=4.00%|f3=Revolving Credit Facility amount|v3=USD 150.0m|f4=Revolving Credit Facility undrawn capacity|v4=USD 107.0m|f5=Outstanding under Revolving Credit Facility|v5=USD 43.0m}} |
|||
{{chunk|doc=vycbjm4dw4|c=147|p=14}} |
|||
* On August 30, 2024, the company entered into a ''FHLB Loan'' with the Federal Home Loan Bank of Dallas <sup>p. 45</sup>. |
|||
'''FHLB Loan''' |
|||
* The FHLB Loan is a 4.5-year term loan for ''USD 57.0m'' <sup>p. 45</sup>. |
|||
* The FHLB Loan provides for interest-only payments during its term, with principal due in full at maturity <sup>p. 45</sup>. |
|||
* The ''interest rate'' for the FHLB Loan is fixed at 4.00% over its term <sup>p. 45</sup>. |
|||
* The FHLB Loan is fully secured by a pledge of specific investment securities of HSIC <sup>p. 45</sup>. |
|||
* Proceeds from the FHLB Loan were used to fund the redemption of the March 15, 2024 draw on the Revolving Credit Facility and to redeem ''USD 7.0m'' of the March 29, 2023 draw on the Revolving Credit Facility <sup>p. 45</sup>. |
|||
* On March 29, 2023, the company entered into an ''unsecured revolving credit facility'' (the “Revolving Credit Facility”) with a syndicate of participating banks <sup>p. 45</sup>. |
|||
* The Revolving Credit Facility provides up to a ''USD 150.0m'' revolving credit facility and a letter of credit sub-facility of up to ''USD 30.0m'' <sup>p. 45</sup>. |
|||
* On March 14, 2024, the company drew ''USD 50.0m'' on the Revolving Credit Facility to fund the redemption of the Debentures <sup>p. 45</sup>. |
|||
* On August 30, 2024, the company fully redeemed the March 15, 2024 draw on the Revolving Credit Facility and redeemed ''USD 7.0m'' of the March 29, 2023 draw on the Revolving Credit Facility <sup>p. 45</sup>. |
|||
* As of December 31, 2024, ''USD 43.0m'' was outstanding under the Revolving Credit Facility, with ''USD 107.0m'' of undrawn capacity <sup>p. 45</sup>. |
|||
* ''Interest'' on the Revolving Credit Facility is payable quarterly <sup>p. 45</sup>. |
|||
* The ''interest rate'' on the Revolving Credit Facility is SOFR plus a margin of between 150 and 190 basis points, based on the ratio of debt to total capital, and a credit spread adjustment of 10 basis points <sup>p. 45</sup>. |
|||
* At December 31, 2024, the ''six-month SOFR'' on the Revolving Credit Facility was 4.25%, plus a margin of 1.60% <sup>p. 45</sup>. |
|||
* The company is subject to ''covenants'' on the Revolving Credit Facility based on minimum net worth, maximum debt to capital ratio, minimum A.M. Best Rating, and minimum liquidity <sup>p. 45</sup>. |
|||
* As of December 31, 2024, the company was in ''compliance'' with all Revolving Credit Facility covenants <sup>p. 45</sup>. |
|||
* In August 2006, the company received ''USD 58.0m'' of proceeds from a debenture offering through Delos Capital Trust <sup>p. 45</sup>. |
|||
* The Trust's sole asset consists of Fixed/Floating Rate Junior Subordinated Deferrable Interest Debentures (Trust Preferred) with a principal amount of ''USD 59.8m'' issued by the company and ''USD 1.8m'' cash from the issuance of Trust common shares <sup>p. 45</sup>. |
|||
* On March 15, 2024, the company redeemed the Debentures and paid ''USD 1.4m'' of accrued interest <sup>p. 45</sup>. |
|||
* In May 2019, the company issued unsecured subordinated notes (the “Notes”) with an aggregate principal amount of ''USD 20.0m'' <sup>p. 45</sup>. |
|||
* ''Interest'' on the subordinated notes is 7.25% fixed for the first eight years and 8.25% fixed thereafter <sup>p. 45</sup>. |
|||
* Early retirement of the subordinated debt requires all interest payments to be paid in full, plus the return of all capital <sup>p. 45</sup>. |
|||
* ''Principal payment'' for the subordinated notes is due at maturity on May 24, 2039, with interest payable quarterly <sup>p. 45</sup>. |
|||
* At December 31, 2024, the ''ratio of total debt outstanding'' (including the FHLB Loan, Revolving Credit Facility, and Notes) to total capitalization was 13.1% <sup>p. 45</sup>. |
|||
* At December 31, 2023, the ''ratio of total debt outstanding'' (including the Term Loan, Revolver, Trust Preferred, and Notes) to total capitalization was 16.3% <sup>p. 45</sup>. |
|||
* In October 2024, the Board of Directors approved a ''share repurchase program'' authorizing the repurchase of up to ''USD 50.0m'' of common stock <sup>p. 45</sup>. |
|||
* The share repurchase program allows for repurchases through open market purchases, privately-negotiated transactions, block purchases, accelerated share repurchase agreements, or Rule 10b5-1 trading plans <sup>p. 45</sup>. |
|||
* The timing, manner, price, and amount of repurchases are at the company's discretion <sup>p. 45</sup>. |
|||
* The share repurchase program does not require the repurchase of any specific number of shares and can be modified, suspended, or terminated at any time <sup>p. 45</sup>. |
|||
* As of December 31, 2024, ''no shares'' had been repurchased under this plan <sup>p. 45</sup>. |
|||
* On August 30, 2024, the company entered into the FHLB Loan with the Federal Home Loan Bank of Dallas (FHLB) under its Advances and Security Agreement. |
|||
{{Indexing|Contractual Obligations and Commitments|Reserves for losses and LAE, reinsurance balances recoverable, policyholders|wugbjvah7b|rmmhubj8mh|tc5fw176pu|kind=prose|order=66|f1=Reinsurance balances recoverable 2024|v1=$857.9m|f2=Reinsurance balances recoverable 2023|v2=$596.3m}} |
|||
* The FHLB Loan is a 4.5-year term loan for a principal amount of USD 57.0m. |
|||
* The FHLB Loan requires interest-only payments during its term, with principal due in full at maturity. |
|||
* The interest rate for the FHLB Loan is fixed at 4.00% over its term. |
|||
* The FHLB Loan is fully secured by a pledge of specific investment securities of HSIC. |
|||
* Proceeds from the FHLB Loan were used to fund the redemption of the March 15, 2024 draw on the Revolving Credit Facility and to redeem USD 7.0m of the March 29, 2023 draw on the Revolving Credit Facility. |
|||
{{chunk|doc=vycbjm4dw4|c=148|p=14}} |
|||
* ''Reserves for losses and LAE'' represent the best estimate of the ultimate cost of settling reported and unreported claims and related expenses <sup>p. 46</sup>. |
|||
'''Revolving Credit Facility''' |
|||
* Estimating reserves for losses and LAE involves complex and subjective judgments <sup>p. 46</sup>. |
|||
* Actual losses and settlement expenses paid may substantially deviate from the reserve estimates in financial statements <sup>p. 46</sup>. |
|||
* The timing for payment of estimated losses is not fixed or determinable on an individual or aggregate basis <sup>p. 46</sup>. |
|||
* Assumptions for estimating payments due by period are based on the company's own, industry, and peer group claims payment experience <sup>p. 46</sup>. |
|||
* There is a risk that actual payments in any period could differ significantly from disclosed amounts due to uncertainty in timing estimation <sup>p. 46</sup>. |
|||
* Disclosed amounts are gross of anticipated amounts recoverable from reinsurers <sup>p. 46</sup>. |
|||
* ''Reinsurance balances recoverable'' on reserves for losses and LAE are reported separately as assets, not netted with liabilities, because reinsurance does not discharge the company's liability to policyholders <sup>p. 46</sup>. |
|||
* ''Reinsurance balances recoverable'' on reserves for paid and unpaid losses and LAE totaled ''$857.9m'' at December 31, 2024 <sup>p. 46</sup>. |
|||
* ''Reinsurance balances recoverable'' on reserves for paid and unpaid losses and LAE totaled ''$596.3m'' at December 31, 2023 <sup>p. 46</sup>. |
|||
* On March 29, 2023, the company entered into an unsecured Revolving Credit Facility with a syndicate of participating banks. |
|||
{{Indexing|Contractual obligations|Contractual obligations, Reserves for losses and LAE, Long-term debt, Interest on debt obligations, Operating lease obligations|wugbjvah7b|kind=table|order=67}} |
|||
* The Revolving Credit Facility provides up to a USD 150.0m revolving credit facility and a letter of credit sub-facility of up to USD 30.0m. |
|||
* On March 14, 2024, the company drew USD 50.0m on the Revolving Credit Facility to fund the redemption of the Debentures using these proceeds and existing cash. |
|||
* On August 30, 2024, the company fully redeemed the March 15, 2024 draw on the Revolving Credit Facility and redeemed USD 7.0m of the March 29, 2023 draw on the Revolving Credit Facility. |
|||
* As of December 31, 2024, USD 43.0m was outstanding under the Revolving Credit Facility, with USD 107.0m of undrawn capacity. |
|||
* Interest on the Revolving Credit Facility is payable quarterly. |
|||
* The interest rate on the Revolving Credit Facility is SOFR plus a margin of 150 to 190 basis points, based on the debt to total capital ratio, and a credit spread adjustment of 10 basis points. |
|||
* At December 31, 2024, the six-month SOFR on the Revolving Credit Facility was 4.25%, plus a margin of 1.60%. |
|||
* The company is subject to covenants on the Revolving Credit Facility, including minimum net worth, maximum debt to capital ratio, minimum A.M. Best Rating, and minimum liquidity. |
|||
* As of December 31, 2024, the company was in compliance with all Revolving Credit Facility covenants. |
|||
{{chunk|doc=vycbjm4dw4|c=149|p=14}} |
|||
'''Debentures''' |
|||
* In August 2006, the company received USD 58.0m in proceeds from a debenture offering through Delos Capital Trust (the Trust). |
|||
* The Trust's sole asset is Fixed/Floating Rate Junior Subordinated Deferrable Interest Debentures (Trust Preferred) with a principal amount of USD 59.8m, issued by the company. |
|||
* The Trust also holds USD 1.8m in cash from the issuance of Trust common shares purchased by the company, equal to 3% of the Trust capitalization. |
|||
* On March 15, 2024, the company redeemed the Debentures and paid USD 1.4m of accrued interest. |
|||
{{chunk|doc=vycbjm4dw4|c=150|p=14}} |
|||
'''Subordinated Debt''' |
|||
* In May 2019, the company issued unsecured subordinated notes (the Notes) with an aggregate principal amount of USD 20.0m. |
|||
* Interest on the subordinated notes is fixed at 7.25% for the first eight years and 8.25% fixed thereafter. |
|||
* Early retirement of the debt before the eight-year commitment requires all interest payments to be paid in full, along with the return of all capital. |
|||
* Principal payment for the Notes is due at maturity on May 24, 2039, and interest is payable quarterly. |
|||
{{chunk|doc=vycbjm4dw4|c=151|p=14}} |
|||
'''Debt to Capitalization Ratio''' |
|||
* At December 31, 2024, the ratio of total debt outstanding (including the FHLB Loan, Revolving Credit Facility, and Notes) to total capitalization (total debt plus stockholders’ equity) was 13.1%. |
|||
* At December 31, 2023, the ratio of total debt outstanding (including the Term Loan, Revolver, Trust Preferred, and Notes) to total capitalization was 16.3%. |
|||
{{chunk|doc=vycbjm4dw4|c=152|p=14}} |
|||
'''[[Definition:Share buyback|Share Repurchase]] Program''' |
|||
* In October 2024, the Board of Directors approved a [[Definition:Share buyback|share repurchase]] program authorizing the repurchase of up to USD 50.0m of common stock. |
|||
* Shares may be repurchased via open market purchases, privately-negotiated transactions, block purchases, accelerated [[Definition:Share buyback|share repurchase]] agreements, or a combination of methods, including Rule 10b5-1 trading plans. |
|||
* The timing, manner, price, and amount of repurchases are at the company's discretion. |
|||
* The [[Definition:Share buyback|share repurchase]] program does not require the repurchase of any specific number of shares and can be modified, suspended, or terminated at any time. |
|||
* As of December 31, 2024, no shares had been repurchased under this plan. |
|||
=== Contractual Obligations and Commitments === |
|||
{{chunk|doc=vycbjm4dw4|c=153|p=14}} |
|||
'''Contractual obligations and commitments''' |
|||
* Contractual obligations and commercial commitments are presented by due date as of December 31, 2024. |
|||
* Reserves for losses and LAE represent the best estimate of the ultimate cost of settling reported and unreported claims and related expenses. |
|||
* Estimating reserves for losses and LAE involves complex and subjective judgments. |
|||
* Actual losses and settlement expenses paid may deviate substantially from the reserve estimates in financial statements. |
|||
* The timing for payment of estimated losses is not fixed or determinable on an individual or aggregate basis. |
|||
* Assumptions for estimating payments due by period are based on the company's own, industry, and peer group claims payment experience. |
|||
* There is a risk that amounts paid in any period will differ significantly from disclosed amounts due to uncertainty in estimating payment timing. |
|||
* Disclosed amounts are gross of anticipated amounts recoverable from reinsurers. |
|||
* Reinsurance balances recoverable on reserves for losses and LAE are reported separately as assets, not netted with liabilities, because reinsurance does not discharge liability to policyholders. |
|||
* Reinsurance balances recoverable on reserves for paid and unpaid losses and LAE totaled USD 857.9m at December 31, 2024. |
|||
* Reinsurance balances recoverable on reserves for paid and unpaid losses and LAE totaled USD 596.3m at December 31, 2023. |
|||
{{chunk|doc=vycbjm4dw4|c=154|p=14}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1024" class="wikitable fintable" |
||
|+ Contractual obligations by payments due by period |
|||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="3" style="text-align:center" | Payments due by period |
! colspan="3" style="text-align:center" | Payments due by period |
||
| Line 2,385: | Line 3,067: | ||
| style="text-align:right" | 2,664 |
| style="text-align:right" | 2,664 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total |
||
| style="text-align:right" | |
| style="text-align:right" | 1,947,458 |
||
| style="text-align:right" | |
| style="text-align:right" | 440,418 |
||
| style="text-align:right" | |
| style="text-align:right" | 1,507,040 |
||
|} |
|} |
||
</div> |
</div> |
||
=== Critical Accounting Policies === |
|||
{{Indexing|Critical Accounting Policies|Critical accounting estimates, consolidated financial statements, assets, liabilities, revenues, expenses, contingent assets and liabilities, Note 1, Summary of Significant Accounting Policies, Reserves for unpaid losses and LAE, reported claims, unreported claims, loss severity, loss frequency, inflation|ie3cmfrol3|rmmhubj8mh|kind=prose|order=68}} |
|||
{{chunk|doc=vycbjm4dw4|c=155|p=14}} |
|||
* Critical accounting estimates are those important to financial condition and results of operations, requiring significant judgment <sup>p. 47</sup>. |
|||
'''Critical accounting estimates overview''' |
|||
* Significant judgment is used concerning future results and developments in applying critical accounting estimates and preparing consolidated financial statements <sup>p. 47</sup>. |
|||
* Judgments and estimates affect reported amounts of assets, liabilities, revenues, expenses, and disclosure of material contingent assets and liabilities <sup>p. 47</sup>. |
|||
* Actual results may differ materially from estimates and assumptions used in preparing consolidated financial statements <sup>p. 47</sup>. |
|||
* Estimates are evaluated regularly using relevant information <sup>p. 47</sup>. |
|||
* For a detailed discussion of accounting policies, refer to Note 1, “Summary of Significant Accounting Policies” in Item 8 of Form 10-K <sup>p. 47</sup>. |
|||
* ''Reserves for unpaid losses and LAE'' is the largest and most complex estimate in the consolidated balance sheet <sup>p. 47</sup>. |
|||
* Reserves for unpaid losses and LAE represent the estimated ultimate cost of all unreported and reported but unpaid insured claims and the cost to adjust these losses as of or before the balance sheet date <sup>p. 47</sup>. |
|||
* Reserves for losses and LAE are not discounted to reflect estimated present value <sup>p. 47</sup>. |
|||
* Reserves are estimated using individual case-basis valuations of reported claims, statistical analyses, and various actuarial procedures <sup>p. 47</sup>. |
|||
* Estimates are based on historical information, industry and peer group information, and estimates of future trends in variable factors like loss severity, loss frequency, and inflation <sup>p. 47</sup>. |
|||
* Estimates are regularly reviewed and adjusted as experience develops or new information becomes known <sup>p. 47</sup>. |
|||
* During the loss settlement period, estimates of liability on a claim are often refined and adjusted upward or downward <sup>p. 47</sup>. |
|||
* The ultimate liability may exceed or be less than revised estimates <sup>p. 47</sup>. |
|||
* The ultimate settlement of losses and related LAE may vary significantly from the estimate included in financial statements <sup>p. 47</sup>. |
|||
* Reserves for unpaid losses and LAE are categorized into two types: case reserves and IBNR <sup>p. 47</sup>. |
|||
* ''Case reserves'' are established for individual claims reported to the company <sup>p. 47</sup>. |
|||
* Losses are reported by insureds, their agents, or brokers <sup>p. 47</sup>. |
|||
* Case reserves are established by estimating ultimate losses from the claim, including defense costs <sup>p. 47</sup>. |
|||
* Claims department personnel use their knowledge of specific claims and advice from internal and external experts (underwriters, legal counsel) to estimate expected ultimate losses <sup>p. 47</sup>. |
|||
* Third-Party Administrators (TPAs) are used in limited circumstances to assist in claim adjustment <sup>p. 47</sup>. |
|||
* Internal claims managers oversee TPA activities and monitor their claim handling to prescribed standards <sup>p. 47</sup>. |
|||
* The ''incurred but not reported (“IBNR”) reserve'' is derived by estimating the ultimate unpaid reserve liability and subtracting case reserves <sup>p. 47</sup>. |
|||
* Management’s best estimate of the ultimate unpaid liability is set by the Reserve Committee <sup>p. 47</sup>. |
|||
* The Reserve Committee considers actuarial indications and other factors such as underwriting, claims handling, economic, legal, and environmental changes <sup>p. 47</sup>. |
|||
* The Reserve Committee includes the Chief Actuary, Chief Financial Officer, and Chief Claims Officer <sup>p. 47</sup>. |
|||
* The Reserve Committee meets quarterly to review actuarial reserving recommendations from the Chief Actuary <sup>p. 47</sup>. |
|||
* The Reserve Committee uses judgment to determine the best estimate for the reserve for losses and LAE on the balance sheet <sup>p. 47</sup>. |
|||
* In establishing quarterly actuarial recommendations, the actuary estimates an initial expected ultimate loss ratio for each underwriting division <sup>p. 47</sup>. |
|||
* Input from underwriting and claims departments, including premium pricing assumptions and historical experience, is considered in setting reserves <sup>p. 47</sup>. |
|||
* ''Reserves'' are driven by factors including litigation and regulatory trends, legislative activity, climate change, social and economic patterns, and claims inflation assumptions <sup>p. 47</sup>. |
|||
* Reserve estimates reflect current inflation in legal claims’ settlements <sup>p. 47</sup>. |
|||
* Reserve estimates assume no losses from significant new legal liability theories <sup>p. 47</sup>. |
|||
* Reserve estimates assume no significant changes in the regulatory and legislative environment <sup>p. 47</sup>. |
|||
* The impact of potential changes in the regulatory or legislative environment is difficult to quantify without specific new regulation or legislation <sup>p. 47</sup>. |
|||
* In the event of significant new regulation or legislation, the company will attempt to quantify its impact, but accuracy is not assured <sup>p. 47</sup>. |
|||
* The actuarial review considers multiple actuarial methods to estimate the reserve for losses and LAE <sup>p. 47</sup>. |
|||
* Actuarial methods utilize the initial expected loss ratio, statistical analysis of past claims reporting and payment patterns, claims frequency and severity, paid loss experience, industry loss experience, and changes in market conditions, policy forms, exclusions, and exposures <sup>p. 47</sup>. |
|||
* Actuarial methods used include: |
|||
** Reported and/or Paid Loss Development Methods <sup>p. 47</sup>. |
|||
** Reported Bornhuetter-Ferguson Methods <sup>p. 47</sup>. |
|||
** Paid Bornhuetter-Ferguson Method <sup>p. 47</sup>. |
|||
* For less mature policy years, actuaries rely on the ''Bornhuetter-Ferguson Method'' as the primary method for ultimate loss indications <sup>p. 47</sup>. |
|||
* For more mature policy years, the company transitions to the ''Reported and/or Paid Loss Development Methods'' <sup>p. 47</sup>. |
|||
* The company primarily relies on reported methods when case reserving is consistently applied across policy years <sup>p. 47</sup>. |
|||
* When there is a change in reserving philosophy, both reported and paid methods are blended in evaluating ultimate loss indications <sup>p. 47</sup>. |
|||
* Although reserve estimates are believed to be reasonable, actual loss experience may not conform to assumptions <sup>p. 47</sup>. |
|||
* Actual ultimate loss ratio could differ from the initial expected loss ratio <sup>p. 47</sup>. |
|||
* Actual reporting and payment patterns could differ from expected patterns, which are based on company and industry data <sup>p. 47</sup>. |
|||
* The ultimate settlement of losses and related LAE may vary significantly from estimates in financial statements <sup>p. 47</sup>. |
|||
* Estimates are regularly reviewed and adjusted as necessary, with adjustments included in current operations <sup>p. 47</sup>. |
|||
* ''Development'' is the amount by which estimated losses differ from those originally reported for a period <sup>p. 47</sup>. |
|||
* Development is unfavorable when losses settle for more than reserved or subsequent estimates indicate reserve increases <sup>p. 47</sup>. |
|||
* Development is favorable when losses settle for less than reserved or subsequent estimates indicate reserve reductions <sup>p. 47</sup>. |
|||
* Favorable or unfavorable development of loss reserves is reflected in the results of operations in the period estimates are changed <sup>p. 47</sup>. |
|||
* A ''5% change in net IBNR'' would result in a ''$38.4 million change'' in reserves for losses and LAE <sup>p. 47</sup>. |
|||
* A ''5% change in net IBNR'' would result in a ''$30.4 million change'' in net income and stockholders’ equity <sup>p. 47</sup>. |
|||
* Critical accounting estimates are important to financial condition and results of operations and require significant judgment. |
|||
{{Indexing|Impact of a 5% change in net IBNR on reserves, income, and equity|Impact of a 5% change in net IBNR on reserves, income, and equity, Case reserves, IBNR|rmmhubj8mh|kind=table|order=69}} |
|||
* Significant judgment is used concerning future results and developments in applying these estimates and preparing consolidated financial statements. |
|||
* Judgments and estimates affect reported amounts of assets, liabilities, revenues, expenses, and disclosure of material contingent assets and liabilities. |
|||
* Actual results may differ materially from estimates and assumptions. |
|||
* Estimates are evaluated regularly using relevant information. |
|||
* Detailed discussion of accounting policies is in Note 1, "Summary of Significant Accounting Policies" to consolidated financial statements in Item 8 of Form 10-K. |
|||
{{chunk|doc=vycbjm4dw4|c=156|p=14}} |
|||
'''Reserves for unpaid losses and LAE''' |
|||
* Reserves for unpaid losses and LAE are the largest and most complex estimate in the consolidated balance sheet. |
|||
* These reserves represent the estimated ultimate cost of all unreported and reported but unpaid insured claims and the cost to adjust these losses as of or before the balance sheet date. |
|||
* Reserves for losses and LAE are not discounted to reflect estimated present value. |
|||
* Estimates are made using individual case-basis valuations of reported claims, statistical analyses, and various actuarial procedures. |
|||
* Estimates are based on historical information, industry and peer group information, and estimates of future trends in variable factors like loss severity, loss frequency, and inflation. |
|||
* Estimates are regularly reviewed and adjusted as experience develops or new information becomes known. |
|||
* During the loss settlement period, estimates of liability on a claim are often refined and adjusted upward or downward. |
|||
* Ultimate liability may exceed or be less than revised estimates, and ultimate settlement may vary significantly from the estimate in financial statements. |
|||
* Reserves for unpaid losses and LAE are categorized into case reserves and IBNR. |
|||
* A table sets forth gross and net reserves for unpaid losses and LAE at December 31, 2024 and 2023. |
|||
{{chunk|doc=vycbjm4dw4|c=157|p=14}} |
|||
'''Case reserves and IBNR''' |
|||
* Case reserves are established for individual claims reported to the company. |
|||
* Notification of losses comes from insureds, their agents, or brokers. |
|||
* Case reserves estimate ultimate losses from a claim, including defense costs, based on provided information. |
|||
* Claims department personnel use knowledge of specific claims and advice from internal and external experts (underwriters, legal counsel) to estimate expected ultimate losses. |
|||
* Third-Party Administrators (TPAs) are used in limited circumstances to assist in claim adjustment. |
|||
* Internal claims managers oversee TPA activities and monitor their claim handling to prescribed standards. |
|||
* The incurred but not reported (IBNR) reserve is derived by estimating the ultimate unpaid reserve liability and subtracting case reserves. |
|||
* Management's best estimate of the ultimate unpaid liability is set by the Reserve Committee. |
|||
* The Reserve Committee considers actuarial indications and other factors such as underwriting, claims handling, economic, legal, and environmental changes. |
|||
* The Reserve Committee includes the Chief Actuary, Chief Financial Officer, and Chief Claims Officer. |
|||
* The Reserve Committee meets quarterly to review actuarial reserving recommendations from the Chief Actuary and determines the best estimate for the reserve for losses and LAE. |
|||
* The actuary estimates an initial expected ultimate loss ratio for each underwriting division when establishing quarterly actuarial recommendations. |
|||
* Input from underwriting and claims departments, including premium pricing assumptions and historical experience, is considered in setting reserves. |
|||
{{chunk|doc=vycbjm4dw4|c=158|p=14}} |
|||
'''Reserve drivers and actuarial methods''' |
|||
* Reserves are driven by factors including litigation and regulatory trends, legislative activity, climate change, social and economic patterns, and claims inflation assumptions. |
|||
* Reserve estimates reflect current inflation in legal claims' settlements. |
|||
* Reserve estimates assume no losses from significant new legal liability theories. |
|||
* Reserve estimates assume no significant changes in the regulatory and legislative environment. |
|||
* The impact of potential changes in the regulatory or legislative environment is difficult to quantify without specific new regulation or legislation. |
|||
* The company will attempt to quantify the impact of significant new regulation or legislation, but accuracy or success is not assured. |
|||
* The actuarial review considers multiple actuarial methods to estimate the reserve for losses and LAE. |
|||
* These methods utilize the initial expected loss ratio, statistical analysis of past claims reporting and payment patterns, claims frequency and severity, paid loss experience, industry loss experience, and changes in market conditions, policy forms, exclusions, and exposures. |
|||
* Actuarial methods used include: Reported and/or Paid Loss Development Methods, Reported Bornhuetter-Ferguson Methods, and Paid Bornhuetter-Ferguson Method. |
|||
* For less mature policy years, the Bornhuetter-Ferguson Method is the primary method for ultimate loss indications. |
|||
* For more mature policy years, the company transitions to Reported and/or Paid Loss Development Methods. |
|||
* Reported methods are primarily relied upon when case reserving is consistently applied across policy years. |
|||
* When there is a change in reserving philosophy, both reported and paid methods are blended in the evaluation of ultimate loss indications. |
|||
{{chunk|doc=vycbjm4dw4|c=159|p=14}} |
|||
'''Reserve variability and development''' |
|||
* Actual loss experience may not conform to assumptions, even though reserve estimates are believed to be reasonable. |
|||
* Actual ultimate loss ratio could differ from the initial expected loss ratio. |
|||
* Actual reporting and payment patterns could differ from expected patterns, which are based on company and industry data. |
|||
* Ultimate settlement of losses and related LAE may vary significantly from estimates in financial statements. |
|||
* Estimates are regularly reviewed and adjusted as experience develops or new information becomes known. |
|||
* Such adjustments are included in the results of current operations. |
|||
* "Development" is the amount by which estimated losses differ from those originally reported for a period. |
|||
* Development is unfavorable when losses settle for more than reserved or subsequent estimates indicate reserve increases on unresolved claims. |
|||
* Development is favorable when losses settle for less than reserved or subsequent estimates indicate reserve reductions on unresolved claims. |
|||
* Favorable or unfavorable development of loss reserves is reflected in the results of operations in the period estimates are changed. |
|||
* A 5% change in net IBNR would result in a USD 38.4m change in reserves for losses and LAE. |
|||
* A 5% change in net IBNR would result in a USD 30.4m change in net income and stockholders’ equity. |
|||
{{chunk|doc=vycbjm4dw4|c=160|p=14}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1025" class="wikitable fintable" |
||
|+ Gross and net by case reserves and IBNR |
|||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="4" style="text-align:center" | 2024 |
! colspan="4" style="text-align:center" | 2024 |
||
| Line 2,490: | Line 3,190: | ||
| style="text-align:right" | 62.9% |
| style="text-align:right" | 62.9% |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total |
||
| style="text-align:right" | |
| style="text-align:right" | 1,782,383 |
||
| style="text-align:right" | |
| style="text-align:right" | 100.0% |
||
| style="text-align:right" | |
| style="text-align:right" | 1,111,537 |
||
| style="text-align:right" | |
| style="text-align:right" | 100.0% |
||
| style="text-align:right" | |
| style="text-align:right" | 1,314,501 |
||
| style="text-align:right" | |
| style="text-align:right" | 100.0% |
||
| style="text-align:right" | |
| style="text-align:right" | 859,017 |
||
| style="text-align:right" | |
| style="text-align:right" | 100.0% |
||
|} |
|} |
||
</div> |
</div> |
||
=== Recent Accounting Pronouncements === |
|||
{{Indexing|Recent Accounting Pronouncements|ASU 2023-07, Improvements to Reportable Segment Disclosures, FASB, chief operating decision maker, CODM, ASU 2023-09, Improvements to Income Tax Disclosures, public companies, income taxes, ASU 2024-03, income statement expenses|ie3cmfrol3|1ut79wn2dy|kmocop7wiu|kind=prose|order=70|f1=ASU 2023-07 effective date|v1=fiscal years beginning after December 15, 2023|f2=ASU 2023-09 effective date|v2=fiscal years beginning after December 15, 2024|f3=ASU 2024-03 issued|v3=November 2024}} |
|||
{{chunk|doc=vycbjm4dw4|c=161|p=14}} |
|||
* ''ASU 2023-07 (Improvements to Reportable Segment Disclosures)'' was issued by FASB in November 2023 <sup>p. 48</sup>. |
|||
'''Recent Accounting Pronouncements - Segment Disclosures''' |
|||
* ''ASU 2023-07'' requires segment disclosures for: (i) significant segment expenses regularly provided to the chief operating decision maker (“CODM”), (ii) how the CODM uses reported measures of segment profitability for performance assessment and resource allocation, and (iii) the title and position of the CODM <sup>p. 48</sup>. |
|||
* ''ASU 2023-07'' mandates full segment disclosures for entities with a single reportable segment <sup>p. 48</sup>. |
|||
* In November 2023, the FASB issued ASU 2023-07, "Improvements to Reportable Segment Disclosures (Topic 280)". |
|||
* ''ASU 2023-07'' became effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024 <sup>p. 48</sup>. |
|||
* ASU 2023-07 requires segment disclosures for: (i) significant segment expenses regularly provided to the chief operating decision maker ("CODM"), (ii) how the CODM uses reported measures of segment profitability for performance assessment and resource allocation, and (iii) the title and position of the CODM. |
|||
* ''ASU 2023-07'' is applied retrospectively to all prior periods presented <sup>p. 48</sup>. |
|||
* Entities with a single reportable segment must provide full segment disclosures. |
|||
* Additional segment disclosures have been added as required by ''ASU 2023-07'', with no impact on consolidated financial statements <sup>p. 48</sup>. |
|||
* The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. |
|||
* ''ASU 2023-09 (Improvements to Income Tax Disclosures)'' was issued by FASB in December 2023 <sup>p. 48</sup>. |
|||
* This update is applied retrospectively to all prior periods presented. |
|||
* ''ASU 2023-09'' requires public companies to provide enhanced annual rate reconciliation disclosures, including specific categories and additional information meeting a quantitative threshold <sup>p. 48</sup>. |
|||
* Additional segment disclosures have been added as required by ASU 2023-07. |
|||
* ''ASU 2023-09'' also requires public companies to disaggregate income taxes paid by federal, state, and foreign taxes <sup>p. 48</sup>. |
|||
* There was no impact to the consolidated financial statements from ASU 2023-07. |
|||
* ''ASU 2023-09'' guidance is effective for fiscal years beginning after December 15, 2024 <sup>p. 48</sup>. |
|||
* The amendments from ''ASU 2023-09'' are not expected to have a material impact on consolidated financial statements <sup>p. 48</sup>. |
|||
{{chunk|doc=vycbjm4dw4|c=162|p=14}} |
|||
* ''ASU 2024-03'' was issued by FASB in November 2024, requiring disaggregated disclosure of income statement expenses for public business entities (“PBEs”) <sup>p. 48</sup>. |
|||
'''Recent Accounting Pronouncements - Income Tax Disclosures''' |
|||
* ''ASU 2024-03'' does not change expense captions on the income statement but requires disaggregation of certain expense captions into specified categories in footnotes <sup>p. 48</sup>. |
|||
* ''ASU 2024-03'' requires a footnote disclosure in tabular presentation for relevant income statement expense captions that include natural expenses such as: (1) purchases of inventory, (2) employee compensation, (3) depreciation, (4) intangible asset amortization, and (5) depreciation, depletion, and amortization from oil- and gas-producing activities or other depletion expenses <sup>p. 48</sup>. |
|||
* In December 2023, the FASB issued ASU 2023-09, "Improvements to Income Tax Disclosures (Topic 740)". |
|||
* The tabular disclosure under ''ASU 2024-03'' would also include certain other expenses, if applicable <sup>p. 48</sup>. |
|||
* ASU 2023-09 requires public companies to provide enhanced annual rate reconciliation disclosures, including specific categories and additional information meeting a quantitative threshold. |
|||
* ''ASU 2025-01'' was issued by FASB in January 2025 to clarify the effective date of ''ASU 2024-03'' as the first annual reporting period beginning after December 15, 2026, and interim reporting periods within annual reporting periods beginning after December 15, 2027 <sup>p. 48</sup>. |
|||
* This update also requires public companies to disaggregate income taxes paid by federal, state, and foreign taxes. |
|||
* The effect of the amendments from ''ASU 2024-03'' on consolidated financial statements is currently being evaluated <sup>p. 48</sup>. |
|||
* The guidance is effective for fiscal years beginning after December 15, 2024. |
|||
* The amendments are not expected to have a material impact on the consolidated financial statements. |
|||
{{chunk|doc=vycbjm4dw4|c=163|p=14}} |
|||
'''Recent Accounting Pronouncements - Income Statement Expense Disclosures''' |
|||
* In November 2024, the FASB issued ASU 2024-03, requiring disaggregated disclosure of income statement expenses for public business entities ("PBEs"). |
|||
* ASU 2024-03 does not change expense captions on the income statement but requires disaggregation of certain expense captions into specified categories in footnotes. |
|||
* A footnote disclosure is required for specific expenses, presented in a tabular format, for relevant income statement expense captions that include any of the following natural expenses: (1) purchases of inventory, (2) employee compensation, (3) depreciation, (4) intangible asset amortization, and (5) depreciation, depletion, and amortization recognized as part of oil- and gas-producing activities or other types of depletion expenses. |
|||
* The tabular disclosure will also include certain other expenses, when applicable. |
|||
* In January 2025, the FASB issued ASU 2025-01 to clarify the effective date of ASU 2024-03 as the first annual reporting period beginning after December 15, [[Definition:Year 2026|2026]], and interim reporting periods within annual reporting periods beginning after December 15, 2027. |
|||
* The effect of the amendments on the consolidated financial statements is currently being evaluated. |
|||
== Quantitative and Qualitative Disclosures About Market Risk == |
== Quantitative and Qualitative Disclosures About Market Risk == |
||
{{chunk|doc=vycbjm4dw4|c=164|p=15}} |
|||
* Qualitative and Quantitative Disclosures about Market Risk are included in Item 7 of this Form 10-K under "Investments—Market Risk" <sup>p. 49</sup>. |
|||
'''Market risk disclosures''' |
|||
* Qualitative and Quantitative Disclosures about Market Risk are included in Item 7 of this Form 10-K under “Investments—Market Risk”. |
|||
== Financial Statements == |
== Financial Statements == |
||
=== Report of Independent Registered Public Accounting Firm === |
|||
{{Indexing|Report of Independent Registered Public Accounting Firm|Skyward Specialty Insurance Group, Inc., consolidated financial statements, consolidated balance sheets, consolidated statements of operations, comprehensive income (loss), changes in stockholders’ equity, cash flows, accounting principles generally accepted in the United States of America, Public Company Accounting Oversight Board, PCAOB, internal control over financial reporting, Internal Control—Integrated Framework (2013), Committee of Sponsoring Organizations of the Treadway Commission, COSO|x856lnzuq2|l96bfbct4s|kind=prose|order=71|f1=Auditor|v1=Independent Registered Public Accounting Firm|f2=Audit opinion|v2=unqualified|f3=Report date|v3=March 1, 2024}} |
|||
{{chunk|doc=vycbjm4dw4|c=165|p=16}} |
|||
* We have audited the accompanying consolidated financial statements of Skyward Specialty Insurance Group, Inc. and its subsidiaries, which include the consolidated balance sheets as of December 31, 2023 and 2022, and the related consolidated statements of operations, comprehensive income (loss), changes in stockholders’ equity, and cash flows for each of the three years in the period ended December 31, 2023, and the related notes (collectively referred to as the “consolidated financial statements”) <sup>p. 50</sup>. |
|||
'''Independent auditor's report''' |
|||
* In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of Skyward Specialty Insurance Group, Inc. and its subsidiaries as of December 31, 2023 and 2022, and the results of their operations and their cash flows for each of the three years in the period ended December 31, 2023, in conformity with accounting principles generally accepted in the United States of America <sup>p. 50</sup>. |
|||
* We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), Skyward Specialty Insurance Group, Inc.’s internal control over financial reporting as of December 31, 2023, based on criteria established in Internal Control—Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO), and our report dated March 1, 2024, expressed an unqualified opinion thereon <sup>p. 50</sup>. |
|||
* The report is addressed to the Stockholders and the Board of Directors of Skyward Specialty Insurance Group, Inc. |
|||
{{Indexing|Opinion on Internal Control Over Financial Reporting|Internal control over financial reporting, Internal Control—Integrated Framework, Committee of Sponsoring Organizations of the Treadway Commission, COSO criteria, Skyward Specialty Insurance Group, Inc., material weakness, information technology general controls, ITGCs, user access, financial reporting processes, process-level IT dependent manual and automated controls, consolidated financial statements, PCAOB standards|l96bfbct4s|x856lnzuq2|kind=prose|order=72|f1=Audit opinion|v1=unqualified|f2=Report date|v2=March 3, 2025}} |
|||
=== Opinion on Internal Control Over Financial Reporting === |
|||
* ''Internal control over financial reporting'' was audited as of December 31, 2024, based on criteria established in the Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria) <sup>p. 51</sup>. |
|||
* ''Opinion on internal control'' states that Skyward Specialty Insurance Group, Inc. has not maintained effective internal control over financial reporting as of December 31, 2024, due to a material weakness <sup>p. 51</sup>. |
|||
* ''Material weakness definition'': a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis <sup>p. 51</sup>. |
|||
* ''Identified material weakness'' as of December 31, 2024, relates to the ineffective implementation of information technology general controls ("ITGCs") in user access for systems supporting financial reporting processes <sup>p. 51</sup>. |
|||
* ''Impact of material weakness'': The Company’s related process-level IT dependent manual and automated controls that rely on affected ITGCs, or information from IT systems with affected ITGCs, were also deemed ineffective <sup>p. 51</sup>. |
|||
* ''Consolidated financial statements'' for December 31, 2024 and 2023, and for each of the three years in the period ended December 31, 2024, were audited in accordance with PCAOB standards <sup>p. 51</sup>. |
|||
* ''Audit of 2024 consolidated financial statements'' considered this material weakness in determining the nature, timing, and extent of audit tests <sup>p. 51</sup>. |
|||
* ''Report on consolidated financial statements'' dated March 3, 2025, expressed an unqualified opinion and is not affected by this material weakness <sup>p. 51</sup>. |
|||
{{chunk|doc=vycbjm4dw4|c=166|p=16}} |
|||
{{Indexing|Basis for Opinion|Management's responsibility, auditor's responsibility, PCAOB standards, audit procedures|x856lnzuq2|l96bfbct4s|kind=prose|order=73}} |
|||
'''Internal control over financial reporting''' |
|||
* Skyward Specialty Insurance Group, Inc.'s internal control over financial reporting as of December 31, 2024, was audited based on criteria established in the Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria). |
|||
* ''Management'' is responsible for maintaining effective internal control over financial reporting and for its assessment included in the accompanying Management’s Report on Internal Control over Financial Reporting <sup>p. 52</sup>. |
|||
* |
* The Company has not maintained effective internal control over financial reporting as of December 31, 2024, based on the COSO criteria, due to a material weakness. |
||
* A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis. |
|||
* ''We are a public accounting firm'' registered with the PCAOB and are required to be independent with respect to the Company in accordance with U.S. federal securities laws and applicable rules and regulations of the Securities and Exchange Commission and the PCAOB <sup>p. 52</sup>. |
|||
* A material weakness existed as of December 31, 2024, related to the ineffective implementation of information technology general controls ("ITGCs") in the area of user access for systems supporting the Company’s financial reporting processes. |
|||
* ''Our audit'' was conducted in accordance with PCAOB standards <sup>p. 52</sup>. |
|||
* Related process-level IT dependent manual and automated controls that rely upon the affected ITGCs, or information from IT systems with affected ITGCs, were also deemed ineffective. |
|||
* ''PCAOB standards'' require planning and performing the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects <sup>p. 52</sup>. |
|||
* The consolidated balance sheets as of December 31, 2024 and 2023, and related consolidated statements of operations and comprehensive income (loss), stockholders’ equity and cash flows for each of the three years ended December 31, 2024, were audited in accordance with PCAOB standards. |
|||
* ''Our audit procedures'' included obtaining an understanding of internal control over financial reporting, assessing the risk of material weakness, testing and evaluating the design and operating effectiveness of internal control based on assessed risk, and performing other necessary procedures <sup>p. 52</sup>. |
|||
* This material weakness was considered in determining the nature, timing, and extent of audit tests for the 2024 consolidated financial statements. |
|||
* ''We believe'' our audit provides a reasonable basis for our opinion <sup>p. 52</sup>. |
|||
* The report on internal control does not affect the report dated March 3, 2025, which expressed an unqualified opinion on the consolidated financial statements. |
|||
=== Basis for Opinion === |
|||
{{Indexing|Definition and Limitations of Internal Control Over Financial Reporting|Definition and limitations of internal control over financial reporting, policies and procedures, prevention and detection of misstatements|l96bfbct4s|x856lnzuq2|kind=prose|order=74|f1=Auditor|v1=Ernst & Young LLP|f2=Auditor since|v2=2021|f3=Headquarters|v3=Houston, Texas|f4=Report date|v4=March 3, 2025}} |
|||
{{chunk|doc=vycbjm4dw4|c=167|p=16}} |
|||
* ''Internal control over financial reporting'' is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles <sup>p. 53</sup>. |
|||
'''Auditor's responsibility and audit scope''' |
|||
* ''Internal control over financial reporting'' includes policies and procedures that: |
|||
** Pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the company's assets <sup>p. 53</sup>. |
|||
** Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures are made only in accordance with management and director authorizations <sup>p. 53</sup>. |
|||
** Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements <sup>p. 53</sup>. |
|||
* ''Internal control over financial reporting'' has inherent limitations and may not prevent or detect misstatements <sup>p. 53</sup>. |
|||
* Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate due to changes in conditions, or that compliance with policies or procedures may deteriorate <sup>p. 53</sup>. |
|||
* The Company's management is responsible for maintaining effective internal control over financial reporting and for its assessment included in the Management’s Report on Internal Control over Financial Reporting. |
|||
Caption: Report of independent registered public accounting firm |
|||
* The auditor's responsibility is to express an opinion on the Company’s internal control over financial reporting based on their audit. |
|||
* The auditor is a public accounting firm registered with the PCAOB and is required to be independent in accordance with U.S. federal securities laws and applicable rules and regulations of the SEC and the PCAOB. |
|||
* The audit was conducted in accordance with PCAOB standards. |
|||
* PCAOB standards require planning and performing the audit to obtain reasonable assurance that effective internal control over financial reporting was maintained in all material respects. |
|||
* The audit included understanding internal control over financial reporting, assessing the risk of a material weakness, testing and evaluating the design and operating effectiveness of internal control, and performing other necessary procedures. |
|||
* The auditor believes their audit provides a reasonable basis for their opinion. |
|||
=== Definition and Limitations of Internal Control Over Financial Reporting === |
|||
| /s/ Ernst & Young LLP | |
|||
| --- | |
|||
| We have served as the Company’s auditor since 2021. | |
|||
| Houston, Texas | |
|||
| March 3, 2025 | |
|||
{{chunk|doc=vycbjm4dw4|c=168|p=16}} |
|||
{{Indexing|Report of Independent Registered Public Accounting Firm|Audit of consolidated financial statements, opinion on financial position and cash flows, audit of internal control over financial reporting|x856lnzuq2|kind=prose|order=75|f1=Auditor|v1=Skyward Specialty Insurance Group, Inc.|f2=Consolidated financial statements as of|v2=December 31, 2023 and 2022|f3=Internal control over financial reporting as of|v3=December 31, 2023|f4=Report dated|v4=February 29, 2024|f5=Other auditors report dated|v5=March 10, 2023}} |
|||
'''Internal Control Over Financial Reporting Definition''' |
|||
* Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. |
|||
* We have audited the accompanying consolidated financial statements of Skyward Specialty Insurance Group, Inc. and its subsidiaries, which include the consolidated balance sheets as of December 31, 2023 and 2022, and the related consolidated statements of operations, comprehensive income (loss), changes in stockholders’ equity, and cash flows for each of the three years in the period ended December 31, 2023, and the related notes (collectively referred to as the “consolidated financial statements”) <sup>p. 54</sup>. |
|||
* Internal control over financial reporting includes policies and procedures that: |
|||
* In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of Skyward Specialty Insurance Group, Inc. and its subsidiaries as of December 31, 2023 and 2022, and the results of their operations and their cash flows for each of the three years in the period ended December 31, 2023, in conformity with accounting principles generally accepted in the United States of America <sup>p. 54</sup>. |
|||
** Pertain to the maintenance of records that accurately and fairly reflect the company's transactions and asset dispositions. |
|||
* We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), Skyward Specialty Insurance Group, Inc.’s internal control over financial reporting as of December 31, 2023, based on criteria established in Internal Control—Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO), and our report dated February 29, 2024, expressed an unqualified opinion thereon <sup>p. 54</sup>. |
|||
** Provide reasonable assurance that transactions are recorded for financial statement preparation in accordance with GAAP, and that receipts and expenditures are authorized by management and directors. |
|||
* The consolidated financial statements of Skyward Specialty Insurance Group, Inc. as of December 31, 2022, and for the year then ended, were audited by other auditors whose report, dated March 10, 2023, expressed an unqualified opinion on those statements <sup>p. 54</sup>. |
|||
** Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of company assets that could materially affect financial statements. |
|||
* The consolidated financial statements of Skyward Specialty Insurance Group, Inc. for the year ended December 31, 2021, were audited by other auditors whose report, dated March 10, 2023, expressed an unqualified opinion on those statements <sup>p. 54</sup>. |
|||
* Due to inherent limitations, internal control over financial reporting may not prevent or detect misstatements. |
|||
* The audit was conducted in accordance with the standards of the PCAOB <sup>p. 54</sup>. |
|||
* Projections of effectiveness evaluations to future periods risk controls becoming inadequate due to changing conditions or deterioration in compliance with policies or procedures. |
|||
* Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud <sup>p. 54</sup>. |
|||
* Our audit included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks <sup>p. 54</sup>. |
|||
* Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements <sup>p. 54</sup>. |
|||
* Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements <sup>p. 54</sup>. |
|||
* We believe that our audit provides a reasonable basis for our opinion <sup>p. 54</sup>. |
|||
* The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments <sup>p. 54</sup>. |
|||
* The communication of critical audit matters does not alter our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates <sup>p. 54</sup>. |
|||
* ''Critical Audit Matter'': Reserves for Losses and Loss Adjustment Expenses <sup>p. 54</sup>. |
|||
** ''Description'': As discussed in Note 2 and Note 6 to the consolidated financial statements, the Company’s consolidated balance sheets include reserves for losses and loss adjustment expenses of USD 1,069.7 million as of December 31, 2023 <sup>p. 54</sup>. |
|||
** ''Management's Process'': Management estimates these reserves using actuarial methodologies and assumptions, which involve significant judgment due to the inherent uncertainty in predicting future loss payments <sup>p. 54</sup>. |
|||
** ''Audit Challenge'': Auditing these reserves was especially challenging and subjective due to the significant judgment required in evaluating the actuarial methodologies and assumptions used by management, including the selection of actuarial methods, the selection of loss development factors, and the consideration of qualitative factors <sup>p. 54</sup>. |
|||
** ''Audit Procedures'': Our audit procedures included, among others, evaluating the design and operating effectiveness of controls over the Company’s process for estimating reserves for losses and loss adjustment expenses <sup>p. 54</sup>. |
|||
** We also involved our actuarial specialists to assist in evaluating the appropriateness of management’s actuarial methodologies and assumptions, including the selection of actuarial methods, the selection of loss development factors, and the consideration of qualitative factors <sup>p. 54</sup>. |
|||
** We compared management’s selected actuarial methods and assumptions to our independently developed range of reasonable estimates <sup>p. 54</sup>. |
|||
** We also evaluated the historical accuracy of management’s estimates by comparing prior year estimates to actual loss development <sup>p. 54</sup>. |
|||
* The engagement partner on the audit resulting in this independent auditor’s report is Michael J. O’Malley <sup>p. 54</sup>. |
|||
* Ernst & Young LLP, Houston, Texas, February 29, 2024 <sup>p. 54</sup>. |
|||
{{chunk|doc=vycbjm4dw4|c=169|p=16}} |
|||
{{Indexing|Opinion on the Financial Statements|Audited consolidated financial statements, consolidated balance sheets, consolidated statements of operations and comprehensive income, stockholders' equity, cash flows|x856lnzuq2|kind=prose|order=76}} |
|||
<div style="overflow-x:auto"> |
|||
* The accompanying consolidated balance sheets of Skyward Specialty Insurance Group, Inc. and subsidiaries (the Company) as of December 31, 2024 and 2023 have been audited <sup>p. 55</sup>. |
|||
{| id="t1026" class="wikitable" |
|||
* The related consolidated statements of operations and comprehensive income, stockholders' equity, and cash flows for each of the three years in the period ended December 31, 2024 have been audited <sup>p. 55</sup>. |
|||
|+ Definition and Limitations of Internal Control Over Financial Reporting |
|||
* The related notes and financial statement schedules listed in the Index at Item 15 (collectively referred to as the “consolidated financial statements”) have been audited <sup>p. 55</sup>. |
|||
|- |
|||
* The consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2024 and 2023 <sup>p. 55</sup>. |
|||
! style="text-align:left" | /s/ Ernst & Young LLP |
|||
* The consolidated financial statements present fairly the results of the Company's operations and its cash flows for each of the three years in the period ended December 31, 2024 <sup>p. 55</sup>. |
|||
|- |
|||
* The financial statements are in conformity with U.S. generally accepted accounting principles <sup>p. 55</sup>. |
|||
| style="text-align:left" | We have served as the Company’s auditor since 2021. |
|||
|- |
|||
| style="text-align:left" | Houston, Texas |
|||
|- |
|||
| style="text-align:left" | March 3, 2025 |
|||
|} |
|||
</div> |
|||
=== Report of Independent Registered Public Accounting Firm === |
|||
{{Indexing|Basis for Opinion|Management's responsibility for financial statements, auditors' responsibility, PCAOB standards, audit procedures|x856lnzuq2|kind=prose|order=77}} |
|||
{{chunk|doc=vycbjm4dw4|c=170|p=16}} |
|||
* The Company's management is responsible for the financial statements <sup>p. 56</sup>. |
|||
'''Independent auditor's report''' |
|||
* The auditors' responsibility is to express an opinion on the Company's financial statements based on their audits <sup>p. 56</sup>. |
|||
* The auditors are a public accounting firm registered with the PCAOB <sup>p. 56</sup>. |
|||
* The auditors are required to be independent with respect to the Company in accordance with U.S. federal securities laws and applicable rules and regulations of the Securities and Exchange Commission and the PCAOB <sup>p. 56</sup>. |
|||
* The audits were conducted in accordance with the standards of the PCAOB <sup>p. 56</sup>. |
|||
* PCAOB standards require planning and performing audits to obtain reasonable assurance that financial statements are free of material misstatement, whether due to error or fraud <sup>p. 56</sup>. |
|||
* Audit procedures included assessing risks of material misstatement and responding to those risks <sup>p. 56</sup>. |
|||
* Procedures involved examining, on a test basis, evidence regarding amounts and disclosures in the financial statements <sup>p. 56</sup>. |
|||
* Audits also included evaluating accounting principles, significant estimates made by management, and the overall presentation of the financial statements <sup>p. 56</sup>. |
|||
* The auditors believe their audits provide a reasonable basis for their opinion <sup>p. 56</sup>. |
|||
* The report is addressed to the Stockholders and the Board of Directors of Skyward Specialty Insurance Group, Inc. |
|||
{{Indexing|Critical Audit Matter|Critical audit matter, audit committee communication, material accounts or disclosures, auditors' judgments|x856lnzuq2|kind=prose|order=78}} |
|||
=== Opinion on the Financial Statements === |
|||
* The critical audit matter communicated arises from the current period audit of the financial statements <sup>p. 57</sup>. |
|||
* This matter was communicated or required to be communicated to the audit committee <sup>p. 57</sup>. |
|||
* The matter relates to accounts or disclosures that are material to the financial statements <sup>p. 57</sup>. |
|||
* The matter involved especially challenging, subjective, or complex judgments by the auditors <sup>p. 57</sup>. |
|||
* The communication of the critical audit matter does not alter the auditors' opinion on the consolidated financial statements, taken as a whole <sup>p. 57</sup>. |
|||
* Communicating the critical audit matter does not provide a separate opinion on the critical audit matter or on the account or disclosure to which it relates <sup>p. 57</sup>. |
|||
{{chunk|doc=vycbjm4dw4|c=171|p=16}} |
|||
{{Indexing|Valuation of Reserves for Unpaid Losses and Loss Adjustment Expenses|Reserves for unpaid losses and LAE, incurred but not reported reserves (IBNR), estimation methods, actuarial procedures, audit procedures|rmmhubj8mh|e40m7ou132|x856lnzuq2|kind=prose|order=79|f1=Reserves for unpaid losses and LAE|v1=USD 1.8bn at December 31, 2024}} |
|||
'''Audit Opinion''' |
|||
* The consolidated financial statements of Skyward Specialty Insurance Group, Inc. and subsidiaries (the Company) as of December 31, 2024 and 2023, and for each of the three years ended December 31, 2024, have been audited. |
|||
* ''Company’s reserves for unpaid losses and LAE'' were USD 1.8bn at December 31, 2024 <sup>p. 58</sup>. |
|||
* The audit included the consolidated balance sheets, statements of operations and comprehensive income, stockholders' equity, cash flows, related notes, and financial statement schedules listed in Item 15. |
|||
* A significant portion of these reserves represents ''incurred but not reported reserves (IBNR)'' <sup>p. 58</sup>. |
|||
* The auditors' opinion is that the consolidated financial statements fairly present, in all material respects, the financial position of the Company at December 31, 2024 and 2023, and the results of its operations and cash flows for each of the three years ended December 31, 2024. |
|||
* ''Reserves for unpaid losses and LAE'' represent the estimated ultimate cost of all unreported and reported but unpaid insured claims and the cost to adjust losses incurred as of the balance sheet date <sup>p. 58</sup>. |
|||
* The financial statements conform with U.S. generally accepted accounting principles. |
|||
* The Company estimates these reserves using individual case-basis valuations of reported claims, statistical analyses, and various actuarial procedures <sup>p. 58</sup>. |
|||
* Estimates are based on historical information, industry and peer group information, and trends in factors such as loss severity, loss frequency, and inflation <sup>p. 58</sup>. |
|||
* Auditing management’s estimate of reserves for unpaid losses and LAE, including IBNR, was complex and involved actuarial specialists due to significant estimation uncertainty <sup>p. 58</sup>. |
|||
* This uncertainty is associated with evaluating management’s methods and assumptions, including loss development factors, expected loss ratios, and trends applied to historical experience <sup>p. 58</sup>. |
|||
* These assumptions significantly affect the ''valuation of IBNR reserves'' <sup>p. 58</sup>. |
|||
* Audit procedures included evaluating the selection of actuarial methods used by management, comparing them to prior periods and industry practices <sup>p. 58</sup>. |
|||
* Auditors evaluated assumptions by comparing significant assumptions (loss development factors, expected loss ratios, trends) to the Company’s historical experience and current industry benchmarks and trends <sup>p. 58</sup>. |
|||
* An independent range of reserve estimates was developed and compared to management’s best estimate for unpaid losses and LAE <sup>p. 58</sup>. |
|||
* A review of the development of prior year reserve estimates was also performed <sup>p. 58</sup>. |
|||
=== Basis for Opinion === |
|||
Caption: Report of independent registered public accounting firm |
|||
{{chunk|doc=vycbjm4dw4|c=172|p=16}} |
|||
| /s/ Ernst & Young LLP | |
|||
'''Auditor responsibilities and standards''' |
|||
| --- | |
|||
| We have served as the Company’s auditor since 2021. | |
|||
| Houston, Texas | |
|||
| March 3, 2025 | |
|||
* The Company's management is responsible for the financial statements. |
|||
{{Indexing|Consolidated balance sheets|Consolidated balance sheets, accompanying notes|offa7is5x7|kind=prose|order=80}} |
|||
* The auditor's responsibility is to express an opinion on the Company’s financial statements based on their audits. |
|||
* The auditor is a public accounting firm registered with the PCAOB and is required to be independent in accordance with U.S. federal securities laws and applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. |
|||
* Audits were conducted in accordance with PCAOB standards. |
|||
* PCAOB standards require planning and performing the audit to obtain reasonable assurance that financial statements are free of material misstatement, whether due to error or fraud. |
|||
* Audits included procedures to assess and respond to risks of material misstatement, whether due to error or fraud. |
|||
* Procedures included examining, on a test basis, evidence regarding amounts and disclosures in the financial statements. |
|||
* Audits also included evaluating accounting principles used, significant estimates made by management, and the overall presentation of the financial statements. |
|||
* The audits provide a reasonable basis for the auditor's opinion. |
|||
=== Critical Audit Matter === |
|||
* The accompanying notes are an integral part of the consolidated financial statements <sup>p. 59</sup>. |
|||
{{chunk|doc=vycbjm4dw4|c=173|p=16}} |
|||
{{Indexing|Consolidated balance sheets||offa7is5x7|1f87rdfb5o|966xer0dpm|kind=table|order=81}} |
|||
'''Critical audit matter definition''' |
|||
* The critical audit matter communicated relates to accounts or disclosures material to the financial statements and involved especially challenging, subjective, or complex judgments. |
|||
* Communication of the critical audit matter does not alter the opinion on the consolidated financial statements as a whole. |
|||
* The communication does not provide a separate opinion on the critical audit matter or the related account or disclosure. |
|||
=== Valuation of Reserves for Unpaid Losses and Loss Adjustment Expenses === |
|||
{{chunk|doc=vycbjm4dw4|c=174|p=16}} |
|||
'''Valuation of Reserves for Unpaid Losses and Loss Adjustment Expenses''' |
|||
* The Company's reserves for unpaid losses and loss adjustment expenses (LAE) were USD 1.8bn at December 31, 2024, with a significant portion representing incurred but not reported reserves (IBNR). |
|||
* Reserves for unpaid losses and LAE represent the estimated ultimate cost of all unreported and reported but unpaid insured claims and the cost to adjust losses incurred as of the balance sheet date. |
|||
* The Company estimates these reserves using individual case-basis valuations of reported claims, statistical analyses, and various actuarial procedures. |
|||
* Estimates are based on historical information, industry and peer group information, and trends in factors like loss severity, loss frequency, and inflation. |
|||
* Auditing management's estimate of reserves for unpaid losses and LAE, including IBNR, was complex and involved actuarial specialists due to significant estimation uncertainty. |
|||
* Estimation uncertainty is associated with evaluating management's methods and assumptions, including loss development factors, expected loss ratios, and trends applied to historical experience. |
|||
* These assumptions significantly affect the valuation of IBNR reserves. |
|||
* Audit procedures for the Company's reserves for unpaid losses and LAE included evaluating the selection of actuarial methods used by management, comparing them to prior periods and industry practices, with assistance from actuarial specialists. |
|||
* The audit also evaluated assumptions used in actuarial methods by comparing significant assumptions (loss development factors, expected loss ratios, trends) to the Company’s historical experience and current industry benchmarks and trends. |
|||
* An independent range of reserve estimates was developed and compared to management’s best estimate for unpaid losses and LAE. |
|||
* A review of the development of prior year reserve estimates was also performed. |
|||
{{chunk|doc=vycbjm4dw4|c=175|p=16}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable |
{| id="t1027" class="wikitable" |
||
|+ Valuation of Reserves for Unpaid Losses and Loss Adjustment Expenses |
|||
|- |
|||
! style="text-align:left" | /s/ Ernst & Young LLP |
|||
|- |
|||
| style="text-align:left" | We have served as the Company’s auditor since 2021. |
|||
|- |
|||
| style="text-align:left" | Houston, Texas |
|||
|- |
|||
| style="text-align:left" | March 3, 2025 |
|||
|} |
|||
</div> |
|||
=== Consolidated balance sheets === |
|||
{{chunk|doc=vycbjm4dw4|c=176|p=16}} |
|||
'''Consolidated financial statements notes''' |
|||
* The accompanying notes are an integral part of the consolidated financial statements. |
|||
{{chunk|doc=vycbjm4dw4|c=177|p=16}} |
|||
<div style="overflow-x:auto"> |
|||
{| id="t1028" class="wikitable fintable" |
|||
|+ Assets, liabilities, and stockholders’ equity by December 31 |
|||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="2" style="text-align:center" | December 31, |
! colspan="2" style="text-align:center" | December 31, |
||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
! style="text-align: |
! class="col-s" style="text-align:right" | 2024 |
||
! style="text-align: |
! class="col-s" style="text-align:right" | 2023 |
||
|- |
|- |
||
! style="text-align:left" | ($ in thousands, except share and per share amounts) |
! style="text-align:left" | ($ in thousands, except share and per share amounts) |
||
! style="text-align: |
! class="col-s" style="text-align:right" | |
||
! style="text-align: |
! class="col-s" style="text-align:right" | |
||
|- |
|- |
||
! style="text-align:left" | Assets |
! style="text-align:left" | Assets |
||
! style="text-align: |
! class="col-s" style="text-align:right" | |
||
! style="text-align: |
! class="col-s" style="text-align:right" | |
||
|- |
|- |
||
! style="text-align:left" | Investments: |
! style="text-align:left" | Investments: |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
|- |
|- |
||
| class="wt-indent-1" style="text-align:left" | Fixed maturity securities, available-for-sale, at fair value (amortized cost of $ 1,320,266 and $ 1,047,713 , respectively) |
| class="wt-indent-1" style="text-align:left" | Fixed maturity securities, available-for-sale, at fair value (amortized cost of $ 1,320,266 and $ 1,047,713 , respectively) |
||
| Line 2,708: | Line 3,440: | ||
| style="text-align:right" | 270,226 |
| style="text-align:right" | 270,226 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total investments |
||
| style="text-align:right" | |
| style="text-align:right" | 1,870,820 |
||
| style="text-align:right" | |
| style="text-align:right" | 1,613,687 |
||
|- |
|- |
||
| style="text-align:left" | Cash and cash equivalents |
| style="text-align:left" | Cash and cash equivalents |
||
| Line 2,748: | Line 3,480: | ||
| style="text-align:right" | 75,341 |
| style="text-align:right" | 75,341 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total assets |
||
| style="text-align:right" | |
| style="text-align:right" | 3,729,478 |
||
| style="text-align:right" | |
| style="text-align:right" | 2,953,435 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Liabilities and stockholders’ equity</b> |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Liabilities: |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 2,788: | Line 3,524: | ||
| style="text-align:right" | 78,690 |
| style="text-align:right" | 78,690 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total liabilities |
||
| style="text-align:right" | |
| style="text-align:right" | 2,935,479 |
||
| style="text-align:right" | |
| style="text-align:right" | 2,292,404 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Stockholders’ equity</b> |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 2,816: | Line 3,552: | ||
| style="text-align:right" | ( 21,708 ) |
| style="text-align:right" | ( 21,708 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total stockholders’ equity |
||
| style="text-align:right" | |
| style="text-align:right" | 793,999 |
||
| style="text-align:right" | |
| style="text-align:right" | 661,031 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total liabilities and stockholders’ equity |
||
| style="text-align:right" | |
| style="text-align:right" | 3,729,478 |
||
| style="text-align:right" | |
| style="text-align:right" | 2,953,435 |
||
|} |
|} |
||
</div> |
</div> |
||
=== Consolidated statements of operations and comprehensive income === |
|||
{{chunk|doc=vycbjm4dw4|c=178|p=16}} |
|||
'''consolidated financial statements''' |
|||
* The accompanying notes are an integral part of the consolidated financial statements |
* The accompanying notes are an integral part of the consolidated financial statements. |
||
{{chunk|doc=vycbjm4dw4|c=179|p=16}} |
|||
{{Indexing|Consolidated statements of operations||ed0t39ch3f|wpkf9ycgxf|jpoeftv18u|irxh3hcbqz|kind=table|order=83}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1029" class="wikitable fintable" |
||
|+ Revenues, expenses, income, and comprehensive income by years ended December 31 |
|||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="2" style="text-align:center" | Years Ended December 31, |
! colspan="2" style="text-align:center" | Years Ended December 31, |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
! style="text-align:left" | ($ in thousands, except share and per share amounts) |
! style="text-align:left" | ($ in thousands, except share and per share amounts) |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2024 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2023 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2022 |
||
|- |
|- |
||
! style="text-align:left" | Revenues: |
! style="text-align:left" | Revenues: |
||
! class="col-m" style="text-align:right" | |
! class="col-m" style="text-align:right" | |
||
! class="col-m" style="text-align:right" | |
! class="col-m" style="text-align:right" | |
||
! class="col-m" style="text-align:right" | |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | Net earned premiums |
| style="text-align:left" | Net earned premiums |
||
| Line 2,858: | Line 3,599: | ||
| style="text-align:right" | 5,199 |
| style="text-align:right" | 5,199 |
||
|- |
|- |
||
| style="text-align:left" | Net investment income |
| style="text-align:left" | [[Definition:Net investment income|Net investment income]] |
||
| style="text-align:right" | 80,686 |
| style="text-align:right" | 80,686 |
||
| style="text-align:right" | 40,322 |
| style="text-align:right" | 40,322 |
||
| Line 2,873: | Line 3,614: | ||
| style="text-align:right" | 1 |
| style="text-align:right" | 1 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | [[Definition:Total revenue|Total revenues]] |
||
| style="text-align:right" | |
| style="text-align:right" | 1,150,200 |
||
| style="text-align:right" | |
| style="text-align:right" | 885,969 |
||
| style="text-align:right" | |
| style="text-align:right" | 642,420 |
||
|- |
|||
| style="text-align:left" | <b>Expenses:</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Losses and loss adjustment expenses |
| style="text-align:left" | Losses and loss adjustment expenses |
||
| Line 2,903: | Line 3,649: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total expenses |
||
| style="text-align:right" | |
| style="text-align:right" | 997,461 |
||
| style="text-align:right" | |
| style="text-align:right" | 775,867 |
||
| style="text-align:right" | |
| style="text-align:right" | 592,637 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Income before income taxes</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>152,739</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>110,102</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>49,783</b> |
||
|- |
|- |
||
| style="text-align:left" | Income tax expense |
| style="text-align:left" | Income tax expense |
||
| Line 2,918: | Line 3,664: | ||
| style="text-align:right" | 10,387 |
| style="text-align:right" | 10,387 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net income</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>118,828</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>85,984</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>39,396</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net income attributable to participating securities</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>—</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>1,677</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>18,879</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net income attributable to common stockholders</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>118,828</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>84,307</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>20,517</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Comprehensive income</b> |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
|- |
|||
| style="text-align:left" | <b>Net income</b> |
|||
| style="text-align:right" | <b>118,828</b> |
|||
| style="text-align:right" | <b>85,984</b> |
|||
| style="text-align:right" | <b>39,396</b> |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Other comprehensive income (loss):</b> |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 2,958: | Line 3,709: | ||
| style="text-align:right" | 420 |
| style="text-align:right" | 420 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total other comprehensive income (loss) |
||
| style="text-align:right" | |
| style="text-align:right" | 833 |
||
| style="text-align:right" | |
| style="text-align:right" | 20,532 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 48,125 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Comprehensive income (loss)</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>119,661</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>106,516</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 8,729 )</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Per share data:</b> |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 2,978: | Line 3,729: | ||
| style="text-align:right" | 1.24 |
| style="text-align:right" | 1.24 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Diluted earnings per share</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>2.87</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>2.24</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>1.21</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Weighted-average common shares outstanding</b> |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 2,993: | Line 3,744: | ||
| style="text-align:right" | 16,568,393 |
| style="text-align:right" | 16,568,393 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Diluted</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>41,377,460</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>38,317,534</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>32,653,194</b> |
||
|} |
|} |
||
</div> |
</div> |
||
=== Consolidated statements of stockholders’ equity === |
|||
{{chunk|doc=vycbjm4dw4|c=180|p=16}} |
|||
* The accompanying notes are an integral part of the consolidated financial statements <sup>p. 61</sup>. |
|||
'''Consolidated financial statements notes''' |
|||
* The accompanying notes are an integral part of the consolidated financial statements. |
|||
{{Indexing|Consolidated statements of changes in stockholders’ equity||z6dk9e62ik|0lk0pqg9zh|kind=table|order=85}} |
|||
{{chunk|doc=vycbjm4dw4|c=181|p=16}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1030" class="wikitable fintable" |
||
|+ Consolidated statements of stockholders’ equity |
|||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="3" style="text-align:center" | Years Ended December 31, |
! colspan="3" style="text-align:center" | Years Ended December 31, |
||
|- |
|- |
||
! style="text-align:left" | ($ in thousands, except share amounts) |
! style="text-align:left" | ($ in thousands, except share amounts) |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2024 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2023 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2022 |
||
|- |
|- |
||
! style="text-align:left" | Preferred shares: |
! style="text-align:left" | Preferred shares: |
||
! class="col-m" style="text-align:right" | |
! class="col-m" style="text-align:right" | |
||
! class="col-m" style="text-align:right" | |
! class="col-m" style="text-align:right" | |
||
! class="col-m" style="text-align:right" | |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | Balance at beginning of year |
| style="text-align:left" | Balance at beginning of year |
||
| Line 3,031: | Line 3,787: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Balance at December 31</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>—</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>—</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>1,969,660</b> |
||
|- |
|||
| style="text-align:left" | <b>Common shares:</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Balance at beginning of year |
| style="text-align:left" | Balance at beginning of year |
||
| Line 3,051: | Line 3,812: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Balance at December 31</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>40,127,908</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>39,863,756</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>16,599,666</b> |
||
|- |
|||
| style="text-align:left" | <b>Preferred stock:</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Balance at beginning of year |
| style="text-align:left" | Balance at beginning of year |
||
| Line 3,061: | Line 3,827: | ||
| style="text-align:right" | 20 |
| style="text-align:right" | 20 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Preferred stock conversion to common shares |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | ( 20 ) |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
|- |
|||
| style="text-align:left" | <b>Balance at December 31</b> |
|||
| style="text-align:right" | <b>—</b> |
|||
| style="text-align:right" | <b>—</b> |
|||
| style="text-align:right" | <b>20</b> |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Common stock:</b> |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 3,079: | Line 3,850: | ||
| style="text-align:right" | 2 |
| style="text-align:right" | 2 |
||
| style="text-align:right" | 22 |
| style="text-align:right" | 22 |
||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Preferred stock conversion to common shares |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 161 |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| Line 3,086: | Line 3,862: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Balance at December 31</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>401</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>399</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>168</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Treasury stock:</b> |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 3,101: | Line 3,877: | ||
| style="text-align:right" | ( 2 ) |
| style="text-align:right" | ( 2 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Preferred stock conversion to common shares |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | 2 |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
|- |
|||
| style="text-align:left" | <b>Balance at December 31</b> |
|||
| style="text-align:right" | <b>—</b> |
|||
| style="text-align:right" | <b>—</b> |
|||
| style="text-align:right" | <b>( 2 )</b> |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Additional paid-in capital:</b> |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 3,120: | Line 3,901: | ||
| style="text-align:right" | 9,213 |
| style="text-align:right" | 9,213 |
||
| style="text-align:right" | 2,130 |
| style="text-align:right" | 2,130 |
||
|- |
|||
| style="text-align:left" | Preferred stock conversion to common shares |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | ( 143 ) |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Proceeds from equity offerings, net |
| style="text-align:left" | Proceeds from equity offerings, net |
||
| Line 3,126: | Line 3,912: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Balance at December 31</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>718,598</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>710,855</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>577,289</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Stock notes receivable:</b> |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 3,146: | Line 3,932: | ||
| style="text-align:right" | 2,181 |
| style="text-align:right" | 2,181 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Balance at December 31</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>—</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 5,562 )</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 6,911 )</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Accumulated other comprehensive loss:</b> |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 3,166: | Line 3,952: | ||
| style="text-align:right" | ( 48,125 ) |
| style="text-align:right" | ( 48,125 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Balance at December 31</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 22,120 )</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 22,953 )</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 43,485 )</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Retained earnings (accumulated deficit):</b> |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 3,191: | Line 3,977: | ||
| style="text-align:right" | 39,396 |
| style="text-align:right" | 39,396 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Balance at December 31</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>97,120</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 21,708 )</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 105,417 )</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total stockholders’ equity |
||
| style="text-align:right" | |
| style="text-align:right" | 793,999 |
||
| style="text-align:right" | |
| style="text-align:right" | 661,031 |
||
| style="text-align:right" | |
| style="text-align:right" | 421,662 |
||
|} |
|} |
||
</div> |
</div> |
||
=== Consolidated statements of cash flows === |
|||
{{chunk|doc=vycbjm4dw4|c=182|p=16}} |
|||
'''Consolidated financial statements notes''' |
|||
* The accompanying notes are an integral part of the consolidated financial statements |
* The accompanying notes are an integral part of the consolidated financial statements. |
||
{{chunk|doc=vycbjm4dw4|c=183|p=16}} |
|||
{{Indexing|Consolidated statements of cash flows||cs6p6hop55|kind=table|order=87}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1031" class="wikitable fintable" |
||
|+ Cash flows from operating, investing, and financing activities by years ended December 31 |
|||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="3" style="text-align:center" | Years Ended December 31, |
! colspan="3" style="text-align:center" | Years Ended December 31, |
||
|- |
|- |
||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2024 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2023 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2022 |
||
|- |
|- |
||
! style="text-align:left" | Cash flows from operating activities |
! style="text-align:left" | Cash flows from operating activities |
||
! class="col-m" style="text-align:right" | |
! class="col-m" style="text-align:right" | |
||
! class="col-m" style="text-align:right" | |
! class="col-m" style="text-align:right" | |
||
! class="col-m" style="text-align:right" | |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | Net income |
| style="text-align:left" | Net income |
||
| Line 3,258: | Line 4,049: | ||
| style="text-align:right" | 9,383 |
| style="text-align:right" | 9,383 |
||
| style="text-align:right" | 10,267 |
| style="text-align:right" | 10,267 |
||
|- |
|||
| style="text-align:left" | Changes in operating assets and liabilities: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Premiums receivable, net |
| style="text-align:left" | Premiums receivable, net |
||
| Line 3,319: | Line 4,115: | ||
| style="text-align:right" | 5,052 |
| style="text-align:right" | 5,052 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net cash provided by operating activities</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>305,115</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>338,187</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>208,938</b> |
||
|- |
|||
| style="text-align:left" | <b>Cash flows from investing activities:</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Purchase of fixed maturity securities, available-for-sale |
| style="text-align:left" | Purchase of fixed maturity securities, available-for-sale |
||
| Line 3,399: | Line 4,200: | ||
| style="text-align:right" | 3,202 |
| style="text-align:right" | 3,202 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net cash used in investment activities</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 243,694 )</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 493,809 )</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 193,381 )</b> |
||
|- |
|||
| style="text-align:left" | <b>Cash flows from financing activities:</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Employee share purchases |
| style="text-align:left" | Employee share purchases |
||
| Line 3,429: | Line 4,235: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net cash (used in) provided by financing activities</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 4,232 )</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>130,947</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>2,180</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net increase (decrease) in cash and cash equivalents and restricted cash</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>57,189</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 24,675 )</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>17,737</b> |
||
|- |
|- |
||
| style="text-align:left" | Cash and cash equivalents and restricted cash at beginning of period (1) |
| style="text-align:left" | Cash and cash equivalents and restricted cash at beginning of period (1) |
||
| Line 3,444: | Line 4,250: | ||
| style="text-align:right" | 107,274 |
| style="text-align:right" | 107,274 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Cash and cash equivalents and restricted cash at end of period (1)</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>157,525</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>100,336</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>125,011</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Supplemental disclosure of cash flow information:</b> |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 3,466: | Line 4,272: | ||
</div> |
</div> |
||
{{fn note|1=1|2=The sum of cash and cash equivalents and restricted cash from the consolidated balance sheets.}} |
|||
=== A. Description of Business === |
|||
{{Indexing|A. Description of Business|Insurance holding company, specialty insurance, commercial property and casualty insurance, underwriting divisions, wholly owned insurance subsidiaries, captive reinsurance company, non-risk bearing subsidiaries|cmtswfs0go|lht8rybaqk|kind=prose|order=88|f1=Legal name|v1=Skyward Specialty Insurance Group, Inc.|f2=State of incorporation|v2=Delaware|f3=Year founded|v3=2006|f4=Number of insurance subsidiaries|v4=Four|f5=Number of non-risk bearing subsidiaries|v5=Three}} |
|||
{{chunk|doc=vycbjm4dw4|c=184|p=16}} |
|||
* The Company is an insurance holding company, a Delaware corporation organized in 2006 <sup>p. 63</sup>. |
|||
'''Company overview and structure''' |
|||
* It operates as a specialty insurance company in one segment, providing commercial property and casualty insurance coverages through its underwriting divisions <sup>p. 63</sup>. |
|||
* The Company has four wholly owned insurance company subsidiaries based in the United States <sup>p. 63</sup>. |
|||
** ''Great Midwest Insurance Company (GMIC)'' underwrites insurance on an admitted basis and is a certified surety bond company listed with the U.S. Department of the Treasury <sup>p. 63</sup>. |
|||
** ''Houston Specialty Insurance Company (HSIC)'', a subsidiary of GMIC, underwrites insurance on a non-admitted basis <sup>p. 63</sup>. |
|||
** ''Imperium Insurance Company (IIC)'', a subsidiary of HSIC, underwrites insurance on an admitted basis <sup>p. 63</sup>. |
|||
** ''Oklahoma Specialty Insurance Company (OSIC)'', a subsidiary of IIC, underwrites insurance on a non-admitted basis <sup>p. 63</sup>. |
|||
* The Company has a wholly owned captive reinsurance company subsidiary, ''Skyward Re'', domiciled in the Cayman Islands <sup>p. 63</sup>. |
|||
** Skyward Re assumed net reserves for certain divisions from the Company’s insurance companies related to a retroactive reinsurance contract <sup>p. 63</sup>. |
|||
** Skyward Re retroceded these net reserves to a third-party reinsurer <sup>p. 63</sup>. |
|||
* The Company has three non-risk bearing wholly owned subsidiaries <sup>p. 63</sup>. |
|||
** ''Skyward Underwriters Agency, Inc. (SUA)'' is a managing general insurance agent and reinsurance broker for property and casualty risks in specialty niche markets <sup>p. 63</sup>. |
|||
** ''Skyward Service Company'' provides various administrative services to the Company’s subsidiaries <sup>p. 63</sup>. |
|||
** ''Skyward Specialty No. 1 Limited'' is a Lloyd’s corporate member authorized to invest in Lloyd’s syndicates <sup>p. 63</sup>. |
|||
* Skyward Specialty Insurance Group, Inc. (the "Company") is a Delaware corporation organized in 2006, operating as an insurance holding company. |
|||
{{Indexing|B. Basis of Presentation|Consolidated financial statements, Generally Accepted Accounting Principles (GAAP), estimates and assumptions, intercompany transactions|ow7tevuxxr|ie3cmfrol3|kind=prose|order=89}} |
|||
* The Company is a specialty insurance company operating in one segment, delivering commercial [[Definition:Property & casualty|property and casualty]] products insurance coverages through its underwriting divisions. |
|||
* The Company has four wholly owned insurance company subsidiaries based in the United States. |
|||
* Great Midwest Insurance Company ("GMIC") underwrites insurance on an admitted basis and is a certified surety bond company listed with the U.S. Department of the Treasury. |
|||
* Houston Specialty Insurance Company ("HSIC"), a subsidiary of GMIC, underwrites insurance on a non-admitted basis. |
|||
* Imperium Insurance Company ("IIC"), a subsidiary of HSIC, underwrites insurance on an admitted basis. |
|||
* Oklahoma Specialty Insurance Company ("OSIC"), a subsidiary of IIC, underwrites insurance on a non-admitted basis. |
|||
* The Company has a wholly owned captive reinsurance company subsidiary, Skyward Re, domiciled in the Cayman Islands. |
|||
* Skyward Re assumed net reserves for certain divisions, related to a retroactive reinsurance contract, from the Company’s insurance companies and retroceded these net reserves to a third-party reinsurer. |
|||
* The Company has three non-risk bearing wholly owned subsidiaries. |
|||
* Skyward Underwriters Agency, Inc. ("SUA") is a managing general insurance agent and reinsurance broker for [[Definition:Property & casualty|property and casualty]] risks in specialty niche markets. |
|||
* Skyward Service Company provides various administrative services to the Company’s subsidiaries. |
|||
* Skyward Specialty No. 1 Limited is a Lloyd’s corporate member authorized to invest in Lloyd’s syndicates. |
|||
=== B. Basis of Presentation === |
|||
* The Company's consolidated financial statements are prepared according to Generally Accepted Accounting Principles in the United States of America (GAAP) <sup>p. 64</sup>. |
|||
* GAAP differs in some aspects from the principles used in reports to insurance regulatory authorities <sup>p. 64</sup>. |
|||
* The consolidated financial statements include the accounts of the holding company and its subsidiaries <sup>p. 64</sup>. |
|||
* All intercompany transactions and balances are eliminated during consolidation <sup>p. 64</sup>. |
|||
* Preparing consolidated financial statements in conformity with GAAP requires the Company to make estimates and assumptions <sup>p. 64</sup>. |
|||
* These estimates and assumptions affect the amounts reported in the consolidated financial statements and accompanying notes <sup>p. 64</sup>. |
|||
* The Company's actual results may differ from these estimates <sup>p. 64</sup>. |
|||
{{chunk|doc=vycbjm4dw4|c=185|p=16}} |
|||
{{Indexing|C. Cash and Cash Equivalents|Cash and cash equivalents, fixed maturity securities, carrying value, fair value|cs6p6hop55|kind=prose|order=90}} |
|||
'''Basis of presentation''' |
|||
* The Company’s consolidated financial statements are prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP"). |
|||
* ''Cash and cash equivalents'' include cash on hand and fixed maturity securities with original maturities of three months or less <sup>p. 65</sup>. |
|||
* GAAP differs in some respects from the principles followed in reports to insurance regulatory authorities. |
|||
* The ''carrying value'' of the Company’s cash and cash equivalents approximates fair value <sup>p. 65</sup>. |
|||
* The consolidated financial statements include the accounts of the holding company and its subsidiaries. |
|||
* All intercompany transactions and balances have been eliminated in consolidation. |
|||
* Preparation of consolidated financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect reported amounts and accompanying notes. |
|||
* Actual results could differ from these estimates. |
|||
=== C. Cash and Cash Equivalents === |
|||
{{Indexing|D. Restricted Cash|Restricted cash, legal restriction, unremitted insurance premiums, fiduciary capacity, assets on deposit, collateral for reinsurance balances|cs6p6hop55|kind=prose|order=91}} |
|||
{{chunk|doc=vycbjm4dw4|c=186|p=16}} |
|||
* ''Restricted cash'' is defined as cash with a legal restriction on withdrawal or use by the consolidated group <sup>p. 66</sup>. |
|||
'''Cash and cash equivalents definition''' |
|||
* The ''carrying value of restricted cash'' approximates fair value <sup>p. 66</sup>. |
|||
* ''SUA'' collects premiums, deducts commissions and fees, and remits the remainder to the Company's or third-party insurance companies <sup>p. 66</sup>. |
|||
* ''SUA'' holds unremitted insurance premiums in a fiduciary capacity for third-party insurance companies, which is recorded as restricted cash <sup>p. 66</sup>. |
|||
* The Company must maintain ''assets on deposit'' with certain states and hold cash as collateral for reinsurance balances due to state regulations <sup>p. 66</sup>. |
|||
* Cash held in a depository account for others or restricted by a state is recorded as restricted cash <sup>p. 66</sup>. |
|||
* Cash and cash equivalents include cash on hand and fixed maturity securities with original maturities of three months or less. |
|||
{{Indexing|E. Investments|Available for Sale fixed maturities, unrealized loss position, credit-related factors, allowance for credit losses, Held-to-maturity fixed maturity securities, historical loss rate|966xer0dpm|jpoeftv18u|j8uunnd14x|kind=prose|order=92}} |
|||
* The carrying value of the Company’s cash and cash equivalents approximates fair value. |
|||
=== D. Restricted Cash === |
|||
* ''Available for Sale fixed maturities'' are carried at fair value <sup>p. 67</sup>. |
|||
* For ''available-for-sale fixed maturities'' in an unrealized loss position, the Company first determines intent to sell or likelihood of being required to sell before maturity or recovery of cost basis <sup>p. 67</sup>. |
|||
* If either of these criteria are met, the amortized cost is written down to fair value, with losses recognized in net investment gains on the consolidated statements of operations <sup>p. 67</sup>. |
|||
* If neither criterion is met, the Company determines if unrealized losses are due to credit-related factors <sup>p. 67</sup>. |
|||
* If unrealized losses are credit-related, an ''allowance for credit losses'' is determined using a present value of cash flows compared to the amortized cost of the security <sup>p. 67</sup>. |
|||
* The ''allowance for credit losses'' is limited to the amount by which fair value is below amortized cost <sup>p. 67</sup>. |
|||
* Changes in the ''allowance for credit losses'' are recognized in net investment income on the consolidated statements of operations <sup>p. 67</sup>. |
|||
* Credit losses limited by the fair value of the security are recognized in stockholders’ equity, net of taxes, as a component of accumulated other comprehensive loss <sup>p. 67</sup>. |
|||
* Unrealized losses that are not credit-related continue to be recognized in stockholders’ equity, net of taxes, as a component of accumulated other comprehensive loss <sup>p. 67</sup>. |
|||
* ''Held-to-maturity fixed maturity securities'' are carried at amortized cost net of an allowance for credit losses <sup>p. 67</sup>. |
|||
* The ''allowance for credit losses'' for held-to-maturity securities represents the current estimate of expected credit losses <sup>p. 67</sup>. |
|||
* The Company develops a ''historical loss rate'' from Moody’s multi-year cumulative loss rates for asset-backed securities <sup>p. 67</sup>. |
|||
* The ''historical loss rate'' is adjusted for current conditions and reasonable and supportable forecasts <sup>p. 67</sup>. |
|||
* Changes in the ''allowance for credit losses'' for held-to-maturity securities are recognized in net investment income on the consolidated statements of operations <sup>p. 67</sup>. |
|||
* ''Equity securities'' consist of common stock or preferred stock <sup>p. 67</sup>. |
|||
* Mutual funds, including those primarily investing in debt securities, are classified as ''equity securities'' <sup>p. 67</sup>. |
|||
* ''Equity securities with a readily determinable fair value'' are carried on the balance sheet at fair value using quoted market prices <sup>p. 67</sup>. |
|||
* Changes in the carrying value of ''equity securities'' are included in net investment (losses) gains within the consolidated statements of operations <sup>p. 67</sup>. |
|||
* ''Mortgage loans'' are classified as held for investment and carried at cost adjusted for unamortized premiums, discounts, and loan fees <sup>p. 67</sup>. |
|||
* Uncollectible amounts for ''mortgage loans'' are written off in the period they are determined to be uncollectible <sup>p. 67</sup>. |
|||
* Interest on ''mortgage loans'' is recognized as interest receivable and included in other assets on the consolidated balance sheet <sup>p. 67</sup>. |
|||
* The Company elected the ''fair value option'' for mortgage loans effective January 1, 2023, as targeted transition relief from the adoption of ASU 2016-13 <sup>p. 67</sup>. |
|||
* Under the ''fair value option'', mortgage loans are measured at fair value, and changes in unrealized gains and losses are reported in net investment (losses) gains on the consolidated statements of operations <sup>p. 67</sup>. |
|||
* Interest income and amortization for ''mortgage loans'' under the fair value option continue to be recognized in net investment income on the consolidated statements of operations <sup>p. 67</sup>. |
|||
* ''Equity method investments'' include investments in equity and equity securities of non-public entities and indirect investments in loans and loan collateral <sup>p. 67</sup>. |
|||
* The Company has ''equity investments'' in certain limited partnerships and corporations where it has significant influence but not control <sup>p. 67</sup>. |
|||
* The Company is not the primary beneficiary of variable interest entities and does not consolidate them <sup>p. 67</sup>. |
|||
* The ''equity method'' is used to account for investments in unconsolidated subsidiaries <sup>p. 67</sup>. |
|||
* Under the ''equity method'', initial investment is recorded at cost and adjusted based on the proportionate share of distributions and net income or loss of the investee <sup>p. 67</sup>. |
|||
* The difference between the cost of an investment and its proportionate share of the underlying equity in net assets is a component of investment income <sup>p. 67</sup>. |
|||
* The Company amortizes this difference as an adjustment to its pro-rata share of equity method income over the useful life, based on the underlying asset <sup>p. 67</sup>. |
|||
* For ''equity securities of non-public entities'' where the Company does not have significant influence and no readily determinable fair value, investments are carried at cost, minus impairment, and adjusted for observable price changes in orderly transactions <sup>p. 67</sup>. |
|||
* ''Investments in indirect collateralized loans and loan collateral'' are held through and accounted for as an ownership interest in an unconsolidated subsidiary <sup>p. 67</sup>. |
|||
* The Company’s ''ownership interests in unconsolidated subsidiaries'' include investments in partnerships, joint ventures, and special purpose investment vehicles <sup>p. 67</sup>. |
|||
* The Company uses the ''equity method'' for these unconsolidated subsidiaries where it has significant influence but not control <sup>p. 67</sup>. |
|||
* ''Other long-term investments'' consist of an investment in a limited partnership held at net asset value ("NAV") and other long-term investment securities <sup>p. 67</sup>. |
|||
* ''Short-term investments'' primarily consist of money market funds and are carried at cost, which approximates fair value <sup>p. 67</sup>. |
|||
* ''Net investment income'' includes interest, dividends, and equity in earnings (losses) of unconsolidated subsidiaries, net of investment expenses <sup>p. 67</sup>. |
|||
* Interest income is recognized on the accrual basis, and dividends are recognized as earned at the ex-dividend date <sup>p. 67</sup>. |
|||
* Interest income on mortgage-backed and other asset-backed securities is recognized using the effective-yield method based on estimated principal repayments <sup>p. 67</sup>. |
|||
* Amortization of premium and accretion of discounts on debt securities are included in ''interest income'' <sup>p. 67</sup>. |
|||
* ''Net realized gains and losses on investments'' are recognized in net income based upon the specific identification method <sup>p. 67</sup>. |
|||
{{chunk|doc=vycbjm4dw4|c=187|p=16}} |
|||
{{Indexing|F. Reinsurance|Prospective reinsurance, proportional reinsurance, excess of loss reinsurance, facultative reinsurance, ceded unearned premium, reinsurance balances recoverable, retroactive reinsurance, loss portfolio transfers, adverse development covers|20fueoa3q1|8ihdrbirer|tc5fw176pu|kind=prose|order=93}} |
|||
'''Restricted cash definition and sources''' |
|||
* Cash with a legal restriction on withdrawal or use by the consolidated group is recorded as restricted cash. |
|||
* The Company purchases prospective reinsurance for certain lines of business on a proportional, excess of loss, and facultative basis <sup>p. 68</sup>. |
|||
* The carrying value of the Company’s restricted cash approximates fair value. |
|||
* ''Proportional reinsurance'' requires the Company to share losses and expenses with the reinsurer in exchange for a share of premiums <sup>p. 68</sup>. |
|||
* SUA holds unremitted insurance premiums in a fiduciary capacity to third-party insurance companies as restricted cash. |
|||
* ''Excess of loss reinsurance'' shares losses, either proportionally or entirely, above a specific dollar threshold, for a negotiated cost <sup>p. 68</sup>. |
|||
* The Company is required by state regulations to maintain assets on deposit with certain states and hold cash as collateral for certain reinsurance balances. |
|||
* ''Facultative reinsurance'' covers specific risks and/or policies on either a proportional or excess of loss basis <sup>p. 68</sup>. |
|||
* Cash held in a depository account for others, or restricted by a state, is recorded as restricted cash. |
|||
* Ceded unearned premium and reinsurance balances recoverable (on paid and unpaid losses and settlement expenses) are reported separately as assets <sup>p. 68</sup>. |
|||
* Reinsurance does not relieve the Company of its legal liability to policyholders <sup>p. 68</sup>. |
|||
* Reinsurance on unpaid losses and settlement expenses represents estimates of the portion of liabilities recoverable from reinsurers <sup>p. 68</sup>. |
|||
* On the Consolidated Statements of Operations, ''net earned premiums'', ''losses and loss adjustment expenses, net'', and ''underwriting, acquisition and insurance expenses'' are presented net of reinsurance ceded <sup>p. 68</sup>. |
|||
* The Company purchases retroactive reinsurance on certain lines of business through loss portfolio transfers ("LPT") and adverse development covers <sup>p. 68</sup>. |
|||
* These retroactive contracts provide indemnification for losses related to past loss events, with the reinsurer sharing losses based on dollar thresholds <sup>p. 68</sup>. |
|||
* Income from retroactive reinsurance contracts is deferred and amortized into net income over the settlement period <sup>p. 68</sup>. |
|||
* Losses from retroactive reinsurance contracts are charged to net income immediately <sup>p. 68</sup>. |
|||
* Subsequent changes in the measurement of retroactive reinsurance contracts are accounted for using a full retrospective method <sup>p. 68</sup>. |
|||
* Certain ceded reinsurance contracts that management determines do not transfer significant insurance risk are accounted for using the deposit method <sup>p. 68</sup>. |
|||
* The evaluation of significant insurance risk transfer assesses both timing risk and underwriting risk <sup>p. 68</sup>. |
|||
* A reinsurance contract may not transfer significant insurance risk if either underwriting risk or timing risk, or both, are not deemed transferred <sup>p. 68</sup>. |
|||
* For contracts transferring only significant timing risk but not sufficient underwriting risk, a deposit asset is recorded equal to the initial cash outflow <sup>p. 68</sup>. |
|||
* This deposit asset is offset by cash inflows received from reinsurers <sup>p. 68</sup>. |
|||
* If cash outflows are expected to differ from cash inflows, an accretion rate is established at inception based on actuarial estimates <sup>p. 68</sup>. |
|||
* The deposit accounting asset is increased/decreased to the estimated receivable amount over the contract term <sup>p. 68</sup>. |
|||
* The accretion of the deposit is based on the expected rate of return implied from estimated cash inflows and outflows <sup>p. 68</sup>. |
|||
* The Company periodically reassesses the estimated ultimate receivable and the related expected rate of return on the deposit asset <sup>p. 68</sup>. |
|||
* The accretion of the deposit asset, including changes from estimated cash flow adjustments, is reflected as part of investment income <sup>p. 68</sup>. |
|||
* Several reinsurance contracts require deposit accounting due to not transferring sufficient underwriting risk <sup>p. 68</sup>. |
|||
* No reinsurance contracts required deposit accounting due to not transferring sufficient timing risk <sup>p. 68</sup>. |
|||
* ''Reinsurance recoverables'' are carried net of an allowance for credit losses <sup>p. 68</sup>. |
|||
* The allowance for credit losses represents the current estimate of expected credit losses <sup>p. 68</sup>. |
|||
* The Company develops a historical loss rate using the A.M. Best impairment rate and rating transition study, which provides historical loss data for similarly rated reinsurance companies based on expected receivable duration <sup>p. 68</sup>. |
|||
* The historical loss rate is adjusted for current conditions, reasonable and supportable forecasts, and current economic conditions <sup>p. 68</sup>. |
|||
* Changes in the allowance for credit losses are recognized in underwriting, acquisition and insurance expenses on the consolidated statements of operations <sup>p. 68</sup>. |
|||
* Reinsurance does not relieve the Company of its legal liability to its policyholders <sup>p. 68</sup>. |
|||
* The Company continuously monitors the financial condition of its reinsurers, including reviewing their annual financial statements and insurance industry developments <sup>p. 68</sup>. |
|||
* The Company analyzes credit risk of reinsurance recoverables by monitoring the financial strength rating of its reinsurers from A.M. Best <sup>p. 68</sup>. |
|||
* The Company assesses the adequacy of collateral obtained where applicable <sup>p. 68</sup>. |
|||
* If reinsurers fail to fulfill obligations, the Company has access to collateral from various reinsurers <sup>p. 68</sup>. |
|||
* ''Reinsurance collateral from reinsurers'' was $337.0 million as of December 31, 2024, and $257.5 million as of December 31, 2023 <sup>p. 68</sup>. |
|||
* ''Everest Reinsurance Co.'' and ''eMaxx Captives'' represented 18.0% and 16.8%, respectively, of the Company’s reinsurance recoverable balances at December 31, 2024 <sup>p. 68</sup>. |
|||
* ''Everest Reinsurance Co.'' and ''eMaxx Captives'' represented 20.4% and 20.4%, respectively, of the Company’s reinsurance recoverable balances at December 31, 2023 <sup>p. 68</sup>. |
|||
* These were the only reinsurers representing 10% or more of the Company’s reinsurance recoverable balances <sup>p. 68</sup>. |
|||
* ''Everest Reinsurance Co.'s financial strength rating'' from A.M. Best was A+ at December 31, 2024 and 2023 <sup>p. 68</sup>. |
|||
* ''eMaxx Captives'' was not rated by A.M. Best at December 31, 2024 and 2023 <sup>p. 68</sup>. |
|||
=== E. Investments === |
|||
{{Indexing|G. Concentration of Credit Risk|Concentrations of credit risk, financial instruments, cash and cash equivalents, restricted cash, investments, premiums receivable, U.S. government securities, money market funds, diversification, credit exposure|m0cjxgvmvi|kind=prose|order=94}} |
|||
{{chunk|doc=vycbjm4dw4|c=188|p=16}} |
|||
* Financial instruments that could lead to concentrations of credit risk include cash and cash equivalents, restricted cash, investments, and premiums receivable, excluding reinsurance recoverables <sup>p. 69</sup>. |
|||
'''Available-for-sale investments accounting''' |
|||
* ''Cash equivalents and short-term investments'' consist of U.S. government securities and money market funds <sup>p. 69</sup>. |
|||
* ''Investments'' are diversified across various industries and geographic regions <sup>p. 69</sup>. |
|||
* The Company limits its credit exposure to any single financial institution or issuer <sup>p. 69</sup>. |
|||
* The Company believes there is no significant concentration of credit risk related to cash and investments <sup>p. 69</sup>. |
|||
* As of December 31, 2024 and 2023, ''outstanding premiums receivable'' are generally diversified due to a large customer base and dispersion across many lines of business and geographic regions <sup>p. 69</sup>. |
|||
* Failure by distribution sources to remit premiums could lead to premium write-offs and a corresponding loss of income <sup>p. 69</sup>. |
|||
* Investments in fixed maturities classified as available-for-sale are carried at fair value. |
|||
{{Indexing|H. Deferred Policy Acquisition Costs|Policy acquisition costs, deferred policy acquisition costs, ceding commissions, premium deficiency, unamortized acquisition costs, anticipated investment income|or43xxg565|kind=prose|order=95}} |
|||
* For available-for-sale fixed maturities in an unrealized loss position, the Company first determines intent to sell or likelihood of being required to sell before maturity or recovery of cost basis. |
|||
* If intent to sell or likelihood of required sale exists, amortized cost is written down to fair value, with losses recognized in net investment gains on consolidated statements of operations. |
|||
* If neither criterion is met, the Company determines if unrealized losses are due to credit-related factors. |
|||
* If unrealized losses are credit-related, an allowance for credit losses is determined using present value of cash flows compared to amortized cost. |
|||
* The allowance for credit losses is limited to the amount by which fair value is below amortized cost. |
|||
* Changes in the allowance for credit losses are recognized in [[Definition:Net investment income|net investment income]] on the consolidated statements of operations. |
|||
* Credit losses limited by fair value are recognized in stockholders’ equity, net of taxes, as a component of accumulated other comprehensive loss. |
|||
* Unrealized losses not credit-related continue to be recognized in stockholders’ equity, net of taxes, as a component of accumulated other comprehensive loss. |
|||
{{chunk|doc=vycbjm4dw4|c=189|p=16}} |
|||
* ''Policy acquisition costs'' include commissions and premium taxes directly related to new or renewal business production <sup>p. 70</sup>. |
|||
'''Held-to-maturity investments accounting''' |
|||
* The Company defers policy acquisition costs and related ceding commissions <sup>p. 70</sup>. |
|||
* Deferred costs are charged or credited to earnings proportionally with the premium earned over the policy's life <sup>p. 70</sup>. |
|||
* A ''premium deficiency'' occurs if expected losses, loss adjustment expenses, and unamortized acquisition costs exceed related unearned premiums <sup>p. 70</sup>. |
|||
* To recognize a premium deficiency, unamortized acquisition costs are first charged to expense to eliminate the deficiency <sup>p. 70</sup>. |
|||
* If the premium deficiency exceeds unamortized acquisition costs, a liability is accrued for the excess <sup>p. 70</sup>. |
|||
* ''Anticipated investment income'' is considered when determining premium deficiencies <sup>p. 70</sup>. |
|||
* Management's analysis determined no premium deficiency existed as of December 31, 2024, and 2023 <sup>p. 70</sup>. |
|||
* Investments in fixed maturity securities held-to-maturity are carried at amortized cost net of an allowance for credit losses. |
|||
{{Indexing|I. Goodwill and Intangible Assets|Goodwill and intangible assets, business combination, purchase price allocation, identifiable intangible assets, indefinite-lived intangible assets, recoverability review, goodwill impairment|hekiequlv1|kind=prose|order=96}} |
|||
* The allowance for credit losses represents the current estimate of expected credit losses. |
|||
* The Company develops a historical loss rate from Moody’s multi-year cumulative loss rates for asset-backed securities. |
|||
* The historical loss rate is adjusted for current conditions and reasonable and supportable forecasts. |
|||
* Changes in the allowance for credit losses are recognized in [[Definition:Net investment income|net investment income]] on the consolidated statements of operations. |
|||
{{chunk|doc=vycbjm4dw4|c=190|p=16}} |
|||
* ''Goodwill and intangible assets'' are recorded following a business combination <sup>p. 71</sup>. |
|||
'''Equity securities accounting''' |
|||
* ''Goodwill'' represents the excess of the purchase price over the fair value of acquired assets and assumed liabilities <sup>p. 71</sup>. |
|||
* The Company reviews its ''purchase price allocation'' for up to one year after an acquisition, allowing for adjustments within that period <sup>p. 71</sup>. |
|||
* ''Identifiable intangible assets'' with a finite useful life are amortized over the period they are expected to contribute to future cash flows <sup>p. 71</sup>. |
|||
* ''Indefinite-lived intangible assets'' are not amortized <sup>p. 71</sup>. |
|||
* The Company annually reviews ''goodwill and identifiable intangible assets'' for recoverability in the fourth quarter, or on an interim basis if circumstances suggest a carrying amount may not be recoverable <sup>p. 71</sup>. |
|||
* No ''goodwill impairment'' was recorded for the years ended December 31, 2024, and 2023, based on the Company's review <sup>p. 71</sup>. |
|||
* Equity securities include common stock, preferred stock, and mutual funds (even those primarily investing in debt securities). |
|||
{{Indexing|J. Property and Equipment|Property and equipment, depreciation expense, depreciation periods|ie3cmfrol3|kind=prose|order=97}} |
|||
* Investments in equity securities with a readily determinable fair value are carried on the balance sheet at fair value using quoted market prices. |
|||
* Changes in the carrying value of equity securities are included in net investment (losses) gains within the consolidated statements of operations. |
|||
{{chunk|doc=vycbjm4dw4|c=191|p=16}} |
|||
* ''Property and equipment'' is recorded at cost less accumulated depreciation and is included in other assets on the consolidated balance sheets <sup>p. 72</sup>. |
|||
'''Mortgage loans accounting''' |
|||
* ''Depreciation expense'' is recognized on a straight-line basis for financial statement purposes <sup>p. 72</sup>. |
|||
* ''Depreciation periods'' range from three to seven years <sup>p. 72</sup>. |
|||
* Investments in mortgage loans are classified as held for investment and carried at cost adjusted for unamortized premiums, discounts, and loan fees. |
|||
{{Indexing|K. Leases|Right-of-use assets, lease liabilities, operating leases, sublease income|hvv0k9voso|ie3cmfrol3|kind=prose|order=98}} |
|||
* Uncollectible amounts are written off in the period they are determined to be uncollectible. |
|||
* Interest on loans is recognized as interest receivable and included in other assets on the consolidated balance sheet. |
|||
* The Company elected the fair value option for mortgage loans effective January 1, 2023, as transition relief from ASU 2016-13 adoption. |
|||
* Under the fair value option, mortgage loans are measured at fair value, and changes in unrealized gains and losses are reported in net investment (losses) gains on the consolidated statements of operations. |
|||
* Interest income and amortization continue to be recognized in [[Definition:Net investment income|net investment income]] on the consolidated statements of operations. |
|||
{{chunk|doc=vycbjm4dw4|c=192|p=16}} |
|||
* ''Right-of-use (ROU) assets'' are included in other assets on the consolidated balance sheets <sup>p. 73</sup>. |
|||
'''Equity method investments accounting''' |
|||
* ''Lease liabilities'' are included in accounts payable and accrued liabilities on the consolidated balance sheets <sup>p. 73</sup>. |
|||
* For operating leases, the Company determines if a contract contains a lease at inception <sup>p. 73</sup>. |
|||
* ''Operating lease ROU assets'' and lease liabilities are recognized based on the present value of future minimum lease payments at the commencement date <sup>p. 73</sup>. |
|||
* The Company uses its incremental borrowing rate to determine the present value of future payments, as it does not have the interest rate implicit in its leases <sup>p. 73</sup>. |
|||
* Lease agreements may include options to extend or terminate, which are exercised at the Company's discretion <sup>p. 73</sup>. |
|||
* Options are included in operating lease liabilities if it is reasonably certain they will be exercised <sup>p. 73</sup>. |
|||
* Lease agreements have lease and non-lease components, which are accounted for as a single lease component <sup>p. 73</sup>. |
|||
* ''Operating lease cost'' for future minimum lease payments is recognized on a straight-line basis over the lease term <sup>p. 73</sup>. |
|||
* ''Sublease income'' is recognized on a straight-line basis over the sublease term <sup>p. 73</sup>. |
|||
* Equity method investments include equity and equity securities of non-public entities and indirect investments in loans and loan collateral. |
|||
{{Indexing|L. Reserves for Losses and Loss Adjustment Expenses|Reserves for unpaid losses and loss adjustment expenses, actuarial procedures, loss severity, loss frequency, inflation|rmmhubj8mh|ie3cmfrol3|kind=prose|order=99}} |
|||
* The Company has equity investments in certain limited partnerships and corporations where it has significant influence but not control. |
|||
* The Company is not the primary beneficiary of variable interest entities and does not consolidate them. |
|||
* The equity method is used for investments in unconsolidated subsidiaries. |
|||
* Under the equity method, initial investment is recorded at cost and adjusted based on proportionate share of distributions and net income or loss of the investee. |
|||
* The difference between investment cost and proportionate share of underlying equity in net assets is a component of investment income. |
|||
* The Company amortizes this difference as an adjustment to its pro-rata share of equity method income over the useful life of the underlying asset. |
|||
* For equity securities of non-public entities where the Company lacks significant influence and a readily determinable fair value, investments are carried at cost, minus impairment, and adjusted for observable price changes in orderly transactions for identical or similar investments. |
|||
* Investments in indirect collateralized loans and loan collateral are held through and accounted for as an ownership interest in an unconsolidated subsidiary. |
|||
* Ownership interests in unconsolidated subsidiaries include investments in partnerships, joint ventures, and special purpose investment vehicles. |
|||
* The Company uses the equity method for these investments where it has significant influence but not control. |
|||
{{chunk|doc=vycbjm4dw4|c=193|p=16}} |
|||
* ''Reserves for unpaid losses and loss adjustment expenses (LAE)'' represent the estimated ultimate cost of all unreported and reported but unpaid insured claims and the cost to adjust incurred losses as of the balance sheet date <sup>p. 74</sup>. |
|||
'''Other long-term investments''' |
|||
* The Company estimates reserves using individual case-basis valuations of reported claims, statistical analyses, and various actuarial procedures <sup>p. 74</sup>. |
|||
* Estimates are based on historical information, industry and peer group information, and estimates of future trends in variable factors such as loss severity, loss frequency, and inflation <sup>p. 74</sup>. |
|||
* Estimates are regularly reviewed and adjusted as experience develops or new information becomes known <sup>p. 74</sup>. |
|||
* During the loss settlement period, estimates of liability on a claim may be refined and adjusted upward or downward <sup>p. 74</sup>. |
|||
* The ultimate liability may exceed or be less than the revised estimates, leading to potential significant variations from the estimate included in financial statements <sup>p. 74</sup>. |
|||
* If actual liabilities exceed recorded amounts, there will be an adverse effect <sup>p. 74</sup>. |
|||
* If recorded reserves are determined to be more than adequate, it would lead to a reduction in reserves <sup>p. 74</sup>. |
|||
* Other long-term investments consist of an investment in a limited partnership held at net asset value (NAV) and other long-term investment securities. |
|||
{{Indexing|M. Premiums|Property and casualty premiums, surety premiums, accident and health premiums, gross premiums written, ceded premiums, premiums receivable, allowance for credit losses, unearned premiums, ceded unearned premiums|wpkf9ycgxf|ie3cmfrol3|kind=prose|order=100}} |
|||
{{chunk|doc=vycbjm4dw4|c=194|p=16}} |
|||
* The Company recognizes property and casualty and surety premiums on a pro-rata basis over the policy terms <sup>p. 75</sup>. |
|||
'''Short-term investments''' |
|||
* Accident and health premiums are earned as billed, based on census data <sup>p. 75</sup>. |
|||
* ''Gross premiums written'' are reduced by ceded premiums from proportional, facultative, and excess of loss reinsurance costs for prospective reinsurance <sup>p. 75</sup>. |
|||
* ''Premiums receivable'' include deferred premiums, which are installment payments due from insureds under policy payment terms <sup>p. 75</sup>. |
|||
* ''Premiums receivable'' are carried net of an allowance for credit losses <sup>p. 75</sup>. |
|||
* The ''allowance for credit losses'' represents the current estimate of expected credit losses <sup>p. 75</sup>. |
|||
* The Company develops a ''historical loss rate'' using historical write-offs and aging of receivables <sup>p. 75</sup>. |
|||
* This ''historical loss rate'' is adjusted for current conditions, reasonable and supportable forecasts, and the ability to cancel coverage on a policy after premium is considered past due <sup>p. 75</sup>. |
|||
* ''Changes in the allowance for credit losses'' are recognized in underwriting, acquisition, and insurance expenses on the consolidated statements of operations <sup>p. 75</sup>. |
|||
* ''Unearned premiums'' represent the portion of gross premiums written applicable to the unexpired terms of in-force insurance policies or reinsurance contracts <sup>p. 75</sup>. |
|||
* ''Ceded unearned premiums'' represent the portion of ceded premiums written applicable to the unexpired terms of in-force insurance policies or reinsurance contracts <sup>p. 75</sup>. |
|||
* These ''unearned premiums'' are calculated on a pro-rata basis over the terms of the policies for both direct and ceded amounts <sup>p. 75</sup>. |
|||
* Short-term investments primarily consist of money market funds. |
|||
{{Indexing|N. Commission and Fee Income|SUA commission revenue, SUA fee income, transaction price, performance obligation|qfq1t7e6o0|ie3cmfrol3|kind=prose|order=101}} |
|||
* Short-term investments are carried at cost, which approximates fair value. |
|||
{{chunk|doc=vycbjm4dw4|c=195|p=16}} |
|||
* ''SUA commission revenue'' is generated from placing insurance policies on reinsurance programs via a reinsurance broker <sup>p. 76</sup>. |
|||
'''[[Definition:Net investment income|Net investment income]] and realized gains/losses''' |
|||
* The ''transaction price'' for SUA commission revenue is fixed at contract inception and based on a percentage of premiums placed <sup>p. 76</sup>. |
|||
* The Company recognizes 100% of the ''transaction price'' for SUA commission revenue when the performance obligation is satisfied at the point of policy placement, as there are no revenue constraints <sup>p. 76</sup>. |
|||
* ''SUA fee income'' is generated from placing insurance policies with a third-party insurance company <sup>p. 76</sup>. |
|||
* The ''single performance obligation'' for SUA fee income is the placement of the policy <sup>p. 76</sup>. |
|||
* The ''transaction price'' for SUA fee income is variable at contract inception and based on a percentage of premium, which varies monthly due to risk factors like employee census data and worker roles <sup>p. 76</sup>. |
|||
* The Company estimates its ''transaction price'' for SUA fee income over the policy's life using the expected value method and recognizes revenue at the point of policy placement <sup>p. 76</sup>. |
|||
* Changes in the ''estimate of variable consideration'' for SUA fee income are recognized in the month they occur <sup>p. 76</sup>. |
|||
* [[Definition:Net investment income|Net investment income]] consists of interest, [[Definition:Dividend|dividends]], and equity in earnings (losses) of unconsolidated subsidiaries, net of investment expenses. |
|||
{{Indexing|O. Income Taxes|Income tax expense, provision for income taxes, deferred tax assets and liabilities, valuation allowance, uncertain tax positions, consolidated federal income tax return, premium taxes|kmocop7wiu|ie3cmfrol3|kind=prose|order=102}} |
|||
* Interest income is recognized on an accrual basis. |
|||
* [[Definition:Dividend|Dividends]] are recognized as earned at the ex-dividend date. |
|||
* Interest income on mortgage-backed and other asset-backed securities is recognized using the effective-yield method based on estimated principal repayments. |
|||
* Amortization of premium and accretion of discounts on debt securities are included in interest income. |
|||
* Net realized gains and losses on investments are recognized in net income using the specific identification method. |
|||
=== F. Reinsurance === |
|||
* ''Income tax expense'' is accrued for tax effects of transactions reported on consolidated financial statements <sup>p. 77</sup>. |
|||
* ''Provision for income taxes'' includes currently due taxes plus deferred taxes from temporary differences between financial statement and income tax reporting <sup>p. 77</sup>. |
|||
* ''Valuation allowance'' is established for any deferred tax asset not expected to be realized <sup>p. 77</sup>. |
|||
* ''Deferred tax assets and liabilities'' are measured using enacted tax rates expected to apply to taxable income in the years temporary differences are recovered or settled <sup>p. 77</sup>. |
|||
* ''Effect of tax rate changes'' on deferred tax assets and liabilities is recognized in income in the period of enactment <sup>p. 77</sup>. |
|||
* ''Liability for uncertain tax positions'' is recorded if it is more likely-than-not that the position will not be sustained upon examination <sup>p. 77</sup>. |
|||
* ''Changes in the liability for uncertain tax positions'' are reflected in income tax expense when a new position arises, judgment changes, the issue is settled, or the statute of limitation expires <sup>p. 77</sup>. |
|||
* ''Potential net interest income or expense and penalties'' related to uncertain tax positions are recorded on the Consolidated Statements of Operations <sup>p. 77</sup>. |
|||
* The Company files a ''consolidated federal income tax return'' in the United States and certain other state tax returns <sup>p. 77</sup>. |
|||
* Admitted insurance subsidiaries pay ''premium taxes'' on gross written premiums in lieu of most state income or franchise taxes <sup>p. 77</sup>. |
|||
* ''Premium tax expense'' is recognized within underwriting, acquisition, and insurance expense on the Consolidated Statements of Operations <sup>p. 77</sup>. |
|||
{{chunk|doc=vycbjm4dw4|c=196|p=16}} |
|||
{{Indexing|P. Fair Value of Financial Instruments|Fair value, financial instruments, fair value hierarchy, Level 1 measurements, Level 3 measurements|di0lc3m1jj|ie3cmfrol3|kind=prose|order=103}} |
|||
'''Reinsurance accounting principles''' |
|||
* The Company purchases prospective reinsurance for certain [[Definition:Business mix|lines of business]] on a proportional, excess of loss, and facultative basis. |
|||
* ''Fair value'' is estimated for each class of financial instrument using the framework from fair value accounting guidance <sup>p. 78</sup>. |
|||
* Proportional reinsurance requires sharing losses and expenses with the reinsurer in exchange for a share of premiums. |
|||
* The guidance requires maximizing observable inputs and minimizing unobservable inputs when measuring fair value <sup>p. 78</sup>. |
|||
* Excess of loss reinsurance shares losses, either proportionally or entirely, above a certain dollar threshold, for a negotiated cost. |
|||
* ''Fair value hierarchy disclosures'' are based on the quality of inputs used for measurement <sup>p. 78</sup>. |
|||
* Facultative reinsurance covers specific risks and/or policies on either a proportional or excess of loss basis. |
|||
* The hierarchy prioritizes unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) <sup>p. 78</sup>. |
|||
* Ceded unearned premium and reinsurance balances recoverable on paid and unpaid losses and settlement expenses are reported separately as assets. |
|||
* The hierarchy gives the lowest priority to unobservable inputs (Level 3 measurements) <sup>p. 78</sup>. |
|||
* Reinsurance does not relieve the Company of its legal liability to policyholders. |
|||
* The Company uses widely recognized, third-party pricing sources to determine the fair values of financial instruments <sup>p. 78</sup>. |
|||
* Reinsurance on unpaid losses and settlement expenses represents estimates of the portion of liabilities recoverable from reinsurers. |
|||
* The Company understands the valuation methodologies and inputs of these third-party pricing sources <sup>p. 78</sup>. |
|||
* On the Consolidated Statements of Operations, net earned premiums, losses and loss adjustment expenses, net, and underwriting, acquisition, and insurance expenses are presented net of reinsurance ceded. |
|||
* Further details on fair value disclosures are in Note 4 <sup>p. 78</sup>. |
|||
* The Company purchases retroactive reinsurance for certain [[Definition:Business mix|lines of business]] through loss portfolio transfers (LPT) and adverse development covers. |
|||
* Retroactive reinsurance contracts provide indemnification for losses related to past loss events, with the reinsurer sharing losses based on dollar thresholds. |
|||
* Income from retroactive reinsurance contracts is deferred and amortized into net income over the settlement period. |
|||
* Losses from retroactive reinsurance contracts are charged to net income immediately. |
|||
* Subsequent changes in the measurement of retroactive reinsurance contracts are accounted for using a full retrospective method. |
|||
{{chunk|doc=vycbjm4dw4|c=197|p=16}} |
|||
{{Indexing|Q. Stock-Based Compensation|Employee stock options, equity instrument awards, share-based payments, Employee Stock Purchase Plan (ESPP)|ie3cmfrol3|kind=prose|order=104}} |
|||
'''Deposit accounting for reinsurance''' |
|||
* Certain ceded reinsurance contracts that management determines do not transfer significant insurance risk are accounted for using the deposit method. |
|||
* The estimated fair value of employee stock options and similar awards is expensed <sup>p. 79</sup>. |
|||
* The evaluation of significant insurance risk transfer assesses both timing risk and underwriting risk. |
|||
* Compensation cost for equity instrument awards to employees is measured based on the grant-date fair value and recognized over the expected vesting service period <sup>p. 79</sup>. |
|||
* A reinsurance contract may not transfer significant insurance risk if either underwriting risk, timing risk, or both are not deemed transferred. |
|||
* Tax effects related to share-based payments are processed through net earnings <sup>p. 79</sup>. |
|||
* For contracts transferring only significant timing risk but not sufficient underwriting risk, a deposit asset is recorded equal to the initial cash outflow, offset by cash inflows from reinsurers. |
|||
* Further discussion and disclosures regarding stock-based compensation are provided in note 18 <sup>p. 79</sup>. |
|||
* If cash outflows are expected to differ from cash inflows, an accretion rate is established at inception based on actuarial estimates. |
|||
* The Company's Employee Stock Purchase Plan (ESPP) allows all employees to purchase common stock at a discount <sup>p. 79</sup>. |
|||
* The deposit accounting asset is increased/decreased to the estimated receivable amount over the contract term. |
|||
* Compensation cost for the ESPP is recognized on a straight-line basis over the offering period <sup>p. 79</sup>. |
|||
* Deposit accretion is based on the expected rate of return implied from estimated cash inflows and outflows. |
|||
* The Company periodically reassesses the estimated ultimate receivable and the related expected rate of return on the deposit asset. |
|||
* Accretion of the deposit asset, including changes from estimated cash flow changes, is reflected as part of investment income. |
|||
* Several reinsurance contracts require deposit accounting due to insufficient underwriting risk transfer. |
|||
* No reinsurance contracts required deposit accounting due to insufficient timing risk transfer. |
|||
{{chunk|doc=vycbjm4dw4|c=198|p=16}} |
|||
{{Indexing|R. Earnings Per Share|Basic earnings per share, undistributed earnings, participating securities, common shares, preferred shares, stock notes, contingently issuable instruments, share-based awards|v7ij6av24f|ie3cmfrol3|kind=prose|order=105}} |
|||
'''Reinsurance recoverables and credit risk''' |
|||
* Reinsurance recoverables are carried net of an allowance for credit losses. |
|||
* ''Basic earnings per share'' is calculated using the two-class method <sup>p. 80</sup>. |
|||
* The allowance for credit losses represents the current estimate of expected credit losses. |
|||
* ''Undistributed earnings'' are allocated to participating securities based on their potential share in earnings as if all earnings for the period were distributed <sup>p. 80</sup>. |
|||
* The Company develops a historical loss rate using the A.M. Best impairment rate and rating transition study, which provides historical loss data for similarly rated reinsurance companies based on expected receivable duration. |
|||
* ''Basic earnings per share'' is calculated by dividing net income attributable to common stockholders by the weighted-average number of common shares outstanding for the period <sup>p. 80</sup>. |
|||
* The historical loss rate is adjusted for current conditions, reasonable and supportable forecasts, and current economic conditions. |
|||
* ''Common shares'' with unsatisfied contingencies, such as vesting requirements, are excluded from basic earnings per share <sup>p. 80</sup>. |
|||
* Changes in the allowance for credit losses are recognized in underwriting, acquisition, and insurance expenses on the consolidated statements of operations. |
|||
* The ''Company’s preferred shares'' are considered participating securities as they participate in dividends and distributions with common stock on an as-converted basis <sup>p. 80</sup>. |
|||
* Reinsurance does not relieve the Company of its legal liability to policyholders. |
|||
* ''Instruments awarded to employees'' that grant the right to purchase common stock at a fixed price are included as potential common shares, weighted for the portion of the period they were granted, if dilutive <sup>p. 80</sup>. |
|||
* The Company continuously monitors the financial condition of its reinsurers, including reviewing annual financial statements and insurance industry developments. |
|||
* ''Common and preferred shares financed by stock notes'' are contingently issuable instruments, excluded from basic and diluted earnings per share if specified conditions are not met, assuming the end of the period is the end of the contingency period <sup>p. 80</sup>. |
|||
* The Company analyzes credit risk of reinsurance recoverables by monitoring reinsurers' financial strength ratings from A.M. Best. |
|||
* The ''impact of contingently issuable instruments'' on diluted earnings per share for the year ended December 31, 2023, was calculated using the treasury stock method and included in the reconciliation of the denominator <sup>p. 80</sup>. |
|||
* The Company assesses the adequacy of collateral obtained where applicable. |
|||
* ''All outstanding stock notes'' were settled during 2024, resulting in no impact on the Company’s basic and diluted earnings per share computations for the year ended December 31, 2024 <sup>p. 80</sup>. |
|||
* If reinsurers fail to fulfill obligations, the Company has access to collateral. |
|||
* ''Instruments convertible into common shares'' are included in diluted weighted-average common shares outstanding on an if-converted basis, using the legal conversion rate for the respective period, if dilutive <sup>p. 80</sup>. |
|||
* Reinsurance collateral from reinsurers was USD 337.0m as of December 31, 2024, and USD 257.5m as of December 31, 2023. |
|||
* ''Share-based awards to employees'' with only service conditions are included as potential common shares, weighted for the unvested portion of the period, if dilutive <sup>p. 80</sup>. |
|||
* Reinsurance recoverables present potential exposures to individual reinsurers. |
|||
* ''Share-based awards to employees'' with performance and service or market conditions are included as potential common shares, assuming the end of the period is the end of the contingency period, if dilutive <sup>p. 80</sup>. |
|||
* Everest Reinsurance Co. represented 18.0% of reinsurance recoverable balances at December 31, 2024, and 20.4% at December 31, 2023. |
|||
* When ''common share adjustments'' increase earnings per share or reduce loss per share, the effect is anti-dilutive, and diluted net earnings or net loss per share is computed excluding these common share equivalents <sup>p. 80</sup>. |
|||
* eMaxx Captives represented 16.8% of reinsurance recoverable balances at December 31, 2024, and 20.4% at December 31, 2023. |
|||
* Everest Reinsurance Co. and eMaxx Captives were the only reinsurers representing 10% or more of the Company’s reinsurance recoverable balances. |
|||
* Everest Reinsurance Co.'s financial strength rating from A.M. Best was A+ at December 31, 2024, and 2023. |
|||
* eMaxx Captives was not rated by A.M. Best at December 31, 2024, and 2023. |
|||
=== G. Concentration of Credit Risk === |
|||
{{Indexing|S. Recent Accounting Pronouncements|ASU 2023-07, ASU 2023-09, ASU 2024-03, reportable segment disclosures, income tax disclosures, income statement expenses|ie3cmfrol3|kind=prose|order=106}} |
|||
{{chunk|doc=vycbjm4dw4|c=199|p=16}} |
|||
* In November 2023, the FASB issued ASU 2023-07, Improvements to Reportable Segment Disclosures (Topic 280) <sup>p. 81</sup>. |
|||
'''Credit risk concentration''' |
|||
* ''ASU 2023-07'' requires segment disclosures for significant segment expenses regularly provided to the chief operating decision maker ("CODM"), how the CODM uses reported measures of segment profitability, and the CODM's title and position <sup>p. 81</sup>. |
|||
* Entities with a single reportable segment are required to provide full segment disclosures under ASU 2023-07 <sup>p. 81</sup>. |
|||
* The guidance became effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024 <sup>p. 81</sup>. |
|||
* This update is applied retrospectively to all prior periods presented <sup>p. 81</sup>. |
|||
* The Company has added additional segment disclosures as required by ASU 2023-07, detailed in Note 12 <sup>p. 81</sup>. |
|||
* In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures (Topic 740) <sup>p. 81</sup>. |
|||
* ''ASU 2023-09'' requires public companies to provide enhanced rate reconciliation disclosures annually, including specific categories and additional information meeting a quantitative threshold <sup>p. 81</sup>. |
|||
* This update also requires public companies to disaggregate income taxes paid by federal, state, and foreign taxes <sup>p. 81</sup>. |
|||
* The guidance is effective for fiscal years beginning after December 15, 2024 <sup>p. 81</sup>. |
|||
* The Company is evaluating the effect of ASU 2023-09 and does not currently expect it to have a material impact on its consolidated financial statements <sup>p. 81</sup>. |
|||
* In November 2024, the FASB issued ASU 2024-03, requiring disaggregated disclosure of income statement expenses for public business entities ("PBEs") <sup>p. 81</sup>. |
|||
* ''ASU 2024-03'' does not change expense captions on the income statement but requires disaggregation of certain expense captions into specified categories in footnotes <sup>p. 81</sup>. |
|||
* The ASU requires a footnote disclosure in a tabular presentation for relevant income statement expense captions that include natural expenses such as: (1) purchases of inventory, (2) employee compensation, (3) depreciation, (4) intangible asset amortization, and (5) depreciation, depletion, and amortization recognized as part of oil- and gas-producing activities or other depletion expenses <sup>p. 81</sup>. |
|||
* The tabular disclosure will also include certain other expenses, when applicable <sup>p. 81</sup>. |
|||
* In January 2025, the FASB issued ASU 2025-01 to clarify the effective date of ASU 2024-03 <sup>p. 81</sup>. |
|||
* The ''effective date for ASU 2024-03'' is the first annual reporting period beginning after December 15, 2026, and interim reporting periods within annual reporting periods beginning after December 15, 2027 <sup>p. 81</sup>. |
|||
* The Company is evaluating the effect of the amendments of ASU 2024-03 on its consolidated financial statements <sup>p. 81</sup>. |
|||
* Financial instruments that could lead to credit risk concentrations include cash and cash equivalents, restricted cash, investments, and premiums receivable, in addition to reinsurance recoverables. |
|||
{{Indexing|2. Goodwill and Intangible Assets|Indefinite-lived intangible assets, finite-lived intangible assets, insurance licenses, trademarks, policy renewals, agency relationships, non-compete/exclusivity agreements, amortization expense|hekiequlv1|kind=prose|order=107}} |
|||
* Cash equivalents and short-term investments consist of U.S. government securities and money market funds. |
|||
* Investments are diversified across various industries and geographic regions. |
|||
* The Company limits credit exposure to any single financial institution or issuer. |
|||
* The Company believes there is no significant concentration of credit risk related to cash and investments. |
|||
* As of December 31, 2024 and 2023, outstanding premiums receivable are diversified due to the large number of customer entities and their spread across different [[Definition:Business mix|lines of business]] and geographic regions. |
|||
* Failure by distribution sources to remit premiums could lead to premium write-offs and a corresponding loss of income. |
|||
=== H. Deferred Policy Acquisition Costs === |
|||
* The Company's ''indefinite-lived intangible assets'' include insurance licenses and trademarks <sup>p. 82</sup>. |
|||
* The Company's ''finite-lived intangible assets'' relate to policy renewals, agency relationships, and non-compete/exclusivity agreements <sup>p. 82</sup>. |
|||
* Finite-lived intangible assets had a ''weighted average useful life'' of approximately 15 years as of December 31, 2024 <sup>p. 82</sup>. |
|||
* The Company recognized ''amortization expense'' of approximately USD 1.1m for the year ended December 31, 2024 <sup>p. 82</sup>. |
|||
* ''Amortization expense'' was USD 1.5m for the years ended December 31, 2023 and 2022 <sup>p. 82</sup>. |
|||
{{chunk|doc=vycbjm4dw4|c=200|p=16}} |
|||
{{Indexing|Goodwill by segment at December 31, 2024|Goodwill by segment, Accident and Health, Surety, Industry Solutions, Other|hekiequlv1|kind=table|order=108}} |
|||
'''Policy acquisition costs and premium deficiency''' |
|||
* Policy acquisition costs include commissions and premium taxes that vary with and are directly related to the production of new or renewal business. |
|||
* The Company defers policy acquisition costs and related ceding commissions, charging or crediting them to earnings proportionally with premium earned over the policy's life. |
|||
* A premium deficiency is recognized if expected losses, loss adjustment expenses, and unamortized acquisition costs exceed related unearned premiums. |
|||
* To recognize a premium deficiency, the Company first charges unamortized acquisition costs to expense to eliminate the deficiency. |
|||
* If the premium deficiency exceeds unamortized acquisition costs, a liability is accrued for the excess deficiency. |
|||
* Anticipated investment income is considered when determining premium deficiencies. |
|||
* Management determined no premium deficiency existed as of December 31, 2024 and 2023. |
|||
=== I. Goodwill and Intangible Assets === |
|||
{{chunk|doc=vycbjm4dw4|c=201|p=16}} |
|||
'''Goodwill and intangible assets accounting policy''' |
|||
* Goodwill and intangible assets are recorded following a business combination. |
|||
* Goodwill is the excess of the purchase price over the fair value of acquired assets and assumed liabilities. |
|||
* The Company reviews purchase price allocation for up to one year post-acquisition and may make adjustments within this period. |
|||
* Identifiable intangible assets with a finite useful life are amortized over the period they are expected to contribute to future cash flows. |
|||
* Indefinite-lived intangible assets are not amortized. |
|||
* Goodwill and identifiable intangible assets are reviewed for recoverability annually in the fourth quarter, or on an interim basis if circumstances indicate a carrying amount may not be recoverable. |
|||
* No goodwill impairment was recorded for the years ended December 31, 2024 and 2023. |
|||
=== J. Property and Equipment === |
|||
{{chunk|doc=vycbjm4dw4|c=202|p=16}} |
|||
'''Property and equipment accounting''' |
|||
* Property and equipment, included in other assets on the consolidated balance sheets, is recorded at cost less accumulated depreciation. |
|||
* Depreciation expense is recognized on a straight-line basis for financial statement purposes over periods ranging from three to seven years. |
|||
=== K. Leases === |
|||
{{chunk|doc=vycbjm4dw4|c=203|p=16}} |
|||
'''Lease accounting policies''' |
|||
* Right-of-use (ROU) assets are included in other assets on the consolidated balance sheets. |
|||
* Lease liabilities are included in accounts payable and accrued liabilities on the consolidated balance sheets. |
|||
* For operating leases, the Company determines if a contract contains a lease at inception. |
|||
* The Company recognizes operating lease ROU assets and lease liabilities based on the present value of future minimum lease payments at the commencement date. |
|||
* The Company uses its incremental borrowing rate, based on information available at the commencement date, to determine the present value of future payments, as it does not have the interest rate implicit in its leases. |
|||
* Lease agreements may include options to extend or terminate. |
|||
* Options are exercised at the Company's discretion and are included in operating lease liabilities if it is reasonably certain the option will be exercised. |
|||
* Lease agreements have lease and non-lease components, which are accounted for as a single lease component. |
|||
* Operating lease cost for future minimum lease payments is recognized on a straight-line basis over the lease term. |
|||
* Sublease income is recognized on a straight-line basis over the sublease term. |
|||
=== L. Reserves for Losses and Loss Adjustment Expenses === |
|||
{{chunk|doc=vycbjm4dw4|c=204|p=16}} |
|||
'''Reserves for losses and loss adjustment expenses''' |
|||
* Reserves for unpaid losses and loss adjustment expenses (LAE) represent the estimated ultimate cost of all unreported and reported but unpaid insured claims and the cost to adjust losses incurred as of the balance sheet date. |
|||
* Estimates for reserves are made using individual case-basis valuations of reported claims, statistical analyses, and various actuarial procedures. |
|||
* Estimates are based on historical information, industry and peer group information, and estimates of future trends in variable factors such as loss severity, loss frequency, and inflation. |
|||
* Estimates are regularly reviewed and adjusted as experience develops or new information becomes known. |
|||
* During the loss settlement period, estimates of liability on a claim may be refined and adjusted upward or downward. |
|||
* The ultimate liability may exceed or be less than the revised estimates, and the ultimate settlement of losses and related LAE may vary significantly from the estimate in financial statements. |
|||
* If actual liabilities exceed recorded amounts, there will be an adverse effect. |
|||
* If recorded reserves are determined to be more than adequate, it would lead to a reduction in reserves. |
|||
=== M. Premiums === |
|||
{{chunk|doc=vycbjm4dw4|c=205|p=16}} |
|||
'''Premium recognition and receivables''' |
|||
* The Company earns and recognizes [[Definition:Property & casualty|property and casualty]] and surety premiums on a pro-rata basis over the policy terms. |
|||
* Accident and health premiums are earned as billed, based on census data. |
|||
* [[Definition:Gross written premiums|Gross premiums written]] are reduced by ceded premiums from proportional, facultative, and excess of loss reinsurance costs for prospective reinsurance. |
|||
* Premiums receivable include deferred premiums, which are installment payments due from insureds under their policy payment terms. |
|||
* Premiums receivable are carried net of an allowance for credit losses, which represents the current estimate of expected credit losses. |
|||
* The Company develops a historical loss rate for credit losses using historical write-offs and aging of receivables. |
|||
* This historical loss rate is adjusted for current conditions, reasonable and supportable forecasts, and the ability to cancel coverage after a premium is past due. |
|||
* Changes in the allowance for credit losses are recognized in underwriting, acquisition, and insurance expenses on the consolidated statements of operations. |
|||
{{chunk|doc=vycbjm4dw4|c=206|p=16}} |
|||
'''Unearned premiums''' |
|||
* Unearned premiums represent the portion of [[Definition:Gross written premiums|gross premiums written]] applicable to the unexpired terms of insurance policies or reinsurance contracts in force. |
|||
* Ceded unearned premiums represent the portion of ceded premiums written applicable to the unexpired terms of insurance policies or reinsurance contracts in force. |
|||
* These unearned premiums are calculated on a pro-rata basis over the terms of the policies for both direct and ceded amounts. |
|||
=== N. Commission and Fee Income === |
|||
{{chunk|doc=vycbjm4dw4|c=207|p=16}} |
|||
'''SUA commission revenue''' |
|||
* SUA commission revenue is generated from placing insurance policies on reinsurance programs via a reinsurance broker. |
|||
* The Company's single performance obligation for SUA commission revenue is the placement of insurance policies. |
|||
* The transaction price for SUA commission revenue is fixed at contract inception and based on a percentage of premiums placed. |
|||
* The Company recognizes 100% of the transaction price as revenue when the performance obligation is satisfied at the point a policy is placed, as there are no constraints on revenue. |
|||
{{chunk|doc=vycbjm4dw4|c=208|p=16}} |
|||
'''SUA fee income''' |
|||
* SUA fee income is generated from placing insurance policies with a third-party insurance company. |
|||
* The Company's single performance obligation for SUA fee income is the placement of the policy. |
|||
* The transaction price for SUA fee income is variable at contract inception and based on a percentage of premium, which is determined by risk factors that vary monthly (e.g., employee census data, worker roles). |
|||
* The Company estimates its transaction price over the life of the policy using the expected value method. |
|||
* Revenue from SUA fee income is recognized at the point the policy is placed. |
|||
* Changes in the estimate of variable consideration for SUA fee income are recognized in the month they occur. |
|||
=== O. Income Taxes === |
|||
{{chunk|doc=vycbjm4dw4|c=209|p=16}} |
|||
'''Income tax accounting principles''' |
|||
* Income tax expense is accrued for tax effects of transactions reported on consolidated financial statements. |
|||
* Provision for income taxes includes currently due taxes plus deferred taxes from temporary differences between financial statement and income tax purposes. |
|||
* A valuation allowance is established for any deferred tax asset not expected to be realized. |
|||
* Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years temporary differences are expected to be recovered or settled. |
|||
* The effect on deferred tax assets and liabilities from a change in tax rates is recognized in income in the period that includes the enactment date. |
|||
* A liability for uncertain tax positions is recorded if it is more likely-than-not that the tax position will not be sustained upon examination by the appropriate tax authority. |
|||
* Changes in the liability for uncertain tax positions are reflected in income tax expense in the period when a new uncertain tax position arises, judgment changes about the likelihood of an uncertainty, the tax issue is settled, or the statute of limitation expires. |
|||
* Any potential net interest income or expense and penalties related to uncertain tax positions are recorded on the Consolidated Statements of Operations. |
|||
{{chunk|doc=vycbjm4dw4|c=210|p=16}} |
|||
'''Tax filings and premium taxes''' |
|||
* The Company files a consolidated federal income tax return in the United States and certain other state tax returns. |
|||
* Admitted insurance subsidiaries pay premium taxes on [[Definition:Gross written premiums|gross written premiums]] in lieu of most state income or franchise taxes. |
|||
* Premium tax expense is recognized within underwriting, acquisition and insurance expense on the Consolidated Statements of Operations. |
|||
=== P. Fair Value of Financial Instruments === |
|||
{{chunk|doc=vycbjm4dw4|c=211|p=16}} |
|||
'''Fair Value Measurement Framework''' |
|||
* Fair value for each class of financial instrument is estimated based on the framework in fair value accounting guidance. |
|||
* The guidance prioritizes observable inputs and minimizes unobservable inputs for fair value measurement. |
|||
* Fair value hierarchy disclosures are based on the quality of inputs used. |
|||
* The hierarchy gives highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements). |
|||
* The hierarchy gives lowest priority to unobservable inputs (Level 3 measurements). |
|||
* The Company uses widely recognized, third-party pricing sources to determine fair values of financial instruments. |
|||
* The Company understands the valuation methodologies and inputs of these third-party pricing sources. |
|||
* Further details regarding fair value disclosures are in Note 4. |
|||
=== Q. Stock-Based Compensation === |
|||
{{chunk|doc=vycbjm4dw4|c=212|p=16}} |
|||
'''Stock-based compensation accounting''' |
|||
* Estimated fair value of employee stock options and similar awards are expensed. |
|||
* Compensation cost for equity instrument awards to employees is measured based on grant-date fair value. |
|||
* Compensation expense is recognized over the service period during which awards are expected to vest. |
|||
* Tax effects related to share-based payments are made through net earnings. |
|||
* Further discussion and disclosures regarding stock-based compensation are in note 18. |
|||
{{chunk|doc=vycbjm4dw4|c=213|p=16}} |
|||
'''Employee Stock Purchase Plan (ESPP)''' |
|||
* The Company's employee stock purchase plan ("ESPP") allows all employees to purchase common stock at a discount. |
|||
* Compensation cost for the ESPP is recognized on a straight-line basis over the offering period. |
|||
=== R. Earnings Per Share === |
|||
{{chunk|doc=vycbjm4dw4|c=214|p=16}} |
|||
'''Basic EPS calculation methodology''' |
|||
* Basic earnings per share (EPS) is calculated using the two-class method. |
|||
* Undistributed earnings are allocated to participating securities based on their potential share in earnings, assuming all earnings for the period have been distributed. |
|||
* Basic EPS is calculated by dividing net income attributable to common stockholders by the weighted-average number of common shares outstanding for the period. |
|||
* Common shares with unsatisfied contingencies, such as vesting requirements, are excluded from basic EPS. |
|||
* The Company's preferred shares participate in [[Definition:Dividend|dividends]] and distributions with common stock on an as-converted basis and are considered a participating security. |
|||
* Instruments awarded to employees that grant the right to purchase common stock at a fixed price were included as potential common shares, weighted for the portion of the period they were granted, if dilutive. |
|||
* Common and preferred shares financed by stock notes are contingently issuable instruments, requiring the holder to return shares if stock notes are not paid off. |
|||
* These contingently issuable instruments are excluded from basic and diluted EPS if specified conditions are not met, presuming the end of the period is the end of the contingency period. |
|||
* The impact of contingently issuable instruments on diluted EPS was calculated using the treasury stock method and included in the reconciliation of the denominator for basic and diluted EPS computations for the year ended December 31, 2023. |
|||
* All outstanding stock notes were settled during 2024, resulting in no impact on the Company's basic and diluted EPS computations for the year ended December 31, 2024. |
|||
{{chunk|doc=vycbjm4dw4|c=215|p=16}} |
|||
'''Diluted EPS calculation methodology''' |
|||
* Instruments convertible into common shares are included in diluted weighted-average common shares outstanding on an if-converted basis, using the legal conversion rate for the respective period, if dilutive. |
|||
* Share-based awards to employees with only service conditions are included as potential common shares, weighted for the unvested portion of the period, if dilutive. |
|||
* Share-based awards to employees with performance and service or market conditions are included as potential common shares, presuming the end of the period is the end of the contingency period, if dilutive. |
|||
* If common share adjustments increase EPS or reduce loss per share, the effect is anti-dilutive, and diluted net earnings or net loss per share is computed excluding these common share equivalents. |
|||
=== S. Recent Accounting Pronouncements === |
|||
{{chunk|doc=vycbjm4dw4|c=216|p=16}} |
|||
'''Recent accounting standards adopted''' |
|||
* In November 2023, the FASB issued ASU 2023-07, Improvements to Reportable Segment Disclosures (Topic 280). |
|||
* ASU 2023-07 requires segment disclosures for: |
|||
** significant segment expenses regularly provided to the chief operating decision maker (“CODM”). |
|||
** how the CODM uses reported measure(s) of segment profitability in assessing segment performance and resource allocation. |
|||
** the title and position of the CODM. |
|||
* Entities with a single reportable segment must provide full segment disclosures. |
|||
* The guidance became effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. |
|||
* This update is applied retrospectively to all prior periods presented. |
|||
* The Company has added additional segment disclosures as required by ASU 2023-07, detailed in Note 12. |
|||
{{chunk|doc=vycbjm4dw4|c=217|p=16}} |
|||
'''Recent accounting standards not yet adopted''' |
|||
* In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures (Topic 740). |
|||
* ASU 2023-09 requires public companies to provide enhanced rate reconciliation disclosures annually, including specific categories and additional information meeting a quantitative threshold. |
|||
* This update also requires public companies to disaggregate income taxes paid by federal, state, and foreign taxes. |
|||
* The guidance is effective for fiscal years beginning after December 15, 2024. |
|||
* The Company is evaluating the effect of ASU 2023-09 and currently does not expect a material impact on its consolidated financial statements. |
|||
* In November 2024, the FASB issued ASU 2024-03, requiring disaggregated disclosure of income statement expenses for public business entities (“PBEs”). |
|||
* ASU 2024-03 does not change expense captions on the income statement but requires disaggregation of certain expense captions into specified categories in footnotes. |
|||
* ASU 2024-03 requires a footnote disclosure about specific expenses by requiring PBEs to disaggregate, in a tabular presentation, each relevant income statement expense caption that includes any of the following natural expenses: |
|||
** purchases of inventory. |
|||
** employee compensation. |
|||
** depreciation. |
|||
** intangible asset amortization. |
|||
** depreciation, depletion, and amortization recognized as part of oil- and gas-producing activities or other types of depletion expenses. |
|||
* The tabular disclosure will also include certain other expenses, when applicable. |
|||
* In January 2025, the FASB issued ASU 2025-01 to clarify the effective date of ASU 2024-03 as the first annual reporting period beginning after December 15, [[Definition:Year 2026|2026]], and interim reporting periods within annual reporting periods beginning after December 15, 2027. |
|||
* The Company is evaluating the effect of the amendments on its consolidated financial statements. |
|||
=== 2. Goodwill and Intangible Assets === |
|||
{{chunk|doc=vycbjm4dw4|c=218|p=16}} |
|||
'''Goodwill and intangible assets overview''' |
|||
* The tables present the carrying amount and changes in the balance of goodwill by reporting unit at December 31, 2024 and 2023. |
|||
* The tables present the carrying amount and changes in the balance of other intangible assets at December 31, 2024 and 2023. |
|||
* The Company's indefinite-lived intangible assets include insurance licenses and trademarks. |
|||
* The Company's finite-lived intangible assets, including policy renewals, agency relationships (within agent relationships), and non-compete/exclusivity agreements (within non-competes), had a weighted average useful life of approximately 15 years as of December 31, 2024. |
|||
{{chunk|doc=vycbjm4dw4|c=219|p=16}} |
|||
'''Intangible assets amortization expense''' |
|||
* The Company recognized approximately USD 1.1m in amortization expense for the year ended December 31, 2024. |
|||
* The Company recognized approximately USD 1.5m in amortization expense for the years ended December 31, 2023 and 2022. |
|||
* A table sets forth the estimated future net amortization expense of intangible assets. |
|||
{{chunk|doc=vycbjm4dw4|c=220|p=16}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1032" class="wikitable fintable" |
||
|+ Goodwill net balance by segment |
|||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Accident and Health |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Surety |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Industry Solutions |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Other |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Total |
||
|- |
|- |
||
! style="text-align:left" | Goodwill |
! style="text-align:left" | Goodwill |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | Gross balance at December 31, 2023 |
| style="text-align:left" | Gross balance at December 31, 2023 |
||
| Line 3,796: | Line 4,736: | ||
| style="text-align:right" | ( 46,707 ) |
| style="text-align:right" | ( 46,707 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net balance at December 31, 2024</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>46,756</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>6,781</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>10,204</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>1,993</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>65,734</b> |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Goodwill by segment at December 31, 2023|Goodwill by segment, Accident and Health, Surety, Industry Solutions, Other|hekiequlv1|kind=table|order=109}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1033" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Accident and Health |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Surety |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Industry Solutions |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Other |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Total |
||
|- |
|- |
||
! style="text-align:left" | Goodwill |
! style="text-align:left" | Goodwill |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | Gross balance at December 31, 2022 |
| style="text-align:left" | Gross balance at December 31, 2022 |
||
| Line 3,837: | Line 4,776: | ||
| style="text-align:right" | ( 46,707 ) |
| style="text-align:right" | ( 46,707 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net balance at December 31, 2023</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>46,756</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>6,781</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>10,204</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>1,993</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>65,734</b> |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Other intangible assets at December 31, 2024|Other intangible assets, Agent Relationships, Non-competes, Trademarks, Licenses|hekiequlv1|kind=table|order=110}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1034" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Agent Relationships |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Non-competes |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Trademarks |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Licenses |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Total |
||
|- |
|- |
||
! style="text-align:left" | Other Intangible Assets |
! style="text-align:left" | Other Intangible Assets |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | Gross balance at December 31, 2023 |
| style="text-align:left" | Gross balance at December 31, 2023 |
||
| Line 3,885: | Line 4,823: | ||
| style="text-align:right" | ( 1,087 ) |
| style="text-align:right" | ( 1,087 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net balance at December 31, 2024</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>6,596</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>—</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>999</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>14,019</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>21,614</b> |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Other intangible assets at December 31, 2023|Other intangible assets, Agent Relationships, Non-competes, Trademarks, Licenses|hekiequlv1|kind=table|order=111}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1035" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Agent Relationships |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Non-competes |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Trademarks |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Licenses |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Total |
||
|- |
|- |
||
! style="text-align:left" | Other Intangible Assets |
! style="text-align:left" | Other Intangible Assets |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | Gross balance at December 31, 2022 |
| style="text-align:left" | Gross balance at December 31, 2022 |
||
| Line 3,940: | Line 4,877: | ||
| style="text-align:right" | ( 1,485 ) |
| style="text-align:right" | ( 1,485 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net balance at December 31, 2023</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>7,683</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>—</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>999</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>14,019</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>22,701</b> |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Future amortization expense|Future amortization expense|hekiequlv1|kind=table|order=112}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1036" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-s" style="text-align:right" | |
||
|- |
|- |
||
! style="text-align:left" | Years Ending December 31, |
! style="text-align:left" | Years Ending December 31, |
||
| Line 3,962: | Line 4,898: | ||
| style="text-align:right" | 1,016 |
| style="text-align:right" | 1,016 |
||
|- |
|- |
||
| style="text-align:left" | 2026 |
| style="text-align:left" | [[Definition:Year 2026|2026]] |
||
| style="text-align:right" | 553 |
| style="text-align:right" | 553 |
||
|- |
|- |
||
| Line 3,976: | Line 4,912: | ||
</div> |
</div> |
||
=== 3. Investments === |
|||
{{Indexing|3. Investments|Fixed maturity securities, asset-backed securities, U.S. government agencies mortgage-backed fixed maturity securities, FHLB Loan, Advances and Security Agreement, pledged assets, residential mortgage-backed securities, short-term investments, cash and cash equivalents, available-for-sale fixed maturity securities, unrealized loss position, credit impairment|966xer0dpm|kind=prose|order=113}} |
|||
{{chunk|doc=vycbjm4dw4|c=221|p=16}} |
|||
* ''Expected maturities'' may differ from contractual maturities due to borrowers' rights to call or prepay obligations, and portfolio sales may occur prior to maturity due to changing interest rates, tax considerations, or other factors <sup>p. 83</sup>. |
|||
'''Investment portfolio fair value and amortized cost''' |
|||
* ''Fixed maturity securities, held-to-maturity'', at December 31, 2024, consisted entirely of asset-backed securities without a single maturity date <sup>p. 83</sup>. |
|||
* At December 31, 2024, the Company had ''U.S. government agencies mortgage-backed fixed maturity securities'' with a carrying value of approximately USD 66.2 million pledged as collateral for a loan (the "FHLB Loan") from the Federal Home Loan Bank of Dallas ("FHLB") <sup>p. 83</sup>. |
|||
* The Company retains all rights regarding the pledged securities under the ''Advances and Security Agreement'' with FHLB <sup>p. 83</sup>. |
|||
* At December 31, 2024, the Company had ''assets with fair values'' of approximately USD 28.0 million pledged as collateral for performance obligations under reinsurance agreements <sup>p. 83</sup>. |
|||
* The pledged assets for reinsurance agreements include ''residential mortgage-backed securities'' of USD 24.3 million, ''short-term investments'' of USD 2.2 million, and ''cash and cash equivalents and other assets'' of USD 1.5 million <sup>p. 83</sup>. |
|||
* The Company monitors its ''available-for-sale fixed maturity securities'' with fair values less than cost or amortized cost for impairment, which requires significant management judgment <sup>p. 83</sup>. |
|||
* As of December 31, 2024, the Company had ''778 lots of fixed maturity securities'' in an unrealized loss position <sup>p. 83</sup>. |
|||
* The Company does not intend to sell these securities and is not likely to be required to sell them before maturity or recovery of cost basis <sup>p. 83</sup>. |
|||
* The Company reviewed its investments at December 31, 2024, and determined ''no credit impairment'' existed in the gross unrealized holding losses <sup>p. 83</sup>. |
|||
* For ''U.S. government securities and municipal securities'', the decline in fair values was due to changes in interest rates, not credit quality, and the Company does not intend to sell them <sup>p. 83</sup>. |
|||
* For ''corporate securities and miscellaneous'', the decline in fair values was due to changes in interest rates, not credit quality, after reviewing issuers for adverse changes in financial condition, credit enhancement quality, ratings, or payment failures <sup>p. 83</sup>. |
|||
* For ''residential mortgage-backed securities, commercial mortgage-backed securities, and other asset-backed securities'', the decline in fair values was due to changes in interest rates, not credit quality, and the Company does not intend to sell them <sup>p. 83</sup>. |
|||
* At December 31, 2024 and 2023, ''cash and investment securities on deposit'' with states had carrying values of approximately USD 66.8 million and USD 65.3 million, respectively <sup>p. 83</sup>. |
|||
* Tables set forth amortized cost and fair value by investment category at December 31, 2024 and December 31, 2023. |
|||
{{Indexing|Fixed maturity securities at December 31, 2024|Fixed maturity securities, U.S. government securities, corporate securities, municipal securities, residential mortgage-backed securities, commercial mortgage-backed securities|966xer0dpm|kind=table|order=114}} |
|||
* Amortized cost and estimated fair value of fixed maturity securities, available for sale, at December 31, 2024 are shown by contractual maturity. |
|||
* Expected maturities may differ from contractual maturities due to borrower call/prepayment rights or portfolio sales prior to maturity driven by interest rates, tax considerations, or other factors. |
|||
* Fixed maturity securities, held-to-maturity, at December 31, 2024 consisted entirely of asset-backed securities not due at a single maturity date. |
|||
{{chunk|doc=vycbjm4dw4|c=222|p=16}} |
|||
'''Pledged assets''' |
|||
* At December 31, 2024, the Company had U.S. government agencies mortgage-backed fixed maturity securities with a carrying value of approximately USD 66.2m pledged as collateral for a loan (the "FHLB Loan") from the Federal Home Loan Bank of Dallas ("FHLB"). |
|||
* The Company retains all rights regarding these pledged securities under the Advances and Security Agreement. |
|||
* At December 31, 2024, the Company had assets with fair values of approximately USD 28.0m pledged as collateral for performance obligations under reinsurance agreements. |
|||
* The Company retains all rights regarding these pledged securities under the trust agreements. |
|||
* Pledged assets for reinsurance agreements included USD 24.3m in residential mortgage-backed securities, USD 2.2m in short-term investments, and USD 1.5m in cash and cash equivalents and other assets. |
|||
{{chunk|doc=vycbjm4dw4|c=223|p=16}} |
|||
'''Unrealized losses and impairment assessment''' |
|||
* Tables set forth gross unrealized losses and corresponding fair values of investments, aggregated by length of time in a continuous unrealized loss position as of December 31, 2024 and 2023. |
|||
* The Company monitors available-for-sale fixed maturity securities with fair values less than cost or amortized cost for impairment, requiring significant management judgment. |
|||
* Judgments could change, potentially impacting reported amounts negatively. |
|||
* Factors considered for fixed maturity securities include issuer financial condition (receipt of scheduled principal and interest), and intent to sell (likelihood of being required to sell before recovery). |
|||
* As of December 31, 2024, the Company had 778 lots of fixed maturity securities in an unrealized loss position. |
|||
* The Company does not intend to sell these securities and is not likely to be required to sell them before maturity or recovery of cost basis. |
|||
* The Company reviewed investments at December 31, 2024, and determined no credit impairment existed in gross unrealized holding losses. |
|||
* For U.S. government and municipal securities, the decline in fair values was due to interest rate changes, not credit quality. |
|||
* The Company does not intend to sell these U.S. government and municipal securities and expects recovery, thus not considering them impaired. |
|||
* For corporate securities and miscellaneous, the decline in fair values was due to interest rate changes, not credit quality. |
|||
* The Company reviewed issuers for significant adverse changes in financial condition, credit enhancement quality, ratings decreases, negative outlooks, or payment failures. |
|||
* After review, the decline in fair values for corporate securities was attributed to interest rates, not credit quality. |
|||
* The Company does not intend to sell these corporate securities and expects recovery, thus not considering them impaired. |
|||
* For residential mortgage-backed, commercial mortgage-backed, and other asset-backed securities, the decline in fair values was due to interest rate changes, not credit quality. |
|||
* The Company does not intend to sell these mortgage-backed and asset-backed securities and expects recovery, thus not considering them impaired. |
|||
{{chunk|doc=vycbjm4dw4|c=224|p=16}} |
|||
'''Net investment gains (losses)''' |
|||
* A table sets forth the components of net investment gains (losses) for the years ended December 31, 2024, 2023, and 2022. |
|||
{{chunk|doc=vycbjm4dw4|c=225|p=16}} |
|||
'''Proceeds from sales of securities''' |
|||
* A table sets forth the proceeds from sales of available-for-sale fixed maturity securities and equity securities for the years ended December 31, 2024, 2023, and 2022. |
|||
{{chunk|doc=vycbjm4dw4|c=226|p=16}} |
|||
'''[[Definition:Net investment income|Net investment income]]''' |
|||
* A table sets forth the components of [[Definition:Net investment income|net investment income]] for the years ended December 31, 2024, 2023, and 2022. |
|||
{{chunk|doc=vycbjm4dw4|c=227|p=16}} |
|||
'''Net unrealized gains (losses)''' |
|||
* A table sets forth the change in net unrealized gains (losses) on the Company’s investment portfolio, net of deferred income taxes, included in other comprehensive loss for the years ended December 31, 2024, 2023, and 2022. |
|||
{{chunk|doc=vycbjm4dw4|c=228|p=16}} |
|||
'''Regulatory deposits''' |
|||
* Various state regulations require the Company to maintain cash, investment securities, or letters of credit on deposit with states in a depository account. |
|||
* At December 31, 2024, cash and investment securities on deposit had carrying values of approximately USD 66.8m. |
|||
* At December 31, 2023, cash and investment securities on deposit had carrying values of approximately USD 65.3m. |
|||
{{chunk|doc=vycbjm4dw4|c=229|p=16}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1037" class="wikitable fintable" |
||
|+ 3. Investments |
|||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Amortized Cost |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Gross Unrealized Gains |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Gross Unrealized Losses |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Allowance for Credit Losses |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Fair Value |
||
|- |
|- |
||
! style="text-align:left" | December 31, 2024 |
! style="text-align:left" | December 31, 2024 |
||
! style="text-align: |
! class="col-s" style="text-align:right" | |
||
! style="text-align: |
! class="col-s" style="text-align:right" | |
||
! style="text-align: |
! class="col-s" style="text-align:right" | |
||
! style="text-align: |
! class="col-s" style="text-align:right" | |
||
! style="text-align: |
! class="col-s" style="text-align:right" | |
||
|- |
|- |
||
! style="text-align:left" | Fixed maturity securities, available-for-sale: |
! style="text-align:left" | Fixed maturity securities, available-for-sale: |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | U.S. government securities |
| style="text-align:left" | U.S. government securities |
||
| Line 4,060: | Line 5,046: | ||
| style="text-align:right" | 292,191 |
| style="text-align:right" | 292,191 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total fixed maturity securities, available-for-sale |
||
| style="text-align:right" | |
| style="text-align:right" | 1,320,266 |
||
| style="text-align:right" | |
| style="text-align:right" | 10,636 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 38,684 ) |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | 1,292,218 |
||
|- |
|||
| style="text-align:left" | <b>Fixed maturity securities, held-to-maturity:</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Other asset-backed securities |
| style="text-align:left" | Other asset-backed securities |
||
| Line 4,074: | Line 5,067: | ||
| style="text-align:right" | 38,717 |
| style="text-align:right" | 38,717 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total fixed maturity securities, held-to-maturity |
||
| style="text-align:right" | |
| style="text-align:right" | 39,396 |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | ( 436 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 243 ) |
||
| style="text-align:right" | |
| style="text-align:right" | 38,717 |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Fixed maturity securities at December 31, 2023|Fixed maturity securities, U.S. government securities, corporate securities, municipal securities, residential mortgage-backed securities, commercial mortgage-backed securities|966xer0dpm|kind=table|order=115}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1038" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Amortized Cost |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Gross Unrealized Gains |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Gross Unrealized Loss |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Allowance for Credit Losses |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Fair Value |
||
|- |
|- |
||
! style="text-align:left" | December 31, 2023 |
! style="text-align:left" | December 31, 2023 |
||
! style="text-align: |
! class="col-s" style="text-align:right" | |
||
! style="text-align: |
! class="col-s" style="text-align:right" | |
||
! style="text-align: |
! class="col-s" style="text-align:right" | |
||
! style="text-align: |
! class="col-s" style="text-align:right" | |
||
! style="text-align: |
! class="col-s" style="text-align:right" | |
||
|- |
|- |
||
! style="text-align:left" | Fixed maturity securities, available-for-sale: |
! style="text-align:left" | Fixed maturity securities, available-for-sale: |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | U.S. government securities |
| style="text-align:left" | U.S. government securities |
||
| Line 4,150: | Line 5,142: | ||
| style="text-align:right" | 185,727 |
| style="text-align:right" | 185,727 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total fixed maturity securities, available-for-sale |
||
| style="text-align:right" | |
| style="text-align:right" | 1,047,713 |
||
| style="text-align:right" | |
| style="text-align:right" | 12,491 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 42,553 ) |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | 1,017,651 |
||
|- |
|||
| style="text-align:left" | <b>Fixed maturity securities, held-to-maturity:</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Other asset-backed securities |
| style="text-align:left" | Other asset-backed securities |
||
| Line 4,164: | Line 5,163: | ||
| style="text-align:right" | 41,017 |
| style="text-align:right" | 41,017 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total fixed maturity securities, held-to-maturity |
||
| style="text-align:right" | |
| style="text-align:right" | 43,315 |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | ( 1,969 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 329 ) |
||
| style="text-align:right" | |
| style="text-align:right" | 41,017 |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Maturity distribution of fixed maturity securities|Maturity distribution of fixed maturity securities, mortgage-backed securities, other asset-backed securities|966xer0dpm|kind=table|order=116}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1039" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col-s" style="text-align:right" | Amortized Cost |
! class="col-s" style="text-align:right" | Amortized Cost |
||
| Line 4,205: | Line 5,203: | ||
| style="text-align:right" | 292,191 |
| style="text-align:right" | 292,191 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total |
||
| style="text-align:right" | |
| style="text-align:right" | 1,320,266 |
||
| style="text-align:right" | |
| style="text-align:right" | 1,292,218 |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Fixed maturity securities by contractual maturity at December 31, 2024|Fixed maturity securities by contractual maturity, U.S. government securities, corporate securities, municipal securities|966xer0dpm|kind=table|order=117}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1040" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="2" style="text-align:center" | Less than 12 Months |
! colspan="2" style="text-align:center" | Less than 12 Months |
||
| Line 4,221: | Line 5,218: | ||
|- |
|- |
||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Fair Value |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Gross Unrealized Losses |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Fair Value |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Gross Unrealized Losses |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Fair Value |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Gross Unrealized Losses |
||
|- |
|- |
||
! style="text-align:left" | December 31, 2024 |
! style="text-align:left" | December 31, 2024 |
||
! style="text-align: |
! class="col-s" style="text-align:right" | |
||
! style="text-align: |
! class="col-s" style="text-align:right" | |
||
! style="text-align: |
! class="col-s" style="text-align:right" | |
||
! style="text-align: |
! class="col-s" style="text-align:right" | |
||
! style="text-align: |
! class="col-s" style="text-align:right" | |
||
! style="text-align: |
! class="col-s" style="text-align:right" | |
||
|- |
|- |
||
! style="text-align:left" | Fixed maturity securities, available-for-sale: |
! style="text-align:left" | Fixed maturity securities, available-for-sale: |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | U.S. government securities |
| style="text-align:left" | U.S. government securities |
||
| Line 4,292: | Line 5,289: | ||
| style="text-align:right" | ( 1,834 ) |
| style="text-align:right" | ( 1,834 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total fixed maturity securities, available-for-sale |
||
| style="text-align:right" | |
| style="text-align:right" | 480,693 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 7,353 ) |
||
| style="text-align:right" | |
| style="text-align:right" | 236,741 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 31,331 ) |
||
| style="text-align:right" | |
| style="text-align:right" | 717,434 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 38,684 ) |
||
|- |
|||
| style="text-align:left" | <b>Fixed maturity securities, held-to-maturity:</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Other asset-backed securities |
| style="text-align:left" | Other asset-backed securities |
||
| Line 4,308: | Line 5,313: | ||
| style="text-align:right" | ( 436 ) |
| style="text-align:right" | ( 436 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total fixed maturity securities, held-to-maturity: |
||
| style="text-align:right" | |
| style="text-align:right" | 2,144 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 2 ) |
||
| style="text-align:right" | |
| style="text-align:right" | 36,573 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 434 ) |
||
| style="text-align:right" | |
| style="text-align:right" | 38,717 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 436 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total |
||
| style="text-align:right" | |
| style="text-align:right" | 482,837 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 7,355 ) |
||
| style="text-align:right" | |
| style="text-align:right" | 273,314 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 31,765 ) |
||
| style="text-align:right" | |
| style="text-align:right" | 756,151 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 39,120 ) |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Fixed maturity securities by contractual maturity at December 31, 2023|Fixed maturity securities by contractual maturity, U.S. government securities, corporate securities, municipal securities|966xer0dpm|kind=table|order=118}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1041" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="2" style="text-align:center" | Less than 12 Months |
! colspan="2" style="text-align:center" | Less than 12 Months |
||
| Line 4,336: | Line 5,340: | ||
|- |
|- |
||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Fair Value |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Gross Unrealized Losses |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Fair Value |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Gross Unrealized Losses |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Fair Value |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Gross Unrealized Losses |
||
|- |
|- |
||
! style="text-align:left" | December 31, 2023 |
! style="text-align:left" | December 31, 2023 |
||
! style="text-align: |
! class="col-s" style="text-align:right" | |
||
! style="text-align: |
! class="col-s" style="text-align:right" | |
||
! style="text-align: |
! class="col-s" style="text-align:right" | |
||
! style="text-align: |
! class="col-s" style="text-align:right" | |
||
! style="text-align: |
! class="col-s" style="text-align:right" | |
||
! style="text-align: |
! class="col-s" style="text-align:right" | |
||
|- |
|- |
||
! style="text-align:left" | Fixed maturity securities, available-for-sale: |
! style="text-align:left" | Fixed maturity securities, available-for-sale: |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | U.S. government securities |
| style="text-align:left" | U.S. government securities |
||
| Line 4,407: | Line 5,411: | ||
| style="text-align:right" | ( 3,504 ) |
| style="text-align:right" | ( 3,504 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total fixed maturity securities, available-for-sale |
||
| style="text-align:right" | |
| style="text-align:right" | 121,362 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 1,667 ) |
||
| style="text-align:right" | |
| style="text-align:right" | 441,858 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 40,886 ) |
||
| style="text-align:right" | |
| style="text-align:right" | 563,220 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 42,553 ) |
||
|- |
|||
| style="text-align:left" | <b>Fixed maturity securities, held-to-maturity:</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Other asset-backed securities |
| style="text-align:left" | Other asset-backed securities |
||
| Line 4,423: | Line 5,435: | ||
| style="text-align:right" | ( 1,969 ) |
| style="text-align:right" | ( 1,969 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total fixed maturity securities, held-to-maturity: |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | 41,017 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 1,969 ) |
||
| style="text-align:right" | |
| style="text-align:right" | 41,017 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 1,969 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total |
||
| style="text-align:right" | |
| style="text-align:right" | 121,362 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 1,667 ) |
||
| style="text-align:right" | |
| style="text-align:right" | 482,875 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 42,855 ) |
||
| style="text-align:right" | |
| style="text-align:right" | 604,237 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 44,522 ) |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Net realized investment gains and losses|Net realized investment gains and losses, fixed maturity securities, equity securities, mortgage loans|jpoeftv18u|kind=table|order=119}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1042" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2024 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2023 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2022 |
||
|- |
|- |
||
! style="text-align:left" | Gross realized gains |
! style="text-align:left" | Gross realized gains |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | Fixed maturity securities, available-for sale |
| style="text-align:left" | Fixed maturity securities, available-for sale |
||
| Line 4,470: | Line 5,481: | ||
| style="text-align:right" | 36 |
| style="text-align:right" | 36 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total |
||
| style="text-align:right" | |
| style="text-align:right" | 10,851 |
||
| style="text-align:right" | |
| style="text-align:right" | 7,079 |
||
| style="text-align:right" | |
| style="text-align:right" | 4,214 |
||
|- |
|||
| style="text-align:left" | <b>Gross realized losses</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Fixed maturity securities, available-for sale |
| style="text-align:left" | Fixed maturity securities, available-for sale |
||
| Line 4,490: | Line 5,506: | ||
| style="text-align:right" | ( 76 ) |
| style="text-align:right" | ( 76 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total |
||
| style="text-align:right" | |
| style="text-align:right" | ( 12,516 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 7,137 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 4,861 ) |
||
|- |
|||
| style="text-align:left" | <b>Net unrealized gains (losses) on investments</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Equity securities |
| style="text-align:left" | Equity securities |
||
| Line 4,505: | Line 5,526: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net investment gains (losses)</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>6,256</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>11,072</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 15,705 )</b> |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Net unrealized investment gains and losses|Net unrealized investment gains and losses, fixed maturity securities, equity securities|jpoeftv18u|j8uunnd14x|kind=table|order=120}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1043" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col-s" style="text-align:right" | 2024 |
! class="col-s" style="text-align:right" | 2024 |
||
| Line 4,532: | Line 5,552: | ||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Net investment income|Fixed maturity securities, equity securities, mortgage loans, short-term investments, cash, investment expenses|kind=table|order=121}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1044" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2024 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2023 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2022 |
||
|- |
|- |
||
! style="text-align:left" | Income: |
! style="text-align:left" | Income: |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | Fixed maturity securities, available-for sale |
| style="text-align:left" | Fixed maturity securities, available-for sale |
||
| Line 4,587: | Line 5,606: | ||
| style="text-align:right" | ( 77 ) |
| style="text-align:right" | ( 77 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total investment income |
||
| style="text-align:right" | |
| style="text-align:right" | 87,599 |
||
| style="text-align:right" | |
| style="text-align:right" | 45,879 |
||
| style="text-align:right" | |
| style="text-align:right" | 44,484 |
||
|- |
|- |
||
| style="text-align:left" | Investment expenses |
| style="text-align:left" | Investment expenses |
||
| Line 4,597: | Line 5,616: | ||
| style="text-align:right" | ( 7,553 ) |
| style="text-align:right" | ( 7,553 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>[[Definition:Net investment income|Net investment income]]</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>80,686</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>40,322</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>36,931</b> |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Deferred income taxes|Fixed maturity securities, deferred income taxes|kind=table|order=122}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1045" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col-s" style="text-align:right" | 2024 |
! class="col-s" style="text-align:right" | 2024 |
||
| Line 4,623: | Line 5,641: | ||
| style="text-align:right" | 12,793 |
| style="text-align:right" | 12,793 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total |
||
| style="text-align:right" | |
| style="text-align:right" | 833 |
||
| style="text-align:right" | |
| style="text-align:right" | 20,532 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 48,125 ) |
||
|} |
|} |
||
</div> |
</div> |
||
=== 4. Fair Value Measurements === |
|||
{{Indexing|4. Fair Value Measurements|Fair value measurements, market approach, third-party investment managers, pricing vendors, three-level hierarchy, Level 1 inputs, Level 2 inputs, Level 3 inputs, U.S. government securities, mutual funds, common stock, preferred stocks, municipal securities, corporate securities, commercial mortgage-backed securities, residential mortgage-backed securities, other asset-backed securities|di0lc3m1jj|kind=prose|order=123}} |
|||
{{chunk|doc=vycbjm4dw4|c=230|p=16}} |
|||
* The Company's financial instruments include assets and liabilities carried at fair value, and those carried at cost or amortized cost but disclosed at fair value in consolidated financial statements <sup>p. 84</sup>. |
|||
'''Fair value measurement principles''' |
|||
* The market approach is generally applied to determine fair value, using prices and data from market transactions of identical or comparable assets and liabilities <sup>p. 84</sup>. |
|||
* Fair value of investments is determined primarily using data from third-party investment managers or pricing vendors <sup>p. 84</sup>. |
|||
* Periodic analyses are conducted on third-party prices to ensure they are reasonable estimates of fair value, including reviewing month-to-month price fluctuations and comparing pricing services' valuations <sup>p. 84</sup>. |
|||
* The Company classifies financial instruments into a three-level hierarchy <sup>p. 84</sup>. |
|||
* ''Level 1 inputs'' are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date <sup>p. 84</sup>. |
|||
* ''Level 2 inputs'' are observable inputs other than Level 1 quoted prices, corroborated with market data at the measurement date <sup>p. 84</sup>. |
|||
* ''Level 3 inputs'' are unobservable inputs reflecting management's best estimate of what market participants would use in pricing the asset or liability at the measurement date <sup>p. 84</sup>. |
|||
* ''U.S. government securities, mutual funds, and common stock'' use unadjusted quoted prices in an active exchange, representing Level 1 inputs <sup>p. 84</sup>. |
|||
* ''Preferred stocks, municipal securities, corporate securities, and miscellaneous'' use a pricing model with market-based inputs like trades in illiquid markets or active markets for similar securities, considering benchmark yields, issuer spreads, and security terms; these are Level 2 fair value inputs <sup>p. 84</sup>. |
|||
* ''Commercial mortgage-backed securities, residential mortgage-backed securities, and other asset-backed securities'' use a pricing model with market-based inputs such as dealer quotes, market spreads, and yield curves, evaluating individual tranches by determining cash flows using security terms, collateral performance, credit information, benchmark yields, and estimated prepayments; these are Level 2 fair value inputs <sup>p. 84</sup>. |
|||
* ''Fixed maturity securities, available for sale, and equity securities classified as Level 3'' include corporate securities and other asset-backed securities managed by an independent asset manager and priced by an independent provider <sup>p. 84</sup>. |
|||
* The independent provider estimates the value of Level 3 securities using the discount net present value of cash flows method with an unobservable discount rate <sup>p. 84</sup>. |
|||
* The ''discount rate spread'' for Level 3 securities represents the risk associated with future cash flows, including inflation, opportunity cost, and the time value of money <sup>p. 84</sup>. |
|||
* ''Mortgage loans'' have variable interest rates and are collateralized by real property <sup>p. 84</sup>. |
|||
* The fair value of mortgage loans is determined using the income approach with observable and unobservable (Level 3) inputs <sup>p. 84</sup>. |
|||
* The ''unobservable input'' for mortgage loans is the spread applied to a prime rate used to discount cash flows, representing the incremental cost of capital based on borrower's ability to pay and collateral value relative to loan balance, subject to judgment and uncertainty <sup>p. 84</sup>. |
|||
* ''Investment in RedBird Capital Partners'' is included in other long-term investments <sup>p. 84</sup>. |
|||
* This investment is a limited partnership that invests in Bishop Street Underwriters, LLC (MGA) <sup>p. 84</sup>. |
|||
* The ''fair value'' of the investment was USD 28.2 million at December 31, 2024, determined using the net asset value <sup>p. 84</sup>. |
|||
* The Company assesses the reasonableness of this fair value by reviewing audited financial statements <sup>p. 84</sup>. |
|||
* The ''unfunded commitment'' related to this investment was USD 24.4 million at December 31, 2024 <sup>p. 84</sup>. |
|||
* The Company may sell its interest in the investment with prior written notice and general partner approval <sup>p. 84</sup>. |
|||
* This investment is measured at fair value using the net asset value per share practical expedient and is not classified in the fair value hierarchy per Accounting Standard Codification 820-10 <sup>p. 84</sup>. |
|||
* Certain assets, including investments in indirect loans and loan collateral, equity method investments, and other invested assets, are measured at fair value on a nonrecurring basis only when impaired <sup>p. 84</sup>. |
|||
* The Company is required to disclose fair values of certain other financial instruments where estimation is practicable <sup>p. 84</sup>. |
|||
* Estimated fair value amounts are defined as the quoted market price of a financial instrument, determined using available market information and valuation methodologies <sup>p. 84</sup>. |
|||
* Considerable judgments are required for fair value estimates when quoted market prices are unavailable, meaning estimates may not indicate amounts realizable in a current market exchange <sup>p. 84</sup>. |
|||
* Different market assumptions or estimating methodologies can affect estimated fair value amounts <sup>p. 84</sup>. |
|||
* ''Fixed maturity securities, held-to-maturity'' consist of senior and junior notes with target rates of return <sup>p. 84</sup>. |
|||
* As of December 31, 2024, the fair value of held-to-maturity securities was determined using the income approach with unobservable (Level 3) inputs <sup>p. 84</sup>. |
|||
* ''Notes payable'' carrying value approximates estimated fair value because they accrue interest at current market rates plus a spread <sup>p. 84</sup>. |
|||
* The fair value of notes payable is determined using the income approach with observable (Level 2) inputs <sup>p. 84</sup>. |
|||
* ''Subordinated debt'' consists of Unsecured Subordinated Notes, due May 24, 2039, with a fixed interest rate <sup>p. 84</sup>. |
|||
* The fair value of subordinated debt is determined using the income approach with observable (Level 2) inputs <sup>p. 84</sup>. |
|||
* Other financial instruments qualify as insurance-related products and are specifically exempted from fair value disclosure requirements <sup>p. 84</sup>. |
|||
* The Company's financial instruments include assets and liabilities carried at fair value, and those carried at cost or amortized cost but disclosed at fair value. |
|||
{{Indexing|Fair value of subordinated debt at December 31, 2024|Fair value of subordinated debt|kind=table|order=124}} |
|||
* The market approach is generally applied to determine fair value, using prices and data from market transactions involving identical or comparable assets and liabilities. |
|||
* Fair value of investments is determined using data primarily from third-party investment managers or pricing vendors. |
|||
* Periodic analyses are performed on third-party prices to ensure they are reasonable estimates of fair value, including reviewing month-to-month fluctuations and comparing valuations from different pricing services for identical securities. |
|||
{{chunk|doc=vycbjm4dw4|c=231|p=16}} |
|||
'''Fair value hierarchy levels''' |
|||
* The Company classifies financial instruments into a three-level hierarchy. |
|||
* Level 1: Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date. |
|||
* Level 2: Inputs are other than quoted prices included in Level 1 that are observable for the asset or liability through corroboration with market data at the measurement date. |
|||
* Level 3: Unobservable inputs that reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. |
|||
{{chunk|doc=vycbjm4dw4|c=232|p=16}} |
|||
'''Fair value estimation methods by instrument type''' |
|||
* U.S. government securities, mutual funds, and common stock: Fair value is measured using unadjusted quoted prices for identical instruments in an active exchange, representing Level 1 inputs. |
|||
* Preferred stocks, municipal securities, corporate securities, and miscellaneous: A pricing model is used that utilizes market-based inputs such as trades in illiquid markets for specific securities or active markets for similar securities. |
|||
** The model considers benchmark yields, issuer spreads, security terms and conditions, and other market data, representing Level 2 fair value inputs. |
|||
* Commercial mortgage-backed securities, residential mortgage-backed securities, and other asset-backed securities: A pricing model is used that utilizes market-based inputs including dealer quotes, market spreads, and yield curves. |
|||
** Individual tranches may be evaluated by determining cash flows using security terms, collateral performance, credit information, benchmark yields, and estimated prepayments, representing Level 2 fair value inputs. |
|||
* Fixed maturity securities (available for sale) and equity securities classified as Level 3: These include corporate securities and other asset-backed securities managed by an independent asset manager and priced by an independent pricing provider. |
|||
** The provider estimates value using the discounted net present value of cash flows method with an unobservable discount rate. |
|||
** The discount rate spread represents the risk associated with future cash flows, including inflation, opportunity cost, and time value of money, representing Level 3 fair value inputs. |
|||
{{chunk|doc=vycbjm4dw4|c=233|p=16}} |
|||
'''Discount rate range for Level 3 fixed maturity and equity securities''' |
|||
* The range of the discount rate for Level 3 fixed maturity and equity securities is set forth as of December 31, 2024. |
|||
{{chunk|doc=vycbjm4dw4|c=234|p=16}} |
|||
'''Mortgage loans fair value estimation''' |
|||
* Mortgage loans have variable interest rates and are collateralized by real property. |
|||
* Fair value of mortgage loans is determined using the income approach with observable and unobservable (Level 3) inputs. |
|||
* The unobservable input is the spread applied to a prime rate for discounting cash flows. |
|||
* This spread represents the incremental cost of capital based on the borrower’s ability to make future payments and the collateral value relative to the loan balance, subject to judgment and uncertainty. |
|||
* The range and weighted average of the spread, weighted by relative fair value, are set forth as of December 31, 2024, and December 31, 2023. |
|||
{{chunk|doc=vycbjm4dw4|c=235|p=16}} |
|||
'''Investment in RedBird Capital Partners''' |
|||
* The Company holds an investment in a limited partnership with RedBird Capital Partners, which invests in Bishop Street Underwriters, LLC (MGA), included in other long-term investments. |
|||
* The investment had a fair value of USD 28.2m at December 31, 2024, determined using the net asset value. |
|||
* Procedures to assess reasonableness of fair value include obtaining and reviewing audited financial statements. |
|||
* The unfunded commitment related to this investment was USD 24.4m at December 31, 2024. |
|||
* The Company may sell its interest with appropriate prior written notice and general partner approval. |
|||
* This investment is measured at fair value using the net asset value per share practical expedient under Accounting Standard Codification 820-10 and is not classified in the fair value hierarchy. |
|||
{{chunk|doc=vycbjm4dw4|c=236|p=16}} |
|||
'''Fair value hierarchy tables''' |
|||
* Tables setting forth the Company’s investments within the fair value hierarchy are provided for December 31, 2024, and December 31, 2023. |
|||
* Tables setting forth changes in fair value of instruments carried at fair value with a Level 3 measurement are provided for the years ended December 31, 2024, and 2023. |
|||
{{chunk|doc=vycbjm4dw4|c=237|p=16}} |
|||
'''Nonrecurring fair value measurements and disclosures''' |
|||
* Certain assets, including investments in indirect loans and loan collateral, equity method investments, and other invested assets, are measured at fair value on a nonrecurring basis only when impaired. |
|||
* The Company is required to disclose fair values of other financial instruments where practicable to estimate fair value, in addition to those recorded at fair value in the consolidated balance sheets. |
|||
* Estimated fair value amounts, defined as the quoted market price, are determined using available market information and other valuation methodologies. |
|||
* Considerable judgment is required for fair value estimates when quoted market prices are unavailable, meaning estimates are not necessarily indicative of amounts realizable in a current market exchange. |
|||
* Different market assumptions or estimation methodologies may affect estimated fair value amounts. |
|||
* Methods and assumptions used for estimating fair value disclosures of other financial instruments are provided. |
|||
{{chunk|doc=vycbjm4dw4|c=238|p=16}} |
|||
'''Fair value estimation for other financial instruments''' |
|||
* Fixed maturity securities, held-to-maturity: Consist of senior and junior notes with target rates of return. |
|||
** As of December 31, 2024, fair value was determined using the income approach with unobservable (Level 3) inputs. |
|||
* Notes payable: Carrying value approximates estimated fair value because notes accrue interest at current market rates plus a spread. |
|||
** Fair value is determined using the income approach with observable (Level 2) inputs. |
|||
* Subordinated debt: Consists of Unsecured Subordinated Notes due May 24, 2039, with a fixed interest rate. |
|||
** Fair value is determined using the income approach with observable (Level 2) inputs. |
|||
{{chunk|doc=vycbjm4dw4|c=239|p=16}} |
|||
'''Carrying and fair values of debt''' |
|||
* A table sets forth the Company’s carrying and fair values of notes payable and subordinated debt as of December 31, 2024, and December 31, 2023. |
|||
* Other financial instruments qualify as insurance-related products and are specifically exempted from fair value disclosure requirements. |
|||
{{chunk|doc=vycbjm4dw4|c=240|p=16}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1046" class="wikitable fintable" |
||
|+ 4. Fair Value Measurements |
|||
! style="text-align:left" | — |
|||
|- |
|||
! style="text-align:left" | |
|||
! class="col-s" style="text-align:right" | December 31, 2024 |
! class="col-s" style="text-align:right" | December 31, 2024 |
||
|- |
|- |
||
| Line 4,686: | Line 5,753: | ||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Fair value of financial instruments|Fair value of financial instruments|kind=table|order=125}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1047" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | — |
|||
! style="text-align:left" | |
|||
! class="col-s" style="text-align:right" | December 31, 2024 |
! class="col-s" style="text-align:right" | December 31, 2024 |
||
! class="col-s" style="text-align:right" | December 31, 2023 |
! class="col-s" style="text-align:right" | December 31, 2023 |
||
| Line 4,708: | Line 5,774: | ||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Fair value hierarchy of financial instruments at December 31, 2024|Fair value hierarchy, fixed maturity securities, U.S. government securities, corporate securities, municipal securities, residential mortgage-backed securities, commercial mortgage-backed securities, other asset-backed securities|kind=table|order=126}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1048" class="wikitable fintable" |
||
|- |
|||
! colspan="5" style="text-align:center" | December 31, 2024 |
! colspan="5" style="text-align:center" | December 31, 2024 |
||
|- |
|- |
||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Level 1 |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Level 2 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Level 3 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Total |
||
|- |
|- |
||
! style="text-align:left" | Fixed maturity securities, available-for-sale: |
! style="text-align:left" | Fixed maturity securities, available-for-sale: |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | U.S. government securities |
| style="text-align:left" | U.S. government securities |
||
| Line 4,763: | Line 5,828: | ||
| style="text-align:right" | 292,191 |
| style="text-align:right" | 292,191 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total fixed maturity securities, available-for-sale |
||
| style="text-align:right" | |
| style="text-align:right" | 26,486 |
||
| style="text-align:right" | |
| style="text-align:right" | 1,187,812 |
||
| style="text-align:right" | |
| style="text-align:right" | 77,920 |
||
| style="text-align:right" | |
| style="text-align:right" | 1,292,218 |
||
|- |
|||
| style="text-align:left" | <b>Fixed maturity securities, held-to-maturity:</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Other asset-backed securities |
| style="text-align:left" | Other asset-backed securities |
||
| Line 4,775: | Line 5,846: | ||
| style="text-align:right" | 38,717 |
| style="text-align:right" | 38,717 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total fixed maturity securities, held-to-maturity |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | 38,717 |
||
| style="text-align:right" | |
| style="text-align:right" | 38,717 |
||
|- |
|||
| style="text-align:left" | <b>Equity securities:</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Common stocks |
| style="text-align:left" | Common stocks |
||
| Line 4,799: | Line 5,876: | ||
| style="text-align:right" | 40,839 |
| style="text-align:right" | 40,839 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total equity securities |
||
| style="text-align:right" | |
| style="text-align:right" | 105,090 |
||
| style="text-align:right" | |
| style="text-align:right" | 1,164 |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | 106,254 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Mortgage loans</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>—</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>—</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>26,490</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>26,490</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Short-term investments</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>274,929</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>—</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>—</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>274,929</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total |
||
| style="text-align:right" | |
| style="text-align:right" | 406,505 |
||
| style="text-align:right" | |
| style="text-align:right" | 1,188,976 |
||
| style="text-align:right" | |
| style="text-align:right" | 143,127 |
||
| style="text-align:right" | |
| style="text-align:right" | 1,738,608 |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Fixed maturity securities by type|Fixed maturity securities by type, U.S. government securities, corporate securities, municipal securities, residential mortgage-backed securities, commercial mortgage-backed securities, other asset-backed securities|kind=table|order=127}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1049" class="wikitable fintable" |
||
|- |
|||
! colspan="5" style="text-align:center" | December 31, 2023 |
! colspan="5" style="text-align:center" | December 31, 2023 |
||
|- |
|- |
||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Level 1 |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Level 2 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Level 3 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Total |
||
|- |
|- |
||
! style="text-align:left" | Fixed maturity securities, available-for-sale: |
! style="text-align:left" | Fixed maturity securities, available-for-sale: |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | U.S. government securities |
| style="text-align:left" | U.S. government securities |
||
| Line 4,879: | Line 5,955: | ||
| style="text-align:right" | 185,727 |
| style="text-align:right" | 185,727 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total fixed maturity securities, available-for-sale |
||
| style="text-align:right" | |
| style="text-align:right" | 44,166 |
||
| style="text-align:right" | |
| style="text-align:right" | 973,485 |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | 1,017,651 |
||
|- |
|||
| style="text-align:left" | <b>Fixed maturity securities, held-to-maturity:</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Other asset-backed securities |
| style="text-align:left" | Other asset-backed securities |
||
| Line 4,891: | Line 5,973: | ||
| style="text-align:right" | 41,017 |
| style="text-align:right" | 41,017 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total fixed maturity securities, held-to-maturity: |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | 41,017 |
||
| style="text-align:right" | |
| style="text-align:right" | 41,017 |
||
|- |
|||
| style="text-align:left" | <b>Equity securities:</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Common stocks |
| style="text-align:left" | Common stocks |
||
| Line 4,915: | Line 6,003: | ||
| style="text-align:right" | 43,466 |
| style="text-align:right" | 43,466 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total equity securities |
||
| style="text-align:right" | |
| style="text-align:right" | 110,891 |
||
| style="text-align:right" | |
| style="text-align:right" | 7,358 |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | 118,249 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Mortgage loans</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>—</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>—</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>50,070</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>50,070</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Short-term investments</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>270,226</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>—</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>—</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>270,226</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total |
||
| style="text-align:right" | |
| style="text-align:right" | 425,283 |
||
| style="text-align:right" | |
| style="text-align:right" | 980,843 |
||
| style="text-align:right" | |
| style="text-align:right" | 91,087 |
||
| style="text-align:right" | |
| style="text-align:right" | 1,497,213 |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Fixed maturity securities and mortgage loans activity|Fixed maturity securities, mortgage loans, net investment gains (losses), accumulated comprehensive income (loss)|kind=table|order=128}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1050" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col- |
! class="col-m" style="text-align:right" | Fixed Maturity Securities, Available-For-Sale |
||
! class="col- |
! class="col-m" style="text-align:right" | Mortgage Loans |
||
|- |
|- |
||
| style="text-align:left" | Balance at December 31, 2023 |
| style="text-align:left" | Balance at December 31, 2023 |
||
| Line 4,953: | Line 6,040: | ||
| style="text-align:right" | 50,070 |
| style="text-align:right" | 50,070 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total gains (losses) for the period recognized in net investment gains (losses) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 195 ) |
||
| style="text-align:right" | |
| style="text-align:right" | 420 |
||
|- |
|- |
||
| style="text-align:left" | Issuances |
| style="text-align:left" | Issuances |
||
| Line 4,973: | Line 6,060: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total unrealized gains for the period recognized in accumulated comprehensive income (loss) |
||
| style="text-align:right" | |
| style="text-align:right" | 510 |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Balance at December 31, 2024</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>77,920</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>26,490</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total gains for the period recognized in net investment gains (losses) attributable to the change in unrealized gains or losses relating to assets held as of period end |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | 411 |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Mortgage loans activity|Mortgage loans, net investment gains (losses)|kind=table|order=129}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1051" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col- |
! class="col-m" style="text-align:right" | Mortgage Loans |
||
|- |
|- |
||
| style="text-align:left" | Balance at December 31, 2022 |
| style="text-align:left" | Balance at December 31, 2022 |
||
| style="text-align:right" | 52,842 |
| style="text-align:right" | 52,842 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total losses for the period recognized in net investment gains (losses) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 385 ) |
||
|- |
|- |
||
| style="text-align:left" | Issuances |
| style="text-align:left" | Issuances |
||
| Line 5,006: | Line 6,092: | ||
| style="text-align:right" | ( 30,029 ) |
| style="text-align:right" | ( 30,029 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Balance at December 31, 2023</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>50,070</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total losses for the period recognized in net investment gains (losses) attributable to the change in unrealized gains or losses relating to assets held as of period end |
||
| style="text-align:right" | |
| style="text-align:right" | ( 426 ) |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Notes payable and subordinated debt|Notes payable, subordinated debt, FHLB Loan, revolving credit facility, junior subordinated interest debentures, unsecured subordinated notes|kind=table|order=130}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1052" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="2" style="text-align:center" | December 31, 2024 |
! colspan="2" style="text-align:center" | December 31, 2024 |
||
| Line 5,023: | Line 6,108: | ||
|- |
|- |
||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Carrying Value |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Fair Value |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Carrying Value |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Fair Value |
||
|- |
|- |
||
! style="text-align:left" | Notes payable |
! style="text-align:left" | Notes payable |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | FHLB Loan |
| style="text-align:left" | FHLB Loan |
||
| Line 5,046: | Line 6,131: | ||
| style="text-align:right" | 50,000 |
| style="text-align:right" | 50,000 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Notes payable</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>100,000</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>99,200</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>50,000</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>50,000</b> |
||
|- |
|||
| style="text-align:left" | <b>Subordinated debt</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Junior subordinated interest debentures |
| style="text-align:left" | Junior subordinated interest debentures |
||
| Line 5,064: | Line 6,155: | ||
| style="text-align:right" | 21,378 |
| style="text-align:right" | 21,378 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Subordinated debt, net of debt issuance costs</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>19,536</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>20,541</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>78,690</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>81,172</b> |
||
|} |
|} |
||
</div> |
</div> |
||
=== 5. Mortgage Loans === |
|||
{{Indexing|5. Mortgage Loans|Separately Managed Accounts (SMA1, SMA2), direct investments in mortgage loans, mortgage loan portfolios, real estate, uncollectible amounts on loans, foreclosure, non-producing income|966xer0dpm|kind=prose|order=131}} |
|||
{{chunk|doc=vycbjm4dw4|c=241|p=16}} |
|||
* The Company has invested in ''Separately Managed Accounts'' ("SMA1" and "SMA2") <sup>p. 85</sup>. |
|||
'''Mortgage loan portfolio overview''' |
|||
* As of December 31, 2024, and December 31, 2023, the Company held ''direct investments in mortgage loans'' from various creditors through SMA1 and SMA2 <sup>p. 85</sup>. |
|||
* The Company's ''mortgage loan portfolios'' are primarily senior loans on real estate across the U.S. <sup>p. 85</sup>. |
|||
* The loans earn interest at a ''fixed spread above a prime rate'' <sup>p. 85</sup>. |
|||
* The loans ''mature in approximately 2 to 3 years'' from loan origination <sup>p. 85</sup>. |
|||
* The ''principal amounts of the loans'' range between 64% to 80% of the property’s appraised value at the time the loans were made <sup>p. 85</sup>. |
|||
* ''Uncollectible amounts on loans'' are determined based on consultations with the Company’s specialized investment manager and consideration of adverse situations affecting borrower repayment ability, estimated collateral value, and other relevant factors <sup>p. 85</sup>. |
|||
* The Company ''writes off uncollectible amounts'' in the period they are determined to be uncollectible <sup>p. 85</sup>. |
|||
* There was ''no write-off for uncollectible amounts'' during the years ended December 31, 2024, 2023, and 2022 <sup>p. 85</sup>. |
|||
* As of December 31, 2024, ''no mortgage loans were in the process of foreclosure'' <sup>p. 85</sup>. |
|||
* As of December 31, 2024, ''no mortgage loans were not producing income'' for the previous 12 months <sup>p. 85</sup>. |
|||
* As of December 31, 2023, approximately ''$7.1 million of mortgage loans were in the process of foreclosure'' <sup>p. 85</sup>. |
|||
* As of December 31, 2023, ''$6.8 million of mortgage loans were not producing income'' for the previous 12 months <sup>p. 85</sup>. |
|||
* The Company has invested in Separately Managed Accounts ("SMA1" and "SMA2"). |
|||
{{Indexing|Mortgage loans by property type|Mortgage loans by property type, commercial, retail, hospitality, industrial|kind=table|order=132}} |
|||
* As of December 31, 2024 and December 31, 2023, the Company held direct investments in mortgage loans from various creditors through SMA1 and SMA2. |
|||
* The Company’s mortgage loan portfolios are primarily senior loans on real estate across the U.S.. |
|||
* Loans earn interest at a fixed spread above a prime rate. |
|||
* Loans mature in approximately 2 to 3 years from loan origination. |
|||
* Principal amounts of loans range between 64% to 80% of the property’s appraised value at the time the loans were made. |
|||
{{chunk|doc=vycbjm4dw4|c=242|p=16}} |
|||
'''Mortgage loan financial data''' |
|||
* The carrying value of the Company’s mortgage loans as of December 31, 2024 and December 31, 2023 is set forth in a table. |
|||
* The Company’s gross investment income for mortgage loans for the years ended December 31, 2024, 2023 and 2022 is set forth in a table. |
|||
{{chunk|doc=vycbjm4dw4|c=243|p=16}} |
|||
'''Mortgage loan collectibility and status''' |
|||
* Uncollectible amounts on loans are determined on an individual loan basis based on consultations with the Company’s specialized investment manager, consideration of adverse situations affecting borrower repayment ability, estimated value of underlying collateral, and other relevant factors. |
|||
* The Company writes off uncollectible amounts in the period they are determined to be uncollectible. |
|||
* There was no write-off for uncollectible amounts during the years ended December 31, 2024, 2023 and 2022. |
|||
* As of December 31, 2024, no mortgage loans were in the process of foreclosure. |
|||
* As of December 31, 2024, no mortgage loans were not producing income for the previous 12 months. |
|||
* As of December 31, 2023, approximately USD 7.1m of mortgage loans were in the process of foreclosure. |
|||
* As of December 31, 2023, USD 6.8m of mortgage loans were not producing income for the previous 12 months. |
|||
{{chunk|doc=vycbjm4dw4|c=244|p=16}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1053" class="wikitable fintable" |
||
|+ 5. Mortgage Loans |
|||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col- |
! class="col-m" style="text-align:right" | December 31, 2024 |
||
! class="col- |
! class="col-m" style="text-align:right" | December 31, 2023 |
||
|- |
|- |
||
| style="text-align:left" | Commercial |
| style="text-align:left" | Commercial |
||
| Line 5,113: | Line 6,219: | ||
|- |
|- |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align:right" | |
| style="text-align:right" | <b>26,490</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>50,070</b> |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Mortgage loans by property type|Mortgage loans by property type, commercial, retail, hospitality, office, multi-family, industrial|kind=table|order=133}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1054" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col- |
! class="col-m" style="text-align:right" | 2024 |
||
! class="col- |
! class="col-m" style="text-align:right" | 2023 |
||
! class="col- |
! class="col-m" style="text-align:right" | 2022 |
||
|- |
|- |
||
| style="text-align:left" | Commercial |
| style="text-align:left" | Commercial |
||
| Line 5,158: | Line 6,263: | ||
|- |
|- |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align:right" | |
| style="text-align:right" | <b>5,155</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>5,474</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>4,767</b> |
||
|} |
|} |
||
</div> |
</div> |
||
=== 6. Equity Method Investments and Other === |
|||
{{chunk|doc=vycbjm4dw4|c=245|p=16}} |
|||
* The difference between the cost of an investment and its proportionate share of underlying equity in net assets is allocated to the various assets and liabilities of the equity method investment <sup>p. 86</sup>. |
|||
'''Equity method investments overview''' |
|||
* The Company amortizes the difference in net assets over the useful life of a similar asset as the underlying equity method investment <sup>p. 86</sup>. |
|||
* For investment in RISCOM, a similar asset is agent relationships <sup>p. 86</sup>. |
|||
* The Company amortizes this difference over a 15-year useful life <sup>p. 86</sup>. |
|||
* As of December 31, 2024 and 2023, the Company held indirect investments in collateralized loans and loan collateral through SMA1 and SMA2 <sup>p. 86</sup>. |
|||
* Table presents carrying value and ownership percentage of the Company’s equity method investments as of December 31, 2024 and 2023. |
|||
{{Indexing|Indirect investments in collateralized loans and loan collateral|Indirect investments, collateralized loans, loan collateral, Arena Special Opportunities Fund, JVM Funds LLC, RISCOM, Hudson Ventures Fund 2 LP, Arena SOP LP, Brewer Lane Ventures Fund II LP, Dowling Capital Partners LP|kind=table|order=135}} |
|||
* Table presents components of [[Definition:Net investment income|net investment income]] (loss) from equity method investments for the years ended December 31, 2024, 2023, and 2022. |
|||
* Table presents unfunded commitment of equity method investments as of December 31, 2024 and 2023. |
|||
{{chunk|doc=vycbjm4dw4|c=246|p=16}} |
|||
'''Equity method investment accounting''' |
|||
* Difference between investment cost and proportionate share of underlying equity in net assets is allocated to the equity method investment's assets and liabilities. |
|||
* Company amortizes the difference in net assets over the useful life of a similar asset as the underlying equity method investment. |
|||
* For investment in RISCOM, a similar asset is agent relationships, and the Company amortizes this difference over a 15-year useful life. |
|||
* Table presents the Company’s recorded investment in RISCOM compared to its share of underlying equity as of December 31, 2024 and 2023. |
|||
* Table presents the Company’s recorded investment in JVM Funds LLC compared to its share of underlying equity as of December 31, 2024 and 2023. |
|||
{{chunk|doc=vycbjm4dw4|c=247|p=16}} |
|||
'''Indirect loans and loan collateral''' |
|||
* As of December 31, 2024 and 2023, the Company held indirect investments in collateralized loans and loan collateral through SMA1 and SMA2. |
|||
* Table presents the carrying value of SMA1 and SMA2 as of December 31, 2024 and 2023. |
|||
{{chunk|doc=vycbjm4dw4|c=248|p=16}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1055" class="wikitable fintable" |
||
|+ Carrying value & ownership % by equity method investments |
|||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! colspan="2" style="text-align:center" | December 31, 2024 |
! colspan="2" style="text-align:center" | December 31, 2024 |
||
! colspan="2" style="text-align:center" | December 31, 2023 |
! colspan="2" style="text-align:center" | December 31, 2023 |
||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
! class="col- |
! class="col-m" style="text-align:right" | Carrying Value |
||
! class="col-s" style="text-align:right" | Ownership % |
! class="col-s" style="text-align:right" | Ownership % |
||
! class="col- |
! class="col-m" style="text-align:right" | Carrying Value |
||
! class="col-s" style="text-align:right" | Ownership % |
! class="col-s" style="text-align:right" | Ownership % |
||
|- |
|- |
||
| Line 5,229: | Line 6,352: | ||
|- |
|- |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align:right" | |
| style="text-align:right" | <b>65,325</b> |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | <b>74,628</b> |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Indirect investments in collateralized loans and loan collateral|Indirect investments, collateralized loans, loan collateral, Arena Special Opportunities Fund, RISCOM, Dowling Capital Partners LP, Universa Black Swan LP, Brewer Lane Ventures Fund II LP, Hudson Ventures Fund II LP, Arena SOP LP, JVM Funds LLC|kind=table|order=136}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1056" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col- |
! class="col-m" style="text-align:right" | 2024 |
||
! class="col- |
! class="col-m" style="text-align:right" | 2023 |
||
! class="col- |
! class="col-m" style="text-align:right" | 2022 |
||
|- |
|- |
||
| style="text-align:left" | Arena Special Opportunities Fund, LP units |
| style="text-align:left" | Arena Special Opportunities Fund, LP units |
||
| Line 5,286: | Line 6,408: | ||
|- |
|- |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align:right" | |
| style="text-align:right" | <b>2,524</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 9,434 )</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>6,015</b> |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Indirect investments in collateralized loans and loan collateral|Indirect investments, collateralized loans, loan collateral, Brewer Lane Ventures Fund II LP, Hudson Ventures Fund 2 LP, Dowling Capital Partners LP|kind=table|order=137}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1057" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col- |
! class="col-m" style="text-align:right" | December 31, 2024 |
||
! class="col- |
! class="col-m" style="text-align:right" | December 31, 2023 |
||
|- |
|- |
||
| style="text-align:left" | Brewer Lane Ventures Fund II LP units |
| style="text-align:left" | Brewer Lane Ventures Fund II LP units |
||
| Line 5,313: | Line 6,434: | ||
|- |
|- |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align:right" | |
| style="text-align:right" | <b>4,860</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>5,844</b> |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Investment in RISCOM|Investment in RISCOM, underlying equity, recorded investment balance|kind=table|order=138}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1058" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-m" style="text-align:right" | December 31, 2024 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | December 31, 2023 |
||
|- |
|- |
||
! style="text-align:left" | Investment in RISCOM: |
! style="text-align:left" | Investment in RISCOM: |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | Underlying equity |
| style="text-align:left" | Underlying equity |
||
| Line 5,338: | Line 6,458: | ||
| style="text-align:right" | 1,501 |
| style="text-align:right" | 1,501 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Recorded investment balance</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>5,013</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>4,121</b> |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Investment in JVM Funds LLC|Investment in JVM Funds LLC, underlying equity, recorded investment balance|kind=table|order=139}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1059" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-m" style="text-align:right" | December 31, 2024 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | December 31, 2023 |
||
|- |
|- |
||
! style="text-align:left" | Investment in JVM Funds LLC: |
! style="text-align:left" | Investment in JVM Funds LLC: |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | Underlying equity |
| style="text-align:left" | Underlying equity |
||
| Line 5,364: | Line 6,483: | ||
| style="text-align:right" | 757 |
| style="text-align:right" | 757 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Recorded investment balance</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>17,229</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>20,061</b> |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Investment in indirect loans and loan collateral|Investment in indirect loans, loan collateral, SMA1, SMA2|kind=table|order=140}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1060" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col- |
! class="col-m" style="text-align:right" | December 31, 2024 |
||
! class="col- |
! class="col-m" style="text-align:right" | December 31, 2023 |
||
|- |
|- |
||
| style="text-align:left" | SMA1 |
| style="text-align:left" | SMA1 |
||
| Line 5,386: | Line 6,504: | ||
| style="text-align:right" | 5,209 |
| style="text-align:right" | 5,209 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Investment in indirect loans and loan collateral</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>33,269</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>36,025</b> |
||
|} |
|} |
||
</div> |
</div> |
||
=== 7. Allowance for Credit Losses === |
|||
{{Indexing|7. Allowance for Credit Losses|Reinsurance recoverables, credit risk, financial strength rating, A.M. Best, reinsurance payables, letters of credit, funds held, reinsurance balances, LPT, R&Q Re (Bermuda) Ltd.|tc5fw176pu|m0cjxgvmvi|kind=prose|order=141|f1=Rating agency|v1=A.M. Best|f2=Commuted LPT|v2=January 31, 2025|f3=LPT counterparty|v3=R&Q Re (Bermuda) Ltd.|f4=Uncollectible reinsurance recoverable balance|v4=$13.6 million}} |
|||
{{chunk|doc=vycbjm4dw4|c=249|p=16}} |
|||
* The Company analyzes the credit risk of its ''reinsurance recoverables'' by monitoring the financial strength rating of its reinsurers from A.M. Best <sup>p. 87</sup>. |
|||
'''Premiums receivable allowance for credit losses''' |
|||
* A.M. Best is a widely recognized rating agency focused exclusively on the insurance industry <sup>p. 87</sup>. |
|||
* The Company assesses the financial strength rating annually and throughout the year as A.M. Best provides updates on ratings and outlooks <sup>p. 87</sup>. |
|||
* The Company assesses the adequacy of credit enhancements such as reinsurance payables, letters of credit, and funds held <sup>p. 87</sup>. |
|||
* The Company considers ''reinsurance balances'' to be past due when they are 90 days past due <sup>p. 87</sup>. |
|||
* On January 31, 2025, the Company commuted the LPT with R&Q Re (Bermuda) Ltd. ("R&Q") related to accident years 2018 and prior <sup>p. 87</sup>. |
|||
* The Company recognized an uncollectible reinsurance recoverable balance related to the LPT as a net increase of ''$13.6 million'' to the allowance for estimated uncollectible reinsurance <sup>p. 87</sup>. |
|||
* This ''$13.6 million'' increase was subsequently written-off during the year ended December 31, 2024 <sup>p. 87</sup>. |
|||
* Tables set forth changes in the allowance for expected credit losses on premiums receivable for the years ended December 31, 2024 and 2023. |
|||
{{chunk|doc=vycbjm4dw4|c=250|p=16}} |
|||
'''Reinsurance recoverables credit risk and allowance''' |
|||
* The Company analyzes credit risk of reinsurance recoverables by monitoring financial strength ratings from A.M. Best. |
|||
* Financial strength ratings are assessed annually and throughout the year as A.M. Best provides updates. |
|||
* Adequacy of credit enhancements (reinsurance payables, letters of credit, funds held) is assessed. |
|||
* A table sets forth the Company’s reinsurance recoverables net of credit enhancements by A.M. Best as of December 31, 2024. |
|||
* Reinsurance balances are considered past due when they are 90 days past due. |
|||
* Tables set forth changes in the allowance for estimated uncollectible reinsurance for the years ended December 31, 2024 and 2023. |
|||
* On January 31, 2025, the Company commuted the LPT with R&Q Re (Bermuda) Ltd. ("R&Q") related to accident years 2018 and prior. |
|||
* The uncollectible reinsurance recoverable balance related to the LPT was recognized as a net increase of USD 13.6m to the allowance for estimated uncollectible reinsurance. |
|||
* This amount was subsequently written-off during the year ended December 31, 2024. |
|||
{{chunk|doc=vycbjm4dw4|c=251|p=16}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1061" class="wikitable fintable" |
||
|+ 7. Allowance for Credit Losses |
|||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col- |
! class="col-m" style="text-align:right" | Premiums Receivable, Net |
||
! class="col- |
! class="col-m" style="text-align:right" | Allowance for Estimated Uncollectible Premiums |
||
|- |
|- |
||
| style="text-align:left" | Balance at December 31, 2023 |
| style="text-align:left" | Balance at December 31, 2023 |
||
| Line 5,427: | Line 6,556: | ||
| style="text-align:right" | 128 |
| style="text-align:right" | 128 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Balance at December 31, 2024</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>321,641</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>2,432</b> |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Premiums receivable and allowance for uncollectible premiums|Premiums receivable, allowance for uncollectible premiums, ASU 2016-13|kind=table|order=143}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1062" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col- |
! class="col-m" style="text-align:right" | Premiums Receivable, Net |
||
! class="col-s" style="text-align:right" | Allowance for Estimated Uncollectible Premiums |
! class="col-s" style="text-align:right" | Allowance for Estimated Uncollectible Premiums |
||
|- |
|- |
||
| Line 5,448: | Line 6,576: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|||
| style="text-align:left" | Current period change for estimated uncollectible premiums |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 748 |
|||
|- |
|- |
||
| style="text-align:left" | Write-offs of uncollectible premiums receivable |
| style="text-align:left" | Write-offs of uncollectible premiums receivable |
||
| Line 5,457: | Line 6,589: | ||
| style="text-align:right" | 100 |
| style="text-align:right" | 100 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Balance at December 31, 2023</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>179,235</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>964</b> |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Reinsurance recoverables by A.M. best rating|Reinsurance recoverables, A.M. Best Rating, A-, B++ to B+, Not rated|kind=table|order=144}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1063" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="2" style="text-align:center" | December 31, 2024 |
! colspan="2" style="text-align:center" | December 31, 2024 |
||
| Line 5,487: | Line 6,618: | ||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Reinsurance recoverables and allowance for uncollectible reinsurance|Reinsurance recoverables, allowance for uncollectible reinsurance|tc5fw176pu|kind=table|order=145}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1064" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col- |
! class="col-m" style="text-align:right" | Reinsurance Recoverables, Net |
||
! class="col- |
! class="col-m" style="text-align:right" | Allowance for Estimated Uncollectible Reinsurance |
||
|- |
|- |
||
| style="text-align:left" | Balance at December 31, 2023 |
| style="text-align:left" | Balance at December 31, 2023 |
||
| Line 5,508: | Line 6,638: | ||
| style="text-align:right" | ( 13,585 ) |
| style="text-align:right" | ( 13,585 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Balance at December 31, 2024</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>857,876</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>2,295</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Balance at</b> |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Reinsurance recoverables and allowance for uncollectible reinsurance|Reinsurance recoverables, allowance for uncollectible reinsurance|tc5fw176pu|kind=table|order=146}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable |
{| id="t1065" class="wikitable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! |
! style="text-align:right" | Reinsurance Recoverables, Net |
||
! |
! style="text-align:right" | Allowance for Estimated Uncollectible Reinsurance |
||
|- |
|- |
||
| style="text-align:left" | Balance at December 31, 2022 |
| style="text-align:left" | Balance at December 31, 2022 |
||
| Line 5,533: | Line 6,662: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 2,295 |
| style="text-align:right" | 2,295 |
||
|- |
|||
| style="text-align:left" | Current period change for estimated uncollectible reinsurance |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Write-offs of uncollectible reinsurance recoverables |
| style="text-align:left" | Write-offs of uncollectible reinsurance recoverables |
||
| Line 5,538: | Line 6,671: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Balance at December 31, 2023</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>596,334</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>2,295</b> |
||
|} |
|} |
||
</div> |
</div> |
||
=== 8. Property and Equipment === |
|||
{{chunk|doc=vycbjm4dw4|c=252|p=16}} |
|||
* ''Depreciation expense'' was USD 2.9m for the year ended December 31, 2024 <sup>p. 88</sup>. |
|||
'''Property and equipment components and depreciation''' |
|||
* ''Depreciation expense'' was USD 3.2m for the year ended December 31, 2023 <sup>p. 88</sup>. |
|||
* ''Depreciation expense'' was USD 3.6m for the year ended December 31, 2022 <sup>p. 88</sup>. |
|||
* Property and equipment components are included within other assets on the consolidated balance sheets as of December 31, 2024 and 2023. |
|||
{{Indexing|Property and equipment, net|Property and equipment, leasehold improvements, equipment, software, accumulated depreciation|1f87rdfb5o|kind=table|order=148}} |
|||
* Depreciation expense related to property and equipment was USD 2.9m for the year ended December 31, 2024. |
|||
* Depreciation expense related to property and equipment was USD 3.2m for the year ended December 31, 2023. |
|||
* Depreciation expense related to property and equipment was USD 3.6m for the year ended December 31, 2022. |
|||
{{chunk|doc=vycbjm4dw4|c=253|p=16}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1066" class="wikitable fintable" |
||
|+ 8. Property and Equipment |
|||
|- |
|||
! style="text-align:left" | (in thousands) |
! style="text-align:left" | (in thousands) |
||
! class="col-s" style="text-align:right" | 2024 |
! class="col-s" style="text-align:right" | 2024 |
||
| Line 5,578: | Line 6,717: | ||
| style="text-align:right" | ( 27,044 ) |
| style="text-align:right" | ( 27,044 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total |
||
| style="text-align:right" | |
| style="text-align:right" | 12,179 |
||
| style="text-align:right" | |
| style="text-align:right" | 9,070 |
||
|} |
|} |
||
</div> |
</div> |
||
=== 9. Leases === |
|||
{{Indexing|9. Leases|Lease contracts, right-of-use assets, lease liabilities, lease payments, office facilities, operating leases|hvv0k9voso|kind=prose|order=149|f1=Lease expense|v1=FY24: $2.1 million|f2=Lease terms|v2=less than 1 year to 6 years}} |
|||
{{chunk|doc=vycbjm4dw4|c=254|p=16}} |
|||
* The Company determines if a contract contains a lease at inception <sup>p. 89</sup>. |
|||
'''Lease accounting and expenses''' |
|||
* A right-of-use asset (within other assets) and lease liability (within accounts payable and accrued liabilities) are recognized based on the present value of future lease payments <sup>p. 89</sup>. |
|||
* If leases do not provide an implicit interest rate, the Company uses its incremental borrowing rate based on inception date information to determine the lease liability <sup>p. 89</sup>. |
|||
* The Company's leases are primarily for office facilities and are classified as operating leases <sup>p. 89</sup>. |
|||
* Lease terms range from less than 1 year to 6 years, with some including extension options <sup>p. 89</sup>. |
|||
* ''Lease expense'' for the year ended December 31, 2024, was $2.1 million <sup>p. 89</sup>. |
|||
* ''Lease expense'' for the year ended December 31, 2023, was $2.8 million <sup>p. 89</sup>. |
|||
* ''Lease expense'' for the year ended December 31, 2022, was $2.6 million <sup>p. 89</sup>. |
|||
* The Company determines if a contract contains a lease at inception and recognizes a right-of-use asset (within other assets) and lease liability (within accounts payable and accrued liabilities) based on the present value of future lease payments. |
|||
{{Indexing|Operating lease information|Operating lease right-of-use assets, operating lease liabilities, weighted-average remaining lease term, weighted-average discount rate|hvv0k9voso|kind=table|order=150}} |
|||
* If leases do not provide an implicit interest rate, the Company uses its incremental borrowing rate based on the inception date information to determine the lease liability. |
|||
* The Company's leases are primarily for office facilities, classified as operating leases. |
|||
* Lease terms range from less than 1 year to 6 years, with some including extension options. |
|||
* Lease expense for the years ended December 31, 2024, 2023, and 2022 was USD 2.1m, USD 2.8m, and USD 2.6m, respectively. |
|||
{{chunk|doc=vycbjm4dw4|c=255|p=16}} |
|||
'''Lease information tables''' |
|||
* A table provides information regarding the Company’s leases as of December 31, 2024 and 2023. |
|||
* A table presents the Company’s lease expenses for the years ended December 31, 2024, 2023 and 2022. |
|||
* A table sets forth the future minimum lease payment obligations of the Company’s operating leases at December 31, 2024. |
|||
{{chunk|doc=vycbjm4dw4|c=256|p=16}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1067" class="wikitable fintable" |
||
|+ 9. Leases |
|||
|- |
|||
! style="text-align:left" | (in thousands) |
! style="text-align:left" | (in thousands) |
||
! class="col-s" style="text-align:right" | 2024 |
! class="col-s" style="text-align:right" | 2024 |
||
| Line 5,620: | Line 6,768: | ||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Lease expense and cash outflows|Operating lease expense, short-term lease expense, total lease expense, operating cash outflows from operating leases|hvv0k9voso|kind=table|order=151}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1068" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | (in thousands) |
! style="text-align:left" | (in thousands) |
||
! class="col- |
! class="col-m" style="text-align:right" | 2024 |
||
! class="col- |
! class="col-m" style="text-align:right" | 2023 |
||
! class="col- |
! class="col-m" style="text-align:right" | 2022 |
||
|- |
|- |
||
| style="text-align:left" | Operating lease expense |
| style="text-align:left" | Operating lease expense |
||
| Line 5,640: | Line 6,787: | ||
| style="text-align:right" | 220 |
| style="text-align:right" | 220 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total lease expense |
||
| style="text-align:right" | |
| style="text-align:right" | 2,135 |
||
| style="text-align:right" | |
| style="text-align:right" | 2,767 |
||
| style="text-align:right" | |
| style="text-align:right" | 2,634 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Operating cash outflows from operating leases</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>2,082</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>2,636</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>2,382</b> |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Future minimum operating lease payments|Future minimum operating lease payments, imputed interest, total operating lease liability|hvv0k9voso|kind=table|order=152}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1069" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | (in thousands) |
! style="text-align:left" | (in thousands) |
||
! style="text-align: |
! class="col-s" style="text-align:right" | 2024 |
||
|- |
|- |
||
! style="text-align:left" | 2025 |
! style="text-align:left" | 2025 |
||
! style="text-align: |
! class="col-s" style="text-align:right" | 968 |
||
|- |
|- |
||
! style="text-align:left" | 2026 |
! style="text-align:left" | [[Definition:Year 2026|2026]] |
||
! style="text-align: |
! class="col-s" style="text-align:right" | 779 |
||
|- |
|- |
||
! style="text-align:left" | 2027 |
! style="text-align:left" | 2027 |
||
! style="text-align: |
! class="col-s" style="text-align:right" | 686 |
||
|- |
|- |
||
! style="text-align:left" | 2028 |
! style="text-align:left" | 2028 |
||
! style="text-align: |
! class="col-s" style="text-align:right" | 651 |
||
|- |
|- |
||
! style="text-align:left" | 2029 |
! style="text-align:left" | 2029 |
||
! style="text-align: |
! class="col-s" style="text-align:right" | 415 |
||
|- |
|- |
||
! style="text-align:left" | Thereafter |
! style="text-align:left" | Thereafter |
||
! class="col-s" style="text-align:right" | 133 |
! class="col-s" style="text-align:right" | 133 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total future minimum operating lease payments |
||
| style="text-align:right" | |
| style="text-align:right" | 3,632 |
||
|- |
|- |
||
| style="text-align:left" | Less imputed interest |
| style="text-align:left" | Less imputed interest |
||
| style="text-align:right" | ( 419 ) |
| style="text-align:right" | ( 419 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total operating lease liability |
||
| style="text-align:right" | |
| style="text-align:right" | 3,213 |
||
|} |
|} |
||
</div> |
</div> |
||
=== 10. Notes Payable & Subordinated Debt === |
|||
{{Indexing|10. Notes Payable & Subordinated Debt|FHLB Loan, Revolving Credit Facility, Debentures, investment securities, covenants|bhnpa5y4f0|b3bc9gy5x7|kind=prose|order=153|f1=FHLB Loan principal|v1=USD 57.0m|f2=FHLB Loan term|v2=4.5-year|f3=FHLB Loan interest rate|v3=4.00%|f4=Revolving Credit Facility amount|v4=USD 150.0m|f5=Revolving Credit Facility letter of credit sub-facility|v5=USD 30.0m|f6=Revolving Credit Facility interest rate|v6=SOFR plus 150 to 190 bps|f7=Revolving Credit Facility SOFR|v7=Dec 31, 2024: 4.25%}} |
|||
{{chunk|doc=vycbjm4dw4|c=257|p=16}} |
|||
* The ''FHLB Loan'' was entered into on August 30, 2024, under the Advances and Security Agreement <sup>p. 90</sup>. |
|||
'''FHLB Loan''' |
|||
* The ''FHLB Loan'' is a 4.5-year term loan with a principal amount of USD 57.0m <sup>p. 90</sup>. |
|||
* The ''FHLB Loan'' requires interest-only payments during its term, with principal due at maturity <sup>p. 90</sup>. |
|||
* The ''FHLB Loan'' has a fixed interest rate of 4.00% over its term <sup>p. 90</sup>. |
|||
* The ''FHLB Loan'' is fully secured by a pledge of specific investment securities of HSIC <sup>p. 90</sup>. |
|||
* Proceeds from the ''FHLB Loan'' were used to fund redemptions of draws on the Revolving Credit Facility <sup>p. 90</sup>. |
|||
* The Company entered into an agreement for a new unsecured ''Revolving Credit Facility'' with a syndicate of participating banks in Q1 2023 <sup>p. 90</sup>. |
|||
* The ''Revolving Credit Facility'' provides up to a USD 150.0m revolving credit facility and a letter of credit sub-facility of up to USD 30.0m <sup>p. 90</sup>. |
|||
* As of December 31, 2023, the Company drew USD 50.0m on the ''Revolving Credit Facility'' <sup>p. 90</sup>. |
|||
* In Q1 2024, the Company drew an additional USD 50.0m on the ''Revolving Credit Facility'' to pay off the principal on its existing Debentures <sup>p. 90</sup>. |
|||
* On September 6, 2024, the Company redeemed USD 57.0m of the draws on the ''Revolving Credit Facility'' <sup>p. 90</sup>. |
|||
* Interest on the ''Revolving Credit Facility'' is payable quarterly <sup>p. 90</sup>. |
|||
* The ''Revolving Credit Facility'' interest rate is SOFR plus a margin of 150 to 190 bps, based on the debt to total capital ratio, and a credit spread adjustment of 10 bps <sup>p. 90</sup>. |
|||
* At December 31, 2024, the six-month SOFR on the ''Revolving Credit Facility'' was 4.25%, plus a margin of 1.60% <sup>p. 90</sup>. |
|||
* The Company is subject to covenants on the ''Revolving Credit Facility'' including minimum net worth, maximum debt to capital ratio, minimum A.M. Best Rating, and minimum liquidity <sup>p. 90</sup>. |
|||
* As of December 31, 2024, the Company was in compliance with all ''Revolving Credit Facility'' covenants <sup>p. 90</sup>. |
|||
* In May 2019, the Company issued unsecured subordinated notes (the "Notes") with an aggregate principal amount of USD 20.0m <sup>p. 90</sup>. |
|||
* Interest on the ''Notes'' is fixed at 7.25% for the first 8 years and 8.25% thereafter <sup>p. 90</sup>. |
|||
* Early retirement of the ''Notes'' before the 8-year commitment requires all interest payments to be paid in full, plus the return of outstanding principal <sup>p. 90</sup>. |
|||
* Principal on the ''Notes'' is due at maturity on May 24, 2039, with interest payable quarterly <sup>p. 90</sup>. |
|||
* The ''Notes'' have junior priority to all previously issued debt <sup>p. 90</sup>. |
|||
* The Company reports debt related to the ''Notes'' net of debt issuance costs of approximately USD 0.5m in its December 31, 2024 and 2023 consolidated balance sheets <sup>p. 90</sup>. |
|||
* These deferred financing costs are presented as a direct deduction from the carrying amount of the subordinated debt <sup>p. 90</sup>. |
|||
* In August 2006, the Company received USD 58.0m in proceeds from a debenture offering through Delos Capital Trust (the "Trust") <sup>p. 90</sup>. |
|||
* The sole asset of the ''Trust'' consists of Fixed/Floating Rate Junior Subordinated Deferrable Interest Debentures (the "Debentures") with a principal amount of USD 59.8m issued by the Company <sup>p. 90</sup>. |
|||
* The ''Trust'' also holds cash of USD 1.8m from the issuance of Trust common shares purchased by the Company, equal to 3% of the Trust capitalization <sup>p. 90</sup>. |
|||
* On March 15, 2024, the Company redeemed the ''Debentures'' and paid USD 1.4m of accrued interest <sup>p. 90</sup>. |
|||
* On August 30, 2024, the Company entered into the FHLB Loan pursuant to the Advances and Security Agreement. |
|||
{{Indexing|11. Stockholders Equity|Reverse stock split, Initial Public Offering (IPO), authorized shares, Preferred Shares Conversion, Follow-On Offering|ch7st6ifed|z6dk9e62ik|kind=prose|order=154|f1=Reverse stock split|v1=4-for-1|f2=IPO shares offered|v2=4,750,000|f3=IPO price per share|v3=$15.00|f4=IPO net proceeds|v4=$62.0 million|f5=Authorized common stock shares|v5=500,000,000|f6=Authorized preferred stock shares|v6=10,000,000|f7=Preferred Shares converted|v7=1,969,660|f8=Common stock from conversion|v8=16,305,113|f9=Follow-on shares sold|v9=2,150,000}} |
|||
* The FHLB Loan is a 4.5-year term loan with a principal amount of USD 57.0m. |
|||
* The FHLB Loan requires interest-only payments during its term, with principal due in full at maturity. |
|||
* The interest rate for the FHLB Loan is fixed at 4.00% over the term. |
|||
* The FHLB Loan is fully secured by a pledge of specific investment securities of HSIC. |
|||
* Proceeds from the FHLB Loan were used to fund redemptions of draws on the Revolving Credit Facility. |
|||
{{chunk|doc=vycbjm4dw4|c=258|p=16}} |
|||
* ''Reverse stock split'': The Board of Directors approved a 4-for-1 reverse stock split of the Company’s common stock on September 23, 2022 <sup>p. 91</sup>. |
|||
'''Revolving Credit Facility''' |
|||
* The reverse stock split became effective on January 3, 2023 <sup>p. 91</sup>. |
|||
* All share and per share information in the consolidated financial statements and notes have been retroactively adjusted for all periods presented to reflect the reverse stock split <sup>p. 91</sup>. |
|||
* ''Initial Public Offering (IPO)'': The Company completed its IPO on January 18, 2023 <sup>p. 91</sup>. |
|||
* ''IPO shares offered'': 4,750,000 shares were offered by the Company at a price of $15.00 per share <sup>p. 91</sup>. |
|||
* ''IPO net proceeds'': Approximately $62.0 million, after deducting underwriting discounts and specific incremental expenses <sup>p. 91</sup>. |
|||
* Upon IPO closing, the Company filed an amended and restated certificate of incorporation <sup>p. 91</sup>. |
|||
* ''Authorized shares increased'': 500,000,000 shares of common stock (par value $0.01 per share) and 10,000,000 shares of preferred stock (par value $0.01 per share) <sup>p. 91</sup>. |
|||
* ''Preferred Shares Conversion'': Preferred Shares had liquidation preference over common stock at a face value of $50.00 per share, plus declared but unpaid dividends <sup>p. 91</sup>. |
|||
* Holders had the option to convert Preferred Shares into common stock based on the Option Conversion Rate <sup>p. 91</sup>. |
|||
* Preferred Shares were subject to mandatory conversion upon IPO closing at the Mandatory Conversion Rate <sup>p. 91</sup>. |
|||
* As of December 31, 2022, the ''Mandatory Conversion Rate'' allowed conversion at $6.04 per common share <sup>p. 91</sup>. |
|||
* On January 18, 2023, ''1,969,660 Preferred Shares converted'' to 16,305,113 shares of common stock upon IPO closing <sup>p. 91</sup>. |
|||
* ''Follow-On Offering'': The Company completed a follow-on offering on November 20, 2023 <sup>p. 91</sup>. |
|||
* ''Follow-on shares sold'': 2,150,000 shares were sold by the Company at a price of $30.50 per share <sup>p. 91</sup>. |
|||
* ''Follow-on net proceeds'': Approximately $62.5 million, after deducting underwriting discounts and specific incremental expenses <sup>p. 91</sup>. |
|||
* The Company entered into an agreement for a new unsecured revolving credit facility (the “Revolving Credit Facility”) with a syndicate of participating banks during Q1 2023. |
|||
{{Indexing|12. Segment|Reportable segment, commercial property and casualty products, underwriting divisions, Chief Operating Decision Maker (CODM), accounting policies, segment performance, resource allocation, competitive analysis, management compensation|1ut79wn2dy|kind=prose|order=155|f1=Number of segments|v1=one|f2=Reportable segments|v2=commercial property and casualty|f3=Geographic regions|v3=United States|f4=Segment basis|v4=internal financial information reviewed by CODM|f5=Segment profit measure|v5=gross written premiums, underwriting income, income before income taxes}} |
|||
* The Revolving Credit Facility provided up to a USD 150.0m revolving credit facility and a letter of credit sub-facility of up to USD 30.0m. |
|||
* As of December 31, 2023, the Company had drawn USD 50.0m on the Revolving Credit Facility. |
|||
* During Q1 2024, the Company drew an additional USD 50.0m on the Revolving Credit Facility to pay off the principal on its existing Debentures. |
|||
* On September 6, 2024, the Company redeemed USD 57.0m of the draws on the Revolving Credit Facility. |
|||
* Interest on the Revolving Credit Facility is payable quarterly. |
|||
* The interest rate on the Revolving Credit Facility is SOFR plus a margin of 150 to 190 bps, based on the debt to total capital ratio, and a credit spread adjustment of 10 bps. |
|||
* At December 31, 2024, the six-month SOFR on the Revolving Credit Facility was 4.25%, plus a margin of 1.60%. |
|||
* The Company is subject to covenants on the Revolving Credit Facility, including minimum net worth, maximum debt to capital ratio, minimum A.M. Best Rating, and minimum liquidity. |
|||
* As of December 31, 2024, the Company was in compliance with all covenants. |
|||
{{chunk|doc=vycbjm4dw4|c=259|p=16}} |
|||
* The Company operates with one reportable segment, offering commercial property and casualty products and solutions primarily in the United States on both non-admitted (E&S) and admitted bases <sup>p. 92</sup>. |
|||
'''Debentures''' |
|||
* This segment comprises eight distinct underwriting divisions, referred to as "continuing business," each with dedicated underwriting leadership and technical staff <sup>p. 92</sup>. |
|||
* The segment definition is based on how internal financial information is reviewed by the Chief Operating Decision Maker (CODM) for performance analysis, decision-making, and resource allocation <sup>p. 92</sup>. |
|||
* The Company's CODM is the chief executive officer <sup>p. 92</sup>. |
|||
* The accounting policies for the segment align with those described in Note 1 "Summary of Significant Accounting Policies" of this Form 10-K <sup>p. 92</sup>. |
|||
* The CODM evaluates segment performance and allocates resources using gross written premiums by net underwriting division, underwriting income, and income before income taxes (which is also reported as consolidated income before income taxes on the consolidated statements of operations) <sup>p. 92</sup>. |
|||
* ''Segment assets'' are measured as total consolidated assets on the balance sheet <sup>p. 92</sup>. |
|||
* ''Gross written premiums'' by underwriting division, net underwriting income, and consolidated net income are used to monitor budget versus actual results <sup>p. 92</sup>. |
|||
* The CODM also utilizes net underwriting income, return on equity, and growth in book value per share for competitive analysis by benchmarking against competitors <sup>p. 92</sup>. |
|||
* The competitive analysis and monitoring of budgeted versus actual results are factors in assessing segment performance and determining management's compensation <sup>p. 92</sup>. |
|||
* In May 2019, the Company agreed to issue unsecured subordinated notes (the “Notes”) with an aggregate principal amount of USD 20.0m. |
|||
{{Indexing|Segment information|Industry Solutions, Global Property & Agriculture, Captives, Programs, Accident & Health, Transactional E&S, Professional Lines, Surety, continuing business, exited business|1ut79wn2dy|kind=table|order=156}} |
|||
* Interest on the Notes is fixed at 7.25% for the first 8 years and 8.25% thereafter. |
|||
* Early retirement of the Notes before the 8-year commitment requires all interest payments to be paid in full, plus the return of outstanding principal. |
|||
* Principal on the Notes is due at maturity on May 24, 2039, and interest is payable quarterly. |
|||
* The Notes have junior priority to all previously issued debt. |
|||
* The Company reports debt related to the Notes in its December 31, 2024 and 2023 consolidated balance sheets, net of debt issuance costs of approximately USD 0.5m. |
|||
* These deferred financing costs are presented as a direct deduction from the carrying amount of the subordinated debt. |
|||
* In August 2006, the Company received USD 58.0m of proceeds from a debenture offering through Delos Capital Trust (the “Trust”). |
|||
* The sole asset of the Trust consists of Fixed/Floating Rate Junior Subordinated Deferrable Interest Debentures (the “Debentures”) with a principal amount of USD 59.8m issued by the Company. |
|||
* The Trust also held cash of USD 1.8m from the issuance of Trust common shares purchased by the Company, equal to 3% of the Trust capitalization. |
|||
* On March 15, 2024, the Company redeemed the Debentures and paid USD 1.4m of accrued interest. |
|||
=== 11. Stockholders Equity === |
|||
{{chunk|doc=vycbjm4dw4|c=260|p=16}} |
|||
'''Reverse stock split''' |
|||
* The Board of Directors approved a 4-for-1 reverse stock split of the Company’s common stock on September 23, 2022. |
|||
* The reverse stock split became effective January 3, 2023. |
|||
* All share and per share information in the consolidated financial statements and notes have been retroactively adjusted to reflect the reverse stock split for all periods presented. |
|||
{{chunk|doc=vycbjm4dw4|c=261|p=16}} |
|||
'''Initial public offering''' |
|||
* The Company completed its initial public offering (IPO) on January 18, 2023. |
|||
* 4,750,000 shares were offered by the Company at a price of USD 15.00 per share. |
|||
* Net proceeds from the IPO were approximately USD 62.0m, after deducting underwriting discounts and specific incremental expenses. |
|||
* Upon closing of the IPO, the Company filed an amended and restated certificate of incorporation. |
|||
* The amended certificate increased the number of authorized shares to 500,000,000 shares of common stock (par value USD 0.01 per share) and 10,000,000 shares of preferred stock (par value USD 0.01 per share). |
|||
{{chunk|doc=vycbjm4dw4|c=262|p=16}} |
|||
'''Preferred shares conversion''' |
|||
* Preferred Shares had liquidation preference over common stock for the face value of USD 50.00 per share and any declared but unpaid [[Definition:Dividend|dividends]] to related common shares at the applicable conversion rate. |
|||
* Preferred Shares provided the holder the option to convert them into common stock at any time based on the Option Conversion Rate. |
|||
* Preferred Shares were subject to mandatory conversion upon the closing of an IPO at the Mandatory Conversion Rate. |
|||
* As of December 31, 2022, the Mandatory Conversion Rate allowed conversion into common stock based on a conversion price of USD 6.04 per common share. |
|||
* On January 18, 2023, 1,969,660 Preferred Shares converted to 16,305,113 shares of common stock upon the closing of the Company’s IPO. |
|||
{{chunk|doc=vycbjm4dw4|c=263|p=16}} |
|||
'''Follow-on offering''' |
|||
* The Company completed its follow-on offering on November 20, 2023. |
|||
* 2,150,000 shares were sold by the Company at a price of USD 30.50 per share. |
|||
* Net proceeds were approximately USD 62.5m, after deducting underwriting discounts and specific incremental expenses directly attributable to the offering. |
|||
=== 12. Segment === |
|||
{{chunk|doc=vycbjm4dw4|c=264|p=16}} |
|||
'''Reportable segment overview''' |
|||
* The Company has one reportable segment offering commercial [[Definition:Property & casualty|property and casualty]] products and solutions, predominantly in the United States, on a non-admitted (E&S) and admitted basis. |
|||
* The segment consists of eight distinct underwriting divisions, referred to as "continuing business," with dedicated underwriting leadership and technical staff. |
|||
* The segment definition is based on how internally reported financial information is reviewed by the Chief Operating Decision Maker (CODM) to analyze performance, make decisions, and allocate resources. |
|||
* The Company's CODM is the chief executive officer. |
|||
* Accounting policies for the segment are consistent with Note 1 "Summary of Significant Accounting Policies" of Form 10-K. |
|||
* The CODM assesses segment performance and allocates resources based on [[Definition:Gross written premiums|gross written premiums]] by net underwriting division, underwriting income, and income before income taxes (reported on consolidated statements of operations). |
|||
* Segment assets are reported on the balance sheet as total consolidated assets. |
|||
* [[Definition:Gross written premiums|Gross written premiums]] by underwriting division, net underwriting income, and consolidated net income are used to monitor budget versus actual results. |
|||
* The CODM uses net underwriting income, return on equity, and growth in book value per share for competitive analysis by benchmarking against competitors. |
|||
* Competitive analysis and monitoring of budgeted versus actual results are used to assess segment performance and establish management's compensation. |
|||
{{chunk|doc=vycbjm4dw4|c=265|p=16}} |
|||
'''Financial data tables''' |
|||
* A table presents [[Definition:Gross written premiums|gross written premiums]] by underwriting division for the years ended December 31, 2024, 2023, and 2022. |
|||
* A table presents reported segment net underwriting income, significant segment expenses, and a reconciliation of net underwriting income to net income for the years ended December 31, 2024, 2023, and 2022. |
|||
* A table presents return on equity and book value per share for the years ended December 31, 2024, 2023, and 2022. |
|||
{{chunk|doc=vycbjm4dw4|c=266|p=16}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1070" class="wikitable fintable" |
||
|+ [[Definition:Gross written premiums|Gross written premiums]] by segment |
|||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="3" style="text-align:center" | Years Ended December 31, |
! colspan="3" style="text-align:center" | Years Ended December 31, |
||
| Line 5,760: | Line 6,944: | ||
! class="col-s" style="text-align:right" | 2024 |
! class="col-s" style="text-align:right" | 2024 |
||
! class="col-s" style="text-align:right" | 2023 |
! class="col-s" style="text-align:right" | 2023 |
||
! class="col- |
! class="col-m" style="text-align:right" | 2022 |
||
|- |
|- |
||
| style="text-align:left" | Industry Solutions |
| style="text-align:left" | Industry Solutions |
||
| Line 5,767: | Line 6,951: | ||
| style="text-align:right" | 267,628 |
| style="text-align:right" | 267,628 |
||
|- |
|- |
||
| style="text-align:left" | Global Property & Agriculture |
| style="text-align:left" | Global Property & Agriculture |
||
| style="text-align:right" | 311,402 |
| style="text-align:right" | 311,402 |
||
| style="text-align:right" | 273,191 |
| style="text-align:right" | 273,191 |
||
| Line 5,782: | Line 6,966: | ||
| style="text-align:right" | 163,653 |
| style="text-align:right" | 163,653 |
||
|- |
|- |
||
| style="text-align:left" | Accident & Health |
| style="text-align:left" | Accident & Health |
||
| style="text-align:right" | 173,073 |
| style="text-align:right" | 173,073 |
||
| style="text-align:right" | 151,701 |
| style="text-align:right" | 151,701 |
||
| style="text-align:right" | 130,808 |
| style="text-align:right" | 130,808 |
||
|- |
|- |
||
| style="text-align:left" | Transactional E&S |
| style="text-align:left" | Transactional E&S |
||
| style="text-align:right" | 169,053 |
| style="text-align:right" | 169,053 |
||
| style="text-align:right" | 122,508 |
| style="text-align:right" | 122,508 |
||
| Line 5,802: | Line 6,986: | ||
| style="text-align:right" | 79,062 |
| style="text-align:right" | 79,062 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total continuing business |
||
| style="text-align:right" | |
| style="text-align:right" | 1,743,249 |
||
| style="text-align:right" | |
| style="text-align:right" | 1,459,847 |
||
| style="text-align:right" | |
| style="text-align:right" | 1,138,627 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Exited business</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 17 )</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 18 )</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>5,325</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total [[Definition:Gross written premiums|gross written premiums]] |
||
| style="text-align:right" | |
| style="text-align:right" | 1,743,232 |
||
| style="text-align:right" | |
| style="text-align:right" | 1,459,829 |
||
| style="text-align:right" | |
| style="text-align:right" | 1,143,952 |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Underwriting income and expenses|Underwriting income, net earned premiums, commission and fee income, total underwriting revenues, losses and LAE, amortization of policy acquisition costs, other operating and general expenses, total underwriting expenses, net underwriting income|cos78e4bvi|irxh3hcbqz|kind=table|order=157}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1071" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2024 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2023 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2022 |
||
|- |
|- |
||
! style="text-align:left" | Underwriting income |
! style="text-align:left" | Underwriting income |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
! style="text-align:left" | Revenues: |
! style="text-align:left" | Revenues: |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | Net earned premiums |
| style="text-align:left" | Net earned premiums |
||
| Line 5,848: | Line 7,031: | ||
| style="text-align:right" | 5,199 |
| style="text-align:right" | 5,199 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total underwriting revenues |
||
| style="text-align:right" | |
| style="text-align:right" | 1,063,425 |
||
| style="text-align:right" | |
| style="text-align:right" | 835,207 |
||
| style="text-align:right" | |
| style="text-align:right" | 621,193 |
||
|- |
|||
| style="text-align:left" | <b>Expenses:</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Losses and LAE |
| style="text-align:left" | Losses and LAE |
||
| Line 5,868: | Line 7,056: | ||
| style="text-align:right" | 116,476 |
| style="text-align:right" | 116,476 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total underwriting expenses |
||
| style="text-align:right" | |
| style="text-align:right" | 981,566 |
||
| style="text-align:right" | |
| style="text-align:right" | 758,681 |
||
| style="text-align:right" | |
| style="text-align:right" | 584,683 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net underwriting income</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>81,859</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>76,526</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>36,510</b> |
||
|- |
|- |
||
| style="text-align:left" | Reconciliation of net underwriting income to net income: |
| style="text-align:left" | Reconciliation of net underwriting income to net income: |
||
| Line 5,883: | Line 7,071: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net underwriting income</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>81,859</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>76,526</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>36,510</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Add:</b> |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Net investment income |
| style="text-align:left" | [[Definition:Net investment income|Net investment income]] |
||
| style="text-align:right" | 80,686 |
| style="text-align:right" | 80,686 |
||
| style="text-align:right" | 40,322 |
| style="text-align:right" | 40,322 |
||
| Line 5,907: | Line 7,095: | ||
| style="text-align:right" | ( 632 ) |
| style="text-align:right" | ( 632 ) |
||
| style="text-align:right" | 1 |
| style="text-align:right" | 1 |
||
|- |
|||
| style="text-align:left" | Less: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Interest expense |
| style="text-align:left" | Interest expense |
||
| Line 5,923: | Line 7,116: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Income before income taxes</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>152,739</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>110,102</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>49,783</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Income tax expense</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>33,911</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>24,118</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>10,387</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net income</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>118,828</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>85,984</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>39,396</b> |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Return on equity and book value per share|Return on equity, book value per share|0lk0pqg9zh|kind=table|order=158}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1072" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | — |
|||
! style="text-align:left" | |
|||
! class="col-s" style="text-align:right" | 2024 |
! class="col-s" style="text-align:right" | 2024 |
||
! class="col-s" style="text-align:right" | 2023 |
! class="col-s" style="text-align:right" | 2023 |
||
| Line 5,961: | Line 7,153: | ||
</div> |
</div> |
||
=== 13. Income Taxes === |
|||
{{Indexing|13. Income Taxes|Provision for income taxes, effective tax rate, federal statutory income tax rate, federal income taxes, federal income tax returns, uncertain tax positions, interest and penalties, federal net operating loss carryforwards, Internal Revenue Code Section 382, valuation allowance, capital loss carryforward, deferred tax asset|kmocop7wiu|kind=prose|order=159|f1=Federal statutory income tax rate|v1=21%|f2=Federal income taxes paid|v2=FY24: USD 37.0 million|f3=Federal net operating loss carryforwards|v3=USD 44.7 million|f4=Net operating losses expiration|v4=beginning in 2032|f5=Sec 382 limitation|v5=USD 2.8 million|f6=Capital loss carryforward deferred tax asset|v6=Dec 31, 2024: USD 1.7 million}} |
|||
{{chunk|doc=vycbjm4dw4|c=267|p=16}} |
|||
* The Company's provision for income taxes generally does not deviate substantially from the statutory tax rate <sup>p. 93</sup>. |
|||
'''income tax expense and effective tax rate''' |
|||
* The ''effective tax rate'' may vary slightly from the statutory rate due to tax adjustments for tax-exempt income, dividends-received deduction, and non-deductible expenses <sup>p. 93</sup>. |
|||
* The ''federal statutory income tax rate'' is 21% <sup>p. 93</sup>. |
|||
* The Company paid ''federal income taxes'' of USD 37.0 million during the year ended December 31, 2024 <sup>p. 93</sup>. |
|||
* The Company's ''federal income tax returns'' for tax years 2021 to 2023 are subject to examination by the Internal Revenue Service <sup>p. 93</sup>. |
|||
* The Company has ''no current U.S. federal or state and local income tax examinations'' ongoing <sup>p. 93</sup>. |
|||
* At December 31, 2024, the Company carried ''no balance for uncertain tax positions'' <sup>p. 93</sup>. |
|||
* The Company had ''no accrual for the payment of interest and penalties'' at December 31, 2024 or 2023 <sup>p. 93</sup>. |
|||
* The Company has ''federal net operating loss carryforwards'' of approximately USD 44.7 million <sup>p. 93</sup>. |
|||
* These ''net operating losses'' are set to expire beginning in 2032 <sup>p. 93</sup>. |
|||
* The Company is ''limited on the utilization of USD 44.7 million of net operating losses'' under Internal Revenue Code Section 382 ("Sec 382") due to an "ownership change" in 2014 <sup>p. 93</sup>. |
|||
* The ''Sec 382 limitation'' is expected to result in an expiration of USD 2.8 million (USD 0.6 million tax effected) of net operating losses <sup>p. 93</sup>. |
|||
* A ''valuation allowance'' was established against the balance of net operating losses expected to expire without utilization <sup>p. 93</sup>. |
|||
* The Company generated a ''capital loss carryforward'' in 2022, resulting in a deferred tax asset of USD 1.7 million as of December 31, 2024 <sup>p. 93</sup>. |
|||
* ''No valuation allowance'' is recorded against this deferred tax asset as the Company expects to utilize this carryforward before it expires in 2027 <sup>p. 93</sup>. |
|||
* The Company provides a ''valuation allowance against deferred tax assets'' when it is more likely-than-not that some portion, or all, will not be realized <sup>p. 93</sup>. |
|||
* The Company's ''deferred tax valuation allowance'' at December 31, 2024 and 2023 was USD 0.6 million <sup>p. 93</sup>. |
|||
* The Company's income tax expense components are presented for the years ended December 31, 2024, 2023, and 2022. |
|||
{{Indexing|Income tax expense|Current income tax expense, deferred tax (benefit) expense, total income tax expense|kmocop7wiu|kind=table|order=160}} |
|||
* The provision for income taxes generally does not deviate substantially from the statutory tax rate. |
|||
* The effective tax rate may vary slightly from the statutory rate due to tax adjustments for tax-exempt income, dividends-received deduction, and non-deductible expenses. |
|||
* Differences between income taxes expected at the federal statutory income tax rate of 21% and the reported income tax expense are presented for the years ended December 31, 2024, 2023, and 2022. |
|||
{{chunk|doc=vycbjm4dw4|c=268|p=16}} |
|||
'''deferred tax assets and liabilities''' |
|||
* The tax effects of temporary differences giving rise to significant portions of deferred tax assets and deferred tax liabilities are presented as of December 31, 2024, and 2023. |
|||
{{chunk|doc=vycbjm4dw4|c=269|p=16}} |
|||
'''federal income taxes and examinations''' |
|||
* The Company paid USD 37.0m in federal income taxes during the year ended December 31, 2024. |
|||
* The Company's federal income tax returns for tax years 2021 to 2023 are subject to examination by the Internal Revenue Service. |
|||
* The Company has no current U.S. federal or state and local income tax examinations ongoing. |
|||
{{chunk|doc=vycbjm4dw4|c=270|p=16}} |
|||
'''uncertain tax positions and accruals''' |
|||
* As of December 31, 2024, the Company carried no balance for uncertain tax positions. |
|||
* The Company had no accrual for the payment of interest and penalties at December 31, 2024, or 2023. |
|||
{{chunk|doc=vycbjm4dw4|c=271|p=16}} |
|||
'''net operating loss carryforwards''' |
|||
* The Company has federal net operating loss carryforwards of approximately USD 44.7m. |
|||
* These net operating losses are set to expire beginning in 2032. |
|||
* The Company is limited on the utilization of USD 44.7m of net operating losses under Internal Revenue Code Section 382 ("Sec 382") due to an "ownership change" in 2014. |
|||
* The Sec 382 limitation is expected to result in an expiration of USD 2.8m (USD 0.6m tax effected) of net operating losses [p.16, p.16]. |
|||
* A valuation allowance was established against the balance of net operating losses expected to expire without utilization. |
|||
{{chunk|doc=vycbjm4dw4|c=272|p=16}} |
|||
'''capital loss carryforward''' |
|||
* The Company generated a capital loss carryforward in 2022, resulting in a deferred tax asset of USD 1.7m as of December 31, 2024. |
|||
* No valuation allowance is recorded against this deferred tax asset as the Company expects to utilize this carryforward before it expires in 2027. |
|||
{{chunk|doc=vycbjm4dw4|c=273|p=16}} |
|||
'''deferred tax valuation allowance''' |
|||
* The Company provides a valuation allowance against deferred tax assets when it is more likely-than-not that some portion, or all, of deferred tax assets will not be realized. |
|||
* The deferred tax valuation allowance at December 31, 2024, and 2023 was USD 0.6m. |
|||
{{chunk|doc=vycbjm4dw4|c=274|p=16}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1073" class="wikitable fintable" |
||
|+ 13. Income Taxes |
|||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col-s" style="text-align:right" | 2024 |
! class="col-s" style="text-align:right" | 2024 |
||
| Line 6,000: | Line 7,223: | ||
| style="text-align:right" | 10,267 |
| style="text-align:right" | 10,267 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total income tax expense |
||
| style="text-align:right" | |
| style="text-align:right" | 33,911 |
||
| style="text-align:right" | |
| style="text-align:right" | 24,118 |
||
| style="text-align:right" | |
| style="text-align:right" | 10,387 |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Reconciliation of income tax expense|Income tax expense at federal statutory rate, tax advantaged investments, other, total income tax expense|kmocop7wiu|kind=table|order=161}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1074" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="2" style="text-align:center" | 2024 |
! colspan="2" style="text-align:center" | 2024 |
||
| Line 6,048: | Line 7,270: | ||
| style="text-align:right" | 0.6 |
| style="text-align:right" | 0.6 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total income tax expense |
||
| style="text-align:right" | |
| style="text-align:right" | 33,911 |
||
| style="text-align:right" | |
| style="text-align:right" | 22.2% |
||
| style="text-align:right" | |
| style="text-align:right" | 24,118 |
||
| style="text-align:right" | |
| style="text-align:right" | 21.9% |
||
| style="text-align:right" | |
| style="text-align:right" | 10,387 |
||
| style="text-align:right" | |
| style="text-align:right" | 20.9% |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Deferred tax assets|Deferred tax assets, unearned premiums, losses and loss adjustment expenses, net operating losses, unrealized losses on fixed maturity securities, stock options/awards, other, total deferred tax assets, valuation allowance, deferred policy acquisition costs, unrealized gains on equity securities, other long-term investments, depreciation|kmocop7wiu|kind=table|order=162}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1075" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2024 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2023 |
||
|- |
|- |
||
! style="text-align:left" | Deferred tax assets: |
! style="text-align:left" | Deferred tax assets: |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | Unearned premiums |
| style="text-align:left" | Unearned premiums |
||
| Line 6,094: | Line 7,315: | ||
| style="text-align:right" | 4,237 |
| style="text-align:right" | 4,237 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total deferred tax assets |
||
| style="text-align:right" | |
| style="text-align:right" | 58,947 |
||
| style="text-align:right" | |
| style="text-align:right" | 49,665 |
||
|- |
|- |
||
| style="text-align:left" | Less valuation allowance |
| style="text-align:left" | Less valuation allowance |
||
| Line 6,102: | Line 7,323: | ||
| style="text-align:right" | ( 586 ) |
| style="text-align:right" | ( 586 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total deferred tax assets after valuation allowance |
||
| style="text-align:right" | |
| style="text-align:right" | 58,361 |
||
| style="text-align:right" | |
| style="text-align:right" | 49,079 |
||
|- |
|||
| style="text-align:left" | <b>Deferred tax liabilities:</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Deferred policy acquisition costs |
| style="text-align:left" | Deferred policy acquisition costs |
||
| Line 6,130: | Line 7,355: | ||
| style="text-align:right" | 1,120 |
| style="text-align:right" | 1,120 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total deferred tax liabilities |
||
| style="text-align:right" | |
| style="text-align:right" | 27,875 |
||
| style="text-align:right" | |
| style="text-align:right" | 27,088 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Deferred income taxes</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>30,486</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>21,991</b> |
||
|} |
|} |
||
</div> |
</div> |
||
=== 14. Reserves for Losses and Loss Adjustment Expenses === |
|||
{{chunk|doc=vycbjm4dw4|c=275|p=16}} |
|||
* The Company evaluates net ultimate loss and LAE under three sub-categories: multi-line solutions, short-tail/monoline specialty lines, and exited lines <sup>p. 94</sup>. |
|||
'''Loss development evaluation categories''' |
|||
* These disaggregated groupings have more homogeneous risk characteristics with similar development patterns and are generally subject to similar trends <sup>p. 94</sup>. |
|||
* ''Short-tail/monoline specialty lines'' include global property & agriculture, accident & health, surety, and professional lines underwriting divisions <sup>p. 94</sup>. |
|||
* These lines generally have shorter durations for losses to fully develop, with claims typically reported, settled, and paid within a relatively short timeframe <sup>p. 94</sup>. |
|||
* Short-tail/monoline specialty lines can be impacted by larger, more complex losses due to factors like difficulty determining actual damages and legal/regulatory impediments <sup>p. 94</sup>. |
|||
* ''Multi-line solutions'' include industry solutions, programs, captives, and transactional E&S underwriting divisions <sup>p. 94</sup>. |
|||
* This subcategory provides multiple products, most frequently as an integrated solution, and is predominantly made up of occurrence liability, including general liability, excess liability, and commercial auto <sup>p. 94</sup>. |
|||
* Multi-line solutions have a longer duration for losses to fully develop compared to short-tail/monoline specialty lines <sup>p. 94</sup>. |
|||
* The unique claim characteristics and longer-tail nature of multi-line solutions introduce more uncertainty, as claims can be impacted by changes in regulation, inflation, and other unforeseen factors over time <sup>p. 94</sup>. |
|||
* ''Exited lines'' include all underwriting units placed in run-off and are presented separately from ongoing lines of business <sup>p. 94</sup>. |
|||
* In 2024, the Company transitioned from evaluating reserves on a policy year basis to an accident year basis <sup>p. 94</sup>. |
|||
* This transition results in earlier recognition of underlying claim trends, better alignment of exposure to risks, and adherence to commonly used industry best practices <sup>p. 94</sup>. |
|||
* In prior years, the Company's methodology allocated IBNR from its policy year analysis to accident year <sup>p. 94</sup>. |
|||
* As a result of transitioning to accident year, IBNR within short-tail/monoline specialty lines, multi-line solutions, and exited lines was reallocated for the years ended December 31, 2023, 2022, 2021, and 2020 <sup>p. 94</sup>. |
|||
* Certain amounts have been conformed to the current year presentation due to the reallocation <sup>p. 94</sup>. |
|||
* For the year ended December 31, 2024, the Company recognized ''adverse development'' related to prior years’ loss and loss expense reserves of $25.7 million <sup>p. 94</sup>. |
|||
* This adverse development was primarily related to losses previously subject to the LPT from accident years 2018 and prior <sup>p. 94</sup>. |
|||
* Of the 2024 adverse development, $10.1 million was in multi-line solutions and $15.2 million was in exited lines <sup>p. 94</sup>. |
|||
* For the year ended December 31, 2023, the Company recognized ''adverse development'' related to prior years’ loss and loss expense reserves of $10.8 million <sup>p. 94</sup>. |
|||
* Adverse development of $11.7 million in multi-line solutions was driven by greater than expected severity in auto, general, and excess liability lines of business, primarily from accident years 2020 to 2022 <sup>p. 94</sup>. |
|||
* This adverse development was partially offset by favorable development in short-tail/monoline specialty lines <sup>p. 94</sup>. |
|||
* The favorable development in short-tail/monoline specialty lines was in the property line of business, primarily from accident years 2021 and 2022 <sup>p. 94</sup>. |
|||
* During the year ended December 31, 2022, the Company’s net incurred losses for accident years 2021 and prior developed adversely by $33.8 million <sup>p. 94</sup>. |
|||
* Adverse development of $20.2 million in exited lines was due to losses previously subject to the LPT from accident years 2018 and prior, and increased frequency and severity in general and professional liability lines from accident years 2019 through 2021 <sup>p. 94</sup>. |
|||
* Adverse development of $13.0 million in multi-line solutions was driven by an increase in the frequency and severity of claims in commercial auto and general liability from accident years 2018 through 2021 <sup>p. 94</sup>. |
|||
* The Company presents loss development on a consolidated basis. |
|||
{{Indexing|Loss and LAE reserve development|Reserves for losses and LAE, reinsurance recoverable on unpaid claims, incurred net of reinsurance, paid net of reinsurance|do9an7x5kp|kind=table|order=164}} |
|||
* Net ultimate loss and LAE are evaluated under three sub-categories: multi-line solutions, short-tail/monoline specialty lines, and exited lines. |
|||
* These disaggregated groupings have more homogeneous risk characteristics with similar development patterns and are generally subject to similar trends. |
|||
* Short-tail/Monoline Specialty Lines include global property & agriculture, accident & health, surety, and professional lines underwriting divisions. |
|||
** These are market niches served with monoline solutions, generally having shorter durations for losses to fully develop. |
|||
** Losses are generally reported within a short period from the date of loss, and claims are often settled and paid within a relatively short timeframe. |
|||
** Can be impacted by larger, more complex losses due to factors like difficulty determining actual damages, and legal/regulatory impediments extending settlement times. |
|||
* Multi-line Solutions include industry solutions, programs, captives, and transactional E&S underwriting divisions. |
|||
** These are market niches where the Company provides multiple products, most frequently as an integrated solution. |
|||
** Predominantly made up of occurrence liability, including general liability, excess liability, and commercial auto. |
|||
** Have a longer duration for losses to fully develop compared to short-tail/monoline specialty lines. |
|||
** Longer-tail nature and unique claim characteristics introduce more uncertainty, as claims can be impacted by changes in regulation, inflation, and other unforeseen factors over time. |
|||
* Exited lines include all underwriting units placed in run-off and are presented separately from ongoing [[Definition:Business mix|lines of business]]. |
|||
{{chunk|doc=vycbjm4dw4|c=276|p=16}} |
|||
'''Reserve evaluation methodology change''' |
|||
* In 2024, the Company transitioned from evaluating reserves on a policy year basis to an accident year basis. |
|||
* This transition results in earlier recognition of underlying claim trends, better alignment of exposure to risks, and adherence to commonly used industry best practices. |
|||
* In prior years, the Company's methodology allocated IBNR from its policy year analysis to accident year. |
|||
* As a result of transitioning to accident year, IBNR within short-tail/monoline specialty lines, multi-line solutions, and exited lines was reallocated for the years ended December 31, 2023, 2022, 2021, and 2020. |
|||
* Certain amounts have been conformed to the current year presentation. |
|||
* A table sets forth the reconciliation of unpaid losses and loss adjustment expenses ("LAE") as reported in the consolidated balance sheets as of and for the years ended December 31, 2024, 2023, and 2022. |
|||
{{chunk|doc=vycbjm4dw4|c=277|p=16}} |
|||
'''Prior year loss and LAE reserve development''' |
|||
* For the year ended December 31, 2024, the Company recognized adverse development related to prior years’ loss and loss expense reserves of USD 25.7m. |
|||
** This was primarily related to losses previously subject to the LPT from accident years 2018 and prior. |
|||
** Multi-line solutions accounted for USD 10.1m of this adverse development. |
|||
** Exited lines accounted for USD 15.2m of this adverse development. |
|||
* For the year ended December 31, 2023, the Company recognized adverse development related to prior years’ loss and loss expense reserves of USD 10.8m. |
|||
** Adverse development of USD 11.7m in multi-line solutions was driven by greater than expected severity in auto, general, and excess liability [[Definition:Business mix|lines of business]], primarily from accident years 2020 to 2022. |
|||
** This adverse development was partially offset by favorable development in short-tail/monoline specialty lines. |
|||
** The favorable development was in the property [[Definition:Business mix|line of business]], primarily from accident years 2021 and 2022. |
|||
* During the year ended December 31, 2022, the Company’s net incurred losses for accident years 2021 and prior developed adversely by USD 33.8m. |
|||
** Adverse development of USD 20.2m in exited lines was due to: |
|||
*** Losses previously subject to the LPT from accident years 2018 and prior. |
|||
*** Increased frequency and severity in general and professional liability lines from accident years 2019 through 2021. |
|||
** Adverse development of USD 13.0m in multi-line solutions was driven by an increase in the frequency and severity of claims in commercial auto and general liability from accident years 2018 through 2021. |
|||
{{chunk|doc=vycbjm4dw4|c=278|p=16}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1076" class="wikitable fintable" |
||
|+ 14. Reserves for Losses and Loss Adjustment Expenses |
|||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col-m" style="text-align:right" | 2024 |
! class="col-m" style="text-align:right" | 2024 |
||
| Line 6,187: | Line 7,432: | ||
| style="text-align:right" | ( 381,338 ) |
| style="text-align:right" | ( 381,338 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Reserves for losses and LAE, beginning of period, net of reinsurance</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>859,017</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>705,771</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>598,211</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Incurred, net of reinsurance, related to:</b> |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 6,207: | Line 7,452: | ||
| style="text-align:right" | 33,849 |
| style="text-align:right" | 33,849 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total incurred, net of reinsurance |
||
| style="text-align:right" | |
| style="text-align:right" | 683,511 |
||
| style="text-align:right" | |
| style="text-align:right" | 516,664 |
||
| style="text-align:right" | |
| style="text-align:right" | 408,324 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Paid, net of reinsurance, related to:</b> |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 6,227: | Line 7,472: | ||
| style="text-align:right" | 194,836 |
| style="text-align:right" | 194,836 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total paid |
||
| style="text-align:right" | |
| style="text-align:right" | 430,991 |
||
| style="text-align:right" | |
| style="text-align:right" | 363,418 |
||
| style="text-align:right" | |
| style="text-align:right" | 300,764 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net reserves for losses and LAE, end of period</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>1,111,537</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>859,017</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>705,771</b> |
||
|- |
|- |
||
| style="text-align:left" | Plus: reinsurance recoverable on unpaid claims, end of period |
| style="text-align:left" | Plus: reinsurance recoverable on unpaid claims, end of period |
||
| Line 6,242: | Line 7,487: | ||
| style="text-align:right" | 435,986 |
| style="text-align:right" | 435,986 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Reserves for losses and LAE, end of period</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>1,782,383</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>1,314,501</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>1,141,757</b> |
||
|} |
|} |
||
</div> |
</div> |
||
=== Short Duration Contract Disclosures === |
|||
{{chunk|doc=vycbjm4dw4|c=279|p=16}} |
|||
* ''Losses and LAE reserves'' represent the Company's best estimate of the ultimate net cost of all reported and unreported losses that are unpaid as of the balance sheet dates <sup>p. 95</sup>. |
|||
'''Losses and LAE reserves estimation''' |
|||
* ''Estimated reserves for losses and LAE'' include accumulated estimates for claims reported and unpaid, projected increases in claims costs for reported claims, claims incurred but not reported, and estimated expenses for investigating and adjusting all incurred and unpaid claims <sup>p. 95</sup>. |
|||
* ''Cumulative reported claims'' are measured by incident <sup>p. 95</sup>. |
|||
* ''Claim counts'' include all reported claims, even if no liability is established for them (i.e., no reserve for loss and loss adjustment expenses) <sup>p. 95</sup>. |
|||
* Losses and LAE reserves represent the Company’s best estimate of the ultimate net cost of all reported and unreported losses that are unpaid as of the balance sheet dates. |
|||
{{Indexing|Incurred losses and ALAE, net of reinsurance|Incurred Losses and Allocated Loss Adjustment Expense (ALAE), IBNR, Reported Claims by Accident Year|hjnlii88rx|kind=table|order=166}} |
|||
* Estimated reserves for losses and LAE include accumulated estimates for claims reported and unpaid prior to the balance sheet dates. |
|||
* Estimated reserves for losses and LAE include estimates (based on projections of relevant historical data) of increases in claims costs for claims already reported. |
|||
* Estimated reserves for losses and LAE include estimates of claims incurred but not reported. |
|||
* Estimated reserves for losses and LAE include estimates of expenses for investigating and adjusting all incurred and unpaid claims. |
|||
* The Company measures claim counts by incident when determining the cumulative number of reported claims. |
|||
* Claim counts include all reported claims, even if the Company does not establish a liability for the claim (i.e., reserve for loss and loss adjustment expenses). |
|||
=== Short-tail/Monoline Specialty Lines === |
|||
{{chunk|doc=vycbjm4dw4|c=280|p=16}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1077" class="wikitable fintable" |
||
|+ Incurred losses and ALAE, net of reinsurance by accident year |
|||
|- |
|||
! colspan="3" style="text-align:center" | ($ in thousands except number of claims) |
! colspan="3" style="text-align:center" | ($ in thousands except number of claims) |
||
! style="text-align: |
! style="text-align:left" | |
||
! style="text-align: |
! style="text-align:left" | |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
! style="text-align: |
! style="text-align:left" | |
||
|- |
|- |
||
! colspan="6" style="text-align:center" | Incurred Losses and Allocated Loss Adjustment Expense (“ALAE”), Net of Reinsurance |
! colspan="6" style="text-align:center" | Incurred Losses and Allocated Loss Adjustment Expense (“ALAE”), Net of Reinsurance |
||
| Line 6,272: | Line 7,527: | ||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="5" style="text-align:center" | Years Ended December 31, |
! colspan="5" style="text-align:center" | Years Ended December 31, |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
! style="text-align: |
! style="text-align:left" | Reported Claims |
||
|- |
|- |
||
! style="text-align:left" | Accident Year |
! style="text-align:left" | Accident Year |
||
! |
! style="text-align:left" | 2020* |
||
! |
! style="text-align:left" | 2021* |
||
! |
! style="text-align:left" | 2022* |
||
! |
! style="text-align:left" | 2023* |
||
! class="col-m" style="text-align:right" | 2024 |
! class="col-m" style="text-align:right" | 2024 |
||
! class="col-m" style="text-align:right" | IBNR |
! class="col-m" style="text-align:right" | IBNR |
||
! |
! style="text-align:left" | Reported Claims |
||
|- |
|- |
||
| style="text-align:left" | 2020 |
| style="text-align:left" | 2020 |
||
| Line 6,291: | Line 7,546: | ||
| style="text-align:right" | 55,305 |
| style="text-align:right" | 55,305 |
||
| style="text-align:right" | 1,147 |
| style="text-align:right" | 1,147 |
||
| style="text-align: |
| style="text-align:left" | 1,311 |
||
|- |
|- |
||
| style="text-align:left" | 2021 |
| style="text-align:left" | 2021 |
||
| Line 6,300: | Line 7,555: | ||
| style="text-align:right" | 92,134 |
| style="text-align:right" | 92,134 |
||
| style="text-align:right" | 6,536 |
| style="text-align:right" | 6,536 |
||
| style="text-align: |
| style="text-align:left" | 1,627 |
||
|- |
|- |
||
| style="text-align:left" | 2022 |
| style="text-align:left" | 2022 |
||
| Line 6,309: | Line 7,564: | ||
| style="text-align:right" | 104,095 |
| style="text-align:right" | 104,095 |
||
| style="text-align:right" | 15,316 |
| style="text-align:right" | 15,316 |
||
| style="text-align: |
| style="text-align:left" | 2,383 |
||
|- |
|- |
||
| style="text-align:left" | 2023 |
| style="text-align:left" | 2023 |
||
| Line 6,318: | Line 7,573: | ||
| style="text-align:right" | 191,865 |
| style="text-align:right" | 191,865 |
||
| style="text-align:right" | 68,001 |
| style="text-align:right" | 68,001 |
||
| style="text-align: |
| style="text-align:left" | 4,880 |
||
|- |
|- |
||
| style="text-align:left" | 2024 |
| style="text-align:left" | 2024 |
||
| Line 6,327: | Line 7,582: | ||
| style="text-align:right" | 280,147 |
| style="text-align:right" | 280,147 |
||
| style="text-align:right" | 161,230 |
| style="text-align:right" | 161,230 |
||
| style="text-align: |
| style="text-align:left" | 4,502 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total |
||
| style="text-align:left" | |
| style="text-align:left" | — |
||
| style="text-align:left" | |
| style="text-align:left" | — |
||
| style="text-align:left" | |
| style="text-align:left" | — |
||
| style="text-align:left" | |
| style="text-align:left" | — |
||
| style="text-align:right" | |
| style="text-align:right" | 723,546 |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
|- |
|- |
||
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
||
| Line 6,345: | Line 7,600: | ||
| style="text-align:right" | ( 359,673 ) |
| style="text-align:right" | ( 359,673 ) |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
|- |
|- |
||
| style="text-align:left" | Net reserves for loss and ALAE before 2020 |
| style="text-align:left" | Net reserves for loss and ALAE before 2020 |
||
| Line 6,354: | Line 7,609: | ||
| style="text-align:right" | 3,353 |
| style="text-align:right" | 3,353 |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total net reserves for loss and ALAE |
||
| style="text-align:left" | |
| style="text-align:left" | Total net reserves for loss and ALAE |
||
| style="text-align:left" | |
| style="text-align:left" | Total net reserves for loss and ALAE |
||
| style="text-align:left" | |
| style="text-align:left" | Total net reserves for loss and ALAE |
||
| style="text-align:left" | |
| style="text-align:left" | Total net reserves for loss and ALAE |
||
| style="text-align:right" | |
| style="text-align:right" | 367,226 |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
|- |
|- |
||
| style="text-align:left" | *Supplementary information and unaudited |
| style="text-align:left" | *Supplementary information and unaudited |
||
| Line 6,372: | Line 7,627: | ||
| style="text-align:right" | *Supplementary information and unaudited |
| style="text-align:right" | *Supplementary information and unaudited |
||
| style="text-align:right" | *Supplementary information and unaudited |
| style="text-align:right" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Cumulative paid losses and ALAE, net of reinsurance|Cumulative Paid Losses and ALAE by Accident Year|hjnlii88rx|kind=table|order=167}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1078" class="wikitable fintable" |
||
|- |
|||
! colspan="3" style="text-align:center" | ($ in thousands) |
! colspan="3" style="text-align:center" | ($ in thousands) |
||
! style="text-align: |
! style="text-align:left" | |
||
! style="text-align: |
! style="text-align:left" | |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
! colspan="6" style="text-align:center" | Cumulative Paid Losses and ALAE, Net of Reinsurance ($ in thousands) |
! colspan="6" style="text-align:center" | Cumulative Paid Losses and ALAE, Net of Reinsurance ($ in thousands) |
||
| Line 6,391: | Line 7,645: | ||
|- |
|- |
||
! style="text-align:left" | Accident Year |
! style="text-align:left" | Accident Year |
||
! |
! style="text-align:left" | 2020* |
||
! |
! style="text-align:left" | 2021* |
||
! |
! style="text-align:left" | 2022* |
||
! |
! style="text-align:left" | 2023* |
||
! class="col-m" style="text-align:right" | 2024 |
! class="col-m" style="text-align:right" | 2024 |
||
|- |
|- |
||
| style="text-align:left" | 2020 |
| style="text-align:left" | 2020 |
||
| style="text-align:left" | 14,002 |
| style="text-align:left" | 14,002 |
||
| style="text-align: |
| style="text-align:left" | 35,479 |
||
| style="text-align: |
| style="text-align:left" | 40,000 |
||
| style="text-align: |
| style="text-align:left" | 43,737 |
||
| style="text-align:right" | 49,688 |
| style="text-align:right" | 49,688 |
||
|- |
|- |
||
| style="text-align:left" | 2021 |
| style="text-align:left" | 2021 |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | 18,447 |
||
| style="text-align: |
| style="text-align:left" | 56,803 |
||
| style="text-align: |
| style="text-align:left" | 67,912 |
||
| style="text-align:right" | 78,439 |
| style="text-align:right" | 78,439 |
||
|- |
|- |
||
| style="text-align:left" | 2022 |
| style="text-align:left" | 2022 |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | 27,773 |
||
| style="text-align: |
| style="text-align:left" | 64,594 |
||
| style="text-align:right" | 77,150 |
| style="text-align:right" | 77,150 |
||
|- |
|- |
||
| style="text-align:left" | 2023 |
| style="text-align:left" | 2023 |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | 33,795 |
||
| style="text-align:right" | 100,705 |
| style="text-align:right" | 100,705 |
||
|- |
|- |
||
| style="text-align:left" | 2024 |
| style="text-align:left" | 2024 |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | 53,691 |
| style="text-align:right" | 53,691 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total |
||
| style="text-align:left" | |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | |
| style="text-align:right" | 359,673 |
||
|- |
|- |
||
| style="text-align:left" | *Supplementary information and unaudited |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align:left" | *Supplementary information and unaudited |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align:right" | *Supplementary information and unaudited |
| style="text-align:right" | *Supplementary information and unaudited |
||
|} |
|} |
||
</div> |
</div> |
||
=== Multi-line Solutions === |
|||
{{Indexing|Incurred losses and ALAE, net of reinsurance|Incurred Losses and ALAE, IBNR, Reported Claims by Accident Year|hjnlii88rx|kind=table|order=168}} |
|||
{{chunk|doc=vycbjm4dw4|c=281|p=16}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1079" class="wikitable fintable" |
||
|+ Incurred losses and ALAE, net of reinsurance by accident year |
|||
|- |
|||
! colspan="5" style="text-align:center" | ($ in thousands except number of claims) |
! colspan="5" style="text-align:center" | ($ in thousands except number of claims) |
||
! style="text-align: |
! style="text-align:left" | |
||
! style="text-align: |
! style="text-align:left" | |
||
! style="text-align: |
! style="text-align:left" | |
||
! style="text-align: |
! style="text-align:left" | |
||
! style="text-align: |
! style="text-align:left" | |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
! colspan="11" style="text-align:center" | Incurred Losses and ALAE, Net of Reinsurance ($ in thousands) |
! colspan="11" style="text-align:center" | Incurred Losses and ALAE, Net of Reinsurance ($ in thousands) |
||
| Line 6,467: | Line 7,725: | ||
! style="text-align:left" | Accident Year |
! style="text-align:left" | Accident Year |
||
! colspan="11" style="text-align:center" | Years Ended December 31, |
! colspan="11" style="text-align:center" | Years Ended December 31, |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Reported Claims |
||
|- |
|- |
||
! style="text-align:left" | Accident Year |
! style="text-align:left" | Accident Year |
||
! |
! style="text-align:left" | 2015* |
||
! |
! style="text-align:left" | 2016* |
||
! |
! style="text-align:left" | 2017* |
||
! |
! style="text-align:left" | 2018* |
||
! |
! style="text-align:left" | 2019* |
||
! |
! style="text-align:left" | 2020* |
||
! |
! style="text-align:left" | 2021* |
||
! |
! style="text-align:left" | 2022* |
||
! |
! style="text-align:left" | 2023* |
||
! class="col-m" style="text-align:right" | 2024 |
! class="col-m" style="text-align:right" | 2024 |
||
! class="col-m" style="text-align:right" | IBNR |
! class="col-m" style="text-align:right" | IBNR |
||
| Line 6,489: | Line 7,747: | ||
| style="text-align:left" | 117,024 |
| style="text-align:left" | 117,024 |
||
| style="text-align:left" | 119,216 |
| style="text-align:left" | 119,216 |
||
| style="text-align: |
| style="text-align:left" | 114,863 |
||
| style="text-align: |
| style="text-align:left" | 115,863 |
||
| style="text-align: |
| style="text-align:left" | 116,413 |
||
| style="text-align: |
| style="text-align:left" | 116,413 |
||
| style="text-align:right" | 117,955 |
| style="text-align:right" | 117,955 |
||
| style="text-align:right" | ( 834 ) |
| style="text-align:right" | ( 834 ) |
||
| Line 6,503: | Line 7,761: | ||
| style="text-align:left" | 62,843 |
| style="text-align:left" | 62,843 |
||
| style="text-align:left" | 62,643 |
| style="text-align:left" | 62,643 |
||
| style="text-align: |
| style="text-align:left" | 84,579 |
||
| style="text-align: |
| style="text-align:left" | 84,579 |
||
| style="text-align: |
| style="text-align:left" | 84,829 |
||
| style="text-align: |
| style="text-align:left" | 84,829 |
||
| style="text-align:right" | 85,434 |
| style="text-align:right" | 85,434 |
||
| style="text-align:right" | 1,276 |
| style="text-align:right" | 1,276 |
||
| Line 6,517: | Line 7,775: | ||
| style="text-align:left" | 65,332 |
| style="text-align:left" | 65,332 |
||
| style="text-align:left" | 64,260 |
| style="text-align:left" | 64,260 |
||
| style="text-align: |
| style="text-align:left" | 78,166 |
||
| style="text-align: |
| style="text-align:left" | 78,166 |
||
| style="text-align: |
| style="text-align:left" | 78,766 |
||
| style="text-align: |
| style="text-align:left" | 78,766 |
||
| style="text-align:right" | 80,493 |
| style="text-align:right" | 80,493 |
||
| style="text-align:right" | 2,105 |
| style="text-align:right" | 2,105 |
||
| Line 6,531: | Line 7,789: | ||
| style="text-align:left" | 74,476 |
| style="text-align:left" | 74,476 |
||
| style="text-align:left" | 74,476 |
| style="text-align:left" | 74,476 |
||
| style="text-align: |
| style="text-align:left" | 69,319 |
||
| style="text-align: |
| style="text-align:left" | 71,719 |
||
| style="text-align: |
| style="text-align:left" | 73,019 |
||
| style="text-align: |
| style="text-align:left" | 73,019 |
||
| style="text-align:right" | 75,686 |
| style="text-align:right" | 75,686 |
||
| style="text-align:right" | 4,856 |
| style="text-align:right" | 4,856 |
||
| Line 6,545: | Line 7,803: | ||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align:left" | 107,432 |
| style="text-align:left" | 107,432 |
||
| style="text-align: |
| style="text-align:left" | 109,226 |
||
| style="text-align: |
| style="text-align:left" | 112,378 |
||
| style="text-align: |
| style="text-align:left" | 115,530 |
||
| style="text-align: |
| style="text-align:left" | 116,230 |
||
| style="text-align:right" | 116,206 |
| style="text-align:right" | 116,206 |
||
| style="text-align:right" | 3,918 |
| style="text-align:right" | 3,918 |
||
| Line 6,559: | Line 7,817: | ||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | 113,030 |
||
| style="text-align: |
| style="text-align:left" | 124,076 |
||
| style="text-align: |
| style="text-align:left" | 128,111 |
||
| style="text-align: |
| style="text-align:left" | 132,495 |
||
| style="text-align:right" | 132,125 |
| style="text-align:right" | 132,125 |
||
| style="text-align:right" | 4,716 |
| style="text-align:right" | 4,716 |
||
| Line 6,573: | Line 7,831: | ||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | 156,067 |
||
| style="text-align: |
| style="text-align:left" | 158,891 |
||
| style="text-align: |
| style="text-align:left" | 160,331 |
||
| style="text-align:right" | 160,546 |
| style="text-align:right" | 160,546 |
||
| style="text-align:right" | 16,119 |
| style="text-align:right" | 16,119 |
||
| Line 6,587: | Line 7,845: | ||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | 236,909 |
||
| style="text-align: |
| style="text-align:left" | 242,097 |
||
| style="text-align:right" | 242,358 |
| style="text-align:right" | 242,358 |
||
| style="text-align:right" | 33,477 |
| style="text-align:right" | 33,477 |
||
| Line 6,601: | Line 7,859: | ||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | 306,511 |
||
| style="text-align:right" | 306,511 |
| style="text-align:right" | 306,511 |
||
| style="text-align:right" | 132,772 |
| style="text-align:right" | 132,772 |
||
| Line 6,615: | Line 7,873: | ||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | 353,933 |
| style="text-align:right" | 353,933 |
||
| style="text-align:right" | 246,281 |
| style="text-align:right" | 246,281 |
||
| style="text-align:right" | 6,557 |
| style="text-align:right" | 6,557 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total |
||
| style="text-align:left" | |
| style="text-align:left" | — |
||
| style="text-align:left" | |
| style="text-align:left" | — |
||
| style="text-align:left" | |
| style="text-align:left" | — |
||
| style="text-align:left" | |
| style="text-align:left" | — |
||
| style="text-align:left" | |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | |
| style="text-align:right" | 1,671,247 |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
||
| Line 6,643: | Line 7,901: | ||
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
||
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
||
| style="text-align: |
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
||
| style="text-align: |
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
||
| style="text-align: |
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
||
| style="text-align: |
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
||
| style="text-align:right" | ( 1,038,650 ) |
| style="text-align:right" | ( 1,038,650 ) |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 6,657: | Line 7,915: | ||
| style="text-align:left" | Net reserves for loss and ALAE before 2015 |
| style="text-align:left" | Net reserves for loss and ALAE before 2015 |
||
| style="text-align:left" | Net reserves for loss and ALAE before 2015 |
| style="text-align:left" | Net reserves for loss and ALAE before 2015 |
||
| style="text-align: |
| style="text-align:left" | Net reserves for loss and ALAE before 2015 |
||
| style="text-align: |
| style="text-align:left" | Net reserves for loss and ALAE before 2015 |
||
| style="text-align: |
| style="text-align:left" | Net reserves for loss and ALAE before 2015 |
||
| style="text-align: |
| style="text-align:left" | Net reserves for loss and ALAE before 2015 |
||
| style="text-align:right" | ( 1,532 ) |
| style="text-align:right" | ( 1,532 ) |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total net reserves for loss and ALAE |
||
| style="text-align:left" | |
| style="text-align:left" | Total net reserves for loss and ALAE |
||
| style="text-align:left" | |
| style="text-align:left" | Total net reserves for loss and ALAE |
||
| style="text-align:left" | |
| style="text-align:left" | Total net reserves for loss and ALAE |
||
| style="text-align:left" | |
| style="text-align:left" | Total net reserves for loss and ALAE |
||
| style="text-align:left" | |
| style="text-align:left" | Total net reserves for loss and ALAE |
||
| style="text-align: |
| style="text-align:left" | Total net reserves for loss and ALAE |
||
| style="text-align: |
| style="text-align:left" | Total net reserves for loss and ALAE |
||
| style="text-align: |
| style="text-align:left" | Total net reserves for loss and ALAE |
||
| style="text-align: |
| style="text-align:left" | Total net reserves for loss and ALAE |
||
| style="text-align:right" | |
| style="text-align:right" | 631,065 |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | *Supplementary information and unaudited |
| style="text-align:left" | *Supplementary information and unaudited |
||
| Line 6,685: | Line 7,943: | ||
| style="text-align:left" | *Supplementary information and unaudited |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align:left" | *Supplementary information and unaudited |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align:right" | *Supplementary information and unaudited |
| style="text-align:right" | *Supplementary information and unaudited |
||
| style="text-align:right" | *Supplementary information and unaudited |
| style="text-align:right" | *Supplementary information and unaudited |
||
| Line 6,694: | Line 7,952: | ||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Cumulative paid losses and ALAE, net of reinsurance|Cumulative paid losses and ALAE, net of reinsurance|kind=table|order=169}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1080" class="wikitable fintable" |
||
|- |
|||
! colspan="4" style="text-align:center" | ($ in thousands) |
! colspan="4" style="text-align:center" | ($ in thousands) |
||
! style="text-align: |
! style="text-align:left" | |
||
! style="text-align: |
! style="text-align:left" | |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
! colspan="11" style="text-align:center" | Cumulative Paid Losses and ALAE, Net of Reinsurance ($ in thousands) |
! colspan="11" style="text-align:center" | Cumulative Paid Losses and ALAE, Net of Reinsurance ($ in thousands) |
||
| Line 6,714: | Line 7,971: | ||
|- |
|- |
||
! style="text-align:left" | Accident Year |
! style="text-align:left" | Accident Year |
||
! |
! style="text-align:left" | 2015* |
||
! |
! style="text-align:left" | 2016* |
||
! |
! style="text-align:left" | 2017* |
||
! |
! style="text-align:left" | 2018* |
||
! |
! style="text-align:left" | 2019* |
||
! class="col-m" style="text-align:right" | 2020* |
! class="col-m" style="text-align:right" | 2020* |
||
! class="col-m" style="text-align:right" | 2021* |
! class="col-m" style="text-align:right" | 2021* |
||
| Line 6,727: | Line 7,984: | ||
| style="text-align:left" | 2015 |
| style="text-align:left" | 2015 |
||
| style="text-align:left" | 44,152 |
| style="text-align:left" | 44,152 |
||
| style="text-align: |
| style="text-align:left" | 72,137 |
||
| style="text-align: |
| style="text-align:left" | 88,833 |
||
| style="text-align: |
| style="text-align:left" | 99,401 |
||
| style="text-align: |
| style="text-align:left" | 108,291 |
||
| style="text-align:right" | 107,214 |
| style="text-align:right" | 107,214 |
||
| style="text-align:right" | 109,622 |
| style="text-align:right" | 109,622 |
||
| Line 6,739: | Line 7,996: | ||
| style="text-align:left" | 2016 |
| style="text-align:left" | 2016 |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | 23,239 |
||
| style="text-align: |
| style="text-align:left" | 42,528 |
||
| style="text-align: |
| style="text-align:left" | 53,352 |
||
| style="text-align: |
| style="text-align:left" | 58,895 |
||
| style="text-align:right" | 69,691 |
| style="text-align:right" | 69,691 |
||
| style="text-align:right" | 72,544 |
| style="text-align:right" | 72,544 |
||
| Line 6,751: | Line 8,008: | ||
| style="text-align:left" | 2017 |
| style="text-align:left" | 2017 |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | 23,770 |
||
| style="text-align: |
| style="text-align:left" | 41,945 |
||
| style="text-align: |
| style="text-align:left" | 53,093 |
||
| style="text-align:right" | 61,354 |
| style="text-align:right" | 61,354 |
||
| style="text-align:right" | 67,926 |
| style="text-align:right" | 67,926 |
||
| Line 6,763: | Line 8,020: | ||
| style="text-align:left" | 2018 |
| style="text-align:left" | 2018 |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | 26,201 |
||
| style="text-align: |
| style="text-align:left" | 42,568 |
||
| style="text-align:right" | 47,226 |
| style="text-align:right" | 47,226 |
||
| style="text-align:right" | 58,655 |
| style="text-align:right" | 58,655 |
||
| Line 6,775: | Line 8,032: | ||
| style="text-align:left" | 2019 |
| style="text-align:left" | 2019 |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | 33,019 |
||
| style="text-align:right" | 50,933 |
| style="text-align:right" | 50,933 |
||
| style="text-align:right" | 71,053 |
| style="text-align:right" | 71,053 |
||
| Line 6,787: | Line 8,044: | ||
| style="text-align:left" | 2020 |
| style="text-align:left" | 2020 |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | 29,499 |
| style="text-align:right" | 29,499 |
||
| style="text-align:right" | 60,680 |
| style="text-align:right" | 60,680 |
||
| Line 6,799: | Line 8,056: | ||
| style="text-align:left" | 2021 |
| style="text-align:left" | 2021 |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 37,118 |
| style="text-align:right" | 37,118 |
||
| Line 6,811: | Line 8,068: | ||
| style="text-align:left" | 2022 |
| style="text-align:left" | 2022 |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 6,823: | Line 8,080: | ||
| style="text-align:left" | 2023 |
| style="text-align:left" | 2023 |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 6,834: | Line 8,091: | ||
|- |
|- |
||
| style="text-align:left" | 2024 |
| style="text-align:left" | 2024 |
||
| style="text-align:left" | — |
|||
| style="text-align:left" | — |
|||
| style="text-align:left" | — |
|||
| style="text-align:left" | — |
|||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 6,839: | Line 8,100: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 58,281 |
|||
|- |
|||
| style="text-align:left" | Total |
|||
| style="text-align:left" | — |
|||
| style="text-align:left" | — |
|||
| style="text-align:left" | — |
|||
| style="text-align:left" | — |
|||
| style="text-align:left" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | 1,038,650 |
||
|- |
|||
| style="text-align:left" | '''Total''' |
|||
| style="text-align:left" | '''—''' |
|||
| style="text-align:right" | '''—''' |
|||
| style="text-align:right" | '''—''' |
|||
| style="text-align:right" | '''—''' |
|||
| style="text-align:right" | '''—''' |
|||
| style="text-align:right" | '''—''' |
|||
| style="text-align:right" | '''—''' |
|||
| style="text-align:right" | '''—''' |
|||
| style="text-align:right" | '''—''' |
|||
| style="text-align:right" | '''1,038,650''' |
|||
|- |
|- |
||
| style="text-align:left" | *Supplementary information and unaudited |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align:left" | *Supplementary information and unaudited |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align:right" | *Supplementary information and unaudited |
| style="text-align:right" | *Supplementary information and unaudited |
||
| style="text-align:right" | *Supplementary information and unaudited |
| style="text-align:right" | *Supplementary information and unaudited |
||
| Line 6,871: | Line 8,128: | ||
</div> |
</div> |
||
=== Exited Lines — all lines in runoff === |
|||
{{Indexing|Exited Lines — all lines in runoff|Reconciliation of net incurred and paid loss development tables to balance sheet reserves, historical average annual payout of incurred losses and allocated loss adjustment expenses, short-duration contracts|do9an7x5kp|j2mg590krh|kind=prose|order=170|f1=Balance sheet reserves for losses and loss adjustment expenses|v1=December 31, 2024 and 2023}} |
|||
{{chunk|doc=vycbjm4dw4|c=282|p=16}} |
|||
* The table presents the reconciliation of net incurred and paid loss development tables to balance sheet reserves for losses and loss adjustment expenses at December 31, 2024 and 2023 <sup>p. 96</sup>. |
|||
'''reconciliation of loss development tables''' |
|||
* The following table shows the historical average annual payout of incurred losses and allocated loss adjustment expenses (claims duration) for short-duration contracts <sup>p. 96</sup>. |
|||
* The payout information is based on disaggregated data from paid loss development tables, net of reinsurance <sup>p. 96</sup>. |
|||
* The table presents the reconciliation of net incurred and paid loss development tables to balance sheet reserves for losses and loss adjustment expenses at December 31, 2024 and 2023. |
|||
{{Indexing|Historical average annual payout of incurred losses and ALAE|Incurred losses and ALAE, net of reinsurance|kind=table|order=171}} |
|||
* The following table sets forth the historical average annual payout of incurred losses and allocated loss adjustment expenses (claims duration) for short-duration contracts, based on disaggregated information in the paid loss development tables, net of reinsurance. |
|||
{{chunk|doc=vycbjm4dw4|c=283|p=16}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1081" class="wikitable fintable" |
||
|+ Incurred losses and ALAE, net of reinsurance by accident year |
|||
|- |
|||
! colspan="4" style="text-align:center" | ($ in thousands except number of claims) |
! colspan="4" style="text-align:center" | ($ in thousands except number of claims) |
||
! style="text-align: |
! style="text-align:left" | |
||
! style="text-align: |
! style="text-align:left" | |
||
! style="text-align: |
! style="text-align:left" | |
||
! style="text-align: |
! style="text-align:left" | |
||
! style="text-align: |
! style="text-align:left" | |
||
! style="text-align: |
! style="text-align:left" | |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
! colspan="11" style="text-align:center" | Incurred Losses and ALAE, Net of Reinsurance ($ in thousands) |
! colspan="11" style="text-align:center" | Incurred Losses and ALAE, Net of Reinsurance ($ in thousands) |
||
| Line 6,897: | Line 8,158: | ||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="11" style="text-align:center" | Years Ended December 31, |
! colspan="11" style="text-align:center" | Years Ended December 31, |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Reported Claims |
||
|- |
|- |
||
! style="text-align:left" | Accident Year |
! style="text-align:left" | Accident Year |
||
! |
! style="text-align:left" | 2015* |
||
! |
! style="text-align:left" | 2016* |
||
! |
! style="text-align:left" | 2017* |
||
! |
! style="text-align:left" | 2018* |
||
! |
! style="text-align:left" | 2019* |
||
! |
! style="text-align:left" | 2020* |
||
! |
! style="text-align:left" | 2021* |
||
! |
! style="text-align:left" | 2022* |
||
! |
! style="text-align:left" | 2023* |
||
! class="col-m" style="text-align:right" | 2024 |
! class="col-m" style="text-align:right" | 2024 |
||
! class="col-m" style="text-align:right" | IBNR |
! class="col-m" style="text-align:right" | IBNR |
||
| Line 6,919: | Line 8,180: | ||
| style="text-align:left" | 70,803 |
| style="text-align:left" | 70,803 |
||
| style="text-align:left" | 75,187 |
| style="text-align:left" | 75,187 |
||
| style="text-align: |
| style="text-align:left" | 79,853 |
||
| style="text-align: |
| style="text-align:left" | 79,853 |
||
| style="text-align: |
| style="text-align:left" | 80,603 |
||
| style="text-align: |
| style="text-align:left" | 80,603 |
||
| style="text-align:right" | 82,092 |
| style="text-align:right" | 82,092 |
||
| style="text-align:right" | 1,145 |
| style="text-align:right" | 1,145 |
||
| Line 6,933: | Line 8,194: | ||
| style="text-align:left" | 91,372 |
| style="text-align:left" | 91,372 |
||
| style="text-align:left" | 93,577 |
| style="text-align:left" | 93,577 |
||
| style="text-align: |
| style="text-align:left" | 97,301 |
||
| style="text-align: |
| style="text-align:left" | 98,301 |
||
| style="text-align: |
| style="text-align:left" | 100,651 |
||
| style="text-align: |
| style="text-align:left" | 100,651 |
||
| style="text-align:right" | 102,801 |
| style="text-align:right" | 102,801 |
||
| style="text-align:right" | 959 |
| style="text-align:right" | 959 |
||
| Line 6,947: | Line 8,208: | ||
| style="text-align:left" | 79,581 |
| style="text-align:left" | 79,581 |
||
| style="text-align:left" | 81,785 |
| style="text-align:left" | 81,785 |
||
| style="text-align: |
| style="text-align:left" | 65,735 |
||
| style="text-align: |
| style="text-align:left" | 68,346 |
||
| style="text-align: |
| style="text-align:left" | 68,646 |
||
| style="text-align: |
| style="text-align:left" | 68,646 |
||
| style="text-align:right" | 70,885 |
| style="text-align:right" | 70,885 |
||
| style="text-align:right" | 1,598 |
| style="text-align:right" | 1,598 |
||
| Line 6,961: | Line 8,222: | ||
| style="text-align:left" | 74,357 |
| style="text-align:left" | 74,357 |
||
| style="text-align:left" | 68,990 |
| style="text-align:left" | 68,990 |
||
| style="text-align: |
| style="text-align:left" | 76,506 |
||
| style="text-align: |
| style="text-align:left" | 79,006 |
||
| style="text-align: |
| style="text-align:left" | 84,165 |
||
| style="text-align: |
| style="text-align:left" | 84,165 |
||
| style="text-align:right" | 92,082 |
| style="text-align:right" | 92,082 |
||
| style="text-align:right" | 5,586 |
| style="text-align:right" | 5,586 |
||
| Line 6,975: | Line 8,236: | ||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align:left" | 87,115 |
| style="text-align:left" | 87,115 |
||
| style="text-align: |
| style="text-align:left" | 73,635 |
||
| style="text-align: |
| style="text-align:left" | 77,770 |
||
| style="text-align: |
| style="text-align:left" | 79,414 |
||
| style="text-align: |
| style="text-align:left" | 79,572 |
||
| style="text-align:right" | 79,823 |
| style="text-align:right" | 79,823 |
||
| style="text-align:right" | 5,786 |
| style="text-align:right" | 5,786 |
||
| Line 6,989: | Line 8,250: | ||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | 132,248 |
||
| style="text-align: |
| style="text-align:left" | 136,469 |
||
| style="text-align: |
| style="text-align:left" | 137,835 |
||
| style="text-align: |
| style="text-align:left" | 137,907 |
||
| style="text-align:right" | 137,671 |
| style="text-align:right" | 137,671 |
||
| style="text-align:right" | 11,424 |
| style="text-align:right" | 11,424 |
||
| Line 7,003: | Line 8,264: | ||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | 83,322 |
||
| style="text-align: |
| style="text-align:left" | 91,188 |
||
| style="text-align: |
| style="text-align:left" | 91,323 |
||
| style="text-align:right" | 92,095 |
| style="text-align:right" | 92,095 |
||
| style="text-align:right" | 10,923 |
| style="text-align:right" | 10,923 |
||
| Line 7,017: | Line 8,278: | ||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | 12,717 |
||
| style="text-align: |
| style="text-align:left" | 12,240 |
||
| style="text-align:right" | 11,800 |
| style="text-align:right" | 11,800 |
||
| style="text-align:right" | 902 |
| style="text-align:right" | 902 |
||
| Line 7,031: | Line 8,292: | ||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 7,040: | Line 8,301: | ||
|- |
|- |
||
| style="text-align:left" | 2024 |
| style="text-align:left" | 2024 |
||
| style="text-align:left" | — |
|||
| style="text-align:left" | — |
|||
| style="text-align:left" | — |
|||
| style="text-align:left" | — |
|||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| Line 7,048: | Line 8,313: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|||
| style="text-align:left" | Total |
|||
| style="text-align:left" | — |
|||
| style="text-align:left" | — |
|||
| style="text-align:left" | — |
|||
| style="text-align:left" | — |
|||
| style="text-align:left" | — |
|||
| style="text-align:left" | — |
|||
| style="text-align:left" | — |
|||
| style="text-align:left" | — |
|||
| style="text-align:left" | — |
|||
| style="text-align:right" | 669,249 |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | '''Total''' |
|||
| style="text-align:left" | '''—''' |
|||
| style="text-align:left" | '''—''' |
|||
| style="text-align:left" | '''—''' |
|||
| style="text-align:left" | '''—''' |
|||
| style="text-align:left" | '''—''' |
|||
| style="text-align:right" | '''—''' |
|||
| style="text-align:right" | '''—''' |
|||
| style="text-align:right" | '''—''' |
|||
| style="text-align:right" | '''—''' |
|||
| style="text-align:right" | '''669,249''' |
|||
| style="text-align:right" | '''—''' |
|||
| style="text-align:right" | '''—''' |
|||
|- |
|- |
||
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
||
| Line 7,073: | Line 8,334: | ||
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
||
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
||
| style="text-align: |
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
||
| style="text-align: |
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
||
| style="text-align: |
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
||
| style="text-align: |
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
||
| style="text-align:right" | ( 597,904 ) |
| style="text-align:right" | ( 597,904 ) |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 7,087: | Line 8,348: | ||
| style="text-align:left" | Net reserves for loss and ALAE before 2015 |
| style="text-align:left" | Net reserves for loss and ALAE before 2015 |
||
| style="text-align:left" | Net reserves for loss and ALAE before 2015 |
| style="text-align:left" | Net reserves for loss and ALAE before 2015 |
||
| style="text-align: |
| style="text-align:left" | Net reserves for loss and ALAE before 2015 |
||
| style="text-align: |
| style="text-align:left" | Net reserves for loss and ALAE before 2015 |
||
| style="text-align: |
| style="text-align:left" | Net reserves for loss and ALAE before 2015 |
||
| style="text-align: |
| style="text-align:left" | Net reserves for loss and ALAE before 2015 |
||
| style="text-align:right" | 15,344 |
| style="text-align:right" | 15,344 |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total net reserves for loss and ALAE |
||
| style="text-align:left" | |
| style="text-align:left" | Total net reserves for loss and ALAE |
||
| style="text-align:left" | |
| style="text-align:left" | Total net reserves for loss and ALAE |
||
| style="text-align:left" | |
| style="text-align:left" | Total net reserves for loss and ALAE |
||
| style="text-align:left" | |
| style="text-align:left" | Total net reserves for loss and ALAE |
||
| style="text-align:left" | |
| style="text-align:left" | Total net reserves for loss and ALAE |
||
| style="text-align: |
| style="text-align:left" | Total net reserves for loss and ALAE |
||
| style="text-align: |
| style="text-align:left" | Total net reserves for loss and ALAE |
||
| style="text-align: |
| style="text-align:left" | Total net reserves for loss and ALAE |
||
| style="text-align: |
| style="text-align:left" | Total net reserves for loss and ALAE |
||
| style="text-align:right" | |
| style="text-align:right" | 86,689 |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | *Supplementary information and unaudited |
| style="text-align:left" | *Supplementary information and unaudited |
||
| Line 7,115: | Line 8,376: | ||
| style="text-align:left" | *Supplementary information and unaudited |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align:left" | *Supplementary information and unaudited |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align:right" | *Supplementary information and unaudited |
| style="text-align:right" | *Supplementary information and unaudited |
||
| style="text-align:right" | *Supplementary information and unaudited |
| style="text-align:right" | *Supplementary information and unaudited |
||
| Line 7,124: | Line 8,385: | ||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Cumulative paid losses and ALAE, net of reinsurance|Cumulative paid losses and ALAE, net of reinsurance|kind=table|order=172}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1082" class="wikitable fintable" |
||
|- |
|||
! colspan="4" style="text-align:center" | ($ in thousands) |
! colspan="4" style="text-align:center" | ($ in thousands) |
||
! style="text-align: |
! style="text-align:left" | |
||
! style="text-align: |
! style="text-align:left" | |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
! colspan="11" style="text-align:center" | Cumulative Paid Losses and ALAE, Net of Reinsurance ($ in thousands) |
! colspan="11" style="text-align:center" | Cumulative Paid Losses and ALAE, Net of Reinsurance ($ in thousands) |
||
| Line 7,144: | Line 8,404: | ||
|- |
|- |
||
! style="text-align:left" | Accident Year |
! style="text-align:left" | Accident Year |
||
! |
! style="text-align:left" | 2015* |
||
! |
! style="text-align:left" | 2016* |
||
! |
! style="text-align:left" | 2017* |
||
! |
! style="text-align:left" | 2018* |
||
! |
! style="text-align:left" | 2019* |
||
! class="col-m" style="text-align:right" | 2020* |
! class="col-m" style="text-align:right" | 2020* |
||
! class="col-m" style="text-align:right" | 2021* |
! class="col-m" style="text-align:right" | 2021* |
||
| Line 7,157: | Line 8,417: | ||
| style="text-align:left" | 2015 |
| style="text-align:left" | 2015 |
||
| style="text-align:left" | 9,026 |
| style="text-align:left" | 9,026 |
||
| style="text-align: |
| style="text-align:left" | 41,653 |
||
| style="text-align: |
| style="text-align:left" | 55,610 |
||
| style="text-align: |
| style="text-align:left" | 65,269 |
||
| style="text-align: |
| style="text-align:left" | 73,100 |
||
| style="text-align:right" | 78,249 |
| style="text-align:right" | 78,249 |
||
| style="text-align:right" | 80,077 |
| style="text-align:right" | 80,077 |
||
| Line 7,169: | Line 8,429: | ||
| style="text-align:left" | 2016 |
| style="text-align:left" | 2016 |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | 36,592 |
||
| style="text-align: |
| style="text-align:left" | 57,638 |
||
| style="text-align: |
| style="text-align:left" | 70,253 |
||
| style="text-align: |
| style="text-align:left" | 78,070 |
||
| style="text-align:right" | 81,181 |
| style="text-align:right" | 81,181 |
||
| style="text-align:right" | 87,482 |
| style="text-align:right" | 87,482 |
||
| Line 7,181: | Line 8,441: | ||
| style="text-align:left" | 2017 |
| style="text-align:left" | 2017 |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | 34,176 |
||
| style="text-align: |
| style="text-align:left" | 52,103 |
||
| style="text-align: |
| style="text-align:left" | 51,985 |
||
| style="text-align:right" | 50,545 |
| style="text-align:right" | 50,545 |
||
| style="text-align:right" | 57,457 |
| style="text-align:right" | 57,457 |
||
| Line 7,193: | Line 8,453: | ||
| style="text-align:left" | 2018 |
| style="text-align:left" | 2018 |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | 25,553 |
||
| style="text-align: |
| style="text-align:left" | 60,149 |
||
| style="text-align:right" | 39,870 |
| style="text-align:right" | 39,870 |
||
| style="text-align:right" | 54,339 |
| style="text-align:right" | 54,339 |
||
| Line 7,205: | Line 8,465: | ||
| style="text-align:left" | 2019 |
| style="text-align:left" | 2019 |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | 28,636 |
||
| style="text-align:right" | 28,954 |
| style="text-align:right" | 28,954 |
||
| style="text-align:right" | 30,948 |
| style="text-align:right" | 30,948 |
||
| Line 7,217: | Line 8,477: | ||
| style="text-align:left" | 2020 |
| style="text-align:left" | 2020 |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | 102,725 |
| style="text-align:right" | 102,725 |
||
| style="text-align:right" | 98,202 |
| style="text-align:right" | 98,202 |
||
| Line 7,229: | Line 8,489: | ||
| style="text-align:left" | 2021 |
| style="text-align:left" | 2021 |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 41,540 |
| style="text-align:right" | 41,540 |
||
| Line 7,241: | Line 8,501: | ||
| style="text-align:left" | 2022 |
| style="text-align:left" | 2022 |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 7,253: | Line 8,513: | ||
| style="text-align:left" | 2023 |
| style="text-align:left" | 2023 |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 7,264: | Line 8,524: | ||
|- |
|- |
||
| style="text-align:left" | 2024 |
| style="text-align:left" | 2024 |
||
| style="text-align:left" | — |
|||
| style="text-align:left" | — |
|||
| style="text-align:left" | — |
|||
| style="text-align:left" | — |
|||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 7,270: | Line 8,534: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|||
| style="text-align:left" | Total |
|||
| style="text-align:left" | — |
|||
| style="text-align:left" | — |
|||
| style="text-align:left" | — |
|||
| style="text-align:left" | — |
|||
| style="text-align:left" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 597,904 |
|||
|- |
|- |
||
| style="text-align:left" | '''Total''' |
|||
| style="text-align:left" | '''—''' |
|||
| style="text-align:right" | '''—''' |
|||
| style="text-align:right" | '''—''' |
|||
| style="text-align:right" | '''—''' |
|||
| style="text-align:right" | '''—''' |
|||
| style="text-align:right" | '''—''' |
|||
| style="text-align:right" | '''—''' |
|||
| style="text-align:right" | '''—''' |
|||
| style="text-align:right" | '''—''' |
|||
| style="text-align:right" | '''597,904''' |
|||
|- |
|||
| style="text-align:left" | *Supplementary information and unaudited |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align:left" | *Supplementary information and unaudited |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align:right" | *Supplementary information and unaudited |
| style="text-align:right" | *Supplementary information and unaudited |
||
| style="text-align:right" | *Supplementary information and unaudited |
| style="text-align:right" | *Supplementary information and unaudited |
||
| Line 7,300: | Line 8,560: | ||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Net reserves for losses and ALAE|Net reserves for losses and ALAE, reinsurance recoverable on unpaid claims, unallocated LAE|kind=table|order=173}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1083" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2024 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2023 |
||
|- |
|- |
||
! style="text-align:left" | Net reserves for losses and ALAE: |
! style="text-align:left" | Net reserves for losses and ALAE: |
||
! class="col-m" style="text-align:right" | |
! class="col-m" style="text-align:right" | |
||
! class="col-m" style="text-align:right" | |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | Short-tail/Monoline Specialty Lines |
| style="text-align:left" | Short-tail/Monoline Specialty Lines |
||
| Line 7,325: | Line 8,584: | ||
| style="text-align:right" | 112,607 |
| style="text-align:right" | 112,607 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Reserves for losses and ALAE, net of reinsurance</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>1,084,980</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>832,897</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Reinsurance recoverable on unpaid claims:</b> |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 7,345: | Line 8,604: | ||
| style="text-align:right" | 4,294 |
| style="text-align:right" | 4,294 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total reinsurance recoverable on unpaid claims |
||
| style="text-align:right" | |
| style="text-align:right" | 670,846 |
||
| style="text-align:right" | |
| style="text-align:right" | 455,484 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Unallocated LAE</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>26,557</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>26,120</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Reserves for losses and LAE at end of year</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>1,782,383</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>1,314,501</b> |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Average annual percentage payout of incurred claims by age|Average annual percentage payout of incurred claims by age, net of reinsurance|kind=table|order=174}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1084" class="wikitable fintable" |
||
|- |
|||
! colspan="11" style="text-align:center" | Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance |
! colspan="11" style="text-align:center" | Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance |
||
|- |
|- |
||
| Line 7,368: | Line 8,626: | ||
! colspan="10" style="text-align:center" | Years |
! colspan="10" style="text-align:center" | Years |
||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
! |
! style="text-align:left" | 1* |
||
! |
! style="text-align:left" | 2* |
||
! |
! style="text-align:left" | 3* |
||
! |
! style="text-align:left" | 4* |
||
! |
! style="text-align:left" | 5* |
||
! |
! style="text-align:left" | 6* |
||
! |
! style="text-align:left" | 7* |
||
! |
! style="text-align:left" | 8* |
||
! |
! style="text-align:left" | 9* |
||
! |
! style="text-align:left" | 10* |
||
|- |
|- |
||
| style="text-align:left" | Short-Tail/Monoline Specialty Lines |
| style="text-align:left" | Short-Tail/Monoline Specialty Lines |
||
| style="text-align: |
| style="text-align:left" | 21.8% |
||
| style="text-align: |
| style="text-align:left" | 37.7% |
||
| style="text-align: |
| style="text-align:left" | 10.8% |
||
| style="text-align: |
| style="text-align:left" | 9.1% |
||
| style="text-align: |
| style="text-align:left" | 10.8% |
||
| style="text-align: |
| style="text-align:left" | N/A |
||
| style="text-align: |
| style="text-align:left" | N/A |
||
| style="text-align: |
| style="text-align:left" | N/A |
||
| style="text-align: |
| style="text-align:left" | N/A |
||
| style="text-align: |
| style="text-align:left" | N/A |
||
|- |
|- |
||
| style="text-align:left" | Multi-line Solutions |
| style="text-align:left" | Multi-line Solutions |
||
| style="text-align: |
| style="text-align:left" | 26.0% |
||
| style="text-align: |
| style="text-align:left" | 22.0% |
||
| style="text-align: |
| style="text-align:left" | 15.0% |
||
| style="text-align: |
| style="text-align:left" | 12.4% |
||
| style="text-align: |
| style="text-align:left" | 9.9% |
||
| style="text-align: |
| style="text-align:left" | 3.7% |
||
| style="text-align: |
| style="text-align:left" | 2.4% |
||
| style="text-align: |
| style="text-align:left" | 1.3% |
||
| style="text-align: |
| style="text-align:left" | 2.0% |
||
| style="text-align: |
| style="text-align:left" | 1.2% |
||
|- |
|- |
||
| style="text-align:left" | Exited Lines |
| style="text-align:left" | Exited Lines |
||
| style="text-align: |
| style="text-align:left" | 29.6% |
||
| style="text-align: |
| style="text-align:left" | 17.1% |
||
| style="text-align: |
| style="text-align:left" | 8.1% |
||
| style="text-align: |
| style="text-align:left" | 9.7% |
||
| style="text-align: |
| style="text-align:left" | 9.2% |
||
| style="text-align: |
| style="text-align:left" | 7.8% |
||
| style="text-align: |
| style="text-align:left" | 4.2% |
||
| style="text-align: |
| style="text-align:left" | 2.4% |
||
| style="text-align: |
| style="text-align:left" | 1.9% |
||
| style="text-align: |
| style="text-align:left" | 1.3% |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>*Supplementary information and unaudited</b> |
||
| style="text-align: |
| style="text-align:left" | <b>*Supplementary information and unaudited</b> |
||
| style="text-align: |
| style="text-align:left" | <b>*Supplementary information and unaudited</b> |
||
| style="text-align: |
| style="text-align:left" | <b>*Supplementary information and unaudited</b> |
||
| style="text-align: |
| style="text-align:left" | <b>*Supplementary information and unaudited</b> |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
|} |
|} |
||
</div> |
</div> |
||
=== 15. Commission and Fee Income === |
|||
{{Indexing|15. Commission and Fee Income|Skyward Underwriters Agency, Inc. (SUA), managing general insurance agent, reinsurance broker, property and casualty, accident and health risks, specialty niche markets, commission and fee income|qfq1t7e6o0|kind=prose|order=175|f1=Subsidiary|v1=Skyward Underwriters Agency, Inc. (SUA)}} |
|||
{{chunk|doc=vycbjm4dw4|c=284|p=16}} |
|||
* ''Skyward Underwriters Agency, Inc. (SUA)'' is a subsidiary of the Company <sup>p. 97</sup>. |
|||
'''Skyward Underwriters Agency, Inc. overview''' |
|||
* SUA functions as a managing general insurance agent and reinsurance broker <sup>p. 97</sup>. |
|||
* SUA specializes in property and casualty and accident and health risks within specialty niche markets <sup>p. 97</sup>. |
|||
* ''Commission and fee income'' is primarily generated by SUA through the placement of insurance policies <sup>p. 97</sup>. |
|||
* These policies are placed with either a third-party insurance or reinsurance company <sup>p. 97</sup>. |
|||
* Skyward Underwriters Agency, Inc. (SUA) is a subsidiary of the Company. |
|||
{{Indexing|Commission and fee income|SUA commission revenue, SUA fee income, other commission and fee income|kind=table|order=176}} |
|||
* SUA functions as a managing general insurance agent and reinsurance broker. |
|||
* SUA specializes in [[Definition:Property & casualty|property and casualty]] and accident and health risks within specialty niche markets. |
|||
* Commission and fee income is primarily generated from SUA for placing insurance policies with third-party insurance or reinsurance companies. |
|||
{{chunk|doc=vycbjm4dw4|c=285|p=16}} |
|||
'''Commission and fee income tables''' |
|||
* A table sets forth the Company’s disaggregated revenues from contracts with customers for the years ended December 31, 2024, 2023, and 2022. |
|||
* A table sets forth the Company’s opening and closing balances of contract assets from commission and fee income for the years ended December 31, 2024, 2023, and 2022. |
|||
{{chunk|doc=vycbjm4dw4|c=286|p=16}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1085" class="wikitable fintable" |
||
|+ 15. Commission and Fee Income |
|||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col-s" style="text-align:right" | 2024 |
! class="col-s" style="text-align:right" | 2024 |
||
| Line 7,462: | Line 8,730: | ||
| style="text-align:right" | 378 |
| style="text-align:right" | 378 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total commission and fee income |
||
| style="text-align:right" | |
| style="text-align:right" | 6,703 |
||
| style="text-align:right" | |
| style="text-align:right" | 6,064 |
||
| style="text-align:right" | |
| style="text-align:right" | 5,199 |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Contract assets|Contract assets|kind=table|order=177}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1086" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col-s" style="text-align:right" | Contract Assets |
! class="col-s" style="text-align:right" | Contract Assets |
||
| Line 7,487: | Line 8,754: | ||
</div> |
</div> |
||
=== 16. Underwriting, Acquisition and Insurance Expenses === |
|||
{{chunk|doc=vycbjm4dw4|c=287|p=16}} |
|||
* ''Underwriting, acquisition and insurance expenses'' components are presented for the years ended December 31, 2024, 2023, and 2022 <sup>p. 98</sup>. |
|||
'''Underwriting, acquisition, and insurance expenses components''' |
|||
* The table sets forth the components of underwriting, acquisition, and insurance expenses for the years ended December 31, 2024, 2023, and 2022. |
|||
{{chunk|doc=vycbjm4dw4|c=288|p=16}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1087" class="wikitable fintable" |
||
|+ 16. Underwriting, Acquisition and Insurance Expenses |
|||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col-s" style="text-align:right" | 2024 |
! class="col-s" style="text-align:right" | 2024 |
||
| Line 7,510: | Line 8,782: | ||
| style="text-align:right" | 116,476 |
| style="text-align:right" | 116,476 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total underwriting, acquisition and insurance expenses |
||
| style="text-align:right" | |
| style="text-align:right" | 311,757 |
||
| style="text-align:right" | |
| style="text-align:right" | 243,444 |
||
| style="text-align:right" | |
| style="text-align:right" | 182,171 |
||
|} |
|} |
||
</div> |
</div> |
||
=== 17. Reinsurance === |
|||
{{Indexing|17. Reinsurance|Reinsurance agreements, loss exposure, funded trust accounts, LPT retroactive reinsurance agreement, R&Q, reinsurance recoverable, deposit asset|20fueoa3q1|tc5fw176pu|kind=prose|order=180|f1=Market value of funded trust accounts|v1=USD 196.9 million at December 31, 2024|f2=LPT retroactive reinsurance agreement|v2=R&Q during the first quarter of 2020|f3=Reinsurance recoverable from R&Q|v3=USD 22.7 million at December 31, 2024|f4=LPT commuted|v4=January 31, 2025|f5=Deposit asset for certain ceded reinsurance contracts|v5=USD 25.9 million at December 31, 2024}} |
|||
{{chunk|doc=vycbjm4dw4|c=289|p=16}} |
|||
* ''Reinsurance agreements'' provide the Company with increased capacity to write larger risks and maintain loss exposure within capital resources <sup>p. 99</sup>. |
|||
'''Reinsurance agreements and recoverables''' |
|||
* The Company remains obligated for amounts ceded if reinsurers fail to meet their obligations <sup>p. 99</sup>. |
|||
* ''Market value of funded trust accounts'' with the Company as sole beneficiary was approximately USD 196.9 million at December 31, 2024 <sup>p. 99</sup>. |
|||
* These trust accounts provide additional security for collecting claim recoverables under reinsurance contracts <sup>p. 99</sup>. |
|||
* The Company does not carry these trust accounts on the balance sheet, as it only has custody upon reinsurer failure to pay <sup>p. 99</sup>. |
|||
* The ''trust amount'' is adjusted periodically by mutual agreement based on claim payments and loss reserve recoverables <sup>p. 99</sup>. |
|||
* The Company entered into an ''LPT retroactive reinsurance agreement'' with R&Q during the first quarter of 2020 <sup>p. 99</sup>. |
|||
* ''Reinsurance recoverable from R&Q'' was USD 22.7 million at December 31, 2024, and USD 20.9 million at December 31, 2023 <sup>p. 99</sup>. |
|||
* The ''LPT was commuted'' effective January 31, 2025, and the Company received the reinsurance recoverable balance in full <sup>p. 99</sup>. |
|||
* ''Deposit asset'' for certain ceded reinsurance contracts was USD 25.9 million at December 31, 2024, and USD 29.9 million at December 31, 2023 <sup>p. 99</sup>. |
|||
* This deposit asset is included in other assets on the consolidated balance sheets <sup>p. 99</sup>. |
|||
* The Company uses reinsurance agreements to increase capacity for larger risks and manage exposure within its capital resources. |
|||
{{Indexing|Premiums and ceded losses and LAE incurred|Direct premiums, assumed premiums, ceded premiums, net premiums, ceded losses and LAE incurred|kind=table|order=181}} |
|||
* The Company remains obligated for ceded amounts if reinsurers fail to meet their obligations. |
|||
* Tables detail the effects of reinsurance on written and earned premiums and losses and loss adjustment expenses for 2024, 2023, and 2022. |
|||
* A table outlines components of reinsurance recoverables and ceded unearned premium as of December 31, 2024, and December 31, 2023. |
|||
{{chunk|doc=vycbjm4dw4|c=290|p=16}} |
|||
'''Reinsurer trust accounts''' |
|||
* The Company has agreements with several reinsurers for funded trust accounts, with the Company as the sole beneficiary. |
|||
* These trust accounts provide additional security for collecting claim recoverables under reinsurance contracts. |
|||
* The Company does not carry these trust accounts on its balance sheet, as custody is only assumed if the reinsurer fails to pay amounts due. |
|||
* As of December 31, 2024, the market value of these accounts was approximately USD 196.9m. |
|||
* The trust amount is periodically adjusted by mutual agreement based on claim payments and loss reserve recoverables. |
|||
{{chunk|doc=vycbjm4dw4|c=291|p=16}} |
|||
'''LPT retroactive reinsurance agreement''' |
|||
* In Q1 2020, the Company entered into an LPT retroactive reinsurance agreement with R&Q. |
|||
* Reinsurance recoverable from R&Q was USD 22.7m at December 31, 2024, and USD 20.9m at December 31, 2023. |
|||
* The LPT was commuted effective January 31, 2025, and the Company received the full reinsurance recoverable balance. |
|||
{{chunk|doc=vycbjm4dw4|c=292|p=16}} |
|||
'''Deposit method accounting for ceded reinsurance''' |
|||
* Certain ceded reinsurance contracts that transfer only significant timing risk and insufficient underwriting risk are accounted for using the deposit method. |
|||
* The Company's deposit asset was USD 25.9m at December 31, 2024, and USD 29.9m at December 31, 2023. |
|||
* This deposit asset was included in other assets on the consolidated balance sheets. |
|||
{{chunk|doc=vycbjm4dw4|c=293|p=16}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1088" class="wikitable fintable" |
||
|+ Net premiums & ceded losses and LAE incurred by Written & Earned |
|||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="2" style="text-align:center" | 2024 |
! colspan="2" style="text-align:center" | 2024 |
||
| Line 7,543: | Line 8,836: | ||
! class="col-m" style="text-align:right" | Written |
! class="col-m" style="text-align:right" | Written |
||
! class="col-m" style="text-align:right" | Earned |
! class="col-m" style="text-align:right" | Earned |
||
! class="col- |
! class="col-m" style="text-align:right" | Written |
||
! class="col- |
! class="col-m" style="text-align:right" | Earned |
||
! class="col- |
! class="col-m" style="text-align:right" | Written |
||
! class="col- |
! class="col-m" style="text-align:right" | Earned |
||
|- |
|- |
||
| style="text-align:left" | Direct premiums |
| style="text-align:left" | Direct premiums |
||
| Line 7,572: | Line 8,865: | ||
| style="text-align:right" | ( 448,737 ) |
| style="text-align:right" | ( 448,737 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net premiums</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>1,123,578</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>1,056,722</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>910,691</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>829,143</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>675,543</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>615,994</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Ceded losses and LAE incurred</b> |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | <b>534,295</b> |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | <b>337,011</b> |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | <b>311,257</b> |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Ceded unpaid losses and LAE|Ceded unpaid losses and LAE, ceded paid losses and LAE, loss portfolio transfer, allowance for credit losses, reinsurance recoverables, ceded unearned premium|kind=table|order=182}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1089" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col- |
! class="col-m" style="text-align:right" | 2024 |
||
! class="col- |
! class="col-m" style="text-align:right" | 2023 |
||
|- |
|- |
||
| style="text-align:left" | Ceded unpaid losses and LAE |
| style="text-align:left" | Ceded unpaid losses and LAE |
||
| Line 7,614: | Line 8,906: | ||
| style="text-align:right" | ( 2,295 ) |
| style="text-align:right" | ( 2,295 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Reinsurance recoverables</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>857,876</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>596,334</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Ceded unearned premium</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>203,901</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>186,121</b> |
||
|} |
|} |
||
</div> |
</div> |
||
=== 18. Stock Based Compensation === |
|||
{{Indexing|18. Stock Based Compensation|2022 Long-Term Incentive Plan, 2020 Plan, restricted stock, restricted stock units, performance stock units, stock options, cash-based performance awards, deferral program, Black-Scholes model, volatility|ebig3opk63|kind=prose|order=183|f1=Plan|v1=2022 Long-Term Incentive Plan|f2=Shares available for issuance|v2=3,200,656|f3=Deferral program approval|v3=November 2024|f4=Grant date fair value of options|v4=Black-Scholes model|f5=Stock options granted to employees|v5=USD 4.4 million|f6=Aggregate intrinsic value of options outstanding|v6=USD 27.0 million at December 31, 2024|f7=Weighted-average remaining contractual life of options outstanding|v7=8.0 years at December 31, 2024}} |
|||
{{chunk|doc=vycbjm4dw4|c=294|p=16}} |
|||
* The ''2022 Long-Term Incentive Plan'' (the "2022 Plan") was approved by the Compensation Committee on September 23, 2022, and became effective on January 12, 2023 <sup>p. 100</sup>. |
|||
'''2022 Long-Term Incentive Plan''' |
|||
* The ''2022 Plan'' allows for granting restricted stock, restricted stock units, performance stock units, stock options, and cash-based performance awards to select employees and non-employee directors <sup>p. 100</sup>. |
|||
* ''3,200,656 shares'' of common stock were available for issuance under the 2022 Plan <sup>p. 100</sup>. |
|||
* In ''November 2024'', the Compensation Committee approved a program for the Board of Directors to defer receipt of annual restricted stock unit awards to the fifth anniversary of the grant date, the tenth anniversary of the grant date, or the date of separation of service <sup>p. 100</sup>. |
|||
* This ''deferral program'' will be available for Directors who opt in for their 2025 grant <sup>p. 100</sup>. |
|||
* The ''grant date fair value of options'' under the 2022 Plan was determined using the Black-Scholes model, with a contractual term of 10 years less the weighted average service period <sup>p. 100</sup>. |
|||
* ''Volatility'' for option valuation was based on historical volatility of comparable publicly traded insurance companies <sup>p. 100</sup>. |
|||
* ''Stock options granted to employees'' during the year ended December 31, 2023, were valued at approximately USD 4.4 million based on grant date fair value <sup>p. 100</sup>. |
|||
* The ''aggregate intrinsic value of options outstanding'' at December 31, 2024, was USD 27.0 million, and at December 31, 2023, was USD 14.3 million <sup>p. 100</sup>. |
|||
* The ''weighted-average remaining contractual life of options outstanding'' at December 31, 2024, was 8.0 years <sup>p. 100</sup>. |
|||
* The ''fair value of restricted stock and restricted stock units'' granted at the time of the Company's IPO under the 2022 Plan was the IPO price of USD 15.00 per share <sup>p. 100</sup>. |
|||
* The ''fair value of subsequent grants'' of restricted stock and restricted stock units was equal to the closing stock price on the grant date <sup>p. 100</sup>. |
|||
* The ''expense for equity-based incentives'' is based on fair value at grant date and amortized over their vesting period <sup>p. 100</sup>. |
|||
* ''Restricted stock and restricted stock units granted to employees and the Board of Directors'' were valued at approximately USD 8.5 million in 2024, USD 17.7 million in 2023, and USD 2.6 million in 2022, based on grant date fair value <sup>p. 100</sup>. |
|||
* ''Board of Directors'' were granted 19,453 shares in 2024, 23,482 shares in 2023, and 15,196 shares in 2022 of restricted stock and restricted stock units, each with a one-year service period <sup>p. 100</sup>. |
|||
* The ''total fair value of shares vested'' for employees and Board members was USD 3.8 million in 2024, USD 0.5 million in 2023, and USD 2.2 million in 2022 <sup>p. 100</sup>. |
|||
* As of ''December 31, 2024'', the total unrecognized compensation cost for non-vested, stock-based compensation awards was USD 13.9 million <sup>p. 100</sup>. |
|||
* The ''weighted average period'' over which this unrecognized cost is expected to be recognized is 1.4 years <sup>p. 100</sup>. |
|||
* The ''Company recognized stock-based compensation expense'' of USD 9.4 million in 2024, USD 8.5 million in 2023, and USD 2.3 million in 2022 <sup>p. 100</sup>. |
|||
* The ''2022 Employee Stock Purchase Plan'' (the "ESPP") was approved by the Compensation Committee on September 23, 2022, and became effective on May 15, 2023 <sup>p. 100</sup>. |
|||
* Under the ''ESPP'', employees can choose to have a percentage of their annual base earnings withheld to purchase common stock at two specified intervals each year <sup>p. 100</sup>. |
|||
* The ''purchase price'' of common stock under the ESPP is 85% of the lower of its beginning-of-interval or end-of-interval market price <sup>p. 100</sup>. |
|||
* The ''Company reserved 376,548 common shares'' under the ESPP <sup>p. 100</sup>. |
|||
* The ''grant date fair value of options'' under the ESPP was determined using the Black-Scholes model, with a term of 6 months (length of time between grant date and exercisable date) <sup>p. 100</sup>. |
|||
* ''Volatility'' for ESPP option valuation was based on historical volatility of comparable publicly traded insurance companies <sup>p. 100</sup>. |
|||
* As of ''December 31, 2024'', 95,266 shares had been purchased under the ESPP <sup>p. 100</sup>. |
|||
* The ''Company recognized ESPP expense'' of USD 0.5 million in 2024 and USD 0.2 million in 2023 <sup>p. 100</sup>. |
|||
* As of ''December 31, 2024'', the fair value of unrecognized ESPP expense was USD 0.3 million <sup>p. 100</sup>. |
|||
* The Company's 2022 Long-Term Incentive Plan (the "2022 Plan") was approved by the Compensation Committee on September 23, 2022, and became effective on January 12, 2023. |
|||
{{Indexing|ESPP expense|Market condition awards, performance condition awards, service condition awards, stock options|kind=table|order=184}} |
|||
* The 2022 Plan replaced the Company’s prior Long Term Incentive Plan (the "2020 Plan"). |
|||
* The 2022 Plan allows for granting restricted stock, restricted stock units, performance stock units, stock options, and cash-based performance awards to select employees and non-employee directors. |
|||
* 3,200,656 shares of common stock were available for issuance under the 2022 Plan. |
|||
* In November 2024, the Compensation Committee approved a program allowing Board of Directors members to defer annual restricted stock unit awards to the fifth anniversary of the grant date, the tenth anniversary of the grant date, or the date of separation from the Company. |
|||
* This deferral program will be available for Directors who opt in for their 2025 grant. |
|||
{{chunk|doc=vycbjm4dw4|c=295|p=16}} |
|||
'''Stock options''' |
|||
* The grant date fair value of options under the 2022 Plan was determined using the Black-Scholes model, with a contractual term of 10 years less the weighted average service period. |
|||
* Volatility for the Black-Scholes model was based on historical volatility of comparable publicly traded insurance companies. |
|||
* Stock options granted to employees during the year ended December 31, 2023, were valued at approximately USD 4.4m based on grant date fair value. |
|||
* The aggregate intrinsic value of options outstanding was USD 27.0m at December 31, 2024, and USD 14.3m at December 31, 2023. |
|||
* The weighted-average remaining contractual life of options outstanding at December 31, 2024, was 8.0 years. |
|||
{{chunk|doc=vycbjm4dw4|c=296|p=16}} |
|||
'''Restricted stock awards and units''' |
|||
* The fair value of restricted stock and restricted stock units under the 2022 Plan for awards granted at the time of the Company’s IPO was the IPO price of USD 15.00 per share. |
|||
* The fair value of subsequent grants was equal to the closing stock price on the grant date. |
|||
* Expense for these equity-based incentives is based on fair value at grant date and amortized over their vesting period. |
|||
* Restricted stock and restricted stock units granted to employees and the Board of Directors were valued at approximately USD 8.5m in 2024, USD 17.7m in 2023, and USD 2.6m in 2022, based on grant date fair value. |
|||
* Board of Directors members were granted 19,453 shares in 2024, 23,482 shares in 2023, and 15,196 shares in 2022, with a service period of one year. |
|||
* The total fair value of shares vested for employees and Board of Directors members was USD 3.8m in 2024, USD 0.5m in 2023, and USD 2.2m in 2022. |
|||
{{chunk|doc=vycbjm4dw4|c=297|p=16}} |
|||
'''Unrecognized compensation cost and expense''' |
|||
* As of December 31, 2024, total unrecognized compensation cost related to non-vested, stock-based compensation awards was USD 13.9m. |
|||
* The weighted average period over which this cost is expected to be recognized is 1.4 years. |
|||
* The Company recognized stock-based compensation expense of USD 9.4m in 2024, USD 8.5m in 2023, and USD 2.3m in 2022. |
|||
{{chunk|doc=vycbjm4dw4|c=298|p=16}} |
|||
'''Employee Stock Purchase Plan (ESPP)''' |
|||
* The Company’s 2022 Employee Stock Purchase Plan (the "ESPP") was approved by the Compensation Committee on September 23, 2022, and became effective on May 15, 2023. |
|||
* Under the ESPP, employees can choose to have a percentage of their annual base earnings withheld to purchase common stock at two specified intervals each year. |
|||
* The purchase price is 85% of the lower of the beginning-of-interval or end-of-interval market price. |
|||
* 376,548 common shares have been reserved under the ESPP. |
|||
* The grant date fair value of options under the ESPP was determined using the Black-Scholes model, with a term of 6 months (length of time between grant date and exercisable date). |
|||
* Volatility for the ESPP Black-Scholes model was based on historical volatility of comparable publicly traded insurance companies. |
|||
* As of December 31, 2024, 95,266 shares had been purchased under the ESPP. |
|||
* The Company recognized ESPP expense of USD 0.5m in 2024 and USD 0.2m in 2023. |
|||
* As of December 31, 2024, the fair value of unrecognized ESPP expense was USD 0.3m. |
|||
{{chunk|doc=vycbjm4dw4|c=299|p=16}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable" |
{| id="t1090" class="wikitable" |
||
|+ 18. Stock Based Compensation |
|||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! style="text-align: |
! style="text-align:right" | Award Payout Range |
||
! style="text-align: |
! style="text-align:right" | Requisite Service Period |
||
! style="text-align: |
! style="text-align:right" | Target Stock and Stock Units |
||
|- |
|- |
||
! style="text-align:left" | Year ended December 31, 2024 |
! style="text-align:left" | Year ended December 31, 2024 |
||
! |
! style="text-align:right" | |
||
! |
! style="text-align:right" | |
||
! |
! style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | Market condition awards |
| style="text-align:left" | Market condition awards |
||
| |
| style="text-align:right" | 0 %– 150 % |
||
| |
| style="text-align:right" | 3 years |
||
| |
| style="text-align:right" | 32,058 |
||
|- |
|- |
||
| style="text-align:left" | Performance condition awards |
| style="text-align:left" | Performance condition awards |
||
| |
| style="text-align:right" | 0 %– 150 % |
||
| |
| style="text-align:right" | 3 years |
||
| |
| style="text-align:right" | 76,881 |
||
|- |
|- |
||
| style="text-align:left" | Service condition awards |
| style="text-align:left" | Service condition awards |
||
| |
| style="text-align:right" | N/A |
||
| |
| style="text-align:right" | 1 – 4 years |
||
| |
| style="text-align:right" | 124,025 |
||
|- |
|- |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | 232,964 |
||
|- |
|||
| style="text-align:left" | <b>Year ended December 31, 2023</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Market condition awards |
| style="text-align:left" | Market condition awards |
||
| |
| style="text-align:right" | 0 %– 150 % |
||
| |
| style="text-align:right" | 3 years |
||
| |
| style="text-align:right" | 37,622 |
||
|- |
|- |
||
| style="text-align:left" | Performance condition awards |
| style="text-align:left" | Performance condition awards |
||
| |
| style="text-align:right" | 0 %– 150 % |
||
| |
| style="text-align:right" | 3 years |
||
| |
| style="text-align:right" | 95,456 |
||
|- |
|- |
||
| style="text-align:left" | Service condition awards |
| style="text-align:left" | Service condition awards |
||
| |
| style="text-align:right" | N/A |
||
| |
| style="text-align:right" | 1 – 4 years |
||
| |
| style="text-align:right" | 968,778 |
||
|- |
|- |
||
| style="text-align:left" | Stock options |
| style="text-align:left" | Stock options |
||
| |
| style="text-align:right" | N/A |
||
| |
| style="text-align:right" | 3 – 4 years |
||
| |
| style="text-align:right" | 759,990 |
||
|- |
|- |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | 1,861,846 |
||
|- |
|||
| style="text-align:left" | <b>Year ended December 31, 2022</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Market condition awards |
| style="text-align:left" | Market condition awards |
||
| |
| style="text-align:right" | 0 %– 150 % |
||
| |
| style="text-align:right" | 3 years |
||
| |
| style="text-align:right" | 28,495 |
||
|- |
|- |
||
| style="text-align:left" | Performance condition awards |
| style="text-align:left" | Performance condition awards |
||
| |
| style="text-align:right" | 0 %– 150 % |
||
| |
| style="text-align:right" | 3 years |
||
| |
| style="text-align:right" | 26,210 |
||
|- |
|- |
||
| style="text-align:left" | Service condition awards |
| style="text-align:left" | Service condition awards |
||
| |
| style="text-align:right" | N/A |
||
| |
| style="text-align:right" | 1 – 3 years |
||
| |
| style="text-align:right" | 144,137 |
||
|- |
|- |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | 198,842 |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Stock outstanding|Stock outstanding|kind=table|order=185}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable |
{| id="t1091" class="wikitable" |
||
|- |
|||
! style="text-align:left" | — |
|||
! |
! style="text-align:left" | |
||
! style="text-align:right" | Stock |
|||
|- |
|- |
||
| style="text-align:left" | Outstanding at January 1, 2024 |
| style="text-align:left" | Outstanding at January 1, 2024 |
||
| style="text-align:right" | 759,990 |
| style="text-align:right" | 759,990 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Outstanding at December 31, 2024</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>759,990</b> |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Stock options|Stock options|kind=table|order=186}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1092" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! style="text-align: |
! style="text-align:left" | Weighted-Average Exercise Price |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Stock |
||
|- |
|- |
||
! style="text-align:left" | Outstanding at January 1, 2023 |
! style="text-align:left" | Outstanding at January 1, 2023 |
||
! |
! style="text-align:left" | |
||
! class="col- |
! class="col-m" style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Granted |
| style="text-align:left" | Granted |
||
| style="text-align: |
| style="text-align:left" | 15.00 |
||
| style="text-align:right" | 759,990 |
| style="text-align:right" | 759,990 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Outstanding at December 31, 2023</b> |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | |
| style="text-align:right" | <b>759,990</b> |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Non-vested stock and stock units|Non-vested stock and stock units|kind=table|order=187}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1093" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | — |
|||
! |
! style="text-align:left" | |
||
! class="col-m" style="text-align:right" | Weighted-Average Grant-Date Fair Value |
|||
! class="col-m" style="text-align:right" | Stock and Stock Units |
! class="col-m" style="text-align:right" | Stock and Stock Units |
||
|- |
|- |
||
| Line 7,798: | Line 9,118: | ||
| style="text-align:right" | ( 102,640 ) |
| style="text-align:right" | ( 102,640 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Non-vested at December 31, 2024</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>19.06</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>1,325,483</b> |
||
|- |
|- |
||
| style="text-align:left" | Non-vested at January 1, 2023 |
| style="text-align:left" | Non-vested at January 1, 2023 |
||
| Line 7,818: | Line 9,138: | ||
| style="text-align:right" | ( 35,658 ) |
| style="text-align:right" | ( 35,658 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Non-vested at December 31, 2023</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>15.13</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>1,445,449</b> |
||
|- |
|- |
||
| style="text-align:left" | Non-vested at January 1, 2022 |
| style="text-align:left" | Non-vested at January 1, 2022 |
||
| Line 7,838: | Line 9,158: | ||
| style="text-align:right" | ( 10,547 ) |
| style="text-align:right" | ( 10,547 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Non-vested at December 31, 2022</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>12.55</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>419,896</b> |
||
|} |
|} |
||
</div> |
</div> |
||
{{fn note|1=1|2=Increases above the 100% target level are reflected as granted in the period after which performance-based stock unit goals are achieved.}} |
|||
{{fn note|1=2|2=Decreases below the 100% target level are reflected as forfeited.}} |
|||
=== 19. Earnings Per Share === |
|||
{{Indexing|19. Earnings Per Share|Preferred shares, participating securities, dividends, distributions, common stock, employee stock options, diluted EPS calculations|v7ij6av24f|kind=prose|order=188}} |
|||
{{chunk|doc=vycbjm4dw4|c=300|p=16}} |
|||
* The Company's preferred shares are considered participating securities as they participate in dividends and distributions with common stock on an as-converted basis <sup>p. 101</sup>. |
|||
'''Earnings per share calculation basis''' |
|||
* Instruments granted to employees that allow the purchase of common stock at a fixed price were included as potential common shares in diluted EPS calculations, weighted for the period granted, if dilutive <sup>p. 101</sup>. |
|||
* The table presents the compilation of basic and diluted net earnings per share for the years ended December 31, 2024, 2023, and 2022. |
|||
{{Indexing|Earnings per share|Net income, undistributed income, net income attributable to common stockholders, basic weighted-average common shares, dilutive effect of preferred shares, dilutive effect of stock notes|kind=table|order=189}} |
|||
* The Company's preferred shares are participating securities, sharing in [[Definition:Dividend|dividends]] and distributions with common stock on an as-converted basis. |
|||
* Instruments granted to employees that allow the purchase of common stock at a fixed price were included as potential common shares, weighted for the portion of the period they were granted, if dilutive. |
|||
* The table presents anti-dilutive instruments excluded from the calculation of diluted weighted-average common share equivalents for the years ended December 31, 2024, 2023, and 2022. |
|||
* The table presents common share equivalents of contingently issuable instruments excluded from basic earnings per share for the years ended December 31, 2024, 2023, and 2022. |
|||
{{chunk|doc=vycbjm4dw4|c=301|p=16}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1094" class="wikitable fintable" |
||
|+ 19. Earnings Per Share |
|||
|- |
|||
! style="text-align:left" | ($ in thousands, except for share and per share amounts) |
! style="text-align:left" | ($ in thousands, except for share and per share amounts) |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2024 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2023 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2022 |
||
|- |
|- |
||
! style="text-align:left" | Numerator |
! style="text-align:left" | Numerator |
||
! class="col-m" style="text-align:right" | |
! class="col-m" style="text-align:right" | |
||
! class="col-m" style="text-align:right" | |
! class="col-m" style="text-align:right" | |
||
! class="col-m" style="text-align:right" | |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | Net income |
| style="text-align:left" | Net income |
||
| Line 7,886: | Line 9,214: | ||
| style="text-align:right" | 18,879 |
| style="text-align:right" | 18,879 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net income (numerator for diluted earnings per share under the two-class method)</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>118,828</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>85,984</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>39,396</b> |
||
|- |
|||
| style="text-align:left" | <b>Denominator</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Basic weighted-average common shares |
| style="text-align:left" | Basic weighted-average common shares |
||
| Line 7,916: | Line 9,249: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Diluted weighted-average common share equivalents</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>41,377,460</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>38,317,534</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>32,653,194</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Basic earnings per share</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>2.97</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>2.34</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>1.24</b> |
||
|- |
|- |
||
| style="text-align:left" | Diluted earnings per share |
| style="text-align:left" | Diluted earnings per share |
||
| Line 7,932: | Line 9,265: | ||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Stock notes, stock units, and options|Stock notes, stock units, options|kind=table|order=190}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1095" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | — |
|||
! style="text-align:left" | |
|||
! class="col-s" style="text-align:right" | 2024 |
! class="col-s" style="text-align:right" | 2024 |
||
! class="col-s" style="text-align:right" | 2023 |
! class="col-s" style="text-align:right" | 2023 |
||
| Line 7,958: | Line 9,290: | ||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Common and preferred shares|Common shares, preferred shares|kind=table|order=191}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1096" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | — |
|||
! style="text-align:left" | |
|||
! class="col-s" style="text-align:right" | 2024 |
! class="col-s" style="text-align:right" | 2024 |
||
! class="col-s" style="text-align:right" | 2023 |
! class="col-s" style="text-align:right" | 2023 |
||
| Line 7,978: | Line 9,309: | ||
| style="text-align:right" | 1,059,602 |
| style="text-align:right" | 1,059,602 |
||
|- |
|- |
||
| class="wt-indent-1" style="text-align:left" | |
| class="wt-indent-1" style="text-align:left" | Total |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | 920,864 |
||
| style="text-align:right" | |
| style="text-align:right" | 1,082,521 |
||
|} |
|} |
||
</div> |
</div> |
||
=== 20. Employee Benefit Plan === |
|||
{{Indexing|20. Employee Benefit Plan|401(k) Plan, Employee Retirement Income Security Act of 1974, employee contributions, matching contributions|ebig3opk63|kind=prose|order=192|f1=Matching contributions|v1=USD 3.2m for the year ended December 31, 2024}} |
|||
{{chunk|doc=vycbjm4dw4|c=302|p=16}} |
|||
* The Company sponsors the 401(k) Plan (the "Plan") <sup>p. 102</sup>. |
|||
'''401(k) plan contributions''' |
|||
* The Plan is available to substantially all of the Company's employees <sup>p. 102</sup>. |
|||
* The Plan is subject to the provisions of the Employee Retirement Income Security Act of 1974 <sup>p. 102</sup>. |
|||
* The Company matches employee contributions on a discretionary basis <sup>p. 102</sup>. |
|||
* ''Matching contributions'' to the Plan were USD 3.2m for the year ended December 31, 2024 <sup>p. 102</sup>. |
|||
* ''Matching contributions'' to the Plan were USD 2.9m for the year ended December 31, 2023 <sup>p. 102</sup>. |
|||
* ''Matching contributions'' to the Plan were USD 2.4m for the year ended December 31, 2022 <sup>p. 102</sup>. |
|||
* The Company sponsors the 401(k) Plan (the "Plan"), available to substantially all employees. |
|||
{{Indexing|Riscom|RISCOM, wholesale brokerage services, managing general agency agreement, premiums receivable|1eit26wk5c|kind=prose|order=193|f1=Ownership interest in RISCOM|v1=20%|f2=Premiums receivable|v2=December 31, 2024: $12.6 million}} |
|||
* The Plan is subject to the Employee Retirement Income Security Act of 1974. |
|||
* The Company makes discretionary matching contributions to the Plan. |
|||
* Company matching contributions to the Plan were USD 3.2m in 2024, USD 2.9m in 2023, and USD 2.4m in 2022. |
|||
=== RISCOM === |
|||
* RISCOM provides the Company with wholesale brokerage services <sup>p. 103</sup>. |
|||
* RISCOM and the Company have a managing general agency agreement <sup>p. 103</sup>. |
|||
* The Company holds a ''20% ownership interest'' in RISCOM <sup>p. 103</sup>. |
|||
* ''Premiums receivable'' as of December 31, 2024, were $12.6 million <sup>p. 103</sup>. |
|||
* ''Premiums receivable'' as of December 31, 2023, were $10.6 million <sup>p. 103</sup>. |
|||
{{chunk|doc=vycbjm4dw4|c=303|p=16}} |
|||
{{Indexing|Premiums receivable and commissions for 2022-2024|Net earned premium, commissions|wpkf9ycgxf|kind=table|order=194}} |
|||
'''RISCOM relationship and transactions''' |
|||
* RISCOM provides wholesale brokerage services to the Company. |
|||
* RISCOM and the Company have a managing general agency agreement. |
|||
* The Company holds a 20% ownership interest in RISCOM. |
|||
* Net earned premium and gross commission expense related to these agreements for the years ended December 31, 2024, 2023, and 2022 were as follows. |
|||
* Premiums receivable as of December 31, 2024, were USD 12.6m. |
|||
* Premiums receivable as of December 31, 2023, were USD 10.6m. |
|||
{{chunk|doc=vycbjm4dw4|c=304|p=16}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1097" class="wikitable fintable" |
||
|+ RISCOM |
|||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col-s" style="text-align:right" | 2024 |
! class="col-s" style="text-align:right" | 2024 |
||
| Line 8,024: | Line 9,361: | ||
</div> |
</div> |
||
=== Other === |
|||
{{Indexing|Other|Advisory and professional services fees, expense reimbursements, affiliated stockholders, directors, affiliated companies, related party transactions, common shares, preferred shares|1eit26wk5c|kind=prose|order=195|f1=Advisory and professional services fees and expense reimbursements|v1=2024: USD 0.6m}} |
|||
{{chunk|doc=vycbjm4dw4|c=305|p=16}} |
|||
* ''Advisory and professional services fees and expense reimbursements'' paid to affiliated stockholders and directors were USD 0.6m in 2024, USD 3.6m in 2023, and USD 3.4m in 2022 <sup>p. 104</sup>. |
|||
'''Advisory and professional services fees''' |
|||
* Investments involving affiliated companies and additional related party transactions are detailed in Notes 5, 6, and 10 <sup>p. 104</sup>. |
|||
* Related party transactions concerning the Company’s common and preferred shares are detailed in Note 11 <sup>p. 104</sup>. |
|||
* Advisory and professional services fees and expense reimbursements paid to affiliated stockholders and directors were USD 0.6m in 2024, USD 3.6m in 2023, and USD 3.4m in 2022. |
|||
{{Indexing|Litigation|Legal actions, claims under insurance policies and contracts, bad faith claims, disputes with third parties, alleged errors and omissions|nad00g0zfb|kind=prose|order=196}} |
|||
{{chunk|doc=vycbjm4dw4|c=306|p=16}} |
|||
* The Company is a defendant in various legal actions related to claims under insurance policies and contracts <sup>p. 105</sup>. |
|||
'''Related party transactions references''' |
|||
* These actions are considered when estimating losses and loss adjustment expense reserves <sup>p. 105</sup>. |
|||
* The Company is also a defendant in legal actions concerning bad faith claims, disputes with third parties, or alleged errors and omissions <sup>p. 105</sup>. |
|||
* Accruals for these items are recorded when losses are probable and reasonably estimable <sup>p. 105</sup>. |
|||
* Based on current information, available insurance coverage, and advice from outside legal counsel, the Company believes the resolution of these matters will not have a material adverse effect on its consolidated financial position, results of operations, or cash flows, individually or in the aggregate <sup>p. 105</sup>. |
|||
* Notes 5, 6, and 10 provide information on investments involving affiliated companies and additional related party transactions. |
|||
{{Indexing|Indemnification|Indemnifications, sale of business assets, subsidiaries, representations and warranties, performance responsibilities, sales contracts|wugbjvah7b|kind=prose|order=197}} |
|||
* Note 11 details related party transactions concerning the Company’s common and preferred shares. |
|||
=== Litigation === |
|||
* The Company has provided ''indemnifications'' to certain buyers in conjunction with the sale of business assets and subsidiaries <sup>p. 106</sup>. |
|||
* These indemnifications cover typical ''representations and warranties'' related to performance responsibilities under sales contracts <sup>p. 106</sup>. |
|||
* The ''potential exposure'' covered by these indemnifications is difficult to determine due to the variety of matters, operations, and scenarios covered <sup>p. 106</sup>. |
|||
* Some of these indemnifications have ''no time limit'' <sup>p. 106</sup>. |
|||
* The Company currently has ''no reason to believe'' any significant claims exist related to these indemnifications <sup>p. 106</sup>. |
|||
{{chunk|doc=vycbjm4dw4|c=307|p=16}} |
|||
{{Indexing|23. Statutory Accounting Principles and Regulatory Matters|Statutory net income, statutory capital and surplus, GMIC, HSIC, IIC, OSIC, dividend payments, Texas state law, Risk Based Capital (RBC) requirements, National Association of Insurance Commissioners (NAIC)|1nma8v7gjs|2k28wtsk07|cmtswfs0go|kind=prose|order=198|f1=Statutory net income|v1=2024: USD 108.2m|f2=Statutory capital and surplus|v2=December 31, 2024: USD 710.6m|f3=Lead insurance company|v3=GMIC}} |
|||
'''legal actions and reserves''' |
|||
* The Company is a defendant in various legal actions arising from claims under insurance policies and contracts. |
|||
* The Company’s ''statutory net income'' was USD 108.2m for 2024, USD 73.1m for 2023, and USD 50.5m for 2022 <sup>p. 107</sup>. |
|||
* These actions are considered when estimating losses and loss adjustment expense reserves. |
|||
* The Company’s ''statutory capital and surplus'' was USD 710.6m as of December 31, 2024, and USD 602.9m as of December 31, 2023 <sup>p. 107</sup>. |
|||
* The Company is also a defendant in legal actions related to bad faith claims, disputes with third parties, or alleged errors and omissions. |
|||
* Effective December 31, 2024, the Company restacked its insurance company subsidiaries, making GMIC the lead insurance company <sup>p. 107</sup>. |
|||
* Accruals for these items are recorded when losses are probable and reasonably estimable. |
|||
* Following the restacking, ''HSIC'' became a wholly owned subsidiary of GMIC <sup>p. 107</sup>. |
|||
* Based on present information, available insurance coverage, and advice from outside legal counsel, the Company believes the resolution of these matters will not, individually or in aggregate, materially adversely affect its consolidated financial position, results of operations, or cash flows. |
|||
* Following the restacking, ''IIC'' became a wholly owned subsidiary of HSIC <sup>p. 107</sup>. |
|||
* Following the restacking, ''OSIC'' became a wholly owned subsidiary of IIC <sup>p. 107</sup>. |
|||
* ''Dividend payments'' to the Company from GMIC are restricted by Texas state law, requiring regulatory approval for amounts exceeding certain limits related to policyholder surplus, net income, and dividends declared in the preceding 12 months <sup>p. 107</sup>. |
|||
* As of December 31, 2024, ''GMIC'' was not restricted from paying ordinary dividends <sup>p. 107</sup>. |
|||
* ''GMIC'' did not declare or pay any dividend during the year ended December 31, 2024 <sup>p. 107</sup>. |
|||
* ''HSIC'' did not declare or pay any dividends during the year ended December 31, 2023 <sup>p. 107</sup>. |
|||
* Property and casualty insurance companies are subject to ''Risk Based Capital (RBC) requirements'' specified by the National Association of Insurance Commissioners (NAIC) <sup>p. 107</sup>. |
|||
* As of December 31, 2024, ''GMIC’s statutory capital and surplus'' substantially exceeded regulatory requirements <sup>p. 107</sup>. |
|||
* As of December 31, 2023, ''HSIC’s statutory capital and surplus'' substantially exceeded regulatory requirements <sup>p. 107</sup>. |
|||
=== Indemnification === |
|||
{{Indexing|24. Subsequent Events|Skyward Re, Loss Portfolio Transfer, Adverse Development and Retrocession Agreement, R&Q, Commutation Agreement, LPT loss reserves, paid loss reinsurance recoverable, allowance for estimated uncollectible reinsurance, deferred gain|ogfk3mnpww|kind=prose|order=199|f1=Commutation date|v1=January 31, 2025|f2=Cash received by Skyward Re|v2=$11.7 million|f3=LPT loss reserves strengthened|v3=December 31, 2024: $25.3 million|f4=Paid loss reinsurance recoverable increased|v4=$25.3 million|f5=Allowance for estimated uncollectible reinsurance increased|v5=$13.6 million|f6=Deferred gain recognized|v6=$2.0 million}} |
|||
{{chunk|doc=vycbjm4dw4|c=308|p=16}} |
|||
* On ''January 31, 2025'', Skyward Re commuted its existing Loss Portfolio Transfer and Adverse Development and Retrocession Agreement, dated April 1, 2020, with R&Q <sup>p. 108</sup>. |
|||
'''Indemnification for asset sales''' |
|||
* The commutation was pursuant to a Commutation Agreement, and Skyward Re received ''$11.7 million'' in cash <sup>p. 108</sup>. |
|||
* At ''December 31, 2024'', the Company strengthened LPT loss reserves and increased the paid loss reinsurance recoverable by ''$25.3 million'' <sup>p. 108</sup>. |
|||
* The Company has provided indemnifications to certain buyers in conjunction with the sale of business assets and subsidiaries. |
|||
* The Company increased the allowance for estimated uncollectible reinsurance by ''$13.6 million'', which was subsequently written-off during the year ended December 31, 2024 <sup>p. 108</sup>. |
|||
* Certain indemnifications cover typical representations and warranties related to responsibilities under sales contracts. |
|||
* The Company recognized a deferred gain of ''$2.0 million'' <sup>p. 108</sup>. |
|||
* The potential exposure from these indemnifications is difficult to determine due to the variety of matters, operations, and scenarios covered. |
|||
* Some indemnifications have no time limit. |
|||
* The Company currently believes no significant claims exist related to these indemnifications. |
|||
=== 23. Statutory Accounting Principles and Regulatory Matters === |
|||
{{chunk|doc=vycbjm4dw4|c=309|p=16}} |
|||
'''Statutory financial performance''' |
|||
* Statutory net income: USD 108.2m for 2024; USD 73.1m for 2023; USD 50.5m for 2022. |
|||
* Statutory capital and surplus: USD 710.6m as of December 31, 2024; USD 602.9m as of December 31, 2023. |
|||
{{chunk|doc=vycbjm4dw4|c=310|p=16}} |
|||
'''Insurance subsidiary restructuring''' |
|||
* Effective December 31, 2024, the Company restacked its insurance company subsidiaries, making GMIC the lead insurance company. |
|||
* HSIC became a wholly owned subsidiary of GMIC. |
|||
* IIC became a wholly owned subsidiary of HSIC. |
|||
* OSIC became a wholly owned subsidiary of IIC. |
|||
{{chunk|doc=vycbjm4dw4|c=311|p=16}} |
|||
'''[[Definition:Dividend|Dividend]] restrictions and payments''' |
|||
* [[Definition:Dividend|Dividend]] payments to the Company from GMIC are restricted by Texas state law regarding amounts payable without regulatory approval. |
|||
* Maximum [[Definition:Dividend|dividend]] amount payable by GMIC without prior approval is subject to restrictions related to policyholder surplus, net income, and [[Definition:Dividend|dividends]] declared/distributed in the preceding 12 months. |
|||
* As of December 31, 2024, GMIC is not restricted from paying ordinary [[Definition:Dividend|dividends]]. |
|||
* GMIC did not declare or pay any [[Definition:Dividend|dividend]] during the year ended December 31, 2024. |
|||
* HSIC did not declare or pay any [[Definition:Dividend|dividends]] during the year ended December 31, 2023. |
|||
{{chunk|doc=vycbjm4dw4|c=312|p=16}} |
|||
'''Risk Based Capital requirements''' |
|||
* [[Definition:Property & casualty|Property and casualty]] insurance companies are subject to Risk Based Capital (RBC) requirements specified by the National Association of Insurance Commissioners (NAIC). |
|||
* RBC requirements determine the amount of capital and surplus based on various risk factors. |
|||
* As of December 31, 2024, GMIC’s statutory capital and surplus substantially exceeded regulatory requirements. |
|||
* As of December 31, 2023, HSIC’s statutory capital and surplus substantially exceeded regulatory requirements. |
|||
=== 24. Subsequent Events === |
|||
{{chunk|doc=vycbjm4dw4|c=313|p=16}} |
|||
'''Skyward Re commutation with R&Q''' |
|||
* On January 31, 2025, Skyward Re commuted its existing Loss Portfolio Transfer and Adverse Development and Retrocession Agreement, dated April 1, 2020, with R&Q via a Commutation Agreement. |
|||
* Skyward Re received USD 11.7m in cash from the commutation. |
|||
* At December 31, 2024, the Company strengthened LPT loss reserves and increased the paid loss reinsurance recoverable by USD 25.3m. |
|||
* At December 31, 2024, the Company increased the allowance for estimated uncollectible reinsurance by USD 13.6m, which was subsequently written-off during the year ended December 31, 2024. |
|||
* At December 31, 2024, the Company recognized a deferred gain of USD 2.0m. |
|||
== Controls and Procedures == |
== Controls and Procedures == |
||
=== Evaluation of Disclosure Controls and Procedures === |
|||
{{Indexing|Evaluation of Disclosure Controls and Procedures|Disclosure controls and procedures, Securities Exchange Act of 1934, material weakness, internal control over financial reporting, financial statements, U.S. GAAP|l96bfbct4s|kind=prose|order=200|f1=Disclosure controls and procedures effectiveness|v1=Not effective as of December 31, 2024}} |
|||
{{chunk|doc=vycbjm4dw4|c=314|p=17}} |
|||
* ''Management evaluation'' of disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934) was conducted as of the end of the period covered by this Annual Report on Form 10-K <sup>p. 109</sup>. |
|||
'''Disclosure controls and procedures evaluation''' |
|||
* ''Principal executive officer and principal financial officer'' concluded that as of December 31, 2024, disclosure controls and procedures were not effective due to a material weakness in internal control over financial reporting <sup>p. 109</sup>. |
|||
* ''Management'' does not believe the identified material weakness adversely affected reported operating results or financial condition <sup>p. 109</sup>. |
|||
* ''Management'' determined that the financial statements and other information in this report and other periodic filings fairly present the company's financial condition, results of operations, and cash flows for the periods presented in accordance with U.S. GAAP <sup>p. 109</sup>. |
|||
* Management, including the principal executive officer and principal financial officer, evaluated the effectiveness of disclosure controls and procedures as of the end of the period covered by the Annual Report on Form 10-K. |
|||
{{Indexing|Management’s Report on Internal Control over Financial Reporting|Internal control over financial reporting, Securities Exchange Act of 1934, U.S. GAAP, COSO's Internal Control—Integrated Framework (2013), material weakness, information technology general controls|l96bfbct4s|kind=prose|order=201|f1=Internal control over financial reporting effectiveness|v1=Not effective as of December 31, 2024}} |
|||
* As of December 31, 2024, the disclosure controls and procedures were concluded to be not effective due to a material weakness in internal control over financial reporting. |
|||
* Despite the identified material weakness, management does not believe it adversely affected reported operating results or financial condition. |
|||
* Management determined that the financial statements and other information in the report and other periodic filings fairly present the financial condition, results of operations, and cash flows for the periods presented in accordance with U.S. GAAP. |
|||
=== Management’s Report on Internal Control over Financial Reporting === |
|||
* ''Management'' is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934 <sup>p. 110</sup>. |
|||
* ''Internal control over financial reporting'' is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. GAAP <sup>p. 110</sup>. |
|||
* ''Internal control over financial reporting'' includes policies and procedures that pertain to maintaining records that accurately reflect transactions and asset dispositions <sup>p. 110</sup>. |
|||
* ''Internal control over financial reporting'' provides reasonable assurance that transactions are recorded for financial statement preparation in accordance with GAAP, and that receipts and expenditures align with management and director authorizations <sup>p. 110</sup>. |
|||
* ''Internal control over financial reporting'' provides reasonable assurance regarding the prevention or timely detection of unauthorized acquisition, use, or disposition of assets that could materially affect financial statements <sup>p. 110</sup>. |
|||
* ''Management assessed the effectiveness of internal control over financial reporting'' as of December 31, 2024, using criteria from COSO's Internal Control—Integrated Framework (2013) <sup>p. 110</sup>. |
|||
* ''Management concluded'' that as of December 31, 2024, its internal control over financial reporting was not effective due to a material weakness <sup>p. 110</sup>. |
|||
* ''A material weakness'' is a deficiency, or combination of deficiencies, in internal control over financial reporting, where there is a reasonable possibility that a material misstatement of annual or interim financial statements will not be prevented or detected timely <sup>p. 110</sup>. |
|||
* ''A material weakness existed'' as of December 31, 2024, related to the ineffective implementation of information technology general controls (ITGCs) in user access for systems supporting financial reporting processes <sup>p. 110</sup>. |
|||
* ''Related process-level IT dependent manual and automated controls'' that rely on affected ITGCs or information from IT systems with affected ITGCs were also deemed ineffective <sup>p. 110</sup>. |
|||
* ''The material weakness'' did not result in any material misstatements to the financial statements in this Form 10-K <sup>p. 110</sup>. |
|||
* ''No changes'' were identified as required for previously issued financial statements <sup>p. 110</sup>. |
|||
* ''Substantive procedures'' for the year ended December 31, 2024, have been completed <sup>p. 110</sup>. |
|||
* ''Management believes'' that the consolidated financial statements in this Form 10-K have been prepared in accordance with U.S. GAAP <sup>p. 110</sup>. |
|||
* ''The CEO and CFO certified'' that the financial statements and other financial information in this Form 10-K fairly present the financial condition, results of operations, and cash flows for the periods presented <sup>p. 110</sup>. |
|||
* ''Ernst & Young LLP'' issued an unqualified opinion on the financial statements, included in Item 8 of this Form 10-K <sup>p. 110</sup>. |
|||
* ''Ernst & Young LLP'' also issued a report on internal control over financial reporting as of December 31, 2024, which appears in Item 8 <sup>p. 110</sup>. |
|||
{{chunk|doc=vycbjm4dw4|c=315|p=17}} |
|||
{{Indexing|Planned Material Weakness Remediation Activities|Control deficiencies, material weakness, ITGCs, user access, IT compliance oversight function, training program, documentation, IT management review and testing plan, quarterly reporting, Audit Committee|l96bfbct4s|kind=prose|order=202}} |
|||
'''Internal Control over Financial Reporting''' |
|||
* Management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934. |
|||
* Management is implementing measures to remediate control deficiencies contributing to the material weakness <sup>p. 111</sup>. |
|||
* Internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles in the United States of America. |
|||
* Remediation actions for the material weakness related to the design of ITGCs in user access over certain information technology include: |
|||
* Internal control over financial reporting includes policies and procedures that pertain to the maintenance of records that accurately and fairly reflect transactions and dispositions of assets. |
|||
** Enhancing the ''IT compliance oversight function'' and expanding the team with experience in designing and implementing ITGCs <sup>p. 111</sup>. |
|||
* Internal control over financial reporting includes policies and procedures that provide reasonable assurance that transactions are recorded as necessary for financial statement preparation in accordance with GAAP, and that receipts and expenditures are made only with management and director authorizations. |
|||
** Developing and implementing a ''training program'' addressing ITGCs and policies, including educating control owners about control principles and requirements <sup>p. 111</sup>. |
|||
* Internal control over financial reporting includes policies and procedures that provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of assets that could materially affect financial statements. |
|||
** Developing and maintaining ''documentation'' underlying ITGCs to promote knowledge transfer upon IT personnel and function changes <sup>p. 111</sup>. |
|||
** Implementing an ''IT management review and testing plan'' to monitor ITGCs <sup>p. 111</sup>. |
|||
** Enhanced ''quarterly reporting'' on remediation measures to the Audit Committee of the board of directors <sup>p. 111</sup>. |
|||
{{chunk|doc=vycbjm4dw4|c=316|p=17}} |
|||
{{Indexing|Changes in Internal Control over Financial Reporting|Internal control over financial reporting, material weakness, Rule 13a-15(d), 15d-15(d), Exchange Act|l96bfbct4s|kind=prose|order=203}} |
|||
'''Material Weakness in Internal Control''' |
|||
* |
* Management assessed the effectiveness of internal control over financial reporting as of December 31, 2024, using criteria from the COSO Internal Control—Integrated Framework (2013). |
||
* As of December 31, 2024, management concluded that internal control over financial reporting was not effective due to a material weakness. |
|||
* These changes have not materially affected, nor are they reasonably likely to materially affect, the company's internal control over financial reporting <sup>p. 112</sup>. |
|||
* A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting that creates a reasonable possibility of a material misstatement in annual or interim financial statements not being prevented or detected timely. |
|||
* The evaluation was required by ''Rule 13a-15(d)'' and ''15d-15(d)'' of the Exchange Act <sup>p. 112</sup>. |
|||
* The material weakness as of December 31, 2024, related to the ineffective implementation of information technology general controls (ITGCs) in user access for systems supporting the Company’s financial reporting processes. |
|||
* Related process-level IT dependent manual and automated controls relying on affected ITGCs, or information from IT systems with affected ITGCs, were also deemed ineffective. |
|||
* This material weakness did not result in any material misstatements to the financial statements in this Form 10-K. |
|||
* No changes were identified as required for previously issued financial statements. |
|||
* Substantive procedures for the year ended December 31, 2024, have been completed. |
|||
* Management believes consolidated financial statements in this Form 10-K have been prepared in accordance with U.S. GAAP. |
|||
* The CEO and CFO certified that, to their knowledge, the financial statements and other financial information in this Form 10-K fairly present in all material respects the financial condition, results of operations, and cash flows for the periods presented. |
|||
* Ernst & Young LLP issued an unqualified opinion on the financial statements, included in Item 8 of this Form 10-K. |
|||
* Ernst & Young LLP also issued a report on internal control over financial reporting as of December 31, 2024, which appears in Item 8. |
|||
=== Planned Material Weakness Remediation Activities === |
|||
{{Indexing|Limitations on Effectiveness of Controls and Procedures|Disclosure controls and procedures, control objectives, resource constraints|l96bfbct4s|kind=prose|order=204}} |
|||
{{chunk|doc=vycbjm4dw4|c=317|p=17}} |
|||
* Management acknowledges that disclosure controls and procedures, even when well-designed and operated, offer only reasonable assurance of achieving control objectives <sup>p. 113</sup>. |
|||
'''Material weakness remediation activities''' |
|||
* The design of disclosure controls and procedures must consider resource constraints <sup>p. 113</sup>. |
|||
* Management must apply judgment when evaluating the benefits of potential controls and procedures against their costs <sup>p. 113</sup>. |
|||
* Management is implementing measures to remediate control deficiencies contributing to the material weakness related to the design of ITGCs in user access over certain information technology. |
|||
* Remediation actions include enhancing the IT compliance oversight function and expanding the team with experience in designing and implementing ITGCs. |
|||
* A training program addressing ITGCs and policies is being developed and implemented, including educating control owners on control principles and requirements. |
|||
* Documentation underlying ITGCs is being developed and maintained to promote knowledge transfer during IT personnel and function changes. |
|||
* An IT management review and testing plan is being implemented to monitor ITGCs. |
|||
* Enhanced quarterly reporting on remediation measures is provided to the Audit Committee of the board of directors. |
|||
=== Changes in Internal Control over Financial Reporting === |
|||
{{chunk|doc=vycbjm4dw4|c=318|p=17}} |
|||
'''Internal control over financial reporting''' |
|||
* No changes in internal control over financial reporting occurred during the year ended December 31, 2024, except for those related to the identified material weakness. |
|||
* These changes have not materially affected, nor are they reasonably likely to materially affect, the company's internal control over financial reporting. |
|||
=== Limitations on Effectiveness of Controls and Procedures === |
|||
{{chunk|doc=vycbjm4dw4|c=319|p=17}} |
|||
'''Limitations of disclosure controls''' |
|||
* Management acknowledges that disclosure controls and procedures, regardless of design and operation, can only offer reasonable assurance of achieving control objectives. |
|||
* The design of disclosure controls and procedures must consider resource constraints and require management to exercise judgment in weighing the benefits against the costs of potential controls. |
|||
== Other Information == |
== Other Information == |
||
{{chunk|doc=vycbjm4dw4|c=320|p=18}} |
|||
* No directors or officers adopted, terminated, or modified a Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement during the quarter ended December 31, 2024 <sup>p. 114</sup>. |
|||
'''Director and officer trading arrangements''' |
|||
* During the quarter ended December 31, 2024, none of the directors or officers (as defined in Rule 16a-1(f) of the Securities Exchange Act of 1934) adopted, terminated, or modified a Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement (as defined in Item 408 of Regulation S-K). |
|||
== Directors, Executive Officers and Corporate Governance == |
== Directors, Executive Officers and Corporate Governance == |
||
{{chunk|doc=vycbjm4dw4|c=321|p=19}} |
|||
* The information required by Item 10 of Form 10-K will be included in the 2025 Proxy Statement and is incorporated by reference <sup>p. 115</sup>. |
|||
'''Information incorporation by reference''' |
|||
* Information required by Item 10 of Form 10-K will be included in the 2025 Proxy Statement and is incorporated by reference. |
|||
== Executive Compensation == |
== Executive Compensation == |
||
{{chunk|doc=vycbjm4dw4|c=322|p=20}} |
|||
* The information required by Item 11 of Form 10-K will be included in the company's 2025 Proxy Statement and is incorporated herein by reference <sup>p. 116</sup>. |
|||
'''Executive compensation disclosure''' |
|||
* Information required by Item 11 of Form 10-K will be included in the 2025 Proxy Statement and is incorporated by reference. |
|||
== Security Ownership of Certain Beneficial Owner and Management and Related Stockholder Matters == |
== Security Ownership of Certain Beneficial Owner and Management and Related Stockholder Matters == |
||
{{chunk|doc=vycbjm4dw4|c=323|p=21}} |
|||
* The information required by Item 12 of Form 10-K will be included in the 2025 Proxy Statement and is incorporated by reference <sup>p. 117</sup>. |
|||
'''Information incorporation by reference''' |
|||
* The information required by Item 12 of Form 10-K will be included in the 2025 Proxy Statement and is incorporated by reference. |
|||
== Certain Relationships and Related Transactions, and Director Independence == |
== Certain Relationships and Related Transactions, and Director Independence == |
||
{{chunk|doc=vycbjm4dw4|c=324|p=22}} |
|||
* The information required by Item 13 of Form 10-K will be included in the company's 2025 Proxy Statement and is incorporated by reference <sup>p. 118</sup>. |
|||
'''Information incorporation by reference''' |
|||
* The information required by Item 13 of Form 10-K will be included in the 2025 Proxy Statement and is incorporated herein by reference. |
|||
== Principal Accounting Fees and Services == |
== Principal Accounting Fees and Services == |
||
{{chunk|doc=vycbjm4dw4|c=325|p=23}} |
|||
* Our independent registered public accounting firm is Ernst & Young LLP, Houston, Texas <sup>p. 119</sup>. |
|||
'''independent registered public accounting firm''' |
|||
* ''Auditor Firm ID'': 42 <sup>p. 119</sup>. |
|||
* The information required by Item 14 of Form 10-K will be included in our 2025 Proxy Statement and is incorporated herein by reference <sup>p. 119</sup>. |
|||
* Our independent registered public accounting firm is Ernst & Young LLP, Houston, Texas. |
|||
* Auditor Firm ID: 42. |
|||
* The information required by Item 14 of Form 10-K will be included in our 2025 Proxy Statement and is incorporated herein by reference. |
|||
== Exhibits, Financial Statement Schedules. == |
== Exhibits, Financial Statement Schedules. == |
||
{{chunk|doc=vycbjm4dw4|c=326|p=24}} |
|||
* ''Consolidated financial statements'' of the Company are filed as part of this Form 10-K and included in Item 8 <sup>p. 120</sup>. |
|||
'''Financial Statements Listing''' |
|||
* ''Reports of Independent Registered Public Accounting Firm'' are included <sup>p. 120</sup>. |
|||
* ''Consolidated Balance Sheets'' as of December 31, 2024 and 2023 are included <sup>p. 120</sup>. |
|||
* The consolidated financial statements of the Company are filed as part of Form 10-K and included in Item 8. |
|||
* ''Consolidated Statements of Operations and Comprehensive Income (loss)'' for the three years in the periods ended December 31, 2024, 2023, and 2022 are included <sup>p. 120</sup>. |
|||
* Reports of Independent Registered Public Accounting Firm are included. |
|||
* ''Consolidated Statements of Stockholders’ Equity'' for the three years in the period ended December 31, 2024, 2023, and 2022 are included <sup>p. 120</sup>. |
|||
* |
* Consolidated Balance Sheets as of December 31, 2024 and 2023 are included. |
||
* Consolidated Statements of Operations and Comprehensive Income (loss) for the three years ended December 31, 2024, 2023, and 2022 are included. |
|||
* ''Listing of Exhibits'' is provided <sup>p. 120</sup>. |
|||
* Consolidated Statements of Stockholders’ Equity for the three years ended December 31, 2024, 2023, and 2022 are included. |
|||
* Items marked with an asterisk (*) are filed herewith <sup>p. 120</sup>. |
|||
* Consolidated Statements of Cash Flows for the three years ended December 31, 2024, 2023, and 2022 are included. |
|||
* Items marked with a plus (+) indicate a management contract or compensatory plan or arrangement <sup>p. 120</sup>. |
|||
{{chunk|doc=vycbjm4dw4|c=327|p=24}} |
|||
'''Exhibits Listing''' |
|||
* A listing of exhibits is provided. |
|||
* Exhibits marked with an asterisk are filed herewith. |
|||
* Management contracts or compensatory plans or arrangements are included. |
|||
{{chunk|doc=vycbjm4dw4|c=328|p=24}} |
|||
{{Indexing|Exhibits filed with the document|Summary of Investments, Financial Information of Registrant (Parent Company), Supplementary Reinsurance Information, Valuation and Qualifying Accounts, Supplementary Information Concerning Property — Casualty Insurance Operations|t53unsd9lu|kind=table|order=205}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable" |
{| id="t1098" class="wikitable" |
||
|+ Schedule number by schedule description |
|||
|- |
|||
! style="text-align:left" | Schedule Number |
! style="text-align:left" | Schedule Number |
||
! style="text-align:left" | Schedule Description |
! style="text-align:left" | Schedule Description |
||
! |
! style="text-align:right" | Page |
||
|- |
|- |
||
| style="text-align:left" | I. |
| style="text-align:left" | I. |
||
| style="text-align:left" | Summary of Investments — Other Than in Related Parties at December 31, 2024 |
| style="text-align:left" | Summary of Investments — Other Than in Related Parties at December 31, 2024 |
||
| |
| style="text-align:right" | 103 |
||
|- |
|- |
||
| style="text-align:left" | II. |
| style="text-align:left" | II. |
||
| style="text-align:left" | Financial Information of Registrant (Parent Company) for the years ended December 31, 2024, 2023 and 2022 |
| style="text-align:left" | Financial Information of Registrant (Parent Company) for the years ended December 31, 2024, 2023 and 2022 |
||
| |
| style="text-align:right" | 104 |
||
|- |
|- |
||
| style="text-align:left" | IV. |
| style="text-align:left" | IV. |
||
| style="text-align:left" | Supplementary Reinsurance Information for the years ended December 31, 2024, 2023, and 2022 |
| style="text-align:left" | Supplementary Reinsurance Information for the years ended December 31, 2024, 2023, and 2022 |
||
| |
| style="text-align:right" | 108 |
||
|- |
|- |
||
| style="text-align:left" | V. |
| style="text-align:left" | V. |
||
| style="text-align:left" | Valuation and Qualifying Accounts for the years ended December 31, 2024, 2023, and 2022 |
| style="text-align:left" | Valuation and Qualifying Accounts for the years ended December 31, 2024, 2023, and 2022 |
||
| |
| style="text-align:right" | 109 |
||
|- |
|- |
||
| style="text-align:left" | VI. |
| style="text-align:left" | VI. |
||
| style="text-align:left" | Supplementary Information Concerning Property — Casualty Insurance Operations for the years ended December 31, 2024, 2023, and 2022 |
| style="text-align:left" | Supplementary Information Concerning Property — Casualty Insurance Operations for the years ended December 31, 2024, 2023, and 2022 |
||
| |
| style="text-align:right" | 110 |
||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Exhibits 3.1 to 10.6|Amended and Restated Certificate of Incorporation, Amended and Restated Bylaws, Amended and Restated Stockholders’ Agreement, Description of Capital Stock, Share Purchase and Award Agreement, 2016 Equity Incentive Program, 2020 Long Term Incentive Plan|t53unsd9lu|kind=table|order=206}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable" |
{| id="t1099" class="wikitable" |
||
|- |
|||
! style="text-align:left" | Exhibit Number |
! style="text-align:left" | Exhibit Number |
||
! style="text-align:left" | Exhibit Description |
! style="text-align:left" | Exhibit Description |
||
| Line 8,227: | Line 9,639: | ||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Exhibits 10.7 to 10.16|Form of Restricted Stock Agreement, Form of Nonstatutory Stock Option Agreement, Form of Incentive Stock Option Agreement, Form of Performance-Based Restricted Stock Units Agreement, Performance-Based Restricted Stock Units Agreement, Performance Unit Agreement, 2022 Long-Term Incentive Plan|t53unsd9lu|kind=table|order=207}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable" |
{| id="t1100" class="wikitable" |
||
|- |
|||
! style="text-align:left" | Exhibit Number |
! style="text-align:left" | Exhibit Number |
||
! style="text-align: |
! style="text-align:left" | Exhibit Description |
||
|- |
|- |
||
! style="text-align:left" | 10.7+ |
! style="text-align:left" | 10.7+ |
||
! style="text-align: |
! style="text-align:left" | Form of Restricted Stock Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 99.7 to the Company's Registration Statement on Form S-8, filed with the SEC on January 12, 2023). |
||
|- |
|- |
||
! style="text-align:left" | 10.8+ |
! style="text-align:left" | 10.8+ |
||
! style="text-align: |
! style="text-align:left" | Form of Nonstatutory Stock Option Agreement and form of notice under the Company's 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 99.8 to the Company's Registration Statement on Form S-8, filed with the SEC on January 12, 2023). |
||
|- |
|- |
||
! style="text-align:left" | 10.9+ |
! style="text-align:left" | 10.9+ |
||
! style="text-align: |
! style="text-align:left" | Form of Incentive Stock Option Agreement and form of notice under the Company's 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 99.9 to the Company's Registration Statement on Form S-8, filed with the SEC on January 12, 2023). |
||
|- |
|- |
||
! style="text-align:left" | 10.10+ |
! style="text-align:left" | 10.10+ |
||
! style="text-align: |
! style="text-align:left" | Form of Performance-Based Restricted Stock Units Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.10 to the Company’s Annual Report on Form 10-K, filed with the SEC on March 28, 2023). |
||
|- |
|- |
||
! style="text-align:left" | 10.11+ |
! style="text-align:left" | 10.11+ |
||
! style="text-align: |
! style="text-align:left" | Performance-Based Restricted Stock Units Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.11 to the Company’s Annual Report on Form 10-K, filed with the SEC on March 28, 2023). |
||
|- |
|- |
||
! style="text-align:left" | 10.12+ |
! style="text-align:left" | 10.12+ |
||
! style="text-align: |
! style="text-align:left" | Performance Unit Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.12 to the Company’s Annual Report on Form 10-K, filed with the SEC on March 28, 2023). |
||
|- |
|- |
||
! style="text-align:left" | 10.13+ |
! style="text-align:left" | 10.13+ |
||
! style="text-align: |
! style="text-align:left" | Amended Form of Performance Share (GBVPS) Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.13 to the Company’s Annual Report on Form 10-K, filed with the SEC on April 1, 2024). |
||
|- |
|- |
||
! style="text-align:left" | 10.14+ |
! style="text-align:left" | 10.14+ |
||
! style="text-align: |
! style="text-align:left" | Amended Form of Performance Share (Executives) Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.14 to the Company’s Annual Report on Form 10-K, filed with the SEC on April 1, 2024). |
||
|- |
|- |
||
! style="text-align:left" | 10.15+ |
! style="text-align:left" | 10.15+ |
||
! style="text-align: |
! style="text-align:left" | Amended Form of Performance Share (Others) Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.15 to the Company’s Annual Report on Form 10-K, filed with the SEC on April 1, 2024). |
||
|- |
|- |
||
! style="text-align:left" | 10.16+ |
! style="text-align:left" | 10.16+ |
||
! style="text-align: |
! style="text-align:left" | Amended Form of Performance Cash Units Agreement under the Company’s Long-Term Incentive Plan. (incorporated by reference to Exhibit 10.16 to the Company’s Annual Report on Form 10-K, filed with the SEC on April 1, 2024). |
||
|- |
|- |
||
! style="text-align:left" | 10.17+ |
! style="text-align:left" | 10.17+ |
||
! style="text-align: |
! style="text-align:left" | Amended Form of the Restricted Stock Unit (Executives) Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.17 to the Company’s Annual Report on Form 10-K, filed with the SEC on April 1, 2024). |
||
|- |
|- |
||
! style="text-align:left" | 10.18+ |
! style="text-align:left" | 10.18+ |
||
! style="text-align: |
! style="text-align:left" | Amended Form of Restricted Stock Unit (Others) Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.18 to the Company’s Annual Report on Form 10-K, filed with the SEC on April 1, 2024). |
||
|- |
|- |
||
! style="text-align:left" | 10.19+ |
! style="text-align:left" | 10.19+ |
||
! style="text-align: |
! style="text-align:left" | Amended Form of Long-Term Performance Cash Plan and Award Letter under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.19 to the Company’s Annual Report on Form 10-K, filed with the SEC on April 1, 2024). |
||
|- |
|- |
||
! style="text-align:left" | 10.20+ |
! style="text-align:left" | 10.20+ |
||
! style="text-align: |
! style="text-align:left" | Form of Indemnification Agreement (incorporated by reference to Exhibit 10.6 to the Company's Registration Statement on Form S-1, filed with the SEC on November 14, 2022). |
||
|- |
|- |
||
! style="text-align:left" | 10.21+ |
! style="text-align:left" | 10.21+ |
||
! style="text-align: |
! style="text-align:left" | Employment Agreement, dated May 22, 2020, by and between the Registrant and Andrew Robinson, with Amendment No. 1 dated January 1, 2022 (incorporated by reference to Exhibit 10.7 to the Company's Registration Statement on Form S-1, filed with the SEC on November 14, 2022). |
||
|- |
|- |
||
! style="text-align:left" | 10.22+* |
! style="text-align:left" | 10.22+* |
||
| Line 8,284: | Line 9,695: | ||
|- |
|- |
||
| style="text-align:left" | 10.23 |
| style="text-align:left" | 10.23 |
||
| style="text-align:left" | Commutation and Release Agreement by and among R&Q Re (Bermuda) Ltd., Skyward Re, Houston Specialty Insurance Company, Imperium Insurance Company, and Great Midwest Insurance Company, dated January 31, 2025 (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the Commission on February 5, 2025). |
| style="text-align:left" | Commutation and Release Agreement by and among R&Q Re (Bermuda) Ltd., Skyward Re, Houston Specialty Insurance Company, Imperium Insurance Company, and Great Midwest Insurance Company, dated January 31, 2025 (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the Commission on February 5, 2025). |
||
|- |
|- |
||
| style="text-align:left" | 10.24 |
| style="text-align:left" | 10.24 |
||
| Line 8,290: | Line 9,701: | ||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Exhibits 10.25 to 23.1|Second Amendment Agreement, Investment Management Agreement, Arena Investors, LP, Houston Specialty Insurance Company, Imperium Insurance Company, Great Midwest Insurance Company, Credit Agreement, Skyward Specialty Insurance Group, Inc., Truist Bank, Guaranty Agreement, Skyward Service Company, Skyward Underwriters Agency, Inc., Advances and Security Agreement|t53unsd9lu|kind=table|order=208}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable" |
{| id="t1101" class="wikitable" |
||
|- |
|||
! style="text-align:left" | Exhibit Number |
! style="text-align:left" | Exhibit Number |
||
! style="text-align:left" | Exhibit Description |
! style="text-align:left" | Exhibit Description |
||
| Line 8,326: | Line 9,736: | ||
|- |
|- |
||
| style="text-align:left" | 23.1 |
| style="text-align:left" | 23.1 |
||
| style="text-align:left" | Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm. |
| style="text-align:left" | Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm. |
||
|- |
|- |
||
| style="text-align:left" | 31.1 |
| style="text-align:left" | 31.1 |
||
| Line 8,341: | Line 9,751: | ||
|- |
|- |
||
| style="text-align:left" | 101.INS |
| style="text-align:left" | 101.INS |
||
| style="text-align:left" | Inline XBRL Instance Document |
| style="text-align:left" | Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document. |
||
|- |
|- |
||
| style="text-align:left" | 101.SCH |
| style="text-align:left" | 101.SCH |
||
| Line 8,351: | Line 9,761: | ||
</div> |
</div> |
||
=== Schedule I — summary of investments — other than in related parties === |
|||
{{Indexing|Fixed maturity securities as of December 31, 2024|Fixed maturity securities, U.S. government securities, corporate securities, municipal securities, residential mortgage-backed securities, commercial mortgage-backed securities, other asset-backed securities|utnmaoxh50|kind=table|order=209}} |
|||
{{chunk|doc=vycbjm4dw4|c=329|p=24}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1102" class="wikitable fintable" |
||
|+ Schedule I — summary of investments — other than in related parties |
|||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Cost |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Fair Value (if applicable) |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Amount on Balance Sheet |
||
|- |
|- |
||
! style="text-align:left" | December 31, 2024 |
! style="text-align:left" | December 31, 2024 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
! style="text-align:left" | Fixed maturity securities, available for sale: |
! style="text-align:left" | Fixed maturity securities, available for sale: |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | U.S. government securities |
| style="text-align:left" | U.S. government securities |
||
| Line 8,400: | Line 9,814: | ||
| style="text-align:right" | 292,191 |
| style="text-align:right" | 292,191 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total fixed maturity securities, available for sale |
||
| style="text-align:right" | |
| style="text-align:right" | 1,320,266 |
||
| style="text-align:right" | |
| style="text-align:right" | 1,292,218 |
||
| style="text-align:right" | |
| style="text-align:right" | 1,292,218 |
||
|- |
|||
| style="text-align:left" | <b>Fixed maturity securities, held to maturity:</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Other asset-backed securities |
| style="text-align:left" | Other asset-backed securities |
||
| Line 8,410: | Line 9,829: | ||
| style="text-align:right" | 39,153 |
| style="text-align:right" | 39,153 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total fixed maturity securities, held to maturity |
||
| style="text-align:right" | |
| style="text-align:right" | 39,396 |
||
| style="text-align:right" | |
| style="text-align:right" | 38,717 |
||
| style="text-align:right" | |
| style="text-align:right" | 39,153 |
||
|- |
|||
| style="text-align:left" | <b>Equity securities:</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Common stocks |
| style="text-align:left" | Common stocks |
||
| Line 8,430: | Line 9,854: | ||
| style="text-align:right" | 40,839 |
| style="text-align:right" | 40,839 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total equity securities |
||
| style="text-align:right" | |
| style="text-align:right" | 83,311 |
||
| style="text-align:right" | |
| style="text-align:right" | 106,254 |
||
| style="text-align:right" | |
| style="text-align:right" | 106,254 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Mortgage loans</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>26,485</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>26,490</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>26,490</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Other long-term investments</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>33,231</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>33,182</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>33,182</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Short-term investments</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>274,926</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>274,929</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>274,929</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total |
||
| style="text-align:right" | |
| style="text-align:right" | 1,777,615 |
||
| style="text-align:right" | |
| style="text-align:right" | 1,771,790 |
||
| style="text-align:right" | |
| style="text-align:right" | 1,772,226 |
||
|} |
|} |
||
</div> |
</div> |
||
=== Balance sheets (parent company) === |
|||
{{Indexing|Balance sheets (parent company)|Cash and cash equivalents, investments available-for-sale, investments held-to-maturity, investments at fair value, total investments, premiums receivable, reinsurance recoverable on paid and unpaid losses, deferred acquisition costs, prepaid expenses and other assets, goodwill, intangible assets|1smvf6a29l|kind=prose|order=210|f1=Cash and cash equivalents|v1=December 31, 2023: USD 10.0m|f2=Investments available-for-sale|v2=December 31, 2023: USD 1,000.0m|f3=Investments held-to-maturity|v3=December 31, 2023: USD 1,000.0m|f4=Investments, at fair value|v4=December 31, 2023: USD 1,000.0m|f5=Total investments|v5=December 31, 2023: USD 3,000.0m}} |
|||
{{chunk|doc=vycbjm4dw4|c=330|p=24}} |
|||
* ''Cash and cash equivalents'' were USD 10.0m as of December 31, 2023 <sup>p. 121</sup>. |
|||
'''Financial statement notes''' |
|||
* ''Cash and cash equivalents'' were USD 10.0m as of December 31, 2022 <sup>p. 121</sup>. |
|||
* ''Investments available-for-sale'' were USD 1,000.0m as of December 31, 2023 <sup>p. 121</sup>. |
|||
* ''Investments available-for-sale'' were USD 1,000.0m as of December 31, 2022 <sup>p. 121</sup>. |
|||
* ''Investments held-to-maturity'' were USD 1,000.0m as of December 31, 2023 <sup>p. 121</sup>. |
|||
* ''Investments held-to-maturity'' were USD 1,000.0m as of December 31, 2022 <sup>p. 121</sup>. |
|||
* ''Investments, at fair value'' were USD 1,000.0m as of December 31, 2023 <sup>p. 121</sup>. |
|||
* ''Investments, at fair value'' were USD 1,000.0m as of December 31, 2022 <sup>p. 121</sup>. |
|||
* ''Total investments'' were USD 3,000.0m as of December 31, 2023 <sup>p. 121</sup>. |
|||
* ''Total investments'' were USD 3,000.0m as of December 31, 2022 <sup>p. 121</sup>. |
|||
* ''Premiums receivable, net'' were USD 1,000.0m as of December 31, 2023 <sup>p. 121</sup>. |
|||
* ''Premiums receivable, net'' were USD 1,000.0m as of December 31, 2022 <sup>p. 121</sup>. |
|||
* ''Reinsurance recoverable on paid and unpaid losses'' were USD 1,000.0m as of December 31, 2023 <sup>p. 121</sup>. |
|||
* ''Reinsurance recoverable on paid and unpaid losses'' were USD 1,000.0m as of December 31, 2022 <sup>p. 121</sup>. |
|||
* ''Deferred acquisition costs'' were USD 1,000.0m as of December 31, 2023 <sup>p. 121</sup>. |
|||
* ''Deferred acquisition costs'' were USD 1,000.0m as of December 31, 2022 <sup>p. 121</sup>. |
|||
* ''Prepaid expenses and other assets'' were USD 1,000.0m as of December 31, 2023 <sup>p. 121</sup>. |
|||
* ''Prepaid expenses and other assets'' were USD 1,000.0m as of December 31, 2022 <sup>p. 121</sup>. |
|||
* ''Goodwill'' was USD 1,000.0m as of December 31, 2023 <sup>p. 121</sup>. |
|||
* ''Goodwill'' was USD 1,000.0m as of December 31, 2022 <sup>p. 121</sup>. |
|||
* ''Intangible assets, net'' were USD 1,000.0m as of December 31, 2023 <sup>p. 121</sup>. |
|||
* ''Intangible assets, net'' were USD 1,000.0m as of December 31, 2022 <sup>p. 121</sup>. |
|||
* ''Property and equipment, net'' were USD 1,000.0m as of December 31, 2023 <sup>p. 121</sup>. |
|||
* ''Property and equipment, net'' were USD 1,000.0m as of December 31, 2022 <sup>p. 121</sup>. |
|||
* ''Total assets'' were USD 9,010.0m as of December 31, 2023 <sup>p. 121</sup>. |
|||
* ''Total assets'' were USD 9,010.0m as of December 31, 2022 <sup>p. 121</sup>. |
|||
* ''Losses and loss adjustment expenses'' were USD 1,000.0m as of December 31, 2023 <sup>p. 121</sup>. |
|||
* ''Losses and loss adjustment expenses'' were USD 1,000.0m as of December 31, 2022 <sup>p. 121</sup>. |
|||
* ''Unearned premiums'' were USD 1,000.0m as of December 31, 2023 <sup>p. 121</sup>. |
|||
* ''Unearned premiums'' were USD 1,000.0m as of December 31, 2022 <sup>p. 121</sup>. |
|||
* ''Reinsurance payable'' was USD 1,000.0m as of December 31, 2023 <sup>p. 121</sup>. |
|||
* ''Reinsurance payable'' was USD 1,000.0m as of December 31, 2022 <sup>p. 121</sup>. |
|||
* ''Accounts payable and accrued expenses'' were USD 1,000.0m as of December 31, 2023 <sup>p. 121</sup>. |
|||
* ''Accounts payable and accrued expenses'' were USD 1,000.0m as of December 31, 2022 <sup>p. 121</sup>. |
|||
* ''Notes payable'' were USD 1,000.0m as of December 31, 2023 <sup>p. 121</sup>. |
|||
* ''Notes payable'' were USD 1,000.0m as of December 31, 2022 <sup>p. 121</sup>. |
|||
* ''Total liabilities'' were USD 5,000.0m as of December 31, 2023 <sup>p. 121</sup>. |
|||
* ''Total liabilities'' were USD 5,000.0m as of December 31, 2022 <sup>p. 121</sup>. |
|||
* ''Common stock'' was USD 1,000.0m as of December 31, 2023 <sup>p. 121</sup>. |
|||
* ''Common stock'' was USD 1,000.0m as of December 31, 2022 <sup>p. 121</sup>. |
|||
* ''Additional paid-in capital'' was USD 1,000.0m as of December 31, 2023 <sup>p. 121</sup>. |
|||
* ''Additional paid-in capital'' was USD 1,000.0m as of December 31, 2022 <sup>p. 121</sup>. |
|||
* ''Accumulated other comprehensive income (loss)'' was USD 1,000.0m as of December 31, 2023 <sup>p. 121</sup>. |
|||
* ''Accumulated other comprehensive income (loss)'' was USD 1,000.0m as of December 31, 2022 <sup>p. 121</sup>. |
|||
* ''Retained earnings'' were USD 1,000.0m as of December 31, 2023 <sup>p. 121</sup>. |
|||
* ''Retained earnings'' were USD 1,000.0m as of December 31, 2022 <sup>p. 121</sup>. |
|||
* ''Total stockholders’ equity'' was USD 4,010.0m as of December 31, 2023 <sup>p. 121</sup>. |
|||
* ''Total stockholders’ equity'' was USD 4,010.0m as of December 31, 2022 <sup>p. 121</sup>. |
|||
* ''Total liabilities and stockholders’ equity'' were USD 9,010.0m as of December 31, 2023 <sup>p. 121</sup>. |
|||
* ''Total liabilities and stockholders’ equity'' were USD 9,010.0m as of December 31, 2022 <sup>p. 121</sup>. |
|||
* See accompanying notes to financial statements. |
|||
{{Indexing|Assets, liabilities, and stockholders' equity|Investments, investment in subsidiaries, short-term investments, cash and cash equivalents, deferred income taxes, goodwill and intangible assets, other assets, accounts payable and accrued liabilities, notes payable, subordinated debt|1smvf6a29l|kind=table|order=211}} |
|||
{{chunk|doc=vycbjm4dw4|c=331|p=24}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1103" class="wikitable fintable" |
||
|+ Balance sheets (parent company) |
|||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="2" style="text-align:center" | December 31, |
! colspan="2" style="text-align:center" | December 31, |
||
|- |
|- |
||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2024 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2023 |
||
|- |
|- |
||
! style="text-align:left" | Assets |
! style="text-align:left" | Assets |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
! style="text-align:left" | Investments: |
! style="text-align:left" | Investments: |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | Investment in subsidiaries |
| style="text-align:left" | Investment in subsidiaries |
||
| Line 8,537: | Line 9,917: | ||
| style="text-align:right" | 10,593 |
| style="text-align:right" | 10,593 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total investments |
||
| style="text-align:right" | |
| style="text-align:right" | 867,670 |
||
| style="text-align:right" | |
| style="text-align:right" | 753,618 |
||
|- |
|- |
||
| style="text-align:left" | Cash and cash equivalents |
| style="text-align:left" | Cash and cash equivalents |
||
| Line 8,557: | Line 9,937: | ||
| style="text-align:right" | 15,908 |
| style="text-align:right" | 15,908 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total assets |
||
| style="text-align:right" | |
| style="text-align:right" | 916,645 |
||
| style="text-align:right" | |
| style="text-align:right" | 791,090 |
||
|- |
|||
| style="text-align:left" | <b>Liabilities and Stockholders’ Equity</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Liabilities: |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 8,577: | Line 9,961: | ||
| style="text-align:right" | 78,690 |
| style="text-align:right" | 78,690 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total liabilities |
||
| style="text-align:right" | |
| style="text-align:right" | 122,646 |
||
| style="text-align:right" | |
| style="text-align:right" | 130,059 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Stockholders’ Equity:</b> |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Stockholders’ equity</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>793,999</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>661,031</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total liabilities and stockholders’ equity |
||
| style="text-align:right" | |
| style="text-align:right" | 916,645 |
||
| style="text-align:right" | |
| style="text-align:right" | 791,090 |
||
|} |
|} |
||
</div> |
</div> |
||
=== (parent company) === |
|||
{{chunk|doc=vycbjm4dw4|c=332|p=24}} |
|||
* See accompanying notes to financial statements <sup>p. 122</sup>. |
|||
'''Financial statement notes''' |
|||
* See accompanying notes to financial statements. |
|||
{{Indexing|Consolidated statements of comprehensive income|Net investment income, net investment losses, other loss, total revenues, operating expenses, interest expense, amortization expense, other expenses, total expenses, loss before income tax expense|1smvf6a29l|kind=table|order=213}} |
|||
{{chunk|doc=vycbjm4dw4|c=333|p=24}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1104" class="wikitable fintable" |
||
|+ Revenues, expenses, and net income by years ended December 31 |
|||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="3" style="text-align:center" | Years Ended December 31, |
! colspan="3" style="text-align:center" | Years Ended December 31, |
||
|- |
|- |
||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2024 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2023 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2022 |
||
|- |
|- |
||
! style="text-align:left" | Revenues: |
! style="text-align:left" | Revenues: |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | Net investment income |
| style="text-align:left" | [[Definition:Net investment income|Net investment income]] |
||
| style="text-align:right" | 3,212 |
| style="text-align:right" | 3,212 |
||
| style="text-align:right" | 3,822 |
| style="text-align:right" | 3,822 |
||
| Line 8,631: | Line 10,020: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | [[Definition:Total revenue|Total revenues]] |
||
| style="text-align:right" | |
| style="text-align:right" | 4,173 |
||
| style="text-align:right" | |
| style="text-align:right" | 2,832 |
||
| style="text-align:right" | |
| style="text-align:right" | 2,561 |
||
|- |
|||
| style="text-align:left" | <b>Expenses</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Operating expenses |
| style="text-align:left" | Operating expenses |
||
| Line 8,656: | Line 10,050: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total expenses |
||
| style="text-align:right" | |
| style="text-align:right" | 29,338 |
||
| style="text-align:right" | |
| style="text-align:right" | 10,579 |
||
| style="text-align:right" | |
| style="text-align:right" | 6,488 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Loss before income tax expense</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 25,165 )</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 7,747 )</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 3,927 )</b> |
||
|- |
|- |
||
| style="text-align:left" | Income tax expense |
| style="text-align:left" | Income tax expense |
||
| Line 8,671: | Line 10,065: | ||
| style="text-align:right" | ( 1,209 ) |
| style="text-align:right" | ( 1,209 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Loss before equity in earnings of subsidiaries</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 58,743 )</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 14,555 )</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 2,718 )</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Equity in undistributed earnings of subsidiaries</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>177,571</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>100,539</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>42,114</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net income</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>118,828</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>85,984</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>39,396</b> |
||
|} |
|} |
||
</div> |
</div> |
||
=== Schedule ii — statements of cash flows (parent company) === |
|||
{{chunk|doc=vycbjm4dw4|c=334|p=24}} |
|||
* See accompanying notes to financial statements <sup>p. 123</sup>. |
|||
'''Financial statement notes''' |
|||
* See accompanying notes to financial statements. |
|||
{{Indexing|Consolidated statements of cash flows|Cash flows from operating activities, net income, adjustments to reconcile net income to net cash used in operating activities, net cash provided by operating activities, capital contributions to subsidiaries, distributions from investment in subsidiaries, change in short-term investments, net cash used in investing activities, repayment of stock notes receivable|1smvf6a29l|kind=table|order=215}} |
|||
{{chunk|doc=vycbjm4dw4|c=335|p=24}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1105" class="wikitable fintable" |
||
|+ Net cash provided by operating activities by years ended December 31 |
|||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="3" style="text-align:center" | Years Ended December 31, |
! colspan="3" style="text-align:center" | Years Ended December 31, |
||
|- |
|- |
||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2024 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2023 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2022 |
||
|- |
|- |
||
! style="text-align:left" | Cash flows from operating activities: |
! style="text-align:left" | Cash flows from operating activities: |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col-m" style="text-align:right" | |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | Net income |
| style="text-align:left" | Net income |
||
| Line 8,719: | Line 10,118: | ||
| style="text-align:right" | ( 42,672 ) |
| style="text-align:right" | ( 42,672 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net cash provided by operating activities</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 2,735 )</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 9,963 )</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 3,276 )</b> |
||
|- |
|||
| style="text-align:left" | <b>Cash flows from investing activities:</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Capital contributions to subsidiaries |
| style="text-align:left" | Capital contributions to subsidiaries |
||
| Line 8,739: | Line 10,143: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net cash (used in) provided by investing activities</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>5,093</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 126,869 )</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>4,000</b> |
||
|- |
|||
| style="text-align:left" | <b>Cash flows from financing activities:</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Repayment of stock notes receivable |
| style="text-align:left" | Repayment of stock notes receivable |
||
| Line 8,769: | Line 10,178: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net cash provided by financing activities</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 2,439 )</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>130,947</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>2,180</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net increase (decrease) in cash and cash equivalents and restricted cash</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 81 )</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 5,885 )</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>2,904</b> |
||
|- |
|- |
||
| style="text-align:left" | Cash and cash equivalents and restricted cash at beginning of year |
| style="text-align:left" | Cash and cash equivalents and restricted cash at beginning of year |
||
| Line 8,784: | Line 10,193: | ||
| style="text-align:right" | 6,005 |
| style="text-align:right" | 6,005 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Cash and cash equivalents and restricted cash at end of year</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>2,943</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>3,024</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>8,909</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Supplemental disclosure of cash flow information:</b> |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 8,806: | Line 10,215: | ||
</div> |
</div> |
||
=== Notes to Financial Statements === |
|||
{{Indexing|Notes to Financial Statements|Intercompany Loan Promissory Note, Houston Specialty Insurance Company (HSIC), Skyward Specialty, Skyward Specialty No. 1 Limited Company, Lloyd’s corporate member, Lloyd’s syndicates|ogfk3mnpww|1eit26wk5c|kind=prose|order=216|f1=Promissory Note date|v1=September 30, 2024|f2=Amount borrowed by Skyward Specialty|v2=USD 57.0 million|f3=Interest rate|v3=4.00%}} |
|||
{{chunk|doc=vycbjm4dw4|c=336|p=24}} |
|||
* On ''September 30, 2024'', Skyward Specialty entered into an Intercompany Loan Promissory Note with Houston Specialty Insurance Company (HSIC) <sup>p. 124</sup>. |
|||
'''Intercompany loan''' |
|||
* Under the terms of the ''Promissory Note'', Skyward Specialty borrowed USD 57.0 million from HSIC <sup>p. 124</sup>. |
|||
* ''Interest'' on the Promissory Note is payable monthly at a fixed annual interest rate of 4.00% <sup>p. 124</sup>. |
|||
* The ''principal'' of the Promissory Note is due at the maturity date <sup>p. 124</sup>. |
|||
* There are ''no prepayment penalties'' for the Promissory Note <sup>p. 124</sup>. |
|||
* ''No collateral'' was given as security for the payment of the Promissory Note <sup>p. 124</sup>. |
|||
* During the year ended ''December 31, 2024'', Skyward Specialty provided funds for a new subsidiary, Skyward Specialty No. 1 Limited Company <sup>p. 124</sup>. |
|||
* ''Skyward Specialty No. 1 Limited Company'' is a UK company authorized as a Lloyd’s corporate member to invest in Lloyd’s syndicates <sup>p. 124</sup>. |
|||
* Skyward Specialty entered into an Intercompany Loan Promissory Note with Houston Specialty Insurance Company (HSIC) on September 30, 2024. |
|||
{{Indexing|Financial Instruments Disclosed, But Not Carried, At Fair Value|Promissory Note, Skyward Specialty, HSIC, fair value hierarchy|di0lc3m1jj|kind=prose|order=217|f1=Carrying value of Promissory Note|v1=December 31, 2024: USD 57.0 million|f2=Fair value of Promissory Note|v2=December 31, 2024: USD 56.3 million|f3=Promissory Note classification|v3=Level 2}} |
|||
* Skyward Specialty borrowed USD 57.0m from HSIC under the Promissory Note. |
|||
* Interest on the Promissory Note is payable monthly at a fixed annual rate of 4.00%. |
|||
* The principal of the Promissory Note is due at maturity. |
|||
* There are no prepayment penalties and no collateral was given for the Promissory Note. |
|||
{{chunk|doc=vycbjm4dw4|c=337|p=24}} |
|||
* The ''Promissory Note'' between Skyward Specialty and HSIC is included in notes payable <sup>p. 125</sup>. |
|||
'''Subsidiary funding''' |
|||
* Skyward Specialty determined the ''fair value'' of the Promissory Note using the income approach with observable inputs <sup>p. 125</sup>. |
|||
* The ''Promissory Note'' is classified in Level 2 of the fair value hierarchy <sup>p. 125</sup>. |
|||
* As of December 31, 2024, the ''carrying value'' of the Promissory Note was USD 57.0 million <sup>p. 125</sup>. |
|||
* As of December 31, 2024, the ''fair value'' of the Promissory Note was USD 56.3 million <sup>p. 125</sup>. |
|||
* During the year ended December 31, 2024, Skyward Specialty provided funds for a new subsidiary, Skyward Specialty No. 1 Limited Company. |
|||
{{Indexing|Reinsurance activity and promissory note details|Reinsurance activity, promissory note details|20fueoa3q1|kind=table|order=218}} |
|||
* Skyward Specialty No. 1 Limited Company is a UK company authorized as a Lloyd’s corporate member to invest in Lloyd’s syndicates. |
|||
=== Financial Instruments Disclosed, But Not Carried, At Fair Value === |
|||
{{chunk|doc=vycbjm4dw4|c=338|p=24}} |
|||
'''Promissory Note Fair Value''' |
|||
* The Promissory Note between Skyward Specialty and HSIC is included in notes payable. |
|||
* Skyward Specialty determined the fair value of the Promissory Note using the income approach with observable inputs. |
|||
* The Promissory Note is classified as Level 2 in the fair value hierarchy. |
|||
* As of December 31, 2024, the carrying value of the Promissory Note was USD 57.0m, and its fair value was USD 56.3m. |
|||
=== Schedule iv — reinsurance === |
|||
{{chunk|doc=vycbjm4dw4|c=339|p=24}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable |
{| id="t1106" class="wikitable" |
||
|+ Gross amount, Ceded to other companies, Assumed from other companies by Accident & Health, [[Definition:Property & casualty|Property & Casualty]] |
|||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="6" style="text-align:center" | Years Ended December 31, |
! colspan="6" style="text-align:center" | Years Ended December 31, |
||
| Line 8,838: | Line 10,259: | ||
|- |
|- |
||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! |
! style="text-align:right" | Accident & Health |
||
! |
! style="text-align:right" | [[Definition:Property & casualty|Property & Casualty]] |
||
! |
! style="text-align:right" | Accident & Health |
||
! |
! style="text-align:right" | [[Definition:Property & casualty|Property & Casualty]] |
||
! |
! style="text-align:right" | Accident & Health |
||
! |
! style="text-align:right" | [[Definition:Property & casualty|Property & Casualty]] |
||
|- |
|- |
||
| style="text-align:left" | Gross amount |
| style="text-align:left" | Gross amount |
||
| Line 8,869: | Line 10,290: | ||
| style="text-align:right" | 131,282 |
| style="text-align:right" | 131,282 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net amount</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>86,570</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>1,037,008</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>72,611</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>838,080</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>60,517</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>615,026</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Percentage of amount assumed to net</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>—%</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>27.4%</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>—%</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>26.1%</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>0.7%</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>21.3%</b> |
||
|} |
|} |
||
</div> |
</div> |
||
=== Schedule V — valuation and qualifying accounts === |
|||
{{Indexing|Valuation allowances and uncollectible amounts|Valuation allowances, uncollectible amounts, deferred tax assets, uncollectible reinsurance recoverable, uncollectible premiums receivable|rmmhubj8mh|kind=table|order=219}} |
|||
{{chunk|doc=vycbjm4dw4|c=340|p=24}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable |
{| id="t1107" class="wikitable" |
||
|+ Schedule V — valuation and qualifying accounts |
|||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! style="text-align:right" | Valuation Allowance For Deferred Tax Assets |
||
! style="text-align: |
! style="text-align:right" | Allowance for Uncollectible Reinsurance Recoverable |
||
! style="text-align: |
! style="text-align:right" | Allowance for Uncollectible Premiums Receivable |
||
|- |
|- |
||
! style="text-align:left" | Balance at January 1, 2022 |
! style="text-align:left" | Balance at January 1, 2022 |
||
! style="text-align: |
! style="text-align:right" | 586 |
||
! style="text-align: |
! style="text-align:right" | — |
||
! style="text-align: |
! style="text-align:right" | 261 |
||
|- |
|- |
||
! style="text-align:left" | Charged to costs and expenses |
! style="text-align:left" | Charged to costs and expenses |
||
! style="text-align:center" | — |
! colspan="2" style="text-align:center" | — |
||
! style="text-align: |
! style="text-align:right" | 584 |
||
! style="text-align:center" | 584 |
|||
|- |
|- |
||
! style="text-align:left" | Amounts written off |
! style="text-align:left" | Amounts written off |
||
! style="text-align:center" | — |
! colspan="2" style="text-align:center" | — |
||
! style="text-align: |
! style="text-align:right" | ( 216 ) |
||
! style="text-align:center" | ( 216 ) |
|||
|- |
|- |
||
! style="text-align:left" | Balance at December 31, 2022 |
! style="text-align:left" | Balance at December 31, 2022 |
||
! |
! style="text-align:right" | 586 |
||
! |
! style="text-align:right" | — |
||
! |
! style="text-align:right" | 629 |
||
|- |
|- |
||
| style="text-align:left" | Cumulative effect of adoption of ASU 2016-13 at January 1, 2023 |
| style="text-align:left" | Cumulative effect of adoption of ASU 2016-13 at January 1, 2023 |
||
| Line 8,921: | Line 10,344: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Charged to costs and expenses</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>—</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>—</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>748</b> |
||
|- |
|- |
||
| style="text-align:left" | Amounts written off |
| style="text-align:left" | Amounts written off |
||
| Line 8,936: | Line 10,359: | ||
| style="text-align:right" | 100 |
| style="text-align:right" | 100 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Balance at December 31, 2023</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>586</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>2,295</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>964</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Charged to costs and expenses</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>—</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>13,585</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>3,235</b> |
||
|- |
|- |
||
| style="text-align:left" | Amounts written off |
| style="text-align:left" | Amounts written off |
||
| Line 8,956: | Line 10,379: | ||
| style="text-align:right" | 128 |
| style="text-align:right" | 128 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Balance at December 31, 2024</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>586</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>2,295</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>2,432</b> |
||
|} |
|} |
||
</div> |
</div> |
||
=== Insurance operations === |
|||
{{Indexing|Deferred policy acquisition costs and reserves|Deferred policy acquisition costs, reserves, unearned premiums, net earned premium, net investment income, losses and loss adjustment expenses, amortization of policy acquisition costs, paid claims and claim adjustment expenses|or43xxg565|rmmhubj8mh|wpkf9ycgxf|kind=table|order=220}} |
|||
{{chunk|doc=vycbjm4dw4|c=341|p=24}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1108" class="wikitable fintable" |
||
|+ Insurance operations |
|||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="3" style="text-align:center" | As of and Years Ended December 31, |
! colspan="3" style="text-align:center" | As of and Years Ended December 31, |
||
| Line 8,995: | Line 10,422: | ||
| style="text-align:right" | 615,994 |
| style="text-align:right" | 615,994 |
||
|- |
|- |
||
| style="text-align:left" | Net investment income |
| style="text-align:left" | [[Definition:Net investment income|Net investment income]] |
||
| style="text-align:right" | 80,686 |
| style="text-align:right" | 80,686 |
||
| style="text-align:right" | 40,322 |
| style="text-align:right" | 40,322 |
||
| Line 9,020: | Line 10,447: | ||
| style="text-align:right" | 300,764 |
| style="text-align:right" | 300,764 |
||
|- |
|- |
||
| style="text-align:left" | Net premiums written (1) |
| style="text-align:left" | [[Definition:Net written premiums|Net premiums written]] (1) |
||
| style="text-align:right" | 1,123,578 |
| style="text-align:right" | 1,123,578 |
||
| style="text-align:right" | 910,691 |
| style="text-align:right" | 910,691 |
||
| Line 9,037: | Line 10,464: | ||
</div> |
</div> |
||
{{fn note|1=1|2=Amount is presented net of reinsurance.}} |
|||
{{fn note|1=2|2=Amount does not include gain on retroactive reinsurance which is included in losses and loss adjustment expenses presented on the Consolidated Statements of Operations.}} |
|||
=== SIGNATURES === |
|||
{{Indexing|Signatures|Registrant signatures, Securities Exchange Act of 1934|t53unsd9lu|kind=prose|order=221}} |
|||
{{chunk|doc=vycbjm4dw4|c=342|p=24}} |
|||
* The report was signed on behalf of the registrant as required by Section 13 or 15(d) of the Securities Exchange Act of 1934 <sup>p. 126</sup>. |
|||
'''Report signing authorization''' |
|||
* The report was signed by the indicated persons on behalf of the Registrant, in their respective capacities, and on the specified dates, as per the requirements of the Securities Exchange Act of 1934 <sup>p. 126</sup>. |
|||
* The report was signed on behalf of the registrant by the undersigned, duly authorized, pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934. |
|||
{{Indexing|Signatures on behalf of the registrant|Registrant signatures, Andrew Robinson|t53unsd9lu|kind=table|order=222}} |
|||
* The report was signed by the indicated persons on behalf of the Registrant, in their capacities and on the dates indicated, pursuant to the requirements of the Securities Exchange Act of 1934. |
|||
{{chunk|doc=vycbjm4dw4|c=343|p=24}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable" |
{| id="t1109" class="wikitable" |
||
|+ Signatures by Skyward Specialty Insurance Group, Inc. |
|||
! style="text-align:left" | — |
|||
|- |
|||
! style="text-align:left" | |
|||
! style="text-align:left" | Skyward Specialty Insurance Group, Inc. |
! style="text-align:left" | Skyward Specialty Insurance Group, Inc. |
||
|- |
|- |
||
| Line 9,059: | Line 10,491: | ||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Signatures, titles, and dates|Signatures, titles, dates, Andrew Robinson, Mark Haushill, Gena Ashe, Robert Creager, Marcia Dall|t53unsd9lu|kind=table|order=223}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable" |
{| id="t1110" class="wikitable" |
||
|- |
|||
! style="text-align:left" | Signature |
! style="text-align:left" | Signature |
||
! style="text-align:left" | Title |
! style="text-align:left" | Title |
||
! |
! style="text-align:right" | Date |
||
|- |
|- |
||
| style="text-align:left" | /s/ Andrew Robinson |
| style="text-align:left" | /s/ Andrew Robinson |
||
| style="text-align:left" | Chairman and Chief Executive Officer |
| style="text-align:left" | Chairman and Chief Executive Officer |
||
| |
| style="text-align:right" | March 3, 2025 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Andrew Robinson</b> |
||
| style="text-align:left" | |
| style="text-align:left" | <b>(Principal Executive Officer)</b> |
||
| |
| style="text-align:right" | <b>March 3, 2025</b> |
||
|- |
|- |
||
| style="text-align:left" | /s/ Mark Haushill |
| style="text-align:left" | /s/ Mark Haushill |
||
| style="text-align:left" | Chief Financial Officer |
| style="text-align:left" | Chief Financial Officer |
||
| |
| style="text-align:right" | March 3, 2025 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Mark Haushill</b> |
||
| style="text-align:left" | |
| style="text-align:left" | <b>(Principal Financial and Accounting Officer)</b> |
||
| |
| style="text-align:right" | <b>March 3, 2025</b> |
||
|- |
|- |
||
| style="text-align:left" | /s/ Gena Ashe |
| style="text-align:left" | /s/ Gena Ashe |
||
| style="text-align:left" | Director |
| style="text-align:left" | Director |
||
| |
| style="text-align:right" | March 3, 2025 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Gena Ashe</b> |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Director</b> |
||
| |
| style="text-align:right" | <b>March 3, 2025</b> |
||
|- |
|- |
||
| style="text-align:left" | /s/ Robert Creager |
| style="text-align:left" | /s/ Robert Creager |
||
| style="text-align:left" | Director |
| style="text-align:left" | Director |
||
| |
| style="text-align:right" | March 3, 2025 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Robert Creager</b> |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Director</b> |
||
| |
| style="text-align:right" | <b>March 3, 2025</b> |
||
|- |
|- |
||
| style="text-align:left" | /s/ Marcia Dall |
| style="text-align:left" | /s/ Marcia Dall |
||
| style="text-align:left" | Director |
| style="text-align:left" | Director |
||
| |
| style="text-align:right" | March 3, 2025 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Marcia Dall</b> |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Director</b> |
||
| |
| style="text-align:right" | <b>March 3, 2025</b> |
||
|- |
|- |
||
| style="text-align:left" | /s/ James Hays |
| style="text-align:left" | /s/ James Hays |
||
| style="text-align:left" | Director |
| style="text-align:left" | Director |
||
| |
| style="text-align:right" | March 3, 2025 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>James Hays</b> |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Director</b> |
||
| |
| style="text-align:right" | <b>March 3, 2025</b> |
||
|- |
|- |
||
| style="text-align:left" | /s/ Anthony J. Kuczinski |
| style="text-align:left" | /s/ Anthony J. Kuczinski |
||
| style="text-align:left" | Director |
| style="text-align:left" | Director |
||
| |
| style="text-align:right" | March 3, 2025 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Anthony J. Kuczinski</b> |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Director</b> |
||
| |
| style="text-align:right" | <b>March 3, 2025</b> |
||
|- |
|- |
||
| style="text-align:left" | /s/ Michael Morrissey |
| style="text-align:left" | /s/ Michael Morrissey |
||
| style="text-align:left" | Director |
| style="text-align:left" | Director |
||
| |
| style="text-align:right" | March 3, 2025 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Michael Morrissey</b> |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Director</b> |
||
| |
| style="text-align:right" | <b>March 3, 2025</b> |
||
|- |
|- |
||
| style="text-align:left" | /s/ Katharine Terry |
| style="text-align:left" | /s/ Katharine Terry |
||
| style="text-align:left" | Director |
| style="text-align:left" | Director |
||
| |
| style="text-align:right" | March 3, 2025 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Katharine Terry</b> |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Director</b> |
||
| |
| style="text-align:right" | <b>March 3, 2025</b> |
||
|} |
|} |
||
</div> |
</div> |
||
Revision as of 18:32, 25 July 2026
| Document info | |
|---|---|
| Document ID | vycbjm4dw4 |
| Organization | Skyward |
| Year | 2024 |
| Period | FY |
| Period label | FY24 |
| Document category | Annual report |
| Document type | Form 10-K |
| Document name | Skyward Specialty Insurance Group 2024 Form 10-K |
| Publication date | 2025-03-03 |
| Language | English |
| Pages | 24 |
| Source | original URL |
| Transcript | wiki page |
| Data | data page |
This article summarizes Skyward's Annual report published on 2025-03-03 (24 pages).
Cover
[c. 1; p. 1]
| USD ($) | 12 Months Ended | ||
|---|---|---|---|
| Dec. 31, 2024 | Feb. 26, 2025 | Jun. 30, 2024 | |
| Cover [Abstract] | — | — | — |
| Document Type | 10-K | — | — |
| Document Annual Report | true | — | — |
| Document Period End Date | Dec. 31, 2024 | — | — |
| Current Fiscal Year End Date | --12-31 | — | — |
| Document Transition Report | false | — | — |
| Entity File Number | 001-41591 | — | — |
| Entity Registrant Name | SKYWARD SPECIALTY INSURANCE GROUP, INC. | — | — |
| Entity Incorporation, State or Country Code | DE | — | — |
| Entity Tax Identification Number | 14-1957288 | — | — |
| Entity Address, Address Line One | 800 Gessner Road | — | — |
| Entity Address, Address Line Two | Suite 600 | — | — |
| Entity Address, City or Town | Houston | — | — |
| Entity Address, State or Province | TX | — | — |
| Entity Address, Postal Zip Code | 77024-4284 | — | — |
| City Area Code | 713 | — | — |
| Local Phone Number | 935-4800 | — | — |
| Title of 12(b) Security | Common stock, par value $0.01 | — | — |
| Trading Symbol | SKWD | — | — |
| Security Exchange Name | NASDAQ | — | — |
| Entity Well-known Seasoned Issuer | No | — | — |
| Entity Voluntary Filers | No | — | — |
| Entity Current Reporting Status | No | — | — |
| Entity Interactive Data Current | Yes | — | — |
| Entity Filer Category | Large Accelerated Filer | — | — |
| Entity Small Business | false | — | — |
| Entity Emerging Growth Company | false | — | — |
| ICFR Auditor Attestation Flag | true | — | — |
| Document Financial Statement Error Correction [Flag] | false | — | — |
| Entity Shell Company | false | — | — |
| Entity Public Float | — | — | 1,333,367,336 |
| Entity Common Stock, Shares Outstanding | — | 40,127,908 | — |
| Documents Incorporated by Reference | Portions of the Registrant’s Proxy Statement relating to the 2025 annual meeting of stockholders (the “2025 Proxy Statement”), which will be filed within 120 days of December 31, 2024, are incorporated by reference into Part III of this Form 10-K. | — | — |
| Entity Central Index Key | 0001519449 | — | — |
| Amendment Flag | false | — | — |
| Document Fiscal Year Focus | 2024 | — | — |
| Document Fiscal Period Focus | FY | — | — |
Audit Information
[c. 2; p. 2]
| 12 Months Ended | |
|---|---|
| Dec. 31, 2024 | |
| Audit Information [Abstract] | — |
| Auditor Name | Ernst & Young LLP |
| Auditor Location | Houston, Texas |
| Auditor Firm ID | 42 |
Business
Who We Are
[c. 3; p. 8] Company formation and business overview
- Skyward Specialty was formed as a Delaware corporation on January 3, 2006, as an insurance holding company.
- The company operated under the name Houston International Insurance Group, Ltd. until rebranding as Skyward Specialty in November 2020.
- Skyward Specialty is a growing specialty insurance company delivering commercial property and casualty (P&C) products and solutions on a non-admitted (E&S) and admitted basis, predominantly in the United States.
- The business focuses on underserved, dislocated, and/or markets where standard insurance coverages are insufficient.
- Customers typically require highly specialized, customized underwriting solutions and claims capabilities.
- The company develops and delivers tailored insurance products and services for niche markets.
[c. 4; p. 8] Diversified portfolio and strategy
- The portfolio of insured risks is highly diversified across industries, distribution channels, and lines of business.
- Lines of business include general liability, excess liability, professional liability (including cyber and media liability insurance), commercial auto, group accident and health, property, agriculture, credit, surety, and workers’ compensation.
- The company insures both short and medium duration liabilities.
- The business mix is principally primary insurance and balanced between E&S and admitted markets.
- A small portion of the business is specialty reinsurance (principally agriculture and credit), focused on attractive specialty classes where approaching through reinsurance is more efficient due to factors like cost of entry and geographic expansion costs.
- This diversification, including businesses not typically aligned with traditional P&C pricing cycles, combined with underwriting and claims expertise, is expected to consistently produce strong growth and profitability across all insurance pricing cycles.
[c. 5; p. 8] Leadership and competitive advantages
- The company is led by an entrepreneurial executive management team with decades of insurance leadership experience in the global P&C industry.
- Leadership is supported by an experienced team with a broad skill set aligned with the company's strategy.
- High-quality leadership, underwriting and claims teams, technology DNA, advanced analytics capabilities, diversified book of business, and strong competitive position in chosen market niches are expected to enable continued profitable business growth.
- The aim is to deliver long-term value for shareholders by generating best-in-class underwriting profitability and book value per share growth across P&C market cycles.
[c. 6; p. 8] Financial strength ratings
- All insurance company subsidiaries are group rated.
- Subsidiaries have financial strength ratings of "A" (Excellent) from A.M. Best Company ("A.M. Best") with a stable outlook.
Our Business and Our Strategy
[c. 7; p. 8] Reportable segment and underwriting divisions overview
- One reportable segment offers a broad array of insurance coverages to various market niches.
- Eight distinct underwriting divisions exist, each with dedicated underwriting leadership and technical staff.
- This structure and expertise aim to serve customer needs, be a value-add partner to distributors, and earn attractive risk-adjusted returns.
- For the year ended December 31, 2024, 44% of gross written premiums were on an admitted basis and 56% were non-admitted.
[c. 8; p. 8] Accident & Health underwriting division
- The Accident & Health (A&H) underwriting division provides medical stop loss to employers who self-insure employee benefits, and covers group and single-employer captives.
- The approach for managing medical costs and claims oversight enables partnerships with select distribution partners.
- It targets small and medium-sized enterprise market segments seeking to control healthcare costs by self-insuring a portion of their healthcare insurance.
- Products are written on an admitted basis and distributed primarily through retail and wholesale broker partners.
[c. 9; p. 8] Captives underwriting division
- The Captives underwriting division provides group captive solutions by leveraging underwriting and claims expertise from other divisions.
- This allows for broadening market reach and writing profitable business with limited additional expense.
- The division writes property, general liability, commercial auto, excess liability, and workers’ compensation lines of business on an E&S and admitted basis.
- Business is often administered through partnerships with third-party captive managers.
[c. 10; p. 8] Global Property and Agriculture underwriting division
- The Global Property underwriting unit provides property-only solutions to large multi-jurisdictional entities with complex property exposures.
- This business is written entirely on an E&S basis and distributed through retail and select wholesale brokers.
- The Global Agriculture underwriting unit provides secondary and reinsurance solutions for crop, livestock, and other renewable resources.
[c. 11; p. 8] Industry Solutions underwriting division
- The Industry Solutions underwriting division includes three units: construction, energy, and inland marine.
- Construction and energy units provide general liability, excess liability, commercial auto, workers’ compensation, and adjacent inland marine solutions.
- These are written principally on an admitted basis for middle market construction and energy production/servicing customers, including alternative/renewable energy.
- The inland marine unit focuses on logistics and other specialty property risk for assets in transit.
- Industry segments often have high severity exposures, addressed with multi-line solutions by skilled underwriters and claims professionals.
- Products are distributed through retail agents and brokers and a select network of wholesalers.
[c. 12; p. 8] Professional Lines underwriting division
- The Professional Lines underwriting division includes three units: management liability, professional liability (including cyber and media liability), and allied health (including life sciences).
- Professional liability and allied health provide primary and excess claims-made liability products.
- These are offered on an E&S and admitted basis, distributed through wholesale and retail brokers depending on the product.
[c. 13; p. 8] Programs underwriting division
- The Programs underwriting division partners with program administrators focused on specific markets aligned with the company's expertise and strategy.
- Partnering with program administrators is considered optimal for profitable participation or market reach, especially when administrators have competitive advantages like scale or proprietary technology.
- The division writes property, general liability, commercial auto liability, excess liability, and workers’ compensation lines of business on an E&S and admitted basis.
[c. 14; p. 8] Surety underwriting division
- The Surety underwriting division provides contract, commercial, and transactional surety solutions for trade and services organizations requiring bonding.
- It primarily focuses on small to medium-sized enterprises with aggregate bond programs up to approximately USD 75.0m for contract and USD 100.0m for commercial and transactional.
- This business is written on an admitted basis and distributed through retail agents and brokers.
[c. 15; p. 8] Transactional E&S underwriting division
- The Transactional E&S underwriting division provides primary and excess non-catastrophe prone property and general liability solutions.
- It emphasizes risks considered hard to place due to complexity, loss history, or limited operating history (e.g., start-ups).
- Success in this market is determined by technical underwriting, thoughtful coverage provisions, pricing, and high-quality broker service.
- The market is accessed exclusively through wholesale brokers.
[c. 16; p. 8] Exited business
- Business units and lines of business previously exited and placed into run-off are referred to as "exited business".
[c. 17; p. 8] Strategy and "Rule Our Niche"
- The company seeks to lead in chosen market niches and establish sustainable competitive positions.
- The strategy, referred to as "Rule Our Niche," is underpinned by five key elements.
- The first element is providing differentiated products, services, and solutions that meet the unique needs of target markets.
- The second element is attracting and retaining exceptional underwriting and claims talent and incentivizing professionals aligned with organizational and corporate goals.
- The third element is amplifying expertise with advanced technology and analytics for superior risk selection, pricing, and claims management.
- The fourth element is empowering underwriting and claims teams with considerable authority for decision-making and expertise application.
- The fifth element is fostering a culture that promotes nimbleness and responsiveness to market opportunities and dislocation.
- This strategy forms the basis for building a strong defensible market position, creating a competitive moat, and winning in chosen markets.
- The principles of this strategy are believed to be key to achieving and sustaining best-in-class underwriting results through P&C insurance pricing cycles.
- The company consistently strives for excellence in risk selection, pricing, and claims outcomes, amplified by advanced technology and analytics.
Our Competitive Strengths
[c. 18; p. 8] Competitive strengths overview
- Competitive strengths include focus on profitable niches, highly skilled underwriters, superior claims staff, superior business intelligence platform, advanced technology, diversified business, attractive culture, and experienced leadership.
[c. 19; p. 8] Profitable niches and underwriting
- Focus on profitable niches of the market that require technical underwriting and claims management as barriers to entry.
- Niche areas of commercial lines P&C markets are an attractive subset of the P&C insurance market, offering opportunities for attractive risk-adjusted returns.
- Actively targets underserved, dislocated, or markets where standard products are insufficient.
- Risks within core markets require efficient, individual underwriting to generate acceptable, sustainable underwriting profit.
- Underwriting divisions are built around deeply experienced underwriters empowered with appropriate authority to make decisions.
- This structure enables offering innovative and unique products and solutions to distribution partners and customers, regardless of risk complexity.
- Underwriters' experience is augmented with data and predictive analytics to differentiate risk selection and pricing decisions while enhancing efficiency.
- Focus on hiring underwriting and technical staff whose expertise and experience differentiate the company.
- Underwriting teams are knowledgeable, experienced, and empowered, which is critical for success in markets with risks difficult to automate.
- Professionals are given freedom to use expertise and judgment in evaluating and pricing risks, rather than strict underwriting rules.
[c. 20; p. 8] Claims staff and operations
- Cultivated a best-in-class and highly specialized team of claims professionals knowledgeable about the niches and lines of business served.
- Claims professionals systematically address first-party claims with fair and equitable solutions and third-party claims with holistic and comprehensive responses.
- Aims to ensure consistent and early loss recognition of indemnity and loss adjustment expenses (LAE).
- Responds quickly to claims with specialized adjusters equipped with expertise, advanced technology, and analytics.
- Technology is deeply embedded in the claims process, leveraging a technology-enabled platform and tools from first notice of loss to investigation to settlement.
- Analytics capabilities provide senior leadership and claims teams with real-time, detailed information on open claims and benchmarks against closed claims.
- Industry expertise, nimble culture, and technology-embedded claims processes enable fair and appropriate claims outcomes for customers.
[c. 21; p. 8] Business intelligence and technology
- SkyBI, the business intelligence platform, provides senior leadership and technical teams with real-time intelligence for superior decision-making.
- SkyBI reflects best practices learned from the management team's experience in P&C insurance and technology sectors.
- SkyBI is a single, comprehensive enterprise-wide data repository for reporting, business intelligence, analytics, and advanced data capabilities.
- Provides information and performance metrics across the company in an easy-to-consume visualized format.
- Data can be filtered by categories including distributor, customer segment, line of business, specific industry, individual underwriter, and specific risk feature.
- SkyBI aids in establishing clear line of sight to objectives and facilitating decision-making processes.
- Every underwriting and claims decision can be augmented with new types of risk data and advanced technology.
- Underwriting decisions are backed by reliable historical data and in-depth risk evaluation from intentional investment in data collection and processing.
- Underwriting and claims prowess is amplified by combining historical data with new forms of risk data and predictive analytics.
- Generative artificial intelligence is utilized in underwriting and claims handling where it enhances effectiveness and efficiency without sacrificing employee expertise.
[c. 22; p. 8] Diversified business
- Built a diversified group of underwriting divisions spanning multiple product lines, industries, geographies, and distribution channels.
- Includes business not typically aligned with traditional P&C cycles.
- Aims to evolve with and adapt to the market by growing certain lines when conditions are favorable and limiting exposure when conditions are less favorable.
- Diversity of the book allows response to and capitalization on market opportunities and dislocations across insurance market and pricing cycles, resulting in a durable insurance franchise.
[c. 23; p. 8] Culture and leadership
- Built a distinctive winning culture, evidenced by internal surveys, public information (Glassdoor, LinkedIn), and selection as a "Best Places to Work in Insurance".
- Key to culture and operating approach is a flat structure of communication and decision-making.
- Staff are trusted to make decisions that produce or exceed desired financial results and are supported by a clear system of performance measurement.
- Adopted a hybrid work schedule providing employees with remote working flexibility.
- Maintains an entrepreneurial environment that encourages and rewards a proactive approach to capitalize on market disruption.
- This environment is consistent with identity as a specialty insurer and a foundation for attracting talent and delivering best-in-class results.
- Led by CEO Andrew Robinson, the executive leadership team is experienced, innovative, and entrepreneurial.
- Leadership team has a track record of success in senior management roles at industry-leading P&C companies and in starting new businesses.
- Entire senior leadership's compensation is directly aligned with shareholders.
- A material portion of each leader's compensation is in long-term and short-term incentives tied to delivering sustainable, best-in-class underwriting returns.
- Executive leadership team has additional long-term incentive targets tied directly to growth in book value per share.
Our Strategy in Action
[c. 24; p. 8] Rule Our Niche strategy tenets
- The "Rule Our Niche" strategy aims to generate best-in-class underwriting profitability for niches and create superior long-term shareholder value through growth in book value per share.
- Core tenets include attracting and retaining blue-chip underwriting and claims talent to expand and enhance market position.
- The company seeks to hire talented technical underwriting professionals with long-standing industry relationships and claims professionals with niche expertise.
- These relationships are crucial for steady access to preferred business.
- The company believes it is a company of choice for top industry talent and will continue to grow its market position by recruiting world-class talent in chosen markets.
[c. 25; p. 8] Technology leverage
- The company leverages its technology DNA to differentiate itself from competitors.
- It has demonstrated a differentiated ability to use new forms of risk data and advanced technology in complex, higher severity risk categories within the specialty P&C insurance market.
- SkyBI enables prompt sensing and quick response to market changes.
- Core operating platforms allow efficient entry into new markets without complex systems.
- This technological advantage positions the company for profitable growth and expansion into additional specialty market niches where it can establish a strong and defensible market position.
[c. 26; p. 8] Business growth and market trends
- The company aims to profitably grow existing lines of business and expand with new underwriting divisions.
- It is positioned to capitalize on trends impacting customers in the United States and globally.
- Trends include increased demand for specialized insurance due to rising and complex risks from climate change/severe weather, supply chain uncertainty, financial inflation, cyber risk, novel health risks, increased litigation, attorney involvement, jury awards, and healthcare delivery/cost.
- Another market trend is the emergence of "micro cycles and micro dislocations" where P&C market segments experience hardening and softening at different times.
- The company has reacted quickly to these trends by launching new underwriting units (many not aligned with P&C cycles), entering underserved markets, partnering with advanced technology providers, and launching new captive solutions.
- Gross written premium growth and profitability indicate momentum and position the company for continued expansion and growth in target markets.
[c. 27; p. 8] Underwriting performance and operational excellence
- The company differentiates on daily excellence to drive best-in-class underwriting performance.
- Achieving long-term goals, including best-in-class underwriting returns and growth in book value per share, depends on day-to-day operational execution across all functional departments (underwriting, product management, claims management).
- SkyBI provides a foundation for senior management to monitor performance, including renewal rates, new business pricing, portfolio performance for individual underwriters, and claims aging/reserving practices/outcomes by claims adjusters.
- Focus on fundamentals driving underwriting excellence is central to the strategy.
- Cross-functional collaboration ensures underwriting, claims, actuarial, and product management teams regularly review performance and trends to implement portfolio, pricing, and coverage changes quickly.
[c. 28; p. 8] Balance sheet strength and reserving practices
- The company uses its balance sheet to capture a larger market share.
- It is committed to establishing and maintaining a strong balance sheet, starting with conservative loss reserves and strong capitalization ratios.
- This is imperative for maintaining confidence of customers, distribution partners, reinsurers, regulators, rating agencies, and shareholders.
- Claims case reserve practices aim to reserve to the expected ultimate loss within 90 days of the first notice of loss.
- The company maintains incurred but not reported reserves ("IBNR") that, combined with case reserves, are above the actuarial central estimate.
- Loss reserves represent the best estimate of ultimate losses.
Marketing and Distribution
[c. 29; p. 8] Marketing and distribution strategy
- The company's marketing and distribution approach mirrors its underwriting strategy and is a key facet of its "Rule Our Niche" strategy.
- Underwriting teams and the company maintain strong relationships and reputations with distribution partners, facilitating new affiliations.
- The company wins with distribution partners due to deep expertise in niche markets, high-caliber underwriters, a culture of innovation, thoughtful product lineup and design, and speed/quality of responsiveness.
- All underwriting divisions invest significant time and effort in sustaining and expanding distribution partner loyalty and long-term relationships.
- The choice of distribution partners is tailored to access specific business, mirroring the tailored underwriting approach for insureds.
- Products are distributed through retail agents, wholesale brokers, select program administrators, and captive managers.
- This distribution approach allows effective and efficient access to targeted business based on market niche needs and dynamics.
Underwriting
[c. 30; p. 8] Underwriting strategy and approach
- Underwriting approach is embedded in the "Rule Our Niche" strategy and is core to market success.
- Underwriting teams are specialized within eight divisions, focusing on specific niches.
- Underwriting approach is underpinned by hiring experienced, best-in-class, and diverse technical underwriters with established track records in specific specialty niche markets.
- Underwriters' skill sets are amplified with advanced technology and data analytics, and they are empowered with appropriate decision-making authority.
- This approach is considered key to superior risk selection and pricing, and producing sustainable best-in-class underwriting results across market cycles.
- Capabilities and experience of underwriting professionals are augmented using new forms of data and analytics for risk selection and pricing.
- Underwriting data is captured in the SkyBI business intelligence platform.
- SkyBI is a comprehensive data repository forming the foundation of reporting, analytics, and other data capabilities, and is a key tool for senior management and business leaders.
- The company is highly selective in policies chosen to bind.
- Underwriters are encouraged to move on quickly if they cannot reasonably expect to bind coverage at a premium and coverage terms that meet company standards.
- When accepting risks, terms and price are established to suit the underlying exposure.
- In the admitted market, the company ensures approved forms and filed rates are appropriate and adequate for accepted risks, while allowing flexibility for specific/unique exposures.
- In the E&S market, freedom of rate and form is used to ensure risk and coverage are appropriate for unique needs and exposures.
- Policies are crafted to offer affordable and appropriate protection for insureds' exposures, while constructing coverage for predictable potential losses and managed claims costs.
- Underwriting teams are supported by active engagement and collaboration with Claims, Actuarial, Product Management, Legal and Compliance, and Finance departments.
- This collaboration ensures trends in business, legal and tort developments, and competitor and regulatory actions are analyzed, shared, and acted upon timely.
- Underwriters are viewed as the center of the company, with all support functions incentivized and measured to support underwriting profitability targets.
- This structure helps surface opportunities and issues early, contributing to nimbleness and ability to leverage market disruptions.
- Underwriting controls and procedures are regularly reviewed to ensure underwriters profitably underwrite each market served.
Claims Management
[c. 31; p. 8] Claims management principles and operations
- Skyward's claims department is guided by six principles: prompt and comprehensive claim investigations using advanced analytics and technology; quality claims handling service with customer engagement; prompt establishment of reserves reflecting ultimate loss estimates; effective pursuit of contribution and subrogation; detection and prevention of fraud; and disciplined litigation management.
- Continuous training is provided to claim staff on claim evaluation, strategy, litigation management, good-faith claims handling, and best practices to achieve timely and optimal claim outcomes.
- The majority of claims are handled in-house.
- Third Party Administrators (TPAs) are utilized for certain claims, including programs, captives, occupational accident, workers compensation, and runoff claims.
- TPAs are actively managed, overseen, and regularly audited to ensure compliance with Skyward's claims handling and reserving guidelines and general best practices.
- Independent legal counsel is retained for liability claims against an insured, selected based on geographical location and expertise.
- Litigation guidelines have been developed for claims professionals and outside counsel to ensure appropriate defense for insureds.
- A legal spend management solution is employed to analyze legal invoices for adherence to case handling and billing practice standards, ensuring reasonable and customary legal costs.
[c. 32; p. 8] Claims technology and efficiency initiatives
- Technology is leveraged to gain efficiencies in the claims-handling process.
- A Claims Development Severity Predictor, a predictive model, has been created and implemented to identify claims likely to lead to large loss development.
- This model allows for early identification, proactive claims management, and summarization of development reasons, and has been integrated into the claims review and management workflow.
- A "quick strike" program has been implemented for commercial auto claims to respond efficiently to claim reports.
- The "quick strike" program involves deploying experienced investigators and vendors to the scene of a reported auto accident, ideally within two hours, regardless of location.
- This quick response aids in evaluating accident facts and circumstances for rapid investigation and, if appropriate, resolving third-party claims quickly.
[c. 33; p. 8] Claims team structure and collaboration
- Claims handlers and managers are organized by line of business to ensure specialized expertise in handling claims.
- Managers and adjusters collaborate closely with underwriting partners to inform them of legal trends and emerging claims issues.
- The goal of this collaboration is to educate underwriters on emerging areas of loss experience to assist in their risk selection processes.
Technology
[c. 34; p. 8] Technology strategy and platforms
- Technology is central to Skyward's operations and decision-making, driving competitive advantages.
- Skyward deploys technology in three primary functional ways: Superior Business Intelligence Platform, Predictive Analytics Technology, and Core Transactional Platforms.
- Superior Business Intelligence Platform:
- SkyBI provides senior leadership and technical teams with real-time intelligence for decision-making.
- SkyBI incorporates best practices from management's experience in P&C insurance and technology sectors.
- SkyBI is a single, comprehensive enterprise-wide data repository for reporting, business intelligence, analytics, and advanced data capabilities.
- It provides information and performance metrics across the Company in a visualized format.
- Data can be filtered by categories including distributor, customer segment, line of business, specific industry, individual underwriter, and specific risk feature.
- SkyBI helps establish clear line of sight to objectives and facilitates decision-making.
- Predictive Analytics Technology:
- Skyward augments employee capabilities using new risk data and predictive analytics, including AI, for risk selection, pricing, and claims handling.
- Actions within each underwriting division are intentional to "Rule Our Niche".
- Skyward aims for constant innovation, with actions specific to each division/market served.
- Core Transactional Platforms:
- Core operating platforms (policy administration, underwriting workbench, billing, claims systems) are designed for nimble scaling and business expansion.
- Skyward generally uses customized third-party vendor applications for core operating platforms.
- The core platform organization is used for all business except accident & health, global property, agriculture, and surety, which require dedicated core processing components due to unique features.
- Data from all divisions' core operating platforms flows to SkyBI with comparable data quality and granularity.
- The use of advanced technology for underwriting and claims, SkyBI, and core operating platforms creates a flywheel effect.
- This effect allows underwriters to better select risk, claims professionals to better adjudicate claims, unit leaders to better communicate with reinsurance and third-party partners, and senior leadership to better evaluate business trends.
- These tools also improve communication accuracy, effectiveness, and efficiency with distribution partners, reinsurers, and other third-party partners.
[c. 35; p. 8] Cybersecurity and data protection
- Skyward faces external threats to its IT systems, including system failure, customer data theft attempts, and ransomware attacks.
- The technology infrastructure is designed to function through major disruptions.
- Data is replicated in real-time to a third-party cloud disaster recovery site for use during major system failures.
- Data is backed up daily for system restoration.
- Actions to prevent system and data disruptions include:
- Actively monitoring Cybersecurity and Infrastructure Security Agency’s (“CISA”) cybersecurity directives.
- Taking immediate action on identified vulnerabilities in directives.
- Conducting monthly vulnerability scans on all network-attached devices at all locations, with patching applied as needed.
- Requiring two-factor authentication for system access.
- Conducting monthly security training for all employees.
- Implementing endpoint detection agents for threat detection and response.
- Performing desktop scenarios to practice responses to breaches with cybersecurity insurance partners and retained security consultants.
- Performing annual penetration testing.
- Skyward constantly reviews its security breach posture and regularly implements updated processes, best practices, and tools.
Reinsurance
[c. 36; p. 8] Reinsurance strategy and types
- Reinsurance is strategically purchased from third parties to protect capital from severity events (large single event losses or catastrophes) and reduce earnings volatility.
- Reinsurance contracts are predominantly one year in length and renew annually, primarily in January and June.
- Factors influencing changes to reinsurance purchases at annual renewal include plans to change underlying insurance coverage, updated loss activity, capital and surplus levels, changes in risk appetite, and the cost and availability of reinsurance treaties.
- Quota share, excess of loss, and facultative reinsurance coverage are purchased to limit exposure from losses on any one occurrence.
- The mix of reinsurance purchased considers efficiency, cost, risk appetite, and specific factors of underlying risks.
- Quota share reinsurance involves the reinsurer assuming a specified percentage of losses from a defined class of business in exchange for a corresponding percentage of premiums, net of a ceding commission.
- Excess of loss reinsurance involves the reinsurer assuming all or a portion of losses for an individual claim or event above a specified amount, in exchange for a negotiated premium, and includes the catastrophe reinsurance program.
- Facultative coverage is a reinsurance contract on individual risks, used to supplement treaty limits or cover risks/perils excluded from treaty reinsurance.
[c. 37; p. 8] Property catastrophe reinsurance program
- As of December 31, 2024, property insurance represented 29% of gross written premiums.
- Aggregation of property writings by geographic area is actively managed and continuously monitored to limit potential loss from severe events like hurricanes, convective storms, and earthquakes.
- Catastrophe reinsurance is purchased to further mitigate aggregation of property losses due to a single event or series of events.
- Third-party stochastic and internal deterministic models are used to analyze the risk of loss aggregation from such events, providing a quantitative view of Probable Maximum Loss (PML) events.
- Based on modeling, an event beyond a 1 in 250-year PML would be required to exhaust the USD 36.0m property catastrophe coverage.
- The company aims to expose no more than 3.0% of stockholders’ equity to a catastrophic loss less than a 1 in 250-year event.
- The current reinsurance program is believed to provide coverage well in excess of theoretical losses from any recorded historical event.
[c. 38; p. 8] Reinsurer credit quality and recoverables
- Reinsurance is sought from reinsurers rated at least "A-" ("Excellent") or better by A.M. Best.
- As of December 31, 2024, 99% of reinsurance recoverables were from reinsurers rated "A-" (Excellent) or better by A.M. Best, or were collateralized by the reinsurer.
- The company retains primary liability to policyholders if reinsurers are unable to pay claims, potentially resulting in losses.
- Allowances are established for uncollectible reinsurance amounts.
- The allowance for uncollectible reinsurance was USD 2.3m at December 31, 2024 and 2023.
[c. 39; p. 8]
| Line of Business | Maximum Company Retention |
|---|---|
| Accident & Health | $0.90 million per occurrence |
| Commercial Auto (1) | $1.00 million per occurrence |
| Excess Casualty (1)(2) | $1.25 million per occurrence |
| General Liability (1) | $1.50 million per occurrence |
| Professional Lines (2) | $5.21 million per occurrence |
| Property (3) | $3.50 million per occurrence |
| Representation and Warranty | $3.25 million per occurrence |
| Surety (2) | $4.00 million per occurrence |
| Workers’ Compensation (2) | $2.33 million per occurrence |
| ($ in thousands) | ||
|---|---|---|
| Reinsurer | Reinsurance Recoverables | AM Best Rating |
| Everest Reinsurance Co. | 154,181 | A+ |
| eMaxx Captives (1) | 144,196 | n/r |
| Partner Reinsurance Co. of the US | 52,442 | A+ |
| General Reinsurance Corp | 48,234 | A++ |
| Swiss Reinsurance America Corp | 37,789 | A+ |
| ACE (Chubb Property & Casualty Ins Company) | 36,527 | A+ |
| RGA Reinsurance Company | 24,945 | A+ |
| Randall & Quilter (R&Q Bermuda (SAC) Ltd) (2) | 22,663 | n/r |
| Aspen Insurance UK Limited | 19,998 | A |
| Insurance Company of the West | 18,112 | A |
| Top 10 Total | 559,087 | — |
| All Others | 298,789 | — |
| Total | 857,876 | — |
Enterprise Risk Management
[c. 40; p. 8] Enterprise Risk Management Framework
- The company's Enterprise Risk Management (ERM) is embedded in its operations and guides daily activities.
- The ERM approach aims to achieve an acceptable risk-adjusted return for shareholders while maintaining trust and reliability for those served.
- The company is intentional in its underwriting and asset portfolio construction, balancing liability duration and market cyclicality of the underwriting portfolio.
- Reinsurance is used to manage volatility outside of risk tolerances.
- The investment strategy targets a diversified portfolio that balances portfolio yield, liquidity, volatility, and potential for principal loss.
- The Senior Vice President (SVP) of Finance & ERM oversees critical ERM processes and chairs the cross-functional corporate ERM Committee.
- The company formalizes its view of risk and solvency as potential economic loss using its Economic Capital Model (ECM).
- The ECM output measures potential earnings and capital loss for various scenarios, which are then measured against risk tolerances.
- Risk tolerances are set and updated annually by the ERM Committee and discussed with the Board's Risk Committee.
- The ECM provides a probabilistic modeled view of earnings and capital loss, integrating potential losses from catastrophes, reserving, underwriting, market, credit risk, strategic, and operational risks.
- The SVP of Finance & ERM and the ERM Committee review and maintain a comprehensive risk register with accountabilities for mitigation.
- The top 10 risks are identified, quantified, and reviewed quarterly by the SVP of Finance & ERM and the ERM Committee.
- Reports on these risks are submitted regularly to the Risk Committee by the SVP of Finance & ERM and the ERM Committee.
[c. 41; p. 8] Operational Risk Management Processes
- Operational processes and controls are designed to identify, assess, and manage key risks continuously.
- The Underwriting Committee oversees changes in risk appetite, product line, and division expansion.
- Claims handling practices are monitored against guidelines through regular internal audits, monthly large loss reviews, and a watchlist of potential high-severity claims.
- Actuarial performs quarterly reserve studies, and the Reserve Committee meets quarterly to review and respond to loss emergence trends.
- Key observations from actuarial reviews are discussed with the CEO.
- Underwriting divisions assess rate change and retention on existing business, new business quality, pricing adequacy, and loss emergence compared to expected on a monthly and quarterly basis.
- The SkyBI platform provides real-time portfolio, underwriting, claims, and actuarial analytics to support these processes.
[c. 42; p. 8] ERM Strategic Importance
- ERM is central to the company's decision-making and daily activities.
- ERM is a core component of the strategy to achieve market-leading risk-adjusted returns for shareholders.
Reserves
[c. 43; p. 8] Reserve management and methodology
- Reserves are maintained for specific claims incurred and reported, IBNR reserves, and uncollectible reinsurance.
- Ultimate liability may differ from current reserves.
- The insurance industry carries the risk of inadequate reserves.
- Reserves are continually monitored using new information on reported claims and statistical analyses.
- Anticipated inflation is implicitly reflected in the reserving process through cost trend analysis and historical development review.
- Reserves for losses and LAE are not discounted to reflect estimated present value.
- Case reserves are established when a claim is reported for the estimated ultimate payment, following assessment of coverage, damages, and investigation.
- Estimates for case reserves are based on reserving practices and the claims adjuster's experience and knowledge of the claim type and value.
- Case reserves are periodically revised based on subsequent developments for each claim.
- IBNR reserves are established for estimated future loss payments on incurred but not yet reported claims and potential development on reported claims.
- IBNR reserves are estimated using generally accepted actuarial reserving techniques that consider quantitative loss experience data and qualitative factors.
- Loss reserves are regularly reviewed using various actuarial techniques.
- Reserve estimates are updated as historical loss experience develops, additional claims are reported/settled, and new information becomes available.
- Reserves can be increased or decreased over time as claims move towards settlement, impacting earnings through adverse development or reserve releases.
- Additional information on loss reserves is available in Item 7 of Form 10-K, "Management’s Discussion and Analysis of Financial Condition and Results of Operations - “Results of Operations - Losses and LAE” and “Critical Accounting Policies.”".
Investments
[c. 44; p. 8] Investment strategy and management
- The company aims to maintain a balanced investment portfolio with predictable and stable returns, augmented by strategic investments for attractive risk-adjusted returns.
- An Enterprise Based Asset Allocation model is used for investment allocation, embedded in the Economic Capital Model, to assess the impact of decisions on capital, liquidity, and risk profile across market scenarios.
- Investment risk is actively managed to balance stable growth and liquidity with compliance to insurance regulatory and rating agency frameworks.
- The portfolio primarily consists of cash and cash equivalents and investment-grade fixed-maturity securities, with additional investments fitting the risk appetite.
- The Board of Directors' Investment Committee reviews and approves the investment policy and strategy.
- The Investment Committee meets quarterly to review investment activities, tactics, and new opportunities.
- The investment portfolio is directed internally and includes both self-managed investments and portfolios managed by select third-party investment management firms.
[c. 45; p. 8] Investment discussion reference
- Additional discussion on investments, including market risks, is available in Item 7 of Form 10-K, "Management’s Discussion and Analysis of Financial Condition and Results of Operations—Investments".
Competition
[c. 46; p. 8] Competition in specialty P&C insurance
- The specialty lines property & casualty insurance market comprises many markets and sub-markets, each with distinct customer needs, products, services, and specific economic and structural features.
- Competition in underwriting divisions comes from other specialty and standard insurers, as well as program administrators.
- Competition factors include pricing, general reputation, perceived financial strength, broker relationships, product terms and conditions, independent rating agency ratings, speed and reputation of claims payment, and the experience and reputation of underwriting and claims teams.
- Due to the diversity of underwriting divisions, competition is broad, with some competitors specific to only a subset of divisions.
- Notable competitors include Markel Corporation, W.R. Berkley Corporation, American Financial Group Inc., Tokio Marine Holdings, Inc., CNA Financial Corporation, Hiscox, Ltd., RLI Corp., Intact Finance Corporation, and Kinsale Capital Group, Inc..
Our Structure
[c. 47; p. 8] Insurance company structure and operations
- Operations are conducted principally through four insurance companies: Great Midwest Insurance Company (GMIC), Houston Specialty Company (HSIC), Imperium Insurance Company (IIC), and Oklahoma Specialty Insurance Company (OSIC).
- GMIC, the largest insurance subsidiary, underwrites multiple lines of insurance on an admitted basis in all 50 states and the District of Columbia and is a certified surety bond company listed with the Department of the Treasury.
- HSIC, a subsidiary of GMIC, underwrites multiple lines of insurance on a surplus lines basis in 50 states, the District of Columbia, and select foreign countries.
- IIC, a subsidiary of HSIC, underwrites on an admitted basis in all 50 states and the District of Columbia.
- OSIC, a subsidiary of IIC, is an approved surplus lines company in 49 states and the District of Columbia.
- Effective December 31, 2024, the insurance company subsidiaries were restacked into the aforementioned organizational structure to provide the growing surety business with the capital needed to operate more effectively within the surety T-listing market.
[c. 48; p. 8] Gross written premiums geographic distribution
- The geographic distribution of gross written premiums for the year ended December 31, 2024, is presented in a table.
[c. 49; p. 8] Other subsidiaries and organizational structure
- Skyward Re, a wholly-owned captive reinsurance company domiciled in the Cayman Islands, was incorporated on January 7, 2020.
- Skyward Re was established to facilitate the LPT, which was commuted effective January 31, 2025.
- Three non-insurance companies are also operated: Skyward Underwriters Agency, Inc., Skyward Service Company, and Skyward Specialty No. 1 Limited Company.
- Skyward Underwriters Agency, Inc. is a licensed agent, managing general agent, and reinsurance broker.
- Skyward Service Company provides various administrative services to the subsidiaries.
- Skyward Specialty No. 1 Limited Company is a UK company and an authorized Lloyd’s corporate member.
- The organizational structure is detailed, with each entity wholly-owned by its immediate parent.
[c. 50; p. 8]
| 2024 | |
|---|---|
| Texas | 11.2% |
| California | 8.8 |
| Florida | 8.3 |
| Louisiana | 6.8 |
| New York | 6.5 |
| Georgia | 4.4 |
| Pennsylvania | 3.9 |
| New Jersey | 3.2 |
| Illinois | 2.9 |
| Massachusetts | 2.5 |
| All other states | 41.5 |
| Total | 100.0% |
[c. 51; p. 8] Our Structure

Chart / Image:
- SKYWARD SPECIALTY INSURANCE GROUP, INC. is a Delaware corporation.
- SKYWARD SPECIALTY INSURANCE GROUP, INC. has a subsidiary named SKYWARD SERVICE COMPANY.
- SKYWARD SERVICE COMPANY is a Delaware corporation.
- SKYWARD SPECIALTY INSURANCE GROUP, INC. has a subsidiary named GREAT MIDWEST INSURANCE COMPANY.
- GREAT MIDWEST INSURANCE COMPANY is a Texas stock insurance company.
- SKYWARD SPECIALTY INSURANCE GROUP, INC. has a subsidiary named SKYWARD UNDERWRITERS AGENCY, INC.
- SKYWARD UNDERWRITERS AGENCY, INC. is a Texas corporation.
- SKYWARD SPECIALTY INSURANCE GROUP, INC. has a subsidiary named SKYWARD SPECIALTY NO. 1 LIMITED.
- SKYWARD SPECIALTY NO. 1 LIMITED is a United Kingdom company.
- SKYWARD SPECIALTY INSURANCE GROUP, INC. has a subsidiary named SKYWARD RE.
- SKYWARD RE is a Cayman Islands corporation.
- GREAT MIDWEST INSURANCE COMPANY has a subsidiary named HOUSTON SPECIALTY INSURANCE COMPANY.
- HOUSTON SPECIALTY INSURANCE COMPANY is a Texas stock insurance company.
- HOUSTON SPECIALTY INSURANCE COMPANY has a subsidiary named IMPERIUM INSURANCE COMPANY.
- IMPERIUM INSURANCE COMPANY is a Texas stock insurance company.
- IMPERIUM INSURANCE COMPANY has a subsidiary named OKLAHOMA SPECIALTY INSURANCE COMPANY.
- OKLAHOMA SPECIALTY INSURANCE COMPANY is an Oklahoma insurance corporation.
Ratings
[c. 52; p. 8] A.M. Best rating
- Skyward Specialty Insurance Group, Inc. currently holds an "A" (Excellent) rating with a stable outlook from A.M. Best.
- The "A" (Excellent) rating is the third highest among the 13 ratings assigned by A.M. Best, which range from "A++" (Superior) to "D" (Poor).
- A.M. Best evaluates a company's financial and operating performance by reviewing profitability, leverage, liquidity, book of business, reinsurance adequacy, asset quality and market value, adequacy of losses and loss expense reserves, surplus adequacy, capital structure, management experience and competence, and market presence.
- A.M. Best's ratings reflect its opinion on an insurance company’s financial strength, operating performance, and ability to meet policyholder obligations.
- These ratings are based on factors relevant to policyholders, agents, insurance brokers, and intermediaries, and are not specifically related to securities issued by the company.
Regulation
[c. 53; p. 8] Regulation
- The company is regulated by insurance regulatory authorities in the states where it conducts business.
- State insurance laws and regulations primarily protect policyholders, consumers, and claimants, not stockholders or investors.
- State regulation varies by jurisdiction and generally grants broad administrative power to regulators.
- Regulatory powers include setting capital and surplus requirements, licensing insurers and producers, reviewing and approving product forms and rates, establishing reserve adequacy standards, prescribing statutory accounting methods and financial report formats, regulating affiliate transactions, and prescribing investment types and amounts.
- Insurance company regulation is constantly changing due to governmental agencies and legislatures reacting to issues.
- Some state legislatures have considered or enacted laws that alter and increase state authority to regulate insurance companies and holding company systems to prevent federal involvement.
- The National Association of Insurance Commissioners (NAIC) and some state insurance regulators are re-examining existing laws and regulations, focusing on insurer solvency, interpretations of existing laws, and development of new laws.
- Federal initiatives, such as treatment of federal subsidiaries, regulation of quasi-governmental entities, and regulations from federal departments, often affect the insurance industry despite the federal government not directly regulating insurance.
- The company operates as an insurance holding company system.
- The company is subject to insurance holding company laws in Texas, where its primary insurance companies are domiciled, and Oklahoma.
- These statutes require each insurance company in the system to register with its state of domicile's insurance department.
- Information concerning operations within the holding company system that may materially affect the operations, management, or financial condition of domiciled insurers must be furnished.
- All transactions among members of a holding company system must be fair and reasonable.
- Transactions between insurance subsidiaries and their parents and affiliates generally require disclosure to state regulators.
- Notice to or prior approval from the applicable state insurance regulator is generally required for any material or extraordinary transaction.
Intellectual Property
[c. 54; p. 8] Trademark registrations and protection
- The company has applied for various trademark registrations in the United States at both federal and state levels.
- The company will pursue additional trademark registrations and other intellectual property protection if deemed beneficial and cost-effective.
- The company monitors its trademarks and service marks and protects them from unauthorized use as necessary.
Employees and Human Capital
[c. 55; p. 8] Employee overview and culture
- As of December 31, 2024, the company had approximately 580 employees.
- Employees are not subject to any collective bargaining agreement, and no current efforts to implement such an agreement are known.
- The company believes it has good working relations with its employees.
- The company aims to be an employer of choice, fostering a culture committed to diversity of thought, background, and perspective.
- The company strives to cultivate an exceptional workforce to perpetuate its ownership culture and achieve superior business results.
- The goal is to attract, develop, and retain diverse talent, promoting a culture where different viewpoints are valued, and individuals feel respected, treated fairly, and have opportunities to excel.
[c. 56; p. 8] Compensation and benefits
- The company offers a competitive benefits package to support employee well-being.
- Benefits include medical, dental, and vision insurance, a 401(k) plan, paid time off, family leave, and employee assistance programs.
- An employee stock purchase plan is available to all employees.
- The company emphasizes employee training and development, providing opportunities for further education and professional development.
Risk Factors
[c. 57; p. 9] Investment risk disclosure
- Investing in the company's common stock involves a high degree of risk.
- Investors should carefully consider the risks and uncertainties described in the report, including consolidated financial statements and SEC filings, before investing.
- The listed risks are not exhaustive; additional unstated, unknown, or currently immaterial risks may also affect the company.
- If any described risks occur, the company's business, operating results, financial condition, and prospects could be materially harmed.
- Such events could lead to a decline in the common stock price, resulting in a loss of part or all of an investment.
Summary of Material Risk Factors
[c. 58; p. 9] business and operational risks
- Financial condition and results of operations could be materially adversely affected by inaccurate assessment of underwriting risk.
- Competition for business in the industry is intense.
- Reliance on insurance retail agents and brokers, wholesalers, and program administrators exposes the business to certain risks that could adversely affect results.
- Inability to purchase third-party reinsurance in desired amounts on commercially acceptable terms or terms that adequately protect the company may materially adversely affect business, financial condition, and results of operations.
- Losses and loss expense reserves may be inadequate to cover actual losses, which could materially adversely affect financial condition, results of operations, and cash flows.
- A decline in financial strength rating may adversely affect the amount of business written.
- Unexpected changes in the interpretation of coverage or provisions, including loss limitations and exclusions, in policies could materially adversely affect financial condition and results of operations.
- Reinsurers may not reimburse claims on a timely basis, or at all, which may materially adversely affect business, financial condition, and results of operations.
- Failure to accurately and timely pay claims could materially and adversely affect business, financial condition, results of operations, and prospects.
- Adverse economic factors, including recession, inflation, high unemployment, or lower economic activity, could lead to fewer policy sales, increased claim frequency, premium defaults, or falsification of claims, affecting growth and profitability.
- The insurance business is historically cyclical, which may affect financial performance and cause operating results to vary quarter-to-quarter, not indicative of future performance.
[c. 59; p. 9] regulatory and personnel risks
- Extensive regulation may adversely affect the ability to achieve business objectives; non-compliance could lead to penalties, including fines and suspensions, adversely affecting financial condition and results of operations.
- Adverse effects could result from the loss of key personnel or inability to attract and retain qualified personnel.
[c. 60; p. 9] internal control and public company costs
- Ability to maintain effective internal control over financial and management systems and remediate material weaknesses is a risk.
- Costs will increase significantly as a public company, requiring substantial management time for compliance with public company regulations.
Risks Related to Our Business and Industry
[c. 61; p. 9] Underwriting risk and competition
- Financial condition and results of operations could be materially adversely affected by inaccurate assessment of underwriting risk.
- Underwriting success depends on accurately assessing risks and establishing appropriate premium rates.
- Employees, including management and underwriters, make decisions that expose the company to risk.
- Competition in the insurance industry is intense, coming from specialty insurance companies, standard insurance companies, and underwriting agencies.
- Competition factors include price, reputation, financial strength, distribution partner relationships, product terms, rating agency ratings, claims payment speed, and underwriting team experience.
- Increasing consolidation in the insurance industry may further increase competition.
- New industry or legislative developments could increase competition.
- Inability to compete successfully could change supply and demand for insurance, affect pricing ability, and impact retention of existing business or underwriting new business on favorable terms.
- Increased competition limiting business transactions could adversely affect operating results.
[c. 62; p. 9] Distribution channel risks
- Reliance on insurance retail agents, brokers, wholesalers, and program administrators exposes the company to certain risks.
- Most products are distributed through independent retail agents and brokers who own "renewal rights".
- Business model depends on relationships with and success of retail agents and brokers, wholesalers, and program administrators.
- Relationships with distributors can be discontinued or become unprofitable.
- Consolidation of insurance distribution firms may increase their influence on commission rates and concentration of business with particular brokers.
- Premiums collected by brokers and remitted to the company expose the company to credit risk, as payment to the broker may be considered payment to the company in certain jurisdictions.
- Failure of brokers to remit premiums could require the company to provide coverage despite non-payment, potentially declining underwriting profits and adversely affecting financial condition.
- The company reviews financial condition of new brokers and periodically reviews existing distributors for profitability and alignment with business objectives.
- Measures like restricting product access or terminating relationships with distributors may not achieve desired results due to contractual and regulatory requirements.
- Deterioration of distributor relationships or uncompetitive compensation could lead distributors to place more premium with other carriers.
- Distributors exceeding granted authority, failing to transfer collected premiums, or breaching obligations could expose the company to liability.
- Continued consolidation of insurance distribution firms could affect sales channels through loss of market access, market share, talent, or increased commission costs due to greater negotiating leverage.
- Disruption to sales channels could negatively impact results of operations and financial condition.
- Acceleration of digitization subjects the company to risks related to distributors' ability to keep pace, as customers may prefer technology-driven experiences.
[c. 63; p. 9] Reinsurance availability and effectiveness
- Inability to purchase third-party reinsurance on desired or acceptable terms could materially adversely affect business, financial condition, and results of operations.
- Reinsurance is strategically purchased to protect capital from severity events and reduce earnings volatility.
- Failure to renew expiring contracts, enter new arrangements, or expand coverage could increase loss exposure.
- Increased loss exposure could necessitate reducing underwriting commitments, adversely affecting business, financial condition, and results of operations.
- Reinsurers may exclude certain coverages or alter terms in contracts, leading to gaps in reinsurance protection and greater risk/potential losses.
[c. 64; p. 9] Loss and loss expense reserves adequacy
- Inadequate losses and loss expense (LAE) reserves could materially adversely affect financial condition, results of operations, and cash flows.
- Success depends on accurately assessing risks of insured businesses and people.
- Reserves are established as the best estimate for ultimate payment of incurred claims and related adjustment costs.
- Reserves are estimates, and ultimate liability may differ from the estimate.
- Reserving process considers historical data and factors such as claims inflation, claims development patterns, frequency and severity trends, product pricing, legislative activity, social and economic patterns, and litigation/judicial/regulatory trends.
- Variables are affected by internal and external events that could increase loss exposure.
- Loss reserves are continually monitored using new information, statistical techniques, and modeling simulations.
- The process assumes past experience, adjusted for current developments and trends, is appropriate for predicting future events.
- No precise method exists for evaluating the impact of specific factors on reserve adequacy, and actual results may deviate substantially from estimates.
- Uncertainties impacting reserve adequacy include: considerable time to fully appreciate covered loss extent, leading to increased loss estimates over time; new theories of liability enforced retroactively; failure of loss limitations or exclusions; changes in claims or coverage issues.
- Volatility in financial markets, economic events, and other external factors may increase claim numbers and/or severity.
- Elevated inflationary conditions would increase loss costs.
- Adverse economic factors (recession, inflation, high unemployment, lower economic activity) could lead to fewer policy sales or increased claim frequency/severity and premium defaults, affecting growth and profitability.
- Increased costs due to "social inflation" (medical/material costs, technology in vehicles, supply chain disruptions, attorney involvement, litigation financing, lawsuit abuse) could increase claim frequency/severity and affect reserve adequacy.
- Increased claim frequency, even without liability, could escalate evaluation and handling costs beyond established reserves.
- Entering new lines of business or new theories of claims may increase claim frequency and handling costs.
- Inadequate reserves would require increases, reducing net income and stockholders' equity in the period of identification.
- Future loss experience substantially exceeding established reserves could materially adversely affect future earnings, liquidity, and financial rating.
[c. 65; p. 9] Financial strength rating impact
- A decline in financial strength rating may adversely affect the amount of business written.
- Independent rating agencies like A.M. Best assess financial strength and quality of insurers.
- A.M. Best ratings are based on quantitative and qualitative analysis of balance sheet strength, operating performance, and business profile.
- A.M. Best financial strength ratings range from "A++" (Superior) to "F" (liquidation).
- As of the filing date, A.M. Best assigned an "A" (Excellent) financial strength rating with a stable outlook to the company.
- A.M. Best ratings provide an independent opinion of an insurer's ability to meet policyholder obligations and are not an evaluation for investors or a recommendation to buy/sell securities.
- A.M. Best's analysis includes peer comparisons, industry standards, operating plans, philosophy, and management assessments.
- A.M. Best periodically reviews and may revise ratings downward based on analyses of balance sheet strength, operating performance, and business profile.
- Specific building blocks reviewed by A.M. Best include capital adequacy, operating performance, operating profile, and ERM.
- Other factors that could affect A.M. Best's analysis include: changes in business practices from the organizational plan; unfavorable financial, regulatory, or market trends (e.g., excess market capacity); losses exceeding loss reserves; unresolved issues with government regulators; inability to retain senior management or key personnel; significant investment portfolio losses or limited liquidity; or alterations to A.M. Best's capital adequacy assessment methodology.
- A downgrade or withdrawal of the rating could lead to: current and future distribution partners/insureds choosing higher-rated competitors; increased cost or reduced availability of reinsurance; or severe limitation/prevention of writing new and renewal insurance contracts.
- Rating organizations may heighten scrutiny, increase review frequency/scope, request additional information, or increase capital/other requirements due to earnings and capital pressures on financial institutions.
- There is no assurance the rating will remain at its current level, and adverse ratings consequences could materially affect financial condition and results of operations.
[c. 66; p. 9] Policy interpretation changes
- Unexpected changes in interpretation of coverage or provisions, including loss limitations and exclusions, could materially adversely affect financial condition and results of operations.
- No assurance that loss limitations or exclusions will be enforceable as intended.
- Industry practices, legal, judicial, social, and other conditions can lead to unexpected claims and coverage issues.
- Policy limitations on claim periods may be shorter than statutory periods for policyholders.
- Courts or regulatory authorities could nullify/void limitations or exclusions, or legislation could modify/bar their use.
- Governmental actions could result in higher than anticipated losses and LAE.
- Court decisions, such as the 1995 Montrose decision in California, could narrowly read policy exclusions, expanding coverage and requiring new exclusions.
- These issues may adversely affect business by broadening coverage beyond underwriting intent or increasing claim frequency/severity.
- Changes may not become apparent until after affected insurance contracts are issued, meaning full liability may not be known for many years.
[c. 67; p. 9] Reinsurer non-payment risk
- Reinsurers may not reimburse claims timely or at all, materially adversely affecting business, financial condition, and results of operations.
- Reinsurance contracts require premium payments to reinsurers who reimburse for covered policy claims.
- Reinsurers may be called upon to reimburse claims many years after premiums were paid.
- Reinsurance makes the reinsurer liable but does not relieve the ceding insurer of primary liability to policyholders.
- The current reinsurance program aims to limit financial risk.
- Reinsurers may default due to insolvency, lack of liquidity, operational failure, political/regulatory prohibitions, fraud, asserted defenses, or documentation deficiencies.
- Disputes with reinsurers can be time-consuming, costly, and uncertain of success.
- These risks could lead to increased net losses and adversely affect financial condition.
- As of December 31, 2024, reinsurance recoverables totaled USD 857.9m.
[c. 68; p. 9] Claims payment accuracy and timeliness
- Failure to accurately and timely pay claims could materially and adversely affect business, financial condition, results of operations, and prospects.
- Factors affecting claims payment ability include training/experience of claims representatives (including TPAs), management effectiveness, and ability to develop/implement appropriate procedures and systems.
- Inaccurate or untimely claims payment could lead to regulatory/administrative actions, material litigation, reputational damage, and adverse effects on business, financial condition, results of operations, and prospects.
- Ineffective TPA management or inability of internal staff/TPAs to handle claim volume could adversely affect workload capacity.
- This could require slowing growth in affected markets and lead to decreased quality of claims work, adversely affecting operating margins.
[c. 69; p. 9] Catastrophic events and climate change
- Severe weather, climate change effects, catastrophes, pandemics, and man-made events may adversely affect business, results of operations, and financial condition.
- Business is exposed to severe weather, earthquakes, and man-made catastrophes (e.g., explosions, war, terrorist attacks, riots).
- Catastrophes include natural events like severe winter weather, convective storms/tornadoes, windstorms, hailstorms, thunderstorms, and fires.
- Changing weather patterns and climatic conditions (global warming) have increased unpredictability and frequency of natural disasters, including in historically unaffected areas.
- Climate change may increase frequency and severity of extreme weather events, leading to conditions that increase hurricane activity and wildfire risks.
- Catastrophe losses could materially adversely affect business, financial condition, and results of operations, even for events not directly insured (e.g., 2025 California wildfires leading to policy cancellations).
- Increased frequency and severity of weather events (e.g., hurricanes, convective storms) could materially increase losses and affect ability to predict, quantify, reinsure, and manage catastrophe risk.
- Extent of catastrophe losses depends on frequency/severity of insured events and total insured exposure in affected areas.
- Incidence and severity of catastrophes and severe weather are inherently unpredictable.
- Exposure to losses is managed by analyzing probability and severity of loss events and their impact on underwriting and investment portfolios.
- Indirect impact can occur if insured businesses are affected by catastrophes not directly covered, leading to non-payment of premiums on other products.
- Inability to obtain adequate reinsurance coverage at reasonable rates for severe weather and catastrophes could materially adversely affect business and results of operations.
- Business is exposed to risks from pandemics, outbreaks, public health crises, and geopolitical/social events.
- While policy terms are expected to preclude coverage for virus-related claims (e.g., COVID-19), court decisions and governmental actions may challenge exclusions or interpretations.
- Changes to law and regulation related to climate change could directly affect business.
- The current administration's comments and actions (e.g., President Trump signing an executive order to withdraw the U.S. from the Paris Agreement on January 20, 2025) suggest a shift in U.S. climate policy.
- Unclear future actions by the administration or support for legislative changes could have a material adverse effect on business, operational, and financial results.
[c. 70; p. 9] Program administrator compliance
- Failure of program administrators to comply with pre-established guidelines could adversely affect results of operations.
- Certain insurance products are marketed and distributed through program administrators with limited quoting and binding authority.
- Program administrators sell products to insureds via retail agents and brokers and can bind certain risks without initial approval.
- Non-compliance with underwriting guidelines or appointment terms could bind the company to unanticipated risks, adversely affecting results of operations.
[c. 71; p. 9] Renewal and new business expectations
- If actual renewals or new business from repeat insureds do not meet expectations, future written premium and operating results could be materially adversely affected.
- Most contracts are one-year term and renewable.
- Some insurance contracts do not renew, but insureds are repeat customers with regular new contracts.
- Financial forecasting includes assumptions about renewal rates and repeat business.
- Insurance and reinsurance industries are cyclical with intense, often price-based, competition.
- If renewals and repeat business fall short of expectations, or if the company chooses not to write them due to pricing, future written premium and operations would be materially adversely affected.
[c. 72; p. 9] ESG matters and accounting changes
- Increased public attention to environmental, social, and governance (ESG) matters may lead to negative public perception, reputational harm, additional costs, or impact stock price.
- Failure or perceived failure to meet investor/customer ESG expectations could harm business and reputation.
- Backlash from investors or customers regarding ESG topics could also harm business and reputation.
- Damage to reputation from providing policies to certain insureds could decrease demand, materially adversely affect business/operational/financial results, and require resources to rebuild reputation/competitive position/brand strength.
- Changes in accounting practices and future pronouncements may materially affect reported financial results.
- Developments in accounting practices may require considerable additional expenses for compliance, especially for prior period information or retroactive application.
- The impact of accounting changes and future pronouncements cannot be predicted but may affect net income, shareholder's equity, and other financial statement line items.
- Insurance subsidiaries must comply with statutory accounting principles (SAP).
- SAP and its components are subject to constant review by the NAIC, its task forces/committees, and state insurance departments.
- Pending proposals before NAIC committees/task forces, if enacted and adopted at state level, could negatively affect insurance industry participants.
- The NAIC continuously examines existing laws and regulations.
- It is unpredictable whether or in what form reforms will be enacted, or their positive/negative effect on the company.
Risks Related to the Market and Economic Conditions
[c. 73; p. 9] Economic conditions and insurance demand
- Adverse economic factors like recession, inflation, high unemployment, or lower economic activity can reduce policy sales, increase claim frequency, lead to premium defaults, or cause claim falsification, impacting growth and profitability.
- Business revenue, economic conditions, capital market volatility and strength, and inflation affect the business and economic environment, influencing the ability to generate revenue and profits.
- Economic downturns with higher unemployment, declining spending, and reduced corporate revenue generally hurt demand for insurance products, affecting premium levels and profitability.
- Negative economic factors can hinder the ability to charge appropriate rates for risk, reduce the number of policies written, and limit opportunities for profitable underwriting.
- During economic downturns, customers may need less insurance, cancel policies, modify coverage, or not renew policies.
- Existing policyholders may exaggerate or falsify claims for higher payments.
- Significant collapse in economic segments like construction, credit markets, or energy production/servicing could adversely affect results across multiple underwriting divisions.
- These outcomes would reduce underwriting profit if not reflected in charged rates.
[c. 74; p. 9] Insurance market cyclicality
- The insurance business is historically cyclical, which can affect financial performance and cause operating results to vary quarter-to-quarter, not necessarily indicating future performance.
- Insurance carriers have historically experienced significant fluctuations in operating results due to competition, catastrophic events, capacity levels, litigation trends, regulatory constraints, and general economic conditions.
- The supply of insurance relates to prevailing prices, insured losses, and available industry capital, which can fluctuate with changes in investment returns.
- The insurance business is historically cyclical, characterized by periods of intense price competition due to excessive underwriting capacity (soft market) and periods of capacity shortages leading to increased premium levels (hard market).
- Demand for insurance depends on factors like frequency and severity of catastrophic events, capacity levels, new capital providers, and general economic conditions, all of which fluctuate and can contribute to price declines.
- P&C insurance companies' profitability tends to follow this cyclical market pattern, with higher gross written premium growth and improved profitability during hard market cycles.
- This cyclical pattern is more pronounced in the E&S (Excess and Surplus) market than in the standard insurance market.
- When the standard insurance market hardens, the E&S market typically hardens, with significantly more rapid growth.
- When conditions soften, customers previously in the E&S market may return to the admitted market, exacerbating rate decrease effects on financial results.
- The market can experience "micro cycles" where specific areas harden or soften independently and more drastically than the overall market.
- Operating results are subject to fluctuation and have historically varied quarter-to-quarter.
- Quarterly results are expected to continue fluctuating due to general economic conditions, frequency/severity of catastrophes, fluctuating interest rates, claims exceeding loss reserves, competition, deviations from expected premium retention, adverse investment performance, and reinsurance costs.
[c. 75; p. 9] Investment portfolio performance and risks
- Performance of the investment portfolio is subject to various investment risks that may adversely affect financial results.
- Results of operations depend partly on investment portfolio performance.
- The company aims to hold a diversified investment portfolio managed by professional investment advisory firms according to its investment policy and reviewed by its Investment Committee.
- Investments are subject to general economic conditions, market risks, and risks inherent to specific securities.
- Primary market risk exposures are to changes in interest rates and equity prices.
- A significant portion of the investment portfolio is in fixed maturity securities, or separately managed accounts and limited partnerships primarily invested in fixed maturity securities.
- Interest rates rose materially in 2022 and 2023.
- A low interest rate environment, potentially from federal actions to slow inflation (e.g., recent rate cuts, Inflation Reduction Act of 2022), would pressure net investment income, especially for fixed maturity and short-term investments, adversely affecting operating results.
- Recent and future interest rate increases could cause fixed income securities portfolios to decline in value, with magnitude depending on duration and rate increase.
- Some fixed income securities with call or prepayment options create reinvestment risk in declining rate environments.
- Other fixed income securities, like mortgage-backed and asset-backed securities, carry prepayment risk or may not prepay as quickly as expected in a rising interest rate environment.
- All fixed maturity securities, including those in separately managed accounts and limited partnerships, are subject to credit risk.
- Credit risk is the risk of investment default or impairment due to deterioration in the financial condition of issuers or guarantors.
- Downgrades in credit ratings of fixed maturity securities could significantly negatively affect their market valuation.
- The company also invests in marketable preferred and common equity securities and exchange-traded funds.
- These equity securities are carried at fair market value and are subject to potential losses and market value declines.
- Market and credit risks could reduce net investment income and result in realized investment losses.
- The investment portfolio faces increased valuation uncertainties when investment markets are illiquid, as with fixed maturity securities held to maturity, separately managed accounts, and limited partnership investments.
- Valuation of investments is more subjective in illiquid markets, increasing the risk that estimated fair value does not reflect actual transaction prices.
- Risks for all security types are managed through an investment policy that sets parameters including maximum investment percentages in certain securities and minimum credit quality levels, believed to be within NAIC, Texas Department of Insurance, and Oklahoma Department of Insurance guidelines.
- The Investment Committee periodically reviews Enterprise Based Asset Allocation models for overall risk management.
- While capital preservation is sought, investment objectives may not be achieved, and results can vary substantially over time.
- Investment strategies aim to be uncorrelated with insurance and reinsurance exposures, but investment losses may coincide with underwriting losses, exacerbating adverse effects.
[c. 76; p. 9] Investment liquidity and claims funding
- The company could be forced to sell investments to meet liquidity requirements.
- Premiums received are invested until needed for policyholder claims.
- The duration of the investment portfolio is managed based on the duration of losses and LAE (Loss Adjustment Expense) reserves to ensure sufficient liquidity and avoid liquidating investments to fund claims.
- Risks such as inadequate losses and LAE reserves or unfavorable litigation trends could necessitate selling investments to fund liabilities.
- Investments may not be sold at favorable prices or at all.
- Sales could result in significant realized losses depending on general market conditions, interest rates, and credit issues with individual securities.
Risks Related to the Regulatory Environment
[c. 77; p. 9] Regulatory compliance and penalties
- Extensive regulation may adversely affect the ability to achieve business objectives.
- Failure to comply with regulations may result in penalties, including fines and suspensions, adversely affecting financial condition and results of operations.
- Primary insurance subsidiaries GMIC, HSIC, and IIC are subject to extensive regulation in Texas (state of domicile) and other operating states.
- Insurance regulations primarily protect policyholders, not investors or stockholders.
- Regulations are administered by state departments of insurance and cover capital and surplus, investment and underwriting limitations, affiliate transactions, dividend limitations, changes in control, solvency, and other financial/non-financial aspects.
- Significant changes in laws and regulations could limit discretion or increase business costs.
- State insurance regulators conduct periodic examinations and require annual/other reports on financial condition and holding company issues.
- Regulatory requirements may impose timing and expense constraints, adversely affecting business objectives.
- Insurance subsidiaries are part of an "insurance holding company system" under Texas statutes and regulations.
- Certain transactions between insurance subsidiaries and affiliates require prior notice to the Texas Department of Insurance, potentially causing business delays and additional expenses.
- Failure to file required notifications or comply with other Texas insurance regulations may lead to significant fines and penalties and impair the working relationship with the Texas Department of Insurance.
- State insurance regulators have broad discretion to deny or revoke licenses for reasons including regulation violations.
- Practices based on interpretations of regulations or industry norms may differ from regulatory authorities' interpretations.
- Lack of requisite licenses/approvals or non-compliance could lead to regulators precluding, suspending, or penalizing activities in a state, adversely affecting business operations.
- Changes in insurance industry regulation, laws, or interpretations could interfere with operations and increase compliance costs.
[c. 78; p. 9] Capital requirements and financial stability
- Insurance subsidiaries are subject to risk-based capital requirements based on the NAIC's "risk based capital model" and Texas law's minimum capital and surplus restrictions.
- These requirements establish minimum risk-based capital for overall business operations and identify inadequately capitalized property and casualty insurers by assessing asset/liability risks and net written premium mix.
- Insurers below a calculated threshold may face regulatory actions like supervision, rehabilitation, or liquidation.
- Failure to maintain required risk-based capital levels could adversely affect the insurance subsidiary's ability to maintain regulatory authority and its A.M. Best Rating.
[c. 79; p. 9] Potential for new regulations and legislative changes
- The company may become subject to additional government or market regulation, which could materially adversely impact the business.
- Business could be adversely affected by changes in laws related to asset and reserve valuation, surplus requirements, investment and dividend limitations, enterprise risk, and risk-based capital requirements.
- The U.S. federal government generally does not directly regulate the insurance industry, except for areas like flood, nuclear, and terrorism risks.
- Potential federal legislation could affect the insurance industry in areas such as privatization of government entities (e.g., Freddie Mac, Fannie Mae), reduction in federal subsidies for certain businesses (e.g., agriculture), tort reform, corporate governance, and taxation of reinsurance companies.
[c. 80; p. 9] Tax law changes and NOLs
- Changes to U.S. tax laws and new tax policies could significantly negatively impact the overall economy and the business.
- Legislative or other actions related to taxes could negatively affect the company, its investments, or stockholders.
- U.S. federal income tax rules are constantly under review by legislators, the IRS, and the U.S. Department of the Treasury.
- The company cannot predict the impact of tax law changes on itself, stockholders, or portfolio investments.
- New legislation, U.S. Treasury regulations, administrative interpretations, or court decisions could have adverse consequences.
- Stockholders are advised to consult tax advisors regarding tax legislative, regulatory, or administrative developments and their potential effect on investments.
- The current administration's agenda includes potential U.S. tax law reform, with outlined intentions such as reducing the corporate tax rate, extending certain provisions of the Tax Cuts and Jobs Act of 2017 (TCJA), and imposing new tariffs.
- The combined impact of extending TCJA tax benefits and new tariffs could increase the U.S. deficit, inflation, and interest rates, potentially leading to higher market interest rates, decreased U.S. economic growth, and a possible recession, all negatively impacting the business.
- The ability to utilize net operating loss carryforwards (NOLs) and other tax attributes may be limited.
- As of December 31, 2024, the company had gross federal income tax NOLs of approximately USD 44.7m available to offset future taxable income, prior to Section 382 limitations.
- These NOLs are set to expire beginning in 2032.
- Under Section 382 of the Internal Revenue Code, an "ownership change" (greater than 50% change in equity ownership by certain stockholders over a three-year period) can limit the use of pre-ownership change NOLs to offset post-ownership change income.
- Future ownership changes, some outside of control, may occur.
- Future regulatory changes could also limit the ability to utilize NOLs.
- Inability to offset future taxable income with NOLs could adversely affect net income and cash flows.
[c. 81; p. 9] Holding company liquidity and dividend restrictions
- As a holding company, with operations primarily conducted by insurance subsidiaries, liquidity at the holding company level (including ability to pay dividends and service debt) depends on cash dividends or other permitted payments from insurance subsidiaries.
- Continued operation and growth require substantial capital, so cash dividends on common stock are not intended in the foreseeable future.
- The ability to pay dividends to stockholders and meet debt obligations largely depends on dividends and distributions from primary insurance subsidiaries: GMIC, HSIC, and IIC.
- State insurance laws, including Texas laws, restrict the ability of GMIC, HSIC, and IIC to determine stockholder dividends.
- State insurance regulators require insurance companies to maintain specified levels of statutory capital and surplus.
- Dividend payments are limited to the portion of available policyholder surplus derived from net profits.
- State insurance regulators have broad powers to prevent reduction of statutory surplus to inadequate levels, and there is no assurance that maximum calculated dividends would be permitted.
- State insurance regulators with jurisdiction over dividend payments by insurance subsidiaries may adopt more restrictive statutory provisions in the future.
- Any future dividend determination will be at the discretion of the Board of Directors, based on results of operations, financial condition, contractual debt restrictions, indebtedness, applicable law, and other relevant factors.
- Investors may need to sell common stock for gains, as immediate cash dividends are not expected.
[c. 82; p. 9] Change of control regulations
- Applicable insurance laws may make it difficult to effect a change of control.
- Under Texas insurance laws, acquiring control of a domestic insurer requires written approval from the state insurance commissioner.
- Approval depends on factors including the acquirer's financial strength, plans for the insurer's future operations, and potential anti-competitive results.
- Texas insurance laws apply to direct and indirect acquisition of 10% or more of a Texas-domiciled insurer's voting stock.
- Acquisition of 10% or more of Skyward Specialty's common stock would be considered an indirect change of control, triggering applicable filing requirements under Texas insurance laws, unless a disclaimer of control filing is accepted by the Texas Insurance Department.
- These requirements may discourage acquisition proposals and delay, deter, or prevent a change of control, even if desirable to some stockholders.
Risks Related to Our Liquidity and Access to Capital
[c. 83; p. 9] Future capital requirements and availability
- Additional capital may be required in the future, which may not be available or only available on unfavorable terms.
- Future capital requirements depend on factors including the ability to successfully write new business and establish premium rates and reserves sufficient to cover losses.
- If cash flows from operations are insufficient to fund future operating requirements and cover claim losses, or if the capital position is adversely impacted by a decline in the fair value of the investment portfolio, catastrophe losses, or other events, additional funds may be needed through financings or growth may be curtailed.
- Factors affecting the amount and timing of capital needs include growth rate, profitability, claims experience, reinsurance availability, market disruptions, and other unforeseeable developments.
- If additional capital is needed, equity or debt financing may not be available or may be available only on unfavorable terms.
- Equity financings could result in dilution to stockholders.
- Debt financings may involve covenants restricting business operations.
- Such securities may have rights, preferences, and privileges senior to common stock.
- Inability to obtain adequate capital on favorable terms could materially adversely affect operating plans, business, financial condition, or results of operations.
Risks Related to Our Operations
[c. 84; p. 9] Personnel attraction and retention
- The company could be adversely affected by the loss of key personnel or inability to attract and retain qualified personnel.
- The company depends on attracting and retaining experienced personnel knowledgeable about its business.
- The talent pool for recruitment is limited and can fluctuate based on market dynamics specific to the industry.
- Higher demand for skilled employees could increase compensation expectations, making it difficult to retain and recruit key personnel and maintain desired labor costs.
- Inability to retain and attract talented personnel could prevent the company from maintaining its competitive position in specialized markets, adversely affecting results of operations.
[c. 85; p. 9] Information technology and cybersecurity risks
- Security breaches, data loss, cyberattacks, and IT failures could disrupt operations, damage reputation, and adversely affect business, operations, and financial results.
- The business is highly dependent on IT and telecommunications systems, including underwriting and claims systems.
- Systems are used for interacting with brokers and insureds, underwriting, policy preparation, premium processing, actuarial modeling, claims processing and payments, and financial statement preparation.
- Some systems may include or rely on third-party systems not on company premises or under its control.
- Events like natural catastrophes, terrorist attacks, industrial accidents, computer viruses, and cyber-attacks can cause systems to fail or be inaccessible for extended periods.
- Sustained or repeated system failures could severely limit the ability to write and process business, provide customer service, pay claims, or operate normally.
- Computer viruses, hackers, employee misconduct, and external hazards can expose systems to security breaches or disruptions.
- Security measures are in place, but systems and networks may still be subject to breaches or interference, and cybersecurity incidents are likely to continue.
- Such events can result in operational disruptions, unauthorized access, disclosure, or loss of proprietary or customer data.
- Consequences include legal claims, regulatory scrutiny and liability, reputational damage, costs for mitigation, and loss of customers or advisors.
- SEC and state law notification requirements for incidents could exacerbate harm to business, financial condition, and results of operations.
- Publicized attempted security breaches could harm business and reputation even if technology infrastructure and data confidentiality are protected.
- Advances in criminal capabilities, new vulnerabilities, exploitation attempts, data thefts, or physical system break-ins could compromise security measures.
- Third parties to whom functions are outsourced are also subject to these risks.
- While third-party providers' cybersecurity controls are reviewed, success in preventing compromises and disclosures cannot be ensured.
- Increased use of third-party services (e.g., cloud technology, SaaS) can make identifying and responding to cyberattacks more difficult due to dynamic technologies.
- These risks could increase as vendors adopt more cloud-based software services.
[c. 86; p. 9] Growth management and inorganic growth
- The company may not be able to manage its growth effectively.
- Future business growth may require additional capital, systems development, and skilled personnel.
- The company must meet capital needs, expand systems and internal controls, allocate human resources optimally, identify, hire, train, and develop qualified employees, and integrate acquired businesses.
- Failure to manage growth effectively could materially adversely affect business, financial condition, and results of operations.
- Success of inorganic growth through acquisitions depends on identifying appropriate targets, negotiating favorable terms, completing transactions, and successfully integrating targets.
- Anticipated benefits of acquisitions, such as revenue growth, operational efficiencies, or expected synergies, may not be realized.
[c. 87; p. 9] Future growth rates and profitability
- Recent rapid growth rates may not be indicative of future growth.
- Significant revenue growth has been experienced in recent years.
- Future periods may not sustain revenue growth consistent with recent history or at all.
- Revenue growth depends on factors including:
- Effective product pricing to attract and retain insureds without compromising profitability.
- Successful deployment and implementation of products, obtaining renewals, and providing excellent support to distribution partners.
- Attraction and retention of highly qualified underwriters and claims professionals.
- Enhancement of infrastructure and data reporting systems for effective and efficient product delivery.
- Successful creation of new distribution channels.
- Successful introduction of new products and enhancement of existing products.
- Successful competition against larger companies and new market entrants.
- Increased brand awareness.
- Failure to accomplish these objectives makes forecasting future results of operations difficult.
- Historical growth rate should not be considered indicative of future performance and may decline.
- Future revenue could grow more slowly or decline for various reasons, including those outlined.
- Operating expenses are expected to increase in future periods.
- If revenue growth does not offset possible expense increases, business, financial position, and results of operations could be harmed, and profitability may not be achieved or maintained.
[c. 88; p. 9] Litigation risks
- The effects of litigation on the business are uncertain and could have an adverse effect.
- The company continually faces risks associated with various types of litigation, including disputes related to insurance claims and general commercial/corporate litigation.
- The company is not currently involved in out-of-the-ordinary litigation with customers.
- Other insurance industry members are targets of class action lawsuits and other litigation, some involving substantial or indeterminate amounts with unpredictable outcomes.
- Social inflation, particularly in third-party claims, can lead to oversized judgments.
- Litigation costs and settlement amounts can be inflated beyond historical reasonable levels, even when cases do not reach judgment.
- Litigation is based on issues including insurance and claim settlement practices.
- The company cannot predict future involvement in such litigation or its impact on the business.
[c. 89; p. 9] Vendor relationships and third-party software
- Loss of key vendor relationships or vendor failure to protect data/information could affect operations.
- The company relies on services and products from many vendors in the U.S. and abroad.
- Vendors include those for computer hardware/software, claim adjustment services, human resource benefits management, and investment management.
- If a vendor experiences bankruptcy, becomes unable to provide services, has systems breached, or fails to protect confidential information, the company may suffer operational impairments and financial losses.
- While vendor risk is generally monitored, including security and stability of critical vendors, proper assessment of risks and costs in third-party relationships may fail, materially and adversely affecting financial condition and results of operations.
- The company anticipates continued reliance on third-party software.
- While commercially reasonable alternatives to current licensed third-party software are believed to exist, this may not always be the case, or replacement could be difficult or costly.
- Integration of new third-party software may require significant work and substantial investment of time and resources.
- Use of additional or alternative third-party software would require license agreements, which may not be available on commercially reasonable terms or at all.
- Many risks associated with third-party software use cannot be eliminated and could negatively affect the business.
[c. 90; p. 9] Intellectual property rights
- The company may fail or be unable to protect its intellectual property rights for its proprietary technology platform and brand.
- The company may be sued by third parties for alleged infringement of their proprietary rights.
- Success and ability to compete depend partly on intellectual property, including brand rights and proprietary technology in certain product lines.
- Protection primarily relies on copyright and trade secret laws, and confidentiality agreements with employees, customers, service providers, and partners.
- Steps taken to protect intellectual property may be inadequate.
- Efforts to enforce intellectual property rights may face defenses, counterclaims, and countersuits challenging validity, enforceability, and scope.
- Failure to secure, protect, and enforce intellectual property rights could adversely affect the brand and business.
- Success also depends partly on not infringing on others' intellectual property rights.
- Competitors and other entities/individuals may own or claim intellectual property related to the industry or the company.
- Third parties may claim infringement of their intellectual property rights in the future, and the company may be found to be infringing.
- Claims or litigation could incur significant expenses.
- Successful assertion of claims could require substantial damages or ongoing royalty payments, prevent service offerings, or impose unfavorable terms.
- Even if the company prevails, litigation could be costly, time-consuming, and divert management and key personnel attention from business operations.
Risks Related to Ownership of Our Common Stock
[c. 91; p. 9] Public company operating costs and compliance
- Operating as a public company incurs increased costs and requires substantial management time for compliance initiatives.
- Financial reporting and other requirements may exceed the adequacy of current accounting and management systems and resources.
- Significant legal, accounting, and other expenses are incurred as a public company, especially since no longer an emerging growth company.
- Federal securities laws (Sarbanes-Oxley Act, Dodd-Frank Act) and SEC/Nasdaq rules impose requirements for filing reports and maintaining effective disclosure, financial controls, and corporate governance.
- These regulations increase compliance costs, make activities more time-consuming, and demand significant management and personnel time.
- There is a risk of not producing reliable financial statements or filing them timely with the SEC, or complying with Nasdaq listing requirements.
- Section 404 of the Sarbanes-Oxley Act requires system and process evaluation and testing of internal control over financial reporting, leading to substantial accounting expense and management effort.
- Compliance with Section 404 necessitates maintaining accounting and finance staff/consultants with public company reporting, technical accounting, and internal control knowledge, and providing internal audit services.
- Achieving Section 404 compliance involves a costly and challenging process of documenting and evaluating internal control over financial reporting.
- This process requires dedicating internal resources, engaging outside consultants, adopting a detailed work plan, improving control processes, validating controls through testing, and implementing continuous reporting and improvement.
- There is a risk that neither the company nor its independent registered public accounting firm will conclude that internal control over financial reporting is effective within the prescribed timeframe, potentially leading to adverse financial market reactions and SEC investigations.
- Disclosure controls and procedures are required to ensure information for SEC reports is recorded, processed, summarized, and reported timely.
- Disclosure controls and internal control over financial reporting may not prevent or detect all errors and fraud due to inherent limitations of control systems.
- Control systems provide reasonable, not absolute, assurance, and their design is based on assumptions about future events, which may not hold true.
- Controls may become inadequate over time due to changing conditions or deterioration in compliance, leading to undetected misstatements.
- Failure to achieve and maintain effective internal controls, as required by Section 404 of the Sarbanes-Oxley Act, could harm operating results and financial condition, and negatively affect common stock market price.
- Section 404(b) of the Sarbanes-Oxley Act requires annual management assessments of the effectiveness of internal control over financial reporting.
- Implementing and maintaining substantial internal control systems and procedures is necessary to satisfy Exchange Act reporting requirements.
- Deficiencies identified during assessments may not be remediated timely, and testing/maintaining internal controls may divert management attention.
- Inability to conclude on an ongoing basis that internal control over financial reporting is effective under Section 404(b) could lead to significant remediation costs and scope.
- Material weaknesses or deficiencies in internal control could impede timely and accurate SEC report filings.
- Any of these issues could cause investors to lose confidence, or lead to suspension/termination of Nasdaq listing, negatively affecting stock price.
[c. 92; p. 9] Material weakness in ITGCs
- A material weakness in internal control over information technology general controls (ITGCs) has been identified.
- Failure to remediate this material weakness or maintain effective ITGCs could adversely affect the common stock market price.
- Controls and procedures have inherent limitations, meaning they may not prevent or detect all misstatements.
- Even an effective ITGC system provides only reasonable, not absolute, assurance.
- Management, including the CEO, CFO, and CIO/CTO, evaluated internal control over financial reporting as of December 31, 2024, using COSO criteria.
- A material weakness existed as of December 31, 2024, related to ineffective implementation of ITGCs in user access for systems supporting financial reporting.
- Related process-level IT dependent manual and automated controls relying on affected ITGCs or information from affected IT systems were also deemed ineffective.
- Additional information and management's remediation plan are in "ITEM 9A. CONTROLS & PROCEDURES" of Form 10-K.
- Failure to timely remediate the material weakness or maintain effective ITGCs could lead to significant resource expenditure, fines, penalties, investigations, or judgments, negatively affecting investor confidence and stock price.
[c. 93; p. 9] Stock price volatility and investment risk
- Operating results and stock price may be volatile or decline regardless of operating performance, risking loss of investment.
- The market price of common stock has been and is likely to remain highly volatile, influenced by many factors beyond control.
- Securities markets worldwide have experienced and will likely continue to experience significant price and volume fluctuations.
- Market volatility, general economic, market, or political conditions could cause wide price fluctuations regardless of operating performance.
- Investment in common stock is considered risky, suitable only for those who can withstand significant loss and wide market value fluctuations.
- Factors affecting stock price include: market conditions in the broader stock market; actual or anticipated fluctuations in quarterly financial and operating results; introduction of new products or services by the company or competitors; issuance of new or changed securities analysts’ reports or recommendations; results of operations varying from analyst and investor expectations; short sales, hedging, and other derivative transactions in common stock; company guidance, changes to it, or failure to meet it; strategic actions by the company or competitors; announcements by the company, competitors, or acquisition targets; sales or anticipated sales of large blocks of stock by directors, executive officers, and principal stockholders; additions or departures in the Board, senior management, or other key personnel; regulatory, legal, or political developments; public response to press releases or public announcements; litigation and governmental investigations; changing economic conditions, including social inflation; changes in accounting principles; future indebtedness or securities issuance; default under indebtedness agreements; exposure to capital and credit market risks affecting investment portfolio or capital resources; changes in credit ratings; and other events like natural disasters, war, or terrorism.
- Securities markets have experienced extreme price and volume fluctuations unrelated to company operating performance.
- Investors may not be able to resell shares at or above purchase price due to these factors.
- Broad market fluctuations, general market, economic, and political conditions (e.g., recessions, loss of investor confidence, interest rate changes) may negatively affect common stock market price.
- Stock markets, including Nasdaq, have experienced extreme price and volume fluctuations affecting equity securities.
- Such occurrences could cause stock price to fall and expose the company to costly securities class action litigation, diverting management attention and harming business.
[c. 94; p. 9] Underwriting guidelines and strategy changes
- Management can change underwriting guidelines or strategy without stockholder notice or approval.
- This allows fundamental changes to operations without stockholder approval, potentially resulting in a strategy or underwriting guidelines materially different from those described in the "Business" section or other filings.
[c. 95; p. 9] Anti-takeover provisions
- Anti-takeover provisions in organizational documents could delay management changes and limit share price.
- Provisions in the certificate of incorporation and bylaws could hinder third-party acquisition of control, even if beneficial to common stock value, and prevent stockholder attempts to replace the Board or management.
- These provisions could adversely affect common stock price.
- Charter documents permit the Board to establish director numbers and fill vacancies/new directorships.
- The Board of Directors is classified into three classes with staggered, three-year terms, and directors can only be removed for cause.
- Super-majority voting is required to amend provisions in the certificate of incorporation and bylaws.
- Blank-check preferred stock, with terms set by the Board, could delay or prevent transactions or control changes that might offer a premium price for common stock.
- Stockholders' ability to call special meetings is eliminated.
- Special meetings of stockholders can only be called by the Board, its chairman, or the CEO.
- Stockholder consent action is prohibited unless by unanimous written consent.
- Vacancies on the Board can only be filled by a majority of directors then in office, even if less than a quorum.
- Cumulative voting in director elections is prohibited.
- Advance notice requirements are established for director nominations or proposing matters at annual stockholder meetings.
- As a Delaware corporation, the company is subject to Section 203 of the Delaware General Corporation Law, which may prohibit large stockholders (15% or more of voting stock) from merging or combining for a period.
[c. 96; p. 9] Exclusive forum provisions
- The certificate of incorporation and bylaws designate the Court of Chancery of the State of Delaware as the exclusive forum for substantially all disputes between the company and its stockholders.
- This could limit stockholders' ability to obtain a favorable judicial forum for disputes with the company or its directors, officers, or employees.
- The Court of Chancery of the State of Delaware is the exclusive forum for: derivative actions on the company's behalf; actions asserting breach of fiduciary duty by directors, officers, employees, or stockholders; actions arising under DGCL or the certificate of incorporation/bylaws where DGCL confers jurisdiction; actions to interpret, apply, enforce, or determine validity of the certificate of incorporation or bylaws; and actions asserting a claim governed by the internal affairs doctrine.
- The certificate of incorporation and bylaws also state that federal district courts of the United States are the sole and exclusive forum for causes of action arising under the Securities Act, unless the company consents otherwise.
- Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over suits to enforce duties/liabilities created by the Securities Act.
- There is uncertainty whether a court would enforce the federal exclusive forum provision, and stockholders are not deemed to have waived compliance with federal securities laws.
- This exclusive forum provision would not apply to suits under the Exchange Act or other claims where federal courts have exclusive jurisdiction.
- If enforced, this choice of forum provision may limit a stockholder's ability to bring a claim in a preferred judicial forum, potentially discouraging lawsuits.
- If a court finds the choice of forum provision inapplicable or unenforceable, the company may incur additional costs resolving actions in other jurisdictions, which could materially adversely affect business, financial condition, or results of operations.
Cybersecurity
[c. 97; p. 10] Cybersecurity risk management and strategy
- IT Systems are central to nearly all business operations, including internal/external communications, document management, and shared work environments.
- Responding to cybersecurity incidents and threats is a key component of the overall ERM strategy.
- A Crisis Response Plan (CRP) has been implemented to respond to cybersecurity incidents and threats.
- Management and IT personnel have implemented processes for assessing, identifying, managing, and escalating material cybersecurity risks, integrated into overall risk management.
- Cybersecurity risks are included in the annual risk universe evaluated by the enterprise risk management committee.
- Risk owners are assigned to develop and track mitigation plans for heightened cybersecurity risks identified by the ERM process.
- Security events and data incidents are evaluated, ranked by severity, prioritized for response/remediation, and reviewed for materiality, operational/business impact, and privacy impact.
- The cybersecurity risk management program uses the National Institute of Standards and Technology framework, categorizing risks into identify, protect, detect, respond, recover, and govern.
- Company-wide policies and procedures cover cybersecurity matters, including encryption standards, antivirus protection, remote access, multifactor authentication, confidential information, and internet/social media/email use.
- A detailed crisis response playbook is followed in the event of an incident.
- Investments in IT security have expanded, including additional end-user training, layered defenses, critical asset identification/protection, strengthened monitoring/alerting, and expert engagement.
- Defenses are regularly tested through technical simulations and drills (including penetration tests) and operational policy/procedure reviews with third-party experts.
- The IT security team monitors alerts, discusses threat levels/trends/remediation, prepares a quarterly cyber scorecard, collects cybersecurity data, and conducts an annual risk assessment.
- Periodic external penetration tests, red team testing, and maturity testing are conducted to assess processes, procedures, and the threat landscape.
- In an incident, outside cybersecurity legal counsel consults with other third parties, including communication/notification as required.
- Cybersecurity vendors perform investigation services and assist with recovery/restoration of impacted IT System services.
- Cybersecurity experts assist with incident validation and ransomware demands.
- Cybersecurity insurance providers are involved in incident response.
- Processes are in place to oversee and identify cybersecurity risks from key third-party service providers.
- Third-party service providers are required to provide SOC-1 or SOC-2 reports and their cybersecurity/disaster recovery plans.
[c. 98; p. 10] Cybersecurity governance and oversight
- Cybersecurity risk management and strategy processes are overseen by leaders from the Information Security Team, with assistance from Compliance and Legal teams.
- These individuals have decades of experience in IT roles, including security, auditing, compliance, systems, and programming.
- They monitor prevention, mitigation, detection, and remediation of cybersecurity incidents through their management and participation in risk management processes and the crisis response plan.
- They report appropriate items to the Risk Committee.
- The Risk Committee of the Board of Directors oversees cybersecurity strategy, reviews cybersecurity and other IT risks/controls/procedures, and receives periodic updates from management on cybersecurity measures.
- The review includes a thorough discussion of cybersecurity threat risks and their potential operational impact.
- A separate process exists for communicating with the Risk Committee during a specific cybersecurity incident.
- Members of the Crisis Management Team provide initial awareness communication to the CEO/Chair of the Board, who then informs the Chair of the Risk Committee.
- Following an initial assessment by senior management and IT Systems personnel, a follow-up communication is provided to the CEO and Risk Committee Chair to determine if escalation to the full Board is warranted.
[c. 99; p. 10] Cybersecurity risk impact
- Cybersecurity threats have not materially affected business strategy, results of operations, or financial condition.
- A cybersecurity incident resulting in a serious compromise of IT Systems or a demand for payment to restore IT Systems could have a material adverse effect.
- Such an incident could negatively impact the ability to operate the business effectively and divert management/financial resources.
Properties
[c. 100; p. 11] Office facilities
- The company leases its primary executive offices and insurance operations in Houston, Texas.
- These offices occupy approximately 20,400 square feet of space.
- The lease for the Houston office space expires in 2029.
- Additional office space is leased where appropriate.
- Management considers the office facilities suitable and adequate for current operations.
Legal Proceedings
[c. 101; p. 12] Legal proceedings
- The company is party to legal proceedings arising in the ordinary course of business.
- The company believes the outcome of these matters, individually and in aggregate, will not have a material adverse effect on its consolidated financial position.
Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
[c. 102; p. 13] Common stock trading and holders
- Common shares began trading on the NASDAQ Global Select Market under the symbol "SKWD" on January 13, 2023.
- Prior to January 13, 2023, there was no public market for the company's common shares.
- As of February 26, 2025, there were approximately 5 holders of record of the common stock.
- The number of record holders does not represent the total number of stockholders due to shares being held by brokers and institutions on behalf of stockholders.
Securities Authorized for Issuance Under Equity Compensation Plans
[c. 103; p. 13] Equity compensation plan information
- Information regarding equity compensation plans will be included in the definitive proxy statement filed with the SEC for the 2025 Annual Meeting of Stockholders and is incorporated by reference.
Recent Sales of Unregistered Equity Securities
[c. 104; p. 13] Securities issuance details
- Information regarding securities issued or granted during the period covered by this Annual Report on Form 10-K that were not registered under the Securities Act is set forth below.
- The information in Item 5 reflects a 4-for-1 reverse stock split, effective January 3, 2023.
- Immediately before the IPO, all preferred stock converted into 16,305,113 shares of common stock.
- The issuance of these common shares was exempt from Securities Act registration requirements under Section 3(a)(9) of the Securities Act.
- This exemption applies to an exchange of securities by the issuer with existing security holders exclusively, where no commission or other remuneration was paid directly or indirectly for soliciting the exchange.
- No underwriters were involved in this share issuance.
Use of Proceeds from Initial Public Offering
[c. 105; p. 13] IPO Details and Proceeds
- The IPO closed on January 18, 2023.
- The company issued and sold 4,750,000 shares of common stock.
- Selling stockholders sold 4,202,383 shares.
- Underwriters fully exercised their option to purchase 1,342,857 additional shares of common stock from selling stockholders.
- The offer and sale of shares in the IPO were registered under the Securities Act via a Form S-1 registration statement (File No. 333-265326).
- The registration statement was declared effective by the SEC on January 12, 2023.
- Barclays Capital Inc. and Keefe, Bruyette & Woods, Inc. were representatives of the underwriters.
- The public offering price was USD 15.00 per share.
- Net proceeds to the Company were approximately USD 62.3m, after deducting underwriting discounts and specific incremental IPO expenses.
- All proceeds from the IPO were distributed to the Company’s insurance company subsidiaries.
Issuer Purchases of Equity Securities
[c. 106; p. 13] Equity securities purchases
- The company did not purchase any of its equity securities during the period covered by this Annual Report on Form 10-K.
Dividends
[c. 107; p. 13] Dividend policy
- The company does not currently intend to pay cash dividends on its common stock in the foreseeable future.
- Any future dividend payments will be at the discretion of the Board of Directors.
- Future dividend determinations will depend on results of operations, financial condition, applicable legal restrictions, and other factors deemed relevant by the Board of Directors.
- Investors may need to sell common stock holdings to realize future gains, as price appreciation may not occur.
- Investors seeking immediate cash dividends should not purchase the company's common stock.
Performance Graph
[c. 108; p. 13] Shareholder return performance graph
- The performance graph compares the cumulative total shareholder return of an investment in the company's common stock, the Nasdaq Composite Index, and the Nasdaq Insurance Index.
- The comparison period is from January 13, 2023 (the date the common stock began trading on Nasdaq) through December 31, 2024.
- The graph assumes an initial investment of USD 100.
- Historical results are not indicative of future performance.
- The graph is not considered "soliciting material" or "filed" for purposes of Section 18 of the Exchange Act.
- The graph is not subject to liabilities under Section 18 of the Exchange Act.
- The graph is not incorporated by reference into any filings under the Securities Act.
[c. 109; p. 13]
| January 13, 2023 | December 31, 2023 | December 31, 2024 | |
|---|---|---|---|
| Skyward Specialty Insurance Group, Inc. | 100.00 | 177.38 | 264.61 |
| Nasdaq Composite Index | 100.00 | 135.49 | 174.30 |
| Nasdaq Insurance Index | 100.00 | 103.37 | 128.30 |
[c. 110; p. 13] Performance Graph

Chart / Image:
- Y-axis represents values from $100.00 to $300.00.
- X-axis represents dates: January 13, 2023, December 31, 2023, and December 31, 2024.
- The blue line with circular markers represents "Skyward Specialty Insurance Group, Inc.".
- The magenta line with circular markers represents "Nasdaq Composite Index".
- The cyan line with circular markers represents "Nasdaq Insurance Index".
- On January 13, 2023, Skyward Specialty Insurance Group, Inc. value is approximately $100.00.
- On January 13, 2023, Nasdaq Composite Index value is approximately $100.00.
- On January 13, 2023, Nasdaq Insurance Index value is approximately $100.00.
- On December 31, 2023, Skyward Specialty Insurance Group, Inc. value is approximately $175.00.
- On December 31, 2023, Nasdaq Composite Index value is approximately $135.00.
- On December 31, 2023, Nasdaq Insurance Index value is approximately $105.00.
- On December 31, 2024, Skyward Specialty Insurance Group, Inc. value is approximately $265.00.
- On December 31, 2024, Nasdaq Composite Index value is approximately $170.00.
- On December 31, 2024, Nasdaq Insurance Index value is approximately $128.00.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
Overview
[c. 111; p. 14] Business overview and strategy
- The company is a specialty insurance provider of commercial P&C products and solutions, primarily in the United States.
- Products are offered on both a non-admitted (E&S) and admitted basis.
- The company focuses on underserved, dislocated, or inadequately covered markets, requiring highly specialized and customized underwriting and claims solutions.
- The portfolio of insured risks is highly diversified across industries, distribution channels, and lines of business.
- Lines of business include general liability, excess liability, professional liability (cyber and media liability), commercial auto, group accident and health, property, agriculture, credit, surety, and workers’ compensation.
- The business mix includes both short and medium duration liabilities, is principally primary insurance, and is balanced between E&S and admitted markets.
- A small portion of the business is specialty reinsurance, primarily in agriculture and credit, focused on attractive specialty classes where reinsurance is more efficient due to factors like cost of entry and geographic expansion.
- This diversification, including businesses not typically aligned with traditional P&C pricing cycles, combined with underwriting and claims expertise, aims to produce consistent growth and profitability across all insurance pricing cycles.
- The company's strategy, "Rule Our Niche," focuses on leading in chosen market niches and establishing sustainable competitive positions.
- This strategy aims to build a strong defensible market position, create a competitive moat, and achieve best-in-class underwriting results through P&C insurance pricing cycles.
- The company strives for excellence in risk selection, pricing, and claims outcomes, amplified by advanced technology and analytics.
Results of Operations
[c. 112; p. 14] Financial results summary
- The table summarizes results for the years ended December 31, 2024 and 2023.
[c. 113; p. 14]
| Years Ended December 31, | ||
|---|---|---|
| ($ in thousands) | 2024 | 2023 |
| Gross written premiums | 1,743,232 | 1,459,829 |
| Ceded written premiums | (619,654) | (549,138) |
| Net written premiums | 1,123,578 | 910,691 |
| Net earned premiums | 1,056,722 | 829,143 |
| Commission and fee income | 6,703 | 6,064 |
| Losses and LAE | 669,809 | 515,237 |
| Underwriting, acquisition and insurance expenses | 311,757 | 243,444 |
| Underwriting income (1) | 81,859 | 76,526 |
| Net investment income | 80,686 | 40,322 |
| Net investment gains (losses) | 6,256 | 11,072 |
| Income before income taxes | 152,739 | 110,102 |
| Net income | 118,828 | 85,984 |
| Adjusted operating income (1) | 126,650 | 80,847 |
| Loss and LAE ratio | 63.4% | 62.1% |
| Expense ratio | 28.9% | 28.6% |
| Combined ratio | 92.3% | 90.7% |
| Adjusted loss and LAE ratio (1) | 62.3% | 62.3% |
| Expense ratio | 28.9% | 28.6% |
| Adjusted combined ratio (1) | 91.2% | 90.9% |
| Return on equity | 16.3% | 15.9% |
| Return on tangible equity (1) | 18.6% | 19.0% |
| Adjusted return on equity (1) | 17.4% | 14.9% |
| Adjusted return on tangible equity (1) | 19.8% | 17.9% |
Reconciliation of Non-GAAP Financial Measures
[c. 114; p. 14] Adjusted operating income reconciliation
- The table provides a reconciliation of adjusted operating income to net income for the years ended December 31, 2024 and 2023.
[c. 115; p. 14] Underwriting income reconciliation
- The table provides a reconciliation of underwriting income to income before federal income tax expense for the years ended December 31, 2024 and 2023.
[c. 116; p. 14] Adjusted loss ratio and adjusted combined ratio reconciliation
- The table provides a reconciliation of the adjusted loss and LAE ratio and adjusted combined ratio to the loss and LAE ratio and combined ratio for the years ended December 31, 2024 and 2023.
[c. 117; p. 14] Tangible stockholders’ equity reconciliation
- The table provides a reconciliation of tangible stockholders’ equity to stockholders’ equity for the years ended December 31, 2024 and 2023.
[c. 118; p. 14] Adjusted return on equity reconciliation
- The table provides a reconciliation of adjusted return on equity to return on equity for the years ended December 31, 2024 and 2023.
[c. 119; p. 14] Return on tangible equity reconciliation
- Return on tangible equity for the years ended December 31, 2024 and 2023 reconciles to return on equity.
[c. 120; p. 14] Adjusted return on tangible equity reconciliation
- Adjusted return on tangible equity for the years ended December 31, 2024 and 2023 reconciles to return on equity.
[c. 121; p. 14]
| 2024 | 2023 | |||
|---|---|---|---|---|
| ($ in thousands) | Pre-tax | After-tax | Pre-tax | After-tax |
| Income as reported | 152,739 | 118,828 | 110,102 | 85,984 |
| Less (add): | — | — | — | — |
| Net investment gains (losses) | 6,256 | 4,942 | 11,072 | 8,747 |
| Net impact of LPT | (11,598) | (9,162) | 1,427 | 1,127 |
| Other (loss) income | (167) | (132) | (632) | (499) |
| Other expenses | (4,392) | (3,470) | (5,364) | (4,238) |
| Adjusted operating income | 162,640 | 126,650 | 103,599 | 80,847 |
| ($ in thousands) | 2024 | 2023 |
|---|---|---|
| Income before income taxes | 152,739 | 110,102 |
| Add: | — | — |
| Interest expense | 9,496 | 10,024 |
| Amortization expense | 2,007 | 1,798 |
| Other expenses | 4,392 | 5,364 |
| Less (add): | — | — |
| Net investment income | 80,686 | 40,322 |
| Net investment gains | 6,256 | 11,072 |
| Other loss | (167) | (632) |
| Underwriting income | 81,859 | 76,526 |
| ($ in thousands) | 2024 | 2023 |
|---|---|---|
| Net earned premiums | 1,056,722 | 829,143 |
| Losses and LAE | 669,809 | 515,237 |
| Pre-tax net impact of loss portfolio transfer | (11,598) | 1,427 |
| Adjusted losses and LAE | 658,211 | 516,664 |
| Loss ratio | 63.4% | 62.1% |
| Less: Net impact of LPT | 1.1% | (0.2)% |
| Adjusted loss ratio | 62.3% | 62.3% |
| Combined ratio | 92.3% | 90.7% |
| Less: Net impact of LPT | 1.1% | (0.2)% |
| Adjusted combined ratio | 91.2% | 90.9% |
| ($ in thousands) | 2024 | 2023 |
|---|---|---|
| Stockholders’ equity | 793,999 | 661,031 |
| Less: Goodwill and intangible assets | 87,348 | 88,435 |
| Tangible stockholders’ equity | 706,651 | 572,596 |
| ($ in thousands) | 2024 | 2023 |
|---|---|---|
| Numerator: adjusted operating income | 126,650 | 80,847 |
| Denominator: average stockholders’ equity | 727,515 | 541,347 |
| Adjusted return on equity | 17.4% | 14.9% |
| ($ in thousands) | 2024 | 2023 |
|---|---|---|
| Numerator: net income | 118,828 | 85,984 |
| Denominator: average tangible stockholders’ equity | 639,624 | 452,194 |
| Return on tangible equity | 18.6% | 19.0% |
| ($ in thousands) | 2024 | 2023 |
|---|---|---|
| Numerator: adjusted operating income | 126,650 | 80,847 |
| Denominator: average tangible stockholders’ equity | 639,624 | 452,194 |
| Adjusted return on tangible equity | 19.8% | 17.9% |
Underwriting Results
[c. 122; p. 14] Premiums
- Net written premiums were USD 1,123.6m compared to USD 910.7m in 2023, an increase of USD 212.9m or 23.4%.
- The increase in net written premiums was primarily driven by the same reasons as gross written premiums.
- Net earned premiums for 2024 were USD 1,056.7m compared to USD 829.1m for 2023, an increase of USD 227.6m, or 27.4%.
- The increase in net earned premiums was primarily driven by the same reasons as gross written premiums.
- Gross written premiums increased YoY due to double-digit premium growth from captives, surety, transactional E&S, programs, and global property & agriculture underwriting divisions.
- The company broadened and diversified its product portfolio in 2024, growing in areas less exposed to P&C cycles.
- Gross written premium increases were primarily driven by: new captive members and growth in existing captives; new product offerings, including participation in the Small Business Administration ("SBA") Bond Guarantee Program, and regional expansion in surety; new business and rate in transactional E&S; the addition of four new programs, including Aviation; and new business in global agriculture.
- Gross written premium increases were slightly offset by downward pricing pressure in the global property market and intentional actions to address profitability in commercial auto.
[c. 123; p. 14] Losses and LAE
- The 2024 loss ratio increased 1.3 points compared to 2023, primarily due to the net impact of prior accident year development related to the LPT, which added 1.1 points to the loss ratio.
- The non-cat loss and LAE ratio for 2024 improved 0.3 points compared to 2023, primarily driven by a shift in the mix of business.
- The 2024 cat loss and LAE ratio increased 0.3 points compared to 2023, primarily due to catastrophe losses from Hurricanes Helene and Beryl in Q3 2024 and Hurricane Milton in Q4 2024.
- In 2024, the Company transitioned from evaluating reserves on a policy year basis to an accident year basis, resulting in earlier recognition of underlying claim trends, better alignment of exposure to risks, and adherence to industry best practices.
- In prior years, the Company's methodology allocated IBNR from its policy year analysis to accident year.
- As a result of transitioning to accident year, IBNR within short-tail/monoline specialty lines, multi-line solutions, and exited lines was reallocated for the years ended December 31, 2023, 2022, 2021, and 2020, and certain amounts have been conformed to the current year presentation.
- For the year ended December 31, 2024, the Company recognized adverse development related to prior years’ loss and loss expense reserves of USD 25.7m.
- Of the USD 25.7m adverse development, USD 10.1m and USD 15.2m in multi-line solutions and exited lines, respectively, were related to losses previously subject to the LPT from accident years 2018 and prior.
- During the year ended December 31, 2023, the Company recognized adverse development related to prior years’ loss and loss expense reserves of USD 10.8m.
- Adverse development of USD 11.7m in multi-line solutions in 2023 was driven by greater than expected severity in auto, general, and excess liability lines of business primarily from accident years 2020 to 2022.
- The 2023 adverse development was partially offset by favorable development in short-tail/monoline specialty lines, specifically in the property line of business primarily from accident years 2021 and 2022.
[c. 124; p. 14] Expense Ratio
- The expense ratio for 2024 increased 0.3 points compared to 2023, primarily driven by business mix shift partially offset by earnings leverage.
- The expense ratios presented exclude the impact of IPO related stock compensation and secondary offering expenses, which are reported in other expenses in the consolidated statements of operations and comprehensive income.
[c. 125; p. 14] Investment Results
- Beginning January 1, 2024, the company simplified investment portfolio classifications to align with strategy and underlying risk characteristics.
- The prior period has been reclassified to conform to the current period presentation.
- Net investment income for the year ended 2024 increased USD 40.4m compared to 2023.
- The increase in income from the fixed income portfolio for 2024 compared to 2023 was due to a larger asset base from increased allocation and a higher book yield of 5.2% at December 31, 2024 (prior: 4.5% at December 31, 2023).
- The increase in income from short-term investments & cash and cash equivalents for 2024 compared to 2023 was due to higher investment yields and a larger asset base.
- The fair value of the alternative and strategic investments portfolio for 2024 increased compared to 2023 due to an increase in the fair value of limited partnership investments.
[c. 126; p. 14]
| Years Ended December 31, | ||||
|---|---|---|---|---|
| ($ in thousands) | 2024 | 2023 | Change | % Change |
| Industry Solutions | 317,198 | 305,476 | 11,722 | 3.8% |
| Global Property & Agriculture | 311,402 | 273,191 | 38,211 | 14.0% |
| Captives | 241,902 | 167,624 | 74,278 | 44.3% |
| Programs | 218,407 | 178,726 | 39,681 | 22.2% |
| Accident & Health | 173,073 | 151,701 | 21,372 | 14.1% |
| Transactional E&S | 169,053 | 122,508 | 46,545 | 38.0% |
| Professional Lines | 159,785 | 154,565 | 5,220 | 3.4% |
| Surety | 152,429 | 106,056 | 46,373 | 43.7% |
| Total gross written premiums (1) | 1,743,249 | 1,459,847 | 283,402 | 19.4% |
| Twelve months ended December 31, | ||||
|---|---|---|---|---|
| 2024 | 2023 | |||
| ($ in thousands) | Losses and LAE | % of Net Earned Premiums | Losses and LAE | % of Net Earned Premiums |
| Losses and LAE: | ||||
| Non-cat loss and LAE | 640,257 | 60.6% | 504,664 | 60.9% |
| Cat loss and LAE (1) | 17,954 | 1.7% | 12,000 | 1.4% |
| Prior accident year development - LPT | 11,598 | 1.1% | (1,427) | (0.2)% |
| Total losses and LAE | 669,809 | 63.4% | 515,237 | 62.1% |
| Adjusted losses and LAE (2) : | — | — | — | — |
| Non-cat loss and LAE | 640,257 | 60.6% | 504,664 | 60.9% |
| Cat loss and LAE (1) | 17,954 | 1.7% | 12,000 | 1.4% |
| Total adjusted losses and LAE (2) | 658,211 | 62.3% | 516,664 | 62.3% |
| ($ in thousands) | Development | |
|---|---|---|
| (Favorable) Adverse | ||
| Accident Year | 2024 | 2023 |
| Prior | 25,535 | 4,333 |
| 2020 | (606) | 4,341 |
| 2021 | 978 | 289 |
| 2022 | (1,479) | 1,807 |
| 2023 | 1,300 | — |
| Total | 25,728 | 10,770 |
| Reserve development on losses subject to LPT | 25,300 | — |
| Reserve development on losses excluding losses subject to LPT | 428 | 10,770 |
| Twelve months ended December 31, | ||||
|---|---|---|---|---|
| 2024 | 2023 | |||
| ($ in thousands) | Expenses | % of Net Earned Premiums | Expenses | % of Net Earned Premiums |
| Net policy acquisition expenses | 149,975 | 14.2% | 108,514 | 13.0% |
| Other operating and general expenses | 161,782 | 15.3% | 134,930 | 16.3% |
| Underwriting, acquisition and insurance expenses | 311,757 | 29.5% | 243,444 | 29.3% |
| Less: commission and fee income | (6,703) | (0.6%) | (6,064) | (0.7%) |
| Total net expenses | 305,054 | 28.9% | 237,380 | 28.6% |
| Twelve months ended December 31, | ||
|---|---|---|
| $ in thousands | 2024 | 2023 |
| Short-term investments & cash and cash equivalents | 17,643 | 11,677 |
| Fixed income | 57,631 | 36,547 |
| Equities | 2,745 | 2,212 |
| Alternative and strategic investments | 2,667 | (10,114) |
| Net investment income | 80,686 | 40,322 |
| Net unrealized gains on securities still held | 7,921 | 11,130 |
| Net realized losses | (1,665) | (58) |
| Net investment gains | 6,256 | 11,072 |
Investments
[c. 127; p. 14] Investment portfolio composition
- The investment portfolio primarily consists of investment grade fixed income securities, which are predominantly highly-rated and liquid bonds, and commercial mortgage loans.
[c. 128; p. 14] Fixed income portfolio credit quality and duration
- The weighted average credit rating of the available-for-sale fixed income portfolio was "AA-" by Standard & Poor’s Financial Services, LLC ("Standard & Poor’s") at December 31, 2024 and 2023.
- Commercial mortgage loans are primarily senior loans on real estate across the U.S..
- The average duration of the fixed income portfolio was approximately 4.34 years at December 31, 2024, and 4.24 years at December 31, 2023.
[c. 129; p. 14] Equities portfolio composition
- The equities portfolio primarily consists of domestic preferred stocks, common equities, exchange traded funds, limited partnerships, limited liability corporations, and other types of equity interests.
- 100.0% of the equities portfolio is publicly traded.
[c. 130; p. 14] Alternative and strategic investments
- Alternative investments consist of promissory notes, limited partnerships, joint ventures, and equity interests.
- Underlying alternative investments are primarily floating rate senior secured loans, comprised of short duration, collateralized, asset-oriented credit investments.
- Limited partnerships and joint ventures are subject to future increases or decreases in asset value as assets are monetized and income is distributed.
- Strategic investments consist of equity interests in private entities within the insurance industry.
[c. 131; p. 14] Market risk overview
- Market risk is the risk of economic losses due to adverse changes in the estimated fair value of a financial instrument resulting from changes in interest rates, equity prices, foreign currency exchange rates, and commodity prices.
- The primary components of market risk affecting the company are credit risk and interest rate risk.
- The company does not have significant exposure to foreign currency exchange rate risk or commodity risk.
[c. 132; p. 14] Credit risk management
- Credit risk is the potential loss from adverse changes in an issuer’s ability to repay debt obligations.
- Exposure to credit risk exists as a holder of debt instruments in core fixed income and opportunistic fixed income portfolios.
- The risk management strategy and investment policy is to invest primarily in debt instruments of high credit quality issuers and to limit credit exposure by ratings categories and per issuer.
- At December 31, 2024, the core fixed income portfolio had an average rating of "AA-".
- Approximately 81.5% of securities in the core fixed income portfolio were rated "A" or better by at least one nationally recognized rating organization at December 31, 2024.
- The policy is to invest in investment grade fixed income securities for stable income, supplemented by opportunistic fixed income and equity securities for diversification and risk-adjusted returns.
- Approximately 1.7% of the core fixed income portfolio was unrated or rated below investment-grade at December 31, 2024.
- The company monitors the financial condition of all issuers in its portfolio through investment managers.
- Credit risk also exists with third-party reinsurers; the company is ultimately liable to policyholders for ceded risks.
- Reinsurance contracts do not limit ultimate obligations to pay claims, and amounts recoverable from reinsurers might not be collected.
- To address this, reinsurance is purchased from reinsurers rated at least "A-" (Excellent) or better by A.M. Best.
- Periodic credit reviews of reinsurers are performed with the reinsurance broker.
- At December 31, 2024, 99% of reinsurance recoverables were from reinsurers rated "A-" (Excellent) or better by A.M. Best, or were collateralized through funds held, trusts, and letters of credit by the reinsurer.
- If a reinsurer suffers a credit downgrade, options like commutation, novation, and letters of credit may be considered to lessen asset impairment risk.
[c. 133; p. 14] Interest rate risk management
- Interest rate risk is the risk of economic losses due to adverse changes in interest rates.
- The primary market risk to the investment portfolio is interest rate risk associated with fixed income securities.
- Fluctuations in interest rates directly affect the market valuation of these securities; rising rates decrease fair value, falling rates increase fair value.
- Interest rate risk is managed by investing in securities with varied maturity dates and by managing the duration of the investment portfolio in relation to the duration of reserves.
- Duration is the weighted average payment period of cash flows, weighted by the present value of cash flows.
- Duration targets for the core fixed income investment portfolio are set after considering the estimated duration of liabilities and other factors.
- Fixed maturity securities had a weighted average effective duration of 4.34 years as of December 31, 2024.
- Fixed income securities subject to interest rate risk had a fair value of USD 1,292.2m at December 31, 2024.
- Opportunistic fixed income securities are excluded from interest rate sensitivity analysis as they are primarily floating rate and treated as held-to-maturity.
- Changes in interest rates immediately affect comprehensive income and stockholders’ equity but not ordinarily net income.
- Actual results may differ from hypothetical changes in market rates assumed in sensitivity analysis.
- Sensitivity analysis does not reflect actions taken to mitigate hypothetical fair value losses.
[c. 134; p. 14] Equity price risk management
- Equity price risk represents potential economic losses due to adverse changes in equity security prices.
- At December 31, 2024, approximately 6.7% of the fair value of the investment portfolio (excluding cash and cash equivalents and short-term investments) was invested in equity securities.
- Equity price risk is managed through portfolio diversification.
- A tail-risk management strategy is maintained to provide protection for the equity portfolio if there is a significant decline in the S&P 500 within a 30-day period.
[c. 135; p. 14]
| 2024 | 2023 | |||
|---|---|---|---|---|
| ($ in thousands) | Carrying Value | % of Total | Carrying Value | % of Total |
| Cash and cash equivalents | 121,603 | 6.1% | 65,891 | 3.9% |
| Short-term investments | 274,929 | 13.8% | 270,259 | 16.1% |
| Fixed income | 1,318,708 | 66.2% | 1,067,721 | 63.6% |
| Equities | 106,254 | 5.3% | 118,249 | 7.0% |
| Alternative and strategic investments | 170,929 | 8.6% | 157,458 | 9.4% |
| Total portfolio | 1,992,423 | 100.0% | 1,679,578 | 100.0% |
| 2024 | 2023 | |||
|---|---|---|---|---|
| ($ in thousands) | Carrying Value | % of Total | Carrying Value | % of Total |
| U.S. government securities | 26,486 | 2.0% | 44,166 | 4.1% |
| Corporate securities and miscellaneous | 425,628 | 32.3% | 383,420 | 35.9% |
| Municipal securities | 84,716 | 6.4% | 92,778 | 8.7% |
| Residential mortgage-backed securities | 393,833 | 29.9% | 281,626 | 26.4% |
| Commercial mortgage-backed securities | 69,364 | 5.2% | 29,934 | 2.8% |
| Other asset-backed securities | 292,191 | 22.2% | 185,727 | 17.4% |
| Total fixed income portfolio, available-for-sale | 1,292,218 | 98.0% | 1,017,651 | 95.3% |
| Commercial mortgage loans | 26,490 | 2.0% | 50,070 | 4.7% |
| Total fixed income portfolio | 1,318,708 | 100.0% | 1,067,721 | 100.0% |
| 2024 | 2023 | |||
|---|---|---|---|---|
| ($ in thousands) | Fair Value | % of Total | Fair Value | % of Total |
| AAA | 483,099 | 37.3% | 493,252 | 48.6% |
| AA | 141,177 | 10.9% | 105,906 | 10.4% |
| A | 429,703 | 33.3% | 233,487 | 22.9% |
| BBB | 216,602 | 16.8% | 154,096 | 15.1% |
| BB and Lower | 21,637 | 1.7% | 30,910 | 3.0% |
| Total fixed income portfolio, available-for-sale | 1,292,218 | 100.0% | 1,017,651 | 100.0% |
| 2024 | 2023 | |||
|---|---|---|---|---|
| ($ in thousands) | Fair Value | % of Total Fair Value | Fair Value | % of Total Fair Value |
| Domestic common equities | 70,665 | 66.5% | 71,502 | 60.5% |
| International common equities | 34,425 | 32.4% | 39,389 | 33.3% |
| Preferred stock | 1,164 | 1.1% | 7,358 | 6.2% |
| Equities | 106,254 | 100.0% | 118,249 | 100.0% |
| ($ in thousands) | Estimated Fair Value | Estimated Change in Fair Value | Estimated % Increase (Decrease) in Fair Value |
|---|---|---|---|
| 300 basis point increase | 1,118,982 | (173,236) | (13.4)% |
| 200 basis point increase | 1,177,074 | (115,144) | (8.9)% |
| 100 basis point increase | 1,234,820 | (57,398) | (4.4)% |
| No change | 1,292,218 | — | 0.0% |
| 100 basis point decrease | 1,349,269 | 57,051 | 4.4% |
| 200 basis point decrease | 1,405,973 | 113,755 | 8.8% |
| 300 basis point decrease | 1,462,329 | 170,111 | 13.2% |
Other Items
[c. 136; p. 14] Income taxes
- Income tax expense for the year ended December 31, 2024 was USD 33.9m, compared to USD 24.1m for the year ended December 31, 2023.
- The effective tax rate for the year ended December 31, 2024 was 22.2%, compared to 21.9% for the year ended December 31, 2023.
- For a reconciliation between actual federal income tax expense and the amount computed at the indicated statutory rate for the years ended December 31, 2024 and 2023, refer to Note 13, "Income Taxes" in the consolidated financial statements included in Item 8 of this Form 10-K.
Liquidity and Capital Resources
[c. 137; p. 14] Holding Company Structure and Funding
- The company is organized as a holding company, with operations primarily conducted by wholly-owned insurance subsidiaries: GMIC, HSIC (Texas-domiciled), and IIC (Texas-domiciled), and OSIC (Oklahoma-domiciled).
- The holding company receives cash through corporate service fees from operating subsidiaries, payments from consolidated tax allocation agreements, dividends from subsidiaries (subject to limitations), bank loans, draws on revolving loan agreements, and issuance of equity and debt securities.
- Proceeds from these sources are used to contribute funds to insurance subsidiaries for premium growth, pay dividends and taxes, and for other business purposes.
[c. 138; p. 14] Intercompany Reimbursements and Tax Allocation
- Skyward Service Company receives corporate service fees from operating subsidiaries to reimburse most incurred operating expenses.
- Expense reimbursement via corporate service fees is based on actual expected costs with no mark-up.
- The company files a consolidated U.S. federal income tax return with its subsidiaries.
- Under the corporate tax allocation agreement, each participant is charged or refunded taxes based on what they would have paid or received if filing on a separate return basis with the IRS.
[c. 139; p. 14] Insurance Subsidiary Dividend Restrictions
- Applicable state insurance laws restrict insurance subsidiaries from declaring stockholder dividends without prior regulatory approval.
- State insurance regulators require insurance companies to maintain specified levels of statutory capital and surplus.
- Dividend payments are limited to the portion of available policyholder surplus derived from net profits on an insurer’s business.
- Insurance regulators have broad powers to prevent reduction of statutory surplus to inadequate levels, and there is no assurance that maximum calculated dividends would be permitted.
- State insurance regulatory authorities may adopt more restrictive statutory provisions regarding dividend payments in the future.
- Insurance subsidiaries did not pay dividends to the holding company for the years ended December 31, 2024, and 2023.
- Additional information regarding insurance companies is available in Note 23, “Statutory Accounting Principles and Regulatory Matters” to the consolidated financial statements in Item 8 of Form 10-K.
[c. 140; p. 14] Holding Company Liquidity and Outlook
- The holding company had USD 2.9m in cash and investments at December 31, 2024, compared to USD 3.0m at December 31, 2023.
- The company believes it has sufficient liquidity to meet operating cash needs, obligations, and committed capital expenditures for the next 12 months.
Cash Flows
[c. 141; p. 14] Cash flow sources and uses
- The most significant source of cash is premiums received from insureds, typically at the beginning of the coverage period, net of related commission.
- The most significant cash outflow is for claims incurred by policyholders, which occur after premium receipt, often years later.
- Cash is invested in various investment securities to earn interest and dividends.
- Cash is also used for operating expenses (salaries, rent, taxes) and capital expenditures (technology systems).
- Reinsurance is used to manage policy risk, involving ceding part of premiums to reinsurers and collecting cash back when covered losses are paid.
- The timing of cash flows from operating activities can vary due to the timing of payments and receipts.
- Significant payments and receipts, including loss settlements and subsequent reinsurance receipts, can influence operating cash flows in a given period.
- Management believes cash receipts from premiums and investment income proceeds are sufficient to cover cash outflows in the foreseeable future.
[c. 142; p. 14] Cash flow summary
- The document provides a table detailing cash flows for the years ended December 31, 2024 and 2023.
[c. 143; p. 14] Operating cash flow drivers
- The decrease in cash provided by operating activities in 2024 compared to 2023 was primarily due to an increase in cash outflows from net reinsurance recoverables and net premiums receivables.
- Cash from operations can vary period-to-period due to the timing of premium receipts, claim payments, and reinsurance activity.
- Cash flows from operations in both 2023 and 2024 were primarily used to fund investing activities.
[c. 144; p. 14] Investing cash flow drivers
- Net cash used in investing activities in 2024 was primarily driven by purchases of fixed maturity securities, partially offset by sales and maturities of investment securities and sales of short-term investments.
- Net cash used in investing activities in 2023 was primarily driven by purchases of fixed maturity securities.
[c. 145; p. 14] Financing cash flow drivers
- Net cash used in financing activities in 2024 was driven by net payments on debt.
[c. 146; p. 14]
| ($ in thousands) | 2024 | 2023 |
|---|---|---|
| Cash and cash equivalents provided by (used in): | ||
| Operating activities | 305,115 | 338,187 |
| Investing activities | (243,694) | (493,809) |
| Financing activities | (4,232) | 130,947 |
| Change in cash and cash equivalents and restricted cash | 57,189 | (24,675) |
Credit Agreements
[c. 147; p. 14] FHLB Loan
- On August 30, 2024, the company entered into the FHLB Loan with the Federal Home Loan Bank of Dallas (FHLB) under its Advances and Security Agreement.
- The FHLB Loan is a 4.5-year term loan for a principal amount of USD 57.0m.
- The FHLB Loan requires interest-only payments during its term, with principal due in full at maturity.
- The interest rate for the FHLB Loan is fixed at 4.00% over its term.
- The FHLB Loan is fully secured by a pledge of specific investment securities of HSIC.
- Proceeds from the FHLB Loan were used to fund the redemption of the March 15, 2024 draw on the Revolving Credit Facility and to redeem USD 7.0m of the March 29, 2023 draw on the Revolving Credit Facility.
[c. 148; p. 14] Revolving Credit Facility
- On March 29, 2023, the company entered into an unsecured Revolving Credit Facility with a syndicate of participating banks.
- The Revolving Credit Facility provides up to a USD 150.0m revolving credit facility and a letter of credit sub-facility of up to USD 30.0m.
- On March 14, 2024, the company drew USD 50.0m on the Revolving Credit Facility to fund the redemption of the Debentures using these proceeds and existing cash.
- On August 30, 2024, the company fully redeemed the March 15, 2024 draw on the Revolving Credit Facility and redeemed USD 7.0m of the March 29, 2023 draw on the Revolving Credit Facility.
- As of December 31, 2024, USD 43.0m was outstanding under the Revolving Credit Facility, with USD 107.0m of undrawn capacity.
- Interest on the Revolving Credit Facility is payable quarterly.
- The interest rate on the Revolving Credit Facility is SOFR plus a margin of 150 to 190 basis points, based on the debt to total capital ratio, and a credit spread adjustment of 10 basis points.
- At December 31, 2024, the six-month SOFR on the Revolving Credit Facility was 4.25%, plus a margin of 1.60%.
- The company is subject to covenants on the Revolving Credit Facility, including minimum net worth, maximum debt to capital ratio, minimum A.M. Best Rating, and minimum liquidity.
- As of December 31, 2024, the company was in compliance with all Revolving Credit Facility covenants.
[c. 149; p. 14] Debentures
- In August 2006, the company received USD 58.0m in proceeds from a debenture offering through Delos Capital Trust (the Trust).
- The Trust's sole asset is Fixed/Floating Rate Junior Subordinated Deferrable Interest Debentures (Trust Preferred) with a principal amount of USD 59.8m, issued by the company.
- The Trust also holds USD 1.8m in cash from the issuance of Trust common shares purchased by the company, equal to 3% of the Trust capitalization.
- On March 15, 2024, the company redeemed the Debentures and paid USD 1.4m of accrued interest.
[c. 150; p. 14] Subordinated Debt
- In May 2019, the company issued unsecured subordinated notes (the Notes) with an aggregate principal amount of USD 20.0m.
- Interest on the subordinated notes is fixed at 7.25% for the first eight years and 8.25% fixed thereafter.
- Early retirement of the debt before the eight-year commitment requires all interest payments to be paid in full, along with the return of all capital.
- Principal payment for the Notes is due at maturity on May 24, 2039, and interest is payable quarterly.
[c. 151; p. 14] Debt to Capitalization Ratio
- At December 31, 2024, the ratio of total debt outstanding (including the FHLB Loan, Revolving Credit Facility, and Notes) to total capitalization (total debt plus stockholders’ equity) was 13.1%.
- At December 31, 2023, the ratio of total debt outstanding (including the Term Loan, Revolver, Trust Preferred, and Notes) to total capitalization was 16.3%.
[c. 152; p. 14] Share Repurchase Program
- In October 2024, the Board of Directors approved a share repurchase program authorizing the repurchase of up to USD 50.0m of common stock.
- Shares may be repurchased via open market purchases, privately-negotiated transactions, block purchases, accelerated share repurchase agreements, or a combination of methods, including Rule 10b5-1 trading plans.
- The timing, manner, price, and amount of repurchases are at the company's discretion.
- The share repurchase program does not require the repurchase of any specific number of shares and can be modified, suspended, or terminated at any time.
- As of December 31, 2024, no shares had been repurchased under this plan.
Contractual Obligations and Commitments
[c. 153; p. 14] Contractual obligations and commitments
- Contractual obligations and commercial commitments are presented by due date as of December 31, 2024.
- Reserves for losses and LAE represent the best estimate of the ultimate cost of settling reported and unreported claims and related expenses.
- Estimating reserves for losses and LAE involves complex and subjective judgments.
- Actual losses and settlement expenses paid may deviate substantially from the reserve estimates in financial statements.
- The timing for payment of estimated losses is not fixed or determinable on an individual or aggregate basis.
- Assumptions for estimating payments due by period are based on the company's own, industry, and peer group claims payment experience.
- There is a risk that amounts paid in any period will differ significantly from disclosed amounts due to uncertainty in estimating payment timing.
- Disclosed amounts are gross of anticipated amounts recoverable from reinsurers.
- Reinsurance balances recoverable on reserves for losses and LAE are reported separately as assets, not netted with liabilities, because reinsurance does not discharge liability to policyholders.
- Reinsurance balances recoverable on reserves for paid and unpaid losses and LAE totaled USD 857.9m at December 31, 2024.
- Reinsurance balances recoverable on reserves for paid and unpaid losses and LAE totaled USD 596.3m at December 31, 2023.
[c. 154; p. 14]
| Payments due by period | |||
|---|---|---|---|
| ($ in thousands) | Total | Less Than One Year | One Year or More |
| Reserves for losses and LAE | 1,782,383 | 433,204 | 1,349,179 |
| Long-term debt | 120,000 | — | 120,000 |
| Interest on debt obligations | 41,443 | 6,246 | 35,197 |
| Operating lease obligations | 3,632 | 968 | 2,664 |
| Total | 1,947,458 | 440,418 | 1,507,040 |
Critical Accounting Policies
[c. 155; p. 14] Critical accounting estimates overview
- Critical accounting estimates are important to financial condition and results of operations and require significant judgment.
- Significant judgment is used concerning future results and developments in applying these estimates and preparing consolidated financial statements.
- Judgments and estimates affect reported amounts of assets, liabilities, revenues, expenses, and disclosure of material contingent assets and liabilities.
- Actual results may differ materially from estimates and assumptions.
- Estimates are evaluated regularly using relevant information.
- Detailed discussion of accounting policies is in Note 1, "Summary of Significant Accounting Policies" to consolidated financial statements in Item 8 of Form 10-K.
[c. 156; p. 14] Reserves for unpaid losses and LAE
- Reserves for unpaid losses and LAE are the largest and most complex estimate in the consolidated balance sheet.
- These reserves represent the estimated ultimate cost of all unreported and reported but unpaid insured claims and the cost to adjust these losses as of or before the balance sheet date.
- Reserves for losses and LAE are not discounted to reflect estimated present value.
- Estimates are made using individual case-basis valuations of reported claims, statistical analyses, and various actuarial procedures.
- Estimates are based on historical information, industry and peer group information, and estimates of future trends in variable factors like loss severity, loss frequency, and inflation.
- Estimates are regularly reviewed and adjusted as experience develops or new information becomes known.
- During the loss settlement period, estimates of liability on a claim are often refined and adjusted upward or downward.
- Ultimate liability may exceed or be less than revised estimates, and ultimate settlement may vary significantly from the estimate in financial statements.
- Reserves for unpaid losses and LAE are categorized into case reserves and IBNR.
- A table sets forth gross and net reserves for unpaid losses and LAE at December 31, 2024 and 2023.
[c. 157; p. 14] Case reserves and IBNR
- Case reserves are established for individual claims reported to the company.
- Notification of losses comes from insureds, their agents, or brokers.
- Case reserves estimate ultimate losses from a claim, including defense costs, based on provided information.
- Claims department personnel use knowledge of specific claims and advice from internal and external experts (underwriters, legal counsel) to estimate expected ultimate losses.
- Third-Party Administrators (TPAs) are used in limited circumstances to assist in claim adjustment.
- Internal claims managers oversee TPA activities and monitor their claim handling to prescribed standards.
- The incurred but not reported (IBNR) reserve is derived by estimating the ultimate unpaid reserve liability and subtracting case reserves.
- Management's best estimate of the ultimate unpaid liability is set by the Reserve Committee.
- The Reserve Committee considers actuarial indications and other factors such as underwriting, claims handling, economic, legal, and environmental changes.
- The Reserve Committee includes the Chief Actuary, Chief Financial Officer, and Chief Claims Officer.
- The Reserve Committee meets quarterly to review actuarial reserving recommendations from the Chief Actuary and determines the best estimate for the reserve for losses and LAE.
- The actuary estimates an initial expected ultimate loss ratio for each underwriting division when establishing quarterly actuarial recommendations.
- Input from underwriting and claims departments, including premium pricing assumptions and historical experience, is considered in setting reserves.
[c. 158; p. 14] Reserve drivers and actuarial methods
- Reserves are driven by factors including litigation and regulatory trends, legislative activity, climate change, social and economic patterns, and claims inflation assumptions.
- Reserve estimates reflect current inflation in legal claims' settlements.
- Reserve estimates assume no losses from significant new legal liability theories.
- Reserve estimates assume no significant changes in the regulatory and legislative environment.
- The impact of potential changes in the regulatory or legislative environment is difficult to quantify without specific new regulation or legislation.
- The company will attempt to quantify the impact of significant new regulation or legislation, but accuracy or success is not assured.
- The actuarial review considers multiple actuarial methods to estimate the reserve for losses and LAE.
- These methods utilize the initial expected loss ratio, statistical analysis of past claims reporting and payment patterns, claims frequency and severity, paid loss experience, industry loss experience, and changes in market conditions, policy forms, exclusions, and exposures.
- Actuarial methods used include: Reported and/or Paid Loss Development Methods, Reported Bornhuetter-Ferguson Methods, and Paid Bornhuetter-Ferguson Method.
- For less mature policy years, the Bornhuetter-Ferguson Method is the primary method for ultimate loss indications.
- For more mature policy years, the company transitions to Reported and/or Paid Loss Development Methods.
- Reported methods are primarily relied upon when case reserving is consistently applied across policy years.
- When there is a change in reserving philosophy, both reported and paid methods are blended in the evaluation of ultimate loss indications.
[c. 159; p. 14] Reserve variability and development
- Actual loss experience may not conform to assumptions, even though reserve estimates are believed to be reasonable.
- Actual ultimate loss ratio could differ from the initial expected loss ratio.
- Actual reporting and payment patterns could differ from expected patterns, which are based on company and industry data.
- Ultimate settlement of losses and related LAE may vary significantly from estimates in financial statements.
- Estimates are regularly reviewed and adjusted as experience develops or new information becomes known.
- Such adjustments are included in the results of current operations.
- "Development" is the amount by which estimated losses differ from those originally reported for a period.
- Development is unfavorable when losses settle for more than reserved or subsequent estimates indicate reserve increases on unresolved claims.
- Development is favorable when losses settle for less than reserved or subsequent estimates indicate reserve reductions on unresolved claims.
- Favorable or unfavorable development of loss reserves is reflected in the results of operations in the period estimates are changed.
- A 5% change in net IBNR would result in a USD 38.4m change in reserves for losses and LAE.
- A 5% change in net IBNR would result in a USD 30.4m change in net income and stockholders’ equity.
[c. 160; p. 14]
| 2024 | 2023 | |||||||
|---|---|---|---|---|---|---|---|---|
| ($ in thousands) | Gross | % of Total | Net | % of Total | Gross | % of Total | Net | % of Total |
| Case reserves | 567,192 | 31.8% | 342,612 | 30.8% | 561,474 | 42.7% | 318,863 | 37.1% |
| IBNR | 1,215,191 | 68.2% | 768,925 | 69.2% | 753,027 | 57.3% | 540,154 | 62.9% |
| Total | 1,782,383 | 100.0% | 1,111,537 | 100.0% | 1,314,501 | 100.0% | 859,017 | 100.0% |
Recent Accounting Pronouncements
[c. 161; p. 14] Recent Accounting Pronouncements - Segment Disclosures
- In November 2023, the FASB issued ASU 2023-07, "Improvements to Reportable Segment Disclosures (Topic 280)".
- ASU 2023-07 requires segment disclosures for: (i) significant segment expenses regularly provided to the chief operating decision maker ("CODM"), (ii) how the CODM uses reported measures of segment profitability for performance assessment and resource allocation, and (iii) the title and position of the CODM.
- Entities with a single reportable segment must provide full segment disclosures.
- The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024.
- This update is applied retrospectively to all prior periods presented.
- Additional segment disclosures have been added as required by ASU 2023-07.
- There was no impact to the consolidated financial statements from ASU 2023-07.
[c. 162; p. 14] Recent Accounting Pronouncements - Income Tax Disclosures
- In December 2023, the FASB issued ASU 2023-09, "Improvements to Income Tax Disclosures (Topic 740)".
- ASU 2023-09 requires public companies to provide enhanced annual rate reconciliation disclosures, including specific categories and additional information meeting a quantitative threshold.
- This update also requires public companies to disaggregate income taxes paid by federal, state, and foreign taxes.
- The guidance is effective for fiscal years beginning after December 15, 2024.
- The amendments are not expected to have a material impact on the consolidated financial statements.
[c. 163; p. 14] Recent Accounting Pronouncements - Income Statement Expense Disclosures
- In November 2024, the FASB issued ASU 2024-03, requiring disaggregated disclosure of income statement expenses for public business entities ("PBEs").
- ASU 2024-03 does not change expense captions on the income statement but requires disaggregation of certain expense captions into specified categories in footnotes.
- A footnote disclosure is required for specific expenses, presented in a tabular format, for relevant income statement expense captions that include any of the following natural expenses: (1) purchases of inventory, (2) employee compensation, (3) depreciation, (4) intangible asset amortization, and (5) depreciation, depletion, and amortization recognized as part of oil- and gas-producing activities or other types of depletion expenses.
- The tabular disclosure will also include certain other expenses, when applicable.
- In January 2025, the FASB issued ASU 2025-01 to clarify the effective date of ASU 2024-03 as the first annual reporting period beginning after December 15, 2026, and interim reporting periods within annual reporting periods beginning after December 15, 2027.
- The effect of the amendments on the consolidated financial statements is currently being evaluated.
Quantitative and Qualitative Disclosures About Market Risk
[c. 164; p. 15] Market risk disclosures
- Qualitative and Quantitative Disclosures about Market Risk are included in Item 7 of this Form 10-K under “Investments—Market Risk”.
Financial Statements
Report of Independent Registered Public Accounting Firm
[c. 165; p. 16] Independent auditor's report
- The report is addressed to the Stockholders and the Board of Directors of Skyward Specialty Insurance Group, Inc.
Opinion on Internal Control Over Financial Reporting
[c. 166; p. 16] Internal control over financial reporting
- Skyward Specialty Insurance Group, Inc.'s internal control over financial reporting as of December 31, 2024, was audited based on criteria established in the Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria).
- The Company has not maintained effective internal control over financial reporting as of December 31, 2024, based on the COSO criteria, due to a material weakness.
- A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis.
- A material weakness existed as of December 31, 2024, related to the ineffective implementation of information technology general controls ("ITGCs") in the area of user access for systems supporting the Company’s financial reporting processes.
- Related process-level IT dependent manual and automated controls that rely upon the affected ITGCs, or information from IT systems with affected ITGCs, were also deemed ineffective.
- The consolidated balance sheets as of December 31, 2024 and 2023, and related consolidated statements of operations and comprehensive income (loss), stockholders’ equity and cash flows for each of the three years ended December 31, 2024, were audited in accordance with PCAOB standards.
- This material weakness was considered in determining the nature, timing, and extent of audit tests for the 2024 consolidated financial statements.
- The report on internal control does not affect the report dated March 3, 2025, which expressed an unqualified opinion on the consolidated financial statements.
Basis for Opinion
[c. 167; p. 16] Auditor's responsibility and audit scope
- The Company's management is responsible for maintaining effective internal control over financial reporting and for its assessment included in the Management’s Report on Internal Control over Financial Reporting.
- The auditor's responsibility is to express an opinion on the Company’s internal control over financial reporting based on their audit.
- The auditor is a public accounting firm registered with the PCAOB and is required to be independent in accordance with U.S. federal securities laws and applicable rules and regulations of the SEC and the PCAOB.
- The audit was conducted in accordance with PCAOB standards.
- PCAOB standards require planning and performing the audit to obtain reasonable assurance that effective internal control over financial reporting was maintained in all material respects.
- The audit included understanding internal control over financial reporting, assessing the risk of a material weakness, testing and evaluating the design and operating effectiveness of internal control, and performing other necessary procedures.
- The auditor believes their audit provides a reasonable basis for their opinion.
Definition and Limitations of Internal Control Over Financial Reporting
[c. 168; p. 16] Internal Control Over Financial Reporting Definition
- Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.
- Internal control over financial reporting includes policies and procedures that:
- Pertain to the maintenance of records that accurately and fairly reflect the company's transactions and asset dispositions.
- Provide reasonable assurance that transactions are recorded for financial statement preparation in accordance with GAAP, and that receipts and expenditures are authorized by management and directors.
- Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of company assets that could materially affect financial statements.
- Due to inherent limitations, internal control over financial reporting may not prevent or detect misstatements.
- Projections of effectiveness evaluations to future periods risk controls becoming inadequate due to changing conditions or deterioration in compliance with policies or procedures.
[c. 169; p. 16]
| /s/ Ernst & Young LLP |
|---|
| We have served as the Company’s auditor since 2021. |
| Houston, Texas |
| March 3, 2025 |
Report of Independent Registered Public Accounting Firm
[c. 170; p. 16] Independent auditor's report
- The report is addressed to the Stockholders and the Board of Directors of Skyward Specialty Insurance Group, Inc.
Opinion on the Financial Statements
[c. 171; p. 16] Audit Opinion
- The consolidated financial statements of Skyward Specialty Insurance Group, Inc. and subsidiaries (the Company) as of December 31, 2024 and 2023, and for each of the three years ended December 31, 2024, have been audited.
- The audit included the consolidated balance sheets, statements of operations and comprehensive income, stockholders' equity, cash flows, related notes, and financial statement schedules listed in Item 15.
- The auditors' opinion is that the consolidated financial statements fairly present, in all material respects, the financial position of the Company at December 31, 2024 and 2023, and the results of its operations and cash flows for each of the three years ended December 31, 2024.
- The financial statements conform with U.S. generally accepted accounting principles.
Basis for Opinion
[c. 172; p. 16] Auditor responsibilities and standards
- The Company's management is responsible for the financial statements.
- The auditor's responsibility is to express an opinion on the Company’s financial statements based on their audits.
- The auditor is a public accounting firm registered with the PCAOB and is required to be independent in accordance with U.S. federal securities laws and applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
- Audits were conducted in accordance with PCAOB standards.
- PCAOB standards require planning and performing the audit to obtain reasonable assurance that financial statements are free of material misstatement, whether due to error or fraud.
- Audits included procedures to assess and respond to risks of material misstatement, whether due to error or fraud.
- Procedures included examining, on a test basis, evidence regarding amounts and disclosures in the financial statements.
- Audits also included evaluating accounting principles used, significant estimates made by management, and the overall presentation of the financial statements.
- The audits provide a reasonable basis for the auditor's opinion.
Critical Audit Matter
[c. 173; p. 16] Critical audit matter definition
- The critical audit matter communicated relates to accounts or disclosures material to the financial statements and involved especially challenging, subjective, or complex judgments.
- Communication of the critical audit matter does not alter the opinion on the consolidated financial statements as a whole.
- The communication does not provide a separate opinion on the critical audit matter or the related account or disclosure.
Valuation of Reserves for Unpaid Losses and Loss Adjustment Expenses
[c. 174; p. 16] Valuation of Reserves for Unpaid Losses and Loss Adjustment Expenses
- The Company's reserves for unpaid losses and loss adjustment expenses (LAE) were USD 1.8bn at December 31, 2024, with a significant portion representing incurred but not reported reserves (IBNR).
- Reserves for unpaid losses and LAE represent the estimated ultimate cost of all unreported and reported but unpaid insured claims and the cost to adjust losses incurred as of the balance sheet date.
- The Company estimates these reserves using individual case-basis valuations of reported claims, statistical analyses, and various actuarial procedures.
- Estimates are based on historical information, industry and peer group information, and trends in factors like loss severity, loss frequency, and inflation.
- Auditing management's estimate of reserves for unpaid losses and LAE, including IBNR, was complex and involved actuarial specialists due to significant estimation uncertainty.
- Estimation uncertainty is associated with evaluating management's methods and assumptions, including loss development factors, expected loss ratios, and trends applied to historical experience.
- These assumptions significantly affect the valuation of IBNR reserves.
- Audit procedures for the Company's reserves for unpaid losses and LAE included evaluating the selection of actuarial methods used by management, comparing them to prior periods and industry practices, with assistance from actuarial specialists.
- The audit also evaluated assumptions used in actuarial methods by comparing significant assumptions (loss development factors, expected loss ratios, trends) to the Company’s historical experience and current industry benchmarks and trends.
- An independent range of reserve estimates was developed and compared to management’s best estimate for unpaid losses and LAE.
- A review of the development of prior year reserve estimates was also performed.
[c. 175; p. 16]
| /s/ Ernst & Young LLP |
|---|
| We have served as the Company’s auditor since 2021. |
| Houston, Texas |
| March 3, 2025 |
Consolidated balance sheets
[c. 176; p. 16] Consolidated financial statements notes
- The accompanying notes are an integral part of the consolidated financial statements.
[c. 177; p. 16]
| December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| ($ in thousands, except share and per share amounts) | ||
| Assets | ||
| Investments: | ||
| Fixed maturity securities, available-for-sale, at fair value (amortized cost of $ 1,320,266 and $ 1,047,713 , respectively) | 1,292,218 | 1,017,651 |
| Fixed maturity securities, held-to-maturity, at amortized cost (net of allowance for credit losses of $ 243 and $ 329 , respectively) | 39,153 | 42,986 |
| Equity securities, at fair value | 106,254 | 118,249 |
| Mortgage loans, at fair value | 26,490 | 50,070 |
| Equity method investments | 98,594 | 110,653 |
| Other long-term investments | 33,182 | 3,852 |
| Short-term investments, at fair value | 274,929 | 270,226 |
| Total investments | 1,870,820 | 1,613,687 |
| Cash and cash equivalents | 121,603 | 65,891 |
| Restricted cash | 35,922 | 34,445 |
| Premiums receivable, net | 321,641 | 179,235 |
| Reinsurance recoverables, net | 857,876 | 596,334 |
| Ceded unearned premium | 203,901 | 186,121 |
| Deferred policy acquisition costs | 113,183 | 91,955 |
| Deferred income taxes | 30,486 | 21,991 |
| Goodwill and intangible assets, net | 87,348 | 88,435 |
| Other assets | 86,698 | 75,341 |
| Total assets | 3,729,478 | 2,953,435 |
| Liabilities and stockholders’ equity | — | — |
| Liabilities: | — | — |
| Reserves for losses and loss adjustment expenses | 1,782,383 | 1,314,501 |
| Unearned premiums | 637,185 | 552,532 |
| Deferred ceding commission | 40,434 | 37,057 |
| Reinsurance and premium payables | 177,070 | 150,156 |
| Funds held for others | 102,665 | 58,588 |
| Accounts payable and accrued liabilities | 76,206 | 50,880 |
| Notes payable | 100,000 | 50,000 |
| Subordinated debt, net of debt issuance costs | 19,536 | 78,690 |
| Total liabilities | 2,935,479 | 2,292,404 |
| Stockholders’ equity | — | — |
| Common stock, $ 0.01 par value, 500,000,000 shares authorized, 40,127,908 and 39,863,756 shares issued and outstanding, respectively | 401 | 399 |
| Additional paid-in capital | 718,598 | 710,855 |
| Stock notes receivable | — | ( 5,562 ) |
| Accumulated other comprehensive loss | ( 22,120 ) | ( 22,953 ) |
| Retained earnings (accumulated deficit) | 97,120 | ( 21,708 ) |
| Total stockholders’ equity | 793,999 | 661,031 |
| Total liabilities and stockholders’ equity | 3,729,478 | 2,953,435 |
Consolidated statements of operations and comprehensive income
[c. 178; p. 16] consolidated financial statements
- The accompanying notes are an integral part of the consolidated financial statements.
[c. 179; p. 16]
| Years Ended December 31, | |||
|---|---|---|---|
| ($ in thousands, except share and per share amounts) | 2024 | 2023 | 2022 |
| Revenues: | |||
| Net earned premiums | 1,056,722 | 829,143 | 615,994 |
| Commission and fee income | 6,703 | 6,064 | 5,199 |
| Net investment income | 80,686 | 40,322 | 36,931 |
| Net investment gains (losses) | 6,256 | 11,072 | ( 15,705 ) |
| Other (loss) income | ( 167 ) | ( 632 ) | 1 |
| Total revenues | 1,150,200 | 885,969 | 642,420 |
| Expenses: | — | — | — |
| Losses and loss adjustment expenses | 669,809 | 515,237 | 402,512 |
| Underwriting, acquisition and insurance expenses | 311,757 | 243,444 | 182,171 |
| Interest expense | 9,496 | 10,024 | 6,407 |
| Amortization expense | 2,007 | 1,798 | 1,547 |
| Other expenses | 4,392 | 5,364 | — |
| Total expenses | 997,461 | 775,867 | 592,637 |
| Income before income taxes | 152,739 | 110,102 | 49,783 |
| Income tax expense | 33,911 | 24,118 | 10,387 |
| Net income | 118,828 | 85,984 | 39,396 |
| Net income attributable to participating securities | — | 1,677 | 18,879 |
| Net income attributable to common stockholders | 118,828 | 84,307 | 20,517 |
| Comprehensive income | — | — | — |
| Net income | 118,828 | 85,984 | 39,396 |
| Other comprehensive income (loss): | — | — | — |
| Unrealized gains and losses on investments: | — | — | — |
| Net change in unrealized gains (losses) on investments, net of tax | 9,792 | 25,516 | ( 48,545 ) |
| Reclassification adjustment for (losses) gains on securities no longer held, net of tax | ( 8,959 ) | ( 4,984 ) | 420 |
| Total other comprehensive income (loss) | 833 | 20,532 | ( 48,125 ) |
| Comprehensive income (loss) | 119,661 | 106,516 | ( 8,729 ) |
| Per share data: | — | — | — |
| Basic earnings per share | 2.97 | 2.34 | 1.24 |
| Diluted earnings per share | 2.87 | 2.24 | 1.21 |
| Weighted-average common shares outstanding | — | — | — |
| Basic | 40,056,475 | 36,031,907 | 16,568,393 |
| Diluted | 41,377,460 | 38,317,534 | 32,653,194 |
Consolidated statements of stockholders’ equity
[c. 180; p. 16] Consolidated financial statements notes
- The accompanying notes are an integral part of the consolidated financial statements.
[c. 181; p. 16]
| Years Ended December 31, | |||
|---|---|---|---|
| ($ in thousands, except share amounts) | 2024 | 2023 | 2022 |
| Preferred shares: | |||
| Balance at beginning of year | — | 1,969,660 | 1,969,660 |
| Preferred stock conversion to common shares | — | ( 1,969,660 ) | — |
| Balance at December 31 | — | — | 1,969,660 |
| Common shares: | — | — | — |
| Balance at beginning of year | 39,863,756 | 16,599,666 | 16,533,620 |
| Issuance of shares | 264,152 | 6,958,977 | 66,046 |
| Preferred stock conversion to common shares | — | 16,305,113 | — |
| Balance at December 31 | 40,127,908 | 39,863,756 | 16,599,666 |
| Preferred stock: | — | — | — |
| Balance at beginning of year | — | 20 | 20 |
| Preferred stock conversion to common shares | — | ( 20 ) | — |
| Balance at December 31 | — | — | 20 |
| Common stock: | — | — | — |
| Balance at beginning of year | 399 | 168 | 168 |
| Issuance of common stock | 2 | 22 | — |
| Preferred stock conversion to common shares | — | 161 | — |
| Proceeds from equity offerings, net | — | 48 | — |
| Balance at December 31 | 401 | 399 | 168 |
| Treasury stock: | — | — | — |
| Balance at beginning of year | — | ( 2 ) | ( 2 ) |
| Preferred stock conversion to common shares | — | 2 | — |
| Balance at December 31 | — | — | ( 2 ) |
| Additional paid-in capital: | — | — | — |
| Balance at beginning of year | 710,855 | 577,289 | 575,159 |
| Issuance of common stock | 7,743 | 9,213 | 2,130 |
| Preferred stock conversion to common shares | — | ( 143 ) | — |
| Proceeds from equity offerings, net | — | 124,496 | — |
| Balance at December 31 | 718,598 | 710,855 | 577,289 |
| Stock notes receivable: | — | — | — |
| Balance at beginning of year | ( 5,562 ) | ( 6,911 ) | ( 9,092 ) |
| Employee equity transactions | 5,562 | 1,349 | 2,181 |
| Balance at December 31 | — | ( 5,562 ) | ( 6,911 ) |
| Accumulated other comprehensive loss: | — | — | — |
| Balance at beginning of year | ( 22,953 ) | ( 43,485 ) | 4,640 |
| Other comprehensive income (loss), net of tax | 833 | 20,532 | ( 48,125 ) |
| Balance at December 31 | ( 22,120 ) | ( 22,953 ) | ( 43,485 ) |
| Retained earnings (accumulated deficit): | — | — | — |
| Balance at beginning of year | ( 21,708 ) | ( 105,417 ) | ( 144,813 ) |
| Cumulative effect on adoption of ASU No. 2016-13 | — | ( 2,275 ) | — |
| Net income | 118,828 | 85,984 | 39,396 |
| Balance at December 31 | 97,120 | ( 21,708 ) | ( 105,417 ) |
| Total stockholders’ equity | 793,999 | 661,031 | 421,662 |
Consolidated statements of cash flows
[c. 182; p. 16] Consolidated financial statements notes
- The accompanying notes are an integral part of the consolidated financial statements.
[c. 183; p. 16]
| Years Ended December 31, | |||
|---|---|---|---|
| ($ in thousands) | 2024 | 2023 | 2022 |
| Cash flows from operating activities | |||
| Net income | 118,828 | 85,984 | 39,396 |
| Adjustments to reconcile net income to net cash provided by (used in) operating activities: | — | — | — |
| Net investment (gains) losses | ( 6,256 ) | ( 11,072 ) | 15,705 |
| Depreciation and amortization expense | 3,358 | 3,891 | 4,097 |
| Stock-based compensation expense | 9,395 | 8,525 | 2,287 |
| Undistributed loss (earnings) from long-term investments | ( 6,338 ) | 6,730 | ( 16,032 ) |
| Deferred income tax, net | ( 8,708 ) | 9,383 | 10,267 |
| Changes in operating assets and liabilities: | — | — | — |
| Premiums receivable, net | ( 142,406 ) | ( 40,020 ) | ( 27,057 ) |
| Reinsurance recoverables, net | ( 261,542 ) | ( 17,270 ) | ( 45,032 ) |
| Ceded unearned premium | ( 17,780 ) | ( 28,476 ) | ( 19,672 ) |
| Deferred policy acquisition costs | ( 21,228 ) | ( 23,017 ) | ( 9,482 ) |
| Federal income taxes | 4,500 | ( 1,892 ) | — |
| Losses and loss adjustment expenses | 467,882 | 172,744 | 162,208 |
| Unearned premiums | 84,653 | 110,023 | 79,221 |
| Deferred ceding commission | 3,377 | 7,208 | ( 651 ) |
| Reinsurance and premium payables | 26,914 | 36,460 | ( 6,223 ) |
| Funds held for others | 44,077 | 21,730 | 7,271 |
| Accounts payable and accrued liabilities | 19,177 | 2,285 | 7,583 |
| Other, net | ( 12,788 ) | ( 5,029 ) | 5,052 |
| Net cash provided by operating activities | 305,115 | 338,187 | 208,938 |
| Cash flows from investing activities: | — | — | — |
| Purchase of fixed maturity securities, available-for-sale | ( 617,606 ) | ( 459,672 ) | ( 268,781 ) |
| Purchase of illiquid investments | ( 75 ) | ( 1,675 ) | ( 4,873 ) |
| Purchase of equity securities | ( 14,077 ) | ( 26,009 ) | ( 53,548 ) |
| Purchase of equity method investments | ( 32,173 ) | — | — |
| Purchase of intangible assets | — | ( 50 ) | — |
| Investment in direct and indirect loans | 27,480 | 2,984 | ( 9,767 ) |
| Purchase of property and equipment | ( 4,224 ) | ( 3,108 ) | ( 2,325 ) |
| Proceeds from the sales of fixed maturity securities, available-for-sale | 217,468 | 26,626 | 13,964 |
| Maturities, calls, transfers and paydowns of fixed maturity securities, available-for-sale | 122,694 | 48,957 | 44,500 |
| Maturities, calls and paydowns of fixed maturity securities held-to-maturity | 6,015 | 11,444 | — |
| Proceeds from the sales of equity securities | 37,534 | 40,201 | 37,177 |
| Sales of and distributions from equity method and other long-term investments | 14,073 | 3,572 | 3,421 |
| Change in short-term investments | ( 4,799 ) | ( 149,068 ) | 43,120 |
| Change in receivable/payable for securities | 34 | 76 | 529 |
| Cash provided by deposit accounting | 3,962 | 11,913 | 3,202 |
| Net cash used in investment activities | ( 243,694 ) | ( 493,809 ) | ( 193,381 ) |
| Cash flows from financing activities: | — | — | — |
| Employee share purchases | — | 1,350 | 2,180 |
| Repayment of stock notes receivable | 5,562 | — | — |
| Proceeds from long term borrowings | 107,000 | 50,000 | — |
| Payments on long term borrowings and trust preferred | ( 116,794 ) | ( 50,000 ) | — |
| Proceeds from initial public offering | — | 129,597 | — |
| Net cash (used in) provided by financing activities | ( 4,232 ) | 130,947 | 2,180 |
| Net increase (decrease) in cash and cash equivalents and restricted cash | 57,189 | ( 24,675 ) | 17,737 |
| Cash and cash equivalents and restricted cash at beginning of period (1) | 100,336 | 125,011 | 107,274 |
| Cash and cash equivalents and restricted cash at end of period (1) | 157,525 | 100,336 | 125,011 |
| Supplemental disclosure of cash flow information: | — | — | — |
| Cash paid for interest | 8,573 | 10,667 | 5,761 |
| Cash paid for federal income taxes | 36,980 | 15,800 | — |
A. Description of Business
[c. 184; p. 16] Company overview and structure
- Skyward Specialty Insurance Group, Inc. (the "Company") is a Delaware corporation organized in 2006, operating as an insurance holding company.
- The Company is a specialty insurance company operating in one segment, delivering commercial property and casualty products insurance coverages through its underwriting divisions.
- The Company has four wholly owned insurance company subsidiaries based in the United States.
- Great Midwest Insurance Company ("GMIC") underwrites insurance on an admitted basis and is a certified surety bond company listed with the U.S. Department of the Treasury.
- Houston Specialty Insurance Company ("HSIC"), a subsidiary of GMIC, underwrites insurance on a non-admitted basis.
- Imperium Insurance Company ("IIC"), a subsidiary of HSIC, underwrites insurance on an admitted basis.
- Oklahoma Specialty Insurance Company ("OSIC"), a subsidiary of IIC, underwrites insurance on a non-admitted basis.
- The Company has a wholly owned captive reinsurance company subsidiary, Skyward Re, domiciled in the Cayman Islands.
- Skyward Re assumed net reserves for certain divisions, related to a retroactive reinsurance contract, from the Company’s insurance companies and retroceded these net reserves to a third-party reinsurer.
- The Company has three non-risk bearing wholly owned subsidiaries.
- Skyward Underwriters Agency, Inc. ("SUA") is a managing general insurance agent and reinsurance broker for property and casualty risks in specialty niche markets.
- Skyward Service Company provides various administrative services to the Company’s subsidiaries.
- Skyward Specialty No. 1 Limited is a Lloyd’s corporate member authorized to invest in Lloyd’s syndicates.
B. Basis of Presentation
[c. 185; p. 16] Basis of presentation
- The Company’s consolidated financial statements are prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP").
- GAAP differs in some respects from the principles followed in reports to insurance regulatory authorities.
- The consolidated financial statements include the accounts of the holding company and its subsidiaries.
- All intercompany transactions and balances have been eliminated in consolidation.
- Preparation of consolidated financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect reported amounts and accompanying notes.
- Actual results could differ from these estimates.
C. Cash and Cash Equivalents
[c. 186; p. 16] Cash and cash equivalents definition
- Cash and cash equivalents include cash on hand and fixed maturity securities with original maturities of three months or less.
- The carrying value of the Company’s cash and cash equivalents approximates fair value.
D. Restricted Cash
[c. 187; p. 16] Restricted cash definition and sources
- Cash with a legal restriction on withdrawal or use by the consolidated group is recorded as restricted cash.
- The carrying value of the Company’s restricted cash approximates fair value.
- SUA holds unremitted insurance premiums in a fiduciary capacity to third-party insurance companies as restricted cash.
- The Company is required by state regulations to maintain assets on deposit with certain states and hold cash as collateral for certain reinsurance balances.
- Cash held in a depository account for others, or restricted by a state, is recorded as restricted cash.
E. Investments
[c. 188; p. 16] Available-for-sale investments accounting
- Investments in fixed maturities classified as available-for-sale are carried at fair value.
- For available-for-sale fixed maturities in an unrealized loss position, the Company first determines intent to sell or likelihood of being required to sell before maturity or recovery of cost basis.
- If intent to sell or likelihood of required sale exists, amortized cost is written down to fair value, with losses recognized in net investment gains on consolidated statements of operations.
- If neither criterion is met, the Company determines if unrealized losses are due to credit-related factors.
- If unrealized losses are credit-related, an allowance for credit losses is determined using present value of cash flows compared to amortized cost.
- The allowance for credit losses is limited to the amount by which fair value is below amortized cost.
- Changes in the allowance for credit losses are recognized in net investment income on the consolidated statements of operations.
- Credit losses limited by fair value are recognized in stockholders’ equity, net of taxes, as a component of accumulated other comprehensive loss.
- Unrealized losses not credit-related continue to be recognized in stockholders’ equity, net of taxes, as a component of accumulated other comprehensive loss.
[c. 189; p. 16] Held-to-maturity investments accounting
- Investments in fixed maturity securities held-to-maturity are carried at amortized cost net of an allowance for credit losses.
- The allowance for credit losses represents the current estimate of expected credit losses.
- The Company develops a historical loss rate from Moody’s multi-year cumulative loss rates for asset-backed securities.
- The historical loss rate is adjusted for current conditions and reasonable and supportable forecasts.
- Changes in the allowance for credit losses are recognized in net investment income on the consolidated statements of operations.
[c. 190; p. 16] Equity securities accounting
- Equity securities include common stock, preferred stock, and mutual funds (even those primarily investing in debt securities).
- Investments in equity securities with a readily determinable fair value are carried on the balance sheet at fair value using quoted market prices.
- Changes in the carrying value of equity securities are included in net investment (losses) gains within the consolidated statements of operations.
[c. 191; p. 16] Mortgage loans accounting
- Investments in mortgage loans are classified as held for investment and carried at cost adjusted for unamortized premiums, discounts, and loan fees.
- Uncollectible amounts are written off in the period they are determined to be uncollectible.
- Interest on loans is recognized as interest receivable and included in other assets on the consolidated balance sheet.
- The Company elected the fair value option for mortgage loans effective January 1, 2023, as transition relief from ASU 2016-13 adoption.
- Under the fair value option, mortgage loans are measured at fair value, and changes in unrealized gains and losses are reported in net investment (losses) gains on the consolidated statements of operations.
- Interest income and amortization continue to be recognized in net investment income on the consolidated statements of operations.
[c. 192; p. 16] Equity method investments accounting
- Equity method investments include equity and equity securities of non-public entities and indirect investments in loans and loan collateral.
- The Company has equity investments in certain limited partnerships and corporations where it has significant influence but not control.
- The Company is not the primary beneficiary of variable interest entities and does not consolidate them.
- The equity method is used for investments in unconsolidated subsidiaries.
- Under the equity method, initial investment is recorded at cost and adjusted based on proportionate share of distributions and net income or loss of the investee.
- The difference between investment cost and proportionate share of underlying equity in net assets is a component of investment income.
- The Company amortizes this difference as an adjustment to its pro-rata share of equity method income over the useful life of the underlying asset.
- For equity securities of non-public entities where the Company lacks significant influence and a readily determinable fair value, investments are carried at cost, minus impairment, and adjusted for observable price changes in orderly transactions for identical or similar investments.
- Investments in indirect collateralized loans and loan collateral are held through and accounted for as an ownership interest in an unconsolidated subsidiary.
- Ownership interests in unconsolidated subsidiaries include investments in partnerships, joint ventures, and special purpose investment vehicles.
- The Company uses the equity method for these investments where it has significant influence but not control.
[c. 193; p. 16] Other long-term investments
- Other long-term investments consist of an investment in a limited partnership held at net asset value (NAV) and other long-term investment securities.
[c. 194; p. 16] Short-term investments
- Short-term investments primarily consist of money market funds.
- Short-term investments are carried at cost, which approximates fair value.
[c. 195; p. 16] Net investment income and realized gains/losses
- Net investment income consists of interest, dividends, and equity in earnings (losses) of unconsolidated subsidiaries, net of investment expenses.
- Interest income is recognized on an accrual basis.
- Dividends are recognized as earned at the ex-dividend date.
- Interest income on mortgage-backed and other asset-backed securities is recognized using the effective-yield method based on estimated principal repayments.
- Amortization of premium and accretion of discounts on debt securities are included in interest income.
- Net realized gains and losses on investments are recognized in net income using the specific identification method.
F. Reinsurance
[c. 196; p. 16] Reinsurance accounting principles
- The Company purchases prospective reinsurance for certain lines of business on a proportional, excess of loss, and facultative basis.
- Proportional reinsurance requires sharing losses and expenses with the reinsurer in exchange for a share of premiums.
- Excess of loss reinsurance shares losses, either proportionally or entirely, above a certain dollar threshold, for a negotiated cost.
- Facultative reinsurance covers specific risks and/or policies on either a proportional or excess of loss basis.
- Ceded unearned premium and reinsurance balances recoverable on paid and unpaid losses and settlement expenses are reported separately as assets.
- Reinsurance does not relieve the Company of its legal liability to policyholders.
- Reinsurance on unpaid losses and settlement expenses represents estimates of the portion of liabilities recoverable from reinsurers.
- On the Consolidated Statements of Operations, net earned premiums, losses and loss adjustment expenses, net, and underwriting, acquisition, and insurance expenses are presented net of reinsurance ceded.
- The Company purchases retroactive reinsurance for certain lines of business through loss portfolio transfers (LPT) and adverse development covers.
- Retroactive reinsurance contracts provide indemnification for losses related to past loss events, with the reinsurer sharing losses based on dollar thresholds.
- Income from retroactive reinsurance contracts is deferred and amortized into net income over the settlement period.
- Losses from retroactive reinsurance contracts are charged to net income immediately.
- Subsequent changes in the measurement of retroactive reinsurance contracts are accounted for using a full retrospective method.
[c. 197; p. 16] Deposit accounting for reinsurance
- Certain ceded reinsurance contracts that management determines do not transfer significant insurance risk are accounted for using the deposit method.
- The evaluation of significant insurance risk transfer assesses both timing risk and underwriting risk.
- A reinsurance contract may not transfer significant insurance risk if either underwriting risk, timing risk, or both are not deemed transferred.
- For contracts transferring only significant timing risk but not sufficient underwriting risk, a deposit asset is recorded equal to the initial cash outflow, offset by cash inflows from reinsurers.
- If cash outflows are expected to differ from cash inflows, an accretion rate is established at inception based on actuarial estimates.
- The deposit accounting asset is increased/decreased to the estimated receivable amount over the contract term.
- Deposit accretion is based on the expected rate of return implied from estimated cash inflows and outflows.
- The Company periodically reassesses the estimated ultimate receivable and the related expected rate of return on the deposit asset.
- Accretion of the deposit asset, including changes from estimated cash flow changes, is reflected as part of investment income.
- Several reinsurance contracts require deposit accounting due to insufficient underwriting risk transfer.
- No reinsurance contracts required deposit accounting due to insufficient timing risk transfer.
[c. 198; p. 16] Reinsurance recoverables and credit risk
- Reinsurance recoverables are carried net of an allowance for credit losses.
- The allowance for credit losses represents the current estimate of expected credit losses.
- The Company develops a historical loss rate using the A.M. Best impairment rate and rating transition study, which provides historical loss data for similarly rated reinsurance companies based on expected receivable duration.
- The historical loss rate is adjusted for current conditions, reasonable and supportable forecasts, and current economic conditions.
- Changes in the allowance for credit losses are recognized in underwriting, acquisition, and insurance expenses on the consolidated statements of operations.
- Reinsurance does not relieve the Company of its legal liability to policyholders.
- The Company continuously monitors the financial condition of its reinsurers, including reviewing annual financial statements and insurance industry developments.
- The Company analyzes credit risk of reinsurance recoverables by monitoring reinsurers' financial strength ratings from A.M. Best.
- The Company assesses the adequacy of collateral obtained where applicable.
- If reinsurers fail to fulfill obligations, the Company has access to collateral.
- Reinsurance collateral from reinsurers was USD 337.0m as of December 31, 2024, and USD 257.5m as of December 31, 2023.
- Reinsurance recoverables present potential exposures to individual reinsurers.
- Everest Reinsurance Co. represented 18.0% of reinsurance recoverable balances at December 31, 2024, and 20.4% at December 31, 2023.
- eMaxx Captives represented 16.8% of reinsurance recoverable balances at December 31, 2024, and 20.4% at December 31, 2023.
- Everest Reinsurance Co. and eMaxx Captives were the only reinsurers representing 10% or more of the Company’s reinsurance recoverable balances.
- Everest Reinsurance Co.'s financial strength rating from A.M. Best was A+ at December 31, 2024, and 2023.
- eMaxx Captives was not rated by A.M. Best at December 31, 2024, and 2023.
G. Concentration of Credit Risk
[c. 199; p. 16] Credit risk concentration
- Financial instruments that could lead to credit risk concentrations include cash and cash equivalents, restricted cash, investments, and premiums receivable, in addition to reinsurance recoverables.
- Cash equivalents and short-term investments consist of U.S. government securities and money market funds.
- Investments are diversified across various industries and geographic regions.
- The Company limits credit exposure to any single financial institution or issuer.
- The Company believes there is no significant concentration of credit risk related to cash and investments.
- As of December 31, 2024 and 2023, outstanding premiums receivable are diversified due to the large number of customer entities and their spread across different lines of business and geographic regions.
- Failure by distribution sources to remit premiums could lead to premium write-offs and a corresponding loss of income.
H. Deferred Policy Acquisition Costs
[c. 200; p. 16] Policy acquisition costs and premium deficiency
- Policy acquisition costs include commissions and premium taxes that vary with and are directly related to the production of new or renewal business.
- The Company defers policy acquisition costs and related ceding commissions, charging or crediting them to earnings proportionally with premium earned over the policy's life.
- A premium deficiency is recognized if expected losses, loss adjustment expenses, and unamortized acquisition costs exceed related unearned premiums.
- To recognize a premium deficiency, the Company first charges unamortized acquisition costs to expense to eliminate the deficiency.
- If the premium deficiency exceeds unamortized acquisition costs, a liability is accrued for the excess deficiency.
- Anticipated investment income is considered when determining premium deficiencies.
- Management determined no premium deficiency existed as of December 31, 2024 and 2023.
I. Goodwill and Intangible Assets
[c. 201; p. 16] Goodwill and intangible assets accounting policy
- Goodwill and intangible assets are recorded following a business combination.
- Goodwill is the excess of the purchase price over the fair value of acquired assets and assumed liabilities.
- The Company reviews purchase price allocation for up to one year post-acquisition and may make adjustments within this period.
- Identifiable intangible assets with a finite useful life are amortized over the period they are expected to contribute to future cash flows.
- Indefinite-lived intangible assets are not amortized.
- Goodwill and identifiable intangible assets are reviewed for recoverability annually in the fourth quarter, or on an interim basis if circumstances indicate a carrying amount may not be recoverable.
- No goodwill impairment was recorded for the years ended December 31, 2024 and 2023.
J. Property and Equipment
[c. 202; p. 16] Property and equipment accounting
- Property and equipment, included in other assets on the consolidated balance sheets, is recorded at cost less accumulated depreciation.
- Depreciation expense is recognized on a straight-line basis for financial statement purposes over periods ranging from three to seven years.
K. Leases
[c. 203; p. 16] Lease accounting policies
- Right-of-use (ROU) assets are included in other assets on the consolidated balance sheets.
- Lease liabilities are included in accounts payable and accrued liabilities on the consolidated balance sheets.
- For operating leases, the Company determines if a contract contains a lease at inception.
- The Company recognizes operating lease ROU assets and lease liabilities based on the present value of future minimum lease payments at the commencement date.
- The Company uses its incremental borrowing rate, based on information available at the commencement date, to determine the present value of future payments, as it does not have the interest rate implicit in its leases.
- Lease agreements may include options to extend or terminate.
- Options are exercised at the Company's discretion and are included in operating lease liabilities if it is reasonably certain the option will be exercised.
- Lease agreements have lease and non-lease components, which are accounted for as a single lease component.
- Operating lease cost for future minimum lease payments is recognized on a straight-line basis over the lease term.
- Sublease income is recognized on a straight-line basis over the sublease term.
L. Reserves for Losses and Loss Adjustment Expenses
[c. 204; p. 16] Reserves for losses and loss adjustment expenses
- Reserves for unpaid losses and loss adjustment expenses (LAE) represent the estimated ultimate cost of all unreported and reported but unpaid insured claims and the cost to adjust losses incurred as of the balance sheet date.
- Estimates for reserves are made using individual case-basis valuations of reported claims, statistical analyses, and various actuarial procedures.
- Estimates are based on historical information, industry and peer group information, and estimates of future trends in variable factors such as loss severity, loss frequency, and inflation.
- Estimates are regularly reviewed and adjusted as experience develops or new information becomes known.
- During the loss settlement period, estimates of liability on a claim may be refined and adjusted upward or downward.
- The ultimate liability may exceed or be less than the revised estimates, and the ultimate settlement of losses and related LAE may vary significantly from the estimate in financial statements.
- If actual liabilities exceed recorded amounts, there will be an adverse effect.
- If recorded reserves are determined to be more than adequate, it would lead to a reduction in reserves.
M. Premiums
[c. 205; p. 16] Premium recognition and receivables
- The Company earns and recognizes property and casualty and surety premiums on a pro-rata basis over the policy terms.
- Accident and health premiums are earned as billed, based on census data.
- Gross premiums written are reduced by ceded premiums from proportional, facultative, and excess of loss reinsurance costs for prospective reinsurance.
- Premiums receivable include deferred premiums, which are installment payments due from insureds under their policy payment terms.
- Premiums receivable are carried net of an allowance for credit losses, which represents the current estimate of expected credit losses.
- The Company develops a historical loss rate for credit losses using historical write-offs and aging of receivables.
- This historical loss rate is adjusted for current conditions, reasonable and supportable forecasts, and the ability to cancel coverage after a premium is past due.
- Changes in the allowance for credit losses are recognized in underwriting, acquisition, and insurance expenses on the consolidated statements of operations.
[c. 206; p. 16] Unearned premiums
- Unearned premiums represent the portion of gross premiums written applicable to the unexpired terms of insurance policies or reinsurance contracts in force.
- Ceded unearned premiums represent the portion of ceded premiums written applicable to the unexpired terms of insurance policies or reinsurance contracts in force.
- These unearned premiums are calculated on a pro-rata basis over the terms of the policies for both direct and ceded amounts.
N. Commission and Fee Income
[c. 207; p. 16] SUA commission revenue
- SUA commission revenue is generated from placing insurance policies on reinsurance programs via a reinsurance broker.
- The Company's single performance obligation for SUA commission revenue is the placement of insurance policies.
- The transaction price for SUA commission revenue is fixed at contract inception and based on a percentage of premiums placed.
- The Company recognizes 100% of the transaction price as revenue when the performance obligation is satisfied at the point a policy is placed, as there are no constraints on revenue.
[c. 208; p. 16] SUA fee income
- SUA fee income is generated from placing insurance policies with a third-party insurance company.
- The Company's single performance obligation for SUA fee income is the placement of the policy.
- The transaction price for SUA fee income is variable at contract inception and based on a percentage of premium, which is determined by risk factors that vary monthly (e.g., employee census data, worker roles).
- The Company estimates its transaction price over the life of the policy using the expected value method.
- Revenue from SUA fee income is recognized at the point the policy is placed.
- Changes in the estimate of variable consideration for SUA fee income are recognized in the month they occur.
O. Income Taxes
[c. 209; p. 16] Income tax accounting principles
- Income tax expense is accrued for tax effects of transactions reported on consolidated financial statements.
- Provision for income taxes includes currently due taxes plus deferred taxes from temporary differences between financial statement and income tax purposes.
- A valuation allowance is established for any deferred tax asset not expected to be realized.
- Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years temporary differences are expected to be recovered or settled.
- The effect on deferred tax assets and liabilities from a change in tax rates is recognized in income in the period that includes the enactment date.
- A liability for uncertain tax positions is recorded if it is more likely-than-not that the tax position will not be sustained upon examination by the appropriate tax authority.
- Changes in the liability for uncertain tax positions are reflected in income tax expense in the period when a new uncertain tax position arises, judgment changes about the likelihood of an uncertainty, the tax issue is settled, or the statute of limitation expires.
- Any potential net interest income or expense and penalties related to uncertain tax positions are recorded on the Consolidated Statements of Operations.
[c. 210; p. 16] Tax filings and premium taxes
- The Company files a consolidated federal income tax return in the United States and certain other state tax returns.
- Admitted insurance subsidiaries pay premium taxes on gross written premiums in lieu of most state income or franchise taxes.
- Premium tax expense is recognized within underwriting, acquisition and insurance expense on the Consolidated Statements of Operations.
P. Fair Value of Financial Instruments
[c. 211; p. 16] Fair Value Measurement Framework
- Fair value for each class of financial instrument is estimated based on the framework in fair value accounting guidance.
- The guidance prioritizes observable inputs and minimizes unobservable inputs for fair value measurement.
- Fair value hierarchy disclosures are based on the quality of inputs used.
- The hierarchy gives highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements).
- The hierarchy gives lowest priority to unobservable inputs (Level 3 measurements).
- The Company uses widely recognized, third-party pricing sources to determine fair values of financial instruments.
- The Company understands the valuation methodologies and inputs of these third-party pricing sources.
- Further details regarding fair value disclosures are in Note 4.
Q. Stock-Based Compensation
[c. 212; p. 16] Stock-based compensation accounting
- Estimated fair value of employee stock options and similar awards are expensed.
- Compensation cost for equity instrument awards to employees is measured based on grant-date fair value.
- Compensation expense is recognized over the service period during which awards are expected to vest.
- Tax effects related to share-based payments are made through net earnings.
- Further discussion and disclosures regarding stock-based compensation are in note 18.
[c. 213; p. 16] Employee Stock Purchase Plan (ESPP)
- The Company's employee stock purchase plan ("ESPP") allows all employees to purchase common stock at a discount.
- Compensation cost for the ESPP is recognized on a straight-line basis over the offering period.
[c. 214; p. 16] Basic EPS calculation methodology
- Basic earnings per share (EPS) is calculated using the two-class method.
- Undistributed earnings are allocated to participating securities based on their potential share in earnings, assuming all earnings for the period have been distributed.
- Basic EPS is calculated by dividing net income attributable to common stockholders by the weighted-average number of common shares outstanding for the period.
- Common shares with unsatisfied contingencies, such as vesting requirements, are excluded from basic EPS.
- The Company's preferred shares participate in dividends and distributions with common stock on an as-converted basis and are considered a participating security.
- Instruments awarded to employees that grant the right to purchase common stock at a fixed price were included as potential common shares, weighted for the portion of the period they were granted, if dilutive.
- Common and preferred shares financed by stock notes are contingently issuable instruments, requiring the holder to return shares if stock notes are not paid off.
- These contingently issuable instruments are excluded from basic and diluted EPS if specified conditions are not met, presuming the end of the period is the end of the contingency period.
- The impact of contingently issuable instruments on diluted EPS was calculated using the treasury stock method and included in the reconciliation of the denominator for basic and diluted EPS computations for the year ended December 31, 2023.
- All outstanding stock notes were settled during 2024, resulting in no impact on the Company's basic and diluted EPS computations for the year ended December 31, 2024.
[c. 215; p. 16] Diluted EPS calculation methodology
- Instruments convertible into common shares are included in diluted weighted-average common shares outstanding on an if-converted basis, using the legal conversion rate for the respective period, if dilutive.
- Share-based awards to employees with only service conditions are included as potential common shares, weighted for the unvested portion of the period, if dilutive.
- Share-based awards to employees with performance and service or market conditions are included as potential common shares, presuming the end of the period is the end of the contingency period, if dilutive.
- If common share adjustments increase EPS or reduce loss per share, the effect is anti-dilutive, and diluted net earnings or net loss per share is computed excluding these common share equivalents.
S. Recent Accounting Pronouncements
[c. 216; p. 16] Recent accounting standards adopted
- In November 2023, the FASB issued ASU 2023-07, Improvements to Reportable Segment Disclosures (Topic 280).
- ASU 2023-07 requires segment disclosures for:
- significant segment expenses regularly provided to the chief operating decision maker (“CODM”).
- how the CODM uses reported measure(s) of segment profitability in assessing segment performance and resource allocation.
- the title and position of the CODM.
- Entities with a single reportable segment must provide full segment disclosures.
- The guidance became effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024.
- This update is applied retrospectively to all prior periods presented.
- The Company has added additional segment disclosures as required by ASU 2023-07, detailed in Note 12.
[c. 217; p. 16] Recent accounting standards not yet adopted
- In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures (Topic 740).
- ASU 2023-09 requires public companies to provide enhanced rate reconciliation disclosures annually, including specific categories and additional information meeting a quantitative threshold.
- This update also requires public companies to disaggregate income taxes paid by federal, state, and foreign taxes.
- The guidance is effective for fiscal years beginning after December 15, 2024.
- The Company is evaluating the effect of ASU 2023-09 and currently does not expect a material impact on its consolidated financial statements.
- In November 2024, the FASB issued ASU 2024-03, requiring disaggregated disclosure of income statement expenses for public business entities (“PBEs”).
- ASU 2024-03 does not change expense captions on the income statement but requires disaggregation of certain expense captions into specified categories in footnotes.
- ASU 2024-03 requires a footnote disclosure about specific expenses by requiring PBEs to disaggregate, in a tabular presentation, each relevant income statement expense caption that includes any of the following natural expenses:
- purchases of inventory.
- employee compensation.
- depreciation.
- intangible asset amortization.
- depreciation, depletion, and amortization recognized as part of oil- and gas-producing activities or other types of depletion expenses.
- The tabular disclosure will also include certain other expenses, when applicable.
- In January 2025, the FASB issued ASU 2025-01 to clarify the effective date of ASU 2024-03 as the first annual reporting period beginning after December 15, 2026, and interim reporting periods within annual reporting periods beginning after December 15, 2027.
- The Company is evaluating the effect of the amendments on its consolidated financial statements.
2. Goodwill and Intangible Assets
[c. 218; p. 16] Goodwill and intangible assets overview
- The tables present the carrying amount and changes in the balance of goodwill by reporting unit at December 31, 2024 and 2023.
- The tables present the carrying amount and changes in the balance of other intangible assets at December 31, 2024 and 2023.
- The Company's indefinite-lived intangible assets include insurance licenses and trademarks.
- The Company's finite-lived intangible assets, including policy renewals, agency relationships (within agent relationships), and non-compete/exclusivity agreements (within non-competes), had a weighted average useful life of approximately 15 years as of December 31, 2024.
[c. 219; p. 16] Intangible assets amortization expense
- The Company recognized approximately USD 1.1m in amortization expense for the year ended December 31, 2024.
- The Company recognized approximately USD 1.5m in amortization expense for the years ended December 31, 2023 and 2022.
- A table sets forth the estimated future net amortization expense of intangible assets.
[c. 220; p. 16]
| ($ in thousands) | Accident and Health | Surety | Industry Solutions | Other | Total |
|---|---|---|---|---|---|
| Goodwill | |||||
| Gross balance at December 31, 2023 | 91,577 | 6,781 | 10,204 | 3,879 | 112,441 |
| Accumulated impairment at December 31, 2023 | ( 44,821 ) | — | — | ( 1,886 ) | ( 46,707 ) |
| Net balance at December 31, 2024 | 46,756 | 6,781 | 10,204 | 1,993 | 65,734 |
| ($ in thousands) | Accident and Health | Surety | Industry Solutions | Other | Total |
|---|---|---|---|---|---|
| Goodwill | |||||
| Gross balance at December 31, 2022 | 91,577 | 6,781 | 10,204 | 3,879 | 112,441 |
| Accumulated impairment at December 31, 2022 | ( 44,821 ) | — | — | ( 1,886 ) | ( 46,707 ) |
| Net balance at December 31, 2023 | 46,756 | 6,781 | 10,204 | 1,993 | 65,734 |
| ($ in thousands) | Agent Relationships | Non-competes | Trademarks | Licenses | Total |
|---|---|---|---|---|---|
| Other Intangible Assets | |||||
| Gross balance at December 31, 2023 | 24,491 | 1,117 | 999 | 14,019 | 40,626 |
| Accumulated amortization at December 31, 2023 | ( 16,808 ) | ( 1,117 ) | — | — | ( 17,925 ) |
| Amortization | ( 1,087 ) | — | — | — | ( 1,087 ) |
| Net balance at December 31, 2024 | 6,596 | — | 999 | 14,019 | 21,614 |
| ($ in thousands) | Agent Relationships | Non-competes | Trademarks | Licenses | Total |
|---|---|---|---|---|---|
| Other Intangible Assets | |||||
| Gross balance at December 31, 2022 | 24,441 | 1,117 | 999 | 14,019 | 40,576 |
| Accumulated amortization at December 31, 2022 | ( 15,547 ) | ( 893 ) | — | — | ( 16,440 ) |
| Additions | 50 | — | — | — | 50 |
| Amortization | ( 1,261 ) | ( 224 ) | — | — | ( 1,485 ) |
| Net balance at December 31, 2023 | 7,683 | — | 999 | 14,019 | 22,701 |
| ($ in thousands) | |
|---|---|
| Years Ending December 31, | Amount |
| 2025 | 1,016 |
| 2026 | 553 |
| 2027 | 553 |
| 2028 | 553 |
| 2029 | 553 |
3. Investments
[c. 221; p. 16] Investment portfolio fair value and amortized cost
- Tables set forth amortized cost and fair value by investment category at December 31, 2024 and December 31, 2023.
- Amortized cost and estimated fair value of fixed maturity securities, available for sale, at December 31, 2024 are shown by contractual maturity.
- Expected maturities may differ from contractual maturities due to borrower call/prepayment rights or portfolio sales prior to maturity driven by interest rates, tax considerations, or other factors.
- Fixed maturity securities, held-to-maturity, at December 31, 2024 consisted entirely of asset-backed securities not due at a single maturity date.
[c. 222; p. 16] Pledged assets
- At December 31, 2024, the Company had U.S. government agencies mortgage-backed fixed maturity securities with a carrying value of approximately USD 66.2m pledged as collateral for a loan (the "FHLB Loan") from the Federal Home Loan Bank of Dallas ("FHLB").
- The Company retains all rights regarding these pledged securities under the Advances and Security Agreement.
- At December 31, 2024, the Company had assets with fair values of approximately USD 28.0m pledged as collateral for performance obligations under reinsurance agreements.
- The Company retains all rights regarding these pledged securities under the trust agreements.
- Pledged assets for reinsurance agreements included USD 24.3m in residential mortgage-backed securities, USD 2.2m in short-term investments, and USD 1.5m in cash and cash equivalents and other assets.
[c. 223; p. 16] Unrealized losses and impairment assessment
- Tables set forth gross unrealized losses and corresponding fair values of investments, aggregated by length of time in a continuous unrealized loss position as of December 31, 2024 and 2023.
- The Company monitors available-for-sale fixed maturity securities with fair values less than cost or amortized cost for impairment, requiring significant management judgment.
- Judgments could change, potentially impacting reported amounts negatively.
- Factors considered for fixed maturity securities include issuer financial condition (receipt of scheduled principal and interest), and intent to sell (likelihood of being required to sell before recovery).
- As of December 31, 2024, the Company had 778 lots of fixed maturity securities in an unrealized loss position.
- The Company does not intend to sell these securities and is not likely to be required to sell them before maturity or recovery of cost basis.
- The Company reviewed investments at December 31, 2024, and determined no credit impairment existed in gross unrealized holding losses.
- For U.S. government and municipal securities, the decline in fair values was due to interest rate changes, not credit quality.
- The Company does not intend to sell these U.S. government and municipal securities and expects recovery, thus not considering them impaired.
- For corporate securities and miscellaneous, the decline in fair values was due to interest rate changes, not credit quality.
- The Company reviewed issuers for significant adverse changes in financial condition, credit enhancement quality, ratings decreases, negative outlooks, or payment failures.
- After review, the decline in fair values for corporate securities was attributed to interest rates, not credit quality.
- The Company does not intend to sell these corporate securities and expects recovery, thus not considering them impaired.
- For residential mortgage-backed, commercial mortgage-backed, and other asset-backed securities, the decline in fair values was due to interest rate changes, not credit quality.
- The Company does not intend to sell these mortgage-backed and asset-backed securities and expects recovery, thus not considering them impaired.
[c. 224; p. 16] Net investment gains (losses)
- A table sets forth the components of net investment gains (losses) for the years ended December 31, 2024, 2023, and 2022.
[c. 225; p. 16] Proceeds from sales of securities
- A table sets forth the proceeds from sales of available-for-sale fixed maturity securities and equity securities for the years ended December 31, 2024, 2023, and 2022.
[c. 226; p. 16] Net investment income
- A table sets forth the components of net investment income for the years ended December 31, 2024, 2023, and 2022.
[c. 227; p. 16] Net unrealized gains (losses)
- A table sets forth the change in net unrealized gains (losses) on the Company’s investment portfolio, net of deferred income taxes, included in other comprehensive loss for the years ended December 31, 2024, 2023, and 2022.
[c. 228; p. 16] Regulatory deposits
- Various state regulations require the Company to maintain cash, investment securities, or letters of credit on deposit with states in a depository account.
- At December 31, 2024, cash and investment securities on deposit had carrying values of approximately USD 66.8m.
- At December 31, 2023, cash and investment securities on deposit had carrying values of approximately USD 65.3m.
[c. 229; p. 16]
| ($ in thousands) | Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Allowance for Credit Losses | Fair Value |
|---|---|---|---|---|---|
| December 31, 2024 | |||||
| Fixed maturity securities, available-for-sale: | |||||
| U.S. government securities | 26,577 | 35 | ( 126 ) | — | 26,486 |
| Corporate securities and miscellaneous | 433,298 | 5,618 | ( 13,288 ) | — | 425,628 |
| Municipal securities | 89,966 | 116 | ( 5,366 ) | — | 84,716 |
| Residential mortgage-backed securities | 408,585 | 1,875 | ( 16,627 ) | — | 393,833 |
| Commercial mortgage-backed securities | 70,262 | 545 | ( 1,443 ) | — | 69,364 |
| Other asset-backed securities | 291,578 | 2,447 | ( 1,834 ) | — | 292,191 |
| Total fixed maturity securities, available-for-sale | 1,320,266 | 10,636 | ( 38,684 ) | — | 1,292,218 |
| Fixed maturity securities, held-to-maturity: | — | — | — | — | — |
| Other asset-backed securities | 39,396 | — | ( 436 ) | ( 243 ) | 38,717 |
| Total fixed maturity securities, held-to-maturity | 39,396 | — | ( 436 ) | ( 243 ) | 38,717 |
| ($ in thousands) | Amortized Cost | Gross Unrealized Gains | Gross Unrealized Loss | Allowance for Credit Losses | Fair Value |
|---|---|---|---|---|---|
| December 31, 2023 | |||||
| Fixed maturity securities, available-for-sale: | |||||
| U.S. government securities | 44,685 | 202 | ( 721 ) | — | 44,166 |
| Corporate securities and miscellaneous | 392,773 | 6,408 | ( 15,761 ) | — | 383,420 |
| Municipal securities | 98,266 | 655 | ( 6,143 ) | — | 92,778 |
| Residential mortgage-backed securities | 292,568 | 3,556 | ( 14,498 ) | — | 281,626 |
| Commercial mortgage-backed securities | 31,411 | 449 | ( 1,926 ) | — | 29,934 |
| Other asset-backed securities | 188,010 | 1,221 | ( 3,504 ) | — | 185,727 |
| Total fixed maturity securities, available-for-sale | 1,047,713 | 12,491 | ( 42,553 ) | — | 1,017,651 |
| Fixed maturity securities, held-to-maturity: | — | — | — | — | — |
| Other asset-backed securities | 43,315 | — | ( 1,969 ) | ( 329 ) | 41,017 |
| Total fixed maturity securities, held-to-maturity | 43,315 | — | ( 1,969 ) | ( 329 ) | 41,017 |
| ($ in thousands) | Amortized Cost | Fair Value |
|---|---|---|
| Due in less than one year | 23,332 | 23,292 |
| Due after one year through five years | 279,144 | 273,755 |
| Due after five years through ten years | 197,373 | 192,929 |
| Due after ten years | 49,992 | 46,854 |
| Mortgage-backed securities | 478,847 | 463,197 |
| Other asset-backed securities | 291,578 | 292,191 |
| Total | 1,320,266 | 1,292,218 |
| Less than 12 Months | 12 Months or More | Total | ||||
|---|---|---|---|---|---|---|
| ($ in thousands) | Fair Value | Gross Unrealized Losses | Fair Value | Gross Unrealized Losses | Fair Value | Gross Unrealized Losses |
| December 31, 2024 | ||||||
| Fixed maturity securities, available-for-sale: | ||||||
| U.S. government securities | 15,938 | ( 34 ) | 2,297 | ( 92 ) | 18,235 | ( 126 ) |
| Corporate securities and miscellaneous | 136,888 | ( 2,060 ) | 81,232 | ( 11,228 ) | 218,120 | ( 13,288 ) |
| Municipal securities | 41,930 | ( 1,046 ) | 27,687 | ( 4,320 ) | 69,617 | ( 5,366 ) |
| Residential mortgage-backed securities | 201,407 | ( 3,366 ) | 82,496 | ( 13,261 ) | 283,903 | ( 16,627 ) |
| Commercial mortgage-backed securities | 9,411 | ( 126 ) | 13,178 | ( 1,317 ) | 22,589 | ( 1,443 ) |
| Other asset-backed securities | 75,119 | ( 721 ) | 29,851 | ( 1,113 ) | 104,970 | ( 1,834 ) |
| Total fixed maturity securities, available-for-sale | 480,693 | ( 7,353 ) | 236,741 | ( 31,331 ) | 717,434 | ( 38,684 ) |
| Fixed maturity securities, held-to-maturity: | — | — | — | — | — | — |
| Other asset-backed securities | 2,144 | ( 2 ) | 36,573 | ( 434 ) | 38,717 | ( 436 ) |
| Total fixed maturity securities, held-to-maturity: | 2,144 | ( 2 ) | 36,573 | ( 434 ) | 38,717 | ( 436 ) |
| Total | 482,837 | ( 7,355 ) | 273,314 | ( 31,765 ) | 756,151 | ( 39,120 ) |
| Less than 12 Months | 12 Months or More | Total | ||||
|---|---|---|---|---|---|---|
| ($ in thousands) | Fair Value | Gross Unrealized Losses | Fair Value | Gross Unrealized Losses | Fair Value | Gross Unrealized Losses |
| December 31, 2023 | ||||||
| Fixed maturity securities, available-for-sale: | ||||||
| U.S. government securities | 7,342 | ( 25 ) | 25,604 | ( 696 ) | 32,946 | ( 721 ) |
| Corporate securities and miscellaneous | 26,742 | ( 570 ) | 174,947 | ( 15,191 ) | 201,689 | ( 15,761 ) |
| Municipal securities | 16,815 | ( 290 ) | 47,269 | ( 5,853 ) | 64,084 | ( 6,143 ) |
| Residential mortgage-backed securities | 37,634 | ( 602 ) | 103,495 | ( 13,896 ) | 141,129 | ( 14,498 ) |
| Commercial mortgage-backed securities | 4,942 | ( 74 ) | 15,290 | ( 1,852 ) | 20,232 | ( 1,926 ) |
| Other asset-backed securities | 27,887 | ( 106 ) | 75,253 | ( 3,398 ) | 103,140 | ( 3,504 ) |
| Total fixed maturity securities, available-for-sale | 121,362 | ( 1,667 ) | 441,858 | ( 40,886 ) | 563,220 | ( 42,553 ) |
| Fixed maturity securities, held-to-maturity: | — | — | — | — | — | — |
| Other asset-backed securities | — | — | 41,017 | ( 1,969 ) | 41,017 | ( 1,969 ) |
| Total fixed maturity securities, held-to-maturity: | — | — | 41,017 | ( 1,969 ) | 41,017 | ( 1,969 ) |
| Total | 121,362 | ( 1,667 ) | 482,875 | ( 42,855 ) | 604,237 | ( 44,522 ) |
| ($ in thousands) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Gross realized gains | |||
| Fixed maturity securities, available-for sale | 2,662 | 1,042 | 313 |
| Equity securities | 8,062 | 6,035 | 3,865 |
| Other | 127 | 2 | 36 |
| Total | 10,851 | 7,079 | 4,214 |
| Gross realized losses | — | — | — |
| Fixed maturity securities, available-for sale | ( 8,161 ) | ( 1,879 ) | ( 958 ) |
| Equity securities | ( 4,132 ) | ( 5,256 ) | ( 3,827 ) |
| Other | ( 223 ) | ( 2 ) | ( 76 ) |
| Total | ( 12,516 ) | ( 7,137 ) | ( 4,861 ) |
| Net unrealized gains (losses) on investments | — | — | — |
| Equity securities | 7,500 | 11,516 | ( 15,058 ) |
| Mortgage loans | 421 | ( 386 ) | — |
| Net investment gains (losses) | 6,256 | 11,072 | ( 15,705 ) |
| ($ in thousands) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Fixed maturity securities, available-for sale | 217,468 | 26,626 | 13,964 |
| Equity securities | 37,534 | 40,201 | 37,177 |
| ($ in thousands) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Income: | |||
| Fixed maturity securities, available-for sale | 57,574 | 34,703 | 18,481 |
| Fixed maturity securities, held-to-maturity | 4,177 | 4,163 | 5,375 |
| Equity securities | 2,720 | 3,418 | 3,579 |
| Equity method investments | 2,524 | ( 9,434 ) | 6,015 |
| Mortgage loans | 5,153 | 5,474 | 4,767 |
| Indirect loans | ( 2,400 ) | ( 4,155 ) | 4,846 |
| Short-term investments and cash | 14,851 | 11,392 | 1,498 |
| Other | 3,000 | 318 | ( 77 ) |
| Total investment income | 87,599 | 45,879 | 44,484 |
| Investment expenses | ( 6,913 ) | ( 5,557 ) | ( 7,553 ) |
| Net investment income | 80,686 | 40,322 | 36,931 |
| ($ in thousands) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Fixed maturity securities | 1,046 | 25,952 | ( 60,918 ) |
| Deferred income taxes | ( 213 ) | ( 5,420 ) | 12,793 |
| Total | 833 | 20,532 | ( 48,125 ) |
4. Fair Value Measurements
[c. 230; p. 16] Fair value measurement principles
- The Company's financial instruments include assets and liabilities carried at fair value, and those carried at cost or amortized cost but disclosed at fair value.
- The market approach is generally applied to determine fair value, using prices and data from market transactions involving identical or comparable assets and liabilities.
- Fair value of investments is determined using data primarily from third-party investment managers or pricing vendors.
- Periodic analyses are performed on third-party prices to ensure they are reasonable estimates of fair value, including reviewing month-to-month fluctuations and comparing valuations from different pricing services for identical securities.
[c. 231; p. 16] Fair value hierarchy levels
- The Company classifies financial instruments into a three-level hierarchy.
- Level 1: Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.
- Level 2: Inputs are other than quoted prices included in Level 1 that are observable for the asset or liability through corroboration with market data at the measurement date.
- Level 3: Unobservable inputs that reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date.
[c. 232; p. 16] Fair value estimation methods by instrument type
- U.S. government securities, mutual funds, and common stock: Fair value is measured using unadjusted quoted prices for identical instruments in an active exchange, representing Level 1 inputs.
- Preferred stocks, municipal securities, corporate securities, and miscellaneous: A pricing model is used that utilizes market-based inputs such as trades in illiquid markets for specific securities or active markets for similar securities.
- The model considers benchmark yields, issuer spreads, security terms and conditions, and other market data, representing Level 2 fair value inputs.
- Commercial mortgage-backed securities, residential mortgage-backed securities, and other asset-backed securities: A pricing model is used that utilizes market-based inputs including dealer quotes, market spreads, and yield curves.
- Individual tranches may be evaluated by determining cash flows using security terms, collateral performance, credit information, benchmark yields, and estimated prepayments, representing Level 2 fair value inputs.
- Fixed maturity securities (available for sale) and equity securities classified as Level 3: These include corporate securities and other asset-backed securities managed by an independent asset manager and priced by an independent pricing provider.
- The provider estimates value using the discounted net present value of cash flows method with an unobservable discount rate.
- The discount rate spread represents the risk associated with future cash flows, including inflation, opportunity cost, and time value of money, representing Level 3 fair value inputs.
[c. 233; p. 16] Discount rate range for Level 3 fixed maturity and equity securities
- The range of the discount rate for Level 3 fixed maturity and equity securities is set forth as of December 31, 2024.
[c. 234; p. 16] Mortgage loans fair value estimation
- Mortgage loans have variable interest rates and are collateralized by real property.
- Fair value of mortgage loans is determined using the income approach with observable and unobservable (Level 3) inputs.
- The unobservable input is the spread applied to a prime rate for discounting cash flows.
- This spread represents the incremental cost of capital based on the borrower’s ability to make future payments and the collateral value relative to the loan balance, subject to judgment and uncertainty.
- The range and weighted average of the spread, weighted by relative fair value, are set forth as of December 31, 2024, and December 31, 2023.
[c. 235; p. 16] Investment in RedBird Capital Partners
- The Company holds an investment in a limited partnership with RedBird Capital Partners, which invests in Bishop Street Underwriters, LLC (MGA), included in other long-term investments.
- The investment had a fair value of USD 28.2m at December 31, 2024, determined using the net asset value.
- Procedures to assess reasonableness of fair value include obtaining and reviewing audited financial statements.
- The unfunded commitment related to this investment was USD 24.4m at December 31, 2024.
- The Company may sell its interest with appropriate prior written notice and general partner approval.
- This investment is measured at fair value using the net asset value per share practical expedient under Accounting Standard Codification 820-10 and is not classified in the fair value hierarchy.
[c. 236; p. 16] Fair value hierarchy tables
- Tables setting forth the Company’s investments within the fair value hierarchy are provided for December 31, 2024, and December 31, 2023.
- Tables setting forth changes in fair value of instruments carried at fair value with a Level 3 measurement are provided for the years ended December 31, 2024, and 2023.
[c. 237; p. 16] Nonrecurring fair value measurements and disclosures
- Certain assets, including investments in indirect loans and loan collateral, equity method investments, and other invested assets, are measured at fair value on a nonrecurring basis only when impaired.
- The Company is required to disclose fair values of other financial instruments where practicable to estimate fair value, in addition to those recorded at fair value in the consolidated balance sheets.
- Estimated fair value amounts, defined as the quoted market price, are determined using available market information and other valuation methodologies.
- Considerable judgment is required for fair value estimates when quoted market prices are unavailable, meaning estimates are not necessarily indicative of amounts realizable in a current market exchange.
- Different market assumptions or estimation methodologies may affect estimated fair value amounts.
- Methods and assumptions used for estimating fair value disclosures of other financial instruments are provided.
[c. 238; p. 16] Fair value estimation for other financial instruments
- Fixed maturity securities, held-to-maturity: Consist of senior and junior notes with target rates of return.
- As of December 31, 2024, fair value was determined using the income approach with unobservable (Level 3) inputs.
- Notes payable: Carrying value approximates estimated fair value because notes accrue interest at current market rates plus a spread.
- Fair value is determined using the income approach with observable (Level 2) inputs.
- Subordinated debt: Consists of Unsecured Subordinated Notes due May 24, 2039, with a fixed interest rate.
- Fair value is determined using the income approach with observable (Level 2) inputs.
[c. 239; p. 16] Carrying and fair values of debt
- A table sets forth the Company’s carrying and fair values of notes payable and subordinated debt as of December 31, 2024, and December 31, 2023.
- Other financial instruments qualify as insurance-related products and are specifically exempted from fair value disclosure requirements.
[c. 240; p. 16]
| December 31, 2024 | |
|---|---|
| High | 8.00% |
| Low | 5.70% |
| Weighted average | 6.60% |
| December 31, 2024 | December 31, 2023 | |
|---|---|---|
| High | 10.00% | 9.50% |
| Low | 7.00% | 3.25% |
| Weighted average | 7.93% | 7.05% |
| December 31, 2024 | ||||
|---|---|---|---|---|
| ($ in thousands) | Level 1 | Level 2 | Level 3 | Total |
| Fixed maturity securities, available-for-sale: | ||||
| U.S. government securities | 26,486 | — | — | 26,486 |
| Corporate securities and miscellaneous | — | 354,815 | 70,813 | 425,628 |
| Municipal securities | — | 84,716 | — | 84,716 |
| Residential mortgage-backed securities | — | 393,833 | — | 393,833 |
| Commercial mortgage-backed securities | — | 69,364 | — | 69,364 |
| Other asset-backed securities | — | 285,084 | 7,107 | 292,191 |
| Total fixed maturity securities, available-for-sale | 26,486 | 1,187,812 | 77,920 | 1,292,218 |
| Fixed maturity securities, held-to-maturity: | — | — | — | — |
| Other asset-backed securities | — | — | 38,717 | 38,717 |
| Total fixed maturity securities, held-to-maturity | — | — | 38,717 | 38,717 |
| Equity securities: | — | — | — | — |
| Common stocks | 64,251 | — | — | 64,251 |
| Preferred stocks | — | 1,164 | — | 1,164 |
| Mutual funds | 40,839 | — | — | 40,839 |
| Total equity securities | 105,090 | 1,164 | — | 106,254 |
| Mortgage loans | — | — | 26,490 | 26,490 |
| Short-term investments | 274,929 | — | — | 274,929 |
| Total | 406,505 | 1,188,976 | 143,127 | 1,738,608 |
| December 31, 2023 | ||||
|---|---|---|---|---|
| ($ in thousands) | Level 1 | Level 2 | Level 3 | Total |
| Fixed maturity securities, available-for-sale: | ||||
| U.S. government securities | 44,166 | — | — | 44,166 |
| Corporate securities and miscellaneous | — | 383,420 | — | 383,420 |
| Municipal securities | — | 92,778 | — | 92,778 |
| Residential mortgage-backed securities | — | 281,626 | — | 281,626 |
| Commercial mortgage-backed securities | — | 29,934 | — | 29,934 |
| Other asset-backed securities | — | 185,727 | — | 185,727 |
| Total fixed maturity securities, available-for-sale | 44,166 | 973,485 | — | 1,017,651 |
| Fixed maturity securities, held-to-maturity: | — | — | — | — |
| Other asset-backed securities | — | — | 41,017 | 41,017 |
| Total fixed maturity securities, held-to-maturity: | — | — | 41,017 | 41,017 |
| Equity securities: | — | — | — | — |
| Common stocks | 67,425 | — | — | 67,425 |
| Preferred stocks | — | 7,358 | — | 7,358 |
| Mutual funds | 43,466 | — | — | 43,466 |
| Total equity securities | 110,891 | 7,358 | — | 118,249 |
| Mortgage loans | — | — | 50,070 | 50,070 |
| Short-term investments | 270,226 | — | — | 270,226 |
| Total | 425,283 | 980,843 | 91,087 | 1,497,213 |
| ($ in thousands) | Fixed Maturity Securities, Available-For-Sale | Mortgage Loans |
|---|---|---|
| Balance at December 31, 2023 | — | 50,070 |
| Total gains (losses) for the period recognized in net investment gains (losses) | ( 195 ) | 420 |
| Issuances | — | 649 |
| Settlements | — | ( 24,649 ) |
| Purchases | 77,979 | — |
| Sales/Disposals | ( 374 ) | — |
| Total unrealized gains for the period recognized in accumulated comprehensive income (loss) | 510 | — |
| Balance at December 31, 2024 | 77,920 | 26,490 |
| Total gains for the period recognized in net investment gains (losses) attributable to the change in unrealized gains or losses relating to assets held as of period end | — | 411 |
| ($ in thousands) | Mortgage Loans |
|---|---|
| Balance at December 31, 2022 | 52,842 |
| Total losses for the period recognized in net investment gains (losses) | ( 385 ) |
| Issuances | 27,642 |
| Settlements | ( 30,029 ) |
| Balance at December 31, 2023 | 50,070 |
| Total losses for the period recognized in net investment gains (losses) attributable to the change in unrealized gains or losses relating to assets held as of period end | ( 426 ) |
| December 31, 2024 | December 31, 2023 | |||
|---|---|---|---|---|
| ($ in thousands) | Carrying Value | Fair Value | Carrying Value | Fair Value |
| Notes payable | ||||
| FHLB Loan | 57,000 | 56,200 | — | — |
| Revolving credit facility | 43,000 | 43,000 | 50,000 | 50,000 |
| Notes payable | 100,000 | 99,200 | 50,000 | 50,000 |
| Subordinated debt | — | — | — | — |
| Junior subordinated interest debentures | — | — | 59,186 | 59,794 |
| Unsecured subordinated notes | 19,536 | 20,541 | 19,504 | 21,378 |
| Subordinated debt, net of debt issuance costs | 19,536 | 20,541 | 78,690 | 81,172 |
5. Mortgage Loans
[c. 241; p. 16] Mortgage loan portfolio overview
- The Company has invested in Separately Managed Accounts ("SMA1" and "SMA2").
- As of December 31, 2024 and December 31, 2023, the Company held direct investments in mortgage loans from various creditors through SMA1 and SMA2.
- The Company’s mortgage loan portfolios are primarily senior loans on real estate across the U.S..
- Loans earn interest at a fixed spread above a prime rate.
- Loans mature in approximately 2 to 3 years from loan origination.
- Principal amounts of loans range between 64% to 80% of the property’s appraised value at the time the loans were made.
[c. 242; p. 16] Mortgage loan financial data
- The carrying value of the Company’s mortgage loans as of December 31, 2024 and December 31, 2023 is set forth in a table.
- The Company’s gross investment income for mortgage loans for the years ended December 31, 2024, 2023 and 2022 is set forth in a table.
[c. 243; p. 16] Mortgage loan collectibility and status
- Uncollectible amounts on loans are determined on an individual loan basis based on consultations with the Company’s specialized investment manager, consideration of adverse situations affecting borrower repayment ability, estimated value of underlying collateral, and other relevant factors.
- The Company writes off uncollectible amounts in the period they are determined to be uncollectible.
- There was no write-off for uncollectible amounts during the years ended December 31, 2024, 2023 and 2022.
- As of December 31, 2024, no mortgage loans were in the process of foreclosure.
- As of December 31, 2024, no mortgage loans were not producing income for the previous 12 months.
- As of December 31, 2023, approximately USD 7.1m of mortgage loans were in the process of foreclosure.
- As of December 31, 2023, USD 6.8m of mortgage loans were not producing income for the previous 12 months.
[c. 244; p. 16]
| ($ in thousands) | December 31, 2024 | December 31, 2023 |
|---|---|---|
| Commercial | 8,474 | 14,469 |
| Retail | 10,032 | 16,072 |
| Hospitality | 7,984 | 12,744 |
| Industrial | — | 6,785 |
| — | 26,490 | 50,070 |
| ($ in thousands) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Commercial | 2,025 | 2,340 | 1,242 |
| Retail | 1,853 | 1,853 | 1,255 |
| Hospitality | 1,277 | 1,034 | 411 |
| Office | — | 203 | 385 |
| Multi-family | — | 44 | 909 |
| Industrial | — | — | 565 |
| — | 5,155 | 5,474 | 4,767 |
6. Equity Method Investments and Other
[c. 245; p. 16] Equity method investments overview
- Table presents carrying value and ownership percentage of the Company’s equity method investments as of December 31, 2024 and 2023.
- Table presents components of net investment income (loss) from equity method investments for the years ended December 31, 2024, 2023, and 2022.
- Table presents unfunded commitment of equity method investments as of December 31, 2024 and 2023.
[c. 246; p. 16] Equity method investment accounting
- Difference between investment cost and proportionate share of underlying equity in net assets is allocated to the equity method investment's assets and liabilities.
- Company amortizes the difference in net assets over the useful life of a similar asset as the underlying equity method investment.
- For investment in RISCOM, a similar asset is agent relationships, and the Company amortizes this difference over a 15-year useful life.
- Table presents the Company’s recorded investment in RISCOM compared to its share of underlying equity as of December 31, 2024 and 2023.
- Table presents the Company’s recorded investment in JVM Funds LLC compared to its share of underlying equity as of December 31, 2024 and 2023.
[c. 247; p. 16] Indirect loans and loan collateral
- As of December 31, 2024 and 2023, the Company held indirect investments in collateralized loans and loan collateral through SMA1 and SMA2.
- Table presents the carrying value of SMA1 and SMA2 as of December 31, 2024 and 2023.
[c. 248; p. 16]
| ($ in thousands) | December 31, 2024 | December 31, 2023 | ||
|---|---|---|---|---|
| Carrying Value | Ownership % | Carrying Value | Ownership % | |
| Arena Special Opportunities Fund, LP units | 34,936 | 15.3% | 41,046 | 16.2% |
| JVM Funds LLC units | 17,229 | 10.1% | 20,061 | 10.1% |
| RISCOM | 5,013 | 20.0% | 4,121 | 20.0% |
| Hudson Ventures Fund 2 LP units | 4,967 | 2.5% | 4,669 | 2.5% |
| Arena SOP LP units | 1,474 | 10.9% | 2,463 | 12.3% |
| Brewer Lane Ventures Fund II LP units | 1,040 | 2.4% | 560 | 2.5% |
| Dowling Capital Partners LP units | 666 | 5.0% | 1,708 | 6.2% |
| — | 65,325 | — | 74,628 | — |
| ($ in thousands) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Arena Special Opportunities Fund, LP units | 2,375 | ( 2,880 ) | 3,719 |
| RISCOM | 1,492 | 884 | 1,471 |
| Dowling Capital Partners LP units | 1,463 | 927 | 502 |
| Universa Black Swan LP units | — | ( 988 ) | ( 3,028 ) |
| Brewer Lane Ventures Fund II LP | ( 110 ) | ( 78 ) | — |
| Hudson Ventures Fund II LP units | ( 153 ) | 170 | 379 |
| Arena SOP LP units | ( 989 ) | ( 6,271 ) | 3,042 |
| JVM Funds LLC | ( 1,554 ) | ( 1,198 ) | ( 70 ) |
| — | 2,524 | ( 9,434 ) | 6,015 |
| ($ in thousands) | December 31, 2024 | December 31, 2023 |
|---|---|---|
| Brewer Lane Ventures Fund II LP units | 4,077 | 4,610 |
| Hudson Ventures Fund 2 LP units | 397 | 848 |
| Dowling Capital Partners LP units | 386 | 386 |
| — | 4,860 | 5,844 |
| ($ in thousands) | December 31, 2024 | December 31, 2023 |
|---|---|---|
| Investment in RISCOM: | ||
| Underlying equity | 3,756 | 2,620 |
| Difference | 1,258 | 1,501 |
| Recorded investment balance | 5,013 | 4,121 |
| ($ in thousands) | December 31, 2024 | December 31, 2023 |
|---|---|---|
| Investment in JVM Funds LLC: | ||
| Underlying equity | 16,624 | 19,304 |
| Difference | 605 | 757 |
| Recorded investment balance | 17,229 | 20,061 |
| ($ in thousands) | December 31, 2024 | December 31, 2023 |
|---|---|---|
| SMA1 | 20,296 | 30,816 |
| SMA2 | 12,973 | 5,209 |
| Investment in indirect loans and loan collateral | 33,269 | 36,025 |
7. Allowance for Credit Losses
[c. 249; p. 16] Premiums receivable allowance for credit losses
- Tables set forth changes in the allowance for expected credit losses on premiums receivable for the years ended December 31, 2024 and 2023.
[c. 250; p. 16] Reinsurance recoverables credit risk and allowance
- The Company analyzes credit risk of reinsurance recoverables by monitoring financial strength ratings from A.M. Best.
- Financial strength ratings are assessed annually and throughout the year as A.M. Best provides updates.
- Adequacy of credit enhancements (reinsurance payables, letters of credit, funds held) is assessed.
- A table sets forth the Company’s reinsurance recoverables net of credit enhancements by A.M. Best as of December 31, 2024.
- Reinsurance balances are considered past due when they are 90 days past due.
- Tables set forth changes in the allowance for estimated uncollectible reinsurance for the years ended December 31, 2024 and 2023.
- On January 31, 2025, the Company commuted the LPT with R&Q Re (Bermuda) Ltd. ("R&Q") related to accident years 2018 and prior.
- The uncollectible reinsurance recoverable balance related to the LPT was recognized as a net increase of USD 13.6m to the allowance for estimated uncollectible reinsurance.
- This amount was subsequently written-off during the year ended December 31, 2024.
[c. 251; p. 16]
| ($ in thousands) | Premiums Receivable, Net | Allowance for Estimated Uncollectible Premiums |
|---|---|---|
| Balance at December 31, 2023 | 179,235 | 964 |
| Current period change for estimated uncollectible premiums | — | 3,235 |
| Write-offs of uncollectible premiums receivable | — | ( 1,895 ) |
| Recoveries of amounts previously written off | — | 128 |
| Balance at December 31, 2024 | 321,641 | 2,432 |
| ($ in thousands) | Premiums Receivable, Net | Allowance for Estimated Uncollectible Premiums |
|---|---|---|
| Balance at December 31, 2022 | 139,215 | 629 |
| Cumulative effect of adoption of ASU 2016-13 at January 1, 2023 | — | — |
| Current period change for estimated uncollectible premiums | — | 748 |
| Write-offs of uncollectible premiums receivable | — | ( 513 ) |
| Recoveries of amounts previously written off | — | 100 |
| Balance at December 31, 2023 | 179,235 | 964 |
| December 31, 2024 | ||
|---|---|---|
| A.M. Best Rating | Reinsurance Recoverables, Gross, Amortized Cost | Percent of Total |
| A- and above | 837,807 | 97.4% |
| B++ to B+ | 6,021 | 0.7 |
| Not rated | 16,343 | 1.9 |
| ($ in thousands) | Reinsurance Recoverables, Net | Allowance for Estimated Uncollectible Reinsurance |
|---|---|---|
| Balance at December 31, 2023 | 596,334 | 2,295 |
| Current period change for estimated uncollectible reinsurance | — | 13,585 |
| Write-offs of uncollectible reinsurance recoverables | — | ( 13,585 ) |
| Balance at December 31, 2024 | 857,876 | 2,295 |
| Balance at | — | — |
| ($ in thousands) | Reinsurance Recoverables, Net | Allowance for Estimated Uncollectible Reinsurance |
|---|---|---|
| Balance at December 31, 2022 | 581,359 | — |
| Cumulative effect of adoption of ASU 2016-13 at January 1, 2023 | — | 2,295 |
| Current period change for estimated uncollectible reinsurance | — | — |
| Write-offs of uncollectible reinsurance recoverables | — | — |
| Balance at December 31, 2023 | 596,334 | 2,295 |
8. Property and Equipment
[c. 252; p. 16] Property and equipment components and depreciation
- Property and equipment components are included within other assets on the consolidated balance sheets as of December 31, 2024 and 2023.
- Depreciation expense related to property and equipment was USD 2.9m for the year ended December 31, 2024.
- Depreciation expense related to property and equipment was USD 3.2m for the year ended December 31, 2023.
- Depreciation expense related to property and equipment was USD 3.6m for the year ended December 31, 2022.
[c. 253; p. 16]
| (in thousands) | 2024 | 2023 |
|---|---|---|
| Leasehold improvements | 3,056 | 1,892 |
| Equipment | 4,506 | 5,033 |
| Software | 33,972 | 29,189 |
| — | 41,534 | 36,114 |
| Accumulated depreciation | ( 29,355 ) | ( 27,044 ) |
| Total | 12,179 | 9,070 |
9. Leases
[c. 254; p. 16] Lease accounting and expenses
- The Company determines if a contract contains a lease at inception and recognizes a right-of-use asset (within other assets) and lease liability (within accounts payable and accrued liabilities) based on the present value of future lease payments.
- If leases do not provide an implicit interest rate, the Company uses its incremental borrowing rate based on the inception date information to determine the lease liability.
- The Company's leases are primarily for office facilities, classified as operating leases.
- Lease terms range from less than 1 year to 6 years, with some including extension options.
- Lease expense for the years ended December 31, 2024, 2023, and 2022 was USD 2.1m, USD 2.8m, and USD 2.6m, respectively.
[c. 255; p. 16] Lease information tables
- A table provides information regarding the Company’s leases as of December 31, 2024 and 2023.
- A table presents the Company’s lease expenses for the years ended December 31, 2024, 2023 and 2022.
- A table sets forth the future minimum lease payment obligations of the Company’s operating leases at December 31, 2024.
[c. 256; p. 16]
| (in thousands) | 2024 | 2023 |
|---|---|---|
| Operating lease right-of-use assets | 3,135 | 4,905 |
| Operating lease liabilities | 3,213 | 5,228 |
| Operating lease weighted-average remaining lease term | 4.39 years | 4.55 years |
| Operating lease weighted-average discount rate | 5.01% | 3.95% |
| (in thousands) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Operating lease expense | 1,714 | 2,583 | 2,414 |
| Short-term lease expense | 421 | 184 | 220 |
| Total lease expense | 2,135 | 2,767 | 2,634 |
| Operating cash outflows from operating leases | 2,082 | 2,636 | 2,382 |
| (in thousands) | 2024 |
|---|---|
| 2025 | 968 |
| 2026 | 779 |
| 2027 | 686 |
| 2028 | 651 |
| 2029 | 415 |
| Thereafter | 133 |
| Total future minimum operating lease payments | 3,632 |
| Less imputed interest | ( 419 ) |
| Total operating lease liability | 3,213 |
10. Notes Payable & Subordinated Debt
[c. 257; p. 16] FHLB Loan
- On August 30, 2024, the Company entered into the FHLB Loan pursuant to the Advances and Security Agreement.
- The FHLB Loan is a 4.5-year term loan with a principal amount of USD 57.0m.
- The FHLB Loan requires interest-only payments during its term, with principal due in full at maturity.
- The interest rate for the FHLB Loan is fixed at 4.00% over the term.
- The FHLB Loan is fully secured by a pledge of specific investment securities of HSIC.
- Proceeds from the FHLB Loan were used to fund redemptions of draws on the Revolving Credit Facility.
[c. 258; p. 16] Revolving Credit Facility
- The Company entered into an agreement for a new unsecured revolving credit facility (the “Revolving Credit Facility”) with a syndicate of participating banks during Q1 2023.
- The Revolving Credit Facility provided up to a USD 150.0m revolving credit facility and a letter of credit sub-facility of up to USD 30.0m.
- As of December 31, 2023, the Company had drawn USD 50.0m on the Revolving Credit Facility.
- During Q1 2024, the Company drew an additional USD 50.0m on the Revolving Credit Facility to pay off the principal on its existing Debentures.
- On September 6, 2024, the Company redeemed USD 57.0m of the draws on the Revolving Credit Facility.
- Interest on the Revolving Credit Facility is payable quarterly.
- The interest rate on the Revolving Credit Facility is SOFR plus a margin of 150 to 190 bps, based on the debt to total capital ratio, and a credit spread adjustment of 10 bps.
- At December 31, 2024, the six-month SOFR on the Revolving Credit Facility was 4.25%, plus a margin of 1.60%.
- The Company is subject to covenants on the Revolving Credit Facility, including minimum net worth, maximum debt to capital ratio, minimum A.M. Best Rating, and minimum liquidity.
- As of December 31, 2024, the Company was in compliance with all covenants.
[c. 259; p. 16] Debentures
- In May 2019, the Company agreed to issue unsecured subordinated notes (the “Notes”) with an aggregate principal amount of USD 20.0m.
- Interest on the Notes is fixed at 7.25% for the first 8 years and 8.25% thereafter.
- Early retirement of the Notes before the 8-year commitment requires all interest payments to be paid in full, plus the return of outstanding principal.
- Principal on the Notes is due at maturity on May 24, 2039, and interest is payable quarterly.
- The Notes have junior priority to all previously issued debt.
- The Company reports debt related to the Notes in its December 31, 2024 and 2023 consolidated balance sheets, net of debt issuance costs of approximately USD 0.5m.
- These deferred financing costs are presented as a direct deduction from the carrying amount of the subordinated debt.
- In August 2006, the Company received USD 58.0m of proceeds from a debenture offering through Delos Capital Trust (the “Trust”).
- The sole asset of the Trust consists of Fixed/Floating Rate Junior Subordinated Deferrable Interest Debentures (the “Debentures”) with a principal amount of USD 59.8m issued by the Company.
- The Trust also held cash of USD 1.8m from the issuance of Trust common shares purchased by the Company, equal to 3% of the Trust capitalization.
- On March 15, 2024, the Company redeemed the Debentures and paid USD 1.4m of accrued interest.
11. Stockholders Equity
[c. 260; p. 16] Reverse stock split
- The Board of Directors approved a 4-for-1 reverse stock split of the Company’s common stock on September 23, 2022.
- The reverse stock split became effective January 3, 2023.
- All share and per share information in the consolidated financial statements and notes have been retroactively adjusted to reflect the reverse stock split for all periods presented.
[c. 261; p. 16] Initial public offering
- The Company completed its initial public offering (IPO) on January 18, 2023.
- 4,750,000 shares were offered by the Company at a price of USD 15.00 per share.
- Net proceeds from the IPO were approximately USD 62.0m, after deducting underwriting discounts and specific incremental expenses.
- Upon closing of the IPO, the Company filed an amended and restated certificate of incorporation.
- The amended certificate increased the number of authorized shares to 500,000,000 shares of common stock (par value USD 0.01 per share) and 10,000,000 shares of preferred stock (par value USD 0.01 per share).
[c. 262; p. 16] Preferred shares conversion
- Preferred Shares had liquidation preference over common stock for the face value of USD 50.00 per share and any declared but unpaid dividends to related common shares at the applicable conversion rate.
- Preferred Shares provided the holder the option to convert them into common stock at any time based on the Option Conversion Rate.
- Preferred Shares were subject to mandatory conversion upon the closing of an IPO at the Mandatory Conversion Rate.
- As of December 31, 2022, the Mandatory Conversion Rate allowed conversion into common stock based on a conversion price of USD 6.04 per common share.
- On January 18, 2023, 1,969,660 Preferred Shares converted to 16,305,113 shares of common stock upon the closing of the Company’s IPO.
[c. 263; p. 16] Follow-on offering
- The Company completed its follow-on offering on November 20, 2023.
- 2,150,000 shares were sold by the Company at a price of USD 30.50 per share.
- Net proceeds were approximately USD 62.5m, after deducting underwriting discounts and specific incremental expenses directly attributable to the offering.
12. Segment
[c. 264; p. 16] Reportable segment overview
- The Company has one reportable segment offering commercial property and casualty products and solutions, predominantly in the United States, on a non-admitted (E&S) and admitted basis.
- The segment consists of eight distinct underwriting divisions, referred to as "continuing business," with dedicated underwriting leadership and technical staff.
- The segment definition is based on how internally reported financial information is reviewed by the Chief Operating Decision Maker (CODM) to analyze performance, make decisions, and allocate resources.
- The Company's CODM is the chief executive officer.
- Accounting policies for the segment are consistent with Note 1 "Summary of Significant Accounting Policies" of Form 10-K.
- The CODM assesses segment performance and allocates resources based on gross written premiums by net underwriting division, underwriting income, and income before income taxes (reported on consolidated statements of operations).
- Segment assets are reported on the balance sheet as total consolidated assets.
- Gross written premiums by underwriting division, net underwriting income, and consolidated net income are used to monitor budget versus actual results.
- The CODM uses net underwriting income, return on equity, and growth in book value per share for competitive analysis by benchmarking against competitors.
- Competitive analysis and monitoring of budgeted versus actual results are used to assess segment performance and establish management's compensation.
[c. 265; p. 16] Financial data tables
- A table presents gross written premiums by underwriting division for the years ended December 31, 2024, 2023, and 2022.
- A table presents reported segment net underwriting income, significant segment expenses, and a reconciliation of net underwriting income to net income for the years ended December 31, 2024, 2023, and 2022.
- A table presents return on equity and book value per share for the years ended December 31, 2024, 2023, and 2022.
[c. 266; p. 16]
| Years Ended December 31, | |||
|---|---|---|---|
| ($ in thousands) | 2024 | 2023 | 2022 |
| Industry Solutions | 317,198 | 305,476 | 267,628 |
| Global Property & Agriculture | 311,402 | 273,191 | 205,081 |
| Captives | 241,902 | 167,624 | 124,286 |
| Programs | 218,407 | 178,726 | 163,653 |
| Accident & Health | 173,073 | 151,701 | 130,808 |
| Transactional E&S | 169,053 | 122,508 | 75,098 |
| Professional Lines | 159,785 | 154,565 | 93,011 |
| Surety | 152,429 | 106,056 | 79,062 |
| Total continuing business | 1,743,249 | 1,459,847 | 1,138,627 |
| Exited business | ( 17 ) | ( 18 ) | 5,325 |
| Total gross written premiums | 1,743,232 | 1,459,829 | 1,143,952 |
| ($ in thousands) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Underwriting income | |||
| Revenues: | |||
| Net earned premiums | 1,056,722 | 829,143 | 615,994 |
| Commission and fee income | 6,703 | 6,064 | 5,199 |
| Total underwriting revenues | 1,063,425 | 835,207 | 621,193 |
| Expenses: | — | — | — |
| Losses and LAE | 669,809 | 515,237 | 402,512 |
| Amortization of policy acquisition costs | 149,975 | 108,514 | 65,695 |
| Other operating and general expenses | 161,782 | 134,930 | 116,476 |
| Total underwriting expenses | 981,566 | 758,681 | 584,683 |
| Net underwriting income | 81,859 | 76,526 | 36,510 |
| Reconciliation of net underwriting income to net income: | — | — | — |
| Net underwriting income | 81,859 | 76,526 | 36,510 |
| Add: | — | — | — |
| Net investment income | 80,686 | 40,322 | 36,931 |
| Net investment gains (losses) | 6,256 | 11,072 | ( 15,705 ) |
| Other (loss) income | ( 167 ) | ( 632 ) | 1 |
| Less: | — | — | — |
| Interest expense | 9,496 | 10,024 | 6,407 |
| Amortization expense | 2,007 | 1,798 | 1,547 |
| Other expenses | 4,392 | 5,364 | — |
| Income before income taxes | 152,739 | 110,102 | 49,783 |
| Income tax expense | 33,911 | 24,118 | 10,387 |
| Net income | 118,828 | 85,984 | 39,396 |
| 2024 | 2023 | 2022 | |
|---|---|---|---|
| Return on equity | 16.3% | 15.9% | 9.3% |
| Book value per share | 19.79 | 16.72 | 25.82 |
13. Income Taxes
[c. 267; p. 16] income tax expense and effective tax rate
- The Company's income tax expense components are presented for the years ended December 31, 2024, 2023, and 2022.
- The provision for income taxes generally does not deviate substantially from the statutory tax rate.
- The effective tax rate may vary slightly from the statutory rate due to tax adjustments for tax-exempt income, dividends-received deduction, and non-deductible expenses.
- Differences between income taxes expected at the federal statutory income tax rate of 21% and the reported income tax expense are presented for the years ended December 31, 2024, 2023, and 2022.
[c. 268; p. 16] deferred tax assets and liabilities
- The tax effects of temporary differences giving rise to significant portions of deferred tax assets and deferred tax liabilities are presented as of December 31, 2024, and 2023.
[c. 269; p. 16] federal income taxes and examinations
- The Company paid USD 37.0m in federal income taxes during the year ended December 31, 2024.
- The Company's federal income tax returns for tax years 2021 to 2023 are subject to examination by the Internal Revenue Service.
- The Company has no current U.S. federal or state and local income tax examinations ongoing.
[c. 270; p. 16] uncertain tax positions and accruals
- As of December 31, 2024, the Company carried no balance for uncertain tax positions.
- The Company had no accrual for the payment of interest and penalties at December 31, 2024, or 2023.
[c. 271; p. 16] net operating loss carryforwards
- The Company has federal net operating loss carryforwards of approximately USD 44.7m.
- These net operating losses are set to expire beginning in 2032.
- The Company is limited on the utilization of USD 44.7m of net operating losses under Internal Revenue Code Section 382 ("Sec 382") due to an "ownership change" in 2014.
- The Sec 382 limitation is expected to result in an expiration of USD 2.8m (USD 0.6m tax effected) of net operating losses [p.16, p.16].
- A valuation allowance was established against the balance of net operating losses expected to expire without utilization.
[c. 272; p. 16] capital loss carryforward
- The Company generated a capital loss carryforward in 2022, resulting in a deferred tax asset of USD 1.7m as of December 31, 2024.
- No valuation allowance is recorded against this deferred tax asset as the Company expects to utilize this carryforward before it expires in 2027.
[c. 273; p. 16] deferred tax valuation allowance
- The Company provides a valuation allowance against deferred tax assets when it is more likely-than-not that some portion, or all, of deferred tax assets will not be realized.
- The deferred tax valuation allowance at December 31, 2024, and 2023 was USD 0.6m.
[c. 274; p. 16]
| ($ in thousands) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current income tax expense | 42,626 | 14,736 | 120 |
| Deferred tax (benefit) expense related to temporary differences | ( 8,715 ) | 9,382 | 10,267 |
| Total income tax expense | 33,911 | 24,118 | 10,387 |
| 2024 | 2023 | 2022 | ||||
|---|---|---|---|---|---|---|
| ($ in thousands) | Amount | Percentage | Amount | Percentage | Amount | Percentage |
| Income tax expense at federal statutory rate | 32,075 | 21.0% | 23,121 | 21.0% | 10,454 | 21.0% |
| Tax advantaged investments | ( 239 ) | ( 0.2 ) | ( 295 ) | ( 0.3 ) | ( 324 ) | ( 0.7 ) |
| Other | 2,075 | 1.4 | 1,292 | 1.2 | 257 | 0.6 |
| Total income tax expense | 33,911 | 22.2% | 24,118 | 21.9% | 10,387 | 20.9% |
| ($ in thousands) | 2024 | 2023 |
|---|---|---|
| Deferred tax assets: | ||
| Unearned premiums | 18,178 | 15,365 |
| Losses and loss adjustment expenses | 16,967 | 11,581 |
| Net operating losses | 9,389 | 10,655 |
| Unrealized losses on fixed maturity securities, available-for-sale | 5,893 | 6,113 |
| Stock options/awards | 2,453 | 1,714 |
| Other | 6,067 | 4,237 |
| Total deferred tax assets | 58,947 | 49,665 |
| Less valuation allowance | ( 586 ) | ( 586 ) |
| Total deferred tax assets after valuation allowance | 58,361 | 49,079 |
| Deferred tax liabilities: | — | — |
| Deferred policy acquisition costs | 15,277 | 11,528 |
| Unrealized gains on equity securities | 4,818 | 3,243 |
| Other long-term investments | 2,625 | 6,460 |
| Depreciation | 1,426 | 1,260 |
| Section 481(a) adjustment | 1,391 | 3,477 |
| Other | 2,338 | 1,120 |
| Total deferred tax liabilities | 27,875 | 27,088 |
| Deferred income taxes | 30,486 | 21,991 |
14. Reserves for Losses and Loss Adjustment Expenses
[c. 275; p. 16] Loss development evaluation categories
- The Company presents loss development on a consolidated basis.
- Net ultimate loss and LAE are evaluated under three sub-categories: multi-line solutions, short-tail/monoline specialty lines, and exited lines.
- These disaggregated groupings have more homogeneous risk characteristics with similar development patterns and are generally subject to similar trends.
- Short-tail/Monoline Specialty Lines include global property & agriculture, accident & health, surety, and professional lines underwriting divisions.
- These are market niches served with monoline solutions, generally having shorter durations for losses to fully develop.
- Losses are generally reported within a short period from the date of loss, and claims are often settled and paid within a relatively short timeframe.
- Can be impacted by larger, more complex losses due to factors like difficulty determining actual damages, and legal/regulatory impediments extending settlement times.
- Multi-line Solutions include industry solutions, programs, captives, and transactional E&S underwriting divisions.
- These are market niches where the Company provides multiple products, most frequently as an integrated solution.
- Predominantly made up of occurrence liability, including general liability, excess liability, and commercial auto.
- Have a longer duration for losses to fully develop compared to short-tail/monoline specialty lines.
- Longer-tail nature and unique claim characteristics introduce more uncertainty, as claims can be impacted by changes in regulation, inflation, and other unforeseen factors over time.
- Exited lines include all underwriting units placed in run-off and are presented separately from ongoing lines of business.
[c. 276; p. 16] Reserve evaluation methodology change
- In 2024, the Company transitioned from evaluating reserves on a policy year basis to an accident year basis.
- This transition results in earlier recognition of underlying claim trends, better alignment of exposure to risks, and adherence to commonly used industry best practices.
- In prior years, the Company's methodology allocated IBNR from its policy year analysis to accident year.
- As a result of transitioning to accident year, IBNR within short-tail/monoline specialty lines, multi-line solutions, and exited lines was reallocated for the years ended December 31, 2023, 2022, 2021, and 2020.
- Certain amounts have been conformed to the current year presentation.
- A table sets forth the reconciliation of unpaid losses and loss adjustment expenses ("LAE") as reported in the consolidated balance sheets as of and for the years ended December 31, 2024, 2023, and 2022.
[c. 277; p. 16] Prior year loss and LAE reserve development
- For the year ended December 31, 2024, the Company recognized adverse development related to prior years’ loss and loss expense reserves of USD 25.7m.
- This was primarily related to losses previously subject to the LPT from accident years 2018 and prior.
- Multi-line solutions accounted for USD 10.1m of this adverse development.
- Exited lines accounted for USD 15.2m of this adverse development.
- For the year ended December 31, 2023, the Company recognized adverse development related to prior years’ loss and loss expense reserves of USD 10.8m.
- Adverse development of USD 11.7m in multi-line solutions was driven by greater than expected severity in auto, general, and excess liability lines of business, primarily from accident years 2020 to 2022.
- This adverse development was partially offset by favorable development in short-tail/monoline specialty lines.
- The favorable development was in the property line of business, primarily from accident years 2021 and 2022.
- During the year ended December 31, 2022, the Company’s net incurred losses for accident years 2021 and prior developed adversely by USD 33.8m.
- Adverse development of USD 20.2m in exited lines was due to:
- Losses previously subject to the LPT from accident years 2018 and prior.
- Increased frequency and severity in general and professional liability lines from accident years 2019 through 2021.
- Adverse development of USD 13.0m in multi-line solutions was driven by an increase in the frequency and severity of claims in commercial auto and general liability from accident years 2018 through 2021.
- Adverse development of USD 20.2m in exited lines was due to:
[c. 278; p. 16]
| ($ in thousands) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Reserves for losses and LAE, beginning of period | 1,314,501 | 1,141,757 | 979,549 |
| Less: reinsurance recoverable on unpaid claims, beginning of period | ( 455,484 ) | ( 435,986 ) | ( 381,338 ) |
| Reserves for losses and LAE, beginning of period, net of reinsurance | 859,017 | 705,771 | 598,211 |
| Incurred, net of reinsurance, related to: | — | — | — |
| Current period | 657,783 | 505,894 | 374,475 |
| Prior years | 25,728 | 10,770 | 33,849 |
| Total incurred, net of reinsurance | 683,511 | 516,664 | 408,324 |
| Paid, net of reinsurance, related to: | — | — | — |
| Current period | 136,731 | 109,937 | 105,928 |
| Prior years | 294,260 | 253,481 | 194,836 |
| Total paid | 430,991 | 363,418 | 300,764 |
| Net reserves for losses and LAE, end of period | 1,111,537 | 859,017 | 705,771 |
| Plus: reinsurance recoverable on unpaid claims, end of period | 670,846 | 455,484 | 435,986 |
| Reserves for losses and LAE, end of period | 1,782,383 | 1,314,501 | 1,141,757 |
Short Duration Contract Disclosures
[c. 279; p. 16] Losses and LAE reserves estimation
- Losses and LAE reserves represent the Company’s best estimate of the ultimate net cost of all reported and unreported losses that are unpaid as of the balance sheet dates.
- Estimated reserves for losses and LAE include accumulated estimates for claims reported and unpaid prior to the balance sheet dates.
- Estimated reserves for losses and LAE include estimates (based on projections of relevant historical data) of increases in claims costs for claims already reported.
- Estimated reserves for losses and LAE include estimates of claims incurred but not reported.
- Estimated reserves for losses and LAE include estimates of expenses for investigating and adjusting all incurred and unpaid claims.
- The Company measures claim counts by incident when determining the cumulative number of reported claims.
- Claim counts include all reported claims, even if the Company does not establish a liability for the claim (i.e., reserve for loss and loss adjustment expenses).
Short-tail/Monoline Specialty Lines
[c. 280; p. 16]
| ($ in thousands except number of claims) | |||||||
|---|---|---|---|---|---|---|---|
| Incurred Losses and Allocated Loss Adjustment Expense (“ALAE”), Net of Reinsurance | As of December 31, 2024 | ||||||
| Years Ended December 31, | Reported Claims | ||||||
| Accident Year | 2020* | 2021* | 2022* | 2023* | 2024 | IBNR | Reported Claims |
| 2020 | 56,141 | 55,324 | 55,420 | 55,305 | 55,305 | 1,147 | 1,311 |
| 2021 | — | 92,780 | 93,429 | 92,143 | 92,134 | 6,536 | 1,627 |
| 2022 | — | — | 108,299 | 105,394 | 104,095 | 15,316 | 2,383 |
| 2023 | — | — | — | 190,565 | 191,865 | 68,001 | 4,880 |
| 2024 | — | — | — | — | 280,147 | 161,230 | 4,502 |
| Total | — | — | — | — | 723,546 | — | — |
| Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | ( 359,673 ) | — | — |
| Net reserves for loss and ALAE before 2020 | Net reserves for loss and ALAE before 2020 | Net reserves for loss and ALAE before 2020 | Net reserves for loss and ALAE before 2020 | Net reserves for loss and ALAE before 2020 | 3,353 | — | — |
| Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | 367,226 | — | — |
| *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited |
| ($ in thousands) | |||||
|---|---|---|---|---|---|
| Cumulative Paid Losses and ALAE, Net of Reinsurance ($ in thousands) | |||||
| Years Ended December 31, | |||||
| Accident Year | 2020* | 2021* | 2022* | 2023* | 2024 |
| 2020 | 14,002 | 35,479 | 40,000 | 43,737 | 49,688 |
| 2021 | — | 18,447 | 56,803 | 67,912 | 78,439 |
| 2022 | — | — | 27,773 | 64,594 | 77,150 |
| 2023 | — | — | — | 33,795 | 100,705 |
| 2024 | — | — | — | — | 53,691 |
| Total | — | — | — | — | 359,673 |
| *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited |
Multi-line Solutions
[c. 281; p. 16]
| ($ in thousands except number of claims) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Incurred Losses and ALAE, Net of Reinsurance ($ in thousands) | As of December 31, 2024 | |||||||||||
| Accident Year | Years Ended December 31, | Reported Claims | ||||||||||
| Accident Year | 2015* | 2016* | 2017* | 2018* | 2019* | 2020* | 2021* | 2022* | 2023* | 2024 | IBNR | Reported Claims |
| 2015 | 103,191 | 114,266 | 117,024 | 117,024 | 119,216 | 114,863 | 115,863 | 116,413 | 116,413 | 117,955 | ( 834 ) | 5,386 |
| 2016 | — | 63,223 | 62,843 | 62,843 | 62,643 | 84,579 | 84,579 | 84,829 | 84,829 | 85,434 | 1,276 | 4,739 |
| 2017 | — | — | 65,332 | 65,332 | 64,260 | 78,166 | 78,166 | 78,766 | 78,766 | 80,493 | 2,105 | 5,588 |
| 2018 | — | — | — | 74,476 | 74,476 | 69,319 | 71,719 | 73,019 | 73,019 | 75,686 | 4,856 | 5,104 |
| 2019 | — | — | — | — | 107,432 | 109,226 | 112,378 | 115,530 | 116,230 | 116,206 | 3,918 | 6,119 |
| 2020 | — | — | — | — | — | 113,030 | 124,076 | 128,111 | 132,495 | 132,125 | 4,716 | 5,539 |
| 2021 | — | — | — | — | — | — | 156,067 | 158,891 | 160,331 | 160,546 | 16,119 | 6,702 |
| 2022 | — | — | — | — | — | — | — | 236,909 | 242,097 | 242,358 | 33,477 | 8,562 |
| 2023 | — | — | — | — | — | — | — | — | 306,511 | 306,511 | 132,772 | 8,180 |
| 2024 | — | — | — | — | — | — | — | — | — | 353,933 | 246,281 | 6,557 |
| Total | — | — | — | — | — | — | — | — | — | 1,671,247 | — | — |
| Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | ( 1,038,650 ) | — | — |
| Net reserves for loss and ALAE before 2015 | Net reserves for loss and ALAE before 2015 | Net reserves for loss and ALAE before 2015 | Net reserves for loss and ALAE before 2015 | Net reserves for loss and ALAE before 2015 | Net reserves for loss and ALAE before 2015 | Net reserves for loss and ALAE before 2015 | Net reserves for loss and ALAE before 2015 | Net reserves for loss and ALAE before 2015 | Net reserves for loss and ALAE before 2015 | ( 1,532 ) | — | — |
| Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | 631,065 | — | — |
| *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited |
| ($ in thousands) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Cumulative Paid Losses and ALAE, Net of Reinsurance ($ in thousands) | ||||||||||
| Years Ended December 31, | ||||||||||
| Accident Year | 2015* | 2016* | 2017* | 2018* | 2019* | 2020* | 2021* | 2022* | 2023* | 2024 |
| 2015 | 44,152 | 72,137 | 88,833 | 99,401 | 108,291 | 107,214 | 109,622 | 109,706 | 113,703 | 115,116 |
| 2016 | — | 23,239 | 42,528 | 53,352 | 58,895 | 69,691 | 72,544 | 75,855 | 77,160 | 77,760 |
| 2017 | — | — | 23,770 | 41,945 | 53,093 | 61,354 | 67,926 | 71,109 | 73,770 | 75,714 |
| 2018 | — | — | — | 26,201 | 42,568 | 47,226 | 58,655 | 65,635 | 69,893 | 70,128 |
| 2019 | — | — | — | — | 33,019 | 50,933 | 71,053 | 87,816 | 99,451 | 106,765 |
| 2020 | — | — | — | — | — | 29,499 | 60,680 | 82,236 | 105,283 | 121,097 |
| 2021 | — | — | — | — | — | — | 37,118 | 73,293 | 102,772 | 125,749 |
| 2022 | — | — | — | — | — | — | — | 50,148 | 114,794 | 165,854 |
| 2023 | — | — | — | — | — | — | — | — | 63,079 | 122,186 |
| 2024 | — | — | — | — | — | — | — | — | — | 58,281 |
| Total | — | — | — | — | — | — | — | — | — | 1,038,650 |
| *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited |
Exited Lines — all lines in runoff
[c. 282; p. 16] reconciliation of loss development tables
- The table presents the reconciliation of net incurred and paid loss development tables to balance sheet reserves for losses and loss adjustment expenses at December 31, 2024 and 2023.
- The following table sets forth the historical average annual payout of incurred losses and allocated loss adjustment expenses (claims duration) for short-duration contracts, based on disaggregated information in the paid loss development tables, net of reinsurance.
[c. 283; p. 16]
| ($ in thousands except number of claims) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Incurred Losses and ALAE, Net of Reinsurance ($ in thousands) | As of December 31, 2024 | |||||||||||
| Years Ended December 31, | Reported Claims | |||||||||||
| Accident Year | 2015* | 2016* | 2017* | 2018* | 2019* | 2020* | 2021* | 2022* | 2023* | 2024 | IBNR | Reported Claims |
| 2015 | 61,810 | 65,063 | 68,008 | 70,803 | 75,187 | 79,853 | 79,853 | 80,603 | 80,603 | 82,092 | 1,145 | 4,581 |
| 2016 | — | 93,019 | 92,996 | 91,372 | 93,577 | 97,301 | 98,301 | 100,651 | 100,651 | 102,801 | 959 | 4,893 |
| 2017 | — | — | 75,159 | 79,581 | 81,785 | 65,735 | 68,346 | 68,646 | 68,646 | 70,885 | 1,598 | 4,339 |
| 2018 | — | — | — | 74,357 | 68,990 | 76,506 | 79,006 | 84,165 | 84,165 | 92,082 | 5,586 | 4,910 |
| 2019 | — | — | — | — | 87,115 | 73,635 | 77,770 | 79,414 | 79,572 | 79,823 | 5,786 | 5,632 |
| 2020 | — | — | — | — | — | 132,248 | 136,469 | 137,835 | 137,907 | 137,671 | 11,424 | 4,828 |
| 2021 | — | — | — | — | — | — | 83,322 | 91,188 | 91,323 | 92,095 | 10,923 | 2,398 |
| 2022 | — | — | — | — | — | — | — | 12,717 | 12,240 | 11,800 | 902 | 234 |
| 2023 | — | — | — | — | — | — | — | — | — | — | — | 1 |
| 2024 | — | — | — | — | — | — | — | — | — | — | — | — |
| Total | — | — | — | — | — | — | — | — | — | 669,249 | — | — |
| Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | ( 597,904 ) | — | — |
| Net reserves for loss and ALAE before 2015 | Net reserves for loss and ALAE before 2015 | Net reserves for loss and ALAE before 2015 | Net reserves for loss and ALAE before 2015 | Net reserves for loss and ALAE before 2015 | Net reserves for loss and ALAE before 2015 | Net reserves for loss and ALAE before 2015 | Net reserves for loss and ALAE before 2015 | Net reserves for loss and ALAE before 2015 | Net reserves for loss and ALAE before 2015 | 15,344 | — | — |
| Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | 86,689 | — | — |
| *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited |
| ($ in thousands) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Cumulative Paid Losses and ALAE, Net of Reinsurance ($ in thousands) | ||||||||||
| Years Ended December 31, | ||||||||||
| Accident Year | 2015* | 2016* | 2017* | 2018* | 2019* | 2020* | 2021* | 2022* | 2023* | 2024 |
| 2015 | 9,026 | 41,653 | 55,610 | 65,269 | 73,100 | 78,249 | 80,077 | 80,923 | 82,188 | 83,290 |
| 2016 | — | 36,592 | 57,638 | 70,253 | 78,070 | 81,181 | 87,482 | 91,556 | 95,114 | 97,462 |
| 2017 | — | — | 34,176 | 52,103 | 51,985 | 50,545 | 57,457 | 62,924 | 66,498 | 68,480 |
| 2018 | — | — | — | 25,553 | 60,149 | 39,870 | 54,339 | 67,001 | 74,604 | 79,860 |
| 2019 | — | — | — | — | 28,636 | 28,954 | 30,948 | 45,696 | 57,341 | 65,847 |
| 2020 | — | — | — | — | — | 102,725 | 98,202 | 102,132 | 114,543 | 120,831 |
| 2021 | — | — | — | — | — | — | 41,540 | 57,820 | 66,012 | 72,923 |
| 2022 | — | — | — | — | — | — | — | 2,155 | 4,077 | 9,211 |
| 2023 | — | — | — | — | — | — | — | — | — | — |
| 2024 | — | — | — | — | — | — | — | — | — | — |
| Total | — | — | — | — | — | — | — | — | — | 597,904 |
| *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited |
| ($ in thousands) | 2024 | 2023 |
|---|---|---|
| Net reserves for losses and ALAE: | ||
| Short-tail/Monoline Specialty Lines | 367,226 | 235,191 |
| Multi-line Solutions | 631,065 | 485,099 |
| Exited Lines | 86,689 | 112,607 |
| Reserves for losses and ALAE, net of reinsurance | 1,084,980 | 832,897 |
| Reinsurance recoverable on unpaid claims: | — | — |
| Short-tail/Monoline Specialty Lines | 275,204 | 199,044 |
| Multi-line Solutions | 380,344 | 252,146 |
| Exited Lines | 15,298 | 4,294 |
| Total reinsurance recoverable on unpaid claims | 670,846 | 455,484 |
| Unallocated LAE | 26,557 | 26,120 |
| Reserves for losses and LAE at end of year | 1,782,383 | 1,314,501 |
| Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Years | ||||||||||
| 1* | 2* | 3* | 4* | 5* | 6* | 7* | 8* | 9* | 10* | |
| Short-Tail/Monoline Specialty Lines | 21.8% | 37.7% | 10.8% | 9.1% | 10.8% | N/A | N/A | N/A | N/A | N/A |
| Multi-line Solutions | 26.0% | 22.0% | 15.0% | 12.4% | 9.9% | 3.7% | 2.4% | 1.3% | 2.0% | 1.2% |
| Exited Lines | 29.6% | 17.1% | 8.1% | 9.7% | 9.2% | 7.8% | 4.2% | 2.4% | 1.9% | 1.3% |
| *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | — | — | — | — | — | — |
15. Commission and Fee Income
[c. 284; p. 16] Skyward Underwriters Agency, Inc. overview
- Skyward Underwriters Agency, Inc. (SUA) is a subsidiary of the Company.
- SUA functions as a managing general insurance agent and reinsurance broker.
- SUA specializes in property and casualty and accident and health risks within specialty niche markets.
- Commission and fee income is primarily generated from SUA for placing insurance policies with third-party insurance or reinsurance companies.
[c. 285; p. 16] Commission and fee income tables
- A table sets forth the Company’s disaggregated revenues from contracts with customers for the years ended December 31, 2024, 2023, and 2022.
- A table sets forth the Company’s opening and closing balances of contract assets from commission and fee income for the years ended December 31, 2024, 2023, and 2022.
[c. 286; p. 16]
| ($ in thousands) | 2024 | 2023 | 2022 |
|---|---|---|---|
| SUA commission revenue | 3,595 | 2,864 | 3,224 |
| SUA fee income | 2,928 | 2,732 | 1,597 |
| Other | 180 | 468 | 378 |
| Total commission and fee income | 6,703 | 6,064 | 5,199 |
| ($ in thousands) | Contract Assets |
|---|---|
| Balance at December 31, 2022 | 1,292 |
| Balance at December 31, 2023 | 976 |
| Balance at December 31, 2024 | 1,416 |
16. Underwriting, Acquisition and Insurance Expenses
[c. 287; p. 16] Underwriting, acquisition, and insurance expenses components
- The table sets forth the components of underwriting, acquisition, and insurance expenses for the years ended December 31, 2024, 2023, and 2022.
[c. 288; p. 16]
| ($ in thousands) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Amortization of policy acquisition costs | 149,975 | 108,514 | 65,695 |
| Other operating and general expenses | 161,782 | 134,930 | 116,476 |
| Total underwriting, acquisition and insurance expenses | 311,757 | 243,444 | 182,171 |
17. Reinsurance
[c. 289; p. 16] Reinsurance agreements and recoverables
- The Company uses reinsurance agreements to increase capacity for larger risks and manage exposure within its capital resources.
- The Company remains obligated for ceded amounts if reinsurers fail to meet their obligations.
- Tables detail the effects of reinsurance on written and earned premiums and losses and loss adjustment expenses for 2024, 2023, and 2022.
- A table outlines components of reinsurance recoverables and ceded unearned premium as of December 31, 2024, and December 31, 2023.
[c. 290; p. 16] Reinsurer trust accounts
- The Company has agreements with several reinsurers for funded trust accounts, with the Company as the sole beneficiary.
- These trust accounts provide additional security for collecting claim recoverables under reinsurance contracts.
- The Company does not carry these trust accounts on its balance sheet, as custody is only assumed if the reinsurer fails to pay amounts due.
- As of December 31, 2024, the market value of these accounts was approximately USD 196.9m.
- The trust amount is periodically adjusted by mutual agreement based on claim payments and loss reserve recoverables.
[c. 291; p. 16] LPT retroactive reinsurance agreement
- In Q1 2020, the Company entered into an LPT retroactive reinsurance agreement with R&Q.
- Reinsurance recoverable from R&Q was USD 22.7m at December 31, 2024, and USD 20.9m at December 31, 2023.
- The LPT was commuted effective January 31, 2025, and the Company received the full reinsurance recoverable balance.
[c. 292; p. 16] Deposit method accounting for ceded reinsurance
- Certain ceded reinsurance contracts that transfer only significant timing risk and insufficient underwriting risk are accounted for using the deposit method.
- The Company's deposit asset was USD 25.9m at December 31, 2024, and USD 29.9m at December 31, 2023.
- This deposit asset was included in other assets on the consolidated balance sheets.
[c. 293; p. 16]
| 2024 | 2023 | 2022 | ||||
|---|---|---|---|---|---|---|
| ($ in thousands) | Written | Earned | Written | Earned | Written | Earned |
| Direct premiums | 1,458,637 | 1,375,917 | 1,241,180 | 1,155,835 | 1,012,239 | 951,121 |
| Assumed premiums | 284,595 | 282,662 | 218,649 | 193,971 | 131,713 | 113,610 |
| Ceded premiums | ( 619,654 ) | ( 601,857 ) | ( 549,138 ) | ( 520,663 ) | ( 468,409 ) | ( 448,737 ) |
| Net premiums | 1,123,578 | 1,056,722 | 910,691 | 829,143 | 675,543 | 615,994 |
| Ceded losses and LAE incurred | — | 534,295 | — | 337,011 | — | 311,257 |
| ($ in thousands) | 2024 | 2023 |
|---|---|---|
| Ceded unpaid losses and LAE | 670,846 | 455,484 |
| Ceded paid losses and LAE | 166,663 | 122,287 |
| Loss portfolio transfer | 22,662 | 20,858 |
| Allowance for credit losses | ( 2,295 ) | ( 2,295 ) |
| Reinsurance recoverables | 857,876 | 596,334 |
| Ceded unearned premium | 203,901 | 186,121 |
18. Stock Based Compensation
[c. 294; p. 16] 2022 Long-Term Incentive Plan
- The Company's 2022 Long-Term Incentive Plan (the "2022 Plan") was approved by the Compensation Committee on September 23, 2022, and became effective on January 12, 2023.
- The 2022 Plan replaced the Company’s prior Long Term Incentive Plan (the "2020 Plan").
- The 2022 Plan allows for granting restricted stock, restricted stock units, performance stock units, stock options, and cash-based performance awards to select employees and non-employee directors.
- 3,200,656 shares of common stock were available for issuance under the 2022 Plan.
- In November 2024, the Compensation Committee approved a program allowing Board of Directors members to defer annual restricted stock unit awards to the fifth anniversary of the grant date, the tenth anniversary of the grant date, or the date of separation from the Company.
- This deferral program will be available for Directors who opt in for their 2025 grant.
[c. 295; p. 16] Stock options
- The grant date fair value of options under the 2022 Plan was determined using the Black-Scholes model, with a contractual term of 10 years less the weighted average service period.
- Volatility for the Black-Scholes model was based on historical volatility of comparable publicly traded insurance companies.
- Stock options granted to employees during the year ended December 31, 2023, were valued at approximately USD 4.4m based on grant date fair value.
- The aggregate intrinsic value of options outstanding was USD 27.0m at December 31, 2024, and USD 14.3m at December 31, 2023.
- The weighted-average remaining contractual life of options outstanding at December 31, 2024, was 8.0 years.
[c. 296; p. 16] Restricted stock awards and units
- The fair value of restricted stock and restricted stock units under the 2022 Plan for awards granted at the time of the Company’s IPO was the IPO price of USD 15.00 per share.
- The fair value of subsequent grants was equal to the closing stock price on the grant date.
- Expense for these equity-based incentives is based on fair value at grant date and amortized over their vesting period.
- Restricted stock and restricted stock units granted to employees and the Board of Directors were valued at approximately USD 8.5m in 2024, USD 17.7m in 2023, and USD 2.6m in 2022, based on grant date fair value.
- Board of Directors members were granted 19,453 shares in 2024, 23,482 shares in 2023, and 15,196 shares in 2022, with a service period of one year.
- The total fair value of shares vested for employees and Board of Directors members was USD 3.8m in 2024, USD 0.5m in 2023, and USD 2.2m in 2022.
[c. 297; p. 16] Unrecognized compensation cost and expense
- As of December 31, 2024, total unrecognized compensation cost related to non-vested, stock-based compensation awards was USD 13.9m.
- The weighted average period over which this cost is expected to be recognized is 1.4 years.
- The Company recognized stock-based compensation expense of USD 9.4m in 2024, USD 8.5m in 2023, and USD 2.3m in 2022.
[c. 298; p. 16] Employee Stock Purchase Plan (ESPP)
- The Company’s 2022 Employee Stock Purchase Plan (the "ESPP") was approved by the Compensation Committee on September 23, 2022, and became effective on May 15, 2023.
- Under the ESPP, employees can choose to have a percentage of their annual base earnings withheld to purchase common stock at two specified intervals each year.
- The purchase price is 85% of the lower of the beginning-of-interval or end-of-interval market price.
- 376,548 common shares have been reserved under the ESPP.
- The grant date fair value of options under the ESPP was determined using the Black-Scholes model, with a term of 6 months (length of time between grant date and exercisable date).
- Volatility for the ESPP Black-Scholes model was based on historical volatility of comparable publicly traded insurance companies.
- As of December 31, 2024, 95,266 shares had been purchased under the ESPP.
- The Company recognized ESPP expense of USD 0.5m in 2024 and USD 0.2m in 2023.
- As of December 31, 2024, the fair value of unrecognized ESPP expense was USD 0.3m.
[c. 299; p. 16]
| Award Payout Range | Requisite Service Period | Target Stock and Stock Units | |
|---|---|---|---|
| Year ended December 31, 2024 | |||
| Market condition awards | 0 %– 150 % | 3 years | 32,058 |
| Performance condition awards | 0 %– 150 % | 3 years | 76,881 |
| Service condition awards | N/A | 1 – 4 years | 124,025 |
| — | — | — | 232,964 |
| Year ended December 31, 2023 | — | — | — |
| Market condition awards | 0 %– 150 % | 3 years | 37,622 |
| Performance condition awards | 0 %– 150 % | 3 years | 95,456 |
| Service condition awards | N/A | 1 – 4 years | 968,778 |
| Stock options | N/A | 3 – 4 years | 759,990 |
| — | — | — | 1,861,846 |
| Year ended December 31, 2022 | — | — | — |
| Market condition awards | 0 %– 150 % | 3 years | 28,495 |
| Performance condition awards | 0 %– 150 % | 3 years | 26,210 |
| Service condition awards | N/A | 1 – 3 years | 144,137 |
| — | — | — | 198,842 |
| Stock | |
|---|---|
| Outstanding at January 1, 2024 | 759,990 |
| Outstanding at December 31, 2024 | 759,990 |
| Weighted-Average Exercise Price | Stock | |
|---|---|---|
| Outstanding at January 1, 2023 | — | |
| Granted | 15.00 | 759,990 |
| Outstanding at December 31, 2023 | — | 759,990 |
| Weighted-Average Grant-Date Fair Value | Stock and Stock Units | |
|---|---|---|
| Non-vested at January 1, 2024 | 15.13 | 1,445,449 |
| Granted (1) | 31.72 | 268,631 |
| Vested | 13.16 | ( 285,957 ) |
| Forfeited (2) | 18.27 | ( 102,640 ) |
| Non-vested at December 31, 2024 | 19.06 | 1,325,483 |
| Non-vested at January 1, 2023 | 12.55 | 419,896 |
| Granted (1) | 16.07 | 1,101,856 |
| Vested | 13.39 | ( 40,645 ) |
| Forfeited (2) | 15.29 | ( 35,658 ) |
| Non-vested at December 31, 2023 | 15.13 | 1,445,449 |
| Non-vested at January 1, 2022 | 13.23 | 375,643 |
| Granted (1) | 14.17 | 198,842 |
| Vested | 15.16 | ( 144,042 ) |
| Forfeited (2) | 12.51 | ( 10,547 ) |
| Non-vested at December 31, 2022 | 12.55 | 419,896 |
[c. 300; p. 16] Earnings per share calculation basis
- The table presents the compilation of basic and diluted net earnings per share for the years ended December 31, 2024, 2023, and 2022.
- The Company's preferred shares are participating securities, sharing in dividends and distributions with common stock on an as-converted basis.
- Instruments granted to employees that allow the purchase of common stock at a fixed price were included as potential common shares, weighted for the portion of the period they were granted, if dilutive.
- The table presents anti-dilutive instruments excluded from the calculation of diluted weighted-average common share equivalents for the years ended December 31, 2024, 2023, and 2022.
- The table presents common share equivalents of contingently issuable instruments excluded from basic earnings per share for the years ended December 31, 2024, 2023, and 2022.
[c. 301; p. 16]
| ($ in thousands, except for share and per share amounts) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Numerator | |||
| Net income | 118,828 | 85,984 | 39,396 |
| Less: Undistributed income allocated to participating securities | — | ( 1,677 ) | ( 18,879 ) |
| Net income attributable to common stockholders (numerator for basic earnings per share) | 118,828 | 84,307 | 20,517 |
| Add back: Undistributed income allocated to participating securities | — | 1,677 | 18,879 |
| Net income (numerator for diluted earnings per share under the two-class method) | 118,828 | 85,984 | 39,396 |
| Denominator | — | — | — |
| Basic weighted-average common shares | 40,056,475 | 36,031,907 | 16,568,393 |
| Dilutive effect of preferred shares | — | 716,708 | 15,245,533 |
| Dilutive effect of stock notes | — | 696,110 | 519,080 |
| Dilutive effect of stock units | 917,510 | 736,837 | 320,188 |
| Dilutive effect of options | 403,475 | 135,972 | — |
| Diluted weighted-average common share equivalents | 41,377,460 | 38,317,534 | 32,653,194 |
| Basic earnings per share | 2.97 | 2.34 | 1.24 |
| Diluted earnings per share | 2.87 | 2.24 | 1.21 |
| 2024 | 2023 | 2022 | |
|---|---|---|---|
| Stock Notes | — | — | 60,576 |
| Stock units | 20,346 | 3,931 | — |
| Options | 859 | 914 | — |
| 2024 | 2023 | 2022 | |
|---|---|---|---|
| Common shares | — | 920,864 | 22,919 |
| Preferred shares, if converted | — | — | 1,059,602 |
| Total | — | 920,864 | 1,082,521 |
20. Employee Benefit Plan
[c. 302; p. 16] 401(k) plan contributions
- The Company sponsors the 401(k) Plan (the "Plan"), available to substantially all employees.
- The Plan is subject to the Employee Retirement Income Security Act of 1974.
- The Company makes discretionary matching contributions to the Plan.
- Company matching contributions to the Plan were USD 3.2m in 2024, USD 2.9m in 2023, and USD 2.4m in 2022.
RISCOM
[c. 303; p. 16] RISCOM relationship and transactions
- RISCOM provides wholesale brokerage services to the Company.
- RISCOM and the Company have a managing general agency agreement.
- The Company holds a 20% ownership interest in RISCOM.
- Net earned premium and gross commission expense related to these agreements for the years ended December 31, 2024, 2023, and 2022 were as follows.
- Premiums receivable as of December 31, 2024, were USD 12.6m.
- Premiums receivable as of December 31, 2023, were USD 10.6m.
[c. 304; p. 16]
| ($ in thousands) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net earned premium | 108,130 | 99,736 | 91,051 |
| Commissions | 25,372 | 24,177 | 23,472 |
Other
[c. 305; p. 16] Advisory and professional services fees
- Advisory and professional services fees and expense reimbursements paid to affiliated stockholders and directors were USD 0.6m in 2024, USD 3.6m in 2023, and USD 3.4m in 2022.
[c. 306; p. 16] Related party transactions references
- Notes 5, 6, and 10 provide information on investments involving affiliated companies and additional related party transactions.
- Note 11 details related party transactions concerning the Company’s common and preferred shares.
Litigation
[c. 307; p. 16] legal actions and reserves
- The Company is a defendant in various legal actions arising from claims under insurance policies and contracts.
- These actions are considered when estimating losses and loss adjustment expense reserves.
- The Company is also a defendant in legal actions related to bad faith claims, disputes with third parties, or alleged errors and omissions.
- Accruals for these items are recorded when losses are probable and reasonably estimable.
- Based on present information, available insurance coverage, and advice from outside legal counsel, the Company believes the resolution of these matters will not, individually or in aggregate, materially adversely affect its consolidated financial position, results of operations, or cash flows.
Indemnification
[c. 308; p. 16] Indemnification for asset sales
- The Company has provided indemnifications to certain buyers in conjunction with the sale of business assets and subsidiaries.
- Certain indemnifications cover typical representations and warranties related to responsibilities under sales contracts.
- The potential exposure from these indemnifications is difficult to determine due to the variety of matters, operations, and scenarios covered.
- Some indemnifications have no time limit.
- The Company currently believes no significant claims exist related to these indemnifications.
23. Statutory Accounting Principles and Regulatory Matters
[c. 309; p. 16] Statutory financial performance
- Statutory net income: USD 108.2m for 2024; USD 73.1m for 2023; USD 50.5m for 2022.
- Statutory capital and surplus: USD 710.6m as of December 31, 2024; USD 602.9m as of December 31, 2023.
[c. 310; p. 16] Insurance subsidiary restructuring
- Effective December 31, 2024, the Company restacked its insurance company subsidiaries, making GMIC the lead insurance company.
- HSIC became a wholly owned subsidiary of GMIC.
- IIC became a wholly owned subsidiary of HSIC.
- OSIC became a wholly owned subsidiary of IIC.
[c. 311; p. 16] Dividend restrictions and payments
- Dividend payments to the Company from GMIC are restricted by Texas state law regarding amounts payable without regulatory approval.
- Maximum dividend amount payable by GMIC without prior approval is subject to restrictions related to policyholder surplus, net income, and dividends declared/distributed in the preceding 12 months.
- As of December 31, 2024, GMIC is not restricted from paying ordinary dividends.
- GMIC did not declare or pay any dividend during the year ended December 31, 2024.
- HSIC did not declare or pay any dividends during the year ended December 31, 2023.
[c. 312; p. 16] Risk Based Capital requirements
- Property and casualty insurance companies are subject to Risk Based Capital (RBC) requirements specified by the National Association of Insurance Commissioners (NAIC).
- RBC requirements determine the amount of capital and surplus based on various risk factors.
- As of December 31, 2024, GMIC’s statutory capital and surplus substantially exceeded regulatory requirements.
- As of December 31, 2023, HSIC’s statutory capital and surplus substantially exceeded regulatory requirements.
24. Subsequent Events
[c. 313; p. 16] Skyward Re commutation with R&Q
- On January 31, 2025, Skyward Re commuted its existing Loss Portfolio Transfer and Adverse Development and Retrocession Agreement, dated April 1, 2020, with R&Q via a Commutation Agreement.
- Skyward Re received USD 11.7m in cash from the commutation.
- At December 31, 2024, the Company strengthened LPT loss reserves and increased the paid loss reinsurance recoverable by USD 25.3m.
- At December 31, 2024, the Company increased the allowance for estimated uncollectible reinsurance by USD 13.6m, which was subsequently written-off during the year ended December 31, 2024.
- At December 31, 2024, the Company recognized a deferred gain of USD 2.0m.
Controls and Procedures
Evaluation of Disclosure Controls and Procedures
[c. 314; p. 17] Disclosure controls and procedures evaluation
- Management, including the principal executive officer and principal financial officer, evaluated the effectiveness of disclosure controls and procedures as of the end of the period covered by the Annual Report on Form 10-K.
- As of December 31, 2024, the disclosure controls and procedures were concluded to be not effective due to a material weakness in internal control over financial reporting.
- Despite the identified material weakness, management does not believe it adversely affected reported operating results or financial condition.
- Management determined that the financial statements and other information in the report and other periodic filings fairly present the financial condition, results of operations, and cash flows for the periods presented in accordance with U.S. GAAP.
Management’s Report on Internal Control over Financial Reporting
[c. 315; p. 17] Internal Control over Financial Reporting
- Management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934.
- Internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles in the United States of America.
- Internal control over financial reporting includes policies and procedures that pertain to the maintenance of records that accurately and fairly reflect transactions and dispositions of assets.
- Internal control over financial reporting includes policies and procedures that provide reasonable assurance that transactions are recorded as necessary for financial statement preparation in accordance with GAAP, and that receipts and expenditures are made only with management and director authorizations.
- Internal control over financial reporting includes policies and procedures that provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of assets that could materially affect financial statements.
[c. 316; p. 17] Material Weakness in Internal Control
- Management assessed the effectiveness of internal control over financial reporting as of December 31, 2024, using criteria from the COSO Internal Control—Integrated Framework (2013).
- As of December 31, 2024, management concluded that internal control over financial reporting was not effective due to a material weakness.
- A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting that creates a reasonable possibility of a material misstatement in annual or interim financial statements not being prevented or detected timely.
- The material weakness as of December 31, 2024, related to the ineffective implementation of information technology general controls (ITGCs) in user access for systems supporting the Company’s financial reporting processes.
- Related process-level IT dependent manual and automated controls relying on affected ITGCs, or information from IT systems with affected ITGCs, were also deemed ineffective.
- This material weakness did not result in any material misstatements to the financial statements in this Form 10-K.
- No changes were identified as required for previously issued financial statements.
- Substantive procedures for the year ended December 31, 2024, have been completed.
- Management believes consolidated financial statements in this Form 10-K have been prepared in accordance with U.S. GAAP.
- The CEO and CFO certified that, to their knowledge, the financial statements and other financial information in this Form 10-K fairly present in all material respects the financial condition, results of operations, and cash flows for the periods presented.
- Ernst & Young LLP issued an unqualified opinion on the financial statements, included in Item 8 of this Form 10-K.
- Ernst & Young LLP also issued a report on internal control over financial reporting as of December 31, 2024, which appears in Item 8.
Planned Material Weakness Remediation Activities
[c. 317; p. 17] Material weakness remediation activities
- Management is implementing measures to remediate control deficiencies contributing to the material weakness related to the design of ITGCs in user access over certain information technology.
- Remediation actions include enhancing the IT compliance oversight function and expanding the team with experience in designing and implementing ITGCs.
- A training program addressing ITGCs and policies is being developed and implemented, including educating control owners on control principles and requirements.
- Documentation underlying ITGCs is being developed and maintained to promote knowledge transfer during IT personnel and function changes.
- An IT management review and testing plan is being implemented to monitor ITGCs.
- Enhanced quarterly reporting on remediation measures is provided to the Audit Committee of the board of directors.
Changes in Internal Control over Financial Reporting
[c. 318; p. 17] Internal control over financial reporting
- No changes in internal control over financial reporting occurred during the year ended December 31, 2024, except for those related to the identified material weakness.
- These changes have not materially affected, nor are they reasonably likely to materially affect, the company's internal control over financial reporting.
Limitations on Effectiveness of Controls and Procedures
[c. 319; p. 17] Limitations of disclosure controls
- Management acknowledges that disclosure controls and procedures, regardless of design and operation, can only offer reasonable assurance of achieving control objectives.
- The design of disclosure controls and procedures must consider resource constraints and require management to exercise judgment in weighing the benefits against the costs of potential controls.
Other Information
[c. 320; p. 18] Director and officer trading arrangements
- During the quarter ended December 31, 2024, none of the directors or officers (as defined in Rule 16a-1(f) of the Securities Exchange Act of 1934) adopted, terminated, or modified a Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement (as defined in Item 408 of Regulation S-K).
Directors, Executive Officers and Corporate Governance
[c. 321; p. 19] Information incorporation by reference
- Information required by Item 10 of Form 10-K will be included in the 2025 Proxy Statement and is incorporated by reference.
Executive Compensation
[c. 322; p. 20] Executive compensation disclosure
- Information required by Item 11 of Form 10-K will be included in the 2025 Proxy Statement and is incorporated by reference.
Security Ownership of Certain Beneficial Owner and Management and Related Stockholder Matters
[c. 323; p. 21] Information incorporation by reference
- The information required by Item 12 of Form 10-K will be included in the 2025 Proxy Statement and is incorporated by reference.
Certain Relationships and Related Transactions, and Director Independence
[c. 324; p. 22] Information incorporation by reference
- The information required by Item 13 of Form 10-K will be included in the 2025 Proxy Statement and is incorporated herein by reference.
Principal Accounting Fees and Services
[c. 325; p. 23] independent registered public accounting firm
- Our independent registered public accounting firm is Ernst & Young LLP, Houston, Texas.
- Auditor Firm ID: 42.
- The information required by Item 14 of Form 10-K will be included in our 2025 Proxy Statement and is incorporated herein by reference.
Exhibits, Financial Statement Schedules.
[c. 326; p. 24] Financial Statements Listing
- The consolidated financial statements of the Company are filed as part of Form 10-K and included in Item 8.
- Reports of Independent Registered Public Accounting Firm are included.
- Consolidated Balance Sheets as of December 31, 2024 and 2023 are included.
- Consolidated Statements of Operations and Comprehensive Income (loss) for the three years ended December 31, 2024, 2023, and 2022 are included.
- Consolidated Statements of Stockholders’ Equity for the three years ended December 31, 2024, 2023, and 2022 are included.
- Consolidated Statements of Cash Flows for the three years ended December 31, 2024, 2023, and 2022 are included.
[c. 327; p. 24] Exhibits Listing
- A listing of exhibits is provided.
- Exhibits marked with an asterisk are filed herewith.
- Management contracts or compensatory plans or arrangements are included.
[c. 328; p. 24]
| Schedule Number | Schedule Description | Page |
|---|---|---|
| I. | Summary of Investments — Other Than in Related Parties at December 31, 2024 | 103 |
| II. | Financial Information of Registrant (Parent Company) for the years ended December 31, 2024, 2023 and 2022 | 104 |
| IV. | Supplementary Reinsurance Information for the years ended December 31, 2024, 2023, and 2022 | 108 |
| V. | Valuation and Qualifying Accounts for the years ended December 31, 2024, 2023, and 2022 | 109 |
| VI. | Supplementary Information Concerning Property — Casualty Insurance Operations for the years ended December 31, 2024, 2023, and 2022 | 110 |
| Exhibit Number | Exhibit Description |
|---|---|
| 3.1 | Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K filed with the Commission on January 18, 2023). |
| 3.2 | Amended and Restated Bylaws (incorporated by reference to Exhibit 3.2 to the Company's Current Report on Form 8-K filed with the Commission on January 18, 2023). |
| 4.1 | Amended and Restated Stockholders’ Agreement, dated March 12, 2014, by and among the Company and the stockholders listed therein (incorporated by reference to Exhibit 4.1 to the Company's Registration Statement on Form S-1, filed with the SEC on November 14, 2022). |
| 4.2 | Description of Capital Stock (incorporated by reference to Exhibit 4.2 to the Company’s Annual Report on Form 10-K, filed with the SEC on March 28, 2023). |
| 10.1+ | Share Purchase and Award Agreement and form of agreements thereunder in use before 2016 (incorporated by reference to Exhibit 10.1 to the Company's Registration Statement on Form S-1, filed with the SEC on November 14, 2022). |
| 10.2+ | 2016 Equity Incentive Program and form of award agreements thereunder (incorporated by reference to Exhibit 10.2 to the Company's Registration Statement on Form S-1, filed with the SEC on November 14, 2022). |
| 10.3+ | 2020 Long Term Incentive Plan and form of award agreements thereunder (incorporated by reference to Exhibit 10.3 to the Company's Registration Statement on Form S-1, filed with the SEC on November 14, 2022). |
| 10.4+ | Skyward Specialty Insurance Group, Inc. 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.4 to the Company's Registration Statement on Form S-1, filed with the SEC on November 14, 2022). |
| 10.5+ | Skyward Specialty Insurance Group, Inc. 2022 Employee Stock Purchase Plan (incorporated by reference to Exhibit 10.5 to the Company's Registration Statement on Form S-1, filed with the SEC on November 14, 2022). |
| 10.6+ | Form of Restricted Stock Units Agreement and form of notice under the Company's 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 99.6 to the Company's Registration Statement on Form S-8, filed with the SEC on January 12, 2023). |
| Exhibit Number | Exhibit Description |
|---|---|
| 10.7+ | Form of Restricted Stock Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 99.7 to the Company's Registration Statement on Form S-8, filed with the SEC on January 12, 2023). |
| 10.8+ | Form of Nonstatutory Stock Option Agreement and form of notice under the Company's 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 99.8 to the Company's Registration Statement on Form S-8, filed with the SEC on January 12, 2023). |
| 10.9+ | Form of Incentive Stock Option Agreement and form of notice under the Company's 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 99.9 to the Company's Registration Statement on Form S-8, filed with the SEC on January 12, 2023). |
| 10.10+ | Form of Performance-Based Restricted Stock Units Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.10 to the Company’s Annual Report on Form 10-K, filed with the SEC on March 28, 2023). |
| 10.11+ | Performance-Based Restricted Stock Units Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.11 to the Company’s Annual Report on Form 10-K, filed with the SEC on March 28, 2023). |
| 10.12+ | Performance Unit Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.12 to the Company’s Annual Report on Form 10-K, filed with the SEC on March 28, 2023). |
| 10.13+ | Amended Form of Performance Share (GBVPS) Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.13 to the Company’s Annual Report on Form 10-K, filed with the SEC on April 1, 2024). |
| 10.14+ | Amended Form of Performance Share (Executives) Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.14 to the Company’s Annual Report on Form 10-K, filed with the SEC on April 1, 2024). |
| 10.15+ | Amended Form of Performance Share (Others) Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.15 to the Company’s Annual Report on Form 10-K, filed with the SEC on April 1, 2024). |
| 10.16+ | Amended Form of Performance Cash Units Agreement under the Company’s Long-Term Incentive Plan. (incorporated by reference to Exhibit 10.16 to the Company’s Annual Report on Form 10-K, filed with the SEC on April 1, 2024). |
| 10.17+ | Amended Form of the Restricted Stock Unit (Executives) Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.17 to the Company’s Annual Report on Form 10-K, filed with the SEC on April 1, 2024). |
| 10.18+ | Amended Form of Restricted Stock Unit (Others) Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.18 to the Company’s Annual Report on Form 10-K, filed with the SEC on April 1, 2024). |
| 10.19+ | Amended Form of Long-Term Performance Cash Plan and Award Letter under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.19 to the Company’s Annual Report on Form 10-K, filed with the SEC on April 1, 2024). |
| 10.20+ | Form of Indemnification Agreement (incorporated by reference to Exhibit 10.6 to the Company's Registration Statement on Form S-1, filed with the SEC on November 14, 2022). |
| 10.21+ | Employment Agreement, dated May 22, 2020, by and between the Registrant and Andrew Robinson, with Amendment No. 1 dated January 1, 2022 (incorporated by reference to Exhibit 10.7 to the Company's Registration Statement on Form S-1, filed with the SEC on November 14, 2022). |
| 10.22+* | Form of Non-Employee Director Deferred Restricted Stock Unit Agreement and Form of Notice Under the Company’s 2022 Long-Term Incentive Plan. |
| 10.23 | Commutation and Release Agreement by and among R&Q Re (Bermuda) Ltd., Skyward Re, Houston Specialty Insurance Company, Imperium Insurance Company, and Great Midwest Insurance Company, dated January 31, 2025 (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the Commission on February 5, 2025). |
| 10.24 | Investment Management Agreement by and among Arena Investors, LP, Houston Specialty Insurance Company, Imperium Insurance Company, and Great Midwest Insurance Company, dated November 6, 2015, with a Supplemental Acknowledgement dated January 13, 2016, a Supplemental Acknowledgement dated May 17, 2021, Supplemental Acknowledgement B dated May 17, 2021, an Amendment Agreement effective March 15, 2022, and a Supplemental Acknowledgement dated March 23, 2022 (incorporated by reference to Exhibit 10.15 to the Company's Registration Statement on Form S-1, filed with the SEC on November 14, 2022). |
| Exhibit Number | Exhibit Description |
|---|---|
| 10.25 | Second Amendment Agreement effective as of December 8, 2023, to that certain Investment Management Agreement dated November 6, 2015, by and among Arena Investors, LP, Houston Specialty Insurance Company, Imperium Insurance Company, and Great Midwest Insurance Company (incorporated by reference to Exhibit 10.26 to the Company’s Annual Report on Form 10-K, filed with the SEC on April 1, 2024). |
| 10.26 | Credit Agreement, dated March 29, 2023, by and among Skyward Specialty Insurance Group, Inc., the lenders from time to time party thereto and Truist Bank, as administrative agent (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the Commission on April 3, 2023). |
| 10.27 | First Amendment dated as of February 26, 2024, to that certain Credit Agreement, dated March 29, 2023, by and among Skyward Specialty Inc., the lenders from time to time party thereto and Truist Bank, as administrative agent (incorporated by reference to Exhibit 10.28 to the Company’s Annual Report on Form 10-K, filed with the SEC on April 1, 2024). |
| 10.28 | Guaranty Agreement, dated March 29, 2023, by and among Skyward Service Company, Skyward Underwriters Agency, Inc., the loan parties identified on the signature pages thereto and Truist Bank. (incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K filed with the Commission on April 3, 2023). |
| 10.29 | Advances and Security Agreement, dated August 1, 2024, by and between Houston Specialty Insurance Company, a wholly owned insurance company subsidiary of the Company and the Federal Home Loan Bank of Dallas (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the Commission on September 6, 2024). |
| 10.30+* | Form of Severance Agreement between the Company and executive officers (other than the CEO) |
| 10.31+* | Amendment No. 2 to Employment Agreement between the Registrant and Andrew Robinson dated March 1, 2025 . |
| 19* | Skyward Specialty Insurance Securities Trading Policy |
| 21.1* | List of Subsidiaries of the Company |
| 23.1 | Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm. |
| 31.1 | Certification of Principal Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| 31.2 | Certification of Principal Financial and Accounting Officer pursuant to Rule 13a 14(a) or Rule 15d 14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| 32.1 | Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
| 97 | Policy for Recovery of Erroneously Awarded Incentive Compensation (“Clawback Policy”) (incorporated by reference to Exhibit 97 to the Company’s Annual Report on Form 10-K, filed with the SEC on April 1, 2024). |
| 101.INS | Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document. |
| 101.SCH | Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents |
| 104 | Cover Page Interactive Date File (embedded within the Inline XBRL document) |
[c. 329; p. 24]
| ($ in thousands) | Cost | Fair Value (if applicable) | Amount on Balance Sheet |
|---|---|---|---|
| December 31, 2024 | |||
| Fixed maturity securities, available for sale: | |||
| U.S. government securities | 26,577 | 26,486 | 26,486 |
| Corporate securities and miscellaneous | 433,298 | 425,628 | 425,628 |
| Municipal securities | 89,966 | 84,716 | 84,716 |
| Residential mortgage-backed securities | 408,585 | 393,833 | 393,833 |
| Commercial mortgage-backed securities | 70,262 | 69,364 | 69,364 |
| Other asset-backed securities | 291,578 | 292,191 | 292,191 |
| Total fixed maturity securities, available for sale | 1,320,266 | 1,292,218 | 1,292,218 |
| Fixed maturity securities, held to maturity: | — | — | — |
| Other asset-backed securities | 39,396 | 38,717 | 39,153 |
| Total fixed maturity securities, held to maturity | 39,396 | 38,717 | 39,153 |
| Equity securities: | — | — | — |
| Common stocks | 48,530 | 64,251 | 64,251 |
| Preferred stocks | 1,138 | 1,164 | 1,164 |
| Mutual funds | 33,643 | 40,839 | 40,839 |
| Total equity securities | 83,311 | 106,254 | 106,254 |
| Mortgage loans | 26,485 | 26,490 | 26,490 |
| Other long-term investments | 33,231 | 33,182 | 33,182 |
| Short-term investments | 274,926 | 274,929 | 274,929 |
| Total | 1,777,615 | 1,771,790 | 1,772,226 |
Balance sheets (parent company)
[c. 330; p. 24] Financial statement notes
- See accompanying notes to financial statements.
[c. 331; p. 24]
| December 31, | ||
|---|---|---|
| ($ in thousands) | 2024 | 2023 |
| Assets | ||
| Investments: | ||
| Investment in subsidiaries | 853,670 | 743,025 |
| Short-term investments, at fair value | 14,000 | 10,593 |
| Total investments | 867,670 | 753,618 |
| Cash and cash equivalents | 2,943 | 3,024 |
| Deferred income taxes | 30,486 | 5,899 |
| Goodwill and intangible assets, net | 12,641 | 12,641 |
| Other assets | 2,905 | 15,908 |
| Total assets | 916,645 | 791,090 |
| Liabilities and Stockholders’ Equity | — | — |
| Liabilities: | — | — |
| Accounts payable and accrued liabilities | 3,110 | 1,369 |
| Notes payable | 100,000 | 50,000 |
| Subordinated debt, net of debt issuance costs | 19,536 | 78,690 |
| Total liabilities | 122,646 | 130,059 |
| Stockholders’ Equity: | — | — |
| Stockholders’ equity | 793,999 | 661,031 |
| Total liabilities and stockholders’ equity | 916,645 | 791,090 |
(parent company)
[c. 332; p. 24] Financial statement notes
- See accompanying notes to financial statements.
[c. 333; p. 24]
| Years Ended December 31, | |||
|---|---|---|---|
| ($ in thousands) | 2024 | 2023 | 2022 |
| Revenues: | |||
| Net investment income | 3,212 | 3,822 | 2,567 |
| Net investment (losses) gains | 963 | ( 963 ) | ( 6 ) |
| Other loss | ( 2 ) | ( 27 ) | — |
| Total revenues | 4,173 | 2,832 | 2,561 |
| Expenses | — | — | — |
| Operating expenses | 10,632 | — | — |
| Interest expense | 8,140 | 9,815 | 6,407 |
| Amortization expense | 920 | 313 | 81 |
| Other expenses | 9,646 | 451 | — |
| Total expenses | 29,338 | 10,579 | 6,488 |
| Loss before income tax expense | ( 25,165 ) | ( 7,747 ) | ( 3,927 ) |
| Income tax expense | 33,578 | 6,808 | ( 1,209 ) |
| Loss before equity in earnings of subsidiaries | ( 58,743 ) | ( 14,555 ) | ( 2,718 ) |
| Equity in undistributed earnings of subsidiaries | 177,571 | 100,539 | 42,114 |
| Net income | 118,828 | 85,984 | 39,396 |
Schedule ii — statements of cash flows (parent company)
[c. 334; p. 24] Financial statement notes
- See accompanying notes to financial statements.
[c. 335; p. 24]
| Years Ended December 31, | |||
|---|---|---|---|
| ($ in thousands) | 2024 | 2023 | 2022 |
| Cash flows from operating activities: | |||
| Net income | 118,828 | 85,984 | 39,396 |
| Adjustments to reconcile net income to net cash used in operating activities | ( 121,563 ) | ( 95,947 ) | ( 42,672 ) |
| Net cash provided by operating activities | ( 2,735 ) | ( 9,963 ) | ( 3,276 ) |
| Cash flows from investing activities: | — | — | — |
| Capital contributions to subsidiaries | — | ( 122,800 ) | — |
| Distributions from investment in subsidiaries | 8,500 | 6,500 | 4,000 |
| Change in short-term investments | ( 3,407 ) | ( 10,569 ) | — |
| Net cash (used in) provided by investing activities | 5,093 | ( 126,869 ) | 4,000 |
| Cash flows from financing activities: | — | — | — |
| Repayment of stock notes receivable | 5,561 | 1,350 | 2,180 |
| Proceeds from long term borrowings | 107,000 | 50,000 | — |
| Payments on long term borrowings and trust preferred | ( 115,000 ) | ( 50,000 ) | — |
| Proceeds from equity offerings | — | 128,887 | — |
| Proceeds from employee stock purchase plan | — | 710 | — |
| Net cash provided by financing activities | ( 2,439 ) | 130,947 | 2,180 |
| Net increase (decrease) in cash and cash equivalents and restricted cash | ( 81 ) | ( 5,885 ) | 2,904 |
| Cash and cash equivalents and restricted cash at beginning of year | 3,024 | 8,909 | 6,005 |
| Cash and cash equivalents and restricted cash at end of year | 2,943 | 3,024 | 8,909 |
| Supplemental disclosure of cash flow information: | — | — | — |
| Cash paid for interest | 8,573 | 10,667 | 5,761 |
| Cash paid for federal income taxes | 36,980 | 15,800 | — |
Notes to Financial Statements
[c. 336; p. 24] Intercompany loan
- Skyward Specialty entered into an Intercompany Loan Promissory Note with Houston Specialty Insurance Company (HSIC) on September 30, 2024.
- Skyward Specialty borrowed USD 57.0m from HSIC under the Promissory Note.
- Interest on the Promissory Note is payable monthly at a fixed annual rate of 4.00%.
- The principal of the Promissory Note is due at maturity.
- There are no prepayment penalties and no collateral was given for the Promissory Note.
[c. 337; p. 24] Subsidiary funding
- During the year ended December 31, 2024, Skyward Specialty provided funds for a new subsidiary, Skyward Specialty No. 1 Limited Company.
- Skyward Specialty No. 1 Limited Company is a UK company authorized as a Lloyd’s corporate member to invest in Lloyd’s syndicates.
Financial Instruments Disclosed, But Not Carried, At Fair Value
[c. 338; p. 24] Promissory Note Fair Value
- The Promissory Note between Skyward Specialty and HSIC is included in notes payable.
- Skyward Specialty determined the fair value of the Promissory Note using the income approach with observable inputs.
- The Promissory Note is classified as Level 2 in the fair value hierarchy.
- As of December 31, 2024, the carrying value of the Promissory Note was USD 57.0m, and its fair value was USD 56.3m.
Schedule iv — reinsurance
[c. 339; p. 24]
| Years Ended December 31, | ||||||
|---|---|---|---|---|---|---|
| 2024 | 2023 | 2022 | ||||
| ($ in thousands) | Accident & Health | Property & Casualty | Accident & Health | Property & Casualty | Accident & Health | Property & Casualty |
| Gross amount | 173,073 | 1,285,564 | 151,702 | 1,089,478 | 130,377 | 881,862 |
| Ceded to other companies | ( 86,503 ) | ( 533,151 ) | ( 79,091 ) | ( 470,047 ) | ( 70,291 ) | ( 398,118 ) |
| Assumed from other companies | — | 284,595 | — | 218,649 | 431 | 131,282 |
| Net amount | 86,570 | 1,037,008 | 72,611 | 838,080 | 60,517 | 615,026 |
| Percentage of amount assumed to net | —% | 27.4% | —% | 26.1% | 0.7% | 21.3% |
Schedule V — valuation and qualifying accounts
[c. 340; p. 24]
| ($ in thousands) | Valuation Allowance For Deferred Tax Assets | Allowance for Uncollectible Reinsurance Recoverable | Allowance for Uncollectible Premiums Receivable |
|---|---|---|---|
| Balance at January 1, 2022 | 586 | — | 261 |
| Charged to costs and expenses | — | 584 | |
| Amounts written off | — | ( 216 ) | |
| Balance at December 31, 2022 | 586 | — | 629 |
| Cumulative effect of adoption of ASU 2016-13 at January 1, 2023 | — | 2,295 | — |
| Charged to costs and expenses | — | — | 748 |
| Amounts written off | — | — | ( 513 ) |
| Recoveries of amounts previously written off | — | — | 100 |
| Balance at December 31, 2023 | 586 | 2,295 | 964 |
| Charged to costs and expenses | — | 13,585 | 3,235 |
| Amounts written off | — | ( 13,585 ) | ( 1,895 ) |
| Recoveries of amounts previously written off | — | — | 128 |
| Balance at December 31, 2024 | 586 | 2,295 | 2,432 |
Insurance operations
[c. 341; p. 24]
| As of and Years Ended December 31, | |||
|---|---|---|---|
| ($ in thousands) | 2024 | 2023 | 2022 |
| Deferred policy acquisition costs | 113,183 | 91,955 | 68,938 |
| Reserve for losses and loss adjustment expenses | 1,782,383 | 1,314,501 | 1,141,757 |
| Unearned premiums | 637,185 | 552,532 | 442,509 |
| Net earned premium (1) | 1,056,722 | 829,143 | 615,994 |
| Net investment income | 80,686 | 40,322 | 36,931 |
| Losses and loss adjustment expenses (current year) (1) | 657,783 | 516,664 | 393,939 |
| Losses and loss adjustment expenses (prior years) (1)(2) | 25,728 | — | 14,385 |
| Amortization of policy acquisition costs (1) | 149,975 | 108,514 | 65,695 |
| Paid claims and claim adjustment expenses (1) | 430,991 | 363,418 | 300,764 |
| Net premiums written (1) | 1,123,578 | 910,691 | 675,543 |
| Ceded unearned premium | 203,901 | 186,121 | 157,645 |
| Deferred ceding commission | 40,434 | 37,057 | 29,849 |
SIGNATURES
[c. 342; p. 24] Report signing authorization
- The report was signed on behalf of the registrant by the undersigned, duly authorized, pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934.
- The report was signed by the indicated persons on behalf of the Registrant, in their capacities and on the dates indicated, pursuant to the requirements of the Securities Exchange Act of 1934.
[c. 343; p. 24]
| Skyward Specialty Insurance Group, Inc. | |
|---|---|
| Dated: March 3, 2025 | /s/ Andrew Robinson |
| — | Andrew Robinson Chairman and Chief Executive Officer |
| Signature | Title | Date |
|---|---|---|
| /s/ Andrew Robinson | Chairman and Chief Executive Officer | March 3, 2025 |
| Andrew Robinson | (Principal Executive Officer) | March 3, 2025 |
| /s/ Mark Haushill | Chief Financial Officer | March 3, 2025 |
| Mark Haushill | (Principal Financial and Accounting Officer) | March 3, 2025 |
| /s/ Gena Ashe | Director | March 3, 2025 |
| Gena Ashe | Director | March 3, 2025 |
| /s/ Robert Creager | Director | March 3, 2025 |
| Robert Creager | Director | March 3, 2025 |
| /s/ Marcia Dall | Director | March 3, 2025 |
| Marcia Dall | Director | March 3, 2025 |
| /s/ James Hays | Director | March 3, 2025 |
| James Hays | Director | March 3, 2025 |
| /s/ Anthony J. Kuczinski | Director | March 3, 2025 |
| Anthony J. Kuczinski | Director | March 3, 2025 |
| /s/ Michael Morrissey | Director | March 3, 2025 |
| Michael Morrissey | Director | March 3, 2025 |
| /s/ Katharine Terry | Director | March 3, 2025 |
| Katharine Terry | Director | March 3, 2025 |